data_2lec_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lec _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.377 0.132 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.46 -81.55 0.03 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -153.86 69.09 6.32 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 125.342 1.457 . . . . 0.0 110.346 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 118.04 5.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.087 2.525 . . . . 0.0 109.986 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.08 113.8 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.83 3.02 . . . . 0.0 110.894 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -87.83 -167.88 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.928 3.085 . . . . 0.0 109.849 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -137.59 41.71 2.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 109.511 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 17.7 m -52.7 -14.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.941 1.696 . . . . 0.0 113.693 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -88.4 5.23 43.21 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.124 0.569 . . . . 0.0 111.303 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.02 19.82 0.66 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 5.1 ptt? -139.39 166.61 24.11 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.793 0.796 . . . . 0.0 111.835 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -63.34 -26.54 68.81 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t 44.03 58.85 3.45 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.19 0.996 . . . . 0.0 112.478 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 23.4 tp -63.91 164.4 10.38 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -137.21 142.08 42.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.339 1.055 . . . . 0.0 109.986 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.39 152.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -153.37 -167.78 2.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.107 1.363 . . . . 0.0 110.542 -174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 82.9 28.29 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.69 1.596 . . . . 0.0 113.309 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.64 126.18 22.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.795 0.838 . . . . 0.0 109.303 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -68.91 168.25 14.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -62.52 3.29 0.21 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -139.14 18.5 2.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.771 0.829 . . . . 0.0 112.078 -174.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -112.38 165.56 12.09 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.895 0.478 . . . . 0.0 110.391 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 82.8 p -149.59 167.06 13.78 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.319 1.048 . . . . 0.0 109.038 -176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.4 Cg_endo -68.98 -26.75 30.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.403 2.069 . . . . 0.0 111.68 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.86 -33.78 74.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.997 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -74.9 -44.38 49.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.442 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -58.67 -20.91 52.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.8 -0.562 . . . . 0.0 111.103 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -82.02 -56.62 3.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -62.91 -24.75 67.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.684 0.22 . . . . 0.0 110.481 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.9 t -83.11 -34.96 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.715 0.406 . . . . 0.0 110.644 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CD1' HD13 ' A' ' 30' ' ' LEU . 20.2 m-85 -99.27 -10.96 21.72 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -72.71 -26.61 61.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.634 -0.666 . . . . 0.0 111.441 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.98 -22.93 64.07 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -73.28 -20.89 60.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.844 0.458 . . . . 0.0 111.267 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.05 -88.92 0.1 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -154.23 164.47 38.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.37 0.605 . . . . 0.0 111.733 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.66 133.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.29 -24.43 24.32 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -161.65 152.69 18.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.077 0.465 . . . . 0.0 110.084 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.87 103.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -150.18 161.63 42.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.101 -167.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 mt -134.35 132.21 20.89 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.33 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.11 -29.69 32.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.962 2.441 . . . . 0.0 111.325 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 36.92 30.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.257 1.823 . . . . 0.0 114.708 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 50' ' ' TYR . 7.1 m-20 51.39 12.31 0.14 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.674 0.79 . . . . 0.0 112.812 -175.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 52.53 -14.18 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.879 2.472 . . . . 0.0 116.064 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 48' ' ' ASP . 22.2 p90 -155.47 4.12 0.19 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.686 1.13 . . . . 0.0 113.271 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 -25.6 3.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.846 0.748 . . . . 0.0 112.054 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.1 21.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.962 2.105 . . . . 0.0 115.008 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.95 -11.66 59.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.772 -0.58 . . . . 0.0 112.371 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.5 t -83.56 -78.11 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.048 0.385 . . . . 0.0 110.684 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.66 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.255 2.222 . . . . 0.0 115.894 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.11 -2.64 32.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.79 -0.569 . . . . 0.0 112.559 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -155.71 169.86 23.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.124 0.57 . . . . 0.0 110.097 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.79 103.54 3.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -66.11 92.2 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.695 0.798 . . . . 0.0 108.889 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.5 t -87.27 155.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.9 ttt180 -138.31 131.84 30.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 123.148 0.28 . . . . 0.0 111.236 -172.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -115.11 170.8 8.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.657 0.265 . . . . 0.0 111.143 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -32.96 2.02 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.42 122.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.04 -54.23 49.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -33.18 70.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -85.32 -21.22 29.03 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.983 0.356 . . . . 0.0 110.542 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.85 -42.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.941 0.496 . . . . 0.0 110.22 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -73.84 -25.57 60.14 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.05 -0.407 . . . . 0.0 110.511 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.15 -47.68 34.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.232 0.469 . . . . 0.0 110.393 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -31.53 71.72 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.347 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.8 ttp -74.01 -42.75 59.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.119 0.568 . . . . 0.0 110.452 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.8 2.96 24.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.024 0.13 . . . . 0.0 111.215 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.24 -5.59 4.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttm -137.88 -29.4 0.85 Allowed 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -64.15 140.23 58.85 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.932 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 75.8 6.98 83.18 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.72 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.8 32.06 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.165 0.983 . . . . 0.0 110.784 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.575 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 23.0 t -73.99 164.61 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.846 0.858 . . . . 0.0 111.569 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.7 5.06 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.9 3.3 1.82 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.145 0.43 . . . . 0.0 112.076 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.63 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.313 0.482 . . . . 0.0 112.632 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -172.44 115.19 0.31 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.268 1.027 . . . . 0.0 109.008 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 79.6 mm-40 -130.88 -50.45 1.04 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.119 171.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -140.53 153.54 46.21 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.304 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -151.79 113.96 4.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 167.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.34 135.79 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-O 121.227 0.536 . . . . 0.0 110.445 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.5 173.05 10.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.423 1.489 . . . . 0.0 108.275 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.51 147.62 50.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.524 0.73 . . . . 0.0 111.102 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.73 150.18 29.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -141.99 21.17 2.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -145.55 143.56 30.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.15 179.36 21.02 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 117.885 0.312 . . . . 0.0 112.876 -169.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -57.64 148.81 54.95 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.018 0.527 . . . . 0.0 110.981 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.02 135.64 21.37 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.65 2.9 . . . . 0.0 111.089 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.36 -39.9 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.589 2.192 . . . . 0.0 109.379 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.04 136.33 1.46 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.486 1.115 . . . . 0.0 109.503 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--N 1.333 -0.13 0 C-N-CA 124.062 0.945 . . . . 0.0 110.287 178.347 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.777 0.322 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.31 -73.38 2.6 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -178.73 52.4 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.07 139.63 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.544 2.163 . . . . 0.0 110.595 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.93 115.37 3.28 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.657 2.905 . . . . 0.0 110.097 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.27 -166.97 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.842 3.028 . . . . 0.0 110.571 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -132.41 28.69 4.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.244 1.018 . . . . 0.0 110.463 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.5 m -53.98 -18.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 124.771 1.228 . . . . 0.0 113.425 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -77.5 4.58 10.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.341 0.656 . . . . 0.0 111.912 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 16.66 0.67 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.017 -0.879 . . . . 0.0 112.324 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.07 166.91 23.37 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 1.206 . . . . 0.0 113.38 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -61.26 -27.67 68.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -167.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.1 m 44.48 38.55 2.67 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -62.58 132.88 53.86 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.704 -0.623 . . . . 0.0 109.844 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 68.8 tttt -97.68 148.88 22.88 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.524 0.73 . . . . 0.0 112.518 -170.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -127.12 147.96 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -155.32 -176.83 6.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.479 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 51.9 t30 84.96 38.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.179 1.392 . . . . 0.0 113.4 171.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.4 138.09 57.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.846 0.859 . . . . 0.0 108.96 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 24' ' ' ARG . 6.7 m -80.4 166.16 21.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.737 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -62.88 6.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.431 1.092 . . . . 0.0 113.373 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 22' ' ' THR . 34.8 ptt180 -135.06 20.34 3.46 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.965 1.306 . . . . 0.0 111.337 -174.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -123.87 165.02 18.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.817 0.447 . . . . 0.0 110.531 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.8 p -149.4 165.5 17.49 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 124.047 0.939 . . . . 0.0 109.351 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 61.9 Cg_endo -71.15 -25.16 22.66 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.052 1.835 . . . . 0.0 111.868 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.43 -34.19 75.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 121.839 -0.538 . . . . 0.0 109.674 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.5 m -75.63 -43.28 48.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -56.19 -23.48 35.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.623 -0.673 . . . . 0.0 111.093 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -80.61 -55.63 4.71 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -61.29 -28.74 69.4 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.042 0.383 . . . . 0.0 110.645 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -80.48 -33.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 122.94 0.496 . . . . 0.0 111.542 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.427 ' CD1' HD12 ' A' ' 30' ' ' LEU . 28.7 m-85 -103.07 -9.27 19.87 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.44 -24.32 57.03 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.733 -0.604 . . . . 0.0 111.016 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.91 -22.55 63.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.249 0.477 . . . . 0.0 112.169 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.26 -17.49 61.89 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 122.342 0.257 . . . . 0.0 111.123 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.2 -76.38 0.17 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -164.14 162.49 22.86 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.547 0.739 . . . . 0.0 110.445 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -136.42 144.16 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.23 -24.48 19.16 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -162.36 149.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 117.085 0.443 . . . . 0.0 111.062 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -139.26 113.59 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -146.4 160.47 42.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.2 92.1 40.08 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.651 0.38 . . . . 0.0 110.85 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -49.14 135.06 30.6 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 124.049 3.166 . . . . 0.0 111.147 173.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -164.78 164.68 21.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 50' ' ' TYR . 65.9 m-20 -69.09 117.48 10.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -67.48 16.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -169.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 10.2 p90 -146.89 -3.05 0.6 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.692 1.197 . . . . 0.0 112.001 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.427 HG21 ' CD2' ' A' ' 50' ' ' TYR . 44.6 p -123.68 -24.72 4.45 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.72 0.691 . . . . 0.0 110.371 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptt 49.88 26.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.979 1.712 . . . . 0.0 113.119 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.66 5.88 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.9 m 58.92 -178.18 0.08 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -141.62 0.09 1.42 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.55 16.97 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.887 0.767 . . . . 0.0 113.432 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -153.91 169.63 22.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.321 1.06 . . . . 0.0 110.026 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.0 96.69 3.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -63.04 115.94 4.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -116.99 163.16 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -139.06 125.58 20.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.826 0.704 . . . . 0.0 110.587 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 21.8 m-85 -96.34 158.62 15.35 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.561 0.744 . . . . 0.0 109.936 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.478 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -114.56 -30.98 6.35 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.653 0.595 . . . . 0.0 112.348 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.77 119.39 21.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HZ1' ' HB3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -61.49 -45.13 95.51 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.341 0.257 . . . . 0.0 110.644 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.473 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -67.13 -28.96 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -90.96 -13.34 33.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.97 -42.78 25.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.473 ' HB3' ' HZ1' ' A' ' 65' ' ' LYS . 10.3 pt-20 -77.42 -25.24 50.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.614 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.33 -47.11 36.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.646 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.87 73.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.4 ttp -73.3 -42.16 62.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.781 0.432 . . . . 0.0 110.369 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.02 3.21 27.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.263 -0.273 . . . . 0.0 111.558 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.53 -6.52 4.68 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.8 ttm -139.45 -26.54 0.81 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.14 134.72 56.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.396 0.998 . . . . 0.0 110.755 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 8.67 85.68 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.128 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.41 33.4 0.35 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.19 0.995 . . . . 0.0 111.098 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.587 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 46.1 t -69.42 164.52 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.012 0.925 . . . . 0.0 112.209 -173.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.97 9.95 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.68 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -149.88 4.4 0.56 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.107 0.867 . . . . 0.0 113.249 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.55 -20.35 4.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.852 -0.53 . . . . 0.0 111.974 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.486 ' C ' HG11 ' A' ' 79' ' ' VAL . 6.2 ptp180 -175.23 143.65 0.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.112 1.765 . . . . 0.0 106.651 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.587 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.2 mm-40 -141.59 -47.62 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.643 169.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -139.92 159.29 42.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.79 0.805 . . . . 0.0 112.124 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 10.1 mmm180 -152.33 114.34 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.88 127.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -167.46 165.17 14.94 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.86 142.21 58.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.366 -172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.65 167.81 6.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.133 0.573 . . . . 0.0 111.524 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -139.39 -8.19 1.3 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 123.346 0.658 . . . . 0.0 110.993 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -140.25 173.61 11.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -116.79 175.61 15.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 117.719 0.236 . . . . 0.0 112.834 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -60.36 142.21 90.65 Favored Pre-proline 0 C--O 1.233 0.19 0 C-N-CA 123.737 0.815 . . . . 0.0 110.136 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.05 130.41 31.63 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.321 2.681 . . . . 0.0 113.403 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.66 -25.31 9.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.761 2.307 . . . . 0.0 109.324 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -159.31 161.61 35.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.127 1.371 . . . . 0.0 107.679 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.111 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 110.965 -0.013 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.77 45.42 27.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.534 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 38.94 50.39 2.63 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.161 1.384 . . . . 0.0 114.36 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.01 149.28 52.61 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.209 2.606 . . . . 0.0 110.89 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.93 123.84 8.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.254 2.636 . . . . 0.0 110.499 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -81.85 -165.98 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.813 3.009 . . . . 0.0 110.367 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.69 30.17 4.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.922 0.889 . . . . 0.0 109.691 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.7 m -57.06 -12.23 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.607 1.163 . . . . 0.0 112.646 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.83 -0.04 8.22 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.919 0.887 . . . . 0.0 112.388 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.93 32.29 0.18 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.889 -0.951 . . . . 0.0 113.472 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.454 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.1 ptt? -142.89 164.86 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.546 1.173 . . . . 0.0 111.675 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -60.63 -28.01 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -170.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m 43.24 59.25 3.03 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 16.3 tp -66.42 169.58 7.24 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 13.9 pttt -139.09 155.58 47.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.402 0.546 . . . . 0.0 111.05 171.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.2 t -134.15 145.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -150.06 -174.59 4.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.48 1.112 . . . . 0.0 109.815 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 92.52 29.88 0.01 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.221 1.409 . . . . 0.0 112.968 169.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.92 117.74 3.19 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.538 1.135 . . . . 0.0 109.802 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -67.44 171.09 6.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -62.84 3.09 0.25 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.094 0.958 . . . . 0.0 113.01 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ptt-85 -134.26 14.28 3.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.388 0.675 . . . . 0.0 111.85 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -113.34 165.51 12.36 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.489 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.3 p -150.89 167.94 11.98 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.57 1.148 . . . . 0.0 108.839 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 62.4 Cg_endo -69.52 -35.02 14.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.264 1.976 . . . . 0.0 110.721 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -61.51 -36.07 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.117 0.484 . . . . 0.0 109.886 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -71.79 -44.23 64.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.65 -23.88 19.18 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.227 -0.296 . . . . 0.0 111.585 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -78.77 -56.56 4.31 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -65.29 -20.38 66.39 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.778 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.75 -32.1 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.636 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -106.16 -7.92 17.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.982 0.513 . . . . 0.0 112.277 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.47 -26.14 55.04 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.217 0.462 . . . . 0.0 111.155 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -67.64 -23.69 65.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.223 0.465 . . . . 0.0 112.244 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.89 -17.76 61.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.667 0.387 . . . . 0.0 111.526 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.84 -82.26 0.11 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.78 163.09 37.05 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.159 0.584 . . . . 0.0 110.789 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -135.3 140.25 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.59 -21.5 21.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -161.86 155.86 21.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.703 0.752 . . . . 0.0 111.713 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -147.46 125.34 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 46' ' ' PRO . 1.6 t80 -157.48 152.66 25.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.53 71.2 52.33 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 20.4 Cg_endo -93.29 -6.45 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.616 1 C-N-CA 126.48 4.787 . . . . 0.0 117.979 -167.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -48.86 -36.43 16.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.366 1.439 . . . . 0.0 111.97 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 50' ' ' TYR . 20.5 m-20 -144.17 101.51 3.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 168.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -62.12 8.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.717 1.607 . . . . 0.0 114.908 -169.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.416 ' CD1' HG21 ' A' ' 51' ' ' THR . 18.6 p90 -150.84 6.09 0.51 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.33 1.052 . . . . 0.0 112.279 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.416 HG21 ' CD1' ' A' ' 50' ' ' TYR . 11.5 p -130.57 -29.02 2.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.866 0.757 . . . . 0.0 111.72 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 54' ' ' SER . 0.0 OUTLIER 46.93 23.87 0.31 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.466 1.506 . . . . 0.0 113.029 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.65 11.18 0.2 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 56' ' ' GLY . 49.5 m -131.92 25.47 4.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.472 0.709 . . . . 0.0 110.207 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 8.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.995 1.718 . . . . 0.0 114.831 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 54' ' ' SER . . . -60.38 -3.46 2.95 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.492 0.587 . . . . 0.0 111.768 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -152.88 168.04 27.09 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.407 1.083 . . . . 0.0 109.082 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.32 97.23 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.3 109.92 1.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.1 m -107.27 170.03 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.4 ptm180 -144.53 145.65 31.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.764 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -112.73 166.71 11.11 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.068 0.547 . . . . 0.0 109.926 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.454 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.87 -30.91 2.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.698 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.07 125.4 30.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -61.21 -54.2 47.24 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -32.14 69.29 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -86.76 -18.19 31.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.952 0.342 . . . . 0.0 110.762 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.36 -43.96 16.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 122.709 0.404 . . . . 0.0 110.147 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -73.25 -26.62 61.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.267 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -73.82 -46.47 44.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.322 0.51 . . . . 0.0 110.717 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.97 72.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.5 ttp -75.07 -40.98 59.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.105 0.562 . . . . 0.0 110.347 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.9 2.99 31.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.065 0.146 . . . . 0.0 111.279 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.83 -5.83 4.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.2 ttm -137.42 -28.95 0.9 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.1 t70 -64.51 137.86 58.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 120.161 1.346 . . . . 0.0 110.007 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.73 16.42 79.21 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.729 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.85 29.46 1.02 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.115 0.958 . . . . 0.0 110.371 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.473 HG11 ' C ' ' A' ' 83' ' ' ARG . 41.2 t -72.66 170.47 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.168 1.387 . . . . 0.0 112.486 -170.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -153.82 3.32 0.27 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -139.69 2.08 1.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.75 -20.02 4.38 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.241 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.473 ' C ' HG11 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -177.77 135.22 0.17 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.995 1.318 . . . . 0.0 108.074 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 79' ' ' VAL . 9.6 mt-10 -140.85 -37.56 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.019 171.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -144.4 149.98 36.98 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.703 0.401 . . . . 0.0 111.872 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -151.79 106.56 3.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.623 1.569 . . . . 0.0 106.879 166.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.428 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -133.87 126.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 CA-C-O 121.226 0.536 . . . . 0.0 110.495 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -156.59 175.29 14.24 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 125.67 1.588 . . . . 0.0 108.923 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.99 145.83 53.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.034 0.934 . . . . 0.0 110.389 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.44 170.34 16.3 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.966 0.506 . . . . 0.0 111.652 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -147.07 3.23 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.167 0.587 . . . . 0.0 110.985 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -131.73 175.17 9.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.314 0.646 . . . . 0.0 109.579 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.0 177.2 16.48 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 121.507 0.504 . . . . 0.0 114.176 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -62.43 160.14 35.8 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.427 1.491 . . . . 0.0 112.634 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -34.05 103.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 126.527 4.818 . . . . 0.0 116.637 178.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.526 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 75.5 Cg_endo -81.12 -60.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.91 2.406 . . . . 0.0 109.433 169.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 12.8 t0 -179.1 131.14 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.317 1.447 . . . . 0.0 109.882 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.462 0.169 0 C-N-CA 125.297 1.439 . . . . 0.0 110.008 176.322 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.24 36.16 21.71 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.985 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.89 57.25 0.94 Allowed Pre-proline 0 N--CA 1.465 0.284 0 C-N-CA 125.51 1.524 . . . . 0.0 113.146 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.52 147.73 77.41 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.23 2.62 . . . . 0.0 109.668 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 114.97 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.562 2.841 . . . . 0.0 110.649 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.47 -162.65 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.42 3.414 . . . . 0.0 110.182 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 11' ' ' GLU . 11.8 p-10 -134.51 33.06 3.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.23 0.612 . . . . 0.0 111.14 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 m -64.5 6.13 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.187 1.395 . . . . 0.0 113.373 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 9' ' ' ASP . 69.8 mm-40 -65.71 2.9 0.86 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.973 0.909 . . . . 0.0 113.194 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.9 -8.88 0.04 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.507 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -65.64 169.69 5.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.592 1.196 . . . . 0.0 111.866 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -58.67 -26.37 63.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m 43.72 37.09 1.46 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -63.75 136.03 57.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.42 155.34 46.57 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -171.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.35 158.03 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.297 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -154.78 -173.74 4.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.167 0.987 . . . . 0.0 110.777 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.549 HD22 ' HB2' ' A' ' 83' ' ' ARG . 20.3 t30 96.81 27.94 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.744 1.617 . . . . 0.0 113.077 168.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 117.58 4.37 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.494 1.117 . . . . 0.0 109.778 -175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 24' ' ' ARG . 8.3 m -70.8 166.89 20.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -62.95 10.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.964 1.306 . . . . 0.0 113.907 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' THR . 20.3 ptt180 -130.04 17.8 5.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.893 0.877 . . . . 0.0 111.618 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -126.82 170.32 12.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 94.4 p -152.7 163.74 22.56 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.253 1.021 . . . . 0.0 109.296 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.8 -28.08 25.49 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.506 2.137 . . . . 0.0 111.717 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.57 -33.03 74.2 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.95 -0.469 . . . . 0.0 109.822 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.0 m -75.51 -46.48 32.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -56.94 -19.8 20.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -55.78 5.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -62.74 -31.27 72.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.188 0.995 . . . . 0.0 110.968 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.01 -32.71 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.442 0.297 . . . . 0.0 111.619 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.427 ' CD1' HD11 ' A' ' 30' ' ' LEU . 18.0 m-85 -98.67 -11.23 22.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.977 0.353 . . . . 0.0 111.941 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.55 -27.74 62.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.689 -0.632 . . . . 0.0 111.679 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.35 -22.54 65.58 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -73.78 -18.67 60.94 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.72 0.408 . . . . 0.0 111.129 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.88 -79.37 0.1 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -158.62 165.06 35.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 110.398 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -133.88 138.7 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.98 -26.61 7.4 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -163.08 161.35 25.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.916 0.358 . . . . 0.0 110.33 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' CG2' HG22 ' A' ' 60' ' ' VAL . 1.5 p -168.73 110.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.25 176.13 13.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.543 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mt -125.2 85.87 57.63 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.13 -23.71 17.83 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.449 3.433 . . . . 0.0 113.281 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -64.01 115.77 5.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 41.58 69.22 0.37 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 110.222 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -54.6 5.55 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.045 2.138 . . . . 0.0 116.61 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -143.54 7.41 1.5 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.514 1.125 . . . . 0.0 110.81 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -124.76 -38.23 2.39 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.02 24.7 0.13 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.228 2.211 . . . . 0.0 113.142 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -65.02 -21.2 66.81 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -76.93 -49.7 14.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.573 0.349 . . . . 0.0 110.824 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 37.07 31.64 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.627 1.971 . . . . 0.0 114.783 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.34 -10.47 74.68 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.59 -0.694 . . . . 0.0 112.016 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -163.13 169.11 19.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.603 0.701 . . . . 0.0 111.084 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 102.63 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -67.92 94.78 0.49 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 59.4 t -81.35 160.74 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -143.84 134.94 25.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.043 0.537 . . . . 0.0 109.987 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -117.28 148.27 41.83 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.484 1.113 . . . . 0.0 109.836 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.582 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -99.59 -27.21 13.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -173.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.66 134.2 55.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 110.458 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.66 -45.6 93.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.745 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -33.77 76.56 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.98 0.809 . . . . 0.0 111.969 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.7 -24.71 36.03 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.68 -47.29 19.55 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.072 0.949 . . . . 0.0 110.839 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HA ' ' HE1' ' A' ' 72' ' ' MET . 8.8 pt-20 -74.09 -27.29 60.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.79 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -70.97 -40.46 71.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.278 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.39 73.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.024 -0.422 . . . . 0.0 111.333 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.456 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 6.5 ptp -78.8 -37.61 40.36 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.509 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -77.12 -0.73 25.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.23 0.612 . . . . 0.0 111.743 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.87 -4.99 4.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.7 ttm -138.02 -25.57 0.97 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.449 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.7 t70 -63.52 138.31 58.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 118.398 -1.321 . . . . 0.0 110.005 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.76 14.96 77.98 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.914 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.08 36.71 0.52 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.041 0.921 . . . . 0.0 110.257 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.553 HG23 ' H ' ' A' ' 81' ' ' ASP . 6.2 p -72.12 176.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -169.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.497 ' H ' HG23 ' A' ' 79' ' ' VAL . 1.1 pt? -151.78 -1.22 0.32 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.723 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.553 ' H ' HG23 ' A' ' 79' ' ' VAL . 37.3 t70 -144.45 -0.77 0.95 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.45 -19.09 6.0 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.549 ' HB2' HD22 ' A' ' 20' ' ' ASN . 0.1 OUTLIER -165.96 136.04 3.43 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 19.7 mm-40 -144.79 -41.82 0.24 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.89 150.29 44.41 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.834 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -152.27 108.11 3.35 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 126.121 1.769 . . . . 0.0 106.659 168.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -134.96 134.77 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.238 0.542 . . . . 0.0 111.284 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 89' ' ' MET . 31.4 tt0 -166.26 168.02 15.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.322 1.449 . . . . 0.0 108.11 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.454 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 11.6 mmt -61.28 142.31 56.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.176 0.99 . . . . 0.0 110.773 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 155.52 38.15 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.889 0.476 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -140.11 9.81 2.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.499 0.72 . . . . 0.0 109.608 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -131.43 169.18 16.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.015 0.926 . . . . 0.0 109.335 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.3 -177.64 14.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -56.02 145.0 56.57 Favored Pre-proline 0 C--O 1.233 0.194 0 C-N-CA 123.271 0.629 . . . . 0.0 110.501 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.01 145.75 56.63 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.44 2.76 . . . . 0.0 112.276 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.0 -23.39 4.58 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.451 3.434 . . . . 0.0 112.198 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -149.96 164.53 35.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.601 1.16 . . . . 0.0 108.965 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.126 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.97 92.51 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.414 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.8 ptm85 -168.91 42.87 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.527 1.163 . . . . 0.0 113.539 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 69.2 Cg_endo -68.99 136.11 34.12 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.52 1.48 . . . . 0.0 108.93 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.64 116.29 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.846 3.031 . . . . 0.0 110.98 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.61 -162.05 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.912 3.075 . . . . 0.0 110.142 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.67 30.5 2.85 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 31.2 m -63.48 -7.05 2.6 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 C-N-CA 123.881 0.872 . . . . 0.0 112.624 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.51 0.26 15.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.75 0.82 . . . . 0.0 112.812 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.25 51.43 0.13 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.252 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.459 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 11.7 ptp -132.39 173.8 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.821 0.811 . . . . 0.0 112.957 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -70.21 -22.5 62.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.173 0.989 . . . . 0.0 112.066 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 m 42.09 59.85 2.47 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.442 1.097 . . . . 0.0 113.618 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 22.5 tp -61.66 162.22 8.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 17.2 pttp -132.1 151.4 51.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.107 0.412 . . . . 0.0 110.655 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.17 143.04 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -149.31 -177.85 6.07 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 124.187 0.93 . . . . 0.0 110.413 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 t30 91.12 26.21 0.02 OUTLIER 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.158 1.383 . . . . 0.0 113.38 169.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.17 121.5 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.985 0.914 . . . . 0.0 109.682 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 24' ' ' ARG . 13.4 m -67.75 167.75 12.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -63.61 8.99 0.07 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.657 1.183 . . . . 0.0 113.471 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 22' ' ' THR . 29.6 ptt180 -133.58 16.44 3.99 Favored 'General case' 0 C--N 1.335 -0.041 0 C-N-CA 123.858 0.863 . . . . 0.0 111.818 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -124.05 165.63 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.459 0.303 . . . . 0.0 111.246 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 59.5 p -151.68 168.57 10.92 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.706 1.202 . . . . 0.0 109.256 -175.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 56.7 Cg_endo -68.94 -27.57 30.31 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.319 2.013 . . . . 0.0 111.713 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.85 -30.62 68.15 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.482 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 97.0 m -75.1 -45.08 43.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.415 HD12 ' CD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -59.02 -19.14 40.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.905 -0.497 . . . . 0.0 110.935 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -81.48 -56.63 3.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.385 0.539 . . . . 0.0 110.604 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.482 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -69.91 -15.46 63.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.276 -175.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.84 -30.93 4.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 123.419 0.688 . . . . 0.0 111.363 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.415 ' CD1' HD12 ' A' ' 30' ' ' LEU . 21.1 m-85 -103.12 -9.94 19.27 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.438 0.563 . . . . 0.0 112.288 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.97 -26.43 62.26 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.751 -0.593 . . . . 0.0 111.187 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.78 -24.14 64.38 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.68 -17.01 61.68 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.47 -80.43 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -162.53 167.24 23.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.023 0.529 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -133.09 138.95 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.19 -25.27 14.56 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -162.74 154.19 17.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.883 0.473 . . . . 0.0 110.17 174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.33 107.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -151.36 162.25 41.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.513 -166.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.76 126.43 15.74 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.48 42.46 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.702 3.601 . . . . 0.0 110.413 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -44.42 -44.8 8.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.928 1.291 . . . . 0.0 111.561 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -178.34 165.02 1.78 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.36 1.464 . . . . 0.0 108.898 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.79 -5.66 2.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.633 169.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -168.3 14.93 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.564 1.146 . . . . 0.0 111.717 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 p -129.45 -14.58 4.18 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -168.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 43.14 24.1 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.608 1.563 . . . . 0.0 113.772 -172.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.436 ' HB3' ' H ' ' A' ' 54' ' ' SER . 97.0 mt-10 -77.63 -155.95 0.08 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.081 0.952 . . . . 0.0 110.358 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.436 ' H ' ' HB3' ' A' ' 53' ' ' GLU . 29.0 m -156.09 169.59 24.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.224 1.41 . . . . 0.0 109.615 175.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -130.03 -172.42 2.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.932 0.893 . . . . 0.0 108.897 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.57 29.61 5.83 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.264 0.935 . . . . 0.0 112.406 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -153.63 170.95 19.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.479 0.712 . . . . 0.0 109.576 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.89 101.78 3.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -67.22 91.74 0.25 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.444 0.698 . . . . 0.0 109.387 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 48.6 t -81.53 159.35 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 172.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.1 ttt180 -140.24 131.74 27.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.688 0.395 . . . . 0.0 110.421 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -113.58 157.92 21.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.057 0.39 . . . . 0.0 111.647 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.458 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -113.18 -34.6 5.62 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.1 128.05 33.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -64.56 -50.53 66.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.396 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -29.54 68.81 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.55 -20.72 31.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.5 49.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 9.1 pt-20 -77.36 -19.99 55.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.493 -0.13 . . . . 0.0 111.271 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.78 -41.58 44.09 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.199 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.4 75.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.161 -0.337 . . . . 0.0 111.395 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.401 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 11.0 ptp -75.52 -41.33 55.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.766 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -75.51 1.29 14.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.572 0.749 . . . . 0.0 111.705 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -5.96 3.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.3 ttm -141.23 -25.82 0.72 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.57 137.97 58.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.708 1.14 . . . . 0.0 111.101 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.92 9.18 75.2 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.373 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.42 29.34 0.51 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 84' ' ' GLU . 4.9 m -66.48 175.29 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 126.345 1.858 . . . . 0.0 113.847 -172.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.93 -1.3 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -143.49 4.3 1.36 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.433 0.56 . . . . 0.0 112.08 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.92 -27.4 3.33 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.415 ' HA ' HG12 ' A' ' 79' ' ' VAL . 6.3 ptp180 -157.36 160.08 38.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.178 0.489 . . . . 0.0 110.027 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.499 ' N ' HG13 ' A' ' 79' ' ' VAL . 16.4 mt-10 -160.62 -43.91 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.628 1.171 . . . . 0.0 109.68 165.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.47 153.84 47.61 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -153.76 107.21 2.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.256 1.822 . . . . 0.0 106.183 166.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 p -134.23 127.83 51.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 123.029 0.532 . . . . 0.0 110.134 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -156.74 -175.01 5.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.489 1.916 . . . . 0.0 108.112 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.2 mmt -82.84 142.27 31.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.13 155.66 40.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.374 0.269 . . . . 0.0 111.249 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -137.93 9.17 2.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.416 1.087 . . . . 0.0 110.488 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.2 175.63 8.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 109.678 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.68 175.78 17.82 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 117.943 0.338 . . . . 0.0 113.054 -173.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -61.73 156.41 55.33 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.109 0.964 . . . . 0.0 111.399 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -27.49 95.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 1 C-N-CA 126.413 4.742 . . . . 0.0 117.292 -176.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.72 -26.07 1.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.56 2.84 . . . . 0.0 110.083 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -158.13 -177.63 6.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.772 1.629 . . . . 0.0 107.273 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.389 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.86 -80.22 1.84 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 170.87 68.6 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.573 1.149 . . . . 0.0 111.5 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.15 167.23 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.397 2.731 . . . . 0.0 111.216 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -98.15 71.83 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.637 1 C-N-CA 125.491 4.127 . . . . 0.0 112.945 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.72 -166.32 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.984 3.123 . . . . 0.0 110.294 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -131.57 34.16 3.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.442 0.697 . . . . 0.0 109.819 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.31 -11.98 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.021 0.928 . . . . 0.0 112.04 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.71 -6.57 47.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.774 0.83 . . . . 0.0 111.909 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.79 -8.16 0.07 OUTLIER Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.546 -0.585 . . . . 0.0 114.053 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.8 mtp -60.68 162.25 6.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.569 1.185 . . . . 0.0 111.013 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -60.34 -23.72 64.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.336 0.254 . . . . 0.0 110.659 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 t 42.92 55.36 4.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.536 1.134 . . . . 0.0 112.859 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 19.3 tp -61.39 159.04 13.3 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -143.98 140.4 29.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.517 0.599 . . . . 0.0 110.75 175.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.511 ' CG1' ' HB ' ' A' ' 60' ' ' VAL . 4.9 p -134.12 149.89 30.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 123.002 0.521 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -151.41 -170.12 3.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.902 1.281 . . . . 0.0 109.868 -176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 t30 87.73 26.76 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.918 1.287 . . . . 0.0 112.125 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.21 127.39 21.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.534 1.134 . . . . 0.0 109.412 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 m -76.22 169.54 18.02 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.295 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -63.13 5.74 0.14 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.921 1.288 . . . . 0.0 114.009 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -133.53 14.25 4.09 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.693 0.679 . . . . 0.0 112.013 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -114.87 165.82 12.43 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.92 0.391 . . . . 0.0 110.919 -173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.502 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 86.7 p -150.42 167.16 13.54 Favored Pre-proline 0 CA--C 1.529 0.139 0 C-N-CA 124.219 1.008 . . . . 0.0 109.63 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.2 Cg_endo -69.78 -34.25 14.9 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.684 2.256 . . . . 0.0 110.274 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.21 -36.17 83.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -72.78 -43.95 62.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -57.12 -21.56 33.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.272 -0.267 . . . . 0.0 110.833 -178.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -80.42 -56.66 4.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -7.97 41.74 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -97.67 -31.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.776 0.43 . . . . 0.0 111.644 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CD1' HD12 ' A' ' 30' ' ' LEU . 21.5 m-85 -101.11 -12.1 19.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.507 0.594 . . . . 0.0 111.874 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.84 -24.17 59.73 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.901 -0.499 . . . . 0.0 111.242 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.61 -23.73 64.49 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.786 -0.571 . . . . 0.0 112.077 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -75.27 -17.64 60.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.468 0.307 . . . . 0.0 111.391 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.53 -85.83 0.09 OUTLIER Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -157.32 162.4 39.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.067 0.547 . . . . 0.0 110.342 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.9 t -134.43 142.05 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -75.92 -46.82 12.71 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.18 171.85 4.0 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.318 0.58 . . . . 0.0 110.661 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.4 m -124.97 143.62 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -152.18 150.71 30.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.742 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mt -139.59 76.01 30.94 Favored Pre-proline 0 CA--C 1.528 0.131 0 C-N-CA 123.317 0.647 . . . . 0.0 109.946 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 95.4 Cg_endo -77.25 178.21 7.92 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 124.529 3.486 . . . . 0.0 111.798 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 46' ' ' PRO . 28.7 tpt180 129.52 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 129.175 2.99 . . . . 0.0 108.281 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 50' ' ' TYR . 20.2 m-20 -147.58 87.42 1.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 174.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -63.96 14.3 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.54 1.536 . . . . 0.0 114.862 -170.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 48' ' ' ASP . 11.5 p90 -145.25 5.14 1.09 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.295 1.438 . . . . 0.0 110.822 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 50' ' ' TYR . 7.0 p -133.38 -33.71 1.1 Allowed 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.135 -0.353 . . . . 0.0 111.154 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 34.29 33.49 0.01 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.956 2.102 . . . . 0.0 113.553 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -6.59 45.73 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.9 t -67.42 162.94 21.94 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.225 0.466 . . . . 0.0 110.849 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -155.26 7.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.3 -12.59 81.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.29 169.46 23.14 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.682 0.793 . . . . 0.0 109.796 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.23 95.65 1.73 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -62.8 97.19 0.1 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 37.8 t -99.66 152.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 6.9 ptm180 -137.03 143.76 42.88 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -113.64 160.5 18.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.479 0.712 . . . . 0.0 111.472 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.461 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -110.79 -36.1 5.79 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.71 133.64 34.79 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -66.54 -54.67 21.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.131 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.407 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -59.36 -34.22 72.12 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -83.11 -20.0 35.67 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.151 0.432 . . . . 0.0 110.872 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.99 -44.99 15.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 122.632 0.373 . . . . 0.0 110.162 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.97 -26.37 64.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.237 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.17 -47.49 43.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.068 0.394 . . . . 0.0 111.171 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.06 -31.75 72.96 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 122.004 -0.435 . . . . 0.0 110.499 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttp -74.32 -43.71 55.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.053 0.541 . . . . 0.0 110.423 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -79.73 1.9 24.8 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.91 -5.25 5.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.7 ttm -136.41 -28.69 1.0 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 4.6 t70 -63.89 136.2 57.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.852 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 74.68 10.69 83.18 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.779 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.17 34.58 0.47 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.945 0.872 . . . . 0.0 109.903 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.566 HG23 ' H ' ' A' ' 81' ' ' ASP . 8.8 p -73.83 174.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.413 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 1.2 pt? -151.98 3.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.703 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.566 ' H ' HG23 ' A' ' 79' ' ' VAL . 36.3 t70 -142.83 -3.5 0.99 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 79' ' ' VAL . . . 110.35 -10.5 30.99 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.62 129.02 4.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.139 0.975 . . . . 0.0 108.643 173.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 11.3 mm-40 -144.42 -50.25 0.28 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 170.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -138.69 152.98 48.49 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 122.828 0.451 . . . . 0.0 111.666 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -150.38 103.09 3.11 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 166.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 4.3 p -131.47 132.99 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.944 0.402 . . . . 0.0 111.145 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -153.21 176.28 12.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.911 1.284 . . . . 0.0 109.595 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.8 mmt -76.7 133.9 39.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.5 0.72 . . . . 0.0 109.069 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.63 149.94 47.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.723 0.297 . . . . 0.0 110.773 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -139.31 18.28 2.58 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.287 1.035 . . . . 0.0 108.917 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -145.33 144.71 30.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -119.79 174.85 15.67 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.739 0.699 . . . . 0.0 114.431 -168.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -61.2 139.53 94.48 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.804 1.242 . . . . 0.0 109.969 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.82 146.78 54.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.848 3.032 . . . . 0.0 112.937 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.81 -24.36 3.42 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.232 3.288 . . . . 0.0 111.545 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -152.36 160.67 43.28 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.526 1.131 . . . . 0.0 109.1 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 p . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.815 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.584 0.23 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.06 -81.94 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 125.268 1.413 . . . . 0.0 109.677 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -152.8 55.98 1.61 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 111.502 -167.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.81 118.42 5.59 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.551 2.167 . . . . 0.0 111.356 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.32 119.08 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.562 2.842 . . . . 0.0 110.883 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -84.38 -166.59 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.16 3.24 . . . . 0.0 110.501 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 11' ' ' GLU . 21.2 m-20 -134.92 36.86 3.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.181 0.992 . . . . 0.0 110.017 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.33 11.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.638 1.575 . . . . 0.0 114.337 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 9' ' ' ASP . 47.4 mt-10 -63.96 0.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.24 -177.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -5.14 0.09 OUTLIER Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.168 0.44 . . . . 0.0 113.363 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 7.5 ptt? -62.6 166.74 5.0 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.168 0.984 . . . . 0.0 112.718 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -59.15 -26.59 64.88 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.5 m 42.17 59.19 2.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.204 1.001 . . . . 0.0 113.512 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 22.1 tp -62.72 164.35 7.92 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.0 ttpp -135.72 145.08 46.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.043 0.937 . . . . 0.0 110.74 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.31 148.69 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.792 0.837 . . . . 0.0 108.952 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -152.26 -169.32 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.7 1.6 . . . . 0.0 110.138 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 83.93 27.37 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.403 1.481 . . . . 0.0 113.51 170.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.2 119.33 4.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.149 0.98 . . . . 0.0 109.93 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 m -70.71 169.87 13.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -62.53 5.22 0.12 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 113.741 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -130.71 14.29 5.38 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.313 0.645 . . . . 0.0 112.018 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -120.24 164.91 15.54 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.088 -173.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 97.5 p -149.08 168.01 11.86 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 124.283 1.033 . . . . 0.0 109.38 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.06 -29.66 22.07 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.627 2.218 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.32 -35.0 78.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.6 m -74.1 -44.74 52.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -56.75 -20.78 23.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.248 -0.282 . . . . 0.0 110.855 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -79.46 -57.34 3.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -14.44 63.0 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.76 -32.25 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.394 0.678 . . . . 0.0 111.502 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.411 ' CD1' HD11 ' A' ' 30' ' ' LEU . 23.0 m-85 -103.38 -9.49 19.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.3 -27.45 63.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.241 0.473 . . . . 0.0 110.908 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -68.45 -23.52 64.61 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.97 -16.89 61.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.187 0.195 . . . . 0.0 111.504 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.12 -80.73 0.13 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -160.29 164.84 32.29 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.992 0.517 . . . . 0.0 110.52 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.32 144.81 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -175.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.64 -21.45 7.88 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.38 157.81 28.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.472 0.636 . . . . 0.0 110.095 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -169.15 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.138 0.975 . . . . 0.0 108.414 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.14 167.54 28.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.5 mm -98.07 103.52 17.95 Favored Pre-proline 0 N--CA 1.456 -0.141 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.82 -46.28 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.549 2.166 . . . . 0.0 111.478 -171.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.39 -178.83 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.79 2.436 . . . . 0.0 116.392 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.97 106.84 8.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -54.22 0.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.39 2.276 . . . . 0.0 114.697 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' CD2' HG23 ' A' ' 51' ' ' THR . 40.6 p90 -137.71 0.57 2.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.835 0.743 . . . . 0.0 112.309 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.4 HG23 ' CD2' ' A' ' 50' ' ' TYR . 28.7 p -127.05 -19.51 4.37 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.677 0.672 . . . . 0.0 111.216 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.404 1.881 . . . . 0.0 113.983 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -125.7 7.2 7.49 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -72.49 -6.73 45.83 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -40.24 141.71 0.46 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.773 1.629 . . . . 0.0 112.426 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.14 -3.56 0.91 Allowed Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.933 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -155.03 166.92 32.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.898 0.879 . . . . 0.0 109.573 174.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 106.76 4.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -70.21 110.85 5.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -113.04 164.68 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.3 ttt180 -142.87 139.74 30.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -116.92 164.97 13.89 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.564 0.54 . . . . 0.0 110.717 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.445 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -123.48 -31.57 3.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.232 0.613 . . . . 0.0 112.462 -177.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.54 125.32 30.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.1 -52.32 64.36 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -33.61 72.36 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -84.02 -19.73 33.98 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.53 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.04 -42.86 18.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.437 ' HA ' ' HE2' ' A' ' 72' ' ' MET . 8.6 pt-20 -71.89 -26.59 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.816 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.11 -40.33 62.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.313 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -33.41 75.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.232 -0.292 . . . . 0.0 111.592 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 69' ' ' GLU . 5.0 ptp -78.06 -37.48 46.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.08 1.74 23.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.141 0.576 . . . . 0.0 111.807 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.33 -6.86 4.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.0 ttm -138.89 -26.71 0.85 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.93 136.16 55.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.229 0.922 . . . . 0.0 110.181 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 77.97 9.9 86.61 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.162 177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.67 32.61 0.42 Allowed 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.309 1.055 . . . . 0.0 110.263 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.518 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 38.7 t -74.62 164.49 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.367 1.067 . . . . 0.0 112.094 -170.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -154.96 10.53 0.34 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.472 0.709 . . . . 0.0 112.217 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.35 5.09 2.24 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.87 0.468 . . . . 0.0 111.507 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.54 -9.84 57.44 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.442 ' C ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.93 124.92 0.55 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.694 1.198 . . . . 0.0 108.131 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.518 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 29.3 mm-40 -137.97 -48.89 0.56 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.249 0.22 . . . . 0.0 110.451 169.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -136.78 156.44 48.51 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 121.419 0.628 . . . . 0.0 112.296 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -148.05 109.08 4.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.955 1.702 . . . . 0.0 106.577 167.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.22 134.23 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -169.58 173.86 6.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.0 mmt -75.64 136.61 40.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.166 0.586 . . . . 0.0 109.909 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.49 151.58 45.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -140.52 21.4 2.37 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.662 0.785 . . . . 0.0 109.597 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -143.88 158.0 43.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.31 178.38 17.73 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.894 0.717 . . . . 0.0 114.894 -168.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.415 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 55.7 mtp180 -62.54 161.66 25.51 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 125.312 1.445 . . . . 0.0 111.034 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 94' ' ' ARG . 13.5 Cg_exo -28.92 96.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 1 C-N-CA 126.001 4.468 . . . . 0.0 114.952 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.448 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 72.0 Cg_endo -76.47 -57.29 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.706 2.271 . . . . 0.0 110.504 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.448 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 27.5 t70 -168.33 21.12 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.199 0.599 . . . . 0.0 111.712 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 C--N 1.33 -0.247 0 C-N-CA 124.008 0.923 . . . . 0.0 112.842 -175.332 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 5' ' ' ARG . 96.8 m-85 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.427 0.156 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.36 -32.06 0.16 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.71 2.1 . . . . 0.0 114.609 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 3' ' ' TYR 0.25 11.8 ptm85 146.06 65.63 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 128.879 2.872 . . . . 0.0 109.643 176.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -58.84 116.61 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.78 2.987 . . . . 0.0 111.324 -168.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -100.98 74.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.962 1 C-N-CA 125.981 4.454 . . . . 0.0 113.758 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 10' ' ' VAL . 67.8 Cg_endo -67.99 -162.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.802 2.334 . . . . 0.0 109.803 170.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -66.05 32.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.744 1.218 . . . . 0.0 113.805 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.443 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 10.5 m -56.68 -9.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.64 -12.83 61.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.888 0.475 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.29 15.15 0.03 OUTLIER Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.188 -0.784 . . . . 0.0 113.802 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 12.8 ptp -65.69 176.5 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.662 1.231 . . . . 0.0 112.263 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -70.08 -24.91 63.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.321 0.648 . . . . 0.0 112.323 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m 46.6 36.86 3.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.492 1.117 . . . . 0.0 113.868 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.87 132.84 49.62 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 17.7 pttt -117.04 161.02 20.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -130.51 147.83 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -151.59 -175.83 5.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.297 1.439 . . . . 0.0 110.34 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 t30 86.44 37.73 0.02 OUTLIER 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 113.455 169.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.43 163.55 10.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 24' ' ' ARG . 20.0 m -116.61 169.53 9.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.611 0.765 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -61.63 4.11 0.11 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.336 1.054 . . . . 0.0 113.438 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.0 ptm180 -136.03 19.11 3.22 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.398 1.079 . . . . 0.0 110.991 -175.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -124.17 167.38 14.34 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.246 0.618 . . . . 0.0 110.276 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.3 p -152.29 165.78 16.76 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.605 0.762 . . . . 0.0 109.754 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.4 Cg_endo -69.58 -27.65 27.07 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.811 2.34 . . . . 0.0 110.03 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -68.13 -37.71 81.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -72.76 -43.53 62.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.93 -19.74 32.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.337 -0.227 . . . . 0.0 111.031 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.64 -55.81 4.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -7.51 37.88 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.194 0.452 . . . . 0.0 112.009 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.21 -31.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.317 0.647 . . . . 0.0 111.113 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CD1' HD11 ' A' ' 30' ' ' LEU . 22.5 m-85 -102.84 -11.26 18.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.98 -24.99 60.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 121.914 -0.491 . . . . 0.0 110.921 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -68.65 -24.04 64.49 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -72.84 -19.51 61.3 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 122.611 0.364 . . . . 0.0 111.52 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.48 -82.99 0.1 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -158.18 164.58 36.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.928 0.491 . . . . 0.0 110.979 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.5 t -135.29 138.58 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.92 -24.0 18.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -163.26 156.08 18.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.915 0.358 . . . . 0.0 110.453 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -153.13 112.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -148.97 159.14 44.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -165.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -121.68 93.48 48.67 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 124.353 1.061 . . . . 0.0 108.938 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.65 33.23 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.599 3.532 . . . . 0.0 112.505 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -65.38 164.02 14.51 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.66 111.0 1.11 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.39 9.11 1.11 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.412 ' CD1' HG23 ' A' ' 51' ' ' THR . 12.0 p90 -144.85 -0.96 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 111.823 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.412 HG23 ' CD1' ' A' ' 50' ' ' TYR . 13.1 p -124.25 -8.04 7.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.381 0.537 . . . . 0.0 110.271 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.87 20.34 0.34 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.215 2.206 . . . . 0.0 113.173 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.7 102.36 0.74 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -57.06 166.57 1.02 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.427 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.34 -4.07 4.34 Favored 'General case' 0 N--CA 1.46 0.075 0 C-N-CA 123.87 0.868 . . . . 0.0 110.732 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.18 68.74 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.192 -0.782 . . . . 0.0 113.144 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.98 172.11 17.98 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.942 1.371 . . . . 0.0 111.746 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 92.71 2.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.472 1.109 . . . . 0.0 108.394 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -62.88 110.8 1.88 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -107.81 167.42 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -140.21 145.08 36.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.58 146.71 47.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.822 0.849 . . . . 0.0 110.694 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.617 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -99.51 -32.63 11.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.812 -177.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.92 127.07 33.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.762 0.425 . . . . 0.0 110.426 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.45 -51.73 58.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -33.69 72.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.61 -21.17 30.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.97 0.35 . . . . 0.0 110.341 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.39 -46.98 18.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.391 0.677 . . . . 0.0 110.225 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.52 -17.51 59.22 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.208 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.6 -40.02 35.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.095 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.38 75.5 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.141 -0.349 . . . . 0.0 111.293 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.2 ptp -74.68 -42.82 57.74 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.362 0.601 . . . . 0.0 109.682 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.99 1.25 13.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.805 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.37 -10.02 4.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.6 ttp -146.84 -17.63 0.41 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -61.84 136.94 58.18 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.715 1.143 . . . . 0.0 110.273 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.07 8.87 65.69 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.611 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.05 29.71 0.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.483 1.141 . . . . 0.0 112.039 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 84' ' ' GLU . 3.9 m -65.61 175.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.418 1.887 . . . . 0.0 114.127 -172.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 0.47 0.82 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -142.31 3.9 1.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.986 0.812 . . . . 0.0 111.992 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.4 -27.42 3.4 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' HA ' HG12 ' A' ' 79' ' ' VAL . 11.4 ptp180 -158.71 160.48 36.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 21.1 mt-10 -160.12 -44.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.702 1.201 . . . . 0.0 110.095 166.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -141.78 151.94 43.3 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.231 0.612 . . . . 0.0 112.217 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -153.49 114.13 4.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 165.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.4 p -139.38 116.82 11.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.499 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -151.53 164.92 35.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.081 1.352 . . . . 0.0 108.489 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.6 mmt -61.82 142.64 57.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.345 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.11 169.8 14.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.638 0.775 . . . . 0.0 110.76 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -142.65 2.98 1.44 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.196 0.598 . . . . 0.0 110.558 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -133.79 166.84 21.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.23 179.28 17.38 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -61.17 145.29 90.16 Favored Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 122.506 0.322 . . . . 0.0 110.776 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.31 150.63 17.48 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.539 2.826 . . . . 0.0 111.834 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.19 -42.44 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.132 2.555 . . . . 0.0 111.025 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.42 148.34 2.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.256 1.022 . . . . 0.0 110.017 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 173.054 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.82 0.343 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 47.56 59.7 5.79 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.566 1.555 . . . . 0.0 113.51 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 39.34 62.53 5.04 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 126.378 1.871 . . . . 0.0 112.668 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.46 155.66 24.84 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.714 2.943 . . . . 0.0 109.645 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.61 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.416 2.744 . . . . 0.0 109.247 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -83.92 -172.35 1.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.837 3.025 . . . . 0.0 111.93 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -133.35 23.77 4.1 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.075 1.35 . . . . 0.0 108.535 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.23 -2.26 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 125.555 1.542 . . . . 0.0 112.858 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.55 9.47 1.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.066 0.946 . . . . 0.0 112.209 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.43 40.0 0.33 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.643 -0.532 . . . . 0.0 112.634 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.3 ptp -135.25 175.11 9.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.927 0.863 . . . . 0.0 112.293 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -71.1 -23.3 62.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.171 0.588 . . . . 0.0 112.405 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.7 m 43.56 57.08 4.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.86 0.864 . . . . 0.0 113.296 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 17.5 tp -65.11 166.3 9.8 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 20.0 pttp -138.28 154.94 49.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.838 170.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.1 t -130.88 143.09 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -148.92 -175.5 4.97 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.928 0.891 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 41.6 t30 83.82 37.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.76 1.224 . . . . 0.0 113.673 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 158.83 11.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.867 0.867 . . . . 0.0 108.958 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 24' ' ' ARG . 6.8 m -118.78 171.54 8.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.639 0.775 . . . . 0.0 109.959 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -63.52 7.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.829 1.252 . . . . 0.0 112.969 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 22' ' ' THR . 8.3 ptm180 -132.17 17.78 4.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.039 1.336 . . . . 0.0 110.401 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.52 167.37 19.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.015 0.526 . . . . 0.0 110.72 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.417 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 95.5 p -154.71 164.05 22.27 Favored Pre-proline 0 N--CA 1.464 0.254 0 C-N-CA 123.994 0.918 . . . . 0.0 109.127 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 49.5 Cg_endo -68.29 -30.16 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.064 1.842 . . . . 0.0 111.701 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.34 -33.88 73.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.09 -44.56 65.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -57.78 -21.3 41.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.145 -0.347 . . . . 0.0 111.222 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -81.28 -57.01 3.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.027 -0.42 . . . . 0.0 109.895 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -9.16 42.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.903 0.481 . . . . 0.0 111.854 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.91 -31.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.214 0.606 . . . . 0.0 111.807 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.411 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.5 m-85 -100.44 -11.45 20.18 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.397 0.544 . . . . 0.0 111.907 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.828 -0.545 . . . . 0.0 111.429 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.37 -23.23 63.72 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -71.04 -31.01 67.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.499 0.32 . . . . 0.0 110.48 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.76 -76.48 0.07 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -162.37 165.71 26.1 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 117.198 0.499 . . . . 0.0 110.577 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.5 t -137.53 138.05 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -71.98 -45.08 43.8 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.99 171.65 6.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.129 0.49 . . . . 0.0 110.265 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.36 128.57 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.979 0.911 . . . . 0.0 109.68 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.58 175.9 10.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.528 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.416 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 8.8 mt -116.6 88.26 23.94 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 124.049 0.94 . . . . 0.0 109.367 -172.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.49 150.92 52.52 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.838 3.025 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -179.16 -178.81 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.034 0.934 . . . . 0.0 108.565 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 50' ' ' TYR . 15.7 m-20 -58.01 109.18 0.69 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -67.58 19.14 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.581 1.552 . . . . 0.0 115.125 -168.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.423 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 5.7 p90 -149.89 -19.24 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.061 0.944 . . . . 0.0 111.991 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.8 p -103.75 -25.27 13.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.662 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.2 31.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.609 1.963 . . . . 0.0 113.966 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.24 -15.73 62.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.084 0.554 . . . . 0.0 112.292 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -97.12 155.74 16.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 111.359 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -171.63 16.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.399 1.079 . . . . 0.0 111.221 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.71 2.03 75.39 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.34 -0.85 . . . . 0.0 113.229 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.21 169.08 24.92 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.038 0.919 . . . . 0.0 110.219 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.67 92.35 2.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.27 110.58 1.68 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -105.6 163.76 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.8 ptm180 -139.06 142.58 38.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.756 0.66 . . . . 0.0 110.678 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -116.57 150.87 37.3 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.799 0.687 . . . . 0.0 111.557 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.565 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -95.83 -50.56 4.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 123.986 0.804 . . . . 0.0 112.008 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.67 135.17 49.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.947 0.499 . . . . 0.0 110.857 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.435 ' HZ1' ' HB3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -69.06 -52.38 29.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 178.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.412 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.68 -31.9 73.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -77.36 -26.34 51.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.871 0.367 . . . . 0.0 110.086 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.48 -40.91 34.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 122.031 -0.418 . . . . 0.0 110.512 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.442 ' HA ' ' HE2' ' A' ' 72' ' ' MET . 9.1 pt-20 -75.71 -22.3 56.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.87 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.87 -40.06 48.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.948 0.794 . . . . 0.0 109.937 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.89 74.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.323 -0.236 . . . . 0.0 111.464 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.442 ' HE2' ' HA ' ' A' ' 69' ' ' GLU . 6.7 ptp -77.42 -39.69 46.1 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.322 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.63 0.64 19.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.133 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.72 -6.28 4.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.1 ttm -139.15 -24.0 0.89 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.64 135.89 57.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.151 0.887 . . . . 0.0 110.099 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.39 10.19 78.62 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.093 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.1 35.01 0.42 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.015 0.908 . . . . 0.0 110.797 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 81' ' ' ASP . 10.0 p -69.09 174.78 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.484 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 1.2 pt? -152.73 -0.12 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.648 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.513 ' H ' HG23 ' A' ' 79' ' ' VAL . 32.5 t70 -145.37 0.02 0.88 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.414 ' H ' HG23 ' A' ' 79' ' ' VAL . . . 127.06 -18.61 6.17 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.48 ' C ' HG21 ' A' ' 79' ' ' VAL . 6.9 ptp180 -161.49 142.04 10.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 171.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 23.3 mm-40 -147.12 -50.38 0.19 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -139.61 151.3 45.9 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 11.0 mmm180 -147.79 109.73 4.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 105.804 167.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.82 134.64 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.116 0.567 . . . . 0.0 109.96 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.423 ' HG2' ' H ' ' A' ' 89' ' ' MET . 36.6 tt0 -169.9 177.67 4.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.423 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 14.1 mmt -73.95 144.83 45.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.841 0.456 . . . . 0.0 109.786 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.78 163.93 15.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.467 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -133.73 -1.29 3.08 Favored 'General case' 0 C--O 1.23 0.051 0 C-N-CA 122.517 0.327 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.58 169.92 15.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.99 179.08 16.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.49 120.17 29.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.84 139.3 47.25 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.493 2.128 . . . . 0.0 111.659 -171.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.43 -17.99 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.492 3.461 . . . . 0.0 112.217 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -140.08 -169.2 2.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.46 1.104 . . . . 0.0 109.592 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p . . . . . 0 N--CA 1.46 0.065 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -174.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.634 0.254 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.09 59.28 0.47 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 45.47 46.98 3.46 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 127.331 2.252 . . . . 0.0 115.753 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.35 154.88 41.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.538 2.159 . . . . 0.0 108.508 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.54 112.87 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.395 2.73 . . . . 0.0 109.994 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -84.39 -165.68 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.355 2.703 . . . . 0.0 110.678 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -133.26 24.55 4.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.855 0.862 . . . . 0.0 109.607 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.72 -5.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 124.356 1.062 . . . . 0.0 112.553 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 6.8 2.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.38 41.07 0.41 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.557 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.43 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . 9.1 ptp -134.43 172.9 12.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.948 0.874 . . . . 0.0 112.593 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -69.21 -23.72 63.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.593 0.757 . . . . 0.0 112.73 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 m 44.84 36.57 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.579 1.151 . . . . 0.0 113.904 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -60.67 133.16 55.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 20.7 ttpp -106.6 147.18 29.78 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.889 0.875 . . . . 0.0 112.052 -171.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.81 154.64 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.932 171.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -154.2 -171.61 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.265 1.426 . . . . 0.0 110.593 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 93.8 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.615 1.966 . . . . 0.0 113.339 169.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 127.94 31.32 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.433 1.093 . . . . 0.0 109.461 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 24' ' ' ARG . 9.5 m -77.09 168.53 19.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.905 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -63.92 6.11 0.19 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.038 . . . . 0.0 112.669 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 22' ' ' THR . 32.7 ptt180 -137.52 19.4 2.91 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.591 1.156 . . . . 0.0 111.218 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -119.18 166.11 13.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.055 0.542 . . . . 0.0 110.431 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 92.7 p -150.71 164.85 18.91 Favored Pre-proline 0 CA--C 1.529 0.141 0 C-N-CA 124.243 1.017 . . . . 0.0 109.397 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.98 -23.75 29.42 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.473 2.115 . . . . 0.0 110.915 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.87 -35.13 72.23 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -76.18 -43.25 43.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -21.74 32.59 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.974 -0.454 . . . . 0.0 110.892 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.49 -56.13 4.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.92 -30.38 69.01 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.085 0.402 . . . . 0.0 110.334 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -78.5 -34.76 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.977 0.511 . . . . 0.0 111.004 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -99.1 -11.34 21.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -74.19 -24.48 59.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.542 0.61 . . . . 0.0 110.778 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -67.68 -24.99 65.48 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -74.56 -19.48 60.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.486 -0.293 . . . . 0.0 111.697 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.29 -80.76 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.476 -0.392 . . . . 0.0 112.173 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.12 166.15 33.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.7 t -137.1 137.36 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -80.49 -45.07 8.18 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -156.72 155.42 31.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.147 0.979 . . . . 0.0 108.444 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.01 117.15 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 175.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -147.99 164.01 35.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.681 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -134.45 92.57 20.23 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -48.36 142.39 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.125 3.217 . . . . 0.0 111.735 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -159.06 160.18 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.981 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 50' ' ' TYR . 2.1 m-20 -67.44 121.84 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.97 17.56 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 48' ' ' ASP . 10.1 p90 -150.94 -5.15 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.275 1.03 . . . . 0.0 112.387 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.413 HG21 ' CD2' ' A' ' 50' ' ' TYR . 35.3 p -119.52 -19.45 8.15 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.054 0.843 . . . . 0.0 110.333 171.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.46 24.58 1.63 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.069 1.748 . . . . 0.0 113.768 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.02 -164.19 0.13 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.236 0.615 . . . . 0.0 110.158 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -137.52 169.73 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.406 0.682 . . . . 0.0 110.836 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -138.18 7.62 2.66 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.344 0.658 . . . . 0.0 112.392 -172.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.77 20.8 35.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.578 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -152.41 165.41 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.57 1.185 . . . . 0.0 111.033 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.89 3.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.81 100.35 0.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 84.5 t -92.16 154.22 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -132.13 140.22 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.8 m-85 -119.92 143.66 47.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.193 0.597 . . . . 0.0 110.35 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.644 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -85.77 -32.71 21.69 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.94 131.14 55.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.375 0.607 . . . . 0.0 111.282 -170.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.15 -46.37 89.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.509 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.555 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -59.45 -34.54 72.64 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.21 -9.88 24.93 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.357 0.526 . . . . 0.0 110.68 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.89 -44.99 25.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.444 ' HA ' ' HE2' ' A' ' 72' ' ' MET . 8.5 pt-20 -75.67 -29.11 58.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.299 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.41 -41.68 80.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.592 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.73 76.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.257 -0.277 . . . . 0.0 111.533 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.444 ' HE2' ' HA ' ' A' ' 69' ' ' GLU . 6.7 ptp -77.4 -39.99 45.21 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.576 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.99 1.52 17.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.332 0.653 . . . . 0.0 111.719 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.51 -8.7 4.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.3 ttp -142.93 -19.98 0.65 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.03 135.38 57.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.398 1.454 . . . . 0.0 110.125 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.14 78.06 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.045 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.39 29.31 0.51 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.083 0.942 . . . . 0.0 110.966 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 84' ' ' GLU . 5.3 m -67.91 174.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 126.194 1.798 . . . . 0.0 113.361 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.79 9.99 0.92 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.809 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -139.41 7.31 2.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.162 0.585 . . . . 0.0 110.317 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.07 -17.33 48.58 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.82 136.7 7.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.409 0.683 . . . . 0.0 109.189 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.477 ' N ' HG13 ' A' ' 79' ' ' VAL . 81.2 mm-40 -150.76 -43.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 110.27 170.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -137.59 151.71 48.63 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.043 0.537 . . . . 0.0 112.122 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -152.28 112.92 4.14 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 166.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.13 133.12 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.364 0.602 . . . . 0.0 110.73 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -167.96 162.24 13.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.125 1.37 . . . . 0.0 108.546 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 mmt -59.15 139.26 57.08 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.732 0.813 . . . . 0.0 111.336 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.74 52.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -129.89 16.56 5.74 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.232 1.013 . . . . 0.0 108.378 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -147.28 142.38 27.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.29 1.436 . . . . 0.0 107.175 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.28 -176.11 17.43 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -170.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -53.76 132.18 56.54 Favored Pre-proline 0 N--CA 1.455 -0.212 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.29 143.14 52.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.143 2.562 . . . . 0.0 112.486 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.24 -21.84 10.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.199 3.266 . . . . 0.0 111.699 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -146.88 162.57 38.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.463 1.105 . . . . 0.0 108.092 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.45 35.32 20.45 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.855 0.741 . . . . 0.0 112.647 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 34.05 50.65 0.88 Allowed Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.486 1.514 . . . . 0.0 114.433 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.39 151.45 42.78 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.115 2.543 . . . . 0.0 110.692 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.21 117.97 4.23 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.784 2.99 . . . . 0.0 110.353 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.94 -169.01 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.02 3.146 . . . . 0.0 109.915 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -121.53 21.44 10.93 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.695 0.798 . . . . 0.0 109.31 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 12' ' ' GLY . 8.5 p -60.27 -8.28 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.663 1.185 . . . . 0.0 113.274 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.49 4.09 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.961 -0.462 . . . . 0.0 111.131 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 10' ' ' VAL . . . -149.54 28.12 1.2 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.42 1.01 . . . . 0.0 110.743 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.9 mtm -129.65 165.57 21.54 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.464 0.632 . . . . 0.0 111.405 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -67.0 -22.6 65.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 t 44.16 60.19 2.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 15.9 tp -65.49 166.13 10.92 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.2 ptmt -138.35 148.06 44.15 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 123.342 0.657 . . . . 0.0 110.913 172.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -129.41 143.06 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -153.01 -173.81 4.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.979 0.911 . . . . 0.0 109.738 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.2 t30 88.44 29.85 0.03 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.792 1.237 . . . . 0.0 112.558 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.56 134.97 35.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.055 1.342 . . . . 0.0 109.752 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 24' ' ' ARG . 1.6 m -74.28 168.01 20.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -64.66 4.25 0.42 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.846 0.858 . . . . 0.0 112.853 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 22' ' ' THR . 42.9 ptt85 -135.28 18.69 3.39 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.187 0.995 . . . . 0.0 111.482 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -119.2 165.1 14.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 122.935 0.494 . . . . 0.0 110.289 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.7 p -147.46 166.57 15.68 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.525 0.73 . . . . 0.0 110.03 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.2 Cg_endo -70.65 -32.08 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.858 2.372 . . . . 0.0 110.896 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.24 -35.33 80.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -73.23 -45.32 56.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.412 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -55.46 -21.04 14.53 Favored 'General case' 0 N--CA 1.457 -0.095 0 O-C-N 122.203 -0.31 . . . . 0.0 111.418 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -78.66 -57.8 3.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -64.99 -21.61 66.87 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.735 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.7 t -84.03 -32.88 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 119.612 -0.232 . . . . 0.0 111.007 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.412 ' CD1' HD11 ' A' ' 30' ' ' LEU . 19.3 m-85 -102.14 -10.2 19.85 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.0 -26.33 62.19 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.081 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -68.41 -23.19 64.61 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.86 -16.08 61.14 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.444 0.298 . . . . 0.0 111.035 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.31 -66.42 0.27 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-O 119.94 -0.366 . . . . 0.0 112.405 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -165.02 168.45 17.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.667 0.387 . . . . 0.0 110.59 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -141.85 135.31 29.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.92 -22.1 16.59 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -158.84 155.69 28.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.289 0.545 . . . . 0.0 110.425 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -170.89 100.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.79 1.236 . . . . 0.0 109.944 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.6 177.26 10.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 mm -106.57 98.51 20.6 Favored Pre-proline 0 C--N 1.34 0.193 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.49 -41.78 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.501 2.801 . . . . 0.0 115.953 -166.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -70.39 155.12 41.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.866 0.757 . . . . 0.0 110.947 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 50' ' ' TYR . 18.1 m-20 37.41 70.49 0.18 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.564 1.146 . . . . 0.0 112.139 -174.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -57.04 5.4 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.117 1.767 . . . . 0.0 115.559 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' A' ' 48' ' ' ASP . 10.2 p90 -145.28 1.21 0.94 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.207 1.003 . . . . 0.0 112.297 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -121.15 -12.08 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.169 0.44 . . . . 0.0 110.189 173.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.76 29.13 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 127.765 2.426 . . . . 0.0 113.619 -176.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.13 -176.08 1.34 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.47 0.653 . . . . 0.0 109.299 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 56' ' ' GLY . 4.7 t 50.75 24.96 1.9 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.291 1.036 . . . . 0.0 112.142 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 9.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.172 1.789 . . . . 0.0 114.095 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 54' ' ' SER . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.64 0.655 . . . . 0.0 112.254 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -155.95 166.91 32.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.8 0.8 . . . . 0.0 110.522 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.22 101.7 3.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.91 118.31 11.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -119.5 165.29 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.3 ptm180 -144.54 149.66 36.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.35 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -117.18 164.8 14.23 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.089 0.868 . . . . 0.0 111.078 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.4 -27.15 10.12 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -120.59 149.33 42.63 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.149 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.12 -45.83 83.48 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.131 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -66.42 -40.0 89.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -80.74 -15.92 55.22 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.102 0.865 . . . . 0.0 110.959 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.1 -47.45 9.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.046 0.538 . . . . 0.0 110.16 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -68.35 -25.07 64.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.448 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.68 -47.46 31.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.904 0.32 . . . . 0.0 110.549 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.33 73.69 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.056 0.389 . . . . 0.0 110.623 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.8 ttp -73.4 -43.01 61.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.755 0.422 . . . . 0.0 110.031 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.26 2.33 24.97 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.171 -0.331 . . . . 0.0 111.521 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.23 -7.28 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.9 ttm -137.6 -26.44 0.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.67 134.75 56.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.537 1.062 . . . . 0.0 109.831 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.7 42.73 86.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 21.92 12.55 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 122.125 0.964 . . . . 0.0 110.269 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.59 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 6.1 t -63.55 162.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -165.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.45 13.26 0.23 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.96 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -135.61 8.8 3.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.19 0.596 . . . . 0.0 110.861 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.03 -13.38 58.9 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.512 ' CA ' HG12 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -177.36 133.55 0.18 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.438 1.895 . . . . 0.0 106.473 176.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 79' ' ' VAL . 20.4 pt-20 -146.15 -32.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.338 168.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.478 ' CD2' ' HG3' ' A' ' 84' ' ' GLU . 1.5 mm? -141.41 140.06 33.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -174.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 33.1 mmt180 -149.62 116.76 6.02 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 125.579 1.552 . . . . 0.0 106.991 167.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -134.52 142.98 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.752 0.821 . . . . 0.0 110.2 -174.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -170.49 -178.79 2.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.451 0.701 . . . . 0.0 110.22 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.7 mmt -75.51 139.6 42.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.463 0.705 . . . . 0.0 109.455 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 164.53 26.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.408 0.683 . . . . 0.0 111.225 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -142.94 9.23 1.71 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.744 0.418 . . . . 0.0 110.981 172.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -126.18 167.02 15.98 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.056 0.942 . . . . 0.0 109.142 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.1 173.62 14.91 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-O 120.999 0.221 . . . . 0.0 113.245 -173.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -65.37 159.91 62.97 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.109 0.963 . . . . 0.0 111.464 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -37.82 104.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.862 1 C-N-CA 125.618 4.212 . . . . 0.0 115.492 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.47 -26.83 1.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.06 2.507 . . . . 0.0 109.632 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -160.42 168.7 24.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.8 1.64 . . . . 0.0 106.786 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.282 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.32 -44.27 58.08 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.463 -0.632 . . . . 0.0 113.721 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 18.4 ptt-85 -160.2 24.52 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 74.4 Cg_endo -70.63 144.07 48.37 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 CA-C-N 121.614 1.612 . . . . 0.0 108.51 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.67 115.25 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.357 2.705 . . . . 0.0 110.779 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.0 -164.2 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.727 2.951 . . . . 0.0 109.841 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -133.27 25.47 4.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.621 0.769 . . . . 0.0 110.238 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 m -55.2 -15.82 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.817 0.847 . . . . 0.0 111.822 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.75 -4.13 32.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.008 0.923 . . . . 0.0 112.219 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.9 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.598 -0.557 . . . . 0.0 112.797 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.0 ptt? -135.63 162.65 32.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.002 0.901 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 m -76.05 82.44 2.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 122.888 0.475 . . . . 0.0 109.827 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.4 m -65.87 67.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.946 1.698 . . . . 0.0 110.459 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 1.6 tm? -86.36 131.52 34.19 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -128.63 153.67 47.03 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.48 153.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.783 -177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -152.75 -173.19 4.48 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.291 1.436 . . . . 0.0 109.738 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 t30 86.76 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.737 1.215 . . . . 0.0 112.666 171.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.0 134.2 55.59 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.386 1.075 . . . . 0.0 109.132 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -81.17 169.05 17.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.981 176.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -62.46 1.18 0.38 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -125.69 12.72 7.99 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.595 0.634 . . . . 0.0 112.001 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -116.09 165.22 13.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.322 0.249 . . . . 0.0 110.996 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -150.19 165.15 18.14 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 124.226 1.01 . . . . 0.0 109.19 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 60.6 Cg_endo -70.43 -25.78 25.12 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.205 1.936 . . . . 0.0 111.604 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.76 -32.42 69.55 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.898 -0.502 . . . . 0.0 109.954 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.4 m -77.43 -44.91 27.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.456 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -56.66 -22.4 34.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.636 -0.665 . . . . 0.0 110.496 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -78.38 -57.98 3.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -61.09 -30.61 70.45 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.645 0.202 . . . . 0.0 110.539 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.88 -34.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 123.442 0.464 . . . . 0.0 110.811 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' CD1' HD11 ' A' ' 30' ' ' LEU . 18.6 m-85 -98.74 -13.12 20.36 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.25 -25.73 63.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.895 -0.503 . . . . 0.0 110.91 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -69.45 -23.22 63.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.888 -0.508 . . . . 0.0 112.243 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -74.62 -16.94 60.77 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.459 0.304 . . . . 0.0 111.653 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.65 -85.71 0.1 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -160.77 162.5 32.41 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.992 0.517 . . . . 0.0 110.893 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 t -137.42 137.76 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.61 -36.22 9.66 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -164.05 159.2 20.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.366 0.583 . . . . 0.0 111.194 174.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.01 117.96 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.681 1.192 . . . . 0.0 108.335 -176.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.07 176.98 11.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.374 0.607 . . . . 0.0 112.518 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.7 mt -129.81 91.73 39.29 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 124.035 0.934 . . . . 0.0 108.6 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.79 8.68 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.879 3.719 . . . . 0.0 113.733 -172.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -52.75 -43.15 65.58 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.013 0.824 . . . . 0.0 109.834 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -149.37 116.69 6.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -71.17 12.19 0.34 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.436 ' CD2' HG23 ' A' ' 51' ' ' THR . 15.7 p90 -146.28 2.77 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.937 0.895 . . . . 0.0 111.34 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.436 HG23 ' CD2' ' A' ' 50' ' ' TYR . 17.1 p -129.15 -36.02 1.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.478 0.581 . . . . 0.0 109.769 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.55 41.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 126.683 1.993 . . . . 0.0 113.214 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -129.39 1.34 5.09 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 t -64.03 -43.88 94.24 Favored 'General case' 0 CA--C 1.526 0.047 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 58.94 157.54 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.403 1.881 . . . . 0.0 113.582 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.41 -21.5 0.55 Allowed Glycine 0 CA--C 1.526 0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.329 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.56 166.13 29.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.029 0.931 . . . . 0.0 109.464 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.2 94.51 1.84 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -66.24 101.55 0.74 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -173.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 2.3 m -94.82 167.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 171.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -145.94 116.43 7.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.213 0.946 . . . . 0.0 110.601 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 13.6 m-85 -92.48 169.76 10.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.229 1.012 . . . . 0.0 109.711 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.415 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -124.71 -37.06 2.52 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 123.989 0.806 . . . . 0.0 112.469 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.42 127.92 32.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.325 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -60.91 -53.72 53.8 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -32.35 68.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -89.09 -17.85 28.43 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.084 0.402 . . . . 0.0 110.999 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.95 -45.62 20.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -75.42 -25.85 57.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.585 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.99 -46.89 40.87 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.719 0.69 . . . . 0.0 111.103 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.8 73.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.122 0.419 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.403 ' HA ' ' CG1' ' A' ' 87' ' ' VAL . 9.9 ttp -73.86 -41.23 62.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.55 0.34 . . . . 0.0 110.952 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.46 2.87 26.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.426 0.103 . . . . 0.0 111.231 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.19 -6.1 4.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.6 ttm -137.13 -27.81 0.96 Allowed 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.45 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 6.2 t70 -63.19 136.46 57.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.945 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.45 85.65 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.542 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.64 34.22 0.48 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.02 0.91 . . . . 0.0 110.49 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 81' ' ' ASP . 9.6 p -69.83 172.1 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.484 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 0.3 OUTLIER -156.58 5.47 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.972 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.542 ' H ' HG22 ' A' ' 79' ' ' VAL . 37.3 t70 -148.26 -2.44 0.52 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' H ' HG22 ' A' ' 79' ' ' VAL . . . 124.0 -17.14 7.66 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.485 ' C ' HG23 ' A' ' 79' ' ' VAL . 5.3 ptp180 -161.0 140.55 10.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 10.0 mm-40 -146.57 -49.57 0.2 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -139.95 150.36 44.43 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 124.064 0.852 . . . . 0.0 112.445 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -148.66 98.84 2.93 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 167.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 7.1 p -126.45 129.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 121.336 0.588 . . . . 0.0 110.097 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -165.78 164.38 18.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.356 1.063 . . . . 0.0 109.138 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.4 mmt -57.97 136.84 57.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.895 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 155.74 27.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -136.52 4.71 2.88 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.623 0.369 . . . . 0.0 110.838 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.95 163.81 28.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.4 172.71 15.2 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -66.16 156.05 85.78 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.58 0.352 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.81 146.77 30.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.579 2.853 . . . . 0.0 111.722 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.4 -24.33 5.46 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.194 3.263 . . . . 0.0 111.855 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -154.13 161.47 41.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.359 1.064 . . . . 0.0 109.121 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.519 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.59 65.05 4.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 42.63 49.5 4.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.433 1.493 . . . . 0.0 114.745 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.83 154.03 63.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.249 1.966 . . . . 0.0 108.522 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.77 115.99 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.263 2.642 . . . . 0.0 110.679 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.17 -163.79 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.859 3.039 . . . . 0.0 109.885 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -132.17 20.19 4.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.516 0.726 . . . . 0.0 110.343 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -56.71 -12.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.428 1.091 . . . . 0.0 112.244 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.34 -1.0 9.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.749 0.819 . . . . 0.0 112.496 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.69 30.06 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.77 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.17 168.15 20.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.807 1.304 . . . . 0.0 112.461 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -57.95 -28.32 64.21 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -168.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.4 m 42.1 58.97 2.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 113.172 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 17.6 tp -65.17 167.15 8.55 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 14.9 pttt -136.95 157.63 46.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.107 0.412 . . . . 0.0 111.82 170.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -133.78 148.13 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -150.42 -175.43 5.09 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.662 1.185 . . . . 0.0 110.677 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 t30 91.92 28.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.741 1.616 . . . . 0.0 114.121 168.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 120.66 9.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.25 1.02 . . . . 0.0 109.867 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 24' ' ' ARG . 11.7 m -75.09 171.58 13.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -63.96 7.2 0.13 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.113 0.965 . . . . 0.0 112.949 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 22' ' ' THR . 19.3 ptt180 -131.08 14.88 5.19 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.982 0.913 . . . . 0.0 111.838 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 m -122.8 166.43 14.98 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.466 0.306 . . . . 0.0 111.068 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 91.4 p -151.86 166.4 15.32 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.67 -29.24 19.84 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.576 2.184 . . . . 0.0 110.904 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -67.63 -33.92 75.94 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.0 m -75.25 -44.87 43.66 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.26 -19.84 15.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.315 0.246 . . . . 0.0 111.117 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -80.4 -57.98 3.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -12.31 60.35 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -91.97 -32.86 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.189 0.595 . . . . 0.0 111.514 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.72 -9.71 18.9 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -26.01 61.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.18 0.446 . . . . 0.0 111.018 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -69.76 -23.78 63.42 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -72.56 -19.2 61.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.842 0.457 . . . . 0.0 111.468 176.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.0 -86.46 0.1 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -156.25 165.12 37.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 111.447 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.52 137.24 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.49 1.116 . . . . 0.0 108.062 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -22.09 23.21 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -163.67 153.85 15.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.403 0.62 . . . . 0.0 110.63 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.92 104.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -146.92 161.79 40.02 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.966 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.4 mt -136.34 126.36 16.17 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.892 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.54 52.21 2.81 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.708 3.605 . . . . 0.0 110.434 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -73.26 70.62 1.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.051 0.94 . . . . 0.0 110.081 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 49' ' ' ARG . 3.5 p30 45.62 -162.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.722 1.609 . . . . 0.0 114.142 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.401 ' H ' ' HB2' ' A' ' 48' ' ' ASP . 11.9 ttm-85 177.58 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.465 1.906 . . . . 0.0 108.199 -170.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -157.34 12.03 0.22 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.448 1.099 . . . . 0.0 111.456 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.7 p -124.18 -7.16 7.69 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.042 0.537 . . . . 0.0 112.035 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.64 42.05 1.92 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.108 1.763 . . . . 0.0 113.971 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.08 -177.79 4.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.187 0.595 . . . . 0.0 110.303 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -142.59 -176.93 5.05 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -172.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.528 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 75.0 mmt-85 -132.25 -2.1 3.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.256 0.622 . . . . 0.0 112.325 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.7 24.44 76.71 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.009 0.368 . . . . 0.0 113.05 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 9.6 p90 -151.6 171.61 17.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.01 0.905 . . . . 0.0 110.692 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.76 103.82 4.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -69.57 92.44 0.64 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.772 0.829 . . . . 0.0 108.879 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 40.5 t -79.99 160.94 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 13.7 ttt180 -141.97 130.46 22.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.355 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -113.03 165.71 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.025 0.375 . . . . 0.0 111.059 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -33.44 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.26 123.39 26.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -60.36 -53.59 55.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -84.95 -21.84 29.43 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.17 -43.54 21.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 122.779 0.432 . . . . 0.0 110.461 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.432 ' HA ' ' HE1' ' A' ' 72' ' ' MET . 8.4 pt-20 -72.05 -28.56 63.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.214 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -40.73 64.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.393 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.52 74.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.137 -0.352 . . . . 0.0 111.441 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.432 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 3.8 ptp -78.71 -38.29 39.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.68 3.13 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.961 0.504 . . . . 0.0 111.674 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -9.7 3.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.6 ttp -146.79 -13.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.27 125.51 23.54 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.762 1.165 . . . . 0.0 108.756 173.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 75.87 28.11 61.41 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.576 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.65 38.33 0.44 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.775 1.288 . . . . 0.0 109.554 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.55 HG23 ' H ' ' A' ' 81' ' ' ASP . 4.8 p -71.81 173.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -168.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.462 ' H ' HG23 ' A' ' 79' ' ' VAL . 1.1 pt? -152.0 -0.32 0.32 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.27 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.55 ' H ' HG23 ' A' ' 79' ' ' VAL . 38.0 t70 -144.95 -1.17 0.87 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.41 ' H ' HG23 ' A' ' 79' ' ' VAL . . . 126.43 -17.31 6.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -164.34 133.38 3.71 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 20.1 mm-40 -143.81 -39.75 0.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 mp -147.63 151.18 35.77 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 123.697 0.623 . . . . 0.0 112.608 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -147.43 121.56 9.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.72 139.27 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.081 0 C-N-CA 122.67 0.388 . . . . 0.0 110.03 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -169.08 174.93 5.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.752 1.221 . . . . 0.0 109.225 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 mmt -73.97 143.27 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.962 0.905 . . . . 0.0 109.981 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.54 155.68 37.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.474 0.31 . . . . 0.0 110.555 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.56 13.42 2.34 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.766 0.826 . . . . 0.0 109.722 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -129.97 158.07 40.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.874 0.87 . . . . 0.0 109.109 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.48 177.95 20.29 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -60.66 156.06 46.77 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 122.235 -0.568 . . . . 0.0 110.131 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.32 120.94 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.322 2.681 . . . . 0.0 113.309 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.51 -45.77 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.125 1.883 . . . . 0.0 108.671 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -161.39 125.49 3.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.172 1.789 . . . . 0.0 107.833 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.826 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.42 -69.01 0.53 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 125.001 1.286 . . . . 0.0 111.697 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.41 59.65 0.64 Allowed Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -171.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.77 153.76 64.13 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.961 2.441 . . . . 0.0 109.326 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.87 116.04 4.53 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.412 2.741 . . . . 0.0 110.544 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -87.58 -162.52 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.062 3.175 . . . . 0.0 110.298 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -136.25 33.4 2.82 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.976 0.91 . . . . 0.0 109.757 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.41 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 33.7 m -61.43 -1.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 124.409 1.083 . . . . 0.0 113.802 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.53 -13.05 60.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.541 0.61 . . . . 0.0 112.256 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.45 20.75 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.91 -0.383 . . . . 0.0 112.933 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . 8.1 ptp -60.47 156.9 15.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.84 0.82 . . . . 0.0 113.206 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -72.23 -18.84 61.8 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.888 0.875 . . . . 0.0 110.466 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 t 45.45 59.54 3.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.044 1.338 . . . . 0.0 113.03 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 20.7 tp -65.7 165.39 12.69 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 16.8 pttt -134.53 154.89 51.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.531 0.332 . . . . 0.0 110.83 170.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.31 148.43 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -148.81 -171.08 3.78 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.997 1.719 . . . . 0.0 109.273 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.88 90.23 0.09 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.497 1.119 . . . . 0.0 111.929 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.5 122.89 49.04 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 m -69.03 165.92 19.16 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.18 -0.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.288 1.035 . . . . 0.0 113.562 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -129.4 23.19 5.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.167 0.987 . . . . 0.0 110.92 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -123.94 165.35 17.57 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.796 0.331 . . . . 0.0 110.73 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.4 p -150.05 165.79 16.7 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.192 0.997 . . . . 0.0 109.527 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 39.1 Cg_endo -66.18 -29.38 47.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.178 1.918 . . . . 0.0 110.911 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.09 -31.9 71.83 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.883 -0.51 . . . . 0.0 110.284 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 100.0 m -74.63 -44.71 49.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.449 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -58.84 -20.01 46.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.044 -0.41 . . . . 0.0 110.957 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -81.1 -57.05 3.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -8.89 39.06 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.867 0.467 . . . . 0.0 111.857 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.56 -30.94 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.318 0.647 . . . . 0.0 111.717 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' ' 30' ' ' LEU . 22.7 m-85 -101.73 -12.05 18.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.249 0.477 . . . . 0.0 112.284 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.47 -27.27 64.1 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.011 -0.431 . . . . 0.0 111.37 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.51 -24.08 65.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -72.04 -21.95 61.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.238 0.215 . . . . 0.0 111.184 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -81.24 0.1 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -159.13 165.84 32.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.044 0.45 . . . . 0.0 111.357 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.9 147.16 29.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 -19.34 8.59 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.57 153.45 25.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.194 0.497 . . . . 0.0 110.374 174.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 p -169.13 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.154 0.982 . . . . 0.0 110.044 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.83 179.63 9.02 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 112.204 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.448 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 13.4 mt -117.73 123.26 29.87 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.98 43.93 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 125.364 4.042 . . . . 0.0 112.054 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -54.89 160.96 1.76 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -54.73 119.42 5.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -67.16 13.27 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -167.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 13.0 p90 -144.72 0.2 0.96 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.666 1.186 . . . . 0.0 111.57 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.434 HG21 ' CD2' ' A' ' 50' ' ' TYR . 30.5 p -127.69 -23.78 3.37 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.709 0.686 . . . . 0.0 110.929 171.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.97 35.62 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.367 1.867 . . . . 0.0 113.815 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.23 1.93 12.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -73.37 170.08 15.82 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.386 0.539 . . . . 0.0 111.153 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 176.92 165.92 0.52 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.386 1.474 . . . . 0.0 110.174 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.31 -22.11 0.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -158.04 170.58 21.99 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 108.6 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.24 105.07 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -68.31 116.56 9.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -116.04 167.83 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 172.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.1 ptm180 -144.58 146.02 32.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.663 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -116.01 162.65 17.07 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.464 0.477 . . . . 0.0 111.239 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -122.27 -32.19 3.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.64 131.13 34.63 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.503 ' HZ1' ' HB3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -65.06 -45.56 84.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.249 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.428 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -172.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.428 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.5 p30 -106.52 -7.01 17.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.347 0.521 . . . . 0.0 111.077 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -74.65 -40.43 61.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB3' ' HZ1' ' A' ' 65' ' ' LYS . 9.8 pt-20 -78.92 -29.99 44.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.343 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -67.91 -40.06 83.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.297 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.53 75.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.851 0.296 . . . . 0.0 111.525 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.403 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 10.6 ptp -77.15 -40.19 46.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.725 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.07 -0.98 20.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.04 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.61 -6.34 5.19 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.8 ttm -137.63 -28.96 0.88 Allowed 'General case' 0 N--CA 1.458 -0.066 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.447 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 3.3 t70 -66.84 142.62 57.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.7 1.136 . . . . 0.0 110.617 -177.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.6 8.67 86.2 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.575 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.04 31.75 0.44 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.328 1.064 . . . . 0.0 111.041 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.578 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 19.8 t -74.45 160.9 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.704 0.802 . . . . 0.0 111.637 -172.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.65 10.94 0.3 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.368 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -146.44 5.3 0.93 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.99 -0.444 . . . . 0.0 112.106 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.51 -11.25 28.23 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.126 0.393 . . . . 0.0 112.334 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -172.14 114.24 0.32 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.088 0.955 . . . . 0.0 108.563 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.578 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 80.2 mm-40 -130.28 -50.78 1.1 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.555 171.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -139.96 155.99 46.86 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.5 mmt-85 -152.18 109.95 3.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.814 1.646 . . . . 0.0 107.299 168.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 2.1 p -139.12 125.38 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-O 121.19 0.519 . . . . 0.0 110.891 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -155.92 179.92 8.74 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.043 1.737 . . . . 0.0 108.382 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.4 mmt -75.75 144.93 41.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.6 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.16 169.15 16.7 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.231 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -145.3 -3.11 0.75 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.379 0.672 . . . . 0.0 110.905 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -129.91 168.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.979 0.511 . . . . 0.0 109.911 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.27 171.42 13.7 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 112.745 -0.142 . . . . 0.0 112.745 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -64.43 152.38 89.2 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 123.514 0.725 . . . . 0.0 110.867 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.01 125.99 13.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.464 2.11 . . . . 0.0 112.116 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.22 -22.11 11.4 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.392 2.728 . . . . 0.0 110.389 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -148.5 150.39 33.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.486 1.514 . . . . 0.0 106.999 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -171.508 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 . . . . . 0 CA--C 1.527 0.072 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.32 45.43 1.15 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 51.42 48.2 5.5 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.227 1.011 . . . . 0.0 112.988 -177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.3 157.04 50.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.79 2.327 . . . . 0.0 110.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.77 113.66 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.017 3.145 . . . . 0.0 110.209 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.33 -163.35 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.123 3.215 . . . . 0.0 110.61 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -134.23 29.11 3.7 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.112 0.965 . . . . 0.0 110.14 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.84 -12.53 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.404 1.082 . . . . 0.0 113.406 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.15 4.9 49.08 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.309 0.644 . . . . 0.0 111.448 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.23 21.09 0.49 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -140.89 161.31 38.13 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.399 0.599 . . . . 0.0 111.51 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.9 m -85.05 83.95 7.87 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.696 0.798 . . . . 0.0 111.924 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 m -64.24 79.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.144 1.378 . . . . 0.0 111.299 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 3.1 tm? -79.62 107.44 12.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.55 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.9 ttpp -79.53 140.94 37.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.71 146.92 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.299 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -150.67 -175.75 5.24 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.532 1.145 . . . . 0.0 110.8 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.477 HD22 ' HB2' ' A' ' 83' ' ' ARG . 16.1 t30 94.05 26.97 0.01 OUTLIER 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.728 1.611 . . . . 0.0 113.79 169.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.65 120.02 5.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.383 1.073 . . . . 0.0 108.468 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.417 HG23 ' CD2' ' A' ' 23' ' ' TYR . 10.8 m -42.18 -63.85 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.189 0.995 . . . . 0.0 112.274 -172.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.417 ' CD2' HG23 ' A' ' 22' ' ' THR . 52.3 p90 165.93 -19.74 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.889 2.875 . . . . 0.0 109.276 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -111.42 -1.07 16.07 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.079 0.952 . . . . 0.0 111.552 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -78.18 173.47 12.22 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.02 0.928 . . . . 0.0 109.665 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.404 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 93.9 p -145.26 163.02 34.63 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.888 0.475 . . . . 0.0 109.882 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HD3' ' CD1' ' A' ' 45' ' ' ILE . 41.9 Cg_endo -68.16 -26.79 36.02 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.986 1.79 . . . . 0.0 110.446 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.91 -27.38 65.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.472 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 99.7 m -78.35 -45.67 21.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' A' ' 34' ' ' PHE . 1.3 mm? -59.16 -19.14 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.145 -0.347 . . . . 0.0 110.515 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -78.73 -58.38 3.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.133 -0.461 . . . . 0.0 109.949 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.472 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -71.56 -16.24 62.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.59 0.632 . . . . 0.0 111.326 -174.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.64 -32.98 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 123.272 0.629 . . . . 0.0 111.608 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 30' ' ' LEU . 22.4 m-85 -101.72 -11.52 19.07 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.176 0.443 . . . . 0.0 111.907 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -74.33 -24.71 59.23 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.782 -0.574 . . . . 0.0 110.842 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.91 -22.91 65.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.217 0.462 . . . . 0.0 112.14 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -73.36 -24.85 60.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.699 0.4 . . . . 0.0 111.731 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.78 -84.79 0.07 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -159.64 167.04 29.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.086 0.47 . . . . 0.0 111.564 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.76 147.88 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.02 -17.92 8.63 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -162.42 149.98 13.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 117.057 0.429 . . . . 0.0 110.332 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 p -166.31 104.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.577 1.151 . . . . 0.0 108.638 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.71 175.02 13.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.292 0.568 . . . . 0.0 112.244 175.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.418 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 12.4 mt -126.31 108.71 23.92 Favored Pre-proline 0 N--CA 1.452 -0.374 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -176.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.45 -13.69 20.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.741 2.961 . . . . 0.0 112.77 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 34.6 -107.71 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 111.12 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 50' ' ' TYR . 5.2 m-20 -140.27 12.78 2.39 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.216 1.006 . . . . 0.0 110.307 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 57.87 -12.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 48' ' ' ASP . 49.3 p90 -148.76 -2.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.548 1.067 . . . . 0.0 113.009 175.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.8 p -121.05 -19.15 7.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.859 0.754 . . . . 0.0 110.516 172.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 50.23 21.11 0.73 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.243 1.417 . . . . 0.0 113.952 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.9 -1.24 6.83 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 t 61.21 173.83 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.015 1.326 . . . . 0.0 113.117 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -139.85 -0.68 1.68 Allowed 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.913 0.885 . . . . 0.0 112.446 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.82 18.44 44.13 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.916 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.07 168.88 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.518 1.159 . . . . 0.0 110.874 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.39 105.59 4.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -70.66 110.83 5.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 59.3 t -100.61 158.76 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.2 ptm180 -143.61 125.6 15.32 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -91.61 -179.19 5.29 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -134.97 -25.06 1.42 Allowed 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 124.057 0.848 . . . . 0.0 113.26 178.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.87 128.59 37.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -62.33 -50.91 69.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.225 -0.416 . . . . 0.0 111.347 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -56.88 -34.61 68.02 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -172.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.52 -11.04 21.4 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 118.761 0.71 . . . . 0.0 111.972 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.62 54.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 72' ' ' MET . 8.0 pt-20 -76.09 -24.65 55.05 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.223 -0.298 . . . . 0.0 111.5 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.06 -40.22 60.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.806 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.053 -0.404 . . . . 0.0 111.312 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.435 ' HE2' ' HA ' ' A' ' 69' ' ' GLU . 9.0 ptp -76.68 -40.2 49.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.559 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.55 2.26 14.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.186 0.594 . . . . 0.0 112.179 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.43 -9.19 3.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -145.44 -11.69 0.53 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.439 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.14 130.03 44.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 120.371 1.441 . . . . 0.0 109.396 174.51 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.46 29.75 61.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.904 -0.942 . . . . 0.0 113.665 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.52 38.88 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.063 1.432 . . . . 0.0 110.193 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.605 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 13.1 t -69.85 162.56 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 113.96 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.04 9.33 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.506 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.41 1.66 0.53 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.85 -22.18 3.49 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 121.744 -0.598 . . . . 0.0 112.648 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.477 ' HB2' HD22 ' A' ' 20' ' ' ASN . 0.4 OUTLIER 174.99 134.89 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.584 1.954 . . . . 0.0 107.278 177.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.605 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 76.3 mm-40 -132.23 -36.45 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.297 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -152.15 151.81 31.51 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -152.57 122.65 7.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 167.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 2.0 p -141.05 137.25 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.183 0.516 . . . . 0.0 111.292 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -165.71 171.41 12.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.999 1.319 . . . . 0.0 109.655 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.83 141.42 53.27 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.218 0.607 . . . . 0.0 110.585 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.88 158.65 35.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.579 0.351 . . . . 0.0 110.132 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -147.95 21.16 1.12 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.601 0.76 . . . . 0.0 109.39 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -146.84 152.06 38.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.25 179.79 22.31 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.046 0.385 . . . . 0.0 113.957 -169.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -62.41 156.91 59.12 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.422 0.689 . . . . 0.0 111.02 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -43.36 114.56 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.202 3.268 . . . . 0.0 114.299 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.87 -23.76 9.12 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.71 2.273 . . . . 0.0 109.334 168.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -156.22 161.84 40.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.811 1.645 . . . . 0.0 107.065 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.144 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.39 80.91 1.74 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 45.3 46.4 2.97 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.26 1.824 . . . . 0.0 114.337 174.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.46 154.22 65.12 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.127 1.885 . . . . 0.0 109.828 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.5 117.23 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.716 2.944 . . . . 0.0 110.599 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -81.6 -169.94 0.88 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.996 3.131 . . . . 0.0 110.352 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -130.62 20.39 5.12 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.587 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.76 -12.02 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 125.403 1.481 . . . . 0.0 112.343 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.96 0.55 3.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.781 0.832 . . . . 0.0 112.616 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 30.64 0.15 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.088 -0.84 . . . . 0.0 113.954 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.09 23.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.91 1.355 . . . . 0.0 112.43 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -59.35 -26.95 65.49 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.0 m 43.09 59.96 2.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 20.5 tp -65.48 167.3 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 171.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 22.8 pttt -136.49 157.26 47.2 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.9 t -131.1 146.85 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -146.83 -175.2 4.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 110.355 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 92.97 24.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.525 1.53 . . . . 0.0 113.594 168.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -57.36 129.84 43.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.348 0.659 . . . . 0.0 109.378 -178.297 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' ARG . 18.0 m -82.43 170.94 14.7 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -64.08 8.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.175 0.99 . . . . 0.0 113.312 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' THR . 13.2 ptt180 -134.57 19.37 3.6 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.604 1.162 . . . . 0.0 111.969 -174.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -127.17 164.87 20.7 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.05 0.54 . . . . 0.0 110.448 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.459 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 85.0 p -149.86 165.16 18.21 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 110.37 -174.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 57.5 Cg_endo -69.42 -28.08 27.32 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.015 2.477 . . . . 0.0 111.192 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.98 -36.26 77.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.4 m -72.15 -44.15 63.55 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -57.35 -21.98 39.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.991 -0.443 . . . . 0.0 111.145 179.397 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.82 -54.15 5.33 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -10.88 58.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.87 0.468 . . . . 0.0 111.869 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -98.95 -32.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 112.031 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.409 ' CD1' HD11 ' A' ' 30' ' ' LEU . 21.8 m-85 -100.9 -10.39 20.69 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -71.35 -28.05 63.79 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.766 -0.583 . . . . 0.0 111.14 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.61 -23.46 64.46 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -72.83 -17.59 61.54 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.317 0.247 . . . . 0.0 110.811 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.28 -76.09 0.11 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -164.81 160.52 19.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.239 0.616 . . . . 0.0 110.599 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.2 t -132.42 128.02 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.7 48.07 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -167.38 159.13 12.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.692 0.758 . . . . 0.0 112.912 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.26 141.29 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.71 1.604 . . . . 0.0 106.701 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -157.79 149.37 21.73 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.485 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 58' ' ' ALA . 5.7 mt -136.57 133.21 18.99 Favored Pre-proline 0 C--O 1.232 0.163 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.89 156.51 4.65 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.375 2.716 . . . . 0.0 111.915 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -140.34 9.54 2.28 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 50' ' ' TYR . 6.0 m-20 43.88 18.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -174.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.251 8.3 ptm180 40.13 8.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.44 3.096 . . . . 0.0 116.832 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.441 ' H ' ' C ' ' A' ' 48' ' ' ASP . 7.5 p90 -162.82 -20.95 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.753 1.221 . . . . 0.0 112.971 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -96.56 -22.25 17.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.037 1.289 . . . . 0.0 110.385 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.99 31.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.812 1.645 . . . . 0.0 113.69 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.23 -160.2 0.08 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -135.83 168.23 19.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.295 0.638 . . . . 0.0 109.781 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.4 ttm105 -146.31 0.98 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.11 20.7 38.08 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.765 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.5 169.37 24.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.059 1.43 . . . . 0.0 111.538 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.413 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -141.9 93.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 108.556 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.72 103.32 0.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.3 m -100.84 168.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 172.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.4 ptm180 -142.1 139.83 32.33 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -109.4 165.92 11.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.292 0.637 . . . . 0.0 110.465 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -33.64 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.2 122.41 24.31 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' HZ2' ' HB3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -60.48 -50.98 71.4 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.631 -0.223 . . . . 0.0 110.403 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.408 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.6 -29.63 70.65 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.254 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -90.11 -15.77 30.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.718 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.75 -39.37 31.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.433 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 9.5 pt-20 -77.38 -25.86 51.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.426 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.89 -47.83 42.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.444 0.565 . . . . 0.0 110.785 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.43 73.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.976 -0.452 . . . . 0.0 110.783 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.1 ttp -73.99 -41.39 61.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.877 0.471 . . . . 0.0 110.05 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.91 3.14 27.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 122.446 -0.159 . . . . 0.0 111.42 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.48 -5.5 4.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.3 ttm -140.44 -27.34 0.74 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.97 134.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.466 1.03 . . . . 0.0 110.221 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.49 85.85 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.539 -0.589 . . . . 0.0 112.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.77 33.23 0.43 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.811 0.806 . . . . 0.0 110.8 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.573 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 48.6 t -69.93 166.16 2.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.64 0.776 . . . . 0.0 112.269 -172.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -154.86 5.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -144.79 4.66 1.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.46 6.15 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.477 ' C ' HG11 ' A' ' 79' ' ' VAL . 5.2 ptp180 -176.14 143.33 0.53 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.004 1.722 . . . . 0.0 107.318 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.573 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 mm-40 -141.52 -46.94 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 169.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -140.96 152.7 45.17 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.941 0.496 . . . . 0.0 111.937 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -148.19 109.09 4.24 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 t -134.95 127.18 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 C-N-CA 122.74 0.416 . . . . 0.0 110.876 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -158.08 173.24 17.04 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.506 1.122 . . . . 0.0 109.412 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.2 mmt -69.59 146.08 52.02 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.786 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.89 165.93 22.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.704 0.402 . . . . 0.0 111.353 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -137.51 -0.04 2.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.717 0.807 . . . . 0.0 109.416 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -139.66 156.11 47.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.328 0.651 . . . . 0.0 109.26 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.25 -16.39 6.15 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.403 ' HD3' ' HD2' ' A' ' 95' ' ' PRO . 21.2 tpp180 -170.46 139.91 1.46 Allowed Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.403 ' HD2' ' HD3' ' A' ' 94' ' ' ARG . 26.7 Cg_endo -60.67 119.7 7.02 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.047 1.831 . . . . 0.0 109.128 171.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.52 -29.43 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.598 2.198 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -153.45 93.56 1.71 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.553 0.692 . . . . 0.0 112.081 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.7 m . . . . . 0 N--CA 1.458 -0.035 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.122 176.537 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.12 36.77 9.65 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.779 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 38.81 50.37 2.55 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 125.076 1.35 . . . . 0.0 113.994 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.91 159.25 50.9 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.742 2.295 . . . . 0.0 110.282 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.53 117.83 4.69 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.59 2.86 . . . . 0.0 110.088 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.55 -170.01 0.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.137 3.225 . . . . 0.0 110.408 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -132.53 25.88 4.42 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.397 0.679 . . . . 0.0 109.459 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 m -58.66 -4.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.332 1.453 . . . . 0.0 112.926 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.79 5.73 47.31 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.271 0.629 . . . . 0.0 110.795 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.66 17.83 0.49 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.412 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.7 ptt? -143.31 164.1 31.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.601 0.701 . . . . 0.0 110.856 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -81.07 84.94 6.38 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 110.952 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -68.21 97.32 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 2.1 tm? -116.54 124.61 50.29 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.025 0.44 . . . . 0.0 109.914 -176.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.3 ttpm? -102.58 146.89 27.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.256 1.423 . . . . 0.0 114.123 -167.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.1 t -124.48 146.4 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.229 174.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -151.62 -171.52 3.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 110.484 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 81.65 37.57 0.07 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.158 1.383 . . . . 0.0 113.199 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.66 175.2 1.14 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.386 1.074 . . . . 0.0 109.299 175.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 24' ' ' ARG . 5.2 m -129.05 167.58 17.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.82 0.848 . . . . 0.0 109.345 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -64.4 4.87 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.455 0.702 . . . . 0.0 112.475 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' H ' ' C ' ' A' ' 22' ' ' THR . 14.8 ptm180 -129.13 18.86 5.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.787 1.235 . . . . 0.0 110.228 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -129.99 163.17 27.03 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.776 0.83 . . . . 0.0 109.382 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.7 p -148.5 164.73 20.44 Favored Pre-proline 0 C--O 1.233 0.201 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 -174.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.9 Cg_endo -68.98 -27.76 29.84 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.792 1.661 . . . . 0.0 111.467 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.06 -32.33 72.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.742 0.701 . . . . 0.0 109.648 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.1 m -74.15 -44.03 55.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -59.88 -20.82 59.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.074 -0.391 . . . . 0.0 111.075 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -56.15 4.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -8.18 50.64 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.983 0.513 . . . . 0.0 112.194 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.4 t -100.79 -31.84 3.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 C-N-CA 123.069 0.547 . . . . 0.0 112.027 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.411 ' CD1' HD12 ' A' ' 30' ' ' LEU . 26.1 m-85 -101.67 -9.76 20.61 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.509 0.595 . . . . 0.0 111.602 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.83 -28.27 62.45 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.728 -0.607 . . . . 0.0 111.463 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.88 -23.0 65.95 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -71.83 -20.26 61.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.398 -0.335 . . . . 0.0 111.007 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -82.58 0.1 OUTLIER Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 175.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -159.63 160.29 34.11 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.236 0.614 . . . . 0.0 110.351 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.44 143.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.12 -15.24 24.28 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.271 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -154.45 142.65 20.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.588 0.694 . . . . 0.0 110.356 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.5 t -153.9 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 107.829 173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 163.69 38.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mm -90.5 110.32 40.24 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.15 -41.83 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.315 2.677 . . . . 0.0 114.688 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -82.41 165.69 20.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.083 0.856 . . . . 0.0 109.963 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 50.68 46.63 25.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.055 0.542 . . . . 0.0 112.057 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.448 ' HG2' ' CD2' ' A' ' 50' ' ' TYR . 18.6 ptt180 -54.7 -4.59 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 49' ' ' ARG . 15.6 p90 -146.77 7.1 0.94 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.871 0.76 . . . . 0.0 112.456 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.405 HG22 ' CD1' ' A' ' 50' ' ' TYR . 27.2 p -125.98 -14.1 6.16 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.844 -0.535 . . . . 0.0 111.264 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.32 27.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.855 2.062 . . . . 0.0 114.421 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.95 11.01 2.42 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.949 -0.469 . . . . 0.0 112.011 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -138.45 159.59 41.69 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.919 0.488 . . . . 0.0 110.339 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -170.51 15.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.969 0.908 . . . . 0.0 111.808 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.3 -12.4 58.16 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 118.154 0.434 . . . . 0.0 112.388 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.73 168.78 25.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.936 0.894 . . . . 0.0 109.921 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 95.43 2.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -63.12 121.34 13.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.2 m -119.38 166.94 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 3.6 ptm180 -145.3 131.22 19.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.554 0.533 . . . . 0.0 111.898 175.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 26.7 m-85 -93.41 172.9 7.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.238 1.015 . . . . 0.0 109.295 171.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.412 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -126.78 -33.91 2.45 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 123.917 0.761 . . . . 0.0 112.754 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.1 133.04 34.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.45 -52.91 63.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.424 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -29.28 70.19 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -85.48 -21.35 28.72 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.899 0.318 . . . . 0.0 110.772 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.11 -45.45 16.44 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.391 0.676 . . . . 0.0 109.889 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -77.59 -24.62 49.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.243 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.82 -45.38 43.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.966 0.803 . . . . 0.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -30.08 71.09 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 110.64 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ttp -75.72 -43.27 47.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.392 0.277 . . . . 0.0 110.599 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.02 -0.33 27.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.531 0.15 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.03 -6.32 6.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.7 ttm -136.38 -27.33 1.07 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.474 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -62.65 137.67 58.32 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.393 1.451 . . . . 0.0 108.56 176.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.3 59.63 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.741 -0.477 . . . . 0.0 112.048 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.22 70.24 1.47 Allowed 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.552 ' HB ' ' CG ' ' A' ' 84' ' ' GLU . 9.9 p -45.19 167.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 -167.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.551 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -144.39 -6.79 0.71 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.241 -2.254 . . . . 0.0 116.675 169.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -157.0 6.95 0.16 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.275 0.943 . . . . 0.0 112.993 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.534 ' H ' ' CG2' ' A' ' 79' ' ' VAL . . . 96.38 16.37 37.67 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 121.812 -0.555 . . . . 0.0 111.801 -174.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -147.2 60.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 123.257 1.503 . . . . 0.0 107.526 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.552 ' CG ' ' HB ' ' A' ' 79' ' ' VAL . 1.3 mp0 -50.3 128.91 20.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 112.794 -2.003 . . . . 0.0 114.381 -166.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.687 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -40.02 137.48 0.96 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.759 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mmt-85 -130.52 128.87 42.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.6 p -145.02 120.82 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.109 0.564 . . . . 0.0 109.751 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -154.19 165.13 37.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.22 1.408 . . . . 0.0 108.746 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -56.61 166.02 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.555 1.142 . . . . 0.0 112.87 -173.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.37 143.84 49.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.383 0.673 . . . . 0.0 111.485 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -151.72 -0.67 0.33 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.381 0.672 . . . . 0.0 111.436 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -78.54 55.39 1.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.127 0.971 . . . . 0.0 112.985 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.72 -149.87 5.13 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 118.301 0.5 . . . . 0.0 112.415 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -153.08 156.47 32.69 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.284 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -32.71 100.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 125.114 3.876 . . . . 0.0 116.367 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -83.61 -24.96 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.421 2.748 . . . . 0.0 110.176 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -150.56 -166.75 2.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.92 1.688 . . . . 0.0 108.481 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.232 0.162 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.489 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.85 -45.9 90.99 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.462 -0.632 . . . . 0.0 111.844 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 16.2 ptm180 -166.49 40.2 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 55.8 Cg_endo -66.0 128.07 18.97 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.487 -1.774 . . . . 0.0 107.487 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.28 113.06 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.582 2.855 . . . . 0.0 111.408 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -88.9 -162.1 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.207 3.271 . . . . 0.0 109.507 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 11' ' ' GLU . 25.5 t0 -138.67 33.03 2.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 0.0 109.753 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -1.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.325 1.45 . . . . 0.0 113.495 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 9' ' ' ASP . 39.5 mt-10 -105.73 7.59 32.59 Favored 'General case' 0 CA--C 1.527 0.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.526 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.05 17.83 0.32 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.424 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 14.9 ptt? -141.01 169.67 17.18 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.538 0.669 . . . . 0.0 110.804 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.3 m -62.1 166.81 4.42 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.4 m -147.64 61.36 1.14 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 18.9 tp -63.18 155.37 28.37 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 13.9 pttp -127.43 143.38 51.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.351 0.407 . . . . 0.0 110.173 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.17 151.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -151.48 -170.98 3.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 109.902 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 82.71 28.1 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.842 1.257 . . . . 0.0 113.049 171.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.41 125.07 15.02 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.684 0.794 . . . . 0.0 109.483 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 24' ' ' ARG . 11.9 m -75.17 168.91 19.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.742 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -65.21 8.49 0.14 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.271 1.028 . . . . 0.0 112.781 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.8 ptt180 -134.56 16.98 3.64 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.486 1.114 . . . . 0.0 111.315 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -120.91 166.57 13.63 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -172.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.437 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.9 p -152.72 164.78 19.23 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.425 1.09 . . . . 0.0 109.052 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 55.3 Cg_endo -68.96 -29.36 27.86 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.686 2.257 . . . . 0.0 111.688 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.83 -36.57 75.72 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.081 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.8 m -72.17 -42.37 65.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -54.64 -25.81 29.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.903 -0.498 . . . . 0.0 111.184 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -79.17 -54.6 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -62.49 -29.99 70.94 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.601 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.38 -32.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 122.974 0.51 . . . . 0.0 110.909 -173.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.414 ' CD1' HD11 ' A' ' 30' ' ' LEU . 24.6 m-85 -102.59 -9.74 19.87 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.27 -25.52 60.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.762 -0.586 . . . . 0.0 111.192 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -68.88 -23.32 64.2 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.004 0.366 . . . . 0.0 111.924 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -72.86 -16.28 61.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.439 0.296 . . . . 0.0 111.252 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.07 -80.59 0.13 Allowed Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -162.3 161.68 27.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.672 0.389 . . . . 0.0 110.443 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -136.98 145.87 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.97 -45.22 6.76 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -169.31 167.68 10.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.684 0.394 . . . . 0.0 110.595 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 m -121.47 152.12 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -149.33 140.92 23.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.348 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.87 108.17 7.62 Favored Pre-proline 0 CA--C 1.53 0.179 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.04 -21.39 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.566 2.844 . . . . 0.0 112.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 36.63 -103.75 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.77 1.228 . . . . 0.0 110.98 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 50' ' ' TYR . 9.2 m-20 -142.88 11.93 1.83 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.381 1.073 . . . . 0.0 109.949 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 55.18 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.523 1.929 . . . . 0.0 115.764 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' H ' ' C ' ' A' ' 48' ' ' ASP . 53.0 p90 -141.96 -2.14 1.19 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.314 1.415 . . . . 0.0 113.612 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.03 -20.37 5.78 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.148 0.431 . . . . 0.0 110.878 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 48.45 24.4 0.73 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.147 1.379 . . . . 0.0 113.843 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.74 19.53 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -142.25 168.81 18.86 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.241 0.543 . . . . 0.0 112.082 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -175.29 20.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.475 1.91 . . . . 0.0 110.113 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.83 -9.06 44.37 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.707 -0.621 . . . . 0.0 113.332 -172.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -159.63 163.88 34.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.892 0.877 . . . . 0.0 109.181 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.86 95.32 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.57 96.74 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 60.7 t -92.75 148.28 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 17.4 ttt180 -126.1 115.73 20.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.905 0.753 . . . . 0.0 111.739 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 34' ' ' PHE . 18.3 m-85 -96.78 163.36 13.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.961 0.104 . . . . 0.0 110.914 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.424 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.1 OUTLIER -127.49 -25.36 3.18 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.085 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.12 119.17 26.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -57.47 -49.29 76.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.809 0.277 . . . . 0.0 110.61 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -62.6 -32.63 73.66 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -88.25 -16.03 34.28 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.39 -47.76 12.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.441 ' HA ' ' HE1' ' A' ' 72' ' ' MET . 9.9 pt-20 -67.86 -27.35 66.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.118 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.4 -40.83 57.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.509 0.595 . . . . 0.0 110.84 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.49 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.13 -0.356 . . . . 0.0 111.261 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.441 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 3.8 ptp -77.73 -37.4 49.35 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.0 1.02 22.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.978 0.511 . . . . 0.0 111.836 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.78 -4.93 3.62 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttm -138.06 -28.01 0.88 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.45 134.66 56.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.916 0.78 . . . . 0.0 110.037 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 81.98 9.96 84.62 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.414 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.9 30.15 0.38 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.081 0.941 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.543 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 42.9 t -72.72 162.49 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.431 1.092 . . . . 0.0 112.234 -172.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.28 16.25 0.21 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.836 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -144.61 4.67 1.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.189 0.595 . . . . 0.0 111.472 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.3 -9.13 57.48 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.43 ' C ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.92 123.1 0.51 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.523 1.129 . . . . 0.0 108.533 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.543 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.7 mm-40 -138.31 -47.32 0.52 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.518 169.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -137.81 153.57 49.63 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.184 0.516 . . . . 0.0 111.937 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -149.0 108.24 3.93 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.772 1.629 . . . . 0.0 106.968 168.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.36 140.7 47.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.293 0.237 . . . . 0.0 111.345 -176.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -171.49 175.84 3.97 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.712 1.605 . . . . 0.0 108.046 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.8 mmt -75.45 146.98 40.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.92 51.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -132.38 19.6 4.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.76 139.68 29.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.46 -165.32 13.63 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 122.878 0.275 . . . . 0.0 112.457 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -45.18 127.85 5.72 Favored Pre-proline 0 CA--C 1.526 0.043 0 C-N-CA 123.813 0.845 . . . . 0.0 110.158 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.98 142.59 57.27 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.813 2.342 . . . . 0.0 110.467 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.68 -34.09 4.52 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.038 2.492 . . . . 0.0 110.668 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -167.8 136.2 2.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.057 0.543 . . . . 0.0 110.704 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 CA--C 1.528 0.103 0 C-N-CA 124.517 1.127 . . . . 0.0 111.192 172.013 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.47 62.68 3.78 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.958 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 17.2 mtp180 106.64 21.59 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 127.325 2.25 . . . . 0.0 116.002 167.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 82.2 Cg_endo -71.82 149.81 54.63 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.593 1.605 . . . . 0.0 110.148 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.41 144.73 29.28 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.453 2.768 . . . . 0.0 111.141 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.55 -169.26 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.761 3.64 . . . . 0.0 110.134 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -131.69 17.38 4.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.781 0.832 . . . . 0.0 109.403 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.27 -5.85 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 125.593 1.557 . . . . 0.0 112.877 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.16 -0.32 3.27 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 112.991 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.83 36.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.217 -0.768 . . . . 0.0 113.702 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 165.06 28.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.652 1.226 . . . . 0.0 112.457 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -73.64 93.14 2.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 123.761 0.824 . . . . 0.0 110.844 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -70.44 85.27 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.026 0.931 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -106.57 134.1 50.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.8 155.34 46.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -168.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.49 155.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -174.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -152.22 -171.09 3.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.679 1.192 . . . . 0.0 110.454 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 87.18 27.36 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.256 1.422 . . . . 0.0 113.145 171.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.77 125.77 15.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.122 0.969 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -77.34 171.92 14.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.264 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -63.36 6.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.774 1.23 . . . . 0.0 114.09 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -134.6 15.0 3.7 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.488 0.586 . . . . 0.0 112.084 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 m -117.7 165.19 13.91 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.507 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -153.3 167.21 13.95 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.648 1.179 . . . . 0.0 109.431 -174.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 43.4 Cg_endo -69.46 -28.47 26.67 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.247 1.965 . . . . 0.0 111.675 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.75 -34.38 75.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.3 m -77.66 -43.77 30.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.401 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -57.87 -21.19 41.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.811 -0.555 . . . . 0.0 110.703 178.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -56.51 4.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -61.37 -31.04 70.93 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.645 0.202 . . . . 0.0 110.597 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.28 -34.92 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 122.765 0.426 . . . . 0.0 111.06 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 30' ' ' LEU . 16.6 m-85 -99.34 -10.68 21.99 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.63 -27.07 61.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.445 0.566 . . . . 0.0 111.233 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -67.25 -22.65 65.67 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -74.04 -23.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.377 0.271 . . . . 0.0 110.988 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.86 -79.56 0.09 OUTLIER Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.143 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -157.31 164.8 37.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.94 133.68 44.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.07 -38.54 7.83 Favored Glycine 0 CA--C 1.519 0.344 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -158.42 161.02 37.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.879 0.872 . . . . 0.0 109.64 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.1 p -139.07 74.37 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-O 123.301 1.524 . . . . 0.0 107.05 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -83.13 143.64 30.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.299 -169.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.8 mt -140.14 130.36 13.84 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.44 151.1 5.02 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.158 2.572 . . . . 0.0 111.712 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.05 19.19 3.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.262 0.625 . . . . 0.0 109.631 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 50' ' ' TYR . 64.9 m-20 42.47 26.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.11 0.964 . . . . 0.0 112.767 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 42.88 3.26 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.642 2.777 . . . . 0.0 116.312 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' A' ' 48' ' ' ASP . 30.0 p90 -165.87 -4.11 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 113.915 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -116.78 -18.9 10.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.154 1.343 . . . . 0.0 111.633 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.69 30.6 0.54 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 125.775 1.63 . . . . 0.0 113.64 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.46 -159.39 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.664 0.786 . . . . 0.0 109.095 171.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.4 t -138.01 172.85 12.32 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.979 0.511 . . . . 0.0 111.384 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -137.02 3.53 2.67 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.514 0.725 . . . . 0.0 111.762 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.34 54.26 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.347 -0.696 . . . . 0.0 112.887 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.81 169.6 23.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.672 1.236 . . . . 0.0 111.318 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.39 101.67 3.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -69.33 89.48 0.48 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.071 1.349 . . . . 0.0 109.066 -175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 68.0 t -75.39 158.59 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 172.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -138.98 128.21 24.05 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -106.05 173.69 6.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.19 1.396 . . . . 0.0 109.555 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -135.6 -38.31 0.74 Allowed 'General case' 0 C--N 1.339 0.127 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.79 124.62 32.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.427 -0.796 . . . . 0.0 109.133 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -53.75 -49.39 68.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.848 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -58.73 -24.9 62.34 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.8 p30 -110.42 -6.57 14.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.714 0.688 . . . . 0.0 111.287 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.34 -46.63 22.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.39 -31.06 48.19 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.569 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -71.27 -43.9 66.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.482 1.037 . . . . 0.0 111.089 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.41 75.12 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 118.146 0.43 . . . . 0.0 110.278 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttp -72.22 -42.52 65.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.751 0.42 . . . . 0.0 110.627 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.19 3.51 23.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.332 -0.23 . . . . 0.0 111.24 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.35 -6.32 4.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.0 ttm -137.47 -28.17 0.92 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.44 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -63.1 137.87 58.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 118.016 -1.473 . . . . 0.0 109.865 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 73.7 10.71 80.27 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.903 177.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 33.0 0.4 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.262 1.031 . . . . 0.0 110.547 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.583 HG23 ' H ' ' A' ' 81' ' ' ASP . 9.8 p -73.28 174.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -170.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.413 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 1.3 pt? -152.69 4.92 0.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.622 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.583 ' H ' HG23 ' A' ' 79' ' ' VAL . 36.8 t70 -141.52 -3.72 1.15 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.548 0.339 . . . . 0.0 111.886 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 79' ' ' VAL . . . 109.87 -10.55 32.15 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.457 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.41 128.18 3.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 13.1 mm-40 -144.24 -49.54 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -138.64 154.61 48.65 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.103 0.561 . . . . 0.0 112.294 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -152.03 112.52 4.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.868 1.667 . . . . 0.0 106.506 166.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.57 125.69 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.232 0.539 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -154.07 163.67 39.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.361 1.464 . . . . 0.0 108.36 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 mmt -61.01 140.94 57.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.577 0.751 . . . . 0.0 110.356 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 156.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -145.74 18.92 1.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.259 1.024 . . . . 0.0 108.661 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.75 135.8 20.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -176.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.32 176.38 21.71 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.333 0.407 . . . . 0.0 113.523 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -63.3 135.87 96.44 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 123.729 0.812 . . . . 0.0 110.266 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.98 134.05 35.7 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.767 2.312 . . . . 0.0 109.799 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.72 -20.99 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.329 2.686 . . . . 0.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -150.73 157.33 42.83 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.608 1.163 . . . . 0.0 107.88 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -175.153 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.39 32.09 43.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.219 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 34.68 57.69 2.19 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.07 1.348 . . . . 0.0 113.034 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.65 150.89 79.71 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.016 2.477 . . . . 0.0 110.464 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.22 122.06 8.05 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.539 2.826 . . . . 0.0 110.571 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -80.88 -167.94 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.775 2.983 . . . . 0.0 110.433 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -129.61 29.35 5.06 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.679 0.792 . . . . 0.0 110.319 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 m -56.23 -12.74 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.678 1.191 . . . . 0.0 112.585 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.07 -0.94 5.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.227 1.011 . . . . 0.0 112.931 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.41 28.74 0.14 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.341 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.34 166.37 25.28 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.856 1.328 . . . . 0.0 112.082 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.409 ' OG1' ' HE3' ' A' ' 65' ' ' LYS . 91.1 m -82.99 90.13 6.97 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.869 0.868 . . . . 0.0 111.285 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.9 m -67.21 85.97 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.889 0.876 . . . . 0.0 110.428 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 31.8 tp -70.95 162.92 28.51 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.245 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.402 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 25.3 ttpp -133.55 143.61 48.82 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.123 0.969 . . . . 0.0 110.529 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.42 146.43 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -150.67 -169.74 3.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.777 1.631 . . . . 0.0 110.406 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.49 27.13 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.755 1.622 . . . . 0.0 113.563 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.22 123.43 11.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.762 0.825 . . . . 0.0 109.959 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' ARG . 10.4 m -72.25 168.04 19.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -64.69 9.7 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 113.123 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' THR . 23.5 ptt180 -135.06 17.88 3.46 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.474 1.11 . . . . 0.0 111.397 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -125.29 162.83 23.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.661 0.385 . . . . 0.0 111.385 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.431 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 62.9 m -148.72 163.79 24.33 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.682 1.193 . . . . 0.0 109.018 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 26' ' ' SER . 55.3 Cg_endo -69.18 -30.54 24.81 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.277 1.985 . . . . 0.0 111.697 -175.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.34 -35.24 79.85 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.942 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.8 m -74.36 -44.19 53.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -56.34 -22.26 29.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.853 -0.53 . . . . 0.0 110.52 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -57.67 3.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.31 -30.71 71.35 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.771 0.319 . . . . 0.0 110.75 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.06 -32.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 30' ' ' LEU . 19.5 m-85 -100.64 -11.67 19.82 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.47 -26.73 64.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.494 -0.754 . . . . 0.0 110.928 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.49 -23.82 65.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.7 -16.38 59.53 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 122.64 0.376 . . . . 0.0 111.603 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.26 -82.16 0.11 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -158.94 165.27 34.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.045 0.45 . . . . 0.0 111.048 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.3 123.11 49.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.82 -23.77 51.65 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -164.68 155.68 14.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.117 0.484 . . . . 0.0 110.896 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.62 125.3 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -159.11 157.61 31.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.95 -167.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.427 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 9.9 mt -127.06 88.8 53.52 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 158.93 4.38 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.102 3.202 . . . . 0.0 111.425 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.488 ' C ' ' H ' ' A' ' 49' ' ' ARG . 82.3 mtm-85 -146.19 157.18 43.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.76 3.66 1.38 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 47' ' ' ARG . 9.2 ttm-85 62.55 -2.42 0.36 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.181 1.392 . . . . 0.0 114.008 172.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -149.37 0.19 0.5 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 p -127.56 -22.49 3.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.635 0.652 . . . . 0.0 111.386 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.0 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.687 1.995 . . . . 0.0 114.877 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.41 5.47 8.74 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.985 -0.447 . . . . 0.0 111.521 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.5 p -65.94 -23.07 66.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -34.8 116.66 0.34 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.803 1.241 . . . . 0.0 112.509 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.24 -6.85 0.28 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.679 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 172.0 15.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.808 0.843 . . . . 0.0 110.231 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.89 94.88 2.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -64.79 109.54 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.1 159.86 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.2 ptm180 -136.85 145.18 44.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.063 -175.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.417 ' HB2' ' CB ' ' A' ' 16' ' ' LEU . 4.7 m-85 -114.8 177.58 4.6 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.77 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.423 ' N ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -134.66 -32.7 0.99 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.85 127.69 32.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.229 0.468 . . . . 0.0 109.988 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HE3' ' OG1' ' A' ' 14' ' ' THR . 2.6 tppp? -60.38 -56.75 17.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -33.21 68.12 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -84.93 -23.93 28.61 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.977 0.353 . . . . 0.0 110.507 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -76.58 -44.15 35.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.42 ' HA ' ' HE1' ' A' ' 72' ' ' MET . 6.5 pt-20 -76.48 -19.3 58.15 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.002 -0.436 . . . . 0.0 111.349 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -79.47 -39.94 30.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.588 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.09 76.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.951 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.42 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 9.1 ptp -75.37 -39.45 59.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.658 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -77.2 1.56 18.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.279 0.632 . . . . 0.0 111.702 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.22 -6.35 3.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttm -138.41 -27.07 0.88 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.06 137.65 57.82 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.926 0.784 . . . . 0.0 110.058 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 79.42 10.36 86.01 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 119.607 -0.552 . . . . 0.0 112.439 175.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.13 30.99 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.076 0.938 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.568 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 43.0 t -75.22 163.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 124.335 1.054 . . . . 0.0 112.176 -171.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.82 10.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.241 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.6 4.75 2.62 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.464 0.705 . . . . 0.0 111.486 -175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.46 -8.49 58.6 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.435 ' C ' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -172.47 123.18 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.397 1.079 . . . . 0.0 108.643 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.568 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.4 mm-40 -137.9 -47.85 0.55 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 169.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -137.78 153.94 49.63 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 111.753 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -148.04 109.34 4.34 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.049 1.739 . . . . 0.0 106.721 167.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.53 134.71 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -168.11 173.03 8.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -76.25 139.94 41.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.168 0.587 . . . . 0.0 110.364 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.57 162.39 29.54 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.499 0.32 . . . . 0.0 110.568 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -144.86 15.25 1.55 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 108.991 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -135.1 166.41 23.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.45 168.28 14.35 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 117.912 0.324 . . . . 0.0 112.923 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 157.86 17.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.101 0.96 . . . . 0.0 111.526 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -33.56 97.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 1 C-N-CA 126.314 4.676 . . . . 0.0 115.924 -176.214 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.481 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 72.8 Cg_endo -77.88 -56.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.499 2.133 . . . . 0.0 109.276 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.481 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 15.6 t0 -176.45 123.03 0.16 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.566 1.146 . . . . 0.0 109.95 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 C--N 1.333 -0.109 0 C-N-CA 124.334 1.054 . . . . 0.0 110.793 177.517 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.7 m -147.06 170.53 16.96 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.155 0.582 . . . . 0.0 110.448 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -60.07 -43.91 95.1 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.925 0.49 . . . . 0.0 111.335 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.46 -81.55 0.03 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.459 ' CD ' " H1'" ' B' ' 107' ' ' ' U' . 28.1 mtp180 -153.86 69.09 6.32 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 125.342 1.457 . . . . 0.0 110.346 -171.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 118.04 5.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.087 2.525 . . . . 0.0 109.986 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.08 113.8 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.83 3.02 . . . . 0.0 110.894 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -87.83 -167.88 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.928 3.085 . . . . 0.0 109.849 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -137.59 41.71 2.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 109.511 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 17.7 m -52.7 -14.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.941 1.696 . . . . 0.0 113.693 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -88.4 5.23 43.21 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.124 0.569 . . . . 0.0 111.303 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.02 19.82 0.66 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 5.1 ptt? -139.39 166.61 24.11 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.793 0.796 . . . . 0.0 111.835 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -63.34 -26.54 68.81 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t 44.03 58.85 3.45 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.19 0.996 . . . . 0.0 112.478 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 23.4 tp -63.91 164.4 10.38 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.582 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 20.4 ttpp -137.21 142.08 42.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.339 1.055 . . . . 0.0 109.986 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.39 152.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -153.37 -167.78 2.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.107 1.363 . . . . 0.0 110.542 -174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 82.9 28.29 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.69 1.596 . . . . 0.0 113.309 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.64 126.18 22.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.795 0.838 . . . . 0.0 109.303 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -68.91 168.25 14.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -62.52 3.29 0.21 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -139.14 18.5 2.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.771 0.829 . . . . 0.0 112.078 -174.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -112.38 165.56 12.09 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.895 0.478 . . . . 0.0 110.391 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 82.8 p -149.59 167.06 13.78 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.319 1.048 . . . . 0.0 109.038 -176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.4 Cg_endo -68.98 -26.75 30.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.403 2.069 . . . . 0.0 111.68 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.86 -33.78 74.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.997 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -74.9 -44.38 49.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.442 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -58.67 -20.91 52.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.8 -0.562 . . . . 0.0 111.103 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -82.02 -56.62 3.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -62.91 -24.75 67.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.684 0.22 . . . . 0.0 110.481 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.9 t -83.11 -34.96 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.715 0.406 . . . . 0.0 110.644 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CD1' HD13 ' A' ' 30' ' ' LEU . 20.2 m-85 -99.27 -10.96 21.72 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -72.71 -26.61 61.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.634 -0.666 . . . . 0.0 111.441 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.98 -22.93 64.07 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -73.28 -20.89 60.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.844 0.458 . . . . 0.0 111.267 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.05 -88.92 0.1 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -154.23 164.47 38.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.37 0.605 . . . . 0.0 111.733 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.66 133.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.29 -24.43 24.32 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -161.65 152.69 18.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.077 0.465 . . . . 0.0 110.084 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.87 103.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.464 ' HH ' " H5'" ' B' ' 106' ' ' ' G' . 4.6 t80 -150.18 161.63 42.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.101 -167.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 mt -134.35 132.21 20.89 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.33 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.11 -29.69 32.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.962 2.441 . . . . 0.0 111.325 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 36.92 30.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.257 1.823 . . . . 0.0 114.708 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 50' ' ' TYR . 7.1 m-20 51.39 12.31 0.14 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.674 0.79 . . . . 0.0 112.812 -175.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 52.53 -14.18 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.879 2.472 . . . . 0.0 116.064 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 48' ' ' ASP . 22.2 p90 -155.47 4.12 0.19 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.686 1.13 . . . . 0.0 113.271 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 -25.6 3.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.846 0.748 . . . . 0.0 112.054 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.1 21.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.962 2.105 . . . . 0.0 115.008 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.95 -11.66 59.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.772 -0.58 . . . . 0.0 112.371 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.5 t -83.56 -78.11 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.048 0.385 . . . . 0.0 110.684 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.66 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.255 2.222 . . . . 0.0 115.894 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.11 -2.64 32.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.79 -0.569 . . . . 0.0 112.559 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -155.71 169.86 23.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.124 0.57 . . . . 0.0 110.097 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.79 103.54 3.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -66.11 92.2 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.695 0.798 . . . . 0.0 108.889 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.5 t -87.27 155.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.9 ttt180 -138.31 131.84 30.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 123.148 0.28 . . . . 0.0 111.236 -172.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -115.11 170.8 8.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.657 0.265 . . . . 0.0 111.143 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -32.96 2.02 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.42 122.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.04 -54.23 49.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -33.18 70.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -85.32 -21.22 29.03 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.983 0.356 . . . . 0.0 110.542 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.85 -42.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.941 0.496 . . . . 0.0 110.22 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -73.84 -25.57 60.14 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.05 -0.407 . . . . 0.0 110.511 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.15 -47.68 34.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.232 0.469 . . . . 0.0 110.393 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -31.53 71.72 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.347 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.8 ttp -74.01 -42.75 59.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.119 0.568 . . . . 0.0 110.452 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.8 2.96 24.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.024 0.13 . . . . 0.0 111.215 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.24 -5.59 4.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttm -137.88 -29.4 0.85 Allowed 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -64.15 140.23 58.85 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.932 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 75.8 6.98 83.18 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.72 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.8 32.06 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.165 0.983 . . . . 0.0 110.784 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.575 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 23.0 t -73.99 164.61 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.846 0.858 . . . . 0.0 111.569 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.7 5.06 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.9 3.3 1.82 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.145 0.43 . . . . 0.0 112.076 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.63 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.313 0.482 . . . . 0.0 112.632 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -172.44 115.19 0.31 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.268 1.027 . . . . 0.0 109.008 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 79.6 mm-40 -130.88 -50.45 1.04 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.119 171.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -140.53 153.54 46.21 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.304 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -151.79 113.96 4.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 167.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.34 135.79 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-O 121.227 0.536 . . . . 0.0 110.445 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.5 173.05 10.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.423 1.489 . . . . 0.0 108.275 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.51 147.62 50.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.524 0.73 . . . . 0.0 111.102 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.73 150.18 29.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -141.99 21.17 2.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.417 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 3.0 t80 -145.55 143.56 30.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -174.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.15 179.36 21.02 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 117.885 0.312 . . . . 0.0 112.876 -169.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -57.64 148.81 54.95 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.018 0.527 . . . . 0.0 110.981 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.02 135.64 21.37 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.65 2.9 . . . . 0.0 111.089 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.36 -39.9 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.589 2.192 . . . . 0.0 109.379 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.04 136.33 1.46 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.486 1.115 . . . . 0.0 109.503 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.5 m -154.58 11.38 0.38 Allowed 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.062 0.945 . . . . 0.0 110.287 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -136.99 6.97 2.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -146.75 171.88 14.49 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.261 0.624 . . . . 0.0 109.881 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.253 1.251 0 CA-C-O 117.252 -1.356 . . . . 0.0 109.778 -179.53 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.029 1 O4'-C1'-N19 115.736 7.536 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.582 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.161 1 C5'-C4'-C3' 109.148 -4.235 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.417 ' N2 ' ' CD2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.413 -3.293 0 C5'-C4'-C3' 109.761 -3.826 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.501 HO2' ' P ' ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.417 -3.014 0 O4'-C1'-N19 112.136 3.936 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.501 ' P ' HO2' ' B' ' 105' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.947 0 P-O3'-C3' 124.478 3.981 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.459 " H1'" ' CD ' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.422 -2.618 1 O4'-C1'-N19 112.376 4.176 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.426 0.155 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.1 p -149.86 174.2 12.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.276 0.63 . . . . 0.0 110.706 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -61.35 -45.8 92.89 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.631 0.772 . . . . 0.0 110.843 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.481 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 81.31 -73.38 2.6 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -178.73 52.4 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.07 139.63 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.544 2.163 . . . . 0.0 110.595 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.93 115.37 3.28 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.657 2.905 . . . . 0.0 110.097 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.27 -166.97 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.842 3.028 . . . . 0.0 110.571 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -132.41 28.69 4.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.244 1.018 . . . . 0.0 110.463 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.5 m -53.98 -18.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 124.771 1.228 . . . . 0.0 113.425 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -77.5 4.58 10.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.341 0.656 . . . . 0.0 111.912 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 16.66 0.67 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.017 -0.879 . . . . 0.0 112.324 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.07 166.91 23.37 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 1.206 . . . . 0.0 113.38 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -61.26 -27.67 68.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -167.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.1 m 44.48 38.55 2.67 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -62.58 132.88 53.86 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.704 -0.623 . . . . 0.0 109.844 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 68.8 tttt -97.68 148.88 22.88 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.524 0.73 . . . . 0.0 112.518 -170.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -127.12 147.96 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -155.32 -176.83 6.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.479 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 51.9 t30 84.96 38.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.179 1.392 . . . . 0.0 113.4 171.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.4 138.09 57.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.846 0.859 . . . . 0.0 108.96 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 24' ' ' ARG . 6.7 m -80.4 166.16 21.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.737 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -62.88 6.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.431 1.092 . . . . 0.0 113.373 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 22' ' ' THR . 34.8 ptt180 -135.06 20.34 3.46 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.965 1.306 . . . . 0.0 111.337 -174.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -123.87 165.02 18.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.817 0.447 . . . . 0.0 110.531 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.8 p -149.4 165.5 17.49 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 124.047 0.939 . . . . 0.0 109.351 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 61.9 Cg_endo -71.15 -25.16 22.66 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.052 1.835 . . . . 0.0 111.868 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.43 -34.19 75.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 121.839 -0.538 . . . . 0.0 109.674 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.5 m -75.63 -43.28 48.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -56.19 -23.48 35.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.623 -0.673 . . . . 0.0 111.093 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -80.61 -55.63 4.71 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -61.29 -28.74 69.4 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.042 0.383 . . . . 0.0 110.645 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -80.48 -33.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 122.94 0.496 . . . . 0.0 111.542 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.427 ' CD1' HD12 ' A' ' 30' ' ' LEU . 28.7 m-85 -103.07 -9.27 19.87 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.44 -24.32 57.03 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.733 -0.604 . . . . 0.0 111.016 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.91 -22.55 63.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.249 0.477 . . . . 0.0 112.169 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.26 -17.49 61.89 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 122.342 0.257 . . . . 0.0 111.123 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.2 -76.38 0.17 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -164.14 162.49 22.86 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.547 0.739 . . . . 0.0 110.445 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -136.42 144.16 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.23 -24.48 19.16 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -162.36 149.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 117.085 0.443 . . . . 0.0 111.062 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -139.26 113.59 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -146.4 160.47 42.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.2 92.1 40.08 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.651 0.38 . . . . 0.0 110.85 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -49.14 135.06 30.6 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 124.049 3.166 . . . . 0.0 111.147 173.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -164.78 164.68 21.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 50' ' ' TYR . 65.9 m-20 -69.09 117.48 10.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.442 ' HD2' " H1'" ' B' ' 105' ' ' ' A' . 9.0 ptm180 -67.48 16.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -169.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 10.2 p90 -146.89 -3.05 0.6 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.692 1.197 . . . . 0.0 112.001 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.427 HG21 ' CD2' ' A' ' 50' ' ' TYR . 44.6 p -123.68 -24.72 4.45 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.72 0.691 . . . . 0.0 110.371 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptt 49.88 26.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.979 1.712 . . . . 0.0 113.119 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.66 5.88 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.9 m 58.92 -178.18 0.08 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -141.62 0.09 1.42 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.55 16.97 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.887 0.767 . . . . 0.0 113.432 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -153.91 169.63 22.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.321 1.06 . . . . 0.0 110.026 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.0 96.69 3.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.444 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 21.6 t80 -63.04 115.94 4.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -116.99 163.16 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -139.06 125.58 20.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.826 0.704 . . . . 0.0 110.587 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 21.8 m-85 -96.34 158.62 15.35 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.561 0.744 . . . . 0.0 109.936 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.478 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -114.56 -30.98 6.35 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.653 0.595 . . . . 0.0 112.348 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.77 119.39 21.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HZ1' ' HB3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -61.49 -45.13 95.51 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.341 0.257 . . . . 0.0 110.644 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.473 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -67.13 -28.96 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -90.96 -13.34 33.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.97 -42.78 25.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.473 ' HB3' ' HZ1' ' A' ' 65' ' ' LYS . 10.3 pt-20 -77.42 -25.24 50.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.614 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.33 -47.11 36.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.646 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.87 73.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.4 ttp -73.3 -42.16 62.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.781 0.432 . . . . 0.0 110.369 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.02 3.21 27.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.263 -0.273 . . . . 0.0 111.558 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.53 -6.52 4.68 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.8 ttm -139.45 -26.54 0.81 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.14 134.72 56.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.396 0.998 . . . . 0.0 110.755 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 8.67 85.68 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.128 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.41 33.4 0.35 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.19 0.995 . . . . 0.0 111.098 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.587 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 46.1 t -69.42 164.52 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.012 0.925 . . . . 0.0 112.209 -173.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.97 9.95 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.68 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -149.88 4.4 0.56 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.107 0.867 . . . . 0.0 113.249 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.55 -20.35 4.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.852 -0.53 . . . . 0.0 111.974 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.486 ' C ' HG11 ' A' ' 79' ' ' VAL . 6.2 ptp180 -175.23 143.65 0.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.112 1.765 . . . . 0.0 106.651 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.587 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.2 mm-40 -141.59 -47.62 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.643 169.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -139.92 159.29 42.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.79 0.805 . . . . 0.0 112.124 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 10.1 mmm180 -152.33 114.34 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.88 127.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -167.46 165.17 14.94 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.86 142.21 58.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.366 -172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.65 167.81 6.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.133 0.573 . . . . 0.0 111.524 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -139.39 -8.19 1.3 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 123.346 0.658 . . . . 0.0 110.993 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.476 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 4.6 m-85 -140.25 173.61 11.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -116.79 175.61 15.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 117.719 0.236 . . . . 0.0 112.834 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -60.36 142.21 90.65 Favored Pre-proline 0 C--O 1.233 0.19 0 C-N-CA 123.737 0.815 . . . . 0.0 110.136 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.446 ' CG ' H5'' ' B' ' 105' ' ' ' A' . 76.7 Cg_exo -51.05 130.41 31.63 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.321 2.681 . . . . 0.0 113.403 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.66 -25.31 9.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.761 2.307 . . . . 0.0 109.324 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -159.31 161.61 35.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.127 1.371 . . . . 0.0 107.679 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p -71.45 89.41 0.94 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.6 t60 51.46 24.36 2.18 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.471 1.108 . . . . 0.0 112.348 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 50.83 28.83 3.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.933 0.893 . . . . 0.0 112.477 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.253 1.245 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.606 -179.192 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.945 1 O4'-C1'-N19 115.752 7.552 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.407 -3.87 0 C1'-O4'-C4' 106.63 -3.3 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.476 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.562 1 P-O3'-C3' 125.953 5.211 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.446 H5'' ' CG ' ' A' ' 95' ' ' PRO . . . . . . . . 0 O4'--C4' 1.416 -3.071 1 P-O3'-C3' 125.271 4.642 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 0 P-O3'-C3' 124.472 3.977 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.481 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.781 0 O4'-C1'-N19 111.724 3.524 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.9 p -153.88 -174.03 4.8 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.066 0.546 . . . . 0.0 110.21 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -57.81 -30.17 65.5 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.893 0.477 . . . . 0.0 110.965 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.77 45.42 27.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.534 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 38.94 50.39 2.63 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.161 1.384 . . . . 0.0 114.36 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.01 149.28 52.61 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.209 2.606 . . . . 0.0 110.89 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.93 123.84 8.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.254 2.636 . . . . 0.0 110.499 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -81.85 -165.98 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.813 3.009 . . . . 0.0 110.367 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.69 30.17 4.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.922 0.889 . . . . 0.0 109.691 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.7 m -57.06 -12.23 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.607 1.163 . . . . 0.0 112.646 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.83 -0.04 8.22 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.919 0.887 . . . . 0.0 112.388 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.93 32.29 0.18 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.889 -0.951 . . . . 0.0 113.472 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.454 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.1 ptt? -142.89 164.86 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.546 1.173 . . . . 0.0 111.675 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -60.63 -28.01 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -170.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m 43.24 59.25 3.03 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 16.3 tp -66.42 169.58 7.24 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 13.9 pttt -139.09 155.58 47.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.402 0.546 . . . . 0.0 111.05 171.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.2 t -134.15 145.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -150.06 -174.59 4.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.48 1.112 . . . . 0.0 109.815 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 92.52 29.88 0.01 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.221 1.409 . . . . 0.0 112.968 169.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.92 117.74 3.19 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.538 1.135 . . . . 0.0 109.802 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -67.44 171.09 6.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -62.84 3.09 0.25 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.094 0.958 . . . . 0.0 113.01 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ptt-85 -134.26 14.28 3.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.388 0.675 . . . . 0.0 111.85 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -113.34 165.51 12.36 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.489 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.3 p -150.89 167.94 11.98 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.57 1.148 . . . . 0.0 108.839 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 62.4 Cg_endo -69.52 -35.02 14.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.264 1.976 . . . . 0.0 110.721 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -61.51 -36.07 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.117 0.484 . . . . 0.0 109.886 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -71.79 -44.23 64.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.65 -23.88 19.18 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.227 -0.296 . . . . 0.0 111.585 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -78.77 -56.56 4.31 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -65.29 -20.38 66.39 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.778 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.75 -32.1 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.636 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -106.16 -7.92 17.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.982 0.513 . . . . 0.0 112.277 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.47 -26.14 55.04 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.217 0.462 . . . . 0.0 111.155 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -67.64 -23.69 65.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.223 0.465 . . . . 0.0 112.244 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.89 -17.76 61.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.667 0.387 . . . . 0.0 111.526 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.84 -82.26 0.11 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.78 163.09 37.05 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.159 0.584 . . . . 0.0 110.789 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -135.3 140.25 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.59 -21.5 21.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.41 ' CG ' ' H1 ' ' B' ' 106' ' ' ' G' . 37.8 t0 -161.86 155.86 21.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.703 0.752 . . . . 0.0 111.713 177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -147.46 125.34 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 46' ' ' PRO . 1.6 t80 -157.48 152.66 25.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.53 71.2 52.33 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 20.4 Cg_endo -93.29 -6.45 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.616 1 C-N-CA 126.48 4.787 . . . . 0.0 117.979 -167.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -48.86 -36.43 16.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.366 1.439 . . . . 0.0 111.97 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 50' ' ' TYR . 20.5 m-20 -144.17 101.51 3.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 168.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.483 ' HD3' " H1'" ' B' ' 105' ' ' ' A' . 13.0 ptt180 -62.12 8.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.717 1.607 . . . . 0.0 114.908 -169.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.416 ' CD1' HG21 ' A' ' 51' ' ' THR . 18.6 p90 -150.84 6.09 0.51 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.33 1.052 . . . . 0.0 112.279 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.416 HG21 ' CD1' ' A' ' 50' ' ' TYR . 11.5 p -130.57 -29.02 2.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.866 0.757 . . . . 0.0 111.72 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 54' ' ' SER . 0.0 OUTLIER 46.93 23.87 0.31 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.466 1.506 . . . . 0.0 113.029 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.65 11.18 0.2 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 56' ' ' GLY . 49.5 m -131.92 25.47 4.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.472 0.709 . . . . 0.0 110.207 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 8.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.995 1.718 . . . . 0.0 114.831 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 54' ' ' SER . . . -60.38 -3.46 2.95 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.492 0.587 . . . . 0.0 111.768 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -152.88 168.04 27.09 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.407 1.083 . . . . 0.0 109.082 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.32 97.23 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 39.0 t80 -61.3 109.92 1.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.1 m -107.27 170.03 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.4 ptm180 -144.53 145.65 31.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.764 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -112.73 166.71 11.11 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.068 0.547 . . . . 0.0 109.926 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.454 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.87 -30.91 2.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.698 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.07 125.4 30.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -61.21 -54.2 47.24 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -32.14 69.29 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -86.76 -18.19 31.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.952 0.342 . . . . 0.0 110.762 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.36 -43.96 16.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 122.709 0.404 . . . . 0.0 110.147 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -73.25 -26.62 61.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.267 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -73.82 -46.47 44.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.322 0.51 . . . . 0.0 110.717 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.97 72.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.5 ttp -75.07 -40.98 59.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.105 0.562 . . . . 0.0 110.347 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.9 2.99 31.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.065 0.146 . . . . 0.0 111.279 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.83 -5.83 4.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.2 ttm -137.42 -28.95 0.9 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.1 t70 -64.51 137.86 58.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 120.161 1.346 . . . . 0.0 110.007 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.73 16.42 79.21 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.729 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.85 29.46 1.02 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.115 0.958 . . . . 0.0 110.371 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.473 HG11 ' C ' ' A' ' 83' ' ' ARG . 41.2 t -72.66 170.47 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.168 1.387 . . . . 0.0 112.486 -170.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -153.82 3.32 0.27 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -139.69 2.08 1.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.75 -20.02 4.38 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.241 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.473 ' C ' HG11 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -177.77 135.22 0.17 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.995 1.318 . . . . 0.0 108.074 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 79' ' ' VAL . 9.6 mt-10 -140.85 -37.56 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.019 171.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -144.4 149.98 36.98 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.703 0.401 . . . . 0.0 111.872 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -151.79 106.56 3.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.623 1.569 . . . . 0.0 106.879 166.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.428 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -133.87 126.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 CA-C-O 121.226 0.536 . . . . 0.0 110.495 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -156.59 175.29 14.24 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 125.67 1.588 . . . . 0.0 108.923 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.99 145.83 53.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.034 0.934 . . . . 0.0 110.389 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.44 170.34 16.3 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.966 0.506 . . . . 0.0 111.652 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -147.07 3.23 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.167 0.587 . . . . 0.0 110.985 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.583 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 19.6 m-85 -131.73 175.17 9.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.314 0.646 . . . . 0.0 109.579 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.0 177.2 16.48 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 121.507 0.504 . . . . 0.0 114.176 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -62.43 160.14 35.8 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.427 1.491 . . . . 0.0 112.634 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -34.05 103.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 126.527 4.818 . . . . 0.0 116.637 178.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.526 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 75.5 Cg_endo -81.12 -60.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.91 2.406 . . . . 0.0 109.433 169.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 12.8 t0 -179.1 131.14 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.317 1.447 . . . . 0.0 109.882 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.2 m -158.1 12.98 0.2 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.297 1.439 . . . . 0.0 110.008 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -143.79 10.03 1.56 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -166.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -148.03 171.4 15.89 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.729 0.412 . . . . 0.0 110.345 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.253 1.267 0 CA-C-O 117.604 -1.188 . . . . 0.0 110.137 -178.493 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.853 0 O4'-C1'-N19 111.714 3.514 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.406 2 O4'-C1'-N19 112.506 4.306 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.583 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 O4'-C1'-N19 111.56 3.36 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.483 " H1'" ' HD3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C3'-C2'-C1' 104.726 3.584 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.41 ' H1 ' ' CG ' ' A' ' 42' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.701 1 P-O3'-C3' 125.376 4.73 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.982 0 O4'-C1'-N19 111.449 3.249 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 ttp . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.6 m 51.18 -177.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.832 1.253 . . . . 0.0 113.579 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -69.71 -31.61 69.73 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.929 -0.482 . . . . 0.0 110.472 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.24 36.16 21.71 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.985 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.89 57.25 0.94 Allowed Pre-proline 0 N--CA 1.465 0.284 0 C-N-CA 125.51 1.524 . . . . 0.0 113.146 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.52 147.73 77.41 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.23 2.62 . . . . 0.0 109.668 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 114.97 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.562 2.841 . . . . 0.0 110.649 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.47 -162.65 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.42 3.414 . . . . 0.0 110.182 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 11' ' ' GLU . 11.8 p-10 -134.51 33.06 3.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.23 0.612 . . . . 0.0 111.14 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 m -64.5 6.13 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.187 1.395 . . . . 0.0 113.373 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 9' ' ' ASP . 69.8 mm-40 -65.71 2.9 0.86 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.973 0.909 . . . . 0.0 113.194 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.9 -8.88 0.04 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.507 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -65.64 169.69 5.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.592 1.196 . . . . 0.0 111.866 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -58.67 -26.37 63.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m 43.72 37.09 1.46 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -63.75 136.03 57.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.42 155.34 46.57 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -171.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.35 158.03 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.297 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -154.78 -173.74 4.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.167 0.987 . . . . 0.0 110.777 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.549 HD22 ' HB2' ' A' ' 83' ' ' ARG . 20.3 t30 96.81 27.94 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.744 1.617 . . . . 0.0 113.077 168.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 117.58 4.37 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.494 1.117 . . . . 0.0 109.778 -175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 24' ' ' ARG . 8.3 m -70.8 166.89 20.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -62.95 10.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.964 1.306 . . . . 0.0 113.907 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' THR . 20.3 ptt180 -130.04 17.8 5.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.893 0.877 . . . . 0.0 111.618 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -126.82 170.32 12.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 94.4 p -152.7 163.74 22.56 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.253 1.021 . . . . 0.0 109.296 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.8 -28.08 25.49 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.506 2.137 . . . . 0.0 111.717 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.57 -33.03 74.2 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.95 -0.469 . . . . 0.0 109.822 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.0 m -75.51 -46.48 32.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -56.94 -19.8 20.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -55.78 5.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -62.74 -31.27 72.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.188 0.995 . . . . 0.0 110.968 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.01 -32.71 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.442 0.297 . . . . 0.0 111.619 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.427 ' CD1' HD11 ' A' ' 30' ' ' LEU . 18.0 m-85 -98.67 -11.23 22.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.977 0.353 . . . . 0.0 111.941 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.55 -27.74 62.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.689 -0.632 . . . . 0.0 111.679 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.35 -22.54 65.58 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -73.78 -18.67 60.94 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.72 0.408 . . . . 0.0 111.129 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.88 -79.37 0.1 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -158.62 165.06 35.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 110.398 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -133.88 138.7 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.98 -26.61 7.4 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -163.08 161.35 25.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.916 0.358 . . . . 0.0 110.33 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' CG2' HG22 ' A' ' 60' ' ' VAL . 1.5 p -168.73 110.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.25 176.13 13.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.543 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mt -125.2 85.87 57.63 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.13 -23.71 17.83 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.449 3.433 . . . . 0.0 113.281 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -64.01 115.77 5.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 41.58 69.22 0.37 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 110.222 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -54.6 5.55 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.045 2.138 . . . . 0.0 116.61 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -143.54 7.41 1.5 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.514 1.125 . . . . 0.0 110.81 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -124.76 -38.23 2.39 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.02 24.7 0.13 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.228 2.211 . . . . 0.0 113.142 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -65.02 -21.2 66.81 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -76.93 -49.7 14.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.573 0.349 . . . . 0.0 110.824 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 37.07 31.64 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.627 1.971 . . . . 0.0 114.783 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.34 -10.47 74.68 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.59 -0.694 . . . . 0.0 112.016 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -163.13 169.11 19.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.603 0.701 . . . . 0.0 111.084 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 102.63 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE2' ' C5 ' ' B' ' 104' ' ' ' G' . 68.0 t80 -67.92 94.78 0.49 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 -175.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 59.4 t -81.35 160.74 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -143.84 134.94 25.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.043 0.537 . . . . 0.0 109.987 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -117.28 148.27 41.83 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.484 1.113 . . . . 0.0 109.836 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.582 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -99.59 -27.21 13.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -173.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.66 134.2 55.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 110.458 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.66 -45.6 93.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.745 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -33.77 76.56 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.98 0.809 . . . . 0.0 111.969 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.7 -24.71 36.03 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.68 -47.29 19.55 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.072 0.949 . . . . 0.0 110.839 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HA ' ' HE1' ' A' ' 72' ' ' MET . 8.8 pt-20 -74.09 -27.29 60.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.79 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -70.97 -40.46 71.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.278 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.39 73.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.024 -0.422 . . . . 0.0 111.333 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.456 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 6.5 ptp -78.8 -37.61 40.36 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.509 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -77.12 -0.73 25.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.23 0.612 . . . . 0.0 111.743 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.87 -4.99 4.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.7 ttm -138.02 -25.57 0.97 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.7 t70 -63.52 138.31 58.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 118.398 -1.321 . . . . 0.0 110.005 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.76 14.96 77.98 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.914 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.08 36.71 0.52 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.041 0.921 . . . . 0.0 110.257 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.553 HG23 ' H ' ' A' ' 81' ' ' ASP . 6.2 p -72.12 176.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -169.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.497 ' H ' HG23 ' A' ' 79' ' ' VAL . 1.1 pt? -151.78 -1.22 0.32 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.723 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.553 ' H ' HG23 ' A' ' 79' ' ' VAL . 37.3 t70 -144.45 -0.77 0.95 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.45 -19.09 6.0 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.549 ' HB2' HD22 ' A' ' 20' ' ' ASN . 0.1 OUTLIER -165.96 136.04 3.43 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 19.7 mm-40 -144.79 -41.82 0.24 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.89 150.29 44.41 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.834 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -152.27 108.11 3.35 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 126.121 1.769 . . . . 0.0 106.659 168.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -134.96 134.77 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.238 0.542 . . . . 0.0 111.284 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 89' ' ' MET . 31.4 tt0 -166.26 168.02 15.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.322 1.449 . . . . 0.0 108.11 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.454 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 11.6 mmt -61.28 142.31 56.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.176 0.99 . . . . 0.0 110.773 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 155.52 38.15 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.889 0.476 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -140.11 9.81 2.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.499 0.72 . . . . 0.0 109.608 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.636 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 20.2 m-85 -131.43 169.18 16.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.015 0.926 . . . . 0.0 109.335 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.3 -177.64 14.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -56.02 145.0 56.57 Favored Pre-proline 0 C--O 1.233 0.194 0 C-N-CA 123.271 0.629 . . . . 0.0 110.501 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.403 ' CB ' H5'' ' B' ' 105' ' ' ' A' . 61.0 Cg_endo -70.01 145.75 56.63 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.44 2.76 . . . . 0.0 112.276 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.0 -23.39 4.58 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.451 3.434 . . . . 0.0 112.198 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -149.96 164.53 35.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.601 1.16 . . . . 0.0 108.965 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.9 p -76.21 -35.32 59.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -167.01 11.22 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.962 0.801 . . . . 0.0 113.157 -174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.423 ' CG ' ' H ' ' A' ' 101' ' ' SER . 34.4 t60 -141.9 172.9 12.05 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.919 -0.488 . . . . 0.0 111.009 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.423 ' H ' ' CG ' ' A' ' 100' ' ' HIS . 61.0 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 117.0 -1.476 . . . . 0.0 110.194 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.269 1 O4'-C1'-N19 114.758 6.558 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.412 ' C5 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.41 -3.576 2 C1'-O4'-C4' 104.914 -5.207 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.636 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.76 1 N19-C1'-C2' 106.869 -4.082 OUTLIER-EPSILON 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.423 ' OP1' " H4'" ' B' ' 104' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.19 1 P-O3'-C3' 125.692 4.993 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.435 " H3'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.644 2 C5'-C4'-C3' 105.931 -6.379 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.435 " H3'" " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.883 0 O4'-C1'-N19 111.196 2.996 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p -59.75 142.84 52.42 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.625 0.37 . . . . 0.0 110.873 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 47.16 18.73 0.09 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.993 1.317 . . . . 0.0 113.556 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.97 92.51 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.8 ptm85 -168.91 42.87 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.527 1.163 . . . . 0.0 113.539 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 69.2 Cg_endo -68.99 136.11 34.12 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.52 1.48 . . . . 0.0 108.93 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.64 116.29 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.846 3.031 . . . . 0.0 110.98 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.61 -162.05 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.912 3.075 . . . . 0.0 110.142 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.67 30.5 2.85 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 31.2 m -63.48 -7.05 2.6 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 C-N-CA 123.881 0.872 . . . . 0.0 112.624 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.51 0.26 15.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.75 0.82 . . . . 0.0 112.812 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.25 51.43 0.13 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.252 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.459 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 11.7 ptp -132.39 173.8 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.821 0.811 . . . . 0.0 112.957 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -70.21 -22.5 62.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.173 0.989 . . . . 0.0 112.066 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 m 42.09 59.85 2.47 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.442 1.097 . . . . 0.0 113.618 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 22.5 tp -61.66 162.22 8.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.586 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 17.2 pttp -132.1 151.4 51.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.107 0.412 . . . . 0.0 110.655 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.17 143.04 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -149.31 -177.85 6.07 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 124.187 0.93 . . . . 0.0 110.413 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 t30 91.12 26.21 0.02 OUTLIER 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.158 1.383 . . . . 0.0 113.38 169.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.17 121.5 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.985 0.914 . . . . 0.0 109.682 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 24' ' ' ARG . 13.4 m -67.75 167.75 12.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -63.61 8.99 0.07 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.657 1.183 . . . . 0.0 113.471 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 22' ' ' THR . 29.6 ptt180 -133.58 16.44 3.99 Favored 'General case' 0 C--N 1.335 -0.041 0 C-N-CA 123.858 0.863 . . . . 0.0 111.818 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -124.05 165.63 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.459 0.303 . . . . 0.0 111.246 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 59.5 p -151.68 168.57 10.92 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.706 1.202 . . . . 0.0 109.256 -175.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 56.7 Cg_endo -68.94 -27.57 30.31 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.319 2.013 . . . . 0.0 111.713 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.85 -30.62 68.15 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.482 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 97.0 m -75.1 -45.08 43.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.415 HD12 ' CD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -59.02 -19.14 40.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.905 -0.497 . . . . 0.0 110.935 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -81.48 -56.63 3.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.385 0.539 . . . . 0.0 110.604 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.482 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -69.91 -15.46 63.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.276 -175.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.84 -30.93 4.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 123.419 0.688 . . . . 0.0 111.363 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.415 ' CD1' HD12 ' A' ' 30' ' ' LEU . 21.1 m-85 -103.12 -9.94 19.27 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.438 0.563 . . . . 0.0 112.288 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.97 -26.43 62.26 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.751 -0.593 . . . . 0.0 111.187 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.78 -24.14 64.38 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.68 -17.01 61.68 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.47 -80.43 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -162.53 167.24 23.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.023 0.529 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -133.09 138.95 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.19 -25.27 14.56 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -162.74 154.19 17.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.883 0.473 . . . . 0.0 110.17 174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.33 107.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -151.36 162.25 41.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.513 -166.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.76 126.43 15.74 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.48 42.46 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.702 3.601 . . . . 0.0 110.413 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -44.42 -44.8 8.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.928 1.291 . . . . 0.0 111.561 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -178.34 165.02 1.78 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.36 1.464 . . . . 0.0 108.898 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 0.2 OUTLIER -134.79 -5.66 2.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.633 169.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -168.3 14.93 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.564 1.146 . . . . 0.0 111.717 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 p -129.45 -14.58 4.18 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -168.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 43.14 24.1 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.608 1.563 . . . . 0.0 113.772 -172.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.436 ' HB3' ' H ' ' A' ' 54' ' ' SER . 97.0 mt-10 -77.63 -155.95 0.08 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.081 0.952 . . . . 0.0 110.358 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.436 ' H ' ' HB3' ' A' ' 53' ' ' GLU . 29.0 m -156.09 169.59 24.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.224 1.41 . . . . 0.0 109.615 175.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -130.03 -172.42 2.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.932 0.893 . . . . 0.0 108.897 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.57 29.61 5.83 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.264 0.935 . . . . 0.0 112.406 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -153.63 170.95 19.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.479 0.712 . . . . 0.0 109.576 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.89 101.78 3.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -67.22 91.74 0.25 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.444 0.698 . . . . 0.0 109.387 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 48.6 t -81.53 159.35 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 172.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.1 ttt180 -140.24 131.74 27.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.688 0.395 . . . . 0.0 110.421 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -113.58 157.92 21.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.057 0.39 . . . . 0.0 111.647 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.458 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -113.18 -34.6 5.62 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.1 128.05 33.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -64.56 -50.53 66.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.396 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -29.54 68.81 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.55 -20.72 31.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.5 49.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 9.1 pt-20 -77.36 -19.99 55.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.493 -0.13 . . . . 0.0 111.271 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.78 -41.58 44.09 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.199 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.4 75.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.161 -0.337 . . . . 0.0 111.395 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.401 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 11.0 ptp -75.52 -41.33 55.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.766 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -75.51 1.29 14.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.572 0.749 . . . . 0.0 111.705 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -5.96 3.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.3 ttm -141.23 -25.82 0.72 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.57 137.97 58.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.708 1.14 . . . . 0.0 111.101 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.92 9.18 75.2 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.373 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.42 29.34 0.51 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 84' ' ' GLU . 4.9 m -66.48 175.29 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 126.345 1.858 . . . . 0.0 113.847 -172.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.93 -1.3 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -143.49 4.3 1.36 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.433 0.56 . . . . 0.0 112.08 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.92 -27.4 3.33 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.415 ' HA ' HG12 ' A' ' 79' ' ' VAL . 6.3 ptp180 -157.36 160.08 38.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.178 0.489 . . . . 0.0 110.027 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.499 ' N ' HG13 ' A' ' 79' ' ' VAL . 16.4 mt-10 -160.62 -43.91 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.628 1.171 . . . . 0.0 109.68 165.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.47 153.84 47.61 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -153.76 107.21 2.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.256 1.822 . . . . 0.0 106.183 166.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 p -134.23 127.83 51.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 123.029 0.532 . . . . 0.0 110.134 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -156.74 -175.01 5.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.489 1.916 . . . . 0.0 108.112 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.2 mmt -82.84 142.27 31.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.13 155.66 40.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.374 0.269 . . . . 0.0 111.249 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -137.93 9.17 2.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.416 1.087 . . . . 0.0 110.488 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.598 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 22.8 m-85 -130.2 175.63 8.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 109.678 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.68 175.78 17.82 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 117.943 0.338 . . . . 0.0 113.054 -173.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -61.73 156.41 55.33 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.109 0.964 . . . . 0.0 111.399 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -27.49 95.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 1 C-N-CA 126.413 4.742 . . . . 0.0 117.292 -176.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.72 -26.07 1.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.56 2.84 . . . . 0.0 110.083 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -158.13 -177.63 6.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.772 1.629 . . . . 0.0 107.273 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.452 ' O ' ' C8 ' ' B' ' 105' ' ' ' A' . 22.9 m -67.47 -31.22 71.23 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -169.65 17.56 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.689 1.131 . . . . 0.0 112.587 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -144.65 170.96 15.08 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.812 0.278 . . . . 0.0 110.994 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.182 -1.389 . . . . 0.0 110.056 -177.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.426 2 O4'-C1'-N19 115.342 7.142 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.586 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.41 -3.568 2 O4'-C1'-N19 113.677 5.477 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.598 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.783 0 N19-C1'-C2' 107.103 -3.936 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.463 " H1'" ' HB3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.417 -2.978 1 O4'-C1'-N19 112.53 4.33 . 0.01 1z . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.504 0 C4'-C3'-C2' 99.564 -3.136 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 C5'-C4'-C3' 110.759 -3.16 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 4' ' ' GLY . 50.8 m -145.62 126.75 14.7 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 60.18 -27.91 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.732 2.013 . . . . 0.0 115.433 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 2' ' ' SER . . . 83.86 -80.22 1.84 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 170.87 68.6 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.573 1.149 . . . . 0.0 111.5 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.15 167.23 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.397 2.731 . . . . 0.0 111.216 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -98.15 71.83 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.637 1 C-N-CA 125.491 4.127 . . . . 0.0 112.945 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.72 -166.32 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.984 3.123 . . . . 0.0 110.294 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -131.57 34.16 3.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.442 0.697 . . . . 0.0 109.819 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.31 -11.98 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.021 0.928 . . . . 0.0 112.04 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.71 -6.57 47.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.774 0.83 . . . . 0.0 111.909 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.79 -8.16 0.07 OUTLIER Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.546 -0.585 . . . . 0.0 114.053 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.8 mtp -60.68 162.25 6.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.569 1.185 . . . . 0.0 111.013 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -60.34 -23.72 64.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.336 0.254 . . . . 0.0 110.659 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 t 42.92 55.36 4.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.536 1.134 . . . . 0.0 112.859 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 19.3 tp -61.39 159.04 13.3 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -143.98 140.4 29.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.517 0.599 . . . . 0.0 110.75 175.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.511 ' CG1' ' HB ' ' A' ' 60' ' ' VAL . 4.9 p -134.12 149.89 30.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 123.002 0.521 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -151.41 -170.12 3.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.902 1.281 . . . . 0.0 109.868 -176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 t30 87.73 26.76 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.918 1.287 . . . . 0.0 112.125 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.21 127.39 21.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.534 1.134 . . . . 0.0 109.412 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 m -76.22 169.54 18.02 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.295 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -63.13 5.74 0.14 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.921 1.288 . . . . 0.0 114.009 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -133.53 14.25 4.09 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.693 0.679 . . . . 0.0 112.013 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -114.87 165.82 12.43 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.92 0.391 . . . . 0.0 110.919 -173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.502 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 86.7 p -150.42 167.16 13.54 Favored Pre-proline 0 CA--C 1.529 0.139 0 C-N-CA 124.219 1.008 . . . . 0.0 109.63 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.2 Cg_endo -69.78 -34.25 14.9 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.684 2.256 . . . . 0.0 110.274 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.21 -36.17 83.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -72.78 -43.95 62.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -57.12 -21.56 33.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.272 -0.267 . . . . 0.0 110.833 -178.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -80.42 -56.66 4.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -7.97 41.74 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -97.67 -31.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.776 0.43 . . . . 0.0 111.644 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CD1' HD12 ' A' ' 30' ' ' LEU . 21.5 m-85 -101.11 -12.1 19.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.507 0.594 . . . . 0.0 111.874 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.84 -24.17 59.73 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.901 -0.499 . . . . 0.0 111.242 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.61 -23.73 64.49 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.786 -0.571 . . . . 0.0 112.077 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -75.27 -17.64 60.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.468 0.307 . . . . 0.0 111.391 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.53 -85.83 0.09 OUTLIER Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -157.32 162.4 39.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.067 0.547 . . . . 0.0 110.342 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.9 t -134.43 142.05 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -75.92 -46.82 12.71 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.18 171.85 4.0 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.318 0.58 . . . . 0.0 110.661 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.4 m -124.97 143.62 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -152.18 150.71 30.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.742 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mt -139.59 76.01 30.94 Favored Pre-proline 0 CA--C 1.528 0.131 0 C-N-CA 123.317 0.647 . . . . 0.0 109.946 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 95.4 Cg_endo -77.25 178.21 7.92 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 124.529 3.486 . . . . 0.0 111.798 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 46' ' ' PRO . 28.7 tpt180 129.52 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 129.175 2.99 . . . . 0.0 108.281 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 50' ' ' TYR . 20.2 m-20 -147.58 87.42 1.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 174.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.535 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 13.7 ptt180 -63.96 14.3 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.54 1.536 . . . . 0.0 114.862 -170.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 48' ' ' ASP . 11.5 p90 -145.25 5.14 1.09 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.295 1.438 . . . . 0.0 110.822 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 50' ' ' TYR . 7.0 p -133.38 -33.71 1.1 Allowed 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.135 -0.353 . . . . 0.0 111.154 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 34.29 33.49 0.01 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.956 2.102 . . . . 0.0 113.553 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -6.59 45.73 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.9 t -67.42 162.94 21.94 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.225 0.466 . . . . 0.0 110.849 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -155.26 7.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.3 -12.59 81.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.29 169.46 23.14 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.682 0.793 . . . . 0.0 109.796 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.23 95.65 1.73 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.4 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 63.0 t80 -62.8 97.19 0.1 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 37.8 t -99.66 152.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 6.9 ptm180 -137.03 143.76 42.88 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -113.64 160.5 18.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.479 0.712 . . . . 0.0 111.472 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.461 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -110.79 -36.1 5.79 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.71 133.64 34.79 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -66.54 -54.67 21.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.131 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.407 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -59.36 -34.22 72.12 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -83.11 -20.0 35.67 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.151 0.432 . . . . 0.0 110.872 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.99 -44.99 15.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 122.632 0.373 . . . . 0.0 110.162 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.97 -26.37 64.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.237 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.17 -47.49 43.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.068 0.394 . . . . 0.0 111.171 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.06 -31.75 72.96 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 122.004 -0.435 . . . . 0.0 110.499 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttp -74.32 -43.71 55.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.053 0.541 . . . . 0.0 110.423 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -79.73 1.9 24.8 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.91 -5.25 5.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.7 ttm -136.41 -28.69 1.0 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 4.6 t70 -63.89 136.2 57.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.852 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 74.68 10.69 83.18 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.779 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.17 34.58 0.47 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.945 0.872 . . . . 0.0 109.903 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.566 HG23 ' H ' ' A' ' 81' ' ' ASP . 8.8 p -73.83 174.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.413 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 1.2 pt? -151.98 3.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.703 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.566 ' H ' HG23 ' A' ' 79' ' ' VAL . 36.3 t70 -142.83 -3.5 0.99 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 79' ' ' VAL . . . 110.35 -10.5 30.99 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.62 129.02 4.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.139 0.975 . . . . 0.0 108.643 173.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 11.3 mm-40 -144.42 -50.25 0.28 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 170.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -138.69 152.98 48.49 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 122.828 0.451 . . . . 0.0 111.666 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -150.38 103.09 3.11 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 166.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 4.3 p -131.47 132.99 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.944 0.402 . . . . 0.0 111.145 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -153.21 176.28 12.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.911 1.284 . . . . 0.0 109.595 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.8 mmt -76.7 133.9 39.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.5 0.72 . . . . 0.0 109.069 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.63 149.94 47.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.723 0.297 . . . . 0.0 110.773 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -139.31 18.28 2.58 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.287 1.035 . . . . 0.0 108.917 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.487 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 2.8 t80 -145.33 144.71 30.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -119.79 174.85 15.67 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.739 0.699 . . . . 0.0 114.431 -168.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -61.2 139.53 94.48 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.804 1.242 . . . . 0.0 109.969 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.82 146.78 54.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.848 3.032 . . . . 0.0 112.937 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.81 -24.36 3.42 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.232 3.288 . . . . 0.0 111.545 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -152.36 160.67 43.28 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.526 1.131 . . . . 0.0 109.1 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.406 ' HA ' " C4'" ' B' ' 105' ' ' ' A' . 37.5 p -72.12 -53.33 13.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -164.29 172.64 13.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.258 0.481 . . . . 0.0 111.146 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -153.34 167.29 29.87 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.231 0.612 . . . . 0.0 110.09 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.084 -1.436 . . . . 0.0 109.938 -179.418 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . 0.534 " H4'" " H5'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.104 1 O4'-C1'-N19 112.352 4.152 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.534 " H5'" " H4'" ' B' ' 102' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.413 -3.357 2 C5'-C4'-C3' 107.62 -5.253 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.487 ' N2 ' ' CD2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.941 0 N19-C1'-C2' 108.614 -2.991 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.535 " H1'" ' HB3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.415 -3.132 0 O4'-C1'-N19 111.618 3.418 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.357 0 O4'-C1'-N19 111.72 3.52 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.429 " H4'" ' CA ' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.716 2 C4'-C3'-C2' 97.468 -5.232 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.9 p -150.03 174.51 12.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.106 0.562 . . . . 0.0 111.003 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -59.74 -41.83 91.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.11 0.564 . . . . 0.0 110.818 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.46 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 64.06 -81.94 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 125.268 1.413 . . . . 0.0 109.677 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -152.8 55.98 1.61 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 111.502 -167.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.81 118.42 5.59 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.551 2.167 . . . . 0.0 111.356 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.32 119.08 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.562 2.842 . . . . 0.0 110.883 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -84.38 -166.59 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.16 3.24 . . . . 0.0 110.501 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 11' ' ' GLU . 21.2 m-20 -134.92 36.86 3.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.181 0.992 . . . . 0.0 110.017 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.33 11.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.638 1.575 . . . . 0.0 114.337 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 9' ' ' ASP . 47.4 mt-10 -63.96 0.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.24 -177.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -5.14 0.09 OUTLIER Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.168 0.44 . . . . 0.0 113.363 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 7.5 ptt? -62.6 166.74 5.0 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.168 0.984 . . . . 0.0 112.718 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -59.15 -26.59 64.88 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.5 m 42.17 59.19 2.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.204 1.001 . . . . 0.0 113.512 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 22.1 tp -62.72 164.35 7.92 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' HE2' ' C5 ' ' B' ' 103' ' ' ' G' . 19.0 ttpp -135.72 145.08 46.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.043 0.937 . . . . 0.0 110.74 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.31 148.69 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.792 0.837 . . . . 0.0 108.952 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -152.26 -169.32 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.7 1.6 . . . . 0.0 110.138 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 83.93 27.37 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.403 1.481 . . . . 0.0 113.51 170.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.2 119.33 4.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.149 0.98 . . . . 0.0 109.93 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 m -70.71 169.87 13.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -62.53 5.22 0.12 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 113.741 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -130.71 14.29 5.38 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.313 0.645 . . . . 0.0 112.018 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -120.24 164.91 15.54 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.088 -173.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 97.5 p -149.08 168.01 11.86 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 124.283 1.033 . . . . 0.0 109.38 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.06 -29.66 22.07 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.627 2.218 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.32 -35.0 78.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.6 m -74.1 -44.74 52.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -56.75 -20.78 23.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.248 -0.282 . . . . 0.0 110.855 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -79.46 -57.34 3.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -14.44 63.0 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.76 -32.25 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.394 0.678 . . . . 0.0 111.502 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.411 ' CD1' HD11 ' A' ' 30' ' ' LEU . 23.0 m-85 -103.38 -9.49 19.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.3 -27.45 63.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.241 0.473 . . . . 0.0 110.908 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -68.45 -23.52 64.61 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.97 -16.89 61.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.187 0.195 . . . . 0.0 111.504 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.12 -80.73 0.13 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -160.29 164.84 32.29 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.992 0.517 . . . . 0.0 110.52 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.32 144.81 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -175.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.64 -21.45 7.88 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.38 157.81 28.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.472 0.636 . . . . 0.0 110.095 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -169.15 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.138 0.975 . . . . 0.0 108.414 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.14 167.54 28.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.5 mm -98.07 103.52 17.95 Favored Pre-proline 0 N--CA 1.456 -0.141 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.459 ' CB ' " H4'" ' B' ' 104' ' ' ' G' . 72.6 Cg_endo -72.82 -46.28 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.549 2.166 . . . . 0.0 111.478 -171.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.39 -178.83 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.79 2.436 . . . . 0.0 116.392 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.97 106.84 8.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -54.22 0.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.39 2.276 . . . . 0.0 114.697 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.4 ' CD2' HG23 ' A' ' 51' ' ' THR . 40.6 p90 -137.71 0.57 2.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.835 0.743 . . . . 0.0 112.309 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.4 HG23 ' CD2' ' A' ' 50' ' ' TYR . 28.7 p -127.05 -19.51 4.37 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.677 0.672 . . . . 0.0 111.216 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.404 1.881 . . . . 0.0 113.983 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -125.7 7.2 7.49 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -72.49 -6.73 45.83 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -40.24 141.71 0.46 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.773 1.629 . . . . 0.0 112.426 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.14 -3.56 0.91 Allowed Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.933 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -155.03 166.92 32.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.898 0.879 . . . . 0.0 109.573 174.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 106.76 4.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -70.21 110.85 5.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -113.04 164.68 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.3 ttt180 -142.87 139.74 30.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -116.92 164.97 13.89 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.564 0.54 . . . . 0.0 110.717 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.445 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -123.48 -31.57 3.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.232 0.613 . . . . 0.0 112.462 -177.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.54 125.32 30.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.1 -52.32 64.36 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -33.61 72.36 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -84.02 -19.73 33.98 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.53 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.04 -42.86 18.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.437 ' HA ' ' HE2' ' A' ' 72' ' ' MET . 8.6 pt-20 -71.89 -26.59 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.816 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.11 -40.33 62.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.313 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -33.41 75.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.232 -0.292 . . . . 0.0 111.592 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 69' ' ' GLU . 5.0 ptp -78.06 -37.48 46.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.08 1.74 23.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.141 0.576 . . . . 0.0 111.807 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.33 -6.86 4.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.0 ttm -138.89 -26.71 0.85 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.93 136.16 55.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.229 0.922 . . . . 0.0 110.181 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 77.97 9.9 86.61 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.162 177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.67 32.61 0.42 Allowed 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.309 1.055 . . . . 0.0 110.263 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.518 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 38.7 t -74.62 164.49 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.367 1.067 . . . . 0.0 112.094 -170.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -154.96 10.53 0.34 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.472 0.709 . . . . 0.0 112.217 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.35 5.09 2.24 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.87 0.468 . . . . 0.0 111.507 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.54 -9.84 57.44 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.442 ' C ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.93 124.92 0.55 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.694 1.198 . . . . 0.0 108.131 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 29.3 mm-40 -137.97 -48.89 0.56 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.249 0.22 . . . . 0.0 110.451 169.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -136.78 156.44 48.51 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 121.419 0.628 . . . . 0.0 112.296 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -148.05 109.08 4.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.955 1.702 . . . . 0.0 106.577 167.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.22 134.23 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -169.58 173.86 6.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.0 mmt -75.64 136.61 40.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.166 0.586 . . . . 0.0 109.909 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.49 151.58 45.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -140.52 21.4 2.37 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.662 0.785 . . . . 0.0 109.597 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -143.88 158.0 43.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.31 178.38 17.73 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.894 0.717 . . . . 0.0 114.894 -168.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.415 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 55.7 mtp180 -62.54 161.66 25.51 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 125.312 1.445 . . . . 0.0 111.034 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 94' ' ' ARG . 13.5 Cg_exo -28.92 96.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 1 C-N-CA 126.001 4.468 . . . . 0.0 114.952 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.448 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 72.0 Cg_endo -76.47 -57.29 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.706 2.271 . . . . 0.0 110.504 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.448 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 27.5 t70 -168.33 21.12 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.199 0.599 . . . . 0.0 111.712 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.411 ' HB2' " H5'" ' B' ' 105' ' ' ' A' . 16.2 m -64.48 -2.99 2.6 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.008 0.923 . . . . 0.0 112.842 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -144.22 8.49 1.41 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 122.84 0.456 . . . . 0.0 112.018 -170.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.578 ' CG ' ' H ' ' A' ' 101' ' ' SER . 29.2 t60 55.78 -179.97 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.827 1.251 . . . . 0.0 112.733 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.578 ' H ' ' CG ' ' A' ' 100' ' ' HIS . 71.0 m . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.414 -1.279 . . . . 0.0 109.854 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.498 2 O4'-C1'-N19 114.13 5.93 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.545 ' C5 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.088 0 O4'-C1'-N19 112.2 4.0 . 0.06 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.459 " H4'" ' CB ' ' A' ' 46' ' ' PRO . . . . . . . . 0 O4'--C4' 1.416 -3.119 2 O4'-C1'-N19 112.786 4.586 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.479 HO2' ' P ' ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.119 0 O4'-C1'-N19 112.194 3.994 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.479 ' P ' HO2' ' B' ' 105' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.914 0 P-O3'-C3' 124.406 3.922 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.46 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.419 -2.832 1 C5'-C4'-C3' 109.235 -4.176 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.419 0.152 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 m -63.55 167.98 5.13 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.184 0.594 . . . . 0.0 111.611 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 5' ' ' ARG . 96.8 m-85 -57.64 -48.34 79.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.343 0.657 . . . . 0.0 110.813 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.36 -32.06 0.16 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.71 2.1 . . . . 0.0 114.609 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 3' ' ' TYR 0.25 11.8 ptm85 146.06 65.63 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 128.879 2.872 . . . . 0.0 109.643 176.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -58.84 116.61 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.78 2.987 . . . . 0.0 111.324 -168.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -100.98 74.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.962 1 C-N-CA 125.981 4.454 . . . . 0.0 113.758 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 10' ' ' VAL . 67.8 Cg_endo -67.99 -162.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.802 2.334 . . . . 0.0 109.803 170.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -66.05 32.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.744 1.218 . . . . 0.0 113.805 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.443 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 10.5 m -56.68 -9.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.64 -12.83 61.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.888 0.475 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.29 15.15 0.03 OUTLIER Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.188 -0.784 . . . . 0.0 113.802 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 12.8 ptp -65.69 176.5 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.662 1.231 . . . . 0.0 112.263 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -70.08 -24.91 63.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.321 0.648 . . . . 0.0 112.323 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m 46.6 36.86 3.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.492 1.117 . . . . 0.0 113.868 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.87 132.84 49.62 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 17.7 pttt -117.04 161.02 20.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -130.51 147.83 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -151.59 -175.83 5.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.297 1.439 . . . . 0.0 110.34 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 t30 86.44 37.73 0.02 OUTLIER 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 113.455 169.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.43 163.55 10.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 24' ' ' ARG . 20.0 m -116.61 169.53 9.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.611 0.765 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -61.63 4.11 0.11 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.336 1.054 . . . . 0.0 113.438 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.0 ptm180 -136.03 19.11 3.22 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.398 1.079 . . . . 0.0 110.991 -175.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -124.17 167.38 14.34 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.246 0.618 . . . . 0.0 110.276 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.3 p -152.29 165.78 16.76 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.605 0.762 . . . . 0.0 109.754 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.4 Cg_endo -69.58 -27.65 27.07 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.811 2.34 . . . . 0.0 110.03 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -68.13 -37.71 81.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -72.76 -43.53 62.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.93 -19.74 32.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.337 -0.227 . . . . 0.0 111.031 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.64 -55.81 4.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -7.51 37.88 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.194 0.452 . . . . 0.0 112.009 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.21 -31.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.317 0.647 . . . . 0.0 111.113 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CD1' HD11 ' A' ' 30' ' ' LEU . 22.5 m-85 -102.84 -11.26 18.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.98 -24.99 60.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 121.914 -0.491 . . . . 0.0 110.921 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -68.65 -24.04 64.49 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -72.84 -19.51 61.3 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 122.611 0.364 . . . . 0.0 111.52 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.48 -82.99 0.1 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -158.18 164.58 36.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.928 0.491 . . . . 0.0 110.979 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.5 t -135.29 138.58 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.92 -24.0 18.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.421 ' CG ' ' H1 ' ' B' ' 106' ' ' ' G' . 24.2 t0 -163.26 156.08 18.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.915 0.358 . . . . 0.0 110.453 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -153.13 112.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -148.97 159.14 44.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -165.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -121.68 93.48 48.67 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 124.353 1.061 . . . . 0.0 108.938 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.65 33.23 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.599 3.532 . . . . 0.0 112.505 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -65.38 164.02 14.51 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.66 111.0 1.11 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.39 9.11 1.11 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.412 ' CD1' HG23 ' A' ' 51' ' ' THR . 12.0 p90 -144.85 -0.96 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 111.823 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.412 HG23 ' CD1' ' A' ' 50' ' ' TYR . 13.1 p -124.25 -8.04 7.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.381 0.537 . . . . 0.0 110.271 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.87 20.34 0.34 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.215 2.206 . . . . 0.0 113.173 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.7 102.36 0.74 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -57.06 166.57 1.02 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.427 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.34 -4.07 4.34 Favored 'General case' 0 N--CA 1.46 0.075 0 C-N-CA 123.87 0.868 . . . . 0.0 110.732 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.18 68.74 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.192 -0.782 . . . . 0.0 113.144 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.98 172.11 17.98 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.942 1.371 . . . . 0.0 111.746 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 92.71 2.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.472 1.109 . . . . 0.0 108.394 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.442 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 30.6 t80 -62.88 110.8 1.88 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -107.81 167.42 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -140.21 145.08 36.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.58 146.71 47.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.822 0.849 . . . . 0.0 110.694 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.617 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -99.51 -32.63 11.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.812 -177.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.92 127.07 33.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.762 0.425 . . . . 0.0 110.426 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.45 -51.73 58.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -33.69 72.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.61 -21.17 30.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.97 0.35 . . . . 0.0 110.341 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.39 -46.98 18.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.391 0.677 . . . . 0.0 110.225 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.52 -17.51 59.22 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.208 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.6 -40.02 35.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.095 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.38 75.5 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.141 -0.349 . . . . 0.0 111.293 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.2 ptp -74.68 -42.82 57.74 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.362 0.601 . . . . 0.0 109.682 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.99 1.25 13.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.805 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.37 -10.02 4.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.6 ttp -146.84 -17.63 0.41 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -61.84 136.94 58.18 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.715 1.143 . . . . 0.0 110.273 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.07 8.87 65.69 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.611 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.05 29.71 0.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.483 1.141 . . . . 0.0 112.039 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 84' ' ' GLU . 3.9 m -65.61 175.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.418 1.887 . . . . 0.0 114.127 -172.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 0.47 0.82 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -142.31 3.9 1.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.986 0.812 . . . . 0.0 111.992 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.4 -27.42 3.4 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' HA ' HG12 ' A' ' 79' ' ' VAL . 11.4 ptp180 -158.71 160.48 36.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 21.1 mt-10 -160.12 -44.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.702 1.201 . . . . 0.0 110.095 166.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -141.78 151.94 43.3 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.231 0.612 . . . . 0.0 112.217 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -153.49 114.13 4.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 165.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.4 p -139.38 116.82 11.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.499 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -151.53 164.92 35.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.081 1.352 . . . . 0.0 108.489 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.6 mmt -61.82 142.64 57.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.345 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.11 169.8 14.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.638 0.775 . . . . 0.0 110.76 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -142.65 2.98 1.44 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.196 0.598 . . . . 0.0 110.558 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.513 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 11.6 m-85 -133.79 166.84 21.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.23 179.28 17.38 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -61.17 145.29 90.16 Favored Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 122.506 0.322 . . . . 0.0 110.776 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.459 ' CB ' H5'' ' B' ' 105' ' ' ' A' . 65.0 Cg_endo -81.31 150.63 17.48 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.539 2.826 . . . . 0.0 111.834 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.19 -42.44 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.132 2.555 . . . . 0.0 111.025 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.42 148.34 2.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.256 1.022 . . . . 0.0 110.017 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.401 ' HB3' " H5'" ' B' ' 105' ' ' ' A' . 3.9 t -164.51 13.31 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 173.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -131.11 177.06 7.74 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.604 0.638 . . . . 0.0 110.902 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -143.13 9.28 1.67 Allowed 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.873 0.469 . . . . 0.0 111.679 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.393 -1.289 . . . . 0.0 110.21 -178.831 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.886 0 O4'-C1'-N19 111.294 3.094 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.544 0 N19-C1'-C2' 108.663 -2.961 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 6d' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.513 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.58 1 P-O3'-C3' 124.933 4.36 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.459 H5'' ' CB ' ' A' ' 95' ' ' PRO . . . . . . . . 0 O4'--C4' 1.419 -2.858 3 O4'-C1'-N19 112.764 4.564 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.456 " H3'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 C2'--C1' 1.506 -2.157 3 O4'-C1'-N19 113.357 5.157 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.456 " H3'" " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.193 2 C1'-O4'-C4' 105.354 -4.718 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.411 0.148 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.8 m -147.46 172.91 13.22 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.158 0.583 . . . . 0.0 110.304 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -60.82 -32.04 71.42 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.134 0.574 . . . . 0.0 111.372 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 47.56 59.7 5.79 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.566 1.555 . . . . 0.0 113.51 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.585 ' HD3' ' C6 ' ' B' ' 107' ' ' ' U' . 8.0 ptm180 39.34 62.53 5.04 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 126.378 1.871 . . . . 0.0 112.668 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.46 155.66 24.84 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.714 2.943 . . . . 0.0 109.645 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.61 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.416 2.744 . . . . 0.0 109.247 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -83.92 -172.35 1.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.837 3.025 . . . . 0.0 111.93 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -133.35 23.77 4.1 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.075 1.35 . . . . 0.0 108.535 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.23 -2.26 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 125.555 1.542 . . . . 0.0 112.858 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.55 9.47 1.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.066 0.946 . . . . 0.0 112.209 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.43 40.0 0.33 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.643 -0.532 . . . . 0.0 112.634 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.3 ptp -135.25 175.11 9.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.927 0.863 . . . . 0.0 112.293 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -71.1 -23.3 62.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.171 0.588 . . . . 0.0 112.405 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.7 m 43.56 57.08 4.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.86 0.864 . . . . 0.0 113.296 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 17.5 tp -65.11 166.3 9.8 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 20.0 pttp -138.28 154.94 49.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.838 170.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.1 t -130.88 143.09 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -148.92 -175.5 4.97 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.928 0.891 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 41.6 t30 83.82 37.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.76 1.224 . . . . 0.0 113.673 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 158.83 11.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.867 0.867 . . . . 0.0 108.958 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 24' ' ' ARG . 6.8 m -118.78 171.54 8.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.639 0.775 . . . . 0.0 109.959 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -63.52 7.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.829 1.252 . . . . 0.0 112.969 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 22' ' ' THR . 8.3 ptm180 -132.17 17.78 4.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.039 1.336 . . . . 0.0 110.401 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.52 167.37 19.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.015 0.526 . . . . 0.0 110.72 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.417 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 95.5 p -154.71 164.05 22.27 Favored Pre-proline 0 N--CA 1.464 0.254 0 C-N-CA 123.994 0.918 . . . . 0.0 109.127 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 49.5 Cg_endo -68.29 -30.16 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.064 1.842 . . . . 0.0 111.701 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.34 -33.88 73.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.09 -44.56 65.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -57.78 -21.3 41.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.145 -0.347 . . . . 0.0 111.222 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -81.28 -57.01 3.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.027 -0.42 . . . . 0.0 109.895 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -9.16 42.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.903 0.481 . . . . 0.0 111.854 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.91 -31.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.214 0.606 . . . . 0.0 111.807 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.411 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.5 m-85 -100.44 -11.45 20.18 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.397 0.544 . . . . 0.0 111.907 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.828 -0.545 . . . . 0.0 111.429 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.37 -23.23 63.72 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -71.04 -31.01 67.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.499 0.32 . . . . 0.0 110.48 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.76 -76.48 0.07 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -162.37 165.71 26.1 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 117.198 0.499 . . . . 0.0 110.577 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.5 t -137.53 138.05 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -71.98 -45.08 43.8 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.99 171.65 6.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.129 0.49 . . . . 0.0 110.265 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.36 128.57 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.979 0.911 . . . . 0.0 109.68 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.58 175.9 10.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.528 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.416 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 8.8 mt -116.6 88.26 23.94 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 124.049 0.94 . . . . 0.0 109.367 -172.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.49 150.92 52.52 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.838 3.025 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -179.16 -178.81 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.034 0.934 . . . . 0.0 108.565 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 50' ' ' TYR . 15.7 m-20 -58.01 109.18 0.69 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -67.58 19.14 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.581 1.552 . . . . 0.0 115.125 -168.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.423 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 5.7 p90 -149.89 -19.24 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.061 0.944 . . . . 0.0 111.991 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.8 p -103.75 -25.27 13.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.662 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.2 31.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.609 1.963 . . . . 0.0 113.966 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.24 -15.73 62.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.084 0.554 . . . . 0.0 112.292 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -97.12 155.74 16.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 111.359 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -171.63 16.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.399 1.079 . . . . 0.0 111.221 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.71 2.03 75.39 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.34 -0.85 . . . . 0.0 113.229 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.21 169.08 24.92 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.038 0.919 . . . . 0.0 110.219 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.67 92.35 2.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.27 110.58 1.68 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -105.6 163.76 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.8 ptm180 -139.06 142.58 38.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.756 0.66 . . . . 0.0 110.678 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -116.57 150.87 37.3 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.799 0.687 . . . . 0.0 111.557 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.565 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -95.83 -50.56 4.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 123.986 0.804 . . . . 0.0 112.008 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.67 135.17 49.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.947 0.499 . . . . 0.0 110.857 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.435 ' HZ1' ' HB3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -69.06 -52.38 29.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 178.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.412 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.68 -31.9 73.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -77.36 -26.34 51.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.871 0.367 . . . . 0.0 110.086 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.48 -40.91 34.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 122.031 -0.418 . . . . 0.0 110.512 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.442 ' HA ' ' HE2' ' A' ' 72' ' ' MET . 9.1 pt-20 -75.71 -22.3 56.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.87 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.87 -40.06 48.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.948 0.794 . . . . 0.0 109.937 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.89 74.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.323 -0.236 . . . . 0.0 111.464 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.442 ' HE2' ' HA ' ' A' ' 69' ' ' GLU . 6.7 ptp -77.42 -39.69 46.1 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.322 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.63 0.64 19.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.133 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.72 -6.28 4.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.1 ttm -139.15 -24.0 0.89 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.64 135.89 57.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.151 0.887 . . . . 0.0 110.099 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.39 10.19 78.62 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.093 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.1 35.01 0.42 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.015 0.908 . . . . 0.0 110.797 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 81' ' ' ASP . 10.0 p -69.09 174.78 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.484 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 1.2 pt? -152.73 -0.12 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.648 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.513 ' H ' HG23 ' A' ' 79' ' ' VAL . 32.5 t70 -145.37 0.02 0.88 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.414 ' H ' HG23 ' A' ' 79' ' ' VAL . . . 127.06 -18.61 6.17 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.48 ' C ' HG21 ' A' ' 79' ' ' VAL . 6.9 ptp180 -161.49 142.04 10.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 171.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 23.3 mm-40 -147.12 -50.38 0.19 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -139.61 151.3 45.9 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 11.0 mmm180 -147.79 109.73 4.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 105.804 167.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.82 134.64 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.116 0.567 . . . . 0.0 109.96 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.423 ' HG2' ' H ' ' A' ' 89' ' ' MET . 36.6 tt0 -169.9 177.67 4.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.423 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 14.1 mmt -73.95 144.83 45.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.841 0.456 . . . . 0.0 109.786 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.78 163.93 15.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.467 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -133.73 -1.29 3.08 Favored 'General case' 0 C--O 1.23 0.051 0 C-N-CA 122.517 0.327 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.58 169.92 15.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.99 179.08 16.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.49 120.17 29.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.435 ' CG ' " H5'" ' B' ' 105' ' ' ' A' . 43.0 Cg_endo -67.84 139.3 47.25 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.493 2.128 . . . . 0.0 111.659 -171.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.43 -17.99 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.492 3.461 . . . . 0.0 112.217 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -140.08 -169.2 2.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.46 1.104 . . . . 0.0 109.592 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p -140.22 30.86 1.96 Allowed 'General case' 0 N--CA 1.46 0.065 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.6 t60 56.97 16.07 2.64 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -147.65 9.75 0.92 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.226 0.61 . . . . 0.0 110.472 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.434 -1.269 . . . . 0.0 110.081 -178.584 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.287 1 O4'-C1'-N19 114.422 6.222 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.147 0 C4'-C3'-C2' 99.438 -3.262 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.206 0 C5'-C4'-O4' 113.918 3.37 . 0.09 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.435 " H5'" ' CG ' ' A' ' 95' ' ' PRO . . . . . . . . 0 O4'--C4' 1.415 -3.182 1 O4'-C1'-N19 113.848 5.648 OUTLIER-DELTA 0.0 OUTLIER '7D dist 7p' 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.558 " C2'" ' H ' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.422 -2.592 1 O4'-C1'-N19 113.369 5.169 . 0.029 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.585 ' C6 ' ' HD3' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.417 -2.991 1 O4'-C1'-N19 113.68 5.48 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.6 p -148.13 -172.79 4.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.492 0.717 . . . . 0.0 110.058 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -133.66 32.09 3.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.26 0.624 . . . . 0.0 110.684 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.429 ' HA2' " H5'" ' B' ' 107' ' ' ' U' . . . -117.09 59.28 0.47 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 45.47 46.98 3.46 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 127.331 2.252 . . . . 0.0 115.753 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.35 154.88 41.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.538 2.159 . . . . 0.0 108.508 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.54 112.87 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.395 2.73 . . . . 0.0 109.994 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -84.39 -165.68 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.355 2.703 . . . . 0.0 110.678 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -133.26 24.55 4.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.855 0.862 . . . . 0.0 109.607 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.72 -5.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 124.356 1.062 . . . . 0.0 112.553 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 6.8 2.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.38 41.07 0.41 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.557 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.43 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . 9.1 ptp -134.43 172.9 12.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.948 0.874 . . . . 0.0 112.593 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -69.21 -23.72 63.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.593 0.757 . . . . 0.0 112.73 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 m 44.84 36.57 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.579 1.151 . . . . 0.0 113.904 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -60.67 133.16 55.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.586 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 20.7 ttpp -106.6 147.18 29.78 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.889 0.875 . . . . 0.0 112.052 -171.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.81 154.64 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.932 171.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -154.2 -171.61 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.265 1.426 . . . . 0.0 110.593 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 93.8 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.615 1.966 . . . . 0.0 113.339 169.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 127.94 31.32 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.433 1.093 . . . . 0.0 109.461 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 24' ' ' ARG . 9.5 m -77.09 168.53 19.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.905 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -63.92 6.11 0.19 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.038 . . . . 0.0 112.669 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 22' ' ' THR . 32.7 ptt180 -137.52 19.4 2.91 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.591 1.156 . . . . 0.0 111.218 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -119.18 166.11 13.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.055 0.542 . . . . 0.0 110.431 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 92.7 p -150.71 164.85 18.91 Favored Pre-proline 0 CA--C 1.529 0.141 0 C-N-CA 124.243 1.017 . . . . 0.0 109.397 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.98 -23.75 29.42 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.473 2.115 . . . . 0.0 110.915 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.87 -35.13 72.23 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -76.18 -43.25 43.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -21.74 32.59 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.974 -0.454 . . . . 0.0 110.892 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.49 -56.13 4.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.92 -30.38 69.01 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.085 0.402 . . . . 0.0 110.334 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -78.5 -34.76 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.977 0.511 . . . . 0.0 111.004 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -99.1 -11.34 21.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -74.19 -24.48 59.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.542 0.61 . . . . 0.0 110.778 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -67.68 -24.99 65.48 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -74.56 -19.48 60.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.486 -0.293 . . . . 0.0 111.697 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.29 -80.76 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.476 -0.392 . . . . 0.0 112.173 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.12 166.15 33.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.7 t -137.1 137.36 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -80.49 -45.07 8.18 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -156.72 155.42 31.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.147 0.979 . . . . 0.0 108.444 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.01 117.15 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 175.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -147.99 164.01 35.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.681 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -134.45 92.57 20.23 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -48.36 142.39 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.125 3.217 . . . . 0.0 111.735 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -159.06 160.18 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.981 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 50' ' ' TYR . 2.1 m-20 -67.44 121.84 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.409 ' HD2' " H1'" ' B' ' 105' ' ' ' A' . 9.4 ptm180 -67.97 17.56 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 48' ' ' ASP . 10.1 p90 -150.94 -5.15 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.275 1.03 . . . . 0.0 112.387 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.413 HG21 ' CD2' ' A' ' 50' ' ' TYR . 35.3 p -119.52 -19.45 8.15 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.054 0.843 . . . . 0.0 110.333 171.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.46 24.58 1.63 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.069 1.748 . . . . 0.0 113.768 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.02 -164.19 0.13 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.236 0.615 . . . . 0.0 110.158 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -137.52 169.73 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.406 0.682 . . . . 0.0 110.836 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -138.18 7.62 2.66 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.344 0.658 . . . . 0.0 112.392 -172.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.77 20.8 35.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.578 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -152.41 165.41 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.57 1.185 . . . . 0.0 111.033 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.89 3.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.81 100.35 0.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 84.5 t -92.16 154.22 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -132.13 140.22 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.8 m-85 -119.92 143.66 47.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.193 0.597 . . . . 0.0 110.35 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.644 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -85.77 -32.71 21.69 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.94 131.14 55.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.375 0.607 . . . . 0.0 111.282 -170.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.15 -46.37 89.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.509 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.555 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -59.45 -34.54 72.64 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.21 -9.88 24.93 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.357 0.526 . . . . 0.0 110.68 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.89 -44.99 25.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.444 ' HA ' ' HE2' ' A' ' 72' ' ' MET . 8.5 pt-20 -75.67 -29.11 58.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.299 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.41 -41.68 80.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.592 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.73 76.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.257 -0.277 . . . . 0.0 111.533 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.444 ' HE2' ' HA ' ' A' ' 69' ' ' GLU . 6.7 ptp -77.4 -39.99 45.21 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.576 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.99 1.52 17.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.332 0.653 . . . . 0.0 111.719 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.51 -8.7 4.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.3 ttp -142.93 -19.98 0.65 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.03 135.38 57.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.398 1.454 . . . . 0.0 110.125 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.14 78.06 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.045 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.39 29.31 0.51 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.083 0.942 . . . . 0.0 110.966 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 84' ' ' GLU . 5.3 m -67.91 174.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 126.194 1.798 . . . . 0.0 113.361 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.79 9.99 0.92 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.809 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -139.41 7.31 2.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.162 0.585 . . . . 0.0 110.317 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.07 -17.33 48.58 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.82 136.7 7.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.409 0.683 . . . . 0.0 109.189 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.477 ' N ' HG13 ' A' ' 79' ' ' VAL . 81.2 mm-40 -150.76 -43.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 110.27 170.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -137.59 151.71 48.63 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.043 0.537 . . . . 0.0 112.122 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -152.28 112.92 4.14 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 166.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.13 133.12 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.364 0.602 . . . . 0.0 110.73 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -167.96 162.24 13.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.125 1.37 . . . . 0.0 108.546 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 mmt -59.15 139.26 57.08 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.732 0.813 . . . . 0.0 111.336 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.74 52.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -129.89 16.56 5.74 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.232 1.013 . . . . 0.0 108.378 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -147.28 142.38 27.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.29 1.436 . . . . 0.0 107.175 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.28 -176.11 17.43 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -170.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -53.76 132.18 56.54 Favored Pre-proline 0 N--CA 1.455 -0.212 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.29 143.14 52.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.143 2.562 . . . . 0.0 112.486 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.24 -21.84 10.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.199 3.266 . . . . 0.0 111.699 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -146.88 162.57 38.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.463 1.105 . . . . 0.0 108.092 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.7 p -59.48 -29.15 67.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -164.72 173.5 11.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.674 0.67 . . . . 0.0 110.14 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -61.62 160.88 10.67 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.083 0.553 . . . . 0.0 111.367 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.561 -1.209 . . . . 0.0 109.96 -179.768 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 110.895 2.695 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.586 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.633 2 O4'-C1'-N19 116.893 8.693 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.558 ' P ' " H1'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.82 2 O4'-C1'-N19 112.75 4.55 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.409 " H1'" ' HD2' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.926 2 C5'-C4'-C3' 104.569 -7.288 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.065 0 O4'-C1'-N19 111.68 3.48 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.429 " H5'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.421 -2.696 1 C4'-C3'-C2' 98.355 -4.345 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -153.66 -179.36 7.73 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.83 0.452 . . . . 0.0 110.081 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -63.1 -28.03 69.79 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.312 1.045 . . . . 0.0 111.972 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.45 35.32 20.45 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.855 0.741 . . . . 0.0 112.647 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 34.05 50.65 0.88 Allowed Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.486 1.514 . . . . 0.0 114.433 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.39 151.45 42.78 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.115 2.543 . . . . 0.0 110.692 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.21 117.97 4.23 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.784 2.99 . . . . 0.0 110.353 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.94 -169.01 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.02 3.146 . . . . 0.0 109.915 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -121.53 21.44 10.93 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.695 0.798 . . . . 0.0 109.31 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 12' ' ' GLY . 8.5 p -60.27 -8.28 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.663 1.185 . . . . 0.0 113.274 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.49 4.09 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.961 -0.462 . . . . 0.0 111.131 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 10' ' ' VAL . . . -149.54 28.12 1.2 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.42 1.01 . . . . 0.0 110.743 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.9 mtm -129.65 165.57 21.54 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.464 0.632 . . . . 0.0 111.405 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -67.0 -22.6 65.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 t 44.16 60.19 2.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 15.9 tp -65.49 166.13 10.92 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.2 ptmt -138.35 148.06 44.15 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 123.342 0.657 . . . . 0.0 110.913 172.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -129.41 143.06 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -153.01 -173.81 4.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.979 0.911 . . . . 0.0 109.738 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.2 t30 88.44 29.85 0.03 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.792 1.237 . . . . 0.0 112.558 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.56 134.97 35.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.055 1.342 . . . . 0.0 109.752 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 24' ' ' ARG . 1.6 m -74.28 168.01 20.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -64.66 4.25 0.42 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.846 0.858 . . . . 0.0 112.853 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 22' ' ' THR . 42.9 ptt85 -135.28 18.69 3.39 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.187 0.995 . . . . 0.0 111.482 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -119.2 165.1 14.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 122.935 0.494 . . . . 0.0 110.289 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.7 p -147.46 166.57 15.68 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.525 0.73 . . . . 0.0 110.03 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.2 Cg_endo -70.65 -32.08 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.858 2.372 . . . . 0.0 110.896 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.24 -35.33 80.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -73.23 -45.32 56.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.412 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -55.46 -21.04 14.53 Favored 'General case' 0 N--CA 1.457 -0.095 0 O-C-N 122.203 -0.31 . . . . 0.0 111.418 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -78.66 -57.8 3.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -64.99 -21.61 66.87 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.735 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.7 t -84.03 -32.88 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 119.612 -0.232 . . . . 0.0 111.007 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.412 ' CD1' HD11 ' A' ' 30' ' ' LEU . 19.3 m-85 -102.14 -10.2 19.85 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.0 -26.33 62.19 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.081 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -68.41 -23.19 64.61 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.86 -16.08 61.14 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.444 0.298 . . . . 0.0 111.035 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.31 -66.42 0.27 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-O 119.94 -0.366 . . . . 0.0 112.405 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -165.02 168.45 17.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.667 0.387 . . . . 0.0 110.59 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -141.85 135.31 29.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.92 -22.1 16.59 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -158.84 155.69 28.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.289 0.545 . . . . 0.0 110.425 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -170.89 100.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.79 1.236 . . . . 0.0 109.944 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.6 177.26 10.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 mm -106.57 98.51 20.6 Favored Pre-proline 0 C--N 1.34 0.193 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' CB ' " H4'" ' B' ' 104' ' ' ' G' . 83.2 Cg_endo -81.49 -41.78 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.501 2.801 . . . . 0.0 115.953 -166.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -70.39 155.12 41.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.866 0.757 . . . . 0.0 110.947 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 50' ' ' TYR . 18.1 m-20 37.41 70.49 0.18 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.564 1.146 . . . . 0.0 112.139 -174.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.515 ' HD3' " H1'" ' B' ' 105' ' ' ' A' . 30.3 ptt180 -57.04 5.4 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.117 1.767 . . . . 0.0 115.559 -173.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' A' ' 48' ' ' ASP . 10.2 p90 -145.28 1.21 0.94 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.207 1.003 . . . . 0.0 112.297 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -121.15 -12.08 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.169 0.44 . . . . 0.0 110.189 173.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.76 29.13 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 127.765 2.426 . . . . 0.0 113.619 -176.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.13 -176.08 1.34 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.47 0.653 . . . . 0.0 109.299 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 56' ' ' GLY . 4.7 t 50.75 24.96 1.9 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.291 1.036 . . . . 0.0 112.142 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 9.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.172 1.789 . . . . 0.0 114.095 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 54' ' ' SER . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.64 0.655 . . . . 0.0 112.254 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -155.95 166.91 32.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.8 0.8 . . . . 0.0 110.522 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.22 101.7 3.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.416 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 50.0 t80 -68.91 118.31 11.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -119.5 165.29 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.3 ptm180 -144.54 149.66 36.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.35 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -117.18 164.8 14.23 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.089 0.868 . . . . 0.0 111.078 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.4 -27.15 10.12 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -120.59 149.33 42.63 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.149 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.12 -45.83 83.48 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.131 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -66.42 -40.0 89.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -80.74 -15.92 55.22 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.102 0.865 . . . . 0.0 110.959 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.1 -47.45 9.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.046 0.538 . . . . 0.0 110.16 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -68.35 -25.07 64.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.448 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.68 -47.46 31.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.904 0.32 . . . . 0.0 110.549 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.33 73.69 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.056 0.389 . . . . 0.0 110.623 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.8 ttp -73.4 -43.01 61.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.755 0.422 . . . . 0.0 110.031 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.26 2.33 24.97 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.171 -0.331 . . . . 0.0 111.521 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.23 -7.28 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.9 ttm -137.6 -26.44 0.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.67 134.75 56.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.537 1.062 . . . . 0.0 109.831 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.7 42.73 86.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 21.92 12.55 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 122.125 0.964 . . . . 0.0 110.269 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.59 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 6.1 t -63.55 162.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -165.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.45 13.26 0.23 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.96 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -135.61 8.8 3.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.19 0.596 . . . . 0.0 110.861 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.03 -13.38 58.9 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.512 ' CA ' HG12 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -177.36 133.55 0.18 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.438 1.895 . . . . 0.0 106.473 176.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 79' ' ' VAL . 20.4 pt-20 -146.15 -32.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.338 168.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.478 ' CD2' ' HG3' ' A' ' 84' ' ' GLU . 1.5 mm? -141.41 140.06 33.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -174.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 33.1 mmt180 -149.62 116.76 6.02 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 125.579 1.552 . . . . 0.0 106.991 167.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -134.52 142.98 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.752 0.821 . . . . 0.0 110.2 -174.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -170.49 -178.79 2.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.451 0.701 . . . . 0.0 110.22 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.7 mmt -75.51 139.6 42.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.463 0.705 . . . . 0.0 109.455 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 164.53 26.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.408 0.683 . . . . 0.0 111.225 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -142.94 9.23 1.71 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.744 0.418 . . . . 0.0 110.981 172.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.683 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 22.1 m-85 -126.18 167.02 15.98 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.056 0.942 . . . . 0.0 109.142 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.1 173.62 14.91 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-O 120.999 0.221 . . . . 0.0 113.245 -173.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -65.37 159.91 62.97 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.109 0.963 . . . . 0.0 111.464 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -37.82 104.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.862 1 C-N-CA 125.618 4.212 . . . . 0.0 115.492 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.47 -26.83 1.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.06 2.507 . . . . 0.0 109.632 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -160.42 168.7 24.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.8 1.64 . . . . 0.0 106.786 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.4 p -82.24 -44.05 16.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -169.77 20.08 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -131.34 0.49 4.09 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.416 -0.803 . . . . 0.0 112.527 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.3 m . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.353 -1.308 . . . . 0.0 110.24 177.61 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.591 0 C5'-C4'-C3' 109.913 -3.724 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.4 2 C1'-O4'-C4' 104.978 -5.136 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.683 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.413 -3.347 2 N19-C1'-C2' 106.221 -4.487 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.515 " H1'" ' HD3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.856 0 C3'-C2'-C1' 104.795 3.661 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.423 " H3'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.165 3 C3'-C2'-C1' 105.809 4.788 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.423 " H3'" " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.413 -3.342 1 C1'-O4'-C4' 105.564 -4.485 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttm . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -149.03 171.6 16.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.291 0.636 . . . . 0.0 110.826 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -78.79 7.85 6.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.46 0.704 . . . . 0.0 111.539 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.506 ' CA ' " H4'" ' B' ' 107' ' ' ' U' . . . -52.32 -44.27 58.08 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.463 -0.632 . . . . 0.0 113.721 -174.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 18.4 ptt-85 -160.2 24.52 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 74.4 Cg_endo -70.63 144.07 48.37 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 CA-C-N 121.614 1.612 . . . . 0.0 108.51 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.67 115.25 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.357 2.705 . . . . 0.0 110.779 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.0 -164.2 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.727 2.951 . . . . 0.0 109.841 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -133.27 25.47 4.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.621 0.769 . . . . 0.0 110.238 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 m -55.2 -15.82 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.817 0.847 . . . . 0.0 111.822 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.75 -4.13 32.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.008 0.923 . . . . 0.0 112.219 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.9 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.598 -0.557 . . . . 0.0 112.797 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.0 ptt? -135.63 162.65 32.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.002 0.901 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 m -76.05 82.44 2.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 122.888 0.475 . . . . 0.0 109.827 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.4 m -65.87 67.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.946 1.698 . . . . 0.0 110.459 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 1.6 tm? -86.36 131.52 34.19 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -128.63 153.67 47.03 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.48 153.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.783 -177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -152.75 -173.19 4.48 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.291 1.436 . . . . 0.0 109.738 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 t30 86.76 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.737 1.215 . . . . 0.0 112.666 171.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.0 134.2 55.59 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.386 1.075 . . . . 0.0 109.132 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -81.17 169.05 17.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.981 176.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -62.46 1.18 0.38 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -125.69 12.72 7.99 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.595 0.634 . . . . 0.0 112.001 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -116.09 165.22 13.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.322 0.249 . . . . 0.0 110.996 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -150.19 165.15 18.14 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 124.226 1.01 . . . . 0.0 109.19 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 60.6 Cg_endo -70.43 -25.78 25.12 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.205 1.936 . . . . 0.0 111.604 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.76 -32.42 69.55 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.898 -0.502 . . . . 0.0 109.954 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.4 m -77.43 -44.91 27.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.456 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -56.66 -22.4 34.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.636 -0.665 . . . . 0.0 110.496 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -78.38 -57.98 3.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -61.09 -30.61 70.45 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.645 0.202 . . . . 0.0 110.539 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.88 -34.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 123.442 0.464 . . . . 0.0 110.811 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' CD1' HD11 ' A' ' 30' ' ' LEU . 18.6 m-85 -98.74 -13.12 20.36 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.25 -25.73 63.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.895 -0.503 . . . . 0.0 110.91 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -69.45 -23.22 63.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.888 -0.508 . . . . 0.0 112.243 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -74.62 -16.94 60.77 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.459 0.304 . . . . 0.0 111.653 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.65 -85.71 0.1 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -160.77 162.5 32.41 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.992 0.517 . . . . 0.0 110.893 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 t -137.42 137.76 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.61 -36.22 9.66 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -164.05 159.2 20.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.366 0.583 . . . . 0.0 111.194 174.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.01 117.96 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.681 1.192 . . . . 0.0 108.335 -176.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.07 176.98 11.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.374 0.607 . . . . 0.0 112.518 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.7 mt -129.81 91.73 39.29 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 124.035 0.934 . . . . 0.0 108.6 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.79 8.68 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.879 3.719 . . . . 0.0 113.733 -172.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -52.75 -43.15 65.58 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.013 0.824 . . . . 0.0 109.834 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -149.37 116.69 6.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.514 ' HD2' " H1'" ' B' ' 105' ' ' ' A' . 7.8 ptm180 -71.17 12.19 0.34 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.436 ' CD2' HG23 ' A' ' 51' ' ' THR . 15.7 p90 -146.28 2.77 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.937 0.895 . . . . 0.0 111.34 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.436 HG23 ' CD2' ' A' ' 50' ' ' TYR . 17.1 p -129.15 -36.02 1.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.478 0.581 . . . . 0.0 109.769 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.55 41.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 126.683 1.993 . . . . 0.0 113.214 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -129.39 1.34 5.09 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 t -64.03 -43.88 94.24 Favored 'General case' 0 CA--C 1.526 0.047 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 58.94 157.54 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.403 1.881 . . . . 0.0 113.582 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.41 -21.5 0.55 Allowed Glycine 0 CA--C 1.526 0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.329 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.56 166.13 29.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.029 0.931 . . . . 0.0 109.464 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.2 94.51 1.84 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.426 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 51.1 t80 -66.24 101.55 0.74 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -173.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 2.3 m -94.82 167.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 171.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -145.94 116.43 7.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.213 0.946 . . . . 0.0 110.601 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 13.6 m-85 -92.48 169.76 10.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.229 1.012 . . . . 0.0 109.711 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.415 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -124.71 -37.06 2.52 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 123.989 0.806 . . . . 0.0 112.469 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.42 127.92 32.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.325 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -60.91 -53.72 53.8 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -32.35 68.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -89.09 -17.85 28.43 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.084 0.402 . . . . 0.0 110.999 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.95 -45.62 20.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -75.42 -25.85 57.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.585 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.99 -46.89 40.87 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.719 0.69 . . . . 0.0 111.103 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.8 73.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.122 0.419 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.403 ' HA ' ' CG1' ' A' ' 87' ' ' VAL . 9.9 ttp -73.86 -41.23 62.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.55 0.34 . . . . 0.0 110.952 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.46 2.87 26.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.426 0.103 . . . . 0.0 111.231 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.19 -6.1 4.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.6 ttm -137.13 -27.81 0.96 Allowed 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.45 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 6.2 t70 -63.19 136.46 57.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.945 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.45 85.65 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.542 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.64 34.22 0.48 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.02 0.91 . . . . 0.0 110.49 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 81' ' ' ASP . 9.6 p -69.83 172.1 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.484 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 0.3 OUTLIER -156.58 5.47 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.972 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.542 ' H ' HG22 ' A' ' 79' ' ' VAL . 37.3 t70 -148.26 -2.44 0.52 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' H ' HG22 ' A' ' 79' ' ' VAL . . . 124.0 -17.14 7.66 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.485 ' C ' HG23 ' A' ' 79' ' ' VAL . 5.3 ptp180 -161.0 140.55 10.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 10.0 mm-40 -146.57 -49.57 0.2 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -139.95 150.36 44.43 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 124.064 0.852 . . . . 0.0 112.445 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -148.66 98.84 2.93 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 167.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 7.1 p -126.45 129.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 121.336 0.588 . . . . 0.0 110.097 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -165.78 164.38 18.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.356 1.063 . . . . 0.0 109.138 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.4 mmt -57.97 136.84 57.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.895 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 155.74 27.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -136.52 4.71 2.88 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.623 0.369 . . . . 0.0 110.838 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.603 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 10.5 m-85 -132.95 163.81 28.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.4 172.71 15.2 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -66.16 156.05 85.78 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.58 0.352 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.81 146.77 30.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.579 2.853 . . . . 0.0 111.722 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.4 -24.33 5.46 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.194 3.263 . . . . 0.0 111.855 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -154.13 161.47 41.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.359 1.064 . . . . 0.0 109.121 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.4 ' HA ' " C4'" ' B' ' 105' ' ' ' A' . 59.8 p -72.4 -50.53 25.81 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -170.75 -42.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.87 0.304 . . . . 0.0 111.219 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -162.13 11.61 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 117.382 -1.294 . . . . 0.0 111.925 -176.572 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.869 0 C5'-C4'-C3' 111.16 -2.893 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.144 2 C1'-O4'-C4' 104.162 -6.042 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.603 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.668 2 O4'-C1'-N19 112.408 4.208 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.514 " H1'" ' HD2' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.415 -3.173 1 P-O3'-C3' 125.36 4.716 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C3'-C2'-C1' 104.355 3.172 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.506 " H4'" ' CA ' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.414 -3.223 1 O4'-C1'-N19 112.355 4.155 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 m -59.91 143.93 50.23 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 122.842 0.457 . . . . 0.0 110.188 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 49.84 19.38 0.43 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.378 1.071 . . . . 0.0 112.695 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.496 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . -83.59 65.05 4.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.438 ' HD3' " H1'" ' B' ' 107' ' ' ' U' . 15.5 ptm180 42.63 49.5 4.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.433 1.493 . . . . 0.0 114.745 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.83 154.03 63.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.249 1.966 . . . . 0.0 108.522 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.77 115.99 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.263 2.642 . . . . 0.0 110.679 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.17 -163.79 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.859 3.039 . . . . 0.0 109.885 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -132.17 20.19 4.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.516 0.726 . . . . 0.0 110.343 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -56.71 -12.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.428 1.091 . . . . 0.0 112.244 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.34 -1.0 9.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.749 0.819 . . . . 0.0 112.496 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.69 30.06 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.77 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.17 168.15 20.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.807 1.304 . . . . 0.0 112.461 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -57.95 -28.32 64.21 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -168.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.4 m 42.1 58.97 2.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 113.172 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 17.6 tp -65.17 167.15 8.55 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 14.9 pttt -136.95 157.63 46.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.107 0.412 . . . . 0.0 111.82 170.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -133.78 148.13 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -150.42 -175.43 5.09 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.662 1.185 . . . . 0.0 110.677 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 t30 91.92 28.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.741 1.616 . . . . 0.0 114.121 168.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 120.66 9.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.25 1.02 . . . . 0.0 109.867 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 24' ' ' ARG . 11.7 m -75.09 171.58 13.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -63.96 7.2 0.13 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.113 0.965 . . . . 0.0 112.949 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 22' ' ' THR . 19.3 ptt180 -131.08 14.88 5.19 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.982 0.913 . . . . 0.0 111.838 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 m -122.8 166.43 14.98 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.466 0.306 . . . . 0.0 111.068 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 91.4 p -151.86 166.4 15.32 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.67 -29.24 19.84 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.576 2.184 . . . . 0.0 110.904 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -67.63 -33.92 75.94 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.0 m -75.25 -44.87 43.66 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.26 -19.84 15.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.315 0.246 . . . . 0.0 111.117 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -80.4 -57.98 3.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -12.31 60.35 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -91.97 -32.86 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.189 0.595 . . . . 0.0 111.514 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.72 -9.71 18.9 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -26.01 61.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.18 0.446 . . . . 0.0 111.018 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -69.76 -23.78 63.42 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -72.56 -19.2 61.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.842 0.457 . . . . 0.0 111.468 176.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.0 -86.46 0.1 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -156.25 165.12 37.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 111.447 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.52 137.24 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.49 1.116 . . . . 0.0 108.062 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -22.09 23.21 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -163.67 153.85 15.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.403 0.62 . . . . 0.0 110.63 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.92 104.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -146.92 161.79 40.02 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.966 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.4 mt -136.34 126.36 16.17 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.892 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.54 52.21 2.81 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.708 3.605 . . . . 0.0 110.434 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -73.26 70.62 1.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.051 0.94 . . . . 0.0 110.081 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 49' ' ' ARG . 3.5 p30 45.62 -162.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.722 1.609 . . . . 0.0 114.142 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' H ' ' HB2' ' A' ' 48' ' ' ASP . 11.9 ttm-85 177.58 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.465 1.906 . . . . 0.0 108.199 -170.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -157.34 12.03 0.22 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.448 1.099 . . . . 0.0 111.456 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.7 p -124.18 -7.16 7.69 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.042 0.537 . . . . 0.0 112.035 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.64 42.05 1.92 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.108 1.763 . . . . 0.0 113.971 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.08 -177.79 4.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.187 0.595 . . . . 0.0 110.303 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -142.59 -176.93 5.05 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -172.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.528 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 75.0 mmt-85 -132.25 -2.1 3.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.256 0.622 . . . . 0.0 112.325 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.7 24.44 76.71 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.009 0.368 . . . . 0.0 113.05 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 9.6 p90 -151.6 171.61 17.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.01 0.905 . . . . 0.0 110.692 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.76 103.82 4.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -69.57 92.44 0.64 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.772 0.829 . . . . 0.0 108.879 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 40.5 t -79.99 160.94 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 13.7 ttt180 -141.97 130.46 22.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.355 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -113.03 165.71 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.025 0.375 . . . . 0.0 111.059 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -33.44 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.26 123.39 26.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -60.36 -53.59 55.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -84.95 -21.84 29.43 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.17 -43.54 21.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 122.779 0.432 . . . . 0.0 110.461 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.432 ' HA ' ' HE1' ' A' ' 72' ' ' MET . 8.4 pt-20 -72.05 -28.56 63.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.214 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -40.73 64.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.393 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.52 74.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.137 -0.352 . . . . 0.0 111.441 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.432 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 3.8 ptp -78.71 -38.29 39.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.68 3.13 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.961 0.504 . . . . 0.0 111.674 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -9.7 3.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.6 ttp -146.79 -13.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.27 125.51 23.54 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.762 1.165 . . . . 0.0 108.756 173.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 75.87 28.11 61.41 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.576 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.65 38.33 0.44 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.775 1.288 . . . . 0.0 109.554 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.55 HG23 ' H ' ' A' ' 81' ' ' ASP . 4.8 p -71.81 173.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -168.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.462 ' H ' HG23 ' A' ' 79' ' ' VAL . 1.1 pt? -152.0 -0.32 0.32 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.27 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.55 ' H ' HG23 ' A' ' 79' ' ' VAL . 38.0 t70 -144.95 -1.17 0.87 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.41 ' H ' HG23 ' A' ' 79' ' ' VAL . . . 126.43 -17.31 6.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -164.34 133.38 3.71 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 20.1 mm-40 -143.81 -39.75 0.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 mp -147.63 151.18 35.77 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 123.697 0.623 . . . . 0.0 112.608 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -147.43 121.56 9.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.72 139.27 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.081 0 C-N-CA 122.67 0.388 . . . . 0.0 110.03 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -169.08 174.93 5.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.752 1.221 . . . . 0.0 109.225 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 mmt -73.97 143.27 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.962 0.905 . . . . 0.0 109.981 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.54 155.68 37.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.474 0.31 . . . . 0.0 110.555 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.56 13.42 2.34 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.766 0.826 . . . . 0.0 109.722 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.434 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 24.3 m-85 -129.97 158.07 40.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.874 0.87 . . . . 0.0 109.109 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.48 177.95 20.29 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -60.66 156.06 46.77 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 122.235 -0.568 . . . . 0.0 110.131 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.32 120.94 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.322 2.681 . . . . 0.0 113.309 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.51 -45.77 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.125 1.883 . . . . 0.0 108.671 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -161.39 125.49 3.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.172 1.789 . . . . 0.0 107.833 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 m -149.46 4.92 0.61 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.826 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -143.9 -25.39 0.55 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -173.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 45.35 23.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.7 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.405 -177.717 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 1 O4'-C1'-N19 116.035 7.835 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.509 HO2' ' P ' ' B' ' 104' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.748 2 O4'-C1'-N19 112.506 4.306 . 0.26 6p . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.509 ' P ' HO2' ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.412 -3.422 0 C5'-C4'-C3' 111.169 -2.887 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.455 ' C8 ' " C5'" ' B' ' 105' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.998 1 C3'-C2'-C1' 105.475 4.416 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.432 HO2' ' HB3' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.416 -3.058 2 P-O3'-C3' 125.354 4.712 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.496 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.415 -3.148 2 C5'-C4'-C3' 107.85 -5.1 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -147.01 170.28 17.45 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.279 0.631 . . . . 0.0 110.426 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -61.94 -56.91 14.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.985 0.514 . . . . 0.0 111.318 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.42 -69.01 0.53 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 125.001 1.286 . . . . 0.0 111.697 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.41 59.65 0.64 Allowed Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -171.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.77 153.76 64.13 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.961 2.441 . . . . 0.0 109.326 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.87 116.04 4.53 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.412 2.741 . . . . 0.0 110.544 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -87.58 -162.52 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.062 3.175 . . . . 0.0 110.298 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -136.25 33.4 2.82 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.976 0.91 . . . . 0.0 109.757 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.41 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 33.7 m -61.43 -1.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 124.409 1.083 . . . . 0.0 113.802 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.53 -13.05 60.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.541 0.61 . . . . 0.0 112.256 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.45 20.75 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.91 -0.383 . . . . 0.0 112.933 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . 8.1 ptp -60.47 156.9 15.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.84 0.82 . . . . 0.0 113.206 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -72.23 -18.84 61.8 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.888 0.875 . . . . 0.0 110.466 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 t 45.45 59.54 3.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.044 1.338 . . . . 0.0 113.03 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 20.7 tp -65.7 165.39 12.69 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 16.8 pttt -134.53 154.89 51.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.531 0.332 . . . . 0.0 110.83 170.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.31 148.43 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -148.81 -171.08 3.78 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.997 1.719 . . . . 0.0 109.273 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.88 90.23 0.09 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.497 1.119 . . . . 0.0 111.929 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.5 122.89 49.04 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 m -69.03 165.92 19.16 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.18 -0.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.288 1.035 . . . . 0.0 113.562 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -129.4 23.19 5.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.167 0.987 . . . . 0.0 110.92 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -123.94 165.35 17.57 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.796 0.331 . . . . 0.0 110.73 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.4 p -150.05 165.79 16.7 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.192 0.997 . . . . 0.0 109.527 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 39.1 Cg_endo -66.18 -29.38 47.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.178 1.918 . . . . 0.0 110.911 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.09 -31.9 71.83 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.883 -0.51 . . . . 0.0 110.284 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 100.0 m -74.63 -44.71 49.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.449 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -58.84 -20.01 46.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.044 -0.41 . . . . 0.0 110.957 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -81.1 -57.05 3.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -8.89 39.06 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.867 0.467 . . . . 0.0 111.857 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.56 -30.94 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.318 0.647 . . . . 0.0 111.717 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' ' 30' ' ' LEU . 22.7 m-85 -101.73 -12.05 18.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.249 0.477 . . . . 0.0 112.284 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.47 -27.27 64.1 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.011 -0.431 . . . . 0.0 111.37 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.51 -24.08 65.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -72.04 -21.95 61.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.238 0.215 . . . . 0.0 111.184 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -81.24 0.1 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -159.13 165.84 32.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.044 0.45 . . . . 0.0 111.357 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.9 147.16 29.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 -19.34 8.59 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.57 153.45 25.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.194 0.497 . . . . 0.0 110.374 174.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 p -169.13 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.154 0.982 . . . . 0.0 110.044 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.83 179.63 9.02 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 112.204 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.448 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 13.4 mt -117.73 123.26 29.87 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.98 43.93 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 125.364 4.042 . . . . 0.0 112.054 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -54.89 160.96 1.76 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -54.73 119.42 5.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -67.16 13.27 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -167.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 13.0 p90 -144.72 0.2 0.96 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.666 1.186 . . . . 0.0 111.57 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.434 HG21 ' CD2' ' A' ' 50' ' ' TYR . 30.5 p -127.69 -23.78 3.37 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.709 0.686 . . . . 0.0 110.929 171.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.97 35.62 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.367 1.867 . . . . 0.0 113.815 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.23 1.93 12.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -73.37 170.08 15.82 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.386 0.539 . . . . 0.0 111.153 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 176.92 165.92 0.52 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.386 1.474 . . . . 0.0 110.174 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.31 -22.11 0.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -158.04 170.58 21.99 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 108.6 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.24 105.07 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 28.2 t80 -68.31 116.56 9.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -177.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -116.04 167.83 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 172.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.1 ptm180 -144.58 146.02 32.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.663 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -116.01 162.65 17.07 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.464 0.477 . . . . 0.0 111.239 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -122.27 -32.19 3.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.64 131.13 34.63 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.503 ' HZ1' ' HB3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -65.06 -45.56 84.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.249 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.428 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -172.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.428 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.5 p30 -106.52 -7.01 17.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.347 0.521 . . . . 0.0 111.077 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -74.65 -40.43 61.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB3' ' HZ1' ' A' ' 65' ' ' LYS . 9.8 pt-20 -78.92 -29.99 44.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.343 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -67.91 -40.06 83.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.297 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.53 75.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.851 0.296 . . . . 0.0 111.525 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.403 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 10.6 ptp -77.15 -40.19 46.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.725 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.07 -0.98 20.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.04 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.61 -6.34 5.19 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.8 ttm -137.63 -28.96 0.88 Allowed 'General case' 0 N--CA 1.458 -0.066 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.447 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 3.3 t70 -66.84 142.62 57.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.7 1.136 . . . . 0.0 110.617 -177.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.6 8.67 86.2 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.575 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.04 31.75 0.44 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.328 1.064 . . . . 0.0 111.041 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.578 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 19.8 t -74.45 160.9 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.704 0.802 . . . . 0.0 111.637 -172.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.65 10.94 0.3 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.368 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -146.44 5.3 0.93 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.99 -0.444 . . . . 0.0 112.106 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.51 -11.25 28.23 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.126 0.393 . . . . 0.0 112.334 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -172.14 114.24 0.32 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.088 0.955 . . . . 0.0 108.563 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.578 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 80.2 mm-40 -130.28 -50.78 1.1 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.555 171.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -139.96 155.99 46.86 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.5 mmt-85 -152.18 109.95 3.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.814 1.646 . . . . 0.0 107.299 168.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 2.1 p -139.12 125.38 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-O 121.19 0.519 . . . . 0.0 110.891 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -155.92 179.92 8.74 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.043 1.737 . . . . 0.0 108.382 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.4 mmt -75.75 144.93 41.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.6 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.16 169.15 16.7 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.231 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -145.3 -3.11 0.75 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.379 0.672 . . . . 0.0 110.905 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.505 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 13.6 m-85 -129.91 168.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.979 0.511 . . . . 0.0 109.911 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.27 171.42 13.7 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 112.745 -0.142 . . . . 0.0 112.745 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -64.43 152.38 89.2 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 123.514 0.725 . . . . 0.0 110.867 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.01 125.99 13.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.464 2.11 . . . . 0.0 112.116 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.22 -22.11 11.4 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.392 2.728 . . . . 0.0 110.389 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -148.5 150.39 33.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.486 1.514 . . . . 0.0 106.999 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 27.6 m -64.17 -43.67 94.4 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -171.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -165.44 7.44 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.301 -0.249 . . . . 0.0 110.902 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -70.46 -1.7 11.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.042 0.937 . . . . 0.0 112.642 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.705 -179.236 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.774 0 O4'-C1'-N19 111.381 3.181 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.409 ' C8 ' ' HD3' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.408 -3.724 2 C1'-O4'-C4' 104.909 -5.212 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.505 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.414 -3.264 1 O4'-C1'-N19 112.479 4.279 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.544 ' C8 ' " H5'" ' B' ' 105' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.133 0 O4'-C1'-N19 111.657 3.457 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.925 0 P-O3'-C3' 123.789 3.408 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.982 0 C1'-O4'-C4' 106.574 -3.362 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 120.254 0.073 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -146.5 -179.4 6.74 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.067 0.547 . . . . 0.0 110.543 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -139.0 36.76 2.14 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 123.943 0.897 . . . . 0.0 109.504 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.32 45.43 1.15 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.466 ' HG3' HO2' ' B' ' 107' ' ' ' U' . 78.0 mtt-85 51.42 48.2 5.5 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.227 1.011 . . . . 0.0 112.988 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.3 157.04 50.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.79 2.327 . . . . 0.0 110.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.77 113.66 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.017 3.145 . . . . 0.0 110.209 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.33 -163.35 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.123 3.215 . . . . 0.0 110.61 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -134.23 29.11 3.7 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.112 0.965 . . . . 0.0 110.14 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.84 -12.53 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.404 1.082 . . . . 0.0 113.406 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.15 4.9 49.08 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.309 0.644 . . . . 0.0 111.448 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.23 21.09 0.49 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -140.89 161.31 38.13 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.399 0.599 . . . . 0.0 111.51 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.9 m -85.05 83.95 7.87 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.696 0.798 . . . . 0.0 111.924 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 m -64.24 79.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.144 1.378 . . . . 0.0 111.299 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 3.1 tm? -79.62 107.44 12.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.55 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.9 ttpp -79.53 140.94 37.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.71 146.92 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.299 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -150.67 -175.75 5.24 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.532 1.145 . . . . 0.0 110.8 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.477 HD22 ' HB2' ' A' ' 83' ' ' ARG . 16.1 t30 94.05 26.97 0.01 OUTLIER 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.728 1.611 . . . . 0.0 113.79 169.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.65 120.02 5.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.383 1.073 . . . . 0.0 108.468 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.417 HG23 ' CD2' ' A' ' 23' ' ' TYR . 10.8 m -42.18 -63.85 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.189 0.995 . . . . 0.0 112.274 -172.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.417 ' CD2' HG23 ' A' ' 22' ' ' THR . 52.3 p90 165.93 -19.74 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.889 2.875 . . . . 0.0 109.276 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -111.42 -1.07 16.07 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.079 0.952 . . . . 0.0 111.552 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -78.18 173.47 12.22 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.02 0.928 . . . . 0.0 109.665 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.404 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 93.9 p -145.26 163.02 34.63 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.888 0.475 . . . . 0.0 109.882 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HD3' ' CD1' ' A' ' 45' ' ' ILE . 41.9 Cg_endo -68.16 -26.79 36.02 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.986 1.79 . . . . 0.0 110.446 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.91 -27.38 65.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.472 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 99.7 m -78.35 -45.67 21.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' A' ' 34' ' ' PHE . 1.3 mm? -59.16 -19.14 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.145 -0.347 . . . . 0.0 110.515 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -78.73 -58.38 3.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.133 -0.461 . . . . 0.0 109.949 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.472 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -71.56 -16.24 62.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.59 0.632 . . . . 0.0 111.326 -174.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.64 -32.98 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 123.272 0.629 . . . . 0.0 111.608 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 30' ' ' LEU . 22.4 m-85 -101.72 -11.52 19.07 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.176 0.443 . . . . 0.0 111.907 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -74.33 -24.71 59.23 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.782 -0.574 . . . . 0.0 110.842 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.91 -22.91 65.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.217 0.462 . . . . 0.0 112.14 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -73.36 -24.85 60.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.699 0.4 . . . . 0.0 111.731 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.78 -84.79 0.07 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -159.64 167.04 29.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.086 0.47 . . . . 0.0 111.564 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.76 147.88 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.02 -17.92 8.63 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.41 ' CG ' ' H21' ' B' ' 106' ' ' ' G' . 46.8 t0 -162.42 149.98 13.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 117.057 0.429 . . . . 0.0 110.332 175.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 p -166.31 104.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.577 1.151 . . . . 0.0 108.638 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.71 175.02 13.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.292 0.568 . . . . 0.0 112.244 175.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.418 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 12.4 mt -126.31 108.71 23.92 Favored Pre-proline 0 N--CA 1.452 -0.374 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -176.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.45 -13.69 20.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.741 2.961 . . . . 0.0 112.77 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 34.6 -107.71 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 111.12 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 50' ' ' TYR . 5.2 m-20 -140.27 12.78 2.39 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.216 1.006 . . . . 0.0 110.307 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 57.87 -12.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 48' ' ' ASP . 49.3 p90 -148.76 -2.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.548 1.067 . . . . 0.0 113.009 175.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.8 p -121.05 -19.15 7.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.859 0.754 . . . . 0.0 110.516 172.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 50.23 21.11 0.73 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.243 1.417 . . . . 0.0 113.952 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.9 -1.24 6.83 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 t 61.21 173.83 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.015 1.326 . . . . 0.0 113.117 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -139.85 -0.68 1.68 Allowed 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.913 0.885 . . . . 0.0 112.446 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.82 18.44 44.13 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.916 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.07 168.88 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.518 1.159 . . . . 0.0 110.874 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.39 105.59 4.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 31.2 t80 -70.66 110.83 5.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 59.3 t -100.61 158.76 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.2 ptm180 -143.61 125.6 15.32 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -91.61 -179.19 5.29 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -134.97 -25.06 1.42 Allowed 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 124.057 0.848 . . . . 0.0 113.26 178.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.87 128.59 37.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -62.33 -50.91 69.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.225 -0.416 . . . . 0.0 111.347 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -56.88 -34.61 68.02 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -172.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.52 -11.04 21.4 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 118.761 0.71 . . . . 0.0 111.972 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.62 54.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 72' ' ' MET . 8.0 pt-20 -76.09 -24.65 55.05 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.223 -0.298 . . . . 0.0 111.5 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.06 -40.22 60.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.806 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.053 -0.404 . . . . 0.0 111.312 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.435 ' HE2' ' HA ' ' A' ' 69' ' ' GLU . 9.0 ptp -76.68 -40.2 49.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.559 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.55 2.26 14.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.186 0.594 . . . . 0.0 112.179 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.43 -9.19 3.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -145.44 -11.69 0.53 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.14 130.03 44.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 120.371 1.441 . . . . 0.0 109.396 174.51 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.46 29.75 61.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.904 -0.942 . . . . 0.0 113.665 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.52 38.88 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.063 1.432 . . . . 0.0 110.193 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.605 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 13.1 t -69.85 162.56 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 113.96 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.04 9.33 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.506 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.41 1.66 0.53 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.85 -22.18 3.49 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 121.744 -0.598 . . . . 0.0 112.648 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.477 ' HB2' HD22 ' A' ' 20' ' ' ASN . 0.4 OUTLIER 174.99 134.89 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.584 1.954 . . . . 0.0 107.278 177.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.605 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 76.3 mm-40 -132.23 -36.45 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.297 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -152.15 151.81 31.51 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -152.57 122.65 7.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 167.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 2.0 p -141.05 137.25 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.183 0.516 . . . . 0.0 111.292 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -165.71 171.41 12.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.999 1.319 . . . . 0.0 109.655 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.83 141.42 53.27 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.218 0.607 . . . . 0.0 110.585 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.88 158.65 35.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.579 0.351 . . . . 0.0 110.132 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -147.95 21.16 1.12 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.601 0.76 . . . . 0.0 109.39 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.404 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 6.4 t80 -146.84 152.06 38.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -175.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.25 179.79 22.31 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.046 0.385 . . . . 0.0 113.957 -169.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -62.41 156.91 59.12 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.422 0.689 . . . . 0.0 111.02 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -43.36 114.56 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.202 3.268 . . . . 0.0 114.299 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.87 -23.76 9.12 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.71 2.273 . . . . 0.0 109.334 168.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -156.22 161.84 40.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.811 1.645 . . . . 0.0 107.065 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m -70.67 -41.87 71.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -170.33 20.01 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.909 0.777 . . . . 0.0 112.602 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -130.33 6.26 4.87 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.345 -0.847 . . . . 0.0 112.47 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 117.721 -1.133 . . . . 0.0 110.011 176.748 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.917 1 O4'-C1'-N19 115.087 6.887 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.469 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.413 -3.343 2 C1'-O4'-C4' 104.187 -6.014 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.482 ' C5 ' ' CE1' ' A' ' 59' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.063 2 O4'-C1'-N19 112.729 4.529 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.419 ' OP1' " H4'" ' B' ' 104' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.686 3 P-O3'-C3' 125.146 4.538 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.559 " H3'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.418 -2.893 0 C3'-C2'-C1' 105.048 3.942 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.559 " H3'" " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.797 1 O4'-C1'-N19 112.456 4.256 . 0.022 2o . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.1 p -60.66 146.07 46.9 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.38 0.272 . . . . 0.0 110.724 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 47.96 22.39 0.38 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.399 1.08 . . . . 0.0 112.903 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.44 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . -82.39 80.91 1.74 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' CD ' " H1'" ' B' ' 107' ' ' ' U' . 11.1 ptm180 45.3 46.4 2.97 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.26 1.824 . . . . 0.0 114.337 174.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.46 154.22 65.12 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.127 1.885 . . . . 0.0 109.828 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.5 117.23 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.716 2.944 . . . . 0.0 110.599 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -81.6 -169.94 0.88 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.996 3.131 . . . . 0.0 110.352 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -130.62 20.39 5.12 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.587 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.76 -12.02 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 125.403 1.481 . . . . 0.0 112.343 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.96 0.55 3.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.781 0.832 . . . . 0.0 112.616 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 30.64 0.15 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.088 -0.84 . . . . 0.0 113.954 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.09 23.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.91 1.355 . . . . 0.0 112.43 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -59.35 -26.95 65.49 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.0 m 43.09 59.96 2.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 20.5 tp -65.48 167.3 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 171.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 22.8 pttt -136.49 157.26 47.2 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.9 t -131.1 146.85 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -146.83 -175.2 4.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 110.355 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 92.97 24.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.525 1.53 . . . . 0.0 113.594 168.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -57.36 129.84 43.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.348 0.659 . . . . 0.0 109.378 -178.297 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' ARG . 18.0 m -82.43 170.94 14.7 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -64.08 8.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.175 0.99 . . . . 0.0 113.312 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' THR . 13.2 ptt180 -134.57 19.37 3.6 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.604 1.162 . . . . 0.0 111.969 -174.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -127.17 164.87 20.7 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.05 0.54 . . . . 0.0 110.448 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.459 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 85.0 p -149.86 165.16 18.21 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 110.37 -174.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 57.5 Cg_endo -69.42 -28.08 27.32 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.015 2.477 . . . . 0.0 111.192 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.98 -36.26 77.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.4 m -72.15 -44.15 63.55 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -57.35 -21.98 39.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.991 -0.443 . . . . 0.0 111.145 179.397 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.82 -54.15 5.33 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -10.88 58.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.87 0.468 . . . . 0.0 111.869 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -98.95 -32.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 112.031 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.409 ' CD1' HD11 ' A' ' 30' ' ' LEU . 21.8 m-85 -100.9 -10.39 20.69 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -71.35 -28.05 63.79 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.766 -0.583 . . . . 0.0 111.14 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.61 -23.46 64.46 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -72.83 -17.59 61.54 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.317 0.247 . . . . 0.0 110.811 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.28 -76.09 0.11 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -164.81 160.52 19.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.239 0.616 . . . . 0.0 110.599 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.2 t -132.42 128.02 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.7 48.07 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -167.38 159.13 12.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.692 0.758 . . . . 0.0 112.912 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.26 141.29 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.71 1.604 . . . . 0.0 106.701 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.558 ' HH ' " H3'" ' B' ' 105' ' ' ' A' . 7.5 t80 -157.79 149.37 21.73 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.485 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 58' ' ' ALA . 5.7 mt -136.57 133.21 18.99 Favored Pre-proline 0 C--O 1.232 0.163 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.89 156.51 4.65 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.375 2.716 . . . . 0.0 111.915 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -140.34 9.54 2.28 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 50' ' ' TYR . 6.0 m-20 43.88 18.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -174.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' HD2' " H1'" ' B' ' 105' ' ' ' A' 0.251 8.3 ptm180 40.13 8.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.44 3.096 . . . . 0.0 116.832 -178.393 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.441 ' H ' ' C ' ' A' ' 48' ' ' ASP . 7.5 p90 -162.82 -20.95 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.753 1.221 . . . . 0.0 112.971 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -96.56 -22.25 17.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.037 1.289 . . . . 0.0 110.385 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.99 31.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.812 1.645 . . . . 0.0 113.69 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.23 -160.2 0.08 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -135.83 168.23 19.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.295 0.638 . . . . 0.0 109.781 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.4 ttm105 -146.31 0.98 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.11 20.7 38.08 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.765 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.5 169.37 24.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.059 1.43 . . . . 0.0 111.538 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.413 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -141.9 93.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 108.556 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.505 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 19.6 t80 -62.72 103.32 0.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.3 m -100.84 168.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 172.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.4 ptm180 -142.1 139.83 32.33 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -109.4 165.92 11.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.292 0.637 . . . . 0.0 110.465 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -33.64 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.2 122.41 24.31 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' HZ2' ' HB3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -60.48 -50.98 71.4 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.631 -0.223 . . . . 0.0 110.403 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.408 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.6 -29.63 70.65 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.254 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -90.11 -15.77 30.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.718 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.75 -39.37 31.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.433 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 9.5 pt-20 -77.38 -25.86 51.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.426 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.89 -47.83 42.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.444 0.565 . . . . 0.0 110.785 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.43 73.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.976 -0.452 . . . . 0.0 110.783 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.1 ttp -73.99 -41.39 61.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.877 0.471 . . . . 0.0 110.05 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.91 3.14 27.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 122.446 -0.159 . . . . 0.0 111.42 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.48 -5.5 4.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.3 ttm -140.44 -27.34 0.74 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.97 134.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.466 1.03 . . . . 0.0 110.221 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.49 85.85 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.539 -0.589 . . . . 0.0 112.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.77 33.23 0.43 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.811 0.806 . . . . 0.0 110.8 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.573 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 48.6 t -69.93 166.16 2.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.64 0.776 . . . . 0.0 112.269 -172.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -154.86 5.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -144.79 4.66 1.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.46 6.15 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.477 ' C ' HG11 ' A' ' 79' ' ' VAL . 5.2 ptp180 -176.14 143.33 0.53 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.004 1.722 . . . . 0.0 107.318 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.573 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 mm-40 -141.52 -46.94 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 169.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -140.96 152.7 45.17 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.941 0.496 . . . . 0.0 111.937 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -148.19 109.09 4.24 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 t -134.95 127.18 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 C-N-CA 122.74 0.416 . . . . 0.0 110.876 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -158.08 173.24 17.04 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.506 1.122 . . . . 0.0 109.412 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.2 mmt -69.59 146.08 52.02 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.786 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.89 165.93 22.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.704 0.402 . . . . 0.0 111.353 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -137.51 -0.04 2.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.717 0.807 . . . . 0.0 109.416 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.59 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 40.3 m-85 -139.66 156.11 47.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.328 0.651 . . . . 0.0 109.26 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.25 -16.39 6.15 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.403 ' HD3' ' HD2' ' A' ' 95' ' ' PRO . 21.2 tpp180 -170.46 139.91 1.46 Allowed Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.403 ' HD2' ' HD3' ' A' ' 94' ' ' ARG . 26.7 Cg_endo -60.67 119.7 7.02 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.047 1.831 . . . . 0.0 109.128 171.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.52 -29.43 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.598 2.198 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -153.45 93.56 1.71 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.553 0.692 . . . . 0.0 112.081 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.7 m -146.92 -8.13 0.47 Allowed 'General case' 0 N--CA 1.458 -0.035 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.122 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -150.63 11.16 0.67 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.582 0.628 . . . . 0.0 111.73 -171.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -145.34 9.02 1.21 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.002 0.521 . . . . 0.0 111.316 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.054 -177.834 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.67 0 O4'-C1'-N19 111.617 3.417 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.146 2 O4'-C1'-N19 114.275 6.075 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.59 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.919 3 O4'-C1'-N19 114.091 5.891 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.558 " H3'" ' HH ' ' A' ' 44' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.863 3 C5'-C4'-C3' 106.508 -5.994 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.474 ' P ' HO2' ' B' ' 105' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.977 1 P-O3'-C3' 126.538 5.698 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.475 " H1'" ' CD ' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.897 0 O4'-C1'-N19 111.691 3.491 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.805 0.336 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -148.27 -162.93 1.66 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.647 0.779 . . . . 0.0 109.869 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -47.88 -31.08 4.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.473 1.109 . . . . 0.0 112.979 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.467 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 86.12 36.77 9.65 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.779 175.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.42 ' HG2' " H4'" ' B' ' 107' ' ' ' U' . 14.3 ptm180 38.81 50.37 2.55 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 125.076 1.35 . . . . 0.0 113.994 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.91 159.25 50.9 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.742 2.295 . . . . 0.0 110.282 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.53 117.83 4.69 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.59 2.86 . . . . 0.0 110.088 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.55 -170.01 0.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.137 3.225 . . . . 0.0 110.408 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -132.53 25.88 4.42 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.397 0.679 . . . . 0.0 109.459 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 m -58.66 -4.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.332 1.453 . . . . 0.0 112.926 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.79 5.73 47.31 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.271 0.629 . . . . 0.0 110.795 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.66 17.83 0.49 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.412 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.7 ptt? -143.31 164.1 31.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.601 0.701 . . . . 0.0 110.856 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -81.07 84.94 6.38 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 110.952 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -68.21 97.32 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 2.1 tm? -116.54 124.61 50.29 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.025 0.44 . . . . 0.0 109.914 -176.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.3 ttpm? -102.58 146.89 27.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.256 1.423 . . . . 0.0 114.123 -167.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.1 t -124.48 146.4 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.229 174.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -151.62 -171.52 3.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 110.484 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 81.65 37.57 0.07 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.158 1.383 . . . . 0.0 113.199 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.66 175.2 1.14 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.386 1.074 . . . . 0.0 109.299 175.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 24' ' ' ARG . 5.2 m -129.05 167.58 17.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.82 0.848 . . . . 0.0 109.345 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -64.4 4.87 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.455 0.702 . . . . 0.0 112.475 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' H ' ' C ' ' A' ' 22' ' ' THR . 14.8 ptm180 -129.13 18.86 5.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.787 1.235 . . . . 0.0 110.228 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -129.99 163.17 27.03 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.776 0.83 . . . . 0.0 109.382 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.7 p -148.5 164.73 20.44 Favored Pre-proline 0 C--O 1.233 0.201 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 -174.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.9 Cg_endo -68.98 -27.76 29.84 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.792 1.661 . . . . 0.0 111.467 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.06 -32.33 72.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.742 0.701 . . . . 0.0 109.648 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.1 m -74.15 -44.03 55.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -59.88 -20.82 59.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.074 -0.391 . . . . 0.0 111.075 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -56.15 4.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -8.18 50.64 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.983 0.513 . . . . 0.0 112.194 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.4 t -100.79 -31.84 3.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 C-N-CA 123.069 0.547 . . . . 0.0 112.027 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.411 ' CD1' HD12 ' A' ' 30' ' ' LEU . 26.1 m-85 -101.67 -9.76 20.61 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.509 0.595 . . . . 0.0 111.602 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.83 -28.27 62.45 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.728 -0.607 . . . . 0.0 111.463 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.88 -23.0 65.95 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -71.83 -20.26 61.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.398 -0.335 . . . . 0.0 111.007 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -82.58 0.1 OUTLIER Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 175.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -159.63 160.29 34.11 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.236 0.614 . . . . 0.0 110.351 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.44 143.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.12 -15.24 24.28 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.271 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -154.45 142.65 20.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.588 0.694 . . . . 0.0 110.356 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.5 t -153.9 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 107.829 173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 163.69 38.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mm -90.5 110.32 40.24 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' CB ' " H4'" ' B' ' 104' ' ' ' G' . 95.7 Cg_endo -76.15 -41.83 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.315 2.677 . . . . 0.0 114.688 -167.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -82.41 165.69 20.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.083 0.856 . . . . 0.0 109.963 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 50.68 46.63 25.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.055 0.542 . . . . 0.0 112.057 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.48 ' HD3' " H1'" ' B' ' 105' ' ' ' A' . 18.6 ptt180 -54.7 -4.59 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 49' ' ' ARG . 15.6 p90 -146.77 7.1 0.94 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.871 0.76 . . . . 0.0 112.456 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.405 HG22 ' CD1' ' A' ' 50' ' ' TYR . 27.2 p -125.98 -14.1 6.16 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.844 -0.535 . . . . 0.0 111.264 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.32 27.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.855 2.062 . . . . 0.0 114.421 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.95 11.01 2.42 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.949 -0.469 . . . . 0.0 112.011 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -138.45 159.59 41.69 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.919 0.488 . . . . 0.0 110.339 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -170.51 15.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.969 0.908 . . . . 0.0 111.808 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.3 -12.4 58.16 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 118.154 0.434 . . . . 0.0 112.388 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.73 168.78 25.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.936 0.894 . . . . 0.0 109.921 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 95.43 2.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.472 ' CZ ' ' C5 ' ' B' ' 104' ' ' ' G' . 16.9 t80 -63.12 121.34 13.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.2 m -119.38 166.94 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 3.6 ptm180 -145.3 131.22 19.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.554 0.533 . . . . 0.0 111.898 175.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 26.7 m-85 -93.41 172.9 7.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.238 1.015 . . . . 0.0 109.295 171.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.412 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -126.78 -33.91 2.45 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 123.917 0.761 . . . . 0.0 112.754 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.1 133.04 34.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.45 -52.91 63.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.424 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -29.28 70.19 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -85.48 -21.35 28.72 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.899 0.318 . . . . 0.0 110.772 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.11 -45.45 16.44 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.391 0.676 . . . . 0.0 109.889 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -77.59 -24.62 49.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.243 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.82 -45.38 43.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.966 0.803 . . . . 0.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -30.08 71.09 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 110.64 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ttp -75.72 -43.27 47.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.392 0.277 . . . . 0.0 110.599 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.02 -0.33 27.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.531 0.15 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.03 -6.32 6.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.7 ttm -136.38 -27.33 1.07 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.474 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -62.65 137.67 58.32 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.393 1.451 . . . . 0.0 108.56 176.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.3 59.63 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.741 -0.477 . . . . 0.0 112.048 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.22 70.24 1.47 Allowed 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.552 ' HB ' ' CG ' ' A' ' 84' ' ' GLU . 9.9 p -45.19 167.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 -167.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.551 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -144.39 -6.79 0.71 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.241 -2.254 . . . . 0.0 116.675 169.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -157.0 6.95 0.16 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.275 0.943 . . . . 0.0 112.993 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.534 ' H ' ' CG2' ' A' ' 79' ' ' VAL . . . 96.38 16.37 37.67 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 121.812 -0.555 . . . . 0.0 111.801 -174.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -147.2 60.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 123.257 1.503 . . . . 0.0 107.526 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.552 ' CG ' ' HB ' ' A' ' 79' ' ' VAL . 1.3 mp0 -50.3 128.91 20.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 112.794 -2.003 . . . . 0.0 114.381 -166.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.687 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -40.02 137.48 0.96 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.759 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mmt-85 -130.52 128.87 42.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.6 p -145.02 120.82 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.109 0.564 . . . . 0.0 109.751 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -154.19 165.13 37.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.22 1.408 . . . . 0.0 108.746 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -56.61 166.02 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.555 1.142 . . . . 0.0 112.87 -173.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.37 143.84 49.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.383 0.673 . . . . 0.0 111.485 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -151.72 -0.67 0.33 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.381 0.672 . . . . 0.0 111.436 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.559 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 13.6 m-30 -78.54 55.39 1.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.127 0.971 . . . . 0.0 112.985 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.72 -149.87 5.13 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 118.301 0.5 . . . . 0.0 112.415 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -153.08 156.47 32.69 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.284 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -32.71 100.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 125.114 3.876 . . . . 0.0 116.367 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -83.61 -24.96 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.421 2.748 . . . . 0.0 110.176 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -150.56 -166.75 2.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.92 1.688 . . . . 0.0 108.481 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.9 p -126.64 -79.11 0.59 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -160.61 17.86 0.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.728 0.24 . . . . 0.0 110.883 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -134.78 11.25 3.67 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 122.941 0.496 . . . . 0.0 111.638 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.169 -178.148 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.847 2 O4'-C1'-N19 115.878 7.678 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.399 2 C1'-O4'-C4' 103.71 -6.545 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.559 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.415 -3.19 0 N19-C1'-C2' 107.958 -3.401 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.48 " H1'" ' HD3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 C3'-C2'-C1' 104.743 3.604 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.474 HO2' " C4'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.796 1 O4'-C1'-N19 112.493 4.293 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.474 " C4'" HO2' ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.56 2 C4'-C3'-C2' 98.395 -4.305 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.6 mtp . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.2 p -148.96 155.94 41.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.31 0.644 . . . . 0.0 110.416 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 45.93 24.63 0.25 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.756 1.222 . . . . 0.0 113.408 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.85 -45.9 90.99 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.462 -0.632 . . . . 0.0 111.844 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 16.2 ptm180 -166.49 40.2 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 55.8 Cg_endo -66.0 128.07 18.97 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.487 -1.774 . . . . 0.0 107.487 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.28 113.06 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.582 2.855 . . . . 0.0 111.408 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -88.9 -162.1 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.207 3.271 . . . . 0.0 109.507 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 11' ' ' GLU . 25.5 t0 -138.67 33.03 2.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 0.0 109.753 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -1.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.325 1.45 . . . . 0.0 113.495 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 9' ' ' ASP . 39.5 mt-10 -105.73 7.59 32.59 Favored 'General case' 0 CA--C 1.527 0.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.526 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.05 17.83 0.32 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.424 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 14.9 ptt? -141.01 169.67 17.18 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.538 0.669 . . . . 0.0 110.804 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.3 m -62.1 166.81 4.42 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.4 m -147.64 61.36 1.14 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 18.9 tp -63.18 155.37 28.37 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HE2' ' C5 ' ' B' ' 103' ' ' ' G' . 13.9 pttp -127.43 143.38 51.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.351 0.407 . . . . 0.0 110.173 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.17 151.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -151.48 -170.98 3.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 109.902 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 82.71 28.1 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.842 1.257 . . . . 0.0 113.049 171.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.41 125.07 15.02 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.684 0.794 . . . . 0.0 109.483 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 24' ' ' ARG . 11.9 m -75.17 168.91 19.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.742 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -65.21 8.49 0.14 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.271 1.028 . . . . 0.0 112.781 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.8 ptt180 -134.56 16.98 3.64 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.486 1.114 . . . . 0.0 111.315 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -120.91 166.57 13.63 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -172.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.437 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.9 p -152.72 164.78 19.23 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.425 1.09 . . . . 0.0 109.052 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 55.3 Cg_endo -68.96 -29.36 27.86 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.686 2.257 . . . . 0.0 111.688 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.83 -36.57 75.72 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.081 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.8 m -72.17 -42.37 65.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -54.64 -25.81 29.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.903 -0.498 . . . . 0.0 111.184 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -79.17 -54.6 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -62.49 -29.99 70.94 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.601 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.38 -32.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 122.974 0.51 . . . . 0.0 110.909 -173.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.414 ' CD1' HD11 ' A' ' 30' ' ' LEU . 24.6 m-85 -102.59 -9.74 19.87 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.27 -25.52 60.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.762 -0.586 . . . . 0.0 111.192 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -68.88 -23.32 64.2 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.004 0.366 . . . . 0.0 111.924 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -72.86 -16.28 61.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.439 0.296 . . . . 0.0 111.252 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.07 -80.59 0.13 Allowed Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -162.3 161.68 27.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.672 0.389 . . . . 0.0 110.443 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -136.98 145.87 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.97 -45.22 6.76 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -169.31 167.68 10.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.684 0.394 . . . . 0.0 110.595 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 m -121.47 152.12 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -149.33 140.92 23.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.348 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.87 108.17 7.62 Favored Pre-proline 0 CA--C 1.53 0.179 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.04 -21.39 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.566 2.844 . . . . 0.0 112.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 36.63 -103.75 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.77 1.228 . . . . 0.0 110.98 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 50' ' ' TYR . 9.2 m-20 -142.88 11.93 1.83 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.381 1.073 . . . . 0.0 109.949 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.457 ' HD3' ' CG ' ' A' ' 99' ' ' HIS . 35.9 ttt85 55.18 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.523 1.929 . . . . 0.0 115.764 -178.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' H ' ' C ' ' A' ' 48' ' ' ASP . 53.0 p90 -141.96 -2.14 1.19 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.314 1.415 . . . . 0.0 113.612 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.03 -20.37 5.78 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.148 0.431 . . . . 0.0 110.878 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 48.45 24.4 0.73 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.147 1.379 . . . . 0.0 113.843 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.74 19.53 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -142.25 168.81 18.86 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.241 0.543 . . . . 0.0 112.082 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -175.29 20.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.475 1.91 . . . . 0.0 110.113 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.83 -9.06 44.37 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.707 -0.621 . . . . 0.0 113.332 -172.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -159.63 163.88 34.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.892 0.877 . . . . 0.0 109.181 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.86 95.32 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.57 96.74 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 60.7 t -92.75 148.28 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 17.4 ttt180 -126.1 115.73 20.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.905 0.753 . . . . 0.0 111.739 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 34' ' ' PHE . 18.3 m-85 -96.78 163.36 13.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.961 0.104 . . . . 0.0 110.914 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.424 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.1 OUTLIER -127.49 -25.36 3.18 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.085 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.12 119.17 26.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -57.47 -49.29 76.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.809 0.277 . . . . 0.0 110.61 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -62.6 -32.63 73.66 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -88.25 -16.03 34.28 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.39 -47.76 12.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.441 ' HA ' ' HE1' ' A' ' 72' ' ' MET . 9.9 pt-20 -67.86 -27.35 66.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.118 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.4 -40.83 57.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.509 0.595 . . . . 0.0 110.84 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.49 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.13 -0.356 . . . . 0.0 111.261 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.441 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 3.8 ptp -77.73 -37.4 49.35 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.0 1.02 22.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.978 0.511 . . . . 0.0 111.836 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.78 -4.93 3.62 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttm -138.06 -28.01 0.88 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.45 134.66 56.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.916 0.78 . . . . 0.0 110.037 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 81.98 9.96 84.62 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.414 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.9 30.15 0.38 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.081 0.941 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.543 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 42.9 t -72.72 162.49 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.431 1.092 . . . . 0.0 112.234 -172.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.28 16.25 0.21 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.836 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -144.61 4.67 1.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.189 0.595 . . . . 0.0 111.472 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.3 -9.13 57.48 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.43 ' C ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.92 123.1 0.51 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.523 1.129 . . . . 0.0 108.533 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.543 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.7 mm-40 -138.31 -47.32 0.52 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.518 169.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -137.81 153.57 49.63 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.184 0.516 . . . . 0.0 111.937 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -149.0 108.24 3.93 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.772 1.629 . . . . 0.0 106.968 168.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.36 140.7 47.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.293 0.237 . . . . 0.0 111.345 -176.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -171.49 175.84 3.97 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.712 1.605 . . . . 0.0 108.046 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.8 mmt -75.45 146.98 40.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.92 51.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -132.38 19.6 4.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.76 139.68 29.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.46 -165.32 13.63 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 122.878 0.275 . . . . 0.0 112.457 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -45.18 127.85 5.72 Favored Pre-proline 0 CA--C 1.526 0.043 0 C-N-CA 123.813 0.845 . . . . 0.0 110.158 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.412 ' HG3' " H5'" ' B' ' 105' ' ' ' A' . 47.1 Cg_endo -67.98 142.59 57.27 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.813 2.342 . . . . 0.0 110.467 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.68 -34.09 4.52 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.038 2.492 . . . . 0.0 110.668 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -167.8 136.2 2.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.057 0.543 . . . . 0.0 110.704 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m -149.94 0.58 0.47 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.517 1.127 . . . . 0.0 111.192 172.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.457 ' CG ' ' HD3' ' A' ' 49' ' ' ARG . 86.1 t60 -153.31 131.36 11.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.648 0.379 . . . . 0.0 110.025 -172.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -157.61 1.4 0.11 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 C--O 1.251 1.178 0 CA-C-O 116.914 -1.517 . . . . 0.0 111.561 -178.621 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.023 2 O4'-C1'-N19 112.446 4.246 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.553 ' C5 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.422 -2.548 2 O4'-C1'-N19 116.696 8.496 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.541 ' P ' " H1'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.414 -3.289 1 O4'-C1'-N19 114.079 5.879 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.412 " H5'" ' HG3' ' A' ' 95' ' ' PRO . . . . . . . . 0 P--O5' 1.624 3.056 1 C5'-C4'-C3' 107.317 -5.456 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.82 1 C4'-C3'-C2' 98.531 -4.169 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 C4'-C3'-C2' 100.137 -2.563 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m -58.18 136.83 57.34 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 122.798 0.439 . . . . 0.0 110.724 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 44.33 29.4 0.37 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.367 1.467 . . . . 0.0 113.117 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.47 62.68 3.78 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.958 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 17.2 mtp180 106.64 21.59 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 127.325 2.25 . . . . 0.0 116.002 167.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 82.2 Cg_endo -71.82 149.81 54.63 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.593 1.605 . . . . 0.0 110.148 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.41 144.73 29.28 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.453 2.768 . . . . 0.0 111.141 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.55 -169.26 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.761 3.64 . . . . 0.0 110.134 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -131.69 17.38 4.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.781 0.832 . . . . 0.0 109.403 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.27 -5.85 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 125.593 1.557 . . . . 0.0 112.877 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.16 -0.32 3.27 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 112.991 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.83 36.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.217 -0.768 . . . . 0.0 113.702 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 165.06 28.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.652 1.226 . . . . 0.0 112.457 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -73.64 93.14 2.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 123.761 0.824 . . . . 0.0 110.844 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -70.44 85.27 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.026 0.931 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -106.57 134.1 50.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.8 155.34 46.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -168.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.49 155.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -174.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -152.22 -171.09 3.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.679 1.192 . . . . 0.0 110.454 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 87.18 27.36 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.256 1.422 . . . . 0.0 113.145 171.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.77 125.77 15.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.122 0.969 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -77.34 171.92 14.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.264 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -63.36 6.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.774 1.23 . . . . 0.0 114.09 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -134.6 15.0 3.7 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.488 0.586 . . . . 0.0 112.084 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 m -117.7 165.19 13.91 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.507 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -153.3 167.21 13.95 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.648 1.179 . . . . 0.0 109.431 -174.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 43.4 Cg_endo -69.46 -28.47 26.67 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.247 1.965 . . . . 0.0 111.675 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.75 -34.38 75.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.3 m -77.66 -43.77 30.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.401 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -57.87 -21.19 41.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.811 -0.555 . . . . 0.0 110.703 178.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -56.51 4.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -61.37 -31.04 70.93 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.645 0.202 . . . . 0.0 110.597 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.28 -34.92 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 122.765 0.426 . . . . 0.0 111.06 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 30' ' ' LEU . 16.6 m-85 -99.34 -10.68 21.99 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.63 -27.07 61.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.445 0.566 . . . . 0.0 111.233 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -67.25 -22.65 65.67 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -74.04 -23.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.377 0.271 . . . . 0.0 110.988 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.86 -79.56 0.09 OUTLIER Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.143 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -157.31 164.8 37.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.94 133.68 44.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.07 -38.54 7.83 Favored Glycine 0 CA--C 1.519 0.344 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -158.42 161.02 37.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.879 0.872 . . . . 0.0 109.64 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.1 p -139.07 74.37 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-O 123.301 1.524 . . . . 0.0 107.05 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.468 ' CD2' ' C5 ' ' B' ' 106' ' ' ' G' . 1.7 t80 -83.13 143.64 30.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.299 -169.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.8 mt -140.14 130.36 13.84 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.44 151.1 5.02 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.158 2.572 . . . . 0.0 111.712 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.05 19.19 3.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.262 0.625 . . . . 0.0 109.631 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 50' ' ' TYR . 64.9 m-20 42.47 26.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.11 0.964 . . . . 0.0 112.767 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 42.88 3.26 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.642 2.777 . . . . 0.0 116.312 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' A' ' 48' ' ' ASP . 30.0 p90 -165.87 -4.11 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 113.915 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -116.78 -18.9 10.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.154 1.343 . . . . 0.0 111.633 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.69 30.6 0.54 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 125.775 1.63 . . . . 0.0 113.64 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.46 -159.39 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.664 0.786 . . . . 0.0 109.095 171.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.4 t -138.01 172.85 12.32 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.979 0.511 . . . . 0.0 111.384 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -137.02 3.53 2.67 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.514 0.725 . . . . 0.0 111.762 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.34 54.26 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.347 -0.696 . . . . 0.0 112.887 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.81 169.6 23.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.672 1.236 . . . . 0.0 111.318 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.39 101.67 3.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.604 ' CE2' ' C5 ' ' B' ' 104' ' ' ' G' . 51.5 t80 -69.33 89.48 0.48 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.071 1.349 . . . . 0.0 109.066 -175.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 68.0 t -75.39 158.59 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 172.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -138.98 128.21 24.05 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -106.05 173.69 6.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.19 1.396 . . . . 0.0 109.555 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -135.6 -38.31 0.74 Allowed 'General case' 0 C--N 1.339 0.127 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.79 124.62 32.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.427 -0.796 . . . . 0.0 109.133 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -53.75 -49.39 68.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.848 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -58.73 -24.9 62.34 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.8 p30 -110.42 -6.57 14.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.714 0.688 . . . . 0.0 111.287 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.34 -46.63 22.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.39 -31.06 48.19 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.569 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -71.27 -43.9 66.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.482 1.037 . . . . 0.0 111.089 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.41 75.12 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 118.146 0.43 . . . . 0.0 110.278 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttp -72.22 -42.52 65.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.751 0.42 . . . . 0.0 110.627 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.19 3.51 23.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.332 -0.23 . . . . 0.0 111.24 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.35 -6.32 4.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.0 ttm -137.47 -28.17 0.92 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.44 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -63.1 137.87 58.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 118.016 -1.473 . . . . 0.0 109.865 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 73.7 10.71 80.27 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.903 177.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 33.0 0.4 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.262 1.031 . . . . 0.0 110.547 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.583 HG23 ' H ' ' A' ' 81' ' ' ASP . 9.8 p -73.28 174.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -170.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.413 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 1.3 pt? -152.69 4.92 0.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.622 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.583 ' H ' HG23 ' A' ' 79' ' ' VAL . 36.8 t70 -141.52 -3.72 1.15 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.548 0.339 . . . . 0.0 111.886 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 79' ' ' VAL . . . 109.87 -10.55 32.15 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.457 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.41 128.18 3.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 13.1 mm-40 -144.24 -49.54 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -138.64 154.61 48.65 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.103 0.561 . . . . 0.0 112.294 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -152.03 112.52 4.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.868 1.667 . . . . 0.0 106.506 166.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.57 125.69 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.232 0.539 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -154.07 163.67 39.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.361 1.464 . . . . 0.0 108.36 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 mmt -61.01 140.94 57.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.577 0.751 . . . . 0.0 110.356 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 156.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -145.74 18.92 1.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.259 1.024 . . . . 0.0 108.661 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.472 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 3.3 t80 -148.75 135.8 20.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.32 176.38 21.71 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.333 0.407 . . . . 0.0 113.523 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -63.3 135.87 96.44 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 123.729 0.812 . . . . 0.0 110.266 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.419 ' HG3' " C5'" ' B' ' 105' ' ' ' A' . 36.0 Cg_endo -65.98 134.05 35.7 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.767 2.312 . . . . 0.0 109.799 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.72 -20.99 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.329 2.686 . . . . 0.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -150.73 157.33 42.83 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.608 1.163 . . . . 0.0 107.88 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p -65.41 -14.41 60.83 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -162.59 25.96 0.1 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.822 1.192 . . . . 0.0 112.13 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -145.51 168.57 20.28 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.083 -0.385 . . . . 0.0 109.986 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.255 -179.743 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.15 1 O4'-C1'-N19 115.388 7.188 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.434 HO2' ' P ' ' B' ' 104' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.41 -3.593 1 C1'-O4'-C4' 105.327 -4.748 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.604 ' C5 ' ' CE2' ' A' ' 59' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.192 0 P-O3'-C3' 123.523 3.186 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.419 " C5'" ' HG3' ' A' ' 95' ' ' PRO . . . . . . . . 0 O4'--C4' 1.419 -2.839 0 O5'-C5'-C4' 114.368 2.977 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.468 ' C5 ' ' CD2' ' A' ' 44' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.107 0 C5'-C4'-C3' 109.589 -3.941 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.463 " C3'" ' HD2' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.412 -3.41 2 C1'-O4'-C4' 104.119 -6.091 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m -144.8 -175.11 4.54 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.325 0.65 . . . . 0.0 110.27 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -130.53 -22.56 2.71 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.835 0.454 . . . . 0.0 111.481 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.459 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 78.39 32.09 43.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.219 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' HD3' " H1'" ' B' ' 107' ' ' ' U' . 11.3 ptm180 34.68 57.69 2.19 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.07 1.348 . . . . 0.0 113.034 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.65 150.89 79.71 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.016 2.477 . . . . 0.0 110.464 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.22 122.06 8.05 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.539 2.826 . . . . 0.0 110.571 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -80.88 -167.94 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.775 2.983 . . . . 0.0 110.433 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -129.61 29.35 5.06 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.679 0.792 . . . . 0.0 110.319 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 m -56.23 -12.74 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.678 1.191 . . . . 0.0 112.585 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.07 -0.94 5.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.227 1.011 . . . . 0.0 112.931 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.41 28.74 0.14 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.341 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.34 166.37 25.28 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.856 1.328 . . . . 0.0 112.082 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.409 ' OG1' ' HE3' ' A' ' 65' ' ' LYS . 91.1 m -82.99 90.13 6.97 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.869 0.868 . . . . 0.0 111.285 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.9 m -67.21 85.97 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.889 0.876 . . . . 0.0 110.428 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 31.8 tp -70.95 162.92 28.51 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.245 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.522 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 25.3 ttpp -133.55 143.61 48.82 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.123 0.969 . . . . 0.0 110.529 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.42 146.43 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -150.67 -169.74 3.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.777 1.631 . . . . 0.0 110.406 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.49 27.13 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.755 1.622 . . . . 0.0 113.563 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.22 123.43 11.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.762 0.825 . . . . 0.0 109.959 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 24' ' ' ARG . 10.4 m -72.25 168.04 19.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -64.69 9.7 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 113.123 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 22' ' ' THR . 23.5 ptt180 -135.06 17.88 3.46 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.474 1.11 . . . . 0.0 111.397 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -125.29 162.83 23.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.661 0.385 . . . . 0.0 111.385 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.431 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 62.9 m -148.72 163.79 24.33 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.682 1.193 . . . . 0.0 109.018 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 26' ' ' SER . 55.3 Cg_endo -69.18 -30.54 24.81 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.277 1.985 . . . . 0.0 111.697 -175.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.34 -35.24 79.85 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.942 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.8 m -74.36 -44.19 53.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -56.34 -22.26 29.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.853 -0.53 . . . . 0.0 110.52 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -57.67 3.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.31 -30.71 71.35 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.771 0.319 . . . . 0.0 110.75 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.06 -32.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 30' ' ' LEU . 19.5 m-85 -100.64 -11.67 19.82 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.47 -26.73 64.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.494 -0.754 . . . . 0.0 110.928 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.49 -23.82 65.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.7 -16.38 59.53 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 122.64 0.376 . . . . 0.0 111.603 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.26 -82.16 0.11 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -158.94 165.27 34.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.045 0.45 . . . . 0.0 111.048 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.3 123.11 49.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.82 -23.77 51.65 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -164.68 155.68 14.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.117 0.484 . . . . 0.0 110.896 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.62 125.3 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -159.11 157.61 31.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.95 -167.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.427 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 9.9 mt -127.06 88.8 53.52 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 158.93 4.38 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.102 3.202 . . . . 0.0 111.425 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.488 ' C ' ' H ' ' A' ' 49' ' ' ARG . 82.3 mtm-85 -146.19 157.18 43.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.76 3.66 1.38 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 47' ' ' ARG . 9.2 ttm-85 62.55 -2.42 0.36 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.181 1.392 . . . . 0.0 114.008 172.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -149.37 0.19 0.5 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 p -127.56 -22.49 3.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.635 0.652 . . . . 0.0 111.386 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.0 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.687 1.995 . . . . 0.0 114.877 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.41 5.47 8.74 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.985 -0.447 . . . . 0.0 111.521 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.5 p -65.94 -23.07 66.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -34.8 116.66 0.34 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.803 1.241 . . . . 0.0 112.509 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.24 -6.85 0.28 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.679 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 172.0 15.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.808 0.843 . . . . 0.0 110.231 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.89 94.88 2.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 18.8 t80 -64.79 109.54 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.1 159.86 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.2 ptm180 -136.85 145.18 44.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.063 -175.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.417 ' HB2' ' CB ' ' A' ' 16' ' ' LEU . 4.7 m-85 -114.8 177.58 4.6 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.77 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -134.66 -32.7 0.99 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.85 127.69 32.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.229 0.468 . . . . 0.0 109.988 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HE3' ' OG1' ' A' ' 14' ' ' THR . 2.6 tppp? -60.38 -56.75 17.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -33.21 68.12 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -84.93 -23.93 28.61 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.977 0.353 . . . . 0.0 110.507 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -76.58 -44.15 35.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.42 ' HA ' ' HE1' ' A' ' 72' ' ' MET . 6.5 pt-20 -76.48 -19.3 58.15 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.002 -0.436 . . . . 0.0 111.349 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -79.47 -39.94 30.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.588 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.09 76.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.951 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.42 ' HE1' ' HA ' ' A' ' 69' ' ' GLU . 9.1 ptp -75.37 -39.45 59.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.658 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -77.2 1.56 18.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.279 0.632 . . . . 0.0 111.702 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.22 -6.35 3.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttm -138.41 -27.07 0.88 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.06 137.65 57.82 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.926 0.784 . . . . 0.0 110.058 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 79' ' ' VAL . . . 79.42 10.36 86.01 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 119.607 -0.552 . . . . 0.0 112.439 175.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.13 30.99 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.076 0.938 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.568 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 43.0 t -75.22 163.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 124.335 1.054 . . . . 0.0 112.176 -171.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.82 10.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.241 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.6 4.75 2.62 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.464 0.705 . . . . 0.0 111.486 -175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.46 -8.49 58.6 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.435 ' C ' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -172.47 123.18 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.397 1.079 . . . . 0.0 108.643 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.568 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.4 mm-40 -137.9 -47.85 0.55 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 169.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -137.78 153.94 49.63 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 111.753 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -148.04 109.34 4.34 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.049 1.739 . . . . 0.0 106.721 167.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.53 134.71 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -168.11 173.03 8.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -76.25 139.94 41.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.168 0.587 . . . . 0.0 110.364 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.57 162.39 29.54 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.499 0.32 . . . . 0.0 110.568 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -144.86 15.25 1.55 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 108.991 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.652 ' HB2' ' H21' ' B' ' 104' ' ' ' G' . 23.1 m-85 -135.1 166.41 23.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.45 168.28 14.35 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 117.912 0.324 . . . . 0.0 112.923 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 157.86 17.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.101 0.96 . . . . 0.0 111.526 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -33.56 97.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 1 C-N-CA 126.314 4.676 . . . . 0.0 115.924 -176.214 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.481 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 72.8 Cg_endo -77.88 -56.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.499 2.133 . . . . 0.0 109.276 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.481 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 15.6 t0 -176.45 123.03 0.16 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.566 1.146 . . . . 0.0 109.95 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.41 ' HB2' " H5'" ' B' ' 105' ' ' ' A' . 17.7 m -156.19 8.5 0.23 Allowed 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 124.334 1.054 . . . . 0.0 110.793 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -144.87 18.0 1.62 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -166.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -62.54 168.65 3.51 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.041 0.537 . . . . 0.0 111.731 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 117.132 -1.413 . . . . 0.0 109.798 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.386 1 O4'-C1'-N19 114.477 6.277 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' ' G' . . . . . 0.522 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.845 2 O4'-C1'-N19 115.681 7.481 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ' G' . . . . . 0.652 ' H21' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.743 0 P-O3'-C3' 124.059 3.632 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ' A' . . . . . 0.5 HO2' ' P ' ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.908 2 C3'-C2'-C1' 105.287 4.208 OUTLIER-EPSILON 0.01 1z . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.5 ' P ' HO2' ' B' ' 105' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 P-O3'-C3' 124.293 3.828 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.481 " H1'" ' HD3' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.421 -2.679 1 C5'-C4'-C3' 108.484 -4.677 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.377 0.132 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.46 -81.55 0.03 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -153.86 69.09 6.32 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 125.342 1.457 . . . . 0.0 110.346 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 118.04 5.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.087 2.525 . . . . 0.0 109.986 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.08 113.8 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.83 3.02 . . . . 0.0 110.894 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -87.83 -167.88 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.928 3.085 . . . . 0.0 109.849 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -137.59 41.71 2.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 109.511 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 17.7 m -52.7 -14.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.941 1.696 . . . . 0.0 113.693 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -88.4 5.23 43.21 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.124 0.569 . . . . 0.0 111.303 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.02 19.82 0.66 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.45 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 5.1 ptt? -139.39 166.61 24.11 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.793 0.796 . . . . 0.0 111.835 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -63.34 -26.54 68.81 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t 44.03 58.85 3.45 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.19 0.996 . . . . 0.0 112.478 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 23.4 tp -63.91 164.4 10.38 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 20.4 ttpp -137.21 142.08 42.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.339 1.055 . . . . 0.0 109.986 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -135.39 152.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 174.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -153.37 -167.78 2.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.107 1.363 . . . . 0.0 110.542 -174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 82.9 28.29 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.69 1.596 . . . . 0.0 113.309 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.64 126.18 22.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.795 0.838 . . . . 0.0 109.303 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -68.91 168.25 14.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -62.52 3.29 0.21 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -139.14 18.5 2.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.771 0.829 . . . . 0.0 112.078 -174.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -112.38 165.56 12.09 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.895 0.478 . . . . 0.0 110.391 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 82.8 p -149.59 167.06 13.78 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.319 1.048 . . . . 0.0 109.038 -176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.4 Cg_endo -68.98 -26.75 30.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.403 2.069 . . . . 0.0 111.68 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.86 -33.78 74.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.997 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -74.9 -44.38 49.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -58.67 -20.91 52.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.8 -0.562 . . . . 0.0 111.103 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -82.02 -56.62 3.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -62.91 -24.75 67.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.684 0.22 . . . . 0.0 110.481 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.9 t -83.11 -34.96 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.715 0.406 . . . . 0.0 110.644 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CD1' HD13 ' A' ' 30' ' ' LEU . 20.2 m-85 -99.27 -10.96 21.72 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -72.71 -26.61 61.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.634 -0.666 . . . . 0.0 111.441 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.98 -22.93 64.07 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -73.28 -20.89 60.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.844 0.458 . . . . 0.0 111.267 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.05 -88.92 0.1 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -154.23 164.47 38.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.37 0.605 . . . . 0.0 111.733 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.66 133.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.29 -24.43 24.32 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -161.65 152.69 18.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.077 0.465 . . . . 0.0 110.084 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -149.87 103.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 176.026 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -150.18 161.63 42.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.101 -167.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 mt -134.35 132.21 20.89 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.33 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.11 -29.69 32.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.962 2.441 . . . . 0.0 111.325 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 36.92 30.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.257 1.823 . . . . 0.0 114.708 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 51.39 12.31 0.14 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.674 0.79 . . . . 0.0 112.812 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 52.53 -14.18 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.879 2.472 . . . . 0.0 116.064 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -155.47 4.12 0.19 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.686 1.13 . . . . 0.0 113.271 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 -25.6 3.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.846 0.748 . . . . 0.0 112.054 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.1 21.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.962 2.105 . . . . 0.0 115.008 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.95 -11.66 59.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.772 -0.58 . . . . 0.0 112.371 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.5 t -83.56 -78.11 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.048 0.385 . . . . 0.0 110.684 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.66 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.255 2.222 . . . . 0.0 115.894 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.11 -2.64 32.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.79 -0.569 . . . . 0.0 112.559 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -155.71 169.86 23.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.124 0.57 . . . . 0.0 110.097 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.79 103.54 3.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -66.11 92.2 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.695 0.798 . . . . 0.0 108.889 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 30' ' ' LEU . 92.5 t -87.27 155.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.9 ttt180 -138.31 131.84 30.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 123.148 0.28 . . . . 0.0 111.236 -172.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 6.4 m-85 -115.11 170.8 8.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.657 0.265 . . . . 0.0 111.143 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -32.96 2.02 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.42 122.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.04 -54.23 49.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.421 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -58.86 -33.18 70.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -85.32 -21.22 29.03 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.983 0.356 . . . . 0.0 110.542 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.85 -42.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.941 0.496 . . . . 0.0 110.22 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -73.84 -25.57 60.14 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.05 -0.407 . . . . 0.0 110.511 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.15 -47.68 34.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.232 0.469 . . . . 0.0 110.393 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -31.53 71.72 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.347 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.8 ttp -74.01 -42.75 59.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.119 0.568 . . . . 0.0 110.452 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.8 2.96 24.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.024 0.13 . . . . 0.0 111.215 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.24 -5.59 4.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttm -137.88 -29.4 0.85 Allowed 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -64.15 140.23 58.85 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.932 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.8 6.98 83.18 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.72 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.8 32.06 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.165 0.983 . . . . 0.0 110.784 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.585 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 23.0 t -73.99 164.61 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.846 0.858 . . . . 0.0 111.569 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.7 5.06 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.9 3.3 1.82 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.145 0.43 . . . . 0.0 112.076 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.63 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.313 0.482 . . . . 0.0 112.632 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -172.44 115.19 0.31 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.268 1.027 . . . . 0.0 109.008 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.585 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 79.6 mm-40 -130.88 -50.45 1.04 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.119 171.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.438 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -140.53 153.54 46.21 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.304 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 22.6 mmt180 -151.79 113.96 4.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 167.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.34 135.79 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-O 121.227 0.536 . . . . 0.0 110.445 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.5 173.05 10.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.423 1.489 . . . . 0.0 108.275 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.51 147.62 50.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.524 0.73 . . . . 0.0 111.102 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.73 150.18 29.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -141.99 21.17 2.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -145.55 143.56 30.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.15 179.36 21.02 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 117.885 0.312 . . . . 0.0 112.876 -169.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -57.64 148.81 54.95 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.018 0.527 . . . . 0.0 110.981 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.02 135.64 21.37 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.65 2.9 . . . . 0.0 111.089 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.36 -39.9 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.589 2.192 . . . . 0.0 109.379 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.04 136.33 1.46 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.486 1.115 . . . . 0.0 109.503 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--N 1.333 -0.13 0 C-N-CA 124.062 0.945 . . . . 0.0 110.287 178.347 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.777 0.322 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.31 -73.38 2.6 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -178.73 52.4 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.07 139.63 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.544 2.163 . . . . 0.0 110.595 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.93 115.37 3.28 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.657 2.905 . . . . 0.0 110.097 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.27 -166.97 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.842 3.028 . . . . 0.0 110.571 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -132.41 28.69 4.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.244 1.018 . . . . 0.0 110.463 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.5 m -53.98 -18.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 124.771 1.228 . . . . 0.0 113.425 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -77.5 4.58 10.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.341 0.656 . . . . 0.0 111.912 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 16.66 0.67 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.017 -0.879 . . . . 0.0 112.324 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.07 166.91 23.37 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 1.206 . . . . 0.0 113.38 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -61.26 -27.67 68.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -167.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.1 m 44.48 38.55 2.67 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.561 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -62.58 132.88 53.86 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.704 -0.623 . . . . 0.0 109.844 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 68.8 tttt -97.68 148.88 22.88 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.524 0.73 . . . . 0.0 112.518 -170.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 60' ' ' VAL . 98.2 t -127.12 147.96 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -155.32 -176.83 6.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.479 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 51.9 t30 84.96 38.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.179 1.392 . . . . 0.0 113.4 171.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.4 138.09 57.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.846 0.859 . . . . 0.0 108.96 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.429 HG22 ' CD1' ' A' ' 23' ' ' TYR . 6.7 m -80.4 166.16 21.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.737 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CD1' HG22 ' A' ' 22' ' ' THR . 52.6 p90 -62.88 6.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.431 1.092 . . . . 0.0 113.373 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 22' ' ' THR . 34.8 ptt180 -135.06 20.34 3.46 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.965 1.306 . . . . 0.0 111.337 -174.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -123.87 165.02 18.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.817 0.447 . . . . 0.0 110.531 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.474 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.8 p -149.4 165.5 17.49 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 124.047 0.939 . . . . 0.0 109.351 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 61.9 Cg_endo -71.15 -25.16 22.66 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.052 1.835 . . . . 0.0 111.868 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.43 -34.19 75.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 121.839 -0.538 . . . . 0.0 109.674 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.5 m -75.63 -43.28 48.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.484 HD11 HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -56.19 -23.48 35.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.623 -0.673 . . . . 0.0 111.093 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -80.61 -55.63 4.71 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -61.29 -28.74 69.4 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.042 0.383 . . . . 0.0 110.645 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -80.48 -33.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 122.94 0.496 . . . . 0.0 111.542 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 30' ' ' LEU . 28.7 m-85 -103.07 -9.27 19.87 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.44 -24.32 57.03 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.733 -0.604 . . . . 0.0 111.016 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.91 -22.55 63.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.249 0.477 . . . . 0.0 112.169 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.26 -17.49 61.89 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 122.342 0.257 . . . . 0.0 111.123 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.2 -76.38 0.17 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -164.14 162.49 22.86 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.547 0.739 . . . . 0.0 110.445 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -136.42 144.16 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.23 -24.48 19.16 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -162.36 149.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 117.085 0.443 . . . . 0.0 111.062 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 60' ' ' VAL . 87.0 t -139.26 113.59 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -146.4 160.47 42.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.2 92.1 40.08 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.651 0.38 . . . . 0.0 110.85 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -49.14 135.06 30.6 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 124.049 3.166 . . . . 0.0 111.147 173.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -164.78 164.68 21.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.09 117.48 10.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -67.48 16.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -169.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.458 ' CD2' HG23 ' A' ' 51' ' ' THR . 10.2 p90 -146.89 -3.05 0.6 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.692 1.197 . . . . 0.0 112.001 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.458 HG23 ' CD2' ' A' ' 50' ' ' TYR . 44.6 p -123.68 -24.72 4.45 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.72 0.691 . . . . 0.0 110.371 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptt 49.88 26.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.979 1.712 . . . . 0.0 113.119 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.66 5.88 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.9 m 58.92 -178.18 0.08 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -141.62 0.09 1.42 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.55 16.97 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.887 0.767 . . . . 0.0 113.432 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -153.91 169.63 22.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.321 1.06 . . . . 0.0 110.026 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.0 96.69 3.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -63.04 115.94 4.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.507 HG12 HG13 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -116.99 163.16 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -139.06 125.58 20.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.826 0.704 . . . . 0.0 110.587 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 21.8 m-85 -96.34 158.62 15.35 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.561 0.744 . . . . 0.0 109.936 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.56 -30.98 6.35 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.653 0.595 . . . . 0.0 112.348 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.77 119.39 21.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -61.49 -45.13 95.51 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.341 0.257 . . . . 0.0 110.644 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.502 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -67.13 -28.96 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.519 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -90.96 -13.34 33.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.561 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.97 -42.78 25.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -77.42 -25.24 50.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.614 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.33 -47.11 36.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.646 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.87 73.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.4 ttp -73.3 -42.16 62.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.781 0.432 . . . . 0.0 110.369 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.02 3.21 27.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.263 -0.273 . . . . 0.0 111.558 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.53 -6.52 4.68 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.8 ttm -139.45 -26.54 0.81 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.14 134.72 56.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.396 0.998 . . . . 0.0 110.755 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 8.67 85.68 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.128 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.41 33.4 0.35 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.19 0.995 . . . . 0.0 111.098 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.591 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 46.1 t -69.42 164.52 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.012 0.925 . . . . 0.0 112.209 -173.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.404 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -157.97 9.95 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.68 -178.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -149.88 4.4 0.56 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.107 0.867 . . . . 0.0 113.249 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.55 -20.35 4.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.852 -0.53 . . . . 0.0 111.974 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.511 ' C ' HG13 ' A' ' 79' ' ' VAL . 6.2 ptp180 -175.23 143.65 0.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.112 1.765 . . . . 0.0 106.651 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.591 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.2 mm-40 -141.59 -47.62 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.643 169.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.482 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.92 159.29 42.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.79 0.805 . . . . 0.0 112.124 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 10.1 mmm180 -152.33 114.34 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 16' ' ' LEU . 21.3 t -136.88 127.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -167.46 165.17 14.94 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.86 142.21 58.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.366 -172.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.65 167.81 6.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.133 0.573 . . . . 0.0 111.524 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -139.39 -8.19 1.3 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 123.346 0.658 . . . . 0.0 110.993 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -140.25 173.61 11.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -116.79 175.61 15.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 117.719 0.236 . . . . 0.0 112.834 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -60.36 142.21 90.65 Favored Pre-proline 0 C--O 1.233 0.19 0 C-N-CA 123.737 0.815 . . . . 0.0 110.136 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.05 130.41 31.63 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.321 2.681 . . . . 0.0 113.403 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.66 -25.31 9.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.761 2.307 . . . . 0.0 109.324 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -159.31 161.61 35.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.127 1.371 . . . . 0.0 107.679 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.111 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 110.965 -0.013 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.77 45.42 27.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.534 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 38.94 50.39 2.63 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.161 1.384 . . . . 0.0 114.36 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.01 149.28 52.61 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.209 2.606 . . . . 0.0 110.89 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.93 123.84 8.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.254 2.636 . . . . 0.0 110.499 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -81.85 -165.98 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.813 3.009 . . . . 0.0 110.367 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.69 30.17 4.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.922 0.889 . . . . 0.0 109.691 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 33.7 m -57.06 -12.23 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.607 1.163 . . . . 0.0 112.646 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.83 -0.04 8.22 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.919 0.887 . . . . 0.0 112.388 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.93 32.29 0.18 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.889 -0.951 . . . . 0.0 113.472 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.1 ptt? -142.89 164.86 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.546 1.173 . . . . 0.0 111.675 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -60.63 -28.01 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -170.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m 43.24 59.25 3.03 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 16.3 tp -66.42 169.58 7.24 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 13.9 pttt -139.09 155.58 47.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.402 0.546 . . . . 0.0 111.05 171.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 60' ' ' VAL . 57.2 t -134.15 145.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -150.06 -174.59 4.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.48 1.112 . . . . 0.0 109.815 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 83' ' ' ARG . 8.0 t30 92.52 29.88 0.01 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.221 1.409 . . . . 0.0 112.968 169.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.92 117.74 3.19 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.538 1.135 . . . . 0.0 109.802 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 23' ' ' TYR . 3.0 m -67.44 171.09 6.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' H ' HG22 ' A' ' 22' ' ' THR . 48.9 p90 -62.84 3.09 0.25 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.094 0.958 . . . . 0.0 113.01 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ptt-85 -134.26 14.28 3.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.388 0.675 . . . . 0.0 111.85 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -113.34 165.51 12.36 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.3 p -150.89 167.94 11.98 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.57 1.148 . . . . 0.0 108.839 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 62.4 Cg_endo -69.52 -35.02 14.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.264 1.976 . . . . 0.0 110.721 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -61.51 -36.07 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.117 0.484 . . . . 0.0 109.886 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -71.79 -44.23 64.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.506 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -54.65 -23.88 19.18 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.227 -0.296 . . . . 0.0 111.585 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -78.77 -56.56 4.31 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -65.29 -20.38 66.39 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.778 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.75 -32.1 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.636 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -106.16 -7.92 17.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.982 0.513 . . . . 0.0 112.277 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.47 -26.14 55.04 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.217 0.462 . . . . 0.0 111.155 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -67.64 -23.69 65.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.223 0.465 . . . . 0.0 112.244 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.89 -17.76 61.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.667 0.387 . . . . 0.0 111.526 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.84 -82.26 0.11 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.78 163.09 37.05 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.159 0.584 . . . . 0.0 110.789 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -135.3 140.25 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.59 -21.5 21.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -161.86 155.86 21.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.703 0.752 . . . . 0.0 111.713 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 60' ' ' VAL . 61.1 t -147.46 125.34 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 46' ' ' PRO . 1.6 t80 -157.48 152.66 25.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.53 71.2 52.33 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 20.4 Cg_endo -93.29 -6.45 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.616 1 C-N-CA 126.48 4.787 . . . . 0.0 117.979 -167.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -48.86 -36.43 16.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.366 1.439 . . . . 0.0 111.97 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -144.17 101.51 3.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 168.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -62.12 8.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.717 1.607 . . . . 0.0 114.908 -169.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.507 ' CD1' HG23 ' A' ' 51' ' ' THR . 18.6 p90 -150.84 6.09 0.51 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.33 1.052 . . . . 0.0 112.279 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.507 HG23 ' CD1' ' A' ' 50' ' ' TYR . 11.5 p -130.57 -29.02 2.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.866 0.757 . . . . 0.0 111.72 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.93 23.87 0.31 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.466 1.506 . . . . 0.0 113.029 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.65 11.18 0.2 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -131.92 25.47 4.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.472 0.709 . . . . 0.0 110.207 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 8.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.995 1.718 . . . . 0.0 114.831 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.38 -3.46 2.95 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.492 0.587 . . . . 0.0 111.768 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -152.88 168.04 27.09 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.407 1.083 . . . . 0.0 109.082 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.32 97.23 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.3 109.92 1.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.1 m -107.27 170.03 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.4 ptm180 -144.53 145.65 31.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.764 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 23.2 m-85 -112.73 166.71 11.11 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.068 0.547 . . . . 0.0 109.926 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.455 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.87 -30.91 2.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.698 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.07 125.4 30.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -61.21 -54.2 47.24 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.401 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -58.92 -32.14 69.29 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -86.76 -18.19 31.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.952 0.342 . . . . 0.0 110.762 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.36 -43.96 16.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 122.709 0.404 . . . . 0.0 110.147 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -73.25 -26.62 61.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.267 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -73.82 -46.47 44.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.322 0.51 . . . . 0.0 110.717 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.97 72.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.5 ttp -75.07 -40.98 59.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.105 0.562 . . . . 0.0 110.347 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.9 2.99 31.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.065 0.146 . . . . 0.0 111.279 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.83 -5.83 4.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.2 ttm -137.42 -28.95 0.9 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.445 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.1 t70 -64.51 137.86 58.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 120.161 1.346 . . . . 0.0 110.007 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.73 16.42 79.21 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.729 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.85 29.46 1.02 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.115 0.958 . . . . 0.0 110.371 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.487 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 41.2 t -72.66 170.47 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.168 1.387 . . . . 0.0 112.486 -170.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.44 ' N ' HG12 ' A' ' 79' ' ' VAL . 1.1 pt? -153.82 3.32 0.27 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -139.69 2.08 1.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.75 -20.02 4.38 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.241 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -177.77 135.22 0.17 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.995 1.318 . . . . 0.0 108.074 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.487 ' HG3' ' HA ' ' A' ' 79' ' ' VAL . 9.6 mt-10 -140.85 -37.56 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.019 171.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -144.4 149.98 36.98 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.703 0.401 . . . . 0.0 111.872 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.4 mmt180 -151.79 106.56 3.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.623 1.569 . . . . 0.0 106.879 166.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -133.87 126.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 CA-C-O 121.226 0.536 . . . . 0.0 110.495 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -156.59 175.29 14.24 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 125.67 1.588 . . . . 0.0 108.923 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.99 145.83 53.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.034 0.934 . . . . 0.0 110.389 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.44 170.34 16.3 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.966 0.506 . . . . 0.0 111.652 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -147.07 3.23 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.167 0.587 . . . . 0.0 110.985 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -131.73 175.17 9.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.314 0.646 . . . . 0.0 109.579 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.0 177.2 16.48 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 121.507 0.504 . . . . 0.0 114.176 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -62.43 160.14 35.8 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.427 1.491 . . . . 0.0 112.634 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -34.05 103.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 126.527 4.818 . . . . 0.0 116.637 178.144 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.46 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 75.5 Cg_endo -81.12 -60.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.91 2.406 . . . . 0.0 109.433 169.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.46 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 12.8 t0 -179.1 131.14 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.317 1.447 . . . . 0.0 109.882 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.462 0.169 0 C-N-CA 125.297 1.439 . . . . 0.0 110.008 176.322 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.24 36.16 21.71 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.985 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.89 57.25 0.94 Allowed Pre-proline 0 N--CA 1.465 0.284 0 C-N-CA 125.51 1.524 . . . . 0.0 113.146 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.52 147.73 77.41 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.23 2.62 . . . . 0.0 109.668 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 114.97 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.562 2.841 . . . . 0.0 110.649 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.47 -162.65 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.42 3.414 . . . . 0.0 110.182 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -134.51 33.06 3.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.23 0.612 . . . . 0.0 111.14 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 m -64.5 6.13 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.187 1.395 . . . . 0.0 113.373 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.71 2.9 0.86 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.973 0.909 . . . . 0.0 113.194 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.9 -8.88 0.04 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.507 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -65.64 169.69 5.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.592 1.196 . . . . 0.0 111.866 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -58.67 -26.37 63.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m 43.72 37.09 1.46 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.4 tm? -63.75 136.03 57.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.42 155.34 46.57 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -171.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.35 158.03 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.297 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -154.78 -173.74 4.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.167 0.987 . . . . 0.0 110.777 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.612 HD21 ' HB2' ' A' ' 83' ' ' ARG . 20.3 t30 96.81 27.94 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.744 1.617 . . . . 0.0 113.077 168.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 117.58 4.37 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.494 1.117 . . . . 0.0 109.778 -175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -70.8 166.89 20.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -62.95 10.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.964 1.306 . . . . 0.0 113.907 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -130.04 17.8 5.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.893 0.877 . . . . 0.0 111.618 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 26' ' ' SER . 1.3 m -126.82 170.32 12.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 -173.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 25' ' ' THR . 94.4 p -152.7 163.74 22.56 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.253 1.021 . . . . 0.0 109.296 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.8 -28.08 25.49 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.506 2.137 . . . . 0.0 111.717 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.57 -33.03 74.2 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.95 -0.469 . . . . 0.0 109.822 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.0 m -75.51 -46.48 32.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -56.94 -19.8 20.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -55.78 5.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -62.74 -31.27 72.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.188 0.995 . . . . 0.0 110.968 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.01 -32.71 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.442 0.297 . . . . 0.0 111.619 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.0 m-85 -98.67 -11.23 22.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.977 0.353 . . . . 0.0 111.941 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.55 -27.74 62.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.689 -0.632 . . . . 0.0 111.679 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.35 -22.54 65.58 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -73.78 -18.67 60.94 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.72 0.408 . . . . 0.0 111.129 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.88 -79.37 0.1 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -158.62 165.06 35.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 110.398 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -133.88 138.7 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.98 -26.61 7.4 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -163.08 161.35 25.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.916 0.358 . . . . 0.0 110.33 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.404 ' CG2' HG22 ' A' ' 60' ' ' VAL . 1.5 p -168.73 110.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.25 176.13 13.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.543 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mt -125.2 85.87 57.63 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.13 -23.71 17.83 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.449 3.433 . . . . 0.0 113.281 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 2.1 tpp180 -64.01 115.77 5.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 41.58 69.22 0.37 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 110.222 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -54.6 5.55 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.045 2.138 . . . . 0.0 116.61 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -143.54 7.41 1.5 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.514 1.125 . . . . 0.0 110.81 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -124.76 -38.23 2.39 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.02 24.7 0.13 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.228 2.211 . . . . 0.0 113.142 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -65.02 -21.2 66.81 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -76.93 -49.7 14.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.573 0.349 . . . . 0.0 110.824 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 37.07 31.64 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.627 1.971 . . . . 0.0 114.783 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.34 -10.47 74.68 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.59 -0.694 . . . . 0.0 112.016 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -163.13 169.11 19.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.603 0.701 . . . . 0.0 111.084 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 102.63 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -67.92 94.78 0.49 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG21 HD12 ' A' ' 30' ' ' LEU . 59.4 t -81.35 160.74 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -143.84 134.94 25.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.043 0.537 . . . . 0.0 109.987 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -117.28 148.27 41.83 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.484 1.113 . . . . 0.0 109.836 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 -27.21 13.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -173.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.66 134.2 55.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 110.458 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.66 -45.6 93.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.745 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -33.77 76.56 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.98 0.809 . . . . 0.0 111.969 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.7 -24.71 36.03 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.68 -47.29 19.55 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.072 0.949 . . . . 0.0 110.839 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.09 -27.29 60.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.79 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -70.97 -40.46 71.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.278 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.39 73.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.024 -0.422 . . . . 0.0 111.333 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.5 ptp -78.8 -37.61 40.36 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.509 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -77.12 -0.73 25.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.23 0.612 . . . . 0.0 111.743 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.87 -4.99 4.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.7 ttm -138.02 -25.57 0.97 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.7 t70 -63.52 138.31 58.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 118.398 -1.321 . . . . 0.0 110.005 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.76 14.96 77.98 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.914 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.08 36.71 0.52 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.041 0.921 . . . . 0.0 110.257 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.636 HG22 ' H ' ' A' ' 80' ' ' LEU . 6.2 p -72.12 176.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -169.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.636 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.1 pt? -151.78 -1.22 0.32 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.723 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.541 ' H ' HG22 ' A' ' 79' ' ' VAL . 37.3 t70 -144.45 -0.77 0.95 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.45 -19.09 6.0 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.612 ' HB2' HD21 ' A' ' 20' ' ' ASN . 0.1 OUTLIER -165.96 136.04 3.43 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' N ' HG23 ' A' ' 79' ' ' VAL . 19.7 mm-40 -144.79 -41.82 0.24 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.89 150.29 44.41 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.834 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -152.27 108.11 3.35 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 126.121 1.769 . . . . 0.0 106.659 168.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -134.96 134.77 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.238 0.542 . . . . 0.0 111.284 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 89' ' ' MET . 31.4 tt0 -166.26 168.02 15.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.322 1.449 . . . . 0.0 108.11 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.428 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 11.6 mmt -61.28 142.31 56.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.176 0.99 . . . . 0.0 110.773 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 155.52 38.15 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.889 0.476 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -140.11 9.81 2.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.499 0.72 . . . . 0.0 109.608 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -131.43 169.18 16.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.015 0.926 . . . . 0.0 109.335 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.3 -177.64 14.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -56.02 145.0 56.57 Favored Pre-proline 0 C--O 1.233 0.194 0 C-N-CA 123.271 0.629 . . . . 0.0 110.501 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.01 145.75 56.63 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.44 2.76 . . . . 0.0 112.276 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.0 -23.39 4.58 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.451 3.434 . . . . 0.0 112.198 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -149.96 164.53 35.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.601 1.16 . . . . 0.0 108.965 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.126 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.97 92.51 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.414 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.8 ptm85 -168.91 42.87 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.527 1.163 . . . . 0.0 113.539 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 69.2 Cg_endo -68.99 136.11 34.12 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.52 1.48 . . . . 0.0 108.93 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.64 116.29 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.846 3.031 . . . . 0.0 110.98 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.61 -162.05 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.912 3.075 . . . . 0.0 110.142 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.67 30.5 2.85 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.489 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 31.2 m -63.48 -7.05 2.6 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 C-N-CA 123.881 0.872 . . . . 0.0 112.624 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.51 0.26 15.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.75 0.82 . . . . 0.0 112.812 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.25 51.43 0.13 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.252 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.489 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 11.7 ptp -132.39 173.8 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.821 0.811 . . . . 0.0 112.957 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -70.21 -22.5 62.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.173 0.989 . . . . 0.0 112.066 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 m 42.09 59.85 2.47 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.442 1.097 . . . . 0.0 113.618 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 22.5 tp -61.66 162.22 8.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 17.2 pttp -132.1 151.4 51.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.107 0.412 . . . . 0.0 110.655 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.17 143.04 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -149.31 -177.85 6.07 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 124.187 0.93 . . . . 0.0 110.413 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 t30 91.12 26.21 0.02 OUTLIER 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.158 1.383 . . . . 0.0 113.38 169.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.17 121.5 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.985 0.914 . . . . 0.0 109.682 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 24' ' ' ARG . 13.4 m -67.75 167.75 12.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -63.61 8.99 0.07 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.657 1.183 . . . . 0.0 113.471 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' THR . 29.6 ptt180 -133.58 16.44 3.99 Favored 'General case' 0 C--N 1.335 -0.041 0 C-N-CA 123.858 0.863 . . . . 0.0 111.818 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -124.05 165.63 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.459 0.303 . . . . 0.0 111.246 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 59.5 p -151.68 168.57 10.92 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.706 1.202 . . . . 0.0 109.256 -175.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 56.7 Cg_endo -68.94 -27.57 30.31 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.319 2.013 . . . . 0.0 111.713 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.85 -30.62 68.15 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.478 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 97.0 m -75.1 -45.08 43.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -59.02 -19.14 40.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.905 -0.497 . . . . 0.0 110.935 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -81.48 -56.63 3.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.385 0.539 . . . . 0.0 110.604 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.478 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -69.91 -15.46 63.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.276 -175.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.84 -30.93 4.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 123.419 0.688 . . . . 0.0 111.363 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.1 m-85 -103.12 -9.94 19.27 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.438 0.563 . . . . 0.0 112.288 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.97 -26.43 62.26 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.751 -0.593 . . . . 0.0 111.187 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.78 -24.14 64.38 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.68 -17.01 61.68 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.47 -80.43 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -162.53 167.24 23.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.023 0.529 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -133.09 138.95 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.19 -25.27 14.56 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -162.74 154.19 17.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.883 0.473 . . . . 0.0 110.17 174.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 60' ' ' VAL . 1.4 p -150.33 107.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -151.36 162.25 41.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.513 -166.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.76 126.43 15.74 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.48 42.46 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.702 3.601 . . . . 0.0 110.413 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -44.42 -44.8 8.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.928 1.291 . . . . 0.0 111.561 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -178.34 165.02 1.78 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.36 1.464 . . . . 0.0 108.898 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.79 -5.66 2.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.633 169.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -168.3 14.93 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.564 1.146 . . . . 0.0 111.717 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 p -129.45 -14.58 4.18 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -168.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 43.14 24.1 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.608 1.563 . . . . 0.0 113.772 -172.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.63 -155.95 0.08 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.081 0.952 . . . . 0.0 110.358 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 m -156.09 169.59 24.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.224 1.41 . . . . 0.0 109.615 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 27.2 mmt180 -130.03 -172.42 2.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.932 0.893 . . . . 0.0 108.897 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.57 29.61 5.83 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.264 0.935 . . . . 0.0 112.406 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 55' ' ' ARG . 38.0 p90 -153.63 170.95 19.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.479 0.712 . . . . 0.0 109.576 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.89 101.78 3.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -67.22 91.74 0.25 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.444 0.698 . . . . 0.0 109.387 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.527 HG21 HD12 ' A' ' 30' ' ' LEU . 48.6 t -81.53 159.35 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 172.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.1 ttt180 -140.24 131.74 27.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.688 0.395 . . . . 0.0 110.421 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.5 m-85 -113.58 157.92 21.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.057 0.39 . . . . 0.0 111.647 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 -34.6 5.62 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.1 128.05 33.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -64.56 -50.53 66.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.396 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -29.54 68.81 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.55 -20.72 31.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.5 49.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -77.36 -19.99 55.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.493 -0.13 . . . . 0.0 111.271 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.78 -41.58 44.09 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.199 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.4 75.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.161 -0.337 . . . . 0.0 111.395 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.0 ptp -75.52 -41.33 55.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.766 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -75.51 1.29 14.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.572 0.749 . . . . 0.0 111.705 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -5.96 3.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.3 ttm -141.23 -25.82 0.72 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -62.57 137.97 58.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.708 1.14 . . . . 0.0 111.101 -177.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.92 9.18 75.2 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.373 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.42 29.34 0.51 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.683 HG12 ' N ' ' A' ' 84' ' ' GLU . 4.9 m -66.48 175.29 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 126.345 1.858 . . . . 0.0 113.847 -172.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.93 -1.3 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -143.49 4.3 1.36 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.433 0.56 . . . . 0.0 112.08 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.92 -27.4 3.33 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -157.36 160.08 38.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.178 0.489 . . . . 0.0 110.027 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.683 ' N ' HG12 ' A' ' 79' ' ' VAL . 16.4 mt-10 -160.62 -43.91 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.628 1.171 . . . . 0.0 109.68 165.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.46 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.2 mm? -139.47 153.84 47.61 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.9 mmt180 -153.76 107.21 2.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.256 1.822 . . . . 0.0 106.183 166.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.6 p -134.23 127.83 51.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 123.029 0.532 . . . . 0.0 110.134 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -156.74 -175.01 5.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.489 1.916 . . . . 0.0 108.112 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.2 mmt -82.84 142.27 31.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.13 155.66 40.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.374 0.269 . . . . 0.0 111.249 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -137.93 9.17 2.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.416 1.087 . . . . 0.0 110.488 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.2 175.63 8.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 109.678 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.68 175.78 17.82 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 117.943 0.338 . . . . 0.0 113.054 -173.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -61.73 156.41 55.33 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.109 0.964 . . . . 0.0 111.399 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -27.49 95.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 1 C-N-CA 126.413 4.742 . . . . 0.0 117.292 -176.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.72 -26.07 1.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.56 2.84 . . . . 0.0 110.083 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -158.13 -177.63 6.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.772 1.629 . . . . 0.0 107.273 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.389 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.86 -80.22 1.84 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 170.87 68.6 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.573 1.149 . . . . 0.0 111.5 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.15 167.23 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.397 2.731 . . . . 0.0 111.216 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -98.15 71.83 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.637 1 C-N-CA 125.491 4.127 . . . . 0.0 112.945 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.72 -166.32 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.984 3.123 . . . . 0.0 110.294 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -131.57 34.16 3.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.442 0.697 . . . . 0.0 109.819 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.31 -11.98 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.021 0.928 . . . . 0.0 112.04 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.71 -6.57 47.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.774 0.83 . . . . 0.0 111.909 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.79 -8.16 0.07 OUTLIER Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.546 -0.585 . . . . 0.0 114.053 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.8 mtp -60.68 162.25 6.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.569 1.185 . . . . 0.0 111.013 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -60.34 -23.72 64.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.336 0.254 . . . . 0.0 110.659 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 t 42.92 55.36 4.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.536 1.134 . . . . 0.0 112.859 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 19.3 tp -61.39 159.04 13.3 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -143.98 140.4 29.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.517 0.599 . . . . 0.0 110.75 175.212 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 60' ' ' VAL . 4.9 p -134.12 149.89 30.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 123.002 0.521 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -151.41 -170.12 3.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.902 1.281 . . . . 0.0 109.868 -176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 87.73 26.76 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.918 1.287 . . . . 0.0 112.125 172.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.21 127.39 21.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.534 1.134 . . . . 0.0 109.412 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 23' ' ' TYR . 7.1 m -76.22 169.54 18.02 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.295 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.455 ' H ' HG22 ' A' ' 22' ' ' THR . 53.6 p90 -63.13 5.74 0.14 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.921 1.288 . . . . 0.0 114.009 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -133.53 14.25 4.09 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.693 0.679 . . . . 0.0 112.013 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 26' ' ' SER . 3.2 m -114.87 165.82 12.43 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.92 0.391 . . . . 0.0 110.919 -173.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 86.7 p -150.42 167.16 13.54 Favored Pre-proline 0 CA--C 1.529 0.139 0 C-N-CA 124.219 1.008 . . . . 0.0 109.63 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.2 Cg_endo -69.78 -34.25 14.9 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.684 2.256 . . . . 0.0 110.274 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.21 -36.17 83.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -72.78 -43.95 62.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -57.12 -21.56 33.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.272 -0.267 . . . . 0.0 110.833 -178.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -80.42 -56.66 4.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -7.97 41.74 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -97.67 -31.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.776 0.43 . . . . 0.0 111.644 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.5 m-85 -101.11 -12.1 19.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.507 0.594 . . . . 0.0 111.874 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.84 -24.17 59.73 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.901 -0.499 . . . . 0.0 111.242 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.61 -23.73 64.49 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.786 -0.571 . . . . 0.0 112.077 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -75.27 -17.64 60.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.468 0.307 . . . . 0.0 111.391 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.53 -85.83 0.09 OUTLIER Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -157.32 162.4 39.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.067 0.547 . . . . 0.0 110.342 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.9 t -134.43 142.05 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.92 -46.82 12.71 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.18 171.85 4.0 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.318 0.58 . . . . 0.0 110.661 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG12 HG22 ' A' ' 60' ' ' VAL . 14.4 m -124.97 143.62 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 172.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -152.18 150.71 30.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.742 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mt -139.59 76.01 30.94 Favored Pre-proline 0 CA--C 1.528 0.131 0 C-N-CA 123.317 0.647 . . . . 0.0 109.946 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 95.4 Cg_endo -77.25 178.21 7.92 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 124.529 3.486 . . . . 0.0 111.798 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 46' ' ' PRO . 28.7 tpt180 129.52 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 129.175 2.99 . . . . 0.0 108.281 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 50' ' ' TYR . 20.2 m-20 -147.58 87.42 1.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 174.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -63.96 14.3 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.54 1.536 . . . . 0.0 114.862 -170.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.525 ' CD1' HG23 ' A' ' 51' ' ' THR . 11.5 p90 -145.25 5.14 1.09 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.295 1.438 . . . . 0.0 110.822 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.525 HG23 ' CD1' ' A' ' 50' ' ' TYR . 7.0 p -133.38 -33.71 1.1 Allowed 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.135 -0.353 . . . . 0.0 111.154 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 34.29 33.49 0.01 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.956 2.102 . . . . 0.0 113.553 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -6.59 45.73 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.9 t -67.42 162.94 21.94 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.225 0.466 . . . . 0.0 110.849 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -155.26 7.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.3 -12.59 81.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.29 169.46 23.14 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.682 0.793 . . . . 0.0 109.796 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.23 95.65 1.73 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -62.8 97.19 0.1 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 43' ' ' VAL . 37.8 t -99.66 152.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 6.9 ptm180 -137.03 143.76 42.88 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 15.8 m-85 -113.64 160.5 18.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.479 0.712 . . . . 0.0 111.472 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -36.1 5.79 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.71 133.64 34.79 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -66.54 -54.67 21.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.131 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.468 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -59.36 -34.22 72.12 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.452 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -83.11 -20.0 35.67 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.151 0.432 . . . . 0.0 110.872 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -81.99 -44.99 15.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 122.632 0.373 . . . . 0.0 110.162 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.97 -26.37 64.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.237 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.17 -47.49 43.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.068 0.394 . . . . 0.0 111.171 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.06 -31.75 72.96 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 122.004 -0.435 . . . . 0.0 110.499 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttp -74.32 -43.71 55.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.053 0.541 . . . . 0.0 110.423 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -79.73 1.9 24.8 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.91 -5.25 5.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.7 ttm -136.41 -28.69 1.0 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.534 ' HB2' HG12 ' A' ' 87' ' ' VAL . 4.6 t70 -63.89 136.2 57.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.852 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.68 10.69 83.18 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.779 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.17 34.58 0.47 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.945 0.872 . . . . 0.0 109.903 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 81' ' ' ASP . 8.8 p -73.83 174.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.595 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.2 pt? -151.98 3.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.703 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.616 ' H ' HG22 ' A' ' 79' ' ' VAL . 36.3 t70 -142.83 -3.5 0.99 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.35 -10.5 30.99 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.573 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.62 129.02 4.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.139 0.975 . . . . 0.0 108.643 173.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 79' ' ' VAL . 11.3 mm-40 -144.42 -50.25 0.28 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 170.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.4 mm? -138.69 152.98 48.49 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 122.828 0.451 . . . . 0.0 111.666 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -150.38 103.09 3.11 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 166.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 76' ' ' ASP . 4.3 p -131.47 132.99 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.944 0.402 . . . . 0.0 111.145 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -153.21 176.28 12.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.911 1.284 . . . . 0.0 109.595 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.8 mmt -76.7 133.9 39.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.5 0.72 . . . . 0.0 109.069 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.63 149.94 47.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.723 0.297 . . . . 0.0 110.773 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -139.31 18.28 2.58 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.287 1.035 . . . . 0.0 108.917 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -145.33 144.71 30.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -119.79 174.85 15.67 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.739 0.699 . . . . 0.0 114.431 -168.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -61.2 139.53 94.48 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.804 1.242 . . . . 0.0 109.969 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.82 146.78 54.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.848 3.032 . . . . 0.0 112.937 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.81 -24.36 3.42 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.232 3.288 . . . . 0.0 111.545 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -152.36 160.67 43.28 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.526 1.131 . . . . 0.0 109.1 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 p . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.815 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.584 0.23 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.06 -81.94 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 125.268 1.413 . . . . 0.0 109.677 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -152.8 55.98 1.61 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 111.502 -167.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.81 118.42 5.59 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.551 2.167 . . . . 0.0 111.356 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.32 119.08 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.562 2.842 . . . . 0.0 110.883 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -84.38 -166.59 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.16 3.24 . . . . 0.0 110.501 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -134.92 36.86 3.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.181 0.992 . . . . 0.0 110.017 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.33 11.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.638 1.575 . . . . 0.0 114.337 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.96 0.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.24 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -5.14 0.09 OUTLIER Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.168 0.44 . . . . 0.0 113.363 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 7.5 ptt? -62.6 166.74 5.0 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.168 0.984 . . . . 0.0 112.718 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -59.15 -26.59 64.88 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.5 m 42.17 59.19 2.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.204 1.001 . . . . 0.0 113.512 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 22.1 tp -62.72 164.35 7.92 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 19.0 ttpp -135.72 145.08 46.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.043 0.937 . . . . 0.0 110.74 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.589 ' HB ' HG22 ' A' ' 60' ' ' VAL . 92.4 t -130.31 148.69 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.792 0.837 . . . . 0.0 108.952 173.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -152.26 -169.32 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.7 1.6 . . . . 0.0 110.138 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 83.93 27.37 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.403 1.481 . . . . 0.0 113.51 170.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.2 119.33 4.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.149 0.98 . . . . 0.0 109.93 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 23' ' ' TYR . 19.9 m -70.71 169.87 13.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.476 ' H ' HG22 ' A' ' 22' ' ' THR . 54.7 p90 -62.53 5.22 0.12 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 113.741 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -130.71 14.29 5.38 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.313 0.645 . . . . 0.0 112.018 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 26' ' ' SER . 2.4 m -120.24 164.91 15.54 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.088 -173.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.528 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 97.5 p -149.08 168.01 11.86 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 124.283 1.033 . . . . 0.0 109.38 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.06 -29.66 22.07 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.627 2.218 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.32 -35.0 78.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.6 m -74.1 -44.74 52.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.552 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -56.75 -20.78 23.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.248 -0.282 . . . . 0.0 110.855 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -79.46 -57.34 3.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -14.44 63.0 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.76 -32.25 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.394 0.678 . . . . 0.0 111.502 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 30' ' ' LEU . 23.0 m-85 -103.38 -9.49 19.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.3 -27.45 63.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.241 0.473 . . . . 0.0 110.908 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -68.45 -23.52 64.61 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.97 -16.89 61.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.187 0.195 . . . . 0.0 111.504 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.12 -80.73 0.13 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -160.29 164.84 32.29 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.992 0.517 . . . . 0.0 110.52 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.32 144.81 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -175.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.64 -21.45 7.88 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.38 157.81 28.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.472 0.636 . . . . 0.0 110.095 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.402 HG23 HG12 ' A' ' 60' ' ' VAL . 2.2 p -169.15 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.138 0.975 . . . . 0.0 108.414 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.14 167.54 28.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.5 mm -98.07 103.52 17.95 Favored Pre-proline 0 N--CA 1.456 -0.141 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.82 -46.28 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.549 2.166 . . . . 0.0 111.478 -171.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.39 -178.83 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.79 2.436 . . . . 0.0 116.392 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.97 106.84 8.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -54.22 0.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.39 2.276 . . . . 0.0 114.697 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CD2' HG23 ' A' ' 51' ' ' THR . 40.6 p90 -137.71 0.57 2.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.835 0.743 . . . . 0.0 112.309 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.465 HG23 ' CD2' ' A' ' 50' ' ' TYR . 28.7 p -127.05 -19.51 4.37 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.677 0.672 . . . . 0.0 111.216 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.404 1.881 . . . . 0.0 113.983 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -125.7 7.2 7.49 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -72.49 -6.73 45.83 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -40.24 141.71 0.46 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.773 1.629 . . . . 0.0 112.426 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.14 -3.56 0.91 Allowed Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.933 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -155.03 166.92 32.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.898 0.879 . . . . 0.0 109.573 174.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 106.76 4.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -70.21 110.85 5.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.589 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -113.04 164.68 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.3 ttt180 -142.87 139.74 30.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 11.0 m-85 -116.92 164.97 13.89 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.564 0.54 . . . . 0.0 110.717 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.436 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -123.48 -31.57 3.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.232 0.613 . . . . 0.0 112.462 -177.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.54 125.32 30.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.1 -52.32 64.36 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.433 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -60.11 -33.61 72.36 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -84.02 -19.73 33.98 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.53 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.04 -42.86 18.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.89 -26.59 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.816 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.11 -40.33 62.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.313 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -33.41 75.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.232 -0.292 . . . . 0.0 111.592 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.0 ptp -78.06 -37.48 46.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.08 1.74 23.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.141 0.576 . . . . 0.0 111.807 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.33 -6.86 4.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.0 ttm -138.89 -26.71 0.85 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.93 136.16 55.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.229 0.922 . . . . 0.0 110.181 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.97 9.9 86.61 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.162 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.67 32.61 0.42 Allowed 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.309 1.055 . . . . 0.0 110.263 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.527 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 38.7 t -74.62 164.49 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.367 1.067 . . . . 0.0 112.094 -170.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -154.96 10.53 0.34 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.472 0.709 . . . . 0.0 112.217 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.35 5.09 2.24 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.87 0.468 . . . . 0.0 111.507 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.54 -9.84 57.44 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.93 124.92 0.55 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.694 1.198 . . . . 0.0 108.131 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.527 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 29.3 mm-40 -137.97 -48.89 0.56 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.249 0.22 . . . . 0.0 110.451 169.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -136.78 156.44 48.51 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 121.419 0.628 . . . . 0.0 112.296 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.0 mmm180 -148.05 109.08 4.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.955 1.702 . . . . 0.0 106.577 167.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.22 134.23 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -169.58 173.86 6.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.0 mmt -75.64 136.61 40.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.166 0.586 . . . . 0.0 109.909 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.49 151.58 45.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -140.52 21.4 2.37 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.662 0.785 . . . . 0.0 109.597 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -143.88 158.0 43.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.31 178.38 17.73 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.894 0.717 . . . . 0.0 114.894 -168.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.442 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 55.7 mtp180 -62.54 161.66 25.51 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 125.312 1.445 . . . . 0.0 111.034 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 94' ' ' ARG . 13.5 Cg_exo -28.92 96.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 1 C-N-CA 126.001 4.468 . . . . 0.0 114.952 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.47 -57.29 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.706 2.271 . . . . 0.0 110.504 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -168.33 21.12 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.199 0.599 . . . . 0.0 111.712 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 C--N 1.33 -0.247 0 C-N-CA 124.008 0.923 . . . . 0.0 112.842 -175.332 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.427 0.156 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.36 -32.06 0.16 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.71 2.1 . . . . 0.0 114.609 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 5' ' ' ARG 0.25 11.8 ptm85 146.06 65.63 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 128.879 2.872 . . . . 0.0 109.643 176.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -58.84 116.61 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.78 2.987 . . . . 0.0 111.324 -168.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -100.98 74.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.962 1 C-N-CA 125.981 4.454 . . . . 0.0 113.758 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.99 -162.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.802 2.334 . . . . 0.0 109.803 170.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -66.05 32.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.744 1.218 . . . . 0.0 113.805 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.481 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 10.5 m -56.68 -9.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.64 -12.83 61.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.888 0.475 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.29 15.15 0.03 OUTLIER Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.188 -0.784 . . . . 0.0 113.802 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 12.8 ptp -65.69 176.5 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.662 1.231 . . . . 0.0 112.263 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -70.08 -24.91 63.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.321 0.648 . . . . 0.0 112.323 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m 46.6 36.86 3.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.492 1.117 . . . . 0.0 113.868 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.2 tm? -65.87 132.84 49.62 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 17.7 pttt -117.04 161.02 20.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -130.51 147.83 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -151.59 -175.83 5.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.297 1.439 . . . . 0.0 110.34 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 2.0 t-20 86.44 37.73 0.02 OUTLIER 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 113.455 169.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.43 163.55 10.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 24' ' ' ARG . 20.0 m -116.61 169.53 9.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.611 0.765 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -61.63 4.11 0.11 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.336 1.054 . . . . 0.0 113.438 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.0 ptm180 -136.03 19.11 3.22 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.398 1.079 . . . . 0.0 110.991 -175.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 26' ' ' SER . 1.9 m -124.17 167.38 14.34 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.246 0.618 . . . . 0.0 110.276 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.3 p -152.29 165.78 16.76 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.605 0.762 . . . . 0.0 109.754 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.4 Cg_endo -69.58 -27.65 27.07 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.811 2.34 . . . . 0.0 110.03 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -68.13 -37.71 81.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -72.76 -43.53 62.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.93 -19.74 32.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.337 -0.227 . . . . 0.0 111.031 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.64 -55.81 4.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -7.51 37.88 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.194 0.452 . . . . 0.0 112.009 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.435 HG12 ' HE1' ' A' ' 75' ' ' MET . 60.4 t -98.21 -31.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.317 0.647 . . . . 0.0 111.113 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.432 ' CD1' HD13 ' A' ' 30' ' ' LEU . 22.5 m-85 -102.84 -11.26 18.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.98 -24.99 60.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 121.914 -0.491 . . . . 0.0 110.921 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -68.65 -24.04 64.49 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -72.84 -19.51 61.3 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 122.611 0.364 . . . . 0.0 111.52 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.48 -82.99 0.1 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -158.18 164.58 36.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.928 0.491 . . . . 0.0 110.979 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.5 t -135.29 138.58 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.92 -24.0 18.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -163.26 156.08 18.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.915 0.358 . . . . 0.0 110.453 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 60' ' ' VAL . 2.5 p -153.13 112.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -148.97 159.14 44.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -165.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -121.68 93.48 48.67 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 124.353 1.061 . . . . 0.0 108.938 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.65 33.23 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.599 3.532 . . . . 0.0 112.505 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -65.38 164.02 14.51 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.66 111.0 1.11 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.39 9.11 1.11 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CD1' HG23 ' A' ' 51' ' ' THR . 12.0 p90 -144.85 -0.96 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 111.823 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.487 HG23 ' CD1' ' A' ' 50' ' ' TYR . 13.1 p -124.25 -8.04 7.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.381 0.537 . . . . 0.0 110.271 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.87 20.34 0.34 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.215 2.206 . . . . 0.0 113.173 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.7 102.36 0.74 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -57.06 166.57 1.02 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.427 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.34 -4.07 4.34 Favored 'General case' 0 N--CA 1.46 0.075 0 C-N-CA 123.87 0.868 . . . . 0.0 110.732 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.18 68.74 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.192 -0.782 . . . . 0.0 113.144 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.98 172.11 17.98 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.942 1.371 . . . . 0.0 111.746 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 92.71 2.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.472 1.109 . . . . 0.0 108.394 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -62.88 110.8 1.88 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -107.81 167.42 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -140.21 145.08 36.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.58 146.71 47.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.822 0.849 . . . . 0.0 110.694 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -99.51 -32.63 11.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.812 -177.509 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.92 127.07 33.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.762 0.425 . . . . 0.0 110.426 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.45 -51.73 58.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -59.8 -33.69 72.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.61 -21.17 30.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.97 0.35 . . . . 0.0 110.341 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.39 -46.98 18.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.391 0.677 . . . . 0.0 110.225 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.52 -17.51 59.22 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.208 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.6 -40.02 35.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.095 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.38 75.5 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.141 -0.349 . . . . 0.0 111.293 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.454 ' HA ' HG13 ' A' ' 87' ' ' VAL . 12.2 ptp -74.68 -42.82 57.74 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.362 0.601 . . . . 0.0 109.682 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.99 1.25 13.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.805 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.37 -10.02 4.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.435 ' HE1' HG12 ' A' ' 33' ' ' VAL . 4.6 ttp -146.84 -17.63 0.41 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.43 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -61.84 136.94 58.18 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.715 1.143 . . . . 0.0 110.273 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.07 8.87 65.69 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.611 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.05 29.71 0.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.483 1.141 . . . . 0.0 112.039 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.675 HG12 ' N ' ' A' ' 84' ' ' GLU . 3.9 m -65.61 175.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.418 1.887 . . . . 0.0 114.127 -172.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 0.47 0.82 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -142.31 3.9 1.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.986 0.812 . . . . 0.0 111.992 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.4 -27.42 3.4 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -158.71 160.48 36.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.675 ' N ' HG12 ' A' ' 79' ' ' VAL . 21.1 mt-10 -160.12 -44.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.702 1.201 . . . . 0.0 110.095 166.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.0 mm? -141.78 151.94 43.3 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.231 0.612 . . . . 0.0 112.217 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 29.8 mmt180 -153.49 114.13 4.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 165.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 72' ' ' MET . 1.4 p -139.38 116.82 11.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.499 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -151.53 164.92 35.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.081 1.352 . . . . 0.0 108.489 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.6 mmt -61.82 142.64 57.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.345 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.11 169.8 14.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.638 0.775 . . . . 0.0 110.76 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -142.65 2.98 1.44 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.196 0.598 . . . . 0.0 110.558 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -133.79 166.84 21.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.23 179.28 17.38 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -61.17 145.29 90.16 Favored Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 122.506 0.322 . . . . 0.0 110.776 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.31 150.63 17.48 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.539 2.826 . . . . 0.0 111.834 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.19 -42.44 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.132 2.555 . . . . 0.0 111.025 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.42 148.34 2.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.256 1.022 . . . . 0.0 110.017 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 173.054 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.82 0.343 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 47.56 59.7 5.79 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.566 1.555 . . . . 0.0 113.51 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 39.34 62.53 5.04 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 126.378 1.871 . . . . 0.0 112.668 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.46 155.66 24.84 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.714 2.943 . . . . 0.0 109.645 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.61 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.416 2.744 . . . . 0.0 109.247 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HB2' HG13 ' A' ' 10' ' ' VAL . 35.1 Cg_endo -83.92 -172.35 1.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.837 3.025 . . . . 0.0 111.93 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -133.35 23.77 4.1 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.075 1.35 . . . . 0.0 108.535 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 8' ' ' PRO . 29.9 m -65.23 -2.26 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 125.555 1.542 . . . . 0.0 112.858 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.55 9.47 1.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.066 0.946 . . . . 0.0 112.209 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.43 40.0 0.33 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.643 -0.532 . . . . 0.0 112.634 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.3 ptp -135.25 175.11 9.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.927 0.863 . . . . 0.0 112.293 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -71.1 -23.3 62.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.171 0.588 . . . . 0.0 112.405 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.7 m 43.56 57.08 4.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.86 0.864 . . . . 0.0 113.296 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.466 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 17.5 tp -65.11 166.3 9.8 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 20.0 pttp -138.28 154.94 49.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.838 170.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.499 ' HB ' HG22 ' A' ' 60' ' ' VAL . 83.1 t -130.88 143.09 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -148.92 -175.5 4.97 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.928 0.891 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 41.6 t30 83.82 37.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.76 1.224 . . . . 0.0 113.673 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 158.83 11.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.867 0.867 . . . . 0.0 108.958 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 24' ' ' ARG . 6.8 m -118.78 171.54 8.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.639 0.775 . . . . 0.0 109.959 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CD2' HG22 ' A' ' 22' ' ' THR . 53.4 p90 -63.52 7.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.829 1.252 . . . . 0.0 112.969 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 22' ' ' THR . 8.3 ptm180 -132.17 17.78 4.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.039 1.336 . . . . 0.0 110.401 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.52 167.37 19.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.015 0.526 . . . . 0.0 110.72 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 95.5 p -154.71 164.05 22.27 Favored Pre-proline 0 N--CA 1.464 0.254 0 C-N-CA 123.994 0.918 . . . . 0.0 109.127 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 49.5 Cg_endo -68.29 -30.16 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.064 1.842 . . . . 0.0 111.701 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.34 -33.88 73.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.09 -44.56 65.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.427 HD11 HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -57.78 -21.3 41.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.145 -0.347 . . . . 0.0 111.222 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -81.28 -57.01 3.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.027 -0.42 . . . . 0.0 109.895 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -9.16 42.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.903 0.481 . . . . 0.0 111.854 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.91 -31.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.214 0.606 . . . . 0.0 111.807 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.5 m-85 -100.44 -11.45 20.18 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.397 0.544 . . . . 0.0 111.907 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.828 -0.545 . . . . 0.0 111.429 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.37 -23.23 63.72 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -71.04 -31.01 67.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.499 0.32 . . . . 0.0 110.48 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.76 -76.48 0.07 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -162.37 165.71 26.1 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 117.198 0.499 . . . . 0.0 110.577 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.5 t -137.53 138.05 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.98 -45.08 43.8 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.99 171.65 6.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.129 0.49 . . . . 0.0 110.265 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -159.36 128.57 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.979 0.911 . . . . 0.0 109.68 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.58 175.9 10.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.528 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -116.6 88.26 23.94 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 124.049 0.94 . . . . 0.0 109.367 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.49 150.92 52.52 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.838 3.025 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -179.16 -178.81 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.034 0.934 . . . . 0.0 108.565 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -58.01 109.18 0.69 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -67.58 19.14 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.581 1.552 . . . . 0.0 115.125 -168.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CD2' HG23 ' A' ' 51' ' ' THR . 5.7 p90 -149.89 -19.24 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.061 0.944 . . . . 0.0 111.991 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.46 HG23 ' CD2' ' A' ' 50' ' ' TYR . 27.8 p -103.75 -25.27 13.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.662 173.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.2 31.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.609 1.963 . . . . 0.0 113.966 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.24 -15.73 62.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.084 0.554 . . . . 0.0 112.292 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -97.12 155.74 16.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 111.359 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -171.63 16.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.399 1.079 . . . . 0.0 111.221 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.71 2.03 75.39 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.34 -0.85 . . . . 0.0 113.229 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.21 169.08 24.92 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.038 0.919 . . . . 0.0 110.219 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.67 92.35 2.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.27 110.58 1.68 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -105.6 163.76 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.8 ptm180 -139.06 142.58 38.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.756 0.66 . . . . 0.0 110.678 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 16.1 m-85 -116.57 150.87 37.3 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.799 0.687 . . . . 0.0 111.557 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 -50.56 4.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 123.986 0.804 . . . . 0.0 112.008 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.67 135.17 49.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.947 0.499 . . . . 0.0 110.857 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -69.06 -52.38 29.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 178.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.457 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.68 -31.9 73.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -77.36 -26.34 51.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.871 0.367 . . . . 0.0 110.086 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -78.48 -40.91 34.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 122.031 -0.418 . . . . 0.0 110.512 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.71 -22.3 56.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.87 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.87 -40.06 48.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.948 0.794 . . . . 0.0 109.937 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.89 74.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.323 -0.236 . . . . 0.0 111.464 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.7 ptp -77.42 -39.69 46.1 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.322 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.63 0.64 19.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.133 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.72 -6.28 4.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.1 ttm -139.15 -24.0 0.89 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.64 135.89 57.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.151 0.887 . . . . 0.0 110.099 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.39 10.19 78.62 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.093 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.1 35.01 0.42 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.015 0.908 . . . . 0.0 110.797 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.626 HG22 ' H ' ' A' ' 80' ' ' LEU . 10.0 p -69.09 174.78 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.626 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.2 pt? -152.73 -0.12 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.648 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.553 ' H ' HG22 ' A' ' 79' ' ' VAL . 32.5 t70 -145.37 0.02 0.88 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.06 -18.61 6.17 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.625 ' C ' HG23 ' A' ' 79' ' ' VAL . 6.9 ptp180 -161.49 142.04 10.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 171.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 85' ' ' LEU . 23.3 mm-40 -147.12 -50.38 0.19 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.61 151.3 45.9 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.0 mmm180 -147.79 109.73 4.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 105.804 167.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.82 134.64 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.116 0.567 . . . . 0.0 109.96 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 89' ' ' MET . 36.6 tt0 -169.9 177.67 4.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.408 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 14.1 mmt -73.95 144.83 45.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.841 0.456 . . . . 0.0 109.786 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.78 163.93 15.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.467 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -133.73 -1.29 3.08 Favored 'General case' 0 C--O 1.23 0.051 0 C-N-CA 122.517 0.327 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.58 169.92 15.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.99 179.08 16.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.49 120.17 29.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.84 139.3 47.25 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.493 2.128 . . . . 0.0 111.659 -171.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.43 -17.99 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.492 3.461 . . . . 0.0 112.217 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -140.08 -169.2 2.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.46 1.104 . . . . 0.0 109.592 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p . . . . . 0 N--CA 1.46 0.065 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -174.838 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.634 0.254 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.09 59.28 0.47 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 45.47 46.98 3.46 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 127.331 2.252 . . . . 0.0 115.753 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.35 154.88 41.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.538 2.159 . . . . 0.0 108.508 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.54 112.87 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.395 2.73 . . . . 0.0 109.994 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -84.39 -165.68 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.355 2.703 . . . . 0.0 110.678 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -133.26 24.55 4.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.855 0.862 . . . . 0.0 109.607 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 31.1 m -64.72 -5.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 124.356 1.062 . . . . 0.0 112.553 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 6.8 2.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.38 41.07 0.41 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.557 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 9.1 ptp -134.43 172.9 12.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.948 0.874 . . . . 0.0 112.593 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -69.21 -23.72 63.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.593 0.757 . . . . 0.0 112.73 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 m 44.84 36.57 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.579 1.151 . . . . 0.0 113.904 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -60.67 133.16 55.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 20.7 ttpp -106.6 147.18 29.78 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.889 0.875 . . . . 0.0 112.052 -171.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' HB ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -132.81 154.64 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.932 171.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -154.2 -171.61 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.265 1.426 . . . . 0.0 110.593 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 93.8 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.615 1.966 . . . . 0.0 113.339 169.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 127.94 31.32 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.433 1.093 . . . . 0.0 109.461 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' ARG . 9.5 m -77.09 168.53 19.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.905 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -63.92 6.11 0.19 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.038 . . . . 0.0 112.669 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 32.7 ptt180 -137.52 19.4 2.91 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.591 1.156 . . . . 0.0 111.218 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -119.18 166.11 13.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.055 0.542 . . . . 0.0 110.431 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 92.7 p -150.71 164.85 18.91 Favored Pre-proline 0 CA--C 1.529 0.141 0 C-N-CA 124.243 1.017 . . . . 0.0 109.397 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.98 -23.75 29.42 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.473 2.115 . . . . 0.0 110.915 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.87 -35.13 72.23 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -76.18 -43.25 43.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -56.96 -21.74 32.59 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.974 -0.454 . . . . 0.0 110.892 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.49 -56.13 4.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.92 -30.38 69.01 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.085 0.402 . . . . 0.0 110.334 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -78.5 -34.76 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.977 0.511 . . . . 0.0 111.004 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -99.1 -11.34 21.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -74.19 -24.48 59.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.542 0.61 . . . . 0.0 110.778 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -67.68 -24.99 65.48 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -74.56 -19.48 60.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.486 -0.293 . . . . 0.0 111.697 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.29 -80.76 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.476 -0.392 . . . . 0.0 112.173 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.12 166.15 33.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.7 t -137.1 137.36 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.49 -45.07 8.18 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -156.72 155.42 31.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.147 0.979 . . . . 0.0 108.444 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.431 HG23 HG22 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -139.01 117.15 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -147.99 164.01 35.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.681 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -134.45 92.57 20.23 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -48.36 142.39 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.125 3.217 . . . . 0.0 111.735 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -159.06 160.18 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.981 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.44 121.84 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.97 17.56 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.447 ' CD2' HG23 ' A' ' 51' ' ' THR . 10.1 p90 -150.94 -5.15 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.275 1.03 . . . . 0.0 112.387 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.447 HG23 ' CD2' ' A' ' 50' ' ' TYR . 35.3 p -119.52 -19.45 8.15 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.054 0.843 . . . . 0.0 110.333 171.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.46 24.58 1.63 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.069 1.748 . . . . 0.0 113.768 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.02 -164.19 0.13 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.236 0.615 . . . . 0.0 110.158 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -137.52 169.73 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.406 0.682 . . . . 0.0 110.836 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -138.18 7.62 2.66 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.344 0.658 . . . . 0.0 112.392 -172.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.77 20.8 35.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.578 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -152.41 165.41 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.57 1.185 . . . . 0.0 111.033 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.89 3.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.81 100.35 0.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 18' ' ' VAL . 84.5 t -92.16 154.22 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -132.13 140.22 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.8 m-85 -119.92 143.66 47.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.193 0.597 . . . . 0.0 110.35 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -32.71 21.69 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.94 131.14 55.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.375 0.607 . . . . 0.0 111.282 -170.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.15 -46.37 89.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.509 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.615 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -59.45 -34.54 72.64 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.21 -9.88 24.93 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.357 0.526 . . . . 0.0 110.68 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.89 -44.99 25.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -75.67 -29.11 58.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.299 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.41 -41.68 80.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.592 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.73 76.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.257 -0.277 . . . . 0.0 111.533 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.7 ptp -77.4 -39.99 45.21 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.576 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.99 1.52 17.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.332 0.653 . . . . 0.0 111.719 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.51 -8.7 4.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.3 ttp -142.93 -19.98 0.65 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.03 135.38 57.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.398 1.454 . . . . 0.0 110.125 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.14 78.06 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.045 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.39 29.31 0.51 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.083 0.942 . . . . 0.0 110.966 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 84' ' ' GLU . 5.3 m -67.91 174.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 126.194 1.798 . . . . 0.0 113.361 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.79 9.99 0.92 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.809 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -139.41 7.31 2.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.162 0.585 . . . . 0.0 110.317 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.07 -17.33 48.58 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.82 136.7 7.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.409 0.683 . . . . 0.0 109.189 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.566 ' N ' HG12 ' A' ' 79' ' ' VAL . 81.2 mm-40 -150.76 -43.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 110.27 170.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -137.59 151.71 48.63 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.043 0.537 . . . . 0.0 112.122 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 29.0 mmt180 -152.28 112.92 4.14 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 166.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.13 133.12 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.364 0.602 . . . . 0.0 110.73 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -167.96 162.24 13.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.125 1.37 . . . . 0.0 108.546 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 mmt -59.15 139.26 57.08 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.732 0.813 . . . . 0.0 111.336 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.74 52.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -129.89 16.56 5.74 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.232 1.013 . . . . 0.0 108.378 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -147.28 142.38 27.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.29 1.436 . . . . 0.0 107.175 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.28 -176.11 17.43 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -170.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -53.76 132.18 56.54 Favored Pre-proline 0 N--CA 1.455 -0.212 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.29 143.14 52.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.143 2.562 . . . . 0.0 112.486 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.24 -21.84 10.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.199 3.266 . . . . 0.0 111.699 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -146.88 162.57 38.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.463 1.105 . . . . 0.0 108.092 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.934 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.45 35.32 20.45 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.855 0.741 . . . . 0.0 112.647 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 34.05 50.65 0.88 Allowed Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.486 1.514 . . . . 0.0 114.433 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.39 151.45 42.78 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.115 2.543 . . . . 0.0 110.692 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.21 117.97 4.23 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.784 2.99 . . . . 0.0 110.353 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.94 -169.01 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.02 3.146 . . . . 0.0 109.915 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -121.53 21.44 10.93 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.695 0.798 . . . . 0.0 109.31 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.27 -8.28 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.663 1.185 . . . . 0.0 113.274 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.49 4.09 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.961 -0.462 . . . . 0.0 111.131 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.54 28.12 1.2 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.42 1.01 . . . . 0.0 110.743 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.9 mtm -129.65 165.57 21.54 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.464 0.632 . . . . 0.0 111.405 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -67.0 -22.6 65.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 t 44.16 60.19 2.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 15.9 tp -65.49 166.13 10.92 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.2 ptmt -138.35 148.06 44.15 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 123.342 0.657 . . . . 0.0 110.913 172.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.569 ' HB ' HG22 ' A' ' 60' ' ' VAL . 94.7 t -129.41 143.06 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -153.01 -173.81 4.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.979 0.911 . . . . 0.0 109.738 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.406 ' CG ' ' HE ' ' A' ' 83' ' ' ARG . 15.2 t30 88.44 29.85 0.03 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.792 1.237 . . . . 0.0 112.558 171.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.56 134.97 35.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.055 1.342 . . . . 0.0 109.752 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 m -74.28 168.01 20.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -64.66 4.25 0.42 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.846 0.858 . . . . 0.0 112.853 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -135.28 18.69 3.39 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.187 0.995 . . . . 0.0 111.482 -175.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -119.2 165.1 14.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 122.935 0.494 . . . . 0.0 110.289 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.7 p -147.46 166.57 15.68 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.525 0.73 . . . . 0.0 110.03 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.2 Cg_endo -70.65 -32.08 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.858 2.372 . . . . 0.0 110.896 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.24 -35.33 80.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -73.23 -45.32 56.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.423 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -55.46 -21.04 14.53 Favored 'General case' 0 N--CA 1.457 -0.095 0 O-C-N 122.203 -0.31 . . . . 0.0 111.418 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -78.66 -57.8 3.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -64.99 -21.61 66.87 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.735 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.7 t -84.03 -32.88 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 119.612 -0.232 . . . . 0.0 111.007 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CD1' HD13 ' A' ' 30' ' ' LEU . 19.3 m-85 -102.14 -10.2 19.85 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.0 -26.33 62.19 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.081 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -68.41 -23.19 64.61 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.86 -16.08 61.14 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.444 0.298 . . . . 0.0 111.035 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.31 -66.42 0.27 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-O 119.94 -0.366 . . . . 0.0 112.405 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -165.02 168.45 17.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.667 0.387 . . . . 0.0 110.59 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -141.85 135.31 29.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.92 -22.1 16.59 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -158.84 155.69 28.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.289 0.545 . . . . 0.0 110.425 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -170.89 100.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.79 1.236 . . . . 0.0 109.944 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.6 177.26 10.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 mm -106.57 98.51 20.6 Favored Pre-proline 0 C--N 1.34 0.193 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.49 -41.78 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.501 2.801 . . . . 0.0 115.953 -166.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -70.39 155.12 41.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.866 0.757 . . . . 0.0 110.947 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 37.41 70.49 0.18 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.564 1.146 . . . . 0.0 112.139 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -57.04 5.4 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.117 1.767 . . . . 0.0 115.559 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -145.28 1.21 0.94 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.207 1.003 . . . . 0.0 112.297 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -121.15 -12.08 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.169 0.44 . . . . 0.0 110.189 173.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.76 29.13 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 127.765 2.426 . . . . 0.0 113.619 -176.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.13 -176.08 1.34 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.47 0.653 . . . . 0.0 109.299 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t 50.75 24.96 1.9 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.291 1.036 . . . . 0.0 112.142 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 9.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.172 1.789 . . . . 0.0 114.095 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.64 0.655 . . . . 0.0 112.254 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -155.95 166.91 32.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.8 0.8 . . . . 0.0 110.522 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.22 101.7 3.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.91 118.31 11.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.569 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -119.5 165.29 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.563 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.3 ptm180 -144.54 149.66 36.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.35 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.8 m-85 -117.18 164.8 14.23 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.089 0.868 . . . . 0.0 111.078 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.4 -27.15 10.12 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -120.59 149.33 42.63 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.149 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.12 -45.83 83.48 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.131 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.627 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -66.42 -40.0 89.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.235 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -80.74 -15.92 55.22 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.102 0.865 . . . . 0.0 110.959 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.1 -47.45 9.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.046 0.538 . . . . 0.0 110.16 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -68.35 -25.07 64.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.448 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.68 -47.46 31.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.904 0.32 . . . . 0.0 110.549 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.33 73.69 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.056 0.389 . . . . 0.0 110.623 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.8 ttp -73.4 -43.01 61.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.755 0.422 . . . . 0.0 110.031 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.26 2.33 24.97 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.171 -0.331 . . . . 0.0 111.521 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.23 -7.28 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.9 ttm -137.6 -26.44 0.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.67 134.75 56.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.537 1.062 . . . . 0.0 109.831 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.7 42.73 86.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 21.92 12.55 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 122.125 0.964 . . . . 0.0 110.269 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.635 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 6.1 t -63.55 162.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -165.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.497 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -157.45 13.26 0.23 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.96 -177.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' H ' HG12 ' A' ' 79' ' ' VAL . 61.3 m-20 -135.61 8.8 3.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.19 0.596 . . . . 0.0 110.861 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.03 -13.38 58.9 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.518 ' N ' HG11 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -177.36 133.55 0.18 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.438 1.895 . . . . 0.0 106.473 176.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 79' ' ' VAL . 20.4 pt-20 -146.15 -32.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.338 168.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.492 ' CD2' ' HG3' ' A' ' 84' ' ' GLU . 1.5 mm? -141.41 140.06 33.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -174.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 33.1 mmt180 -149.62 116.76 6.02 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 125.579 1.552 . . . . 0.0 106.991 167.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -134.52 142.98 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.752 0.821 . . . . 0.0 110.2 -174.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -170.49 -178.79 2.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.451 0.701 . . . . 0.0 110.22 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.7 mmt -75.51 139.6 42.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.463 0.705 . . . . 0.0 109.455 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 164.53 26.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.408 0.683 . . . . 0.0 111.225 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -142.94 9.23 1.71 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.744 0.418 . . . . 0.0 110.981 172.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -126.18 167.02 15.98 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.056 0.942 . . . . 0.0 109.142 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.1 173.62 14.91 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-O 120.999 0.221 . . . . 0.0 113.245 -173.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -65.37 159.91 62.97 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.109 0.963 . . . . 0.0 111.464 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -37.82 104.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.862 1 C-N-CA 125.618 4.212 . . . . 0.0 115.492 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.47 -26.83 1.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.06 2.507 . . . . 0.0 109.632 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -160.42 168.7 24.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.8 1.64 . . . . 0.0 106.786 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.282 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.32 -44.27 58.08 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.463 -0.632 . . . . 0.0 113.721 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.498 ' H ' ' HD3' ' A' ' 6' ' ' PRO . 18.4 ptt-85 -160.2 24.52 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.498 ' HD3' ' H ' ' A' ' 5' ' ' ARG . 74.4 Cg_endo -70.63 144.07 48.37 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 CA-C-N 121.614 1.612 . . . . 0.0 108.51 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.67 115.25 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.357 2.705 . . . . 0.0 110.779 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.0 -164.2 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.727 2.951 . . . . 0.0 109.841 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -133.27 25.47 4.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.621 0.769 . . . . 0.0 110.238 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 m -55.2 -15.82 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.817 0.847 . . . . 0.0 111.822 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.75 -4.13 32.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.008 0.923 . . . . 0.0 112.219 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.9 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.598 -0.557 . . . . 0.0 112.797 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.0 ptt? -135.63 162.65 32.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.002 0.901 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 m -76.05 82.44 2.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 122.888 0.475 . . . . 0.0 109.827 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.4 m -65.87 67.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.946 1.698 . . . . 0.0 110.459 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.577 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.6 tm? -86.36 131.52 34.19 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -128.63 153.67 47.03 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.152 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.862 HG12 HG22 ' A' ' 60' ' ' VAL . 5.9 p -131.48 153.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.783 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -152.75 -173.19 4.48 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.291 1.436 . . . . 0.0 109.738 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 83' ' ' ARG . 34.5 t30 86.76 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.737 1.215 . . . . 0.0 112.666 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.0 134.2 55.59 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.386 1.075 . . . . 0.0 109.132 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -81.17 169.05 17.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.981 176.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -62.46 1.18 0.38 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -125.69 12.72 7.99 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.595 0.634 . . . . 0.0 112.001 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -116.09 165.22 13.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.322 0.249 . . . . 0.0 110.996 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -150.19 165.15 18.14 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 124.226 1.01 . . . . 0.0 109.19 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 60.6 Cg_endo -70.43 -25.78 25.12 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.205 1.936 . . . . 0.0 111.604 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.76 -32.42 69.55 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.898 -0.502 . . . . 0.0 109.954 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.4 m -77.43 -44.91 27.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.48 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -56.66 -22.4 34.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.636 -0.665 . . . . 0.0 110.496 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -78.38 -57.98 3.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -61.09 -30.61 70.45 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.645 0.202 . . . . 0.0 110.539 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.88 -34.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 123.442 0.464 . . . . 0.0 110.811 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.6 m-85 -98.74 -13.12 20.36 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.25 -25.73 63.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.895 -0.503 . . . . 0.0 110.91 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -69.45 -23.22 63.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.888 -0.508 . . . . 0.0 112.243 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -74.62 -16.94 60.77 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.459 0.304 . . . . 0.0 111.653 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.65 -85.71 0.1 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -160.77 162.5 32.41 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.992 0.517 . . . . 0.0 110.893 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 t -137.42 137.76 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.61 -36.22 9.66 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -164.05 159.2 20.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.366 0.583 . . . . 0.0 111.194 174.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -158.01 117.96 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.681 1.192 . . . . 0.0 108.335 -176.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.07 176.98 11.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.374 0.607 . . . . 0.0 112.518 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 58' ' ' ALA . 18.7 mt -129.81 91.73 39.29 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 124.035 0.934 . . . . 0.0 108.6 -173.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.79 8.68 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.879 3.719 . . . . 0.0 113.733 -172.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -52.75 -43.15 65.58 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.013 0.824 . . . . 0.0 109.834 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -149.37 116.69 6.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -71.17 12.19 0.34 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.5 ' CD2' HG23 ' A' ' 51' ' ' THR . 15.7 p90 -146.28 2.77 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.937 0.895 . . . . 0.0 111.34 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.5 HG23 ' CD2' ' A' ' 50' ' ' TYR . 17.1 p -129.15 -36.02 1.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.478 0.581 . . . . 0.0 109.769 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.55 41.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 126.683 1.993 . . . . 0.0 113.214 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -129.39 1.34 5.09 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 t -64.03 -43.88 94.24 Favored 'General case' 0 CA--C 1.526 0.047 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 58.94 157.54 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.403 1.881 . . . . 0.0 113.582 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.41 -21.5 0.55 Allowed Glycine 0 CA--C 1.526 0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.329 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.56 166.13 29.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.029 0.931 . . . . 0.0 109.464 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -153.2 94.51 1.84 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -66.24 101.55 0.74 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -173.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.862 HG22 HG12 ' A' ' 18' ' ' VAL . 2.3 m -94.82 167.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 171.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 61' ' ' ARG . 10.5 ttt180 -145.94 116.43 7.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.213 0.946 . . . . 0.0 110.601 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 13.6 m-85 -92.48 169.76 10.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.229 1.012 . . . . 0.0 109.711 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -124.71 -37.06 2.52 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 123.989 0.806 . . . . 0.0 112.469 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.42 127.92 32.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.325 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -60.91 -53.72 53.8 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -58.35 -32.35 68.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -89.09 -17.85 28.43 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.084 0.402 . . . . 0.0 110.999 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.577 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.95 -45.62 20.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -75.42 -25.85 57.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.585 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.99 -46.89 40.87 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.719 0.69 . . . . 0.0 111.103 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.8 73.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.122 0.419 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.427 ' HA ' HG13 ' A' ' 87' ' ' VAL . 9.9 ttp -73.86 -41.23 62.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.55 0.34 . . . . 0.0 110.952 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.46 2.87 26.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.426 0.103 . . . . 0.0 111.231 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.19 -6.1 4.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.6 ttm -137.13 -27.81 0.96 Allowed 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.596 ' HB2' HG12 ' A' ' 87' ' ' VAL . 6.2 t70 -63.19 136.46 57.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.945 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.45 85.65 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.542 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.64 34.22 0.48 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.02 0.91 . . . . 0.0 110.49 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.648 HG22 ' H ' ' A' ' 80' ' ' LEU . 9.6 p -69.83 172.1 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.648 ' H ' HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -156.58 5.47 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.972 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' HG22 ' A' ' 79' ' ' VAL . 37.3 t70 -148.26 -2.44 0.52 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.0 -17.14 7.66 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.622 ' C ' HG23 ' A' ' 79' ' ' VAL . 5.3 ptp180 -161.0 140.55 10.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.519 ' C ' HD22 ' A' ' 85' ' ' LEU . 10.0 mm-40 -146.57 -49.57 0.2 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.519 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.4 mm? -139.95 150.36 44.43 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 124.064 0.852 . . . . 0.0 112.445 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -148.66 98.84 2.93 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 167.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.676 ' HB ' HG23 ' A' ' 18' ' ' VAL . 7.1 p -126.45 129.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 121.336 0.588 . . . . 0.0 110.097 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -165.78 164.38 18.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.356 1.063 . . . . 0.0 109.138 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.4 mmt -57.97 136.84 57.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.895 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 155.74 27.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -136.52 4.71 2.88 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.623 0.369 . . . . 0.0 110.838 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.95 163.81 28.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.4 172.71 15.2 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -66.16 156.05 85.78 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.58 0.352 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.81 146.77 30.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.579 2.853 . . . . 0.0 111.722 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.4 -24.33 5.46 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.194 3.263 . . . . 0.0 111.855 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -154.13 161.47 41.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.359 1.064 . . . . 0.0 109.121 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.519 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.59 65.05 4.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 42.63 49.5 4.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.433 1.493 . . . . 0.0 114.745 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.83 154.03 63.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.249 1.966 . . . . 0.0 108.522 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.77 115.99 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.263 2.642 . . . . 0.0 110.679 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.17 -163.79 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.859 3.039 . . . . 0.0 109.885 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -132.17 20.19 4.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.516 0.726 . . . . 0.0 110.343 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -56.71 -12.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.428 1.091 . . . . 0.0 112.244 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.34 -1.0 9.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.749 0.819 . . . . 0.0 112.496 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.69 30.06 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.77 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.17 168.15 20.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.807 1.304 . . . . 0.0 112.461 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -57.95 -28.32 64.21 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -168.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.4 m 42.1 58.97 2.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 113.172 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 17.6 tp -65.17 167.15 8.55 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 14.9 pttt -136.95 157.63 46.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.107 0.412 . . . . 0.0 111.82 170.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -133.78 148.13 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -150.42 -175.43 5.09 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.662 1.185 . . . . 0.0 110.677 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 t30 91.92 28.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.741 1.616 . . . . 0.0 114.121 168.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 120.66 9.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.25 1.02 . . . . 0.0 109.867 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 23' ' ' TYR . 11.7 m -75.09 171.58 13.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' H ' HG22 ' A' ' 22' ' ' THR . 54.7 p90 -63.96 7.2 0.13 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.113 0.965 . . . . 0.0 112.949 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 22' ' ' THR . 19.3 ptt180 -131.08 14.88 5.19 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.982 0.913 . . . . 0.0 111.838 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 26' ' ' SER . 1.4 m -122.8 166.43 14.98 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.466 0.306 . . . . 0.0 111.068 -173.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.503 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 91.4 p -151.86 166.4 15.32 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.67 -29.24 19.84 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.576 2.184 . . . . 0.0 110.904 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -67.63 -33.92 75.94 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.0 m -75.25 -44.87 43.66 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.479 HD12 HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -56.26 -19.84 15.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.315 0.246 . . . . 0.0 111.117 178.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -80.4 -57.98 3.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -12.31 60.35 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG12 ' HE1' ' A' ' 75' ' ' MET . 55.8 t -91.97 -32.86 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.189 0.595 . . . . 0.0 111.514 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.72 -9.71 18.9 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -26.01 61.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.18 0.446 . . . . 0.0 111.018 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -69.76 -23.78 63.42 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -72.56 -19.2 61.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.842 0.457 . . . . 0.0 111.468 176.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.0 -86.46 0.1 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -156.25 165.12 37.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 111.447 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.52 137.24 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.49 1.116 . . . . 0.0 108.062 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -22.09 23.21 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -163.67 153.85 15.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.403 0.62 . . . . 0.0 110.63 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.44 HG23 HG22 ' A' ' 60' ' ' VAL . 1.6 p -150.92 104.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -146.92 161.79 40.02 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.966 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.4 mt -136.34 126.36 16.17 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.892 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.54 52.21 2.81 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.708 3.605 . . . . 0.0 110.434 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -73.26 70.62 1.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.051 0.94 . . . . 0.0 110.081 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 p30 45.62 -162.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.722 1.609 . . . . 0.0 114.142 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 177.58 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.465 1.906 . . . . 0.0 108.199 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -157.34 12.03 0.22 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.448 1.099 . . . . 0.0 111.456 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.7 p -124.18 -7.16 7.69 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.042 0.537 . . . . 0.0 112.035 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.64 42.05 1.92 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.108 1.763 . . . . 0.0 113.971 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.08 -177.79 4.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.187 0.595 . . . . 0.0 110.303 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -142.59 -176.93 5.05 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -172.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.552 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 75.0 mmt-85 -132.25 -2.1 3.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.256 0.622 . . . . 0.0 112.325 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.7 24.44 76.71 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.009 0.368 . . . . 0.0 113.05 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 9.6 p90 -151.6 171.61 17.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.01 0.905 . . . . 0.0 110.692 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.76 103.82 4.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -69.57 92.44 0.64 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.772 0.829 . . . . 0.0 108.879 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.479 HG21 HD12 ' A' ' 30' ' ' LEU . 40.5 t -79.99 160.94 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 13.7 ttt180 -141.97 130.46 22.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.355 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.1 m-85 -113.03 165.71 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.025 0.375 . . . . 0.0 111.059 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -33.44 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.26 123.39 26.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -60.36 -53.59 55.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -84.95 -21.84 29.43 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.17 -43.54 21.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 122.779 0.432 . . . . 0.0 110.461 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -72.05 -28.56 63.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.214 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -40.73 64.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.393 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.52 74.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.137 -0.352 . . . . 0.0 111.441 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.8 ptp -78.71 -38.29 39.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.68 3.13 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.961 0.504 . . . . 0.0 111.674 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -9.7 3.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.417 ' HE1' HG12 ' A' ' 33' ' ' VAL . 4.6 ttp -146.79 -13.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.27 125.51 23.54 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.762 1.165 . . . . 0.0 108.756 173.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.87 28.11 61.41 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.576 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.65 38.33 0.44 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.775 1.288 . . . . 0.0 109.554 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.621 HG22 ' H ' ' A' ' 80' ' ' LEU . 4.8 p -71.81 173.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -168.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.621 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.1 pt? -152.0 -0.32 0.32 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.27 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' H ' HG22 ' A' ' 79' ' ' VAL . 38.0 t70 -144.95 -1.17 0.87 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.43 -17.31 6.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.558 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -164.34 133.38 3.71 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.151 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 79' ' ' VAL . 20.1 mm-40 -143.81 -39.75 0.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.413 HD12 ' CB ' ' A' ' 84' ' ' GLU . 3.5 mp -147.63 151.18 35.77 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 123.697 0.623 . . . . 0.0 112.608 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.1 mmm180 -147.43 121.56 9.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.72 139.27 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.081 0 C-N-CA 122.67 0.388 . . . . 0.0 110.03 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -169.08 174.93 5.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.752 1.221 . . . . 0.0 109.225 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 mmt -73.97 143.27 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.962 0.905 . . . . 0.0 109.981 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.54 155.68 37.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.474 0.31 . . . . 0.0 110.555 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.56 13.42 2.34 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.766 0.826 . . . . 0.0 109.722 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -129.97 158.07 40.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.874 0.87 . . . . 0.0 109.109 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.48 177.95 20.29 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -60.66 156.06 46.77 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 122.235 -0.568 . . . . 0.0 110.131 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.32 120.94 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.322 2.681 . . . . 0.0 113.309 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.51 -45.77 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.125 1.883 . . . . 0.0 108.671 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -161.39 125.49 3.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.172 1.789 . . . . 0.0 107.833 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.826 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.42 -69.01 0.53 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 125.001 1.286 . . . . 0.0 111.697 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.41 59.65 0.64 Allowed Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -171.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.77 153.76 64.13 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.961 2.441 . . . . 0.0 109.326 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.87 116.04 4.53 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.412 2.741 . . . . 0.0 110.544 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -87.58 -162.52 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.062 3.175 . . . . 0.0 110.298 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -136.25 33.4 2.82 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.976 0.91 . . . . 0.0 109.757 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.434 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 33.7 m -61.43 -1.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 124.409 1.083 . . . . 0.0 113.802 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.53 -13.05 60.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.541 0.61 . . . . 0.0 112.256 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.45 20.75 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.91 -0.383 . . . . 0.0 112.933 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.451 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . 8.1 ptp -60.47 156.9 15.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.84 0.82 . . . . 0.0 113.206 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -72.23 -18.84 61.8 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.888 0.875 . . . . 0.0 110.466 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 t 45.45 59.54 3.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.044 1.338 . . . . 0.0 113.03 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 68' ' ' ALA . 20.7 tp -65.7 165.39 12.69 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 16.8 pttt -134.53 154.89 51.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.531 0.332 . . . . 0.0 110.83 170.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.54 ' HB ' HG22 ' A' ' 60' ' ' VAL . 61.1 t -134.31 148.43 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -148.81 -171.08 3.78 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.997 1.719 . . . . 0.0 109.273 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.88 90.23 0.09 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.497 1.119 . . . . 0.0 111.929 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.5 122.89 49.04 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 m -69.03 165.92 19.16 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.18 -0.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.288 1.035 . . . . 0.0 113.562 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -129.4 23.19 5.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.167 0.987 . . . . 0.0 110.92 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -123.94 165.35 17.57 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.796 0.331 . . . . 0.0 110.73 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.4 p -150.05 165.79 16.7 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.192 0.997 . . . . 0.0 109.527 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 39.1 Cg_endo -66.18 -29.38 47.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.178 1.918 . . . . 0.0 110.911 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.09 -31.9 71.83 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.883 -0.51 . . . . 0.0 110.284 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 100.0 m -74.63 -44.71 49.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -58.84 -20.01 46.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.044 -0.41 . . . . 0.0 110.957 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -81.1 -57.05 3.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -8.89 39.06 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.867 0.467 . . . . 0.0 111.857 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.56 -30.94 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.318 0.647 . . . . 0.0 111.717 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 30' ' ' LEU . 22.7 m-85 -101.73 -12.05 18.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.249 0.477 . . . . 0.0 112.284 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.47 -27.27 64.1 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.011 -0.431 . . . . 0.0 111.37 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.51 -24.08 65.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -72.04 -21.95 61.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.238 0.215 . . . . 0.0 111.184 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -81.24 0.1 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -159.13 165.84 32.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.044 0.45 . . . . 0.0 111.357 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.9 147.16 29.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 -19.34 8.59 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.57 153.45 25.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.194 0.497 . . . . 0.0 110.374 174.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 60' ' ' VAL . 1.5 p -169.13 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.154 0.982 . . . . 0.0 110.044 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.83 179.63 9.02 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 112.204 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.432 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 13.4 mt -117.73 123.26 29.87 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.98 43.93 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 125.364 4.042 . . . . 0.0 112.054 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 92.6 mtt180 -54.89 160.96 1.76 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -54.73 119.42 5.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -67.16 13.27 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -167.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CD2' HG23 ' A' ' 51' ' ' THR . 13.0 p90 -144.72 0.2 0.96 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.666 1.186 . . . . 0.0 111.57 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.471 HG23 ' CD2' ' A' ' 50' ' ' TYR . 30.5 p -127.69 -23.78 3.37 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.709 0.686 . . . . 0.0 110.929 171.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.97 35.62 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.367 1.867 . . . . 0.0 113.815 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.23 1.93 12.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.413 ' HB2' ' HA ' ' A' ' 47' ' ' ARG . 3.3 m -73.37 170.08 15.82 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.386 0.539 . . . . 0.0 111.153 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 176.92 165.92 0.52 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.386 1.474 . . . . 0.0 110.174 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.31 -22.11 0.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -158.04 170.58 21.99 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 108.6 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.24 105.07 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -68.31 116.56 9.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.54 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -116.04 167.83 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 172.095 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.1 ptm180 -144.58 146.02 32.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.663 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 11.0 m-85 -116.01 162.65 17.07 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.464 0.477 . . . . 0.0 111.239 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -122.27 -32.19 3.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.296 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.64 131.13 34.63 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' HE3' ' HE1' ' A' ' 89' ' ' MET . 0.2 OUTLIER -65.06 -45.56 84.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.249 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -172.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.5 p30 -106.52 -7.01 17.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.347 0.521 . . . . 0.0 111.077 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -74.65 -40.43 61.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.92 -29.99 44.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.343 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -67.91 -40.06 83.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.297 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.53 75.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.851 0.296 . . . . 0.0 111.525 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.407 ' HA ' HG13 ' A' ' 87' ' ' VAL . 10.6 ptp -77.15 -40.19 46.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.725 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.07 -0.98 20.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.04 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.61 -6.34 5.19 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.8 ttm -137.63 -28.96 0.88 Allowed 'General case' 0 N--CA 1.458 -0.066 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.466 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 3.3 t70 -66.84 142.62 57.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.7 1.136 . . . . 0.0 110.617 -177.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.6 8.67 86.2 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.575 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.04 31.75 0.44 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.328 1.064 . . . . 0.0 111.041 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.582 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 19.8 t -74.45 160.9 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.704 0.802 . . . . 0.0 111.637 -172.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.65 10.94 0.3 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.368 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -146.44 5.3 0.93 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.99 -0.444 . . . . 0.0 112.106 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.51 -11.25 28.23 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.126 0.393 . . . . 0.0 112.334 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -172.14 114.24 0.32 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.088 0.955 . . . . 0.0 108.563 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.582 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 80.2 mm-40 -130.28 -50.78 1.1 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.555 171.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.96 155.99 46.86 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 46.5 mmt-85 -152.18 109.95 3.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.814 1.646 . . . . 0.0 107.299 168.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 2.1 p -139.12 125.38 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-O 121.19 0.519 . . . . 0.0 110.891 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -155.92 179.92 8.74 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.043 1.737 . . . . 0.0 108.382 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.414 ' HE1' ' HE3' ' A' ' 65' ' ' LYS . 15.4 mmt -75.75 144.93 41.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.6 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.16 169.15 16.7 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.231 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -145.3 -3.11 0.75 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.379 0.672 . . . . 0.0 110.905 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -129.91 168.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.979 0.511 . . . . 0.0 109.911 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.27 171.42 13.7 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 112.745 -0.142 . . . . 0.0 112.745 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -64.43 152.38 89.2 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 123.514 0.725 . . . . 0.0 110.867 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.01 125.99 13.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.464 2.11 . . . . 0.0 112.116 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.22 -22.11 11.4 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.392 2.728 . . . . 0.0 110.389 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -148.5 150.39 33.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.486 1.514 . . . . 0.0 106.999 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -171.508 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 . . . . . 0 CA--C 1.527 0.072 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.32 45.43 1.15 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 51.42 48.2 5.5 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.227 1.011 . . . . 0.0 112.988 -177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.3 157.04 50.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.79 2.327 . . . . 0.0 110.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.77 113.66 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.017 3.145 . . . . 0.0 110.209 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.33 -163.35 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.123 3.215 . . . . 0.0 110.61 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -134.23 29.11 3.7 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.112 0.965 . . . . 0.0 110.14 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.84 -12.53 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.404 1.082 . . . . 0.0 113.406 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.15 4.9 49.08 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.309 0.644 . . . . 0.0 111.448 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.23 21.09 0.49 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -140.89 161.31 38.13 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.399 0.599 . . . . 0.0 111.51 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.9 m -85.05 83.95 7.87 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.696 0.798 . . . . 0.0 111.924 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 m -64.24 79.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.144 1.378 . . . . 0.0 111.299 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.534 HD11 ' CG2' ' A' ' 87' ' ' VAL . 3.1 tm? -79.62 107.44 12.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.55 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.9 ttpp -79.53 140.94 37.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.71 146.92 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.299 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -150.67 -175.75 5.24 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.532 1.145 . . . . 0.0 110.8 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.55 HD21 ' HB2' ' A' ' 83' ' ' ARG . 16.1 t30 94.05 26.97 0.01 OUTLIER 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.728 1.611 . . . . 0.0 113.79 169.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.65 120.02 5.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.383 1.073 . . . . 0.0 108.468 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 23' ' ' TYR . 10.8 m -42.18 -63.85 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.189 0.995 . . . . 0.0 112.274 -172.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' CD2' HG22 ' A' ' 22' ' ' THR . 52.3 p90 165.93 -19.74 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.889 2.875 . . . . 0.0 109.276 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -111.42 -1.07 16.07 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.079 0.952 . . . . 0.0 111.552 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 26' ' ' SER . 2.9 m -78.18 173.47 12.22 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.02 0.928 . . . . 0.0 109.665 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 25' ' ' THR . 93.9 p -145.26 163.02 34.63 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.888 0.475 . . . . 0.0 109.882 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 41.9 Cg_endo -68.16 -26.79 36.02 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.986 1.79 . . . . 0.0 110.446 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.91 -27.38 65.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.465 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 99.7 m -78.35 -45.67 21.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 60' ' ' VAL . 1.3 mm? -59.16 -19.14 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.145 -0.347 . . . . 0.0 110.515 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -78.73 -58.38 3.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.133 -0.461 . . . . 0.0 109.949 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.465 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -71.56 -16.24 62.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.59 0.632 . . . . 0.0 111.326 -174.475 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.64 -32.98 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 123.272 0.629 . . . . 0.0 111.608 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 22.4 m-85 -101.72 -11.52 19.07 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.176 0.443 . . . . 0.0 111.907 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -74.33 -24.71 59.23 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.782 -0.574 . . . . 0.0 110.842 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.91 -22.91 65.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.217 0.462 . . . . 0.0 112.14 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -73.36 -24.85 60.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.699 0.4 . . . . 0.0 111.731 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.78 -84.79 0.07 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -159.64 167.04 29.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.086 0.47 . . . . 0.0 111.564 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.76 147.88 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.02 -17.92 8.63 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -162.42 149.98 13.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 117.057 0.429 . . . . 0.0 110.332 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 60' ' ' VAL . 1.5 p -166.31 104.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.577 1.151 . . . . 0.0 108.638 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.71 175.02 13.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.292 0.568 . . . . 0.0 112.244 175.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 mt -126.31 108.71 23.92 Favored Pre-proline 0 N--CA 1.452 -0.374 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.45 -13.69 20.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.741 2.961 . . . . 0.0 112.77 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 34.6 -107.71 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 111.12 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -140.27 12.78 2.39 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.216 1.006 . . . . 0.0 110.307 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 57.87 -12.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -148.76 -2.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.548 1.067 . . . . 0.0 113.009 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.8 p -121.05 -19.15 7.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.859 0.754 . . . . 0.0 110.516 172.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 50.23 21.11 0.73 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.243 1.417 . . . . 0.0 113.952 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.9 -1.24 6.83 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 t 61.21 173.83 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.015 1.326 . . . . 0.0 113.117 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -139.85 -0.68 1.68 Allowed 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.913 0.885 . . . . 0.0 112.446 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.82 18.44 44.13 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.916 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.07 168.88 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.518 1.159 . . . . 0.0 110.874 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.39 105.59 4.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -70.66 110.83 5.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 59.3 t -100.61 158.76 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -143.61 125.6 15.32 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 2.0 m-85 -91.61 -179.19 5.29 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 -25.06 1.42 Allowed 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 124.057 0.848 . . . . 0.0 113.26 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.87 128.59 37.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -62.33 -50.91 69.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.225 -0.416 . . . . 0.0 111.347 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.517 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -56.88 -34.61 68.02 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -172.297 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.52 -11.04 21.4 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 118.761 0.71 . . . . 0.0 111.972 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.468 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -72.3 -46.62 54.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.09 -24.65 55.05 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.223 -0.298 . . . . 0.0 111.5 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.06 -40.22 60.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.806 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.053 -0.404 . . . . 0.0 111.312 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.0 ptp -76.68 -40.2 49.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.559 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.55 2.26 14.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.186 0.594 . . . . 0.0 112.179 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.43 -9.19 3.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -145.44 -11.69 0.53 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.14 130.03 44.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 120.371 1.441 . . . . 0.0 109.396 174.51 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.46 29.75 61.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.904 -0.942 . . . . 0.0 113.665 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.52 38.88 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.063 1.432 . . . . 0.0 110.193 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.679 HG22 ' H ' ' A' ' 84' ' ' GLU . 13.1 t -69.85 162.56 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 113.96 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.409 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -158.04 9.33 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.506 179.763 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.41 1.66 0.53 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.85 -22.18 3.49 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 121.744 -0.598 . . . . 0.0 112.648 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.55 ' HB2' HD21 ' A' ' 20' ' ' ASN . 0.4 OUTLIER 174.99 134.89 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.584 1.954 . . . . 0.0 107.278 177.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.679 ' H ' HG22 ' A' ' 79' ' ' VAL . 76.3 mm-40 -132.23 -36.45 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.297 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' CB ' ' A' ' 84' ' ' GLU . 4.0 mp -152.15 151.81 31.51 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 31.5 mmt180 -152.57 122.65 7.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 167.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.534 ' CG2' HD11 ' A' ' 16' ' ' LEU . 2.0 p -141.05 137.25 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.183 0.516 . . . . 0.0 111.292 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -165.71 171.41 12.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.999 1.319 . . . . 0.0 109.655 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.83 141.42 53.27 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.218 0.607 . . . . 0.0 110.585 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.88 158.65 35.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.579 0.351 . . . . 0.0 110.132 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -147.95 21.16 1.12 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.601 0.76 . . . . 0.0 109.39 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -146.84 152.06 38.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.25 179.79 22.31 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.046 0.385 . . . . 0.0 113.957 -169.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -62.41 156.91 59.12 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.422 0.689 . . . . 0.0 111.02 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -43.36 114.56 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.202 3.268 . . . . 0.0 114.299 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.87 -23.76 9.12 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.71 2.273 . . . . 0.0 109.334 168.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -156.22 161.84 40.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.811 1.645 . . . . 0.0 107.065 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.144 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.39 80.91 1.74 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 45.3 46.4 2.97 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.26 1.824 . . . . 0.0 114.337 174.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.46 154.22 65.12 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.127 1.885 . . . . 0.0 109.828 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.5 117.23 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.716 2.944 . . . . 0.0 110.599 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -81.6 -169.94 0.88 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.996 3.131 . . . . 0.0 110.352 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -130.62 20.39 5.12 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.587 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.76 -12.02 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 125.403 1.481 . . . . 0.0 112.343 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.96 0.55 3.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.781 0.832 . . . . 0.0 112.616 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 30.64 0.15 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.088 -0.84 . . . . 0.0 113.954 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.09 23.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.91 1.355 . . . . 0.0 112.43 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -59.35 -26.95 65.49 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.0 m 43.09 59.96 2.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 20.5 tp -65.48 167.3 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 171.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 22.8 pttt -136.49 157.26 47.2 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.555 ' HB ' HG22 ' A' ' 60' ' ' VAL . 86.9 t -131.1 146.85 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -146.83 -175.2 4.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 110.355 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 92.97 24.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.525 1.53 . . . . 0.0 113.594 168.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.413 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -57.36 129.84 43.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.348 0.659 . . . . 0.0 109.378 -178.297 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 24' ' ' ARG . 18.0 m -82.43 170.94 14.7 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -64.08 8.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.175 0.99 . . . . 0.0 113.312 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 22' ' ' THR . 13.2 ptt180 -134.57 19.37 3.6 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.604 1.162 . . . . 0.0 111.969 -174.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -127.17 164.87 20.7 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.05 0.54 . . . . 0.0 110.448 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 85.0 p -149.86 165.16 18.21 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 110.37 -174.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 57.5 Cg_endo -69.42 -28.08 27.32 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.015 2.477 . . . . 0.0 111.192 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.98 -36.26 77.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.4 m -72.15 -44.15 63.55 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.514 HD11 HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -57.35 -21.98 39.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.991 -0.443 . . . . 0.0 111.145 179.397 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.82 -54.15 5.33 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -10.88 58.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.87 0.468 . . . . 0.0 111.869 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -98.95 -32.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 112.031 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.402 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.8 m-85 -100.9 -10.39 20.69 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -71.35 -28.05 63.79 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.766 -0.583 . . . . 0.0 111.14 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.61 -23.46 64.46 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -72.83 -17.59 61.54 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.317 0.247 . . . . 0.0 110.811 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.28 -76.09 0.11 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -164.81 160.52 19.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.239 0.616 . . . . 0.0 110.599 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.2 t -132.42 128.02 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.7 48.07 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -167.38 159.13 12.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.692 0.758 . . . . 0.0 112.912 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.26 141.29 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.71 1.604 . . . . 0.0 106.701 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -157.79 149.37 21.73 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.485 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 58' ' ' ALA . 5.7 mt -136.57 133.21 18.99 Favored Pre-proline 0 C--O 1.232 0.163 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.89 156.51 4.65 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.375 2.716 . . . . 0.0 111.915 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -140.34 9.54 2.28 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 43.88 18.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.251 8.3 ptm180 40.13 8.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.44 3.096 . . . . 0.0 116.832 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -162.82 -20.95 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.753 1.221 . . . . 0.0 112.971 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -96.56 -22.25 17.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.037 1.289 . . . . 0.0 110.385 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.99 31.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.812 1.645 . . . . 0.0 113.69 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.23 -160.2 0.08 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -135.83 168.23 19.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.295 0.638 . . . . 0.0 109.781 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.4 ttm105 -146.31 0.98 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.11 20.7 38.08 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.765 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.5 169.37 24.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.059 1.43 . . . . 0.0 111.538 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -141.9 93.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 108.556 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.72 103.32 0.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.555 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.3 m -100.84 168.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 172.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.4 ptm180 -142.1 139.83 32.33 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 17.3 m-85 -109.4 165.92 11.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.292 0.637 . . . . 0.0 110.465 177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -33.64 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.2 122.41 24.31 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -60.48 -50.98 71.4 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.631 -0.223 . . . . 0.0 110.403 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.6 -29.63 70.65 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.254 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -90.11 -15.77 30.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.718 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -79.75 -39.37 31.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.38 -25.86 51.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.426 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.89 -47.83 42.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.444 0.565 . . . . 0.0 110.785 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.43 73.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.976 -0.452 . . . . 0.0 110.783 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.1 ttp -73.99 -41.39 61.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.877 0.471 . . . . 0.0 110.05 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.91 3.14 27.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 122.446 -0.159 . . . . 0.0 111.42 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.48 -5.5 4.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.3 ttm -140.44 -27.34 0.74 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.97 134.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.466 1.03 . . . . 0.0 110.221 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.49 85.85 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.539 -0.589 . . . . 0.0 112.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.77 33.23 0.43 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.811 0.806 . . . . 0.0 110.8 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.577 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 48.6 t -69.93 166.16 2.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.64 0.776 . . . . 0.0 112.269 -172.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.406 ' N ' HG12 ' A' ' 79' ' ' VAL . 1.1 pt? -154.86 5.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -144.79 4.66 1.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.46 6.15 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.51 ' C ' HG13 ' A' ' 79' ' ' VAL . 5.2 ptp180 -176.14 143.33 0.53 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.004 1.722 . . . . 0.0 107.318 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 mm-40 -141.52 -46.94 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 169.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.488 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -140.96 152.7 45.17 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.941 0.496 . . . . 0.0 111.937 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.2 mmm180 -148.19 109.09 4.24 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 18' ' ' VAL . 33.9 t -134.95 127.18 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 C-N-CA 122.74 0.416 . . . . 0.0 110.876 -173.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -158.08 173.24 17.04 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.506 1.122 . . . . 0.0 109.412 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.2 mmt -69.59 146.08 52.02 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.786 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.89 165.93 22.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.704 0.402 . . . . 0.0 111.353 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -137.51 -0.04 2.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.717 0.807 . . . . 0.0 109.416 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -139.66 156.11 47.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.328 0.651 . . . . 0.0 109.26 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.25 -16.39 6.15 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HD3' ' HD2' ' A' ' 95' ' ' PRO . 21.2 tpp180 -170.46 139.91 1.46 Allowed Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' HD3' ' A' ' 94' ' ' ARG . 26.7 Cg_endo -60.67 119.7 7.02 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.047 1.831 . . . . 0.0 109.128 171.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.52 -29.43 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.598 2.198 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -153.45 93.56 1.71 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.553 0.692 . . . . 0.0 112.081 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.7 m . . . . . 0 N--CA 1.458 -0.035 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.122 176.537 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.12 36.77 9.65 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.779 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 38.81 50.37 2.55 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 125.076 1.35 . . . . 0.0 113.994 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.91 159.25 50.9 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.742 2.295 . . . . 0.0 110.282 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.53 117.83 4.69 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.59 2.86 . . . . 0.0 110.088 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.55 -170.01 0.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.137 3.225 . . . . 0.0 110.408 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -132.53 25.88 4.42 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.397 0.679 . . . . 0.0 109.459 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 m -58.66 -4.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.332 1.453 . . . . 0.0 112.926 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.79 5.73 47.31 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.271 0.629 . . . . 0.0 110.795 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.66 17.83 0.49 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.7 ptt? -143.31 164.1 31.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.601 0.701 . . . . 0.0 110.856 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -81.07 84.94 6.38 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 110.952 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -68.21 97.32 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.489 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 2.1 tm? -116.54 124.61 50.29 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.025 0.44 . . . . 0.0 109.914 -176.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.3 ttpm? -102.58 146.89 27.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.256 1.423 . . . . 0.0 114.123 -167.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.457 ' HB ' HG22 ' A' ' 60' ' ' VAL . 52.1 t -124.48 146.4 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.229 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -151.62 -171.52 3.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 110.484 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 81.65 37.57 0.07 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.158 1.383 . . . . 0.0 113.199 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' H ' ' HA ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -63.66 175.2 1.14 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.386 1.074 . . . . 0.0 109.299 175.344 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 24' ' ' ARG . 5.2 m -129.05 167.58 17.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.82 0.848 . . . . 0.0 109.345 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -64.4 4.87 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.455 0.702 . . . . 0.0 112.475 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.424 ' H ' ' C ' ' A' ' 22' ' ' THR . 14.8 ptm180 -129.13 18.86 5.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.787 1.235 . . . . 0.0 110.228 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -129.99 163.17 27.03 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.776 0.83 . . . . 0.0 109.382 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.7 p -148.5 164.73 20.44 Favored Pre-proline 0 C--O 1.233 0.201 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 -174.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.9 Cg_endo -68.98 -27.76 29.84 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.792 1.661 . . . . 0.0 111.467 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.06 -32.33 72.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.742 0.701 . . . . 0.0 109.648 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.1 m -74.15 -44.03 55.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.448 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -59.88 -20.82 59.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.074 -0.391 . . . . 0.0 111.075 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -56.15 4.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -8.18 50.64 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.983 0.513 . . . . 0.0 112.194 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.4 t -100.79 -31.84 3.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 C-N-CA 123.069 0.547 . . . . 0.0 112.027 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.448 ' CD1' HD13 ' A' ' 30' ' ' LEU . 26.1 m-85 -101.67 -9.76 20.61 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.509 0.595 . . . . 0.0 111.602 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.83 -28.27 62.45 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.728 -0.607 . . . . 0.0 111.463 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.88 -23.0 65.95 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -71.83 -20.26 61.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.398 -0.335 . . . . 0.0 111.007 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -82.58 0.1 OUTLIER Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 175.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -159.63 160.29 34.11 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.236 0.614 . . . . 0.0 110.351 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.44 143.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.12 -15.24 24.28 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.271 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -154.45 142.65 20.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.588 0.694 . . . . 0.0 110.356 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.489 HG13 HG12 ' A' ' 60' ' ' VAL . 46.5 t -153.9 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 107.829 173.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 163.69 38.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mm -90.5 110.32 40.24 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.15 -41.83 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.315 2.677 . . . . 0.0 114.688 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -82.41 165.69 20.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.083 0.856 . . . . 0.0 109.963 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 50.68 46.63 25.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.055 0.542 . . . . 0.0 112.057 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.471 ' HG2' ' CD2' ' A' ' 50' ' ' TYR . 18.6 ptt180 -54.7 -4.59 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.496 ' CD1' HG23 ' A' ' 51' ' ' THR . 15.6 p90 -146.77 7.1 0.94 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.871 0.76 . . . . 0.0 112.456 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.496 HG23 ' CD1' ' A' ' 50' ' ' TYR . 27.2 p -125.98 -14.1 6.16 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.844 -0.535 . . . . 0.0 111.264 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.32 27.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.855 2.062 . . . . 0.0 114.421 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.95 11.01 2.42 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.949 -0.469 . . . . 0.0 112.011 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -138.45 159.59 41.69 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.919 0.488 . . . . 0.0 110.339 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -170.51 15.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.969 0.908 . . . . 0.0 111.808 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.3 -12.4 58.16 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 118.154 0.434 . . . . 0.0 112.388 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HA ' ' H ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -158.73 168.78 25.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.936 0.894 . . . . 0.0 109.921 176.133 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 95.43 2.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -63.12 121.34 13.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.2 m -119.38 166.94 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 3.6 ptm180 -145.3 131.22 19.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.554 0.533 . . . . 0.0 111.898 175.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 26.7 m-85 -93.41 172.9 7.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.238 1.015 . . . . 0.0 109.295 171.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.413 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -126.78 -33.91 2.45 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 123.917 0.761 . . . . 0.0 112.754 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.1 133.04 34.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.45 -52.91 63.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.424 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -29.28 70.19 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -85.48 -21.35 28.72 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.899 0.318 . . . . 0.0 110.772 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -81.11 -45.45 16.44 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.391 0.676 . . . . 0.0 109.889 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -77.59 -24.62 49.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.243 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.82 -45.38 43.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.966 0.803 . . . . 0.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -30.08 71.09 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 110.64 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ttp -75.72 -43.27 47.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.392 0.277 . . . . 0.0 110.599 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.02 -0.33 27.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.531 0.15 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.03 -6.32 6.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.7 ttm -136.38 -27.33 1.07 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.482 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -62.65 137.67 58.32 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.393 1.451 . . . . 0.0 108.56 176.618 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.3 59.63 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.741 -0.477 . . . . 0.0 112.048 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.547 ' O ' HD21 ' A' ' 85' ' ' LEU . . . -131.22 70.24 1.47 Allowed 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.759 HG22 ' N ' ' A' ' 80' ' ' LEU . 9.9 p -45.19 167.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 -167.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.759 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -144.39 -6.79 0.71 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.241 -2.254 . . . . 0.0 116.675 169.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.522 ' H ' HG22 ' A' ' 79' ' ' VAL . 11.8 t70 -157.0 6.95 0.16 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.275 0.943 . . . . 0.0 112.993 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.568 ' H ' ' CG2' ' A' ' 79' ' ' VAL . . . 96.38 16.37 37.67 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 121.812 -0.555 . . . . 0.0 111.801 -174.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -147.2 60.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 123.257 1.503 . . . . 0.0 107.526 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 84' ' ' GLU . 1.3 mp0 -50.3 128.91 20.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 112.794 -2.003 . . . . 0.0 114.381 -166.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.004 ' H ' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -40.02 137.48 0.96 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.759 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mmt-85 -130.52 128.87 42.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.6 p -145.02 120.82 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.109 0.564 . . . . 0.0 109.751 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -154.19 165.13 37.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.22 1.408 . . . . 0.0 108.746 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -56.61 166.02 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.555 1.142 . . . . 0.0 112.87 -173.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.37 143.84 49.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.383 0.673 . . . . 0.0 111.485 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -151.72 -0.67 0.33 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.381 0.672 . . . . 0.0 111.436 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -78.54 55.39 1.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.127 0.971 . . . . 0.0 112.985 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.72 -149.87 5.13 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 118.301 0.5 . . . . 0.0 112.415 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -153.08 156.47 32.69 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.284 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -32.71 100.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 125.114 3.876 . . . . 0.0 116.367 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -83.61 -24.96 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.421 2.748 . . . . 0.0 110.176 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -150.56 -166.75 2.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.92 1.688 . . . . 0.0 108.481 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.232 0.162 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.489 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.85 -45.9 90.99 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.462 -0.632 . . . . 0.0 111.844 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 16.2 ptm180 -166.49 40.2 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 55.8 Cg_endo -66.0 128.07 18.97 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.487 -1.774 . . . . 0.0 107.487 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.28 113.06 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.582 2.855 . . . . 0.0 111.408 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -88.9 -162.1 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.207 3.271 . . . . 0.0 109.507 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -138.67 33.03 2.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 0.0 109.753 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -1.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.325 1.45 . . . . 0.0 113.495 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -105.73 7.59 32.59 Favored 'General case' 0 CA--C 1.527 0.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.526 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.05 17.83 0.32 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.483 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 14.9 ptt? -141.01 169.67 17.18 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.538 0.669 . . . . 0.0 110.804 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.3 m -62.1 166.81 4.42 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.4 m -147.64 61.36 1.14 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 18.9 tp -63.18 155.37 28.37 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 13.9 pttp -127.43 143.38 51.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.351 0.407 . . . . 0.0 110.173 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -128.17 151.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.003 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -151.48 -170.98 3.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 109.902 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 82.71 28.1 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.842 1.257 . . . . 0.0 113.049 171.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.41 125.07 15.02 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.684 0.794 . . . . 0.0 109.483 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 24' ' ' ARG . 11.9 m -75.17 168.91 19.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.742 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -65.21 8.49 0.14 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.271 1.028 . . . . 0.0 112.781 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.8 ptt180 -134.56 16.98 3.64 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.486 1.114 . . . . 0.0 111.315 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 26' ' ' SER . 1.9 m -120.91 166.57 13.63 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -172.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.9 p -152.72 164.78 19.23 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.425 1.09 . . . . 0.0 109.052 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 55.3 Cg_endo -68.96 -29.36 27.86 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.686 2.257 . . . . 0.0 111.688 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.83 -36.57 75.72 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.081 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.8 m -72.17 -42.37 65.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -54.64 -25.81 29.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.903 -0.498 . . . . 0.0 111.184 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -79.17 -54.6 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -62.49 -29.99 70.94 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.601 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.38 -32.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 122.974 0.51 . . . . 0.0 110.909 -173.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.424 ' CD1' HD13 ' A' ' 30' ' ' LEU . 24.6 m-85 -102.59 -9.74 19.87 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.27 -25.52 60.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.762 -0.586 . . . . 0.0 111.192 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -68.88 -23.32 64.2 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.004 0.366 . . . . 0.0 111.924 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -72.86 -16.28 61.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.439 0.296 . . . . 0.0 111.252 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.07 -80.59 0.13 Allowed Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -162.3 161.68 27.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.672 0.389 . . . . 0.0 110.443 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -136.98 145.87 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.97 -45.22 6.76 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -169.31 167.68 10.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.684 0.394 . . . . 0.0 110.595 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 HG22 ' A' ' 60' ' ' VAL . 16.2 m -121.47 152.12 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -149.33 140.92 23.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.348 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.87 108.17 7.62 Favored Pre-proline 0 CA--C 1.53 0.179 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.04 -21.39 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.566 2.844 . . . . 0.0 112.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 36.63 -103.75 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.77 1.228 . . . . 0.0 110.98 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -142.88 11.93 1.83 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.381 1.073 . . . . 0.0 109.949 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 55.18 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.523 1.929 . . . . 0.0 115.764 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -141.96 -2.14 1.19 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.314 1.415 . . . . 0.0 113.612 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.03 -20.37 5.78 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.148 0.431 . . . . 0.0 110.878 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 48.45 24.4 0.73 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.147 1.379 . . . . 0.0 113.843 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.74 19.53 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -142.25 168.81 18.86 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.241 0.543 . . . . 0.0 112.082 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -175.29 20.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.475 1.91 . . . . 0.0 110.113 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.83 -9.06 44.37 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.707 -0.621 . . . . 0.0 113.332 -172.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -159.63 163.88 34.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.892 0.877 . . . . 0.0 109.181 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.86 95.32 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.57 96.74 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 18' ' ' VAL . 60.7 t -92.75 148.28 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 17.4 ttt180 -126.1 115.73 20.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.905 0.753 . . . . 0.0 111.739 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 18.3 m-85 -96.78 163.36 13.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.961 0.104 . . . . 0.0 110.914 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.483 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.1 OUTLIER -127.49 -25.36 3.18 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.085 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.12 119.17 26.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -57.47 -49.29 76.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.809 0.277 . . . . 0.0 110.61 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -62.6 -32.63 73.66 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -88.25 -16.03 34.28 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.39 -47.76 12.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.86 -27.35 66.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.118 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.4 -40.83 57.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.509 0.595 . . . . 0.0 110.84 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.49 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.13 -0.356 . . . . 0.0 111.261 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.8 ptp -77.73 -37.4 49.35 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.0 1.02 22.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.978 0.511 . . . . 0.0 111.836 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.78 -4.93 3.62 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttm -138.06 -28.01 0.88 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.45 134.66 56.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.916 0.78 . . . . 0.0 110.037 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.98 9.96 84.62 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.414 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.9 30.15 0.38 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.081 0.941 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.546 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 42.9 t -72.72 162.49 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.431 1.092 . . . . 0.0 112.234 -172.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.28 16.25 0.21 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.836 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -144.61 4.67 1.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.189 0.595 . . . . 0.0 111.472 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.3 -9.13 57.48 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.92 123.1 0.51 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.523 1.129 . . . . 0.0 108.533 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.546 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.7 mm-40 -138.31 -47.32 0.52 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.518 169.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -137.81 153.57 49.63 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.184 0.516 . . . . 0.0 111.937 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.4 mmm180 -149.0 108.24 3.93 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.772 1.629 . . . . 0.0 106.968 168.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.36 140.7 47.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.293 0.237 . . . . 0.0 111.345 -176.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -171.49 175.84 3.97 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.712 1.605 . . . . 0.0 108.046 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.8 mmt -75.45 146.98 40.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.92 51.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -132.38 19.6 4.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.76 139.68 29.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.46 -165.32 13.63 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 122.878 0.275 . . . . 0.0 112.457 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -45.18 127.85 5.72 Favored Pre-proline 0 CA--C 1.526 0.043 0 C-N-CA 123.813 0.845 . . . . 0.0 110.158 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.98 142.59 57.27 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.813 2.342 . . . . 0.0 110.467 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.68 -34.09 4.52 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.038 2.492 . . . . 0.0 110.668 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -167.8 136.2 2.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.057 0.543 . . . . 0.0 110.704 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 CA--C 1.528 0.103 0 C-N-CA 124.517 1.127 . . . . 0.0 111.192 172.013 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.47 62.68 3.78 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.958 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 17.2 mtp180 106.64 21.59 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 127.325 2.25 . . . . 0.0 116.002 167.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 82.2 Cg_endo -71.82 149.81 54.63 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.593 1.605 . . . . 0.0 110.148 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.41 144.73 29.28 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.453 2.768 . . . . 0.0 111.141 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.55 -169.26 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.761 3.64 . . . . 0.0 110.134 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -131.69 17.38 4.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.781 0.832 . . . . 0.0 109.403 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.27 -5.85 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 125.593 1.557 . . . . 0.0 112.877 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.16 -0.32 3.27 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 112.991 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.83 36.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.217 -0.768 . . . . 0.0 113.702 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 165.06 28.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.652 1.226 . . . . 0.0 112.457 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -73.64 93.14 2.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 123.761 0.824 . . . . 0.0 110.844 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -70.44 85.27 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.026 0.931 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.585 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.7 tm? -106.57 134.1 50.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.8 155.34 46.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -168.637 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.49 155.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -174.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -152.22 -171.09 3.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.679 1.192 . . . . 0.0 110.454 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 87.18 27.36 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.256 1.422 . . . . 0.0 113.145 171.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.77 125.77 15.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.122 0.969 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 23' ' ' TYR . 7.4 m -77.34 171.92 14.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.264 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.519 ' H ' HG22 ' A' ' 22' ' ' THR . 52.5 p90 -63.36 6.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.774 1.23 . . . . 0.0 114.09 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -134.6 15.0 3.7 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.488 0.586 . . . . 0.0 112.084 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 26' ' ' SER . 1.4 m -117.7 165.19 13.91 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -153.3 167.21 13.95 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.648 1.179 . . . . 0.0 109.431 -174.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 43.4 Cg_endo -69.46 -28.47 26.67 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.247 1.965 . . . . 0.0 111.675 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.75 -34.38 75.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.3 m -77.66 -43.77 30.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -57.87 -21.19 41.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.811 -0.555 . . . . 0.0 110.703 178.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -56.51 4.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -61.37 -31.04 70.93 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.645 0.202 . . . . 0.0 110.597 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.28 -34.92 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 122.765 0.426 . . . . 0.0 111.06 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CD1' HD13 ' A' ' 30' ' ' LEU . 16.6 m-85 -99.34 -10.68 21.99 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.63 -27.07 61.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.445 0.566 . . . . 0.0 111.233 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -67.25 -22.65 65.67 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -74.04 -23.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.377 0.271 . . . . 0.0 110.988 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.86 -79.56 0.09 OUTLIER Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.143 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -157.31 164.8 37.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.94 133.68 44.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.07 -38.54 7.83 Favored Glycine 0 CA--C 1.519 0.344 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -158.42 161.02 37.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.879 0.872 . . . . 0.0 109.64 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.628 HG23 HG22 ' A' ' 60' ' ' VAL . 2.1 p -139.07 74.37 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-O 123.301 1.524 . . . . 0.0 107.05 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -83.13 143.64 30.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.299 -169.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.8 mt -140.14 130.36 13.84 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.44 151.1 5.02 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.158 2.572 . . . . 0.0 111.712 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.05 19.19 3.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.262 0.625 . . . . 0.0 109.631 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 50' ' ' TYR . 64.9 m-20 42.47 26.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.11 0.964 . . . . 0.0 112.767 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 42.88 3.26 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.642 2.777 . . . . 0.0 116.312 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.406 ' H ' ' C ' ' A' ' 48' ' ' ASP . 30.0 p90 -165.87 -4.11 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 113.915 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -116.78 -18.9 10.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.154 1.343 . . . . 0.0 111.633 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.69 30.6 0.54 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 125.775 1.63 . . . . 0.0 113.64 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.46 -159.39 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.664 0.786 . . . . 0.0 109.095 171.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.4 t -138.01 172.85 12.32 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.979 0.511 . . . . 0.0 111.384 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -137.02 3.53 2.67 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.514 0.725 . . . . 0.0 111.762 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.34 54.26 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.347 -0.696 . . . . 0.0 112.887 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.81 169.6 23.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.672 1.236 . . . . 0.0 111.318 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.39 101.67 3.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -69.33 89.48 0.48 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.071 1.349 . . . . 0.0 109.066 -175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.628 HG22 HG23 ' A' ' 43' ' ' VAL . 68.0 t -75.39 158.59 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 172.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -138.98 128.21 24.05 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.8 m-85 -106.05 173.69 6.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.19 1.396 . . . . 0.0 109.555 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.6 -38.31 0.74 Allowed 'General case' 0 C--N 1.339 0.127 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.79 124.62 32.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.427 -0.796 . . . . 0.0 109.133 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -53.75 -49.39 68.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.848 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -58.73 -24.9 62.34 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.001 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.8 p30 -110.42 -6.57 14.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.714 0.688 . . . . 0.0 111.287 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.585 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.34 -46.63 22.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.39 -31.06 48.19 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.569 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -71.27 -43.9 66.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.482 1.037 . . . . 0.0 111.089 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.41 75.12 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 118.146 0.43 . . . . 0.0 110.278 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttp -72.22 -42.52 65.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.751 0.42 . . . . 0.0 110.627 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.19 3.51 23.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.332 -0.23 . . . . 0.0 111.24 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.35 -6.32 4.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.0 ttm -137.47 -28.17 0.92 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.452 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -63.1 137.87 58.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 118.016 -1.473 . . . . 0.0 109.865 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.7 10.71 80.27 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.903 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 33.0 0.4 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.262 1.031 . . . . 0.0 110.547 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.637 HG22 ' H ' ' A' ' 81' ' ' ASP . 9.8 p -73.28 174.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -170.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.577 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.3 pt? -152.69 4.92 0.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.622 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.637 ' H ' HG22 ' A' ' 79' ' ' VAL . 36.8 t70 -141.52 -3.72 1.15 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.548 0.339 . . . . 0.0 111.886 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.87 -10.55 32.15 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.55 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.41 128.18 3.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 79' ' ' VAL . 13.1 mm-40 -144.24 -49.54 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.2 mm? -138.64 154.61 48.65 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.103 0.561 . . . . 0.0 112.294 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.7 mmt180 -152.03 112.52 4.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.868 1.667 . . . . 0.0 106.506 166.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.57 125.69 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.232 0.539 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -154.07 163.67 39.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.361 1.464 . . . . 0.0 108.36 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 mmt -61.01 140.94 57.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.577 0.751 . . . . 0.0 110.356 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 156.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -145.74 18.92 1.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.259 1.024 . . . . 0.0 108.661 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.75 135.8 20.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -176.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.32 176.38 21.71 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.333 0.407 . . . . 0.0 113.523 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -63.3 135.87 96.44 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 123.729 0.812 . . . . 0.0 110.266 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.98 134.05 35.7 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.767 2.312 . . . . 0.0 109.799 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.72 -20.99 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.329 2.686 . . . . 0.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -150.73 157.33 42.83 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.608 1.163 . . . . 0.0 107.88 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -175.153 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.39 32.09 43.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.219 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 34.68 57.69 2.19 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.07 1.348 . . . . 0.0 113.034 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.65 150.89 79.71 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.016 2.477 . . . . 0.0 110.464 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.22 122.06 8.05 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.539 2.826 . . . . 0.0 110.571 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -80.88 -167.94 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.775 2.983 . . . . 0.0 110.433 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -129.61 29.35 5.06 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.679 0.792 . . . . 0.0 110.319 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 m -56.23 -12.74 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.678 1.191 . . . . 0.0 112.585 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.07 -0.94 5.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.227 1.011 . . . . 0.0 112.931 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.41 28.74 0.14 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.341 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.34 166.37 25.28 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.856 1.328 . . . . 0.0 112.082 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.408 ' OG1' ' HE3' ' A' ' 65' ' ' LYS . 91.1 m -82.99 90.13 6.97 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.869 0.868 . . . . 0.0 111.285 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.9 m -67.21 85.97 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.889 0.876 . . . . 0.0 110.428 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 31.8 tp -70.95 162.92 28.51 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.245 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.453 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 25.3 ttpp -133.55 143.61 48.82 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.123 0.969 . . . . 0.0 110.529 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 30' ' ' LEU . 95.0 t -131.42 146.43 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -150.67 -169.74 3.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.777 1.631 . . . . 0.0 110.406 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.49 27.13 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.755 1.622 . . . . 0.0 113.563 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.22 123.43 11.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.762 0.825 . . . . 0.0 109.959 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 24' ' ' ARG . 10.4 m -72.25 168.04 19.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -64.69 9.7 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 113.123 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 22' ' ' THR . 23.5 ptt180 -135.06 17.88 3.46 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.474 1.11 . . . . 0.0 111.397 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -125.29 162.83 23.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.661 0.385 . . . . 0.0 111.385 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.465 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 62.9 m -148.72 163.79 24.33 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.682 1.193 . . . . 0.0 109.018 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 26' ' ' SER . 55.3 Cg_endo -69.18 -30.54 24.81 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.277 1.985 . . . . 0.0 111.697 -175.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.34 -35.24 79.85 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.942 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.8 m -74.36 -44.19 53.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -56.34 -22.26 29.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.853 -0.53 . . . . 0.0 110.52 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -57.67 3.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.31 -30.71 71.35 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.771 0.319 . . . . 0.0 110.75 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.06 -32.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.481 ' CD1' HD13 ' A' ' 30' ' ' LEU . 19.5 m-85 -100.64 -11.67 19.82 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.47 -26.73 64.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.494 -0.754 . . . . 0.0 110.928 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.49 -23.82 65.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.7 -16.38 59.53 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 122.64 0.376 . . . . 0.0 111.603 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.26 -82.16 0.11 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -158.94 165.27 34.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.045 0.45 . . . . 0.0 111.048 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.3 123.11 49.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.82 -23.77 51.65 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -164.68 155.68 14.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.117 0.484 . . . . 0.0 110.896 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.62 125.3 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -159.11 157.61 31.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.95 -167.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.407 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 9.9 mt -127.06 88.8 53.52 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 158.93 4.38 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.102 3.202 . . . . 0.0 111.425 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 49' ' ' ARG . 82.3 mtm-85 -146.19 157.18 43.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.76 3.66 1.38 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 47' ' ' ARG . 9.2 ttm-85 62.55 -2.42 0.36 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.181 1.392 . . . . 0.0 114.008 172.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.443 ' CD1' HG23 ' A' ' 51' ' ' THR . 39.9 p90 -149.37 0.19 0.5 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.443 HG23 ' CD1' ' A' ' 50' ' ' TYR . 20.8 p -127.56 -22.49 3.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.635 0.652 . . . . 0.0 111.386 171.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.0 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.687 1.995 . . . . 0.0 114.877 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.41 5.47 8.74 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.985 -0.447 . . . . 0.0 111.521 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.5 p -65.94 -23.07 66.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -34.8 116.66 0.34 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.803 1.241 . . . . 0.0 112.509 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.24 -6.85 0.28 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.679 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 172.0 15.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.808 0.843 . . . . 0.0 110.231 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.89 94.88 2.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -64.79 109.54 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.463 HG11 HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -114.1 159.86 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.2 ptm180 -136.85 145.18 44.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.063 -175.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' HB2' ' CB ' ' A' ' 16' ' ' LEU . 4.7 m-85 -114.8 177.58 4.6 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.77 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.66 -32.7 0.99 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.85 127.69 32.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.229 0.468 . . . . 0.0 109.988 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HE3' ' OG1' ' A' ' 14' ' ' THR . 2.6 tppp? -60.38 -56.75 17.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -33.21 68.12 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -84.93 -23.93 28.61 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.977 0.353 . . . . 0.0 110.507 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -76.58 -44.15 35.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.48 -19.3 58.15 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.002 -0.436 . . . . 0.0 111.349 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -79.47 -39.94 30.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.588 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.09 76.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.951 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.1 ptp -75.37 -39.45 59.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.658 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -77.2 1.56 18.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.279 0.632 . . . . 0.0 111.702 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.22 -6.35 3.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttm -138.41 -27.07 0.88 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.06 137.65 57.82 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.926 0.784 . . . . 0.0 110.058 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 10.36 86.01 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 119.607 -0.552 . . . . 0.0 112.439 175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.13 30.99 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.076 0.938 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.574 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 43.0 t -75.22 163.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 124.335 1.054 . . . . 0.0 112.176 -171.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.82 10.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.241 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.6 4.75 2.62 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.464 0.705 . . . . 0.0 111.486 -175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.46 -8.49 58.6 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.417 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -172.47 123.18 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.397 1.079 . . . . 0.0 108.643 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.574 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.4 mm-40 -137.9 -47.85 0.55 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 169.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -137.78 153.94 49.63 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 111.753 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.2 mmm180 -148.04 109.34 4.34 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.049 1.739 . . . . 0.0 106.721 167.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.53 134.71 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -168.11 173.03 8.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -76.25 139.94 41.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.168 0.587 . . . . 0.0 110.364 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.57 162.39 29.54 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.499 0.32 . . . . 0.0 110.568 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -144.86 15.25 1.55 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 108.991 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -135.1 166.41 23.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.45 168.28 14.35 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 117.912 0.324 . . . . 0.0 112.923 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 157.86 17.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.101 0.96 . . . . 0.0 111.526 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -33.56 97.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 1 C-N-CA 126.314 4.676 . . . . 0.0 115.924 -176.214 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 72.8 Cg_endo -77.88 -56.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.499 2.133 . . . . 0.0 109.276 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 15.6 t0 -176.45 123.03 0.16 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.566 1.146 . . . . 0.0 109.95 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 C--N 1.333 -0.109 0 C-N-CA 124.334 1.054 . . . . 0.0 110.793 177.517 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.7 m -147.06 170.53 16.96 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.155 0.582 . . . . 0.0 110.448 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -60.07 -43.91 95.1 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.925 0.49 . . . . 0.0 111.335 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.46 -81.55 0.03 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.473 ' HD2' " H1'" ' B' ' 107' ' ' ' U' . 28.1 mtp180 -153.86 69.09 6.32 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 125.342 1.457 . . . . 0.0 110.346 -171.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 118.04 5.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.087 2.525 . . . . 0.0 109.986 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.08 113.8 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.83 3.02 . . . . 0.0 110.894 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -87.83 -167.88 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.928 3.085 . . . . 0.0 109.849 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -137.59 41.71 2.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 109.511 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 17.7 m -52.7 -14.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.941 1.696 . . . . 0.0 113.693 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -88.4 5.23 43.21 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.124 0.569 . . . . 0.0 111.303 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.02 19.82 0.66 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.45 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 5.1 ptt? -139.39 166.61 24.11 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.793 0.796 . . . . 0.0 111.835 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -63.34 -26.54 68.81 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t 44.03 58.85 3.45 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.19 0.996 . . . . 0.0 112.478 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 23.4 tp -63.91 164.4 10.38 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.566 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 20.4 ttpp -137.21 142.08 42.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.339 1.055 . . . . 0.0 109.986 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -135.39 152.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 174.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -153.37 -167.78 2.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.107 1.363 . . . . 0.0 110.542 -174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 82.9 28.29 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.69 1.596 . . . . 0.0 113.309 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.64 126.18 22.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.795 0.838 . . . . 0.0 109.303 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -68.91 168.25 14.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -62.52 3.29 0.21 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -139.14 18.5 2.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.771 0.829 . . . . 0.0 112.078 -174.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -112.38 165.56 12.09 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.895 0.478 . . . . 0.0 110.391 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 82.8 p -149.59 167.06 13.78 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.319 1.048 . . . . 0.0 109.038 -176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.4 Cg_endo -68.98 -26.75 30.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.403 2.069 . . . . 0.0 111.68 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.86 -33.78 74.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.997 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -74.9 -44.38 49.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -58.67 -20.91 52.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.8 -0.562 . . . . 0.0 111.103 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -82.02 -56.62 3.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -62.91 -24.75 67.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.684 0.22 . . . . 0.0 110.481 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.9 t -83.11 -34.96 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.715 0.406 . . . . 0.0 110.644 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CD1' HD13 ' A' ' 30' ' ' LEU . 20.2 m-85 -99.27 -10.96 21.72 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -72.71 -26.61 61.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.634 -0.666 . . . . 0.0 111.441 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.98 -22.93 64.07 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -73.28 -20.89 60.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.844 0.458 . . . . 0.0 111.267 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.05 -88.92 0.1 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -154.23 164.47 38.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.37 0.605 . . . . 0.0 111.733 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.66 133.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.29 -24.43 24.32 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -161.65 152.69 18.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.077 0.465 . . . . 0.0 110.084 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -149.87 103.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 176.026 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -150.18 161.63 42.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.101 -167.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 mt -134.35 132.21 20.89 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.33 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.11 -29.69 32.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.962 2.441 . . . . 0.0 111.325 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 36.92 30.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.257 1.823 . . . . 0.0 114.708 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 51.39 12.31 0.14 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.674 0.79 . . . . 0.0 112.812 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 52.53 -14.18 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.879 2.472 . . . . 0.0 116.064 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -155.47 4.12 0.19 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.686 1.13 . . . . 0.0 113.271 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 -25.6 3.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.846 0.748 . . . . 0.0 112.054 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.1 21.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.962 2.105 . . . . 0.0 115.008 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.95 -11.66 59.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.772 -0.58 . . . . 0.0 112.371 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.5 t -83.56 -78.11 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.048 0.385 . . . . 0.0 110.684 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.66 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.255 2.222 . . . . 0.0 115.894 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.11 -2.64 32.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.79 -0.569 . . . . 0.0 112.559 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -155.71 169.86 23.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.124 0.57 . . . . 0.0 110.097 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.79 103.54 3.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -66.11 92.2 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.695 0.798 . . . . 0.0 108.889 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 30' ' ' LEU . 92.5 t -87.27 155.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.9 ttt180 -138.31 131.84 30.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 123.148 0.28 . . . . 0.0 111.236 -172.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 6.4 m-85 -115.11 170.8 8.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.657 0.265 . . . . 0.0 111.143 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -32.96 2.02 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.42 122.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.04 -54.23 49.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -58.86 -33.18 70.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -85.32 -21.22 29.03 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.983 0.356 . . . . 0.0 110.542 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.85 -42.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.941 0.496 . . . . 0.0 110.22 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -73.84 -25.57 60.14 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.05 -0.407 . . . . 0.0 110.511 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.15 -47.68 34.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.232 0.469 . . . . 0.0 110.393 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -31.53 71.72 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.347 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.8 ttp -74.01 -42.75 59.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.119 0.568 . . . . 0.0 110.452 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.8 2.96 24.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.024 0.13 . . . . 0.0 111.215 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.24 -5.59 4.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttm -137.88 -29.4 0.85 Allowed 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -64.15 140.23 58.85 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.932 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.8 6.98 83.18 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.72 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.8 32.06 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.165 0.983 . . . . 0.0 110.784 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.585 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 23.0 t -73.99 164.61 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.846 0.858 . . . . 0.0 111.569 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.7 5.06 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.9 3.3 1.82 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.145 0.43 . . . . 0.0 112.076 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.63 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.313 0.482 . . . . 0.0 112.632 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -172.44 115.19 0.31 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.268 1.027 . . . . 0.0 109.008 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.585 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 79.6 mm-40 -130.88 -50.45 1.04 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.119 171.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.438 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -140.53 153.54 46.21 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.304 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 22.6 mmt180 -151.79 113.96 4.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 167.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.34 135.79 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-O 121.227 0.536 . . . . 0.0 110.445 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.5 173.05 10.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.423 1.489 . . . . 0.0 108.275 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.51 147.62 50.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.524 0.73 . . . . 0.0 111.102 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.73 150.18 29.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -141.99 21.17 2.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.417 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 3.0 t80 -145.55 143.56 30.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -174.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.15 179.36 21.02 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 117.885 0.312 . . . . 0.0 112.876 -169.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -57.64 148.81 54.95 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.018 0.527 . . . . 0.0 110.981 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.02 135.64 21.37 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.65 2.9 . . . . 0.0 111.089 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.36 -39.9 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.589 2.192 . . . . 0.0 109.379 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.04 136.33 1.46 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.486 1.115 . . . . 0.0 109.503 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.5 m -154.58 11.38 0.38 Allowed 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.062 0.945 . . . . 0.0 110.287 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -136.99 6.97 2.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -146.75 171.88 14.49 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.261 0.624 . . . . 0.0 109.881 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.253 1.251 0 CA-C-O 117.252 -1.356 . . . . 0.0 109.778 -179.53 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . 0.43 " C4'" " H5'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.417 -3.029 1 O4'-C1'-N19 115.736 7.536 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.566 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.161 1 C5'-C4'-C3' 109.148 -4.235 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.417 ' N2 ' ' CD2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.413 -3.293 0 C5'-C4'-C3' 109.761 -3.826 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.014 0 O4'-C1'-N19 112.136 3.936 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.947 0 P-O3'-C3' 124.478 3.981 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.473 " H1'" ' HD2' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.422 -2.618 1 O4'-C1'-N19 112.376 4.176 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.426 0.155 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.1 p -149.86 174.2 12.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.276 0.63 . . . . 0.0 110.706 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -61.35 -45.8 92.89 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.631 0.772 . . . . 0.0 110.843 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.485 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 81.31 -73.38 2.6 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -178.73 52.4 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.07 139.63 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.544 2.163 . . . . 0.0 110.595 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.93 115.37 3.28 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.657 2.905 . . . . 0.0 110.097 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.27 -166.97 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.842 3.028 . . . . 0.0 110.571 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -132.41 28.69 4.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.244 1.018 . . . . 0.0 110.463 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.5 m -53.98 -18.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 124.771 1.228 . . . . 0.0 113.425 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -77.5 4.58 10.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.341 0.656 . . . . 0.0 111.912 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 16.66 0.67 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.017 -0.879 . . . . 0.0 112.324 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.07 166.91 23.37 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 1.206 . . . . 0.0 113.38 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -61.26 -27.67 68.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -167.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.1 m 44.48 38.55 2.67 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.561 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -62.58 132.88 53.86 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.704 -0.623 . . . . 0.0 109.844 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 68.8 tttt -97.68 148.88 22.88 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.524 0.73 . . . . 0.0 112.518 -170.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 60' ' ' VAL . 98.2 t -127.12 147.96 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -155.32 -176.83 6.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.479 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 51.9 t30 84.96 38.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.179 1.392 . . . . 0.0 113.4 171.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.4 138.09 57.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.846 0.859 . . . . 0.0 108.96 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.429 HG22 ' CD1' ' A' ' 23' ' ' TYR . 6.7 m -80.4 166.16 21.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.737 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CD1' HG22 ' A' ' 22' ' ' THR . 52.6 p90 -62.88 6.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.431 1.092 . . . . 0.0 113.373 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 22' ' ' THR . 34.8 ptt180 -135.06 20.34 3.46 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.965 1.306 . . . . 0.0 111.337 -174.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -123.87 165.02 18.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.817 0.447 . . . . 0.0 110.531 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.474 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.8 p -149.4 165.5 17.49 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 124.047 0.939 . . . . 0.0 109.351 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 61.9 Cg_endo -71.15 -25.16 22.66 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.052 1.835 . . . . 0.0 111.868 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.43 -34.19 75.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 121.839 -0.538 . . . . 0.0 109.674 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.5 m -75.63 -43.28 48.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.484 HD11 HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -56.19 -23.48 35.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.623 -0.673 . . . . 0.0 111.093 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -80.61 -55.63 4.71 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -61.29 -28.74 69.4 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.042 0.383 . . . . 0.0 110.645 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -80.48 -33.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 122.94 0.496 . . . . 0.0 111.542 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 30' ' ' LEU . 28.7 m-85 -103.07 -9.27 19.87 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.44 -24.32 57.03 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.733 -0.604 . . . . 0.0 111.016 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.91 -22.55 63.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.249 0.477 . . . . 0.0 112.169 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.26 -17.49 61.89 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 122.342 0.257 . . . . 0.0 111.123 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.2 -76.38 0.17 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -164.14 162.49 22.86 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.547 0.739 . . . . 0.0 110.445 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -136.42 144.16 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.23 -24.48 19.16 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -162.36 149.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 117.085 0.443 . . . . 0.0 111.062 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 60' ' ' VAL . 87.0 t -139.26 113.59 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -146.4 160.47 42.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.2 92.1 40.08 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.651 0.38 . . . . 0.0 110.85 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -49.14 135.06 30.6 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 124.049 3.166 . . . . 0.0 111.147 173.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -164.78 164.68 21.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.09 117.48 10.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.4 ' HD2' " H1'" ' B' ' 105' ' ' ' A' . 9.0 ptm180 -67.48 16.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -169.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.458 ' CD2' HG23 ' A' ' 51' ' ' THR . 10.2 p90 -146.89 -3.05 0.6 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.692 1.197 . . . . 0.0 112.001 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.458 HG23 ' CD2' ' A' ' 50' ' ' TYR . 44.6 p -123.68 -24.72 4.45 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.72 0.691 . . . . 0.0 110.371 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptt 49.88 26.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.979 1.712 . . . . 0.0 113.119 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.66 5.88 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.9 m 58.92 -178.18 0.08 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -141.62 0.09 1.42 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.55 16.97 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.887 0.767 . . . . 0.0 113.432 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.403 ' CE2' " H5'" ' B' ' 103' ' ' ' G' . 49.1 p90 -153.91 169.63 22.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.321 1.06 . . . . 0.0 110.026 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.0 96.69 3.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.444 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 21.6 t80 -63.04 115.94 4.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.507 HG12 HG13 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -116.99 163.16 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -139.06 125.58 20.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.826 0.704 . . . . 0.0 110.587 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 21.8 m-85 -96.34 158.62 15.35 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.561 0.744 . . . . 0.0 109.936 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.56 -30.98 6.35 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.653 0.595 . . . . 0.0 112.348 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.77 119.39 21.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -61.49 -45.13 95.51 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.341 0.257 . . . . 0.0 110.644 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.502 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -67.13 -28.96 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -90.96 -13.34 33.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.561 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.97 -42.78 25.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -77.42 -25.24 50.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.614 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.33 -47.11 36.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.646 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.87 73.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.4 ttp -73.3 -42.16 62.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.781 0.432 . . . . 0.0 110.369 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.02 3.21 27.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.263 -0.273 . . . . 0.0 111.558 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.53 -6.52 4.68 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.8 ttm -139.45 -26.54 0.81 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.14 134.72 56.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.396 0.998 . . . . 0.0 110.755 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 8.67 85.68 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.128 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.41 33.4 0.35 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.19 0.995 . . . . 0.0 111.098 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.591 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 46.1 t -69.42 164.52 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.012 0.925 . . . . 0.0 112.209 -173.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.404 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -157.97 9.95 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.68 -178.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -149.88 4.4 0.56 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.107 0.867 . . . . 0.0 113.249 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.55 -20.35 4.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.852 -0.53 . . . . 0.0 111.974 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.511 ' C ' HG13 ' A' ' 79' ' ' VAL . 6.2 ptp180 -175.23 143.65 0.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.112 1.765 . . . . 0.0 106.651 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.591 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.2 mm-40 -141.59 -47.62 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.643 169.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.482 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.92 159.29 42.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.79 0.805 . . . . 0.0 112.124 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 10.1 mmm180 -152.33 114.34 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 16' ' ' LEU . 21.3 t -136.88 127.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -167.46 165.17 14.94 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.86 142.21 58.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.366 -172.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.65 167.81 6.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.133 0.573 . . . . 0.0 111.524 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -139.39 -8.19 1.3 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 123.346 0.658 . . . . 0.0 110.993 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.487 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 4.6 m-85 -140.25 173.61 11.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -116.79 175.61 15.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 117.719 0.236 . . . . 0.0 112.834 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -60.36 142.21 90.65 Favored Pre-proline 0 C--O 1.233 0.19 0 C-N-CA 123.737 0.815 . . . . 0.0 110.136 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.455 ' CG ' H5'' ' B' ' 105' ' ' ' A' . 76.7 Cg_exo -51.05 130.41 31.63 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.321 2.681 . . . . 0.0 113.403 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.66 -25.31 9.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.761 2.307 . . . . 0.0 109.324 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -159.31 161.61 35.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.127 1.371 . . . . 0.0 107.679 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p -71.45 89.41 0.94 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.6 t60 51.46 24.36 2.18 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.471 1.108 . . . . 0.0 112.348 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 50.83 28.83 3.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.933 0.893 . . . . 0.0 112.477 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.253 1.245 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.606 -179.192 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.945 1 O4'-C1'-N19 115.752 7.552 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.484 " H4'" ' OP1' ' B' ' 104' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.407 -3.87 0 C1'-O4'-C4' 106.63 -3.3 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.487 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.562 1 P-O3'-C3' 125.953 5.211 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.455 H5'' ' CG ' ' A' ' 95' ' ' PRO . . . . . . . . 0 O4'--C4' 1.416 -3.071 1 P-O3'-C3' 125.271 4.642 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 0 P-O3'-C3' 124.472 3.977 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.485 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.781 0 O4'-C1'-N19 111.724 3.524 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.9 p -153.88 -174.03 4.8 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.066 0.546 . . . . 0.0 110.21 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -57.81 -30.17 65.5 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.893 0.477 . . . . 0.0 110.965 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.77 45.42 27.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.534 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 38.94 50.39 2.63 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.161 1.384 . . . . 0.0 114.36 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.01 149.28 52.61 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.209 2.606 . . . . 0.0 110.89 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.93 123.84 8.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.254 2.636 . . . . 0.0 110.499 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -81.85 -165.98 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.813 3.009 . . . . 0.0 110.367 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.69 30.17 4.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.922 0.889 . . . . 0.0 109.691 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 33.7 m -57.06 -12.23 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.607 1.163 . . . . 0.0 112.646 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.83 -0.04 8.22 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.919 0.887 . . . . 0.0 112.388 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.93 32.29 0.18 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.889 -0.951 . . . . 0.0 113.472 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.1 ptt? -142.89 164.86 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.546 1.173 . . . . 0.0 111.675 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -60.63 -28.01 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -170.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m 43.24 59.25 3.03 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 16.3 tp -66.42 169.58 7.24 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 13.9 pttt -139.09 155.58 47.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.402 0.546 . . . . 0.0 111.05 171.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 60' ' ' VAL . 57.2 t -134.15 145.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -150.06 -174.59 4.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.48 1.112 . . . . 0.0 109.815 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 83' ' ' ARG . 8.0 t30 92.52 29.88 0.01 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.221 1.409 . . . . 0.0 112.968 169.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.92 117.74 3.19 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.538 1.135 . . . . 0.0 109.802 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 23' ' ' TYR . 3.0 m -67.44 171.09 6.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' H ' HG22 ' A' ' 22' ' ' THR . 48.9 p90 -62.84 3.09 0.25 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.094 0.958 . . . . 0.0 113.01 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ptt-85 -134.26 14.28 3.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.388 0.675 . . . . 0.0 111.85 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -113.34 165.51 12.36 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.3 p -150.89 167.94 11.98 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.57 1.148 . . . . 0.0 108.839 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 62.4 Cg_endo -69.52 -35.02 14.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.264 1.976 . . . . 0.0 110.721 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -61.51 -36.07 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.117 0.484 . . . . 0.0 109.886 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -71.79 -44.23 64.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.506 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -54.65 -23.88 19.18 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.227 -0.296 . . . . 0.0 111.585 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -78.77 -56.56 4.31 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -65.29 -20.38 66.39 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.778 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.75 -32.1 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.636 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -106.16 -7.92 17.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.982 0.513 . . . . 0.0 112.277 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.47 -26.14 55.04 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.217 0.462 . . . . 0.0 111.155 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -67.64 -23.69 65.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.223 0.465 . . . . 0.0 112.244 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.89 -17.76 61.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.667 0.387 . . . . 0.0 111.526 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.84 -82.26 0.11 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.78 163.09 37.05 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.159 0.584 . . . . 0.0 110.789 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -135.3 140.25 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.59 -21.5 21.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' CG ' ' H1 ' ' B' ' 106' ' ' ' G' . 37.8 t0 -161.86 155.86 21.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.703 0.752 . . . . 0.0 111.713 177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 60' ' ' VAL . 61.1 t -147.46 125.34 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 46' ' ' PRO . 1.6 t80 -157.48 152.66 25.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.53 71.2 52.33 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 20.4 Cg_endo -93.29 -6.45 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.616 1 C-N-CA 126.48 4.787 . . . . 0.0 117.979 -167.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -48.86 -36.43 16.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.366 1.439 . . . . 0.0 111.97 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -144.17 101.51 3.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 168.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.494 ' HD3' " H1'" ' B' ' 105' ' ' ' A' . 13.0 ptt180 -62.12 8.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.717 1.607 . . . . 0.0 114.908 -169.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.507 ' CD1' HG23 ' A' ' 51' ' ' THR . 18.6 p90 -150.84 6.09 0.51 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.33 1.052 . . . . 0.0 112.279 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.507 HG23 ' CD1' ' A' ' 50' ' ' TYR . 11.5 p -130.57 -29.02 2.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.866 0.757 . . . . 0.0 111.72 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.93 23.87 0.31 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.466 1.506 . . . . 0.0 113.029 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.65 11.18 0.2 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -131.92 25.47 4.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.472 0.709 . . . . 0.0 110.207 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 8.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.995 1.718 . . . . 0.0 114.831 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.38 -3.46 2.95 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.492 0.587 . . . . 0.0 111.768 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -152.88 168.04 27.09 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.407 1.083 . . . . 0.0 109.082 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.32 97.23 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 39.0 t80 -61.3 109.92 1.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.1 m -107.27 170.03 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.4 ptm180 -144.53 145.65 31.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.764 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 23.2 m-85 -112.73 166.71 11.11 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.068 0.547 . . . . 0.0 109.926 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.455 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.87 -30.91 2.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.698 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.07 125.4 30.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -61.21 -54.2 47.24 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.401 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -58.92 -32.14 69.29 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -86.76 -18.19 31.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.952 0.342 . . . . 0.0 110.762 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.36 -43.96 16.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 122.709 0.404 . . . . 0.0 110.147 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -73.25 -26.62 61.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.267 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -73.82 -46.47 44.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.322 0.51 . . . . 0.0 110.717 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.97 72.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.5 ttp -75.07 -40.98 59.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.105 0.562 . . . . 0.0 110.347 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.9 2.99 31.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.065 0.146 . . . . 0.0 111.279 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.83 -5.83 4.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.2 ttm -137.42 -28.95 0.9 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.445 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.1 t70 -64.51 137.86 58.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 120.161 1.346 . . . . 0.0 110.007 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.73 16.42 79.21 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.729 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.85 29.46 1.02 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.115 0.958 . . . . 0.0 110.371 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.487 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 41.2 t -72.66 170.47 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.168 1.387 . . . . 0.0 112.486 -170.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.44 ' N ' HG12 ' A' ' 79' ' ' VAL . 1.1 pt? -153.82 3.32 0.27 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -139.69 2.08 1.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.75 -20.02 4.38 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.241 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -177.77 135.22 0.17 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.995 1.318 . . . . 0.0 108.074 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.487 ' HG3' ' HA ' ' A' ' 79' ' ' VAL . 9.6 mt-10 -140.85 -37.56 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.019 171.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -144.4 149.98 36.98 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.703 0.401 . . . . 0.0 111.872 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.4 mmt180 -151.79 106.56 3.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.623 1.569 . . . . 0.0 106.879 166.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -133.87 126.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 CA-C-O 121.226 0.536 . . . . 0.0 110.495 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -156.59 175.29 14.24 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 125.67 1.588 . . . . 0.0 108.923 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.99 145.83 53.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.034 0.934 . . . . 0.0 110.389 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.44 170.34 16.3 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.966 0.506 . . . . 0.0 111.652 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -147.07 3.23 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.167 0.587 . . . . 0.0 110.985 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.595 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 19.6 m-85 -131.73 175.17 9.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.314 0.646 . . . . 0.0 109.579 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.0 177.2 16.48 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 121.507 0.504 . . . . 0.0 114.176 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -62.43 160.14 35.8 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.427 1.491 . . . . 0.0 112.634 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -34.05 103.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 126.527 4.818 . . . . 0.0 116.637 178.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.46 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 75.5 Cg_endo -81.12 -60.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.91 2.406 . . . . 0.0 109.433 169.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.46 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 12.8 t0 -179.1 131.14 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.317 1.447 . . . . 0.0 109.882 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.2 m -158.1 12.98 0.2 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.297 1.439 . . . . 0.0 110.008 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -143.79 10.03 1.56 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -166.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -148.03 171.4 15.89 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.729 0.412 . . . . 0.0 110.345 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.253 1.267 0 CA-C-O 117.604 -1.188 . . . . 0.0 110.137 -178.493 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.853 0 O4'-C1'-N19 111.714 3.514 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.406 2 O4'-C1'-N19 112.506 4.306 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.595 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 O4'-C1'-N19 111.56 3.36 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.494 " H1'" ' HD3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C3'-C2'-C1' 104.726 3.584 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.422 ' H1 ' ' CG ' ' A' ' 42' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.701 1 P-O3'-C3' 125.376 4.73 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.403 H5'' " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.417 -2.982 0 O4'-C1'-N19 111.449 3.249 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 ttp . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.6 m 51.18 -177.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.832 1.253 . . . . 0.0 113.579 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -69.71 -31.61 69.73 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.929 -0.482 . . . . 0.0 110.472 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.24 36.16 21.71 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.985 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.89 57.25 0.94 Allowed Pre-proline 0 N--CA 1.465 0.284 0 C-N-CA 125.51 1.524 . . . . 0.0 113.146 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.52 147.73 77.41 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.23 2.62 . . . . 0.0 109.668 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 114.97 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.562 2.841 . . . . 0.0 110.649 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.47 -162.65 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.42 3.414 . . . . 0.0 110.182 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -134.51 33.06 3.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.23 0.612 . . . . 0.0 111.14 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 m -64.5 6.13 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.187 1.395 . . . . 0.0 113.373 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.71 2.9 0.86 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.973 0.909 . . . . 0.0 113.194 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.9 -8.88 0.04 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.507 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -65.64 169.69 5.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.592 1.196 . . . . 0.0 111.866 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -58.67 -26.37 63.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m 43.72 37.09 1.46 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.4 tm? -63.75 136.03 57.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.42 155.34 46.57 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -171.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.35 158.03 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.297 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -154.78 -173.74 4.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.167 0.987 . . . . 0.0 110.777 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.612 HD21 ' HB2' ' A' ' 83' ' ' ARG . 20.3 t30 96.81 27.94 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.744 1.617 . . . . 0.0 113.077 168.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 117.58 4.37 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.494 1.117 . . . . 0.0 109.778 -175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -70.8 166.89 20.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -62.95 10.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.964 1.306 . . . . 0.0 113.907 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -130.04 17.8 5.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.893 0.877 . . . . 0.0 111.618 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 26' ' ' SER . 1.3 m -126.82 170.32 12.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 -173.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 25' ' ' THR . 94.4 p -152.7 163.74 22.56 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.253 1.021 . . . . 0.0 109.296 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.8 -28.08 25.49 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.506 2.137 . . . . 0.0 111.717 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.57 -33.03 74.2 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.95 -0.469 . . . . 0.0 109.822 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.0 m -75.51 -46.48 32.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -56.94 -19.8 20.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -55.78 5.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -62.74 -31.27 72.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.188 0.995 . . . . 0.0 110.968 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.01 -32.71 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.442 0.297 . . . . 0.0 111.619 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.0 m-85 -98.67 -11.23 22.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.977 0.353 . . . . 0.0 111.941 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.55 -27.74 62.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.689 -0.632 . . . . 0.0 111.679 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.35 -22.54 65.58 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -73.78 -18.67 60.94 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.72 0.408 . . . . 0.0 111.129 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.88 -79.37 0.1 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -158.62 165.06 35.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 110.398 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -133.88 138.7 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.98 -26.61 7.4 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -163.08 161.35 25.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.916 0.358 . . . . 0.0 110.33 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' CG2' HG22 ' A' ' 60' ' ' VAL . 1.5 p -168.73 110.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.25 176.13 13.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.543 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mt -125.2 85.87 57.63 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.13 -23.71 17.83 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.449 3.433 . . . . 0.0 113.281 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 2.1 tpp180 -64.01 115.77 5.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 41.58 69.22 0.37 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 110.222 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -54.6 5.55 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.045 2.138 . . . . 0.0 116.61 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -143.54 7.41 1.5 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.514 1.125 . . . . 0.0 110.81 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -124.76 -38.23 2.39 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.02 24.7 0.13 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.228 2.211 . . . . 0.0 113.142 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -65.02 -21.2 66.81 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -76.93 -49.7 14.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.573 0.349 . . . . 0.0 110.824 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 37.07 31.64 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.627 1.971 . . . . 0.0 114.783 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.34 -10.47 74.68 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.59 -0.694 . . . . 0.0 112.016 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -163.13 169.11 19.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.603 0.701 . . . . 0.0 111.084 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 102.63 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE2' ' C5 ' ' B' ' 104' ' ' ' G' . 68.0 t80 -67.92 94.78 0.49 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 -175.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG21 HD12 ' A' ' 30' ' ' LEU . 59.4 t -81.35 160.74 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -143.84 134.94 25.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.043 0.537 . . . . 0.0 109.987 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -117.28 148.27 41.83 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.484 1.113 . . . . 0.0 109.836 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 -27.21 13.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -173.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.66 134.2 55.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 110.458 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.66 -45.6 93.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.745 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -33.77 76.56 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.98 0.809 . . . . 0.0 111.969 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.7 -24.71 36.03 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.68 -47.29 19.55 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.072 0.949 . . . . 0.0 110.839 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.09 -27.29 60.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.79 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -70.97 -40.46 71.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.278 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.39 73.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.024 -0.422 . . . . 0.0 111.333 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.5 ptp -78.8 -37.61 40.36 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.509 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -77.12 -0.73 25.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.23 0.612 . . . . 0.0 111.743 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.87 -4.99 4.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.7 ttm -138.02 -25.57 0.97 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.7 t70 -63.52 138.31 58.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 118.398 -1.321 . . . . 0.0 110.005 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.76 14.96 77.98 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.914 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.08 36.71 0.52 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.041 0.921 . . . . 0.0 110.257 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.636 HG22 ' H ' ' A' ' 80' ' ' LEU . 6.2 p -72.12 176.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -169.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.636 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.1 pt? -151.78 -1.22 0.32 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.723 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.541 ' H ' HG22 ' A' ' 79' ' ' VAL . 37.3 t70 -144.45 -0.77 0.95 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.45 -19.09 6.0 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.612 ' HB2' HD21 ' A' ' 20' ' ' ASN . 0.1 OUTLIER -165.96 136.04 3.43 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' N ' HG23 ' A' ' 79' ' ' VAL . 19.7 mm-40 -144.79 -41.82 0.24 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.89 150.29 44.41 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.834 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -152.27 108.11 3.35 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 126.121 1.769 . . . . 0.0 106.659 168.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -134.96 134.77 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.238 0.542 . . . . 0.0 111.284 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 89' ' ' MET . 31.4 tt0 -166.26 168.02 15.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.322 1.449 . . . . 0.0 108.11 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.428 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 11.6 mmt -61.28 142.31 56.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.176 0.99 . . . . 0.0 110.773 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 155.52 38.15 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.889 0.476 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -140.11 9.81 2.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.499 0.72 . . . . 0.0 109.608 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.652 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 20.2 m-85 -131.43 169.18 16.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.015 0.926 . . . . 0.0 109.335 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.3 -177.64 14.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -56.02 145.0 56.57 Favored Pre-proline 0 C--O 1.233 0.194 0 C-N-CA 123.271 0.629 . . . . 0.0 110.501 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.409 ' CG ' H5'' ' B' ' 105' ' ' ' A' . 61.0 Cg_endo -70.01 145.75 56.63 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.44 2.76 . . . . 0.0 112.276 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.0 -23.39 4.58 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.451 3.434 . . . . 0.0 112.198 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -149.96 164.53 35.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.601 1.16 . . . . 0.0 108.965 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.9 p -76.21 -35.32 59.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -167.01 11.22 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.962 0.801 . . . . 0.0 113.157 -174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -141.9 172.9 12.05 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.919 -0.488 . . . . 0.0 111.009 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 117.0 -1.476 . . . . 0.0 110.194 -178.252 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.269 1 O4'-C1'-N19 114.758 6.558 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.409 ' C5 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.41 -3.576 2 C1'-O4'-C4' 104.914 -5.207 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.652 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.76 1 N19-C1'-C2' 106.869 -4.082 OUTLIER-EPSILON 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.459 ' OP1' " H4'" ' B' ' 104' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.19 1 P-O3'-C3' 125.692 4.993 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 2 C5'-C4'-C3' 105.931 -6.379 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.883 0 O4'-C1'-N19 111.196 2.996 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p -59.75 142.84 52.42 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.625 0.37 . . . . 0.0 110.873 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 47.16 18.73 0.09 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.993 1.317 . . . . 0.0 113.556 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.97 92.51 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.8 ptm85 -168.91 42.87 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.527 1.163 . . . . 0.0 113.539 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 69.2 Cg_endo -68.99 136.11 34.12 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.52 1.48 . . . . 0.0 108.93 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.64 116.29 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.846 3.031 . . . . 0.0 110.98 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.61 -162.05 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.912 3.075 . . . . 0.0 110.142 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.67 30.5 2.85 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.489 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 31.2 m -63.48 -7.05 2.6 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 C-N-CA 123.881 0.872 . . . . 0.0 112.624 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.51 0.26 15.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.75 0.82 . . . . 0.0 112.812 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.25 51.43 0.13 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.252 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.489 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 11.7 ptp -132.39 173.8 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.821 0.811 . . . . 0.0 112.957 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -70.21 -22.5 62.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.173 0.989 . . . . 0.0 112.066 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 m 42.09 59.85 2.47 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.442 1.097 . . . . 0.0 113.618 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 22.5 tp -61.66 162.22 8.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.579 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 17.2 pttp -132.1 151.4 51.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.107 0.412 . . . . 0.0 110.655 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.17 143.04 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -149.31 -177.85 6.07 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 124.187 0.93 . . . . 0.0 110.413 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 t30 91.12 26.21 0.02 OUTLIER 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.158 1.383 . . . . 0.0 113.38 169.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.17 121.5 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.985 0.914 . . . . 0.0 109.682 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 24' ' ' ARG . 13.4 m -67.75 167.75 12.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -63.61 8.99 0.07 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.657 1.183 . . . . 0.0 113.471 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' THR . 29.6 ptt180 -133.58 16.44 3.99 Favored 'General case' 0 C--N 1.335 -0.041 0 C-N-CA 123.858 0.863 . . . . 0.0 111.818 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -124.05 165.63 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.459 0.303 . . . . 0.0 111.246 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 59.5 p -151.68 168.57 10.92 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.706 1.202 . . . . 0.0 109.256 -175.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 56.7 Cg_endo -68.94 -27.57 30.31 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.319 2.013 . . . . 0.0 111.713 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.85 -30.62 68.15 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.478 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 97.0 m -75.1 -45.08 43.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -59.02 -19.14 40.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.905 -0.497 . . . . 0.0 110.935 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -81.48 -56.63 3.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.385 0.539 . . . . 0.0 110.604 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.478 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -69.91 -15.46 63.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.276 -175.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.84 -30.93 4.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 123.419 0.688 . . . . 0.0 111.363 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.1 m-85 -103.12 -9.94 19.27 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.438 0.563 . . . . 0.0 112.288 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.97 -26.43 62.26 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.751 -0.593 . . . . 0.0 111.187 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.78 -24.14 64.38 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.68 -17.01 61.68 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.47 -80.43 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -162.53 167.24 23.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.023 0.529 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -133.09 138.95 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.19 -25.27 14.56 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -162.74 154.19 17.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.883 0.473 . . . . 0.0 110.17 174.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 60' ' ' VAL . 1.4 p -150.33 107.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -151.36 162.25 41.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.513 -166.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.76 126.43 15.74 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.48 42.46 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.702 3.601 . . . . 0.0 110.413 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -44.42 -44.8 8.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.928 1.291 . . . . 0.0 111.561 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -178.34 165.02 1.78 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.36 1.464 . . . . 0.0 108.898 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.467 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 0.2 OUTLIER -134.79 -5.66 2.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.633 169.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -168.3 14.93 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.564 1.146 . . . . 0.0 111.717 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 p -129.45 -14.58 4.18 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -168.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 43.14 24.1 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.608 1.563 . . . . 0.0 113.772 -172.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.63 -155.95 0.08 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.081 0.952 . . . . 0.0 110.358 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 m -156.09 169.59 24.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.224 1.41 . . . . 0.0 109.615 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 27.2 mmt180 -130.03 -172.42 2.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.932 0.893 . . . . 0.0 108.897 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.57 29.61 5.83 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.264 0.935 . . . . 0.0 112.406 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 55' ' ' ARG . 38.0 p90 -153.63 170.95 19.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.479 0.712 . . . . 0.0 109.576 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.89 101.78 3.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -67.22 91.74 0.25 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.444 0.698 . . . . 0.0 109.387 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.527 HG21 HD12 ' A' ' 30' ' ' LEU . 48.6 t -81.53 159.35 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 172.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.1 ttt180 -140.24 131.74 27.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.688 0.395 . . . . 0.0 110.421 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.5 m-85 -113.58 157.92 21.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.057 0.39 . . . . 0.0 111.647 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 -34.6 5.62 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.1 128.05 33.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -64.56 -50.53 66.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.396 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -29.54 68.81 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.55 -20.72 31.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.5 49.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -77.36 -19.99 55.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.493 -0.13 . . . . 0.0 111.271 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.78 -41.58 44.09 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.199 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.4 75.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.161 -0.337 . . . . 0.0 111.395 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.0 ptp -75.52 -41.33 55.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.766 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -75.51 1.29 14.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.572 0.749 . . . . 0.0 111.705 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -5.96 3.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.3 ttm -141.23 -25.82 0.72 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -62.57 137.97 58.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.708 1.14 . . . . 0.0 111.101 -177.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.92 9.18 75.2 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.373 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.42 29.34 0.51 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.683 HG12 ' N ' ' A' ' 84' ' ' GLU . 4.9 m -66.48 175.29 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 126.345 1.858 . . . . 0.0 113.847 -172.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.93 -1.3 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -143.49 4.3 1.36 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.433 0.56 . . . . 0.0 112.08 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.92 -27.4 3.33 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -157.36 160.08 38.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.178 0.489 . . . . 0.0 110.027 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.683 ' N ' HG12 ' A' ' 79' ' ' VAL . 16.4 mt-10 -160.62 -43.91 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.628 1.171 . . . . 0.0 109.68 165.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.46 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.2 mm? -139.47 153.84 47.61 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.9 mmt180 -153.76 107.21 2.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.256 1.822 . . . . 0.0 106.183 166.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.6 p -134.23 127.83 51.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 123.029 0.532 . . . . 0.0 110.134 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -156.74 -175.01 5.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.489 1.916 . . . . 0.0 108.112 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.2 mmt -82.84 142.27 31.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.13 155.66 40.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.374 0.269 . . . . 0.0 111.249 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -137.93 9.17 2.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.416 1.087 . . . . 0.0 110.488 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.601 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 22.8 m-85 -130.2 175.63 8.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 109.678 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.68 175.78 17.82 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 117.943 0.338 . . . . 0.0 113.054 -173.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -61.73 156.41 55.33 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.109 0.964 . . . . 0.0 111.399 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -27.49 95.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 1 C-N-CA 126.413 4.742 . . . . 0.0 117.292 -176.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.72 -26.07 1.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.56 2.84 . . . . 0.0 110.083 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -158.13 -177.63 6.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.772 1.629 . . . . 0.0 107.273 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.452 ' O ' ' C8 ' ' B' ' 105' ' ' ' A' . 22.9 m -67.47 -31.22 71.23 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -169.65 17.56 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.689 1.131 . . . . 0.0 112.587 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -144.65 170.96 15.08 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.812 0.278 . . . . 0.0 110.994 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.182 -1.389 . . . . 0.0 110.056 -177.898 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.426 2 O4'-C1'-N19 115.342 7.142 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.579 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.41 -3.568 2 O4'-C1'-N19 113.677 5.477 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.601 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.783 0 N19-C1'-C2' 107.103 -3.936 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.467 " H1'" ' HB3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.417 -2.978 1 O4'-C1'-N19 112.53 4.33 . 0.01 1z . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.504 0 C4'-C3'-C2' 99.564 -3.136 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 C5'-C4'-C3' 110.759 -3.16 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -145.62 126.75 14.7 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 60.18 -27.91 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.732 2.013 . . . . 0.0 115.433 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.447 ' CA ' " H4'" ' B' ' 107' ' ' ' U' . . . 83.86 -80.22 1.84 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 170.87 68.6 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.573 1.149 . . . . 0.0 111.5 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.15 167.23 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.397 2.731 . . . . 0.0 111.216 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -98.15 71.83 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.637 1 C-N-CA 125.491 4.127 . . . . 0.0 112.945 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.72 -166.32 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.984 3.123 . . . . 0.0 110.294 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -131.57 34.16 3.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.442 0.697 . . . . 0.0 109.819 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.31 -11.98 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.021 0.928 . . . . 0.0 112.04 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.71 -6.57 47.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.774 0.83 . . . . 0.0 111.909 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.79 -8.16 0.07 OUTLIER Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.546 -0.585 . . . . 0.0 114.053 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.8 mtp -60.68 162.25 6.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.569 1.185 . . . . 0.0 111.013 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -60.34 -23.72 64.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.336 0.254 . . . . 0.0 110.659 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 t 42.92 55.36 4.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.536 1.134 . . . . 0.0 112.859 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 19.3 tp -61.39 159.04 13.3 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -143.98 140.4 29.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.517 0.599 . . . . 0.0 110.75 175.212 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 60' ' ' VAL . 4.9 p -134.12 149.89 30.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 123.002 0.521 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -151.41 -170.12 3.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.902 1.281 . . . . 0.0 109.868 -176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 87.73 26.76 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.918 1.287 . . . . 0.0 112.125 172.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.21 127.39 21.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.534 1.134 . . . . 0.0 109.412 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 23' ' ' TYR . 7.1 m -76.22 169.54 18.02 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.295 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.455 ' H ' HG22 ' A' ' 22' ' ' THR . 53.6 p90 -63.13 5.74 0.14 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.921 1.288 . . . . 0.0 114.009 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -133.53 14.25 4.09 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.693 0.679 . . . . 0.0 112.013 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 26' ' ' SER . 3.2 m -114.87 165.82 12.43 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.92 0.391 . . . . 0.0 110.919 -173.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 86.7 p -150.42 167.16 13.54 Favored Pre-proline 0 CA--C 1.529 0.139 0 C-N-CA 124.219 1.008 . . . . 0.0 109.63 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.2 Cg_endo -69.78 -34.25 14.9 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.684 2.256 . . . . 0.0 110.274 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.21 -36.17 83.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -72.78 -43.95 62.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -57.12 -21.56 33.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.272 -0.267 . . . . 0.0 110.833 -178.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -80.42 -56.66 4.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -7.97 41.74 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -97.67 -31.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.776 0.43 . . . . 0.0 111.644 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.5 m-85 -101.11 -12.1 19.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.507 0.594 . . . . 0.0 111.874 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.84 -24.17 59.73 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.901 -0.499 . . . . 0.0 111.242 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.61 -23.73 64.49 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.786 -0.571 . . . . 0.0 112.077 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -75.27 -17.64 60.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.468 0.307 . . . . 0.0 111.391 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.53 -85.83 0.09 OUTLIER Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -157.32 162.4 39.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.067 0.547 . . . . 0.0 110.342 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.9 t -134.43 142.05 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.92 -46.82 12.71 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.18 171.85 4.0 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.318 0.58 . . . . 0.0 110.661 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG12 HG22 ' A' ' 60' ' ' VAL . 14.4 m -124.97 143.62 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 172.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -152.18 150.71 30.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.742 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mt -139.59 76.01 30.94 Favored Pre-proline 0 CA--C 1.528 0.131 0 C-N-CA 123.317 0.647 . . . . 0.0 109.946 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 95.4 Cg_endo -77.25 178.21 7.92 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 124.529 3.486 . . . . 0.0 111.798 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 46' ' ' PRO . 28.7 tpt180 129.52 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 129.175 2.99 . . . . 0.0 108.281 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 50' ' ' TYR . 20.2 m-20 -147.58 87.42 1.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 174.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.54 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 13.7 ptt180 -63.96 14.3 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.54 1.536 . . . . 0.0 114.862 -170.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.525 ' CD1' HG23 ' A' ' 51' ' ' THR . 11.5 p90 -145.25 5.14 1.09 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.295 1.438 . . . . 0.0 110.822 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.525 HG23 ' CD1' ' A' ' 50' ' ' TYR . 7.0 p -133.38 -33.71 1.1 Allowed 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.135 -0.353 . . . . 0.0 111.154 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 34.29 33.49 0.01 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.956 2.102 . . . . 0.0 113.553 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -6.59 45.73 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.9 t -67.42 162.94 21.94 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.225 0.466 . . . . 0.0 110.849 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -155.26 7.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.3 -12.59 81.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.29 169.46 23.14 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.682 0.793 . . . . 0.0 109.796 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.23 95.65 1.73 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.4 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 63.0 t80 -62.8 97.19 0.1 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 43' ' ' VAL . 37.8 t -99.66 152.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 6.9 ptm180 -137.03 143.76 42.88 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 15.8 m-85 -113.64 160.5 18.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.479 0.712 . . . . 0.0 111.472 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -36.1 5.79 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.71 133.64 34.79 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -66.54 -54.67 21.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.131 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.468 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -59.36 -34.22 72.12 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.452 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -83.11 -20.0 35.67 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.151 0.432 . . . . 0.0 110.872 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -81.99 -44.99 15.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 122.632 0.373 . . . . 0.0 110.162 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.97 -26.37 64.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.237 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.17 -47.49 43.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.068 0.394 . . . . 0.0 111.171 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.06 -31.75 72.96 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 122.004 -0.435 . . . . 0.0 110.499 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttp -74.32 -43.71 55.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.053 0.541 . . . . 0.0 110.423 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -79.73 1.9 24.8 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.91 -5.25 5.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.7 ttm -136.41 -28.69 1.0 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.534 ' HB2' HG12 ' A' ' 87' ' ' VAL . 4.6 t70 -63.89 136.2 57.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.852 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.68 10.69 83.18 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.779 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.17 34.58 0.47 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.945 0.872 . . . . 0.0 109.903 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 81' ' ' ASP . 8.8 p -73.83 174.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.595 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.2 pt? -151.98 3.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.703 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.616 ' H ' HG22 ' A' ' 79' ' ' VAL . 36.3 t70 -142.83 -3.5 0.99 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.35 -10.5 30.99 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.573 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.62 129.02 4.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.139 0.975 . . . . 0.0 108.643 173.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 79' ' ' VAL . 11.3 mm-40 -144.42 -50.25 0.28 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 170.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.4 mm? -138.69 152.98 48.49 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 122.828 0.451 . . . . 0.0 111.666 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -150.38 103.09 3.11 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 166.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 76' ' ' ASP . 4.3 p -131.47 132.99 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.944 0.402 . . . . 0.0 111.145 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -153.21 176.28 12.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.911 1.284 . . . . 0.0 109.595 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.8 mmt -76.7 133.9 39.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.5 0.72 . . . . 0.0 109.069 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.63 149.94 47.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.723 0.297 . . . . 0.0 110.773 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -139.31 18.28 2.58 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.287 1.035 . . . . 0.0 108.917 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.487 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 2.8 t80 -145.33 144.71 30.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -119.79 174.85 15.67 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.739 0.699 . . . . 0.0 114.431 -168.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -61.2 139.53 94.48 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.804 1.242 . . . . 0.0 109.969 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.82 146.78 54.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.848 3.032 . . . . 0.0 112.937 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.81 -24.36 3.42 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.232 3.288 . . . . 0.0 111.545 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -152.36 160.67 43.28 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.526 1.131 . . . . 0.0 109.1 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 p -72.12 -53.33 13.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -164.29 172.64 13.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.258 0.481 . . . . 0.0 111.146 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -153.34 167.29 29.87 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.231 0.612 . . . . 0.0 110.09 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.084 -1.436 . . . . 0.0 109.938 -179.418 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . 0.534 " H4'" " H5'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.104 1 O4'-C1'-N19 112.352 4.152 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.534 " H5'" " H4'" ' B' ' 102' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.413 -3.357 2 C5'-C4'-C3' 107.62 -5.253 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.487 ' N2 ' ' CD2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.941 0 N19-C1'-C2' 108.614 -2.991 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.54 " H1'" ' HB3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.415 -3.132 0 O4'-C1'-N19 111.618 3.418 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.357 0 O4'-C1'-N19 111.72 3.52 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.447 " H4'" ' CA ' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.716 2 C4'-C3'-C2' 97.468 -5.232 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.9 p -150.03 174.51 12.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.106 0.562 . . . . 0.0 111.003 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -59.74 -41.83 91.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.11 0.564 . . . . 0.0 110.818 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.445 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 64.06 -81.94 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 125.268 1.413 . . . . 0.0 109.677 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -152.8 55.98 1.61 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 111.502 -167.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.81 118.42 5.59 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.551 2.167 . . . . 0.0 111.356 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.32 119.08 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.562 2.842 . . . . 0.0 110.883 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -84.38 -166.59 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.16 3.24 . . . . 0.0 110.501 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -134.92 36.86 3.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.181 0.992 . . . . 0.0 110.017 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.33 11.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.638 1.575 . . . . 0.0 114.337 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.96 0.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.24 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -5.14 0.09 OUTLIER Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.168 0.44 . . . . 0.0 113.363 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 7.5 ptt? -62.6 166.74 5.0 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.168 0.984 . . . . 0.0 112.718 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -59.15 -26.59 64.88 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.5 m 42.17 59.19 2.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.204 1.001 . . . . 0.0 113.512 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 22.1 tp -62.72 164.35 7.92 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.536 ' HE2' ' C5 ' ' B' ' 103' ' ' ' G' . 19.0 ttpp -135.72 145.08 46.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.043 0.937 . . . . 0.0 110.74 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.589 ' HB ' HG22 ' A' ' 60' ' ' VAL . 92.4 t -130.31 148.69 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.792 0.837 . . . . 0.0 108.952 173.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -152.26 -169.32 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.7 1.6 . . . . 0.0 110.138 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 83.93 27.37 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.403 1.481 . . . . 0.0 113.51 170.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.2 119.33 4.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.149 0.98 . . . . 0.0 109.93 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 23' ' ' TYR . 19.9 m -70.71 169.87 13.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.476 ' H ' HG22 ' A' ' 22' ' ' THR . 54.7 p90 -62.53 5.22 0.12 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 113.741 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -130.71 14.29 5.38 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.313 0.645 . . . . 0.0 112.018 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 26' ' ' SER . 2.4 m -120.24 164.91 15.54 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.088 -173.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.528 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 97.5 p -149.08 168.01 11.86 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 124.283 1.033 . . . . 0.0 109.38 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.06 -29.66 22.07 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.627 2.218 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.32 -35.0 78.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.6 m -74.1 -44.74 52.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.552 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -56.75 -20.78 23.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.248 -0.282 . . . . 0.0 110.855 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -79.46 -57.34 3.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -14.44 63.0 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.76 -32.25 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.394 0.678 . . . . 0.0 111.502 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 30' ' ' LEU . 23.0 m-85 -103.38 -9.49 19.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.3 -27.45 63.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.241 0.473 . . . . 0.0 110.908 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -68.45 -23.52 64.61 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.97 -16.89 61.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.187 0.195 . . . . 0.0 111.504 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.12 -80.73 0.13 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -160.29 164.84 32.29 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.992 0.517 . . . . 0.0 110.52 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.32 144.81 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -175.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.64 -21.45 7.88 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.38 157.81 28.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.472 0.636 . . . . 0.0 110.095 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.402 HG23 HG12 ' A' ' 60' ' ' VAL . 2.2 p -169.15 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.138 0.975 . . . . 0.0 108.414 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.14 167.54 28.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.5 mm -98.07 103.52 17.95 Favored Pre-proline 0 N--CA 1.456 -0.141 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' CB ' " H4'" ' B' ' 104' ' ' ' G' . 72.6 Cg_endo -72.82 -46.28 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.549 2.166 . . . . 0.0 111.478 -171.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.39 -178.83 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.79 2.436 . . . . 0.0 116.392 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.97 106.84 8.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -54.22 0.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.39 2.276 . . . . 0.0 114.697 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CD2' HG23 ' A' ' 51' ' ' THR . 40.6 p90 -137.71 0.57 2.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.835 0.743 . . . . 0.0 112.309 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.465 HG23 ' CD2' ' A' ' 50' ' ' TYR . 28.7 p -127.05 -19.51 4.37 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.677 0.672 . . . . 0.0 111.216 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.404 1.881 . . . . 0.0 113.983 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -125.7 7.2 7.49 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -72.49 -6.73 45.83 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -40.24 141.71 0.46 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.773 1.629 . . . . 0.0 112.426 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.14 -3.56 0.91 Allowed Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.933 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -155.03 166.92 32.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.898 0.879 . . . . 0.0 109.573 174.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 106.76 4.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -70.21 110.85 5.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.589 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -113.04 164.68 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.3 ttt180 -142.87 139.74 30.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 11.0 m-85 -116.92 164.97 13.89 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.564 0.54 . . . . 0.0 110.717 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.436 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -123.48 -31.57 3.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.232 0.613 . . . . 0.0 112.462 -177.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.54 125.32 30.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.1 -52.32 64.36 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.433 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -60.11 -33.61 72.36 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -84.02 -19.73 33.98 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.53 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.04 -42.86 18.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.89 -26.59 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.816 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.11 -40.33 62.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.313 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -33.41 75.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.232 -0.292 . . . . 0.0 111.592 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.0 ptp -78.06 -37.48 46.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.08 1.74 23.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.141 0.576 . . . . 0.0 111.807 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.33 -6.86 4.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.0 ttm -138.89 -26.71 0.85 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.93 136.16 55.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.229 0.922 . . . . 0.0 110.181 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.97 9.9 86.61 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.162 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.67 32.61 0.42 Allowed 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.309 1.055 . . . . 0.0 110.263 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.527 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 38.7 t -74.62 164.49 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.367 1.067 . . . . 0.0 112.094 -170.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -154.96 10.53 0.34 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.472 0.709 . . . . 0.0 112.217 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.35 5.09 2.24 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.87 0.468 . . . . 0.0 111.507 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.54 -9.84 57.44 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.93 124.92 0.55 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.694 1.198 . . . . 0.0 108.131 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.527 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 29.3 mm-40 -137.97 -48.89 0.56 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.249 0.22 . . . . 0.0 110.451 169.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -136.78 156.44 48.51 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 121.419 0.628 . . . . 0.0 112.296 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.0 mmm180 -148.05 109.08 4.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.955 1.702 . . . . 0.0 106.577 167.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.22 134.23 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -169.58 173.86 6.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.0 mmt -75.64 136.61 40.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.166 0.586 . . . . 0.0 109.909 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.49 151.58 45.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -140.52 21.4 2.37 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.662 0.785 . . . . 0.0 109.597 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -143.88 158.0 43.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.31 178.38 17.73 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.894 0.717 . . . . 0.0 114.894 -168.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.442 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 55.7 mtp180 -62.54 161.66 25.51 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 125.312 1.445 . . . . 0.0 111.034 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 94' ' ' ARG . 13.5 Cg_exo -28.92 96.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 1 C-N-CA 126.001 4.468 . . . . 0.0 114.952 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.47 -57.29 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.706 2.271 . . . . 0.0 110.504 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -168.33 21.12 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.199 0.599 . . . . 0.0 111.712 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.444 ' HB2' " H5'" ' B' ' 105' ' ' ' A' . 16.2 m -64.48 -2.99 2.6 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.008 0.923 . . . . 0.0 112.842 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -144.22 8.49 1.41 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 122.84 0.456 . . . . 0.0 112.018 -170.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.536 ' CG ' ' H ' ' A' ' 101' ' ' SER . 29.2 t60 55.78 -179.97 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.827 1.251 . . . . 0.0 112.733 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.536 ' H ' ' CG ' ' A' ' 100' ' ' HIS . 71.0 m . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.414 -1.279 . . . . 0.0 109.854 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.498 2 O4'-C1'-N19 114.13 5.93 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.536 ' C5 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.088 0 O4'-C1'-N19 112.2 4.0 . 0.06 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.426 " H4'" ' CB ' ' A' ' 46' ' ' PRO . . . . . . . . 0 O4'--C4' 1.416 -3.119 2 O4'-C1'-N19 112.786 4.586 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.444 " H5'" ' HB2' ' A' ' 98' ' ' SER . . . . . . . . 0 O4'--C4' 1.416 -3.119 0 O4'-C1'-N19 112.194 3.994 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.914 0 P-O3'-C3' 124.406 3.922 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.445 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.419 -2.832 1 C5'-C4'-C3' 109.235 -4.176 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.419 0.152 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 m -63.55 167.98 5.13 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.184 0.594 . . . . 0.0 111.611 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -57.64 -48.34 79.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.343 0.657 . . . . 0.0 110.813 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.36 -32.06 0.16 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.71 2.1 . . . . 0.0 114.609 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 5' ' ' ARG 0.25 11.8 ptm85 146.06 65.63 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 128.879 2.872 . . . . 0.0 109.643 176.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -58.84 116.61 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.78 2.987 . . . . 0.0 111.324 -168.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -100.98 74.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.962 1 C-N-CA 125.981 4.454 . . . . 0.0 113.758 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.99 -162.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.802 2.334 . . . . 0.0 109.803 170.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -66.05 32.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.744 1.218 . . . . 0.0 113.805 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.481 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 10.5 m -56.68 -9.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.64 -12.83 61.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.888 0.475 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.29 15.15 0.03 OUTLIER Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.188 -0.784 . . . . 0.0 113.802 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 12.8 ptp -65.69 176.5 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.662 1.231 . . . . 0.0 112.263 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -70.08 -24.91 63.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.321 0.648 . . . . 0.0 112.323 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m 46.6 36.86 3.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.492 1.117 . . . . 0.0 113.868 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.2 tm? -65.87 132.84 49.62 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 17.7 pttt -117.04 161.02 20.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -130.51 147.83 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -151.59 -175.83 5.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.297 1.439 . . . . 0.0 110.34 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 2.0 t-20 86.44 37.73 0.02 OUTLIER 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 113.455 169.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.43 163.55 10.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 24' ' ' ARG . 20.0 m -116.61 169.53 9.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.611 0.765 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -61.63 4.11 0.11 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.336 1.054 . . . . 0.0 113.438 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.0 ptm180 -136.03 19.11 3.22 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.398 1.079 . . . . 0.0 110.991 -175.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 26' ' ' SER . 1.9 m -124.17 167.38 14.34 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.246 0.618 . . . . 0.0 110.276 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.3 p -152.29 165.78 16.76 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.605 0.762 . . . . 0.0 109.754 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.4 Cg_endo -69.58 -27.65 27.07 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.811 2.34 . . . . 0.0 110.03 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -68.13 -37.71 81.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -72.76 -43.53 62.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.93 -19.74 32.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.337 -0.227 . . . . 0.0 111.031 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.64 -55.81 4.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -7.51 37.88 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.194 0.452 . . . . 0.0 112.009 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.435 HG12 ' HE1' ' A' ' 75' ' ' MET . 60.4 t -98.21 -31.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.317 0.647 . . . . 0.0 111.113 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.432 ' CD1' HD13 ' A' ' 30' ' ' LEU . 22.5 m-85 -102.84 -11.26 18.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.98 -24.99 60.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 121.914 -0.491 . . . . 0.0 110.921 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -68.65 -24.04 64.49 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -72.84 -19.51 61.3 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 122.611 0.364 . . . . 0.0 111.52 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.48 -82.99 0.1 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -158.18 164.58 36.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.928 0.491 . . . . 0.0 110.979 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.5 t -135.29 138.58 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.92 -24.0 18.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.432 ' CG ' ' H1 ' ' B' ' 106' ' ' ' G' . 24.2 t0 -163.26 156.08 18.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.915 0.358 . . . . 0.0 110.453 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 60' ' ' VAL . 2.5 p -153.13 112.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -148.97 159.14 44.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -165.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -121.68 93.48 48.67 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 124.353 1.061 . . . . 0.0 108.938 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.65 33.23 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.599 3.532 . . . . 0.0 112.505 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -65.38 164.02 14.51 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.66 111.0 1.11 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.39 9.11 1.11 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CD1' HG23 ' A' ' 51' ' ' THR . 12.0 p90 -144.85 -0.96 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 111.823 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.487 HG23 ' CD1' ' A' ' 50' ' ' TYR . 13.1 p -124.25 -8.04 7.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.381 0.537 . . . . 0.0 110.271 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.87 20.34 0.34 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.215 2.206 . . . . 0.0 113.173 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.7 102.36 0.74 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -57.06 166.57 1.02 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.427 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.34 -4.07 4.34 Favored 'General case' 0 N--CA 1.46 0.075 0 C-N-CA 123.87 0.868 . . . . 0.0 110.732 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.18 68.74 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.192 -0.782 . . . . 0.0 113.144 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.98 172.11 17.98 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.942 1.371 . . . . 0.0 111.746 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 92.71 2.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.472 1.109 . . . . 0.0 108.394 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.442 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 30.6 t80 -62.88 110.8 1.88 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -107.81 167.42 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -140.21 145.08 36.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.58 146.71 47.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.822 0.849 . . . . 0.0 110.694 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -99.51 -32.63 11.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.812 -177.509 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.92 127.07 33.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.762 0.425 . . . . 0.0 110.426 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.45 -51.73 58.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -59.8 -33.69 72.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.61 -21.17 30.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.97 0.35 . . . . 0.0 110.341 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.39 -46.98 18.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.391 0.677 . . . . 0.0 110.225 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.52 -17.51 59.22 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.208 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.6 -40.02 35.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.095 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.38 75.5 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.141 -0.349 . . . . 0.0 111.293 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.454 ' HA ' HG13 ' A' ' 87' ' ' VAL . 12.2 ptp -74.68 -42.82 57.74 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.362 0.601 . . . . 0.0 109.682 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.99 1.25 13.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.805 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.37 -10.02 4.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.435 ' HE1' HG12 ' A' ' 33' ' ' VAL . 4.6 ttp -146.84 -17.63 0.41 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.43 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -61.84 136.94 58.18 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.715 1.143 . . . . 0.0 110.273 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.07 8.87 65.69 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.611 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.05 29.71 0.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.483 1.141 . . . . 0.0 112.039 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.675 HG12 ' N ' ' A' ' 84' ' ' GLU . 3.9 m -65.61 175.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.418 1.887 . . . . 0.0 114.127 -172.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 0.47 0.82 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -142.31 3.9 1.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.986 0.812 . . . . 0.0 111.992 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.4 -27.42 3.4 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -158.71 160.48 36.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.675 ' N ' HG12 ' A' ' 79' ' ' VAL . 21.1 mt-10 -160.12 -44.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.702 1.201 . . . . 0.0 110.095 166.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.0 mm? -141.78 151.94 43.3 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.231 0.612 . . . . 0.0 112.217 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 29.8 mmt180 -153.49 114.13 4.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 165.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 72' ' ' MET . 1.4 p -139.38 116.82 11.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.499 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -151.53 164.92 35.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.081 1.352 . . . . 0.0 108.489 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.6 mmt -61.82 142.64 57.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.345 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.11 169.8 14.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.638 0.775 . . . . 0.0 110.76 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -142.65 2.98 1.44 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.196 0.598 . . . . 0.0 110.558 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.505 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 11.6 m-85 -133.79 166.84 21.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.23 179.28 17.38 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -61.17 145.29 90.16 Favored Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 122.506 0.322 . . . . 0.0 110.776 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.459 ' CB ' H5'' ' B' ' 105' ' ' ' A' . 65.0 Cg_endo -81.31 150.63 17.48 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.539 2.826 . . . . 0.0 111.834 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.19 -42.44 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.132 2.555 . . . . 0.0 111.025 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.42 148.34 2.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.256 1.022 . . . . 0.0 110.017 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.452 ' HB3' " H5'" ' B' ' 105' ' ' ' A' . 3.9 t -164.51 13.31 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 173.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -131.11 177.06 7.74 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.604 0.638 . . . . 0.0 110.902 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -143.13 9.28 1.67 Allowed 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.873 0.469 . . . . 0.0 111.679 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.393 -1.289 . . . . 0.0 110.21 -178.831 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.886 0 O4'-C1'-N19 111.294 3.094 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.544 0 N19-C1'-C2' 108.663 -2.961 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 6d' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.505 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.58 1 P-O3'-C3' 124.933 4.36 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.459 H5'' ' CB ' ' A' ' 95' ' ' PRO . . . . . . . . 0 O4'--C4' 1.419 -2.858 3 O4'-C1'-N19 112.764 4.564 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.447 " H3'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 C2'--C1' 1.506 -2.157 3 O4'-C1'-N19 113.357 5.157 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.447 " H3'" " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.193 2 C1'-O4'-C4' 105.354 -4.718 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.411 0.148 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.8 m -147.46 172.91 13.22 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.158 0.583 . . . . 0.0 110.304 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -60.82 -32.04 71.42 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.134 0.574 . . . . 0.0 111.372 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 47.56 59.7 5.79 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.566 1.555 . . . . 0.0 113.51 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.577 ' HD3' ' C6 ' ' B' ' 107' ' ' ' U' . 8.0 ptm180 39.34 62.53 5.04 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 126.378 1.871 . . . . 0.0 112.668 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.46 155.66 24.84 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.714 2.943 . . . . 0.0 109.645 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.61 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.416 2.744 . . . . 0.0 109.247 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HB2' HG13 ' A' ' 10' ' ' VAL . 35.1 Cg_endo -83.92 -172.35 1.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.837 3.025 . . . . 0.0 111.93 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -133.35 23.77 4.1 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.075 1.35 . . . . 0.0 108.535 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 8' ' ' PRO . 29.9 m -65.23 -2.26 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 125.555 1.542 . . . . 0.0 112.858 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.55 9.47 1.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.066 0.946 . . . . 0.0 112.209 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.43 40.0 0.33 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.643 -0.532 . . . . 0.0 112.634 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.3 ptp -135.25 175.11 9.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.927 0.863 . . . . 0.0 112.293 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -71.1 -23.3 62.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.171 0.588 . . . . 0.0 112.405 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.7 m 43.56 57.08 4.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.86 0.864 . . . . 0.0 113.296 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.466 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 17.5 tp -65.11 166.3 9.8 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 20.0 pttp -138.28 154.94 49.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.838 170.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.499 ' HB ' HG22 ' A' ' 60' ' ' VAL . 83.1 t -130.88 143.09 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -148.92 -175.5 4.97 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.928 0.891 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 41.6 t30 83.82 37.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.76 1.224 . . . . 0.0 113.673 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 158.83 11.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.867 0.867 . . . . 0.0 108.958 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 24' ' ' ARG . 6.8 m -118.78 171.54 8.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.639 0.775 . . . . 0.0 109.959 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CD2' HG22 ' A' ' 22' ' ' THR . 53.4 p90 -63.52 7.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.829 1.252 . . . . 0.0 112.969 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 22' ' ' THR . 8.3 ptm180 -132.17 17.78 4.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.039 1.336 . . . . 0.0 110.401 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.52 167.37 19.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.015 0.526 . . . . 0.0 110.72 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 95.5 p -154.71 164.05 22.27 Favored Pre-proline 0 N--CA 1.464 0.254 0 C-N-CA 123.994 0.918 . . . . 0.0 109.127 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 49.5 Cg_endo -68.29 -30.16 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.064 1.842 . . . . 0.0 111.701 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.34 -33.88 73.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.09 -44.56 65.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.427 HD11 HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -57.78 -21.3 41.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.145 -0.347 . . . . 0.0 111.222 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -81.28 -57.01 3.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.027 -0.42 . . . . 0.0 109.895 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -9.16 42.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.903 0.481 . . . . 0.0 111.854 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.91 -31.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.214 0.606 . . . . 0.0 111.807 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.5 m-85 -100.44 -11.45 20.18 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.397 0.544 . . . . 0.0 111.907 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.828 -0.545 . . . . 0.0 111.429 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.37 -23.23 63.72 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -71.04 -31.01 67.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.499 0.32 . . . . 0.0 110.48 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.76 -76.48 0.07 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -162.37 165.71 26.1 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 117.198 0.499 . . . . 0.0 110.577 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.5 t -137.53 138.05 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.98 -45.08 43.8 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.99 171.65 6.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.129 0.49 . . . . 0.0 110.265 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -159.36 128.57 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.979 0.911 . . . . 0.0 109.68 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.58 175.9 10.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.528 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -116.6 88.26 23.94 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 124.049 0.94 . . . . 0.0 109.367 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.49 150.92 52.52 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.838 3.025 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -179.16 -178.81 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.034 0.934 . . . . 0.0 108.565 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -58.01 109.18 0.69 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.438 ' HD2' " H1'" ' B' ' 105' ' ' ' A' . 14.5 ptm180 -67.58 19.14 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.581 1.552 . . . . 0.0 115.125 -168.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CD2' HG23 ' A' ' 51' ' ' THR . 5.7 p90 -149.89 -19.24 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.061 0.944 . . . . 0.0 111.991 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.46 HG23 ' CD2' ' A' ' 50' ' ' TYR . 27.8 p -103.75 -25.27 13.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.662 173.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.2 31.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.609 1.963 . . . . 0.0 113.966 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.24 -15.73 62.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.084 0.554 . . . . 0.0 112.292 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -97.12 155.74 16.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 111.359 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -171.63 16.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.399 1.079 . . . . 0.0 111.221 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.71 2.03 75.39 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.34 -0.85 . . . . 0.0 113.229 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.21 169.08 24.92 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.038 0.919 . . . . 0.0 110.219 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.67 92.35 2.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.27 110.58 1.68 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -105.6 163.76 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.8 ptm180 -139.06 142.58 38.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.756 0.66 . . . . 0.0 110.678 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 16.1 m-85 -116.57 150.87 37.3 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.799 0.687 . . . . 0.0 111.557 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 -50.56 4.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 123.986 0.804 . . . . 0.0 112.008 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.67 135.17 49.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.947 0.499 . . . . 0.0 110.857 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -69.06 -52.38 29.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 178.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.457 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.68 -31.9 73.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -77.36 -26.34 51.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.871 0.367 . . . . 0.0 110.086 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -78.48 -40.91 34.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 122.031 -0.418 . . . . 0.0 110.512 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.71 -22.3 56.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.87 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.87 -40.06 48.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.948 0.794 . . . . 0.0 109.937 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.89 74.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.323 -0.236 . . . . 0.0 111.464 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.7 ptp -77.42 -39.69 46.1 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.322 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.63 0.64 19.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.133 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.72 -6.28 4.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.1 ttm -139.15 -24.0 0.89 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.64 135.89 57.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.151 0.887 . . . . 0.0 110.099 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.39 10.19 78.62 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.093 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.1 35.01 0.42 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.015 0.908 . . . . 0.0 110.797 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.626 HG22 ' H ' ' A' ' 80' ' ' LEU . 10.0 p -69.09 174.78 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.626 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.2 pt? -152.73 -0.12 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.648 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.553 ' H ' HG22 ' A' ' 79' ' ' VAL . 32.5 t70 -145.37 0.02 0.88 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.06 -18.61 6.17 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.625 ' C ' HG23 ' A' ' 79' ' ' VAL . 6.9 ptp180 -161.49 142.04 10.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 171.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 85' ' ' LEU . 23.3 mm-40 -147.12 -50.38 0.19 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.61 151.3 45.9 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.0 mmm180 -147.79 109.73 4.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 105.804 167.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.82 134.64 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.116 0.567 . . . . 0.0 109.96 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 89' ' ' MET . 36.6 tt0 -169.9 177.67 4.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.408 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 14.1 mmt -73.95 144.83 45.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.841 0.456 . . . . 0.0 109.786 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.78 163.93 15.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.467 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -133.73 -1.29 3.08 Favored 'General case' 0 C--O 1.23 0.051 0 C-N-CA 122.517 0.327 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.58 169.92 15.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.99 179.08 16.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.49 120.17 29.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.476 ' CG ' " H5'" ' B' ' 105' ' ' ' A' . 43.0 Cg_endo -67.84 139.3 47.25 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.493 2.128 . . . . 0.0 111.659 -171.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.43 -17.99 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.492 3.461 . . . . 0.0 112.217 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -140.08 -169.2 2.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.46 1.104 . . . . 0.0 109.592 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p -140.22 30.86 1.96 Allowed 'General case' 0 N--CA 1.46 0.065 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.6 t60 56.97 16.07 2.64 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -147.65 9.75 0.92 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.226 0.61 . . . . 0.0 110.472 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.434 -1.269 . . . . 0.0 110.081 -178.584 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.287 1 O4'-C1'-N19 114.422 6.222 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.147 0 C4'-C3'-C2' 99.438 -3.262 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.206 0 C5'-C4'-O4' 113.918 3.37 . 0.09 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.476 " H5'" ' CG ' ' A' ' 95' ' ' PRO . . . . . . . . 0 O4'--C4' 1.415 -3.182 1 O4'-C1'-N19 113.848 5.648 OUTLIER-DELTA 0.0 OUTLIER '7D dist 7p' 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.575 " C2'" ' H ' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.422 -2.592 1 O4'-C1'-N19 113.369 5.169 . 0.029 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.577 ' C6 ' ' HD3' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.417 -2.991 1 O4'-C1'-N19 113.68 5.48 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.6 p -148.13 -172.79 4.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.492 0.717 . . . . 0.0 110.058 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -133.66 32.09 3.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.26 0.624 . . . . 0.0 110.684 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.453 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . -117.09 59.28 0.47 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 45.47 46.98 3.46 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 127.331 2.252 . . . . 0.0 115.753 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.35 154.88 41.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.538 2.159 . . . . 0.0 108.508 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.54 112.87 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.395 2.73 . . . . 0.0 109.994 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -84.39 -165.68 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.355 2.703 . . . . 0.0 110.678 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -133.26 24.55 4.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.855 0.862 . . . . 0.0 109.607 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 31.1 m -64.72 -5.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 124.356 1.062 . . . . 0.0 112.553 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 6.8 2.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.38 41.07 0.41 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.557 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 9.1 ptp -134.43 172.9 12.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.948 0.874 . . . . 0.0 112.593 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -69.21 -23.72 63.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.593 0.757 . . . . 0.0 112.73 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 m 44.84 36.57 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.579 1.151 . . . . 0.0 113.904 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -60.67 133.16 55.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.591 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 20.7 ttpp -106.6 147.18 29.78 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.889 0.875 . . . . 0.0 112.052 -171.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' HB ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -132.81 154.64 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.932 171.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -154.2 -171.61 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.265 1.426 . . . . 0.0 110.593 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 93.8 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.615 1.966 . . . . 0.0 113.339 169.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 127.94 31.32 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.433 1.093 . . . . 0.0 109.461 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' ARG . 9.5 m -77.09 168.53 19.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.905 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -63.92 6.11 0.19 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.038 . . . . 0.0 112.669 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 32.7 ptt180 -137.52 19.4 2.91 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.591 1.156 . . . . 0.0 111.218 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -119.18 166.11 13.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.055 0.542 . . . . 0.0 110.431 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 92.7 p -150.71 164.85 18.91 Favored Pre-proline 0 CA--C 1.529 0.141 0 C-N-CA 124.243 1.017 . . . . 0.0 109.397 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.98 -23.75 29.42 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.473 2.115 . . . . 0.0 110.915 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.87 -35.13 72.23 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -76.18 -43.25 43.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -56.96 -21.74 32.59 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.974 -0.454 . . . . 0.0 110.892 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.49 -56.13 4.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.92 -30.38 69.01 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.085 0.402 . . . . 0.0 110.334 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -78.5 -34.76 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.977 0.511 . . . . 0.0 111.004 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -99.1 -11.34 21.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -74.19 -24.48 59.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.542 0.61 . . . . 0.0 110.778 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -67.68 -24.99 65.48 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -74.56 -19.48 60.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.486 -0.293 . . . . 0.0 111.697 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.29 -80.76 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.476 -0.392 . . . . 0.0 112.173 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.12 166.15 33.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.7 t -137.1 137.36 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.49 -45.07 8.18 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -156.72 155.42 31.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.147 0.979 . . . . 0.0 108.444 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG23 HG22 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -139.01 117.15 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -147.99 164.01 35.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.681 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -134.45 92.57 20.23 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -48.36 142.39 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.125 3.217 . . . . 0.0 111.735 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -159.06 160.18 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.981 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.44 121.84 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HD2' " H1'" ' B' ' 105' ' ' ' A' . 9.4 ptm180 -67.97 17.56 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.447 ' CD2' HG23 ' A' ' 51' ' ' THR . 10.1 p90 -150.94 -5.15 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.275 1.03 . . . . 0.0 112.387 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.447 HG23 ' CD2' ' A' ' 50' ' ' TYR . 35.3 p -119.52 -19.45 8.15 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.054 0.843 . . . . 0.0 110.333 171.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.46 24.58 1.63 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.069 1.748 . . . . 0.0 113.768 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.02 -164.19 0.13 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.236 0.615 . . . . 0.0 110.158 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -137.52 169.73 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.406 0.682 . . . . 0.0 110.836 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -138.18 7.62 2.66 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.344 0.658 . . . . 0.0 112.392 -172.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.77 20.8 35.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.578 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -152.41 165.41 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.57 1.185 . . . . 0.0 111.033 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.89 3.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.81 100.35 0.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 18' ' ' VAL . 84.5 t -92.16 154.22 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -132.13 140.22 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.8 m-85 -119.92 143.66 47.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.193 0.597 . . . . 0.0 110.35 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -32.71 21.69 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.94 131.14 55.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.375 0.607 . . . . 0.0 111.282 -170.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.15 -46.37 89.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.509 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.615 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -59.45 -34.54 72.64 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.21 -9.88 24.93 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.357 0.526 . . . . 0.0 110.68 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.89 -44.99 25.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -75.67 -29.11 58.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.299 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.41 -41.68 80.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.592 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.73 76.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.257 -0.277 . . . . 0.0 111.533 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.7 ptp -77.4 -39.99 45.21 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.576 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.99 1.52 17.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.332 0.653 . . . . 0.0 111.719 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.51 -8.7 4.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.3 ttp -142.93 -19.98 0.65 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.03 135.38 57.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.398 1.454 . . . . 0.0 110.125 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.14 78.06 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.045 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.39 29.31 0.51 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.083 0.942 . . . . 0.0 110.966 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 84' ' ' GLU . 5.3 m -67.91 174.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 126.194 1.798 . . . . 0.0 113.361 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.79 9.99 0.92 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.809 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -139.41 7.31 2.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.162 0.585 . . . . 0.0 110.317 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.07 -17.33 48.58 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.82 136.7 7.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.409 0.683 . . . . 0.0 109.189 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.566 ' N ' HG12 ' A' ' 79' ' ' VAL . 81.2 mm-40 -150.76 -43.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 110.27 170.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -137.59 151.71 48.63 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.043 0.537 . . . . 0.0 112.122 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 29.0 mmt180 -152.28 112.92 4.14 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 166.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.13 133.12 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.364 0.602 . . . . 0.0 110.73 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -167.96 162.24 13.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.125 1.37 . . . . 0.0 108.546 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 mmt -59.15 139.26 57.08 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.732 0.813 . . . . 0.0 111.336 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.74 52.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -129.89 16.56 5.74 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.232 1.013 . . . . 0.0 108.378 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -147.28 142.38 27.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.29 1.436 . . . . 0.0 107.175 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.28 -176.11 17.43 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -170.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -53.76 132.18 56.54 Favored Pre-proline 0 N--CA 1.455 -0.212 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.29 143.14 52.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.143 2.562 . . . . 0.0 112.486 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.24 -21.84 10.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.199 3.266 . . . . 0.0 111.699 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -146.88 162.57 38.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.463 1.105 . . . . 0.0 108.092 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.7 p -59.48 -29.15 67.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -164.72 173.5 11.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.674 0.67 . . . . 0.0 110.14 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -61.62 160.88 10.67 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.083 0.553 . . . . 0.0 111.367 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.561 -1.209 . . . . 0.0 109.96 -179.768 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 110.895 2.695 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.591 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.633 2 O4'-C1'-N19 116.893 8.693 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.442 ' P ' " H1'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.82 2 O4'-C1'-N19 112.75 4.55 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.434 " H1'" ' HD2' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.926 2 C5'-C4'-C3' 104.569 -7.288 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.065 0 O4'-C1'-N19 111.68 3.48 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.453 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.421 -2.696 1 C4'-C3'-C2' 98.355 -4.345 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -153.66 -179.36 7.73 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.83 0.452 . . . . 0.0 110.081 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -63.1 -28.03 69.79 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.312 1.045 . . . . 0.0 111.972 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.45 35.32 20.45 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.855 0.741 . . . . 0.0 112.647 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 34.05 50.65 0.88 Allowed Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.486 1.514 . . . . 0.0 114.433 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.39 151.45 42.78 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.115 2.543 . . . . 0.0 110.692 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.21 117.97 4.23 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.784 2.99 . . . . 0.0 110.353 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.94 -169.01 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.02 3.146 . . . . 0.0 109.915 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -121.53 21.44 10.93 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.695 0.798 . . . . 0.0 109.31 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.27 -8.28 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.663 1.185 . . . . 0.0 113.274 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.49 4.09 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.961 -0.462 . . . . 0.0 111.131 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.54 28.12 1.2 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.42 1.01 . . . . 0.0 110.743 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.9 mtm -129.65 165.57 21.54 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.464 0.632 . . . . 0.0 111.405 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -67.0 -22.6 65.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 t 44.16 60.19 2.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 15.9 tp -65.49 166.13 10.92 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.2 ptmt -138.35 148.06 44.15 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 123.342 0.657 . . . . 0.0 110.913 172.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.569 ' HB ' HG22 ' A' ' 60' ' ' VAL . 94.7 t -129.41 143.06 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -153.01 -173.81 4.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.979 0.911 . . . . 0.0 109.738 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.406 ' CG ' ' HE ' ' A' ' 83' ' ' ARG . 15.2 t30 88.44 29.85 0.03 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.792 1.237 . . . . 0.0 112.558 171.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.56 134.97 35.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.055 1.342 . . . . 0.0 109.752 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 m -74.28 168.01 20.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -64.66 4.25 0.42 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.846 0.858 . . . . 0.0 112.853 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -135.28 18.69 3.39 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.187 0.995 . . . . 0.0 111.482 -175.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -119.2 165.1 14.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 122.935 0.494 . . . . 0.0 110.289 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.7 p -147.46 166.57 15.68 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.525 0.73 . . . . 0.0 110.03 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.2 Cg_endo -70.65 -32.08 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.858 2.372 . . . . 0.0 110.896 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.24 -35.33 80.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -73.23 -45.32 56.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.423 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -55.46 -21.04 14.53 Favored 'General case' 0 N--CA 1.457 -0.095 0 O-C-N 122.203 -0.31 . . . . 0.0 111.418 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -78.66 -57.8 3.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -64.99 -21.61 66.87 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.735 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.7 t -84.03 -32.88 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 119.612 -0.232 . . . . 0.0 111.007 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CD1' HD13 ' A' ' 30' ' ' LEU . 19.3 m-85 -102.14 -10.2 19.85 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.0 -26.33 62.19 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.081 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -68.41 -23.19 64.61 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.86 -16.08 61.14 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.444 0.298 . . . . 0.0 111.035 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.31 -66.42 0.27 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-O 119.94 -0.366 . . . . 0.0 112.405 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -165.02 168.45 17.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.667 0.387 . . . . 0.0 110.59 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -141.85 135.31 29.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.92 -22.1 16.59 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -158.84 155.69 28.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.289 0.545 . . . . 0.0 110.425 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -170.89 100.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.79 1.236 . . . . 0.0 109.944 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.6 177.26 10.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 mm -106.57 98.51 20.6 Favored Pre-proline 0 C--N 1.34 0.193 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.49 -41.78 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.501 2.801 . . . . 0.0 115.953 -166.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -70.39 155.12 41.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.866 0.757 . . . . 0.0 110.947 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 37.41 70.49 0.18 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.564 1.146 . . . . 0.0 112.139 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.528 ' HD3' " H1'" ' B' ' 105' ' ' ' A' . 30.3 ptt180 -57.04 5.4 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.117 1.767 . . . . 0.0 115.559 -173.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -145.28 1.21 0.94 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.207 1.003 . . . . 0.0 112.297 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -121.15 -12.08 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.169 0.44 . . . . 0.0 110.189 173.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.76 29.13 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 127.765 2.426 . . . . 0.0 113.619 -176.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.13 -176.08 1.34 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.47 0.653 . . . . 0.0 109.299 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t 50.75 24.96 1.9 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.291 1.036 . . . . 0.0 112.142 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 9.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.172 1.789 . . . . 0.0 114.095 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.64 0.655 . . . . 0.0 112.254 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -155.95 166.91 32.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.8 0.8 . . . . 0.0 110.522 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.22 101.7 3.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.416 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 50.0 t80 -68.91 118.31 11.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.569 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -119.5 165.29 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.563 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.3 ptm180 -144.54 149.66 36.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.35 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.8 m-85 -117.18 164.8 14.23 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.089 0.868 . . . . 0.0 111.078 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.4 -27.15 10.12 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -120.59 149.33 42.63 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.149 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.12 -45.83 83.48 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.131 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.627 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -66.42 -40.0 89.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.235 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -80.74 -15.92 55.22 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.102 0.865 . . . . 0.0 110.959 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.1 -47.45 9.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.046 0.538 . . . . 0.0 110.16 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -68.35 -25.07 64.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.448 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.68 -47.46 31.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.904 0.32 . . . . 0.0 110.549 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.33 73.69 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.056 0.389 . . . . 0.0 110.623 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.8 ttp -73.4 -43.01 61.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.755 0.422 . . . . 0.0 110.031 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.26 2.33 24.97 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.171 -0.331 . . . . 0.0 111.521 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.23 -7.28 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.9 ttm -137.6 -26.44 0.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.67 134.75 56.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.537 1.062 . . . . 0.0 109.831 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.7 42.73 86.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 21.92 12.55 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 122.125 0.964 . . . . 0.0 110.269 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.635 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 6.1 t -63.55 162.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -165.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.497 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -157.45 13.26 0.23 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.96 -177.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' H ' HG12 ' A' ' 79' ' ' VAL . 61.3 m-20 -135.61 8.8 3.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.19 0.596 . . . . 0.0 110.861 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.03 -13.38 58.9 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.518 ' N ' HG11 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -177.36 133.55 0.18 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.438 1.895 . . . . 0.0 106.473 176.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 79' ' ' VAL . 20.4 pt-20 -146.15 -32.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.338 168.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.492 ' CD2' ' HG3' ' A' ' 84' ' ' GLU . 1.5 mm? -141.41 140.06 33.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -174.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 33.1 mmt180 -149.62 116.76 6.02 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 125.579 1.552 . . . . 0.0 106.991 167.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -134.52 142.98 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.752 0.821 . . . . 0.0 110.2 -174.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -170.49 -178.79 2.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.451 0.701 . . . . 0.0 110.22 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.7 mmt -75.51 139.6 42.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.463 0.705 . . . . 0.0 109.455 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 164.53 26.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.408 0.683 . . . . 0.0 111.225 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -142.94 9.23 1.71 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.744 0.418 . . . . 0.0 110.981 172.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.734 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 22.1 m-85 -126.18 167.02 15.98 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.056 0.942 . . . . 0.0 109.142 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.1 173.62 14.91 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-O 120.999 0.221 . . . . 0.0 113.245 -173.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -65.37 159.91 62.97 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.109 0.963 . . . . 0.0 111.464 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -37.82 104.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.862 1 C-N-CA 125.618 4.212 . . . . 0.0 115.492 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.47 -26.83 1.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.06 2.507 . . . . 0.0 109.632 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -160.42 168.7 24.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.8 1.64 . . . . 0.0 106.786 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.4 p -82.24 -44.05 16.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -169.77 20.08 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -131.34 0.49 4.09 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.416 -0.803 . . . . 0.0 112.527 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.3 m . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.353 -1.308 . . . . 0.0 110.24 177.61 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.591 0 C5'-C4'-C3' 109.913 -3.724 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.4 2 C1'-O4'-C4' 104.978 -5.136 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.734 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.413 -3.347 2 N19-C1'-C2' 106.221 -4.487 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.528 " H1'" ' HD3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.856 0 C3'-C2'-C1' 104.795 3.661 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.41 " H3'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.165 3 C3'-C2'-C1' 105.809 4.788 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.41 " H3'" " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.413 -3.342 1 C1'-O4'-C4' 105.564 -4.485 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttm . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -149.03 171.6 16.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.291 0.636 . . . . 0.0 110.826 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -78.79 7.85 6.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.46 0.704 . . . . 0.0 111.539 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.509 ' CA ' " H4'" ' B' ' 107' ' ' ' U' . . . -52.32 -44.27 58.08 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.463 -0.632 . . . . 0.0 113.721 -174.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.498 ' H ' ' HD3' ' A' ' 6' ' ' PRO . 18.4 ptt-85 -160.2 24.52 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.498 ' HD3' ' H ' ' A' ' 5' ' ' ARG . 74.4 Cg_endo -70.63 144.07 48.37 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 CA-C-N 121.614 1.612 . . . . 0.0 108.51 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.67 115.25 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.357 2.705 . . . . 0.0 110.779 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.0 -164.2 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.727 2.951 . . . . 0.0 109.841 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -133.27 25.47 4.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.621 0.769 . . . . 0.0 110.238 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 m -55.2 -15.82 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.817 0.847 . . . . 0.0 111.822 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.75 -4.13 32.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.008 0.923 . . . . 0.0 112.219 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.9 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.598 -0.557 . . . . 0.0 112.797 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.0 ptt? -135.63 162.65 32.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.002 0.901 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 m -76.05 82.44 2.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 122.888 0.475 . . . . 0.0 109.827 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.4 m -65.87 67.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.946 1.698 . . . . 0.0 110.459 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.577 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.6 tm? -86.36 131.52 34.19 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -128.63 153.67 47.03 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.152 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.862 HG12 HG22 ' A' ' 60' ' ' VAL . 5.9 p -131.48 153.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.783 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -152.75 -173.19 4.48 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.291 1.436 . . . . 0.0 109.738 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 83' ' ' ARG . 34.5 t30 86.76 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.737 1.215 . . . . 0.0 112.666 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.0 134.2 55.59 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.386 1.075 . . . . 0.0 109.132 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -81.17 169.05 17.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.981 176.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -62.46 1.18 0.38 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -125.69 12.72 7.99 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.595 0.634 . . . . 0.0 112.001 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -116.09 165.22 13.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.322 0.249 . . . . 0.0 110.996 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -150.19 165.15 18.14 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 124.226 1.01 . . . . 0.0 109.19 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 60.6 Cg_endo -70.43 -25.78 25.12 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.205 1.936 . . . . 0.0 111.604 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.76 -32.42 69.55 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.898 -0.502 . . . . 0.0 109.954 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.4 m -77.43 -44.91 27.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.48 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -56.66 -22.4 34.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.636 -0.665 . . . . 0.0 110.496 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -78.38 -57.98 3.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -61.09 -30.61 70.45 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.645 0.202 . . . . 0.0 110.539 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.88 -34.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 123.442 0.464 . . . . 0.0 110.811 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.6 m-85 -98.74 -13.12 20.36 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.25 -25.73 63.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.895 -0.503 . . . . 0.0 110.91 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -69.45 -23.22 63.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.888 -0.508 . . . . 0.0 112.243 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -74.62 -16.94 60.77 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.459 0.304 . . . . 0.0 111.653 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.65 -85.71 0.1 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -160.77 162.5 32.41 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.992 0.517 . . . . 0.0 110.893 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 t -137.42 137.76 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.61 -36.22 9.66 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -164.05 159.2 20.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.366 0.583 . . . . 0.0 111.194 174.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -158.01 117.96 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.681 1.192 . . . . 0.0 108.335 -176.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.07 176.98 11.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.374 0.607 . . . . 0.0 112.518 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 58' ' ' ALA . 18.7 mt -129.81 91.73 39.29 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 124.035 0.934 . . . . 0.0 108.6 -173.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.79 8.68 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.879 3.719 . . . . 0.0 113.733 -172.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -52.75 -43.15 65.58 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.013 0.824 . . . . 0.0 109.834 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -149.37 116.69 6.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.541 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 7.8 ptm180 -71.17 12.19 0.34 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.5 ' CD2' HG23 ' A' ' 51' ' ' THR . 15.7 p90 -146.28 2.77 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.937 0.895 . . . . 0.0 111.34 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.5 HG23 ' CD2' ' A' ' 50' ' ' TYR . 17.1 p -129.15 -36.02 1.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.478 0.581 . . . . 0.0 109.769 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.55 41.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 126.683 1.993 . . . . 0.0 113.214 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -129.39 1.34 5.09 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 t -64.03 -43.88 94.24 Favored 'General case' 0 CA--C 1.526 0.047 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 58.94 157.54 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.403 1.881 . . . . 0.0 113.582 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.41 -21.5 0.55 Allowed Glycine 0 CA--C 1.526 0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.329 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.56 166.13 29.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.029 0.931 . . . . 0.0 109.464 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -153.2 94.51 1.84 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.426 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 51.1 t80 -66.24 101.55 0.74 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -173.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.862 HG22 HG12 ' A' ' 18' ' ' VAL . 2.3 m -94.82 167.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 171.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 61' ' ' ARG . 10.5 ttt180 -145.94 116.43 7.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.213 0.946 . . . . 0.0 110.601 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 13.6 m-85 -92.48 169.76 10.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.229 1.012 . . . . 0.0 109.711 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -124.71 -37.06 2.52 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 123.989 0.806 . . . . 0.0 112.469 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.42 127.92 32.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.325 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -60.91 -53.72 53.8 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -58.35 -32.35 68.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -89.09 -17.85 28.43 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.084 0.402 . . . . 0.0 110.999 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.577 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.95 -45.62 20.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -75.42 -25.85 57.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.585 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.99 -46.89 40.87 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.719 0.69 . . . . 0.0 111.103 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.8 73.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.122 0.419 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.427 ' HA ' HG13 ' A' ' 87' ' ' VAL . 9.9 ttp -73.86 -41.23 62.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.55 0.34 . . . . 0.0 110.952 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.46 2.87 26.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.426 0.103 . . . . 0.0 111.231 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.19 -6.1 4.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.6 ttm -137.13 -27.81 0.96 Allowed 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.596 ' HB2' HG12 ' A' ' 87' ' ' VAL . 6.2 t70 -63.19 136.46 57.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.945 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.45 85.65 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.542 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.64 34.22 0.48 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.02 0.91 . . . . 0.0 110.49 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.648 HG22 ' H ' ' A' ' 80' ' ' LEU . 9.6 p -69.83 172.1 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.648 ' H ' HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -156.58 5.47 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.972 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' HG22 ' A' ' 79' ' ' VAL . 37.3 t70 -148.26 -2.44 0.52 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.0 -17.14 7.66 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.622 ' C ' HG23 ' A' ' 79' ' ' VAL . 5.3 ptp180 -161.0 140.55 10.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' C ' HD22 ' A' ' 85' ' ' LEU . 10.0 mm-40 -146.57 -49.57 0.2 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.519 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.4 mm? -139.95 150.36 44.43 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 124.064 0.852 . . . . 0.0 112.445 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -148.66 98.84 2.93 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 167.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.676 ' HB ' HG23 ' A' ' 18' ' ' VAL . 7.1 p -126.45 129.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 121.336 0.588 . . . . 0.0 110.097 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -165.78 164.38 18.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.356 1.063 . . . . 0.0 109.138 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.4 mmt -57.97 136.84 57.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.895 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 155.74 27.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -136.52 4.71 2.88 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.623 0.369 . . . . 0.0 110.838 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.601 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 10.5 m-85 -132.95 163.81 28.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.4 172.71 15.2 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -66.16 156.05 85.78 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.58 0.352 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.81 146.77 30.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.579 2.853 . . . . 0.0 111.722 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.4 -24.33 5.46 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.194 3.263 . . . . 0.0 111.855 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -154.13 161.47 41.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.359 1.064 . . . . 0.0 109.121 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.8 p -72.4 -50.53 25.81 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -170.75 -42.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.87 0.304 . . . . 0.0 111.219 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -162.13 11.61 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 117.382 -1.294 . . . . 0.0 111.925 -176.572 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.869 0 C5'-C4'-C3' 111.16 -2.893 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.144 2 C1'-O4'-C4' 104.162 -6.042 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.601 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.668 2 O4'-C1'-N19 112.408 4.208 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.541 " H1'" ' HB3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.415 -3.173 1 P-O3'-C3' 125.36 4.716 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C3'-C2'-C1' 104.355 3.172 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.509 " H4'" ' CA ' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.414 -3.223 1 O4'-C1'-N19 112.355 4.155 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 m -59.91 143.93 50.23 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 122.842 0.457 . . . . 0.0 110.188 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 49.84 19.38 0.43 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.378 1.071 . . . . 0.0 112.695 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.537 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . -83.59 65.05 4.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 42.63 49.5 4.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.433 1.493 . . . . 0.0 114.745 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.83 154.03 63.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.249 1.966 . . . . 0.0 108.522 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.77 115.99 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.263 2.642 . . . . 0.0 110.679 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.17 -163.79 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.859 3.039 . . . . 0.0 109.885 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -132.17 20.19 4.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.516 0.726 . . . . 0.0 110.343 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -56.71 -12.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.428 1.091 . . . . 0.0 112.244 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.34 -1.0 9.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.749 0.819 . . . . 0.0 112.496 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.69 30.06 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.77 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.17 168.15 20.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.807 1.304 . . . . 0.0 112.461 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -57.95 -28.32 64.21 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -168.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.4 m 42.1 58.97 2.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 113.172 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 17.6 tp -65.17 167.15 8.55 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 14.9 pttt -136.95 157.63 46.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.107 0.412 . . . . 0.0 111.82 170.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -133.78 148.13 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -150.42 -175.43 5.09 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.662 1.185 . . . . 0.0 110.677 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 t30 91.92 28.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.741 1.616 . . . . 0.0 114.121 168.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 120.66 9.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.25 1.02 . . . . 0.0 109.867 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 23' ' ' TYR . 11.7 m -75.09 171.58 13.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' H ' HG22 ' A' ' 22' ' ' THR . 54.7 p90 -63.96 7.2 0.13 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.113 0.965 . . . . 0.0 112.949 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 22' ' ' THR . 19.3 ptt180 -131.08 14.88 5.19 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.982 0.913 . . . . 0.0 111.838 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 26' ' ' SER . 1.4 m -122.8 166.43 14.98 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.466 0.306 . . . . 0.0 111.068 -173.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.503 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 91.4 p -151.86 166.4 15.32 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.67 -29.24 19.84 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.576 2.184 . . . . 0.0 110.904 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -67.63 -33.92 75.94 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.0 m -75.25 -44.87 43.66 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.479 HD12 HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -56.26 -19.84 15.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.315 0.246 . . . . 0.0 111.117 178.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -80.4 -57.98 3.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -12.31 60.35 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG12 ' HE1' ' A' ' 75' ' ' MET . 55.8 t -91.97 -32.86 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.189 0.595 . . . . 0.0 111.514 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.72 -9.71 18.9 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -26.01 61.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.18 0.446 . . . . 0.0 111.018 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -69.76 -23.78 63.42 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -72.56 -19.2 61.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.842 0.457 . . . . 0.0 111.468 176.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.0 -86.46 0.1 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -156.25 165.12 37.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 111.447 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.52 137.24 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.49 1.116 . . . . 0.0 108.062 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -22.09 23.21 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -163.67 153.85 15.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.403 0.62 . . . . 0.0 110.63 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.44 HG23 HG22 ' A' ' 60' ' ' VAL . 1.6 p -150.92 104.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -146.92 161.79 40.02 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.966 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.4 mt -136.34 126.36 16.17 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.892 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.54 52.21 2.81 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.708 3.605 . . . . 0.0 110.434 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -73.26 70.62 1.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.051 0.94 . . . . 0.0 110.081 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HA ' ' C6 ' ' B' ' 105' ' ' ' A' . 3.5 p30 45.62 -162.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.722 1.609 . . . . 0.0 114.142 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 177.58 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.465 1.906 . . . . 0.0 108.199 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -157.34 12.03 0.22 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.448 1.099 . . . . 0.0 111.456 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.7 p -124.18 -7.16 7.69 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.042 0.537 . . . . 0.0 112.035 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.64 42.05 1.92 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.108 1.763 . . . . 0.0 113.971 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.08 -177.79 4.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.187 0.595 . . . . 0.0 110.303 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -142.59 -176.93 5.05 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -172.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.552 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 75.0 mmt-85 -132.25 -2.1 3.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.256 0.622 . . . . 0.0 112.325 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.7 24.44 76.71 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.009 0.368 . . . . 0.0 113.05 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 9.6 p90 -151.6 171.61 17.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.01 0.905 . . . . 0.0 110.692 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.76 103.82 4.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -69.57 92.44 0.64 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.772 0.829 . . . . 0.0 108.879 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.479 HG21 HD12 ' A' ' 30' ' ' LEU . 40.5 t -79.99 160.94 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 13.7 ttt180 -141.97 130.46 22.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.355 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.1 m-85 -113.03 165.71 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.025 0.375 . . . . 0.0 111.059 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -33.44 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.26 123.39 26.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -60.36 -53.59 55.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -84.95 -21.84 29.43 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.17 -43.54 21.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 122.779 0.432 . . . . 0.0 110.461 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -72.05 -28.56 63.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.214 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -40.73 64.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.393 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.52 74.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.137 -0.352 . . . . 0.0 111.441 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.8 ptp -78.71 -38.29 39.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.68 3.13 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.961 0.504 . . . . 0.0 111.674 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -9.7 3.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.417 ' HE1' HG12 ' A' ' 33' ' ' VAL . 4.6 ttp -146.79 -13.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.27 125.51 23.54 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.762 1.165 . . . . 0.0 108.756 173.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.87 28.11 61.41 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.576 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.65 38.33 0.44 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.775 1.288 . . . . 0.0 109.554 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.621 HG22 ' H ' ' A' ' 80' ' ' LEU . 4.8 p -71.81 173.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -168.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.621 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.1 pt? -152.0 -0.32 0.32 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.27 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' H ' HG22 ' A' ' 79' ' ' VAL . 38.0 t70 -144.95 -1.17 0.87 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.43 -17.31 6.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.558 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -164.34 133.38 3.71 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.151 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 79' ' ' VAL . 20.1 mm-40 -143.81 -39.75 0.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.413 HD12 ' CB ' ' A' ' 84' ' ' GLU . 3.5 mp -147.63 151.18 35.77 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 123.697 0.623 . . . . 0.0 112.608 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.1 mmm180 -147.43 121.56 9.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.72 139.27 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.081 0 C-N-CA 122.67 0.388 . . . . 0.0 110.03 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -169.08 174.93 5.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.752 1.221 . . . . 0.0 109.225 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 mmt -73.97 143.27 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.962 0.905 . . . . 0.0 109.981 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.54 155.68 37.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.474 0.31 . . . . 0.0 110.555 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.56 13.42 2.34 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.766 0.826 . . . . 0.0 109.722 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.462 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 24.3 m-85 -129.97 158.07 40.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.874 0.87 . . . . 0.0 109.109 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.48 177.95 20.29 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -60.66 156.06 46.77 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 122.235 -0.568 . . . . 0.0 110.131 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HG3' " H2'" ' B' ' 104' ' ' ' G' . 78.3 Cg_exo -54.32 120.94 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.322 2.681 . . . . 0.0 113.309 -175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.51 -45.77 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.125 1.883 . . . . 0.0 108.671 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -161.39 125.49 3.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.172 1.789 . . . . 0.0 107.833 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 m -149.46 4.92 0.61 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.826 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -143.9 -25.39 0.55 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -173.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 45.35 23.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.7 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.405 -177.717 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 1 O4'-C1'-N19 116.035 7.835 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.748 2 O4'-C1'-N19 112.506 4.306 . 0.26 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.462 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.412 -3.422 0 C5'-C4'-C3' 111.169 -2.887 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.455 ' C8 ' " C5'" ' B' ' 105' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.998 1 C3'-C2'-C1' 105.475 4.416 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.058 2 P-O3'-C3' 125.354 4.712 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.537 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.415 -3.148 2 C5'-C4'-C3' 107.85 -5.1 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -147.01 170.28 17.45 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.279 0.631 . . . . 0.0 110.426 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -61.94 -56.91 14.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.985 0.514 . . . . 0.0 111.318 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.42 -69.01 0.53 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 125.001 1.286 . . . . 0.0 111.697 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.41 59.65 0.64 Allowed Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -171.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.77 153.76 64.13 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.961 2.441 . . . . 0.0 109.326 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.87 116.04 4.53 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.412 2.741 . . . . 0.0 110.544 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -87.58 -162.52 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.062 3.175 . . . . 0.0 110.298 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -136.25 33.4 2.82 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.976 0.91 . . . . 0.0 109.757 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.434 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 33.7 m -61.43 -1.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 124.409 1.083 . . . . 0.0 113.802 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.53 -13.05 60.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.541 0.61 . . . . 0.0 112.256 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.45 20.75 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.91 -0.383 . . . . 0.0 112.933 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.451 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . 8.1 ptp -60.47 156.9 15.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.84 0.82 . . . . 0.0 113.206 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -72.23 -18.84 61.8 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.888 0.875 . . . . 0.0 110.466 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 t 45.45 59.54 3.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.044 1.338 . . . . 0.0 113.03 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 68' ' ' ALA . 20.7 tp -65.7 165.39 12.69 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 16.8 pttt -134.53 154.89 51.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.531 0.332 . . . . 0.0 110.83 170.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.54 ' HB ' HG22 ' A' ' 60' ' ' VAL . 61.1 t -134.31 148.43 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -148.81 -171.08 3.78 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.997 1.719 . . . . 0.0 109.273 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.88 90.23 0.09 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.497 1.119 . . . . 0.0 111.929 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.5 122.89 49.04 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 m -69.03 165.92 19.16 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.18 -0.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.288 1.035 . . . . 0.0 113.562 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -129.4 23.19 5.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.167 0.987 . . . . 0.0 110.92 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -123.94 165.35 17.57 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.796 0.331 . . . . 0.0 110.73 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.4 p -150.05 165.79 16.7 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.192 0.997 . . . . 0.0 109.527 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 39.1 Cg_endo -66.18 -29.38 47.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.178 1.918 . . . . 0.0 110.911 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.09 -31.9 71.83 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.883 -0.51 . . . . 0.0 110.284 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 100.0 m -74.63 -44.71 49.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -58.84 -20.01 46.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.044 -0.41 . . . . 0.0 110.957 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -81.1 -57.05 3.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -8.89 39.06 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.867 0.467 . . . . 0.0 111.857 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.56 -30.94 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.318 0.647 . . . . 0.0 111.717 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 30' ' ' LEU . 22.7 m-85 -101.73 -12.05 18.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.249 0.477 . . . . 0.0 112.284 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.47 -27.27 64.1 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.011 -0.431 . . . . 0.0 111.37 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.51 -24.08 65.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -72.04 -21.95 61.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.238 0.215 . . . . 0.0 111.184 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -81.24 0.1 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -159.13 165.84 32.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.044 0.45 . . . . 0.0 111.357 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.9 147.16 29.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 -19.34 8.59 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.57 153.45 25.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.194 0.497 . . . . 0.0 110.374 174.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 60' ' ' VAL . 1.5 p -169.13 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.154 0.982 . . . . 0.0 110.044 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.83 179.63 9.02 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 112.204 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.432 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 13.4 mt -117.73 123.26 29.87 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.98 43.93 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 125.364 4.042 . . . . 0.0 112.054 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 92.6 mtt180 -54.89 160.96 1.76 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -54.73 119.42 5.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.433 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 7.9 ptm180 -67.16 13.27 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -167.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CD2' HG23 ' A' ' 51' ' ' THR . 13.0 p90 -144.72 0.2 0.96 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.666 1.186 . . . . 0.0 111.57 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.471 HG23 ' CD2' ' A' ' 50' ' ' TYR . 30.5 p -127.69 -23.78 3.37 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.709 0.686 . . . . 0.0 110.929 171.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.97 35.62 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.367 1.867 . . . . 0.0 113.815 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.23 1.93 12.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.413 ' HB2' ' HA ' ' A' ' 47' ' ' ARG . 3.3 m -73.37 170.08 15.82 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.386 0.539 . . . . 0.0 111.153 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 176.92 165.92 0.52 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.386 1.474 . . . . 0.0 110.174 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.31 -22.11 0.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -158.04 170.58 21.99 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 108.6 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.24 105.07 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 28.2 t80 -68.31 116.56 9.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -177.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.54 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -116.04 167.83 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 172.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.1 ptm180 -144.58 146.02 32.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.663 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 11.0 m-85 -116.01 162.65 17.07 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.464 0.477 . . . . 0.0 111.239 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -122.27 -32.19 3.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.296 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.64 131.13 34.63 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' HE3' ' HE1' ' A' ' 89' ' ' MET . 0.2 OUTLIER -65.06 -45.56 84.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.249 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -172.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.5 p30 -106.52 -7.01 17.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.347 0.521 . . . . 0.0 111.077 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -74.65 -40.43 61.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.92 -29.99 44.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.343 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -67.91 -40.06 83.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.297 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.53 75.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.851 0.296 . . . . 0.0 111.525 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.407 ' HA ' HG13 ' A' ' 87' ' ' VAL . 10.6 ptp -77.15 -40.19 46.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.725 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.07 -0.98 20.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.04 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.61 -6.34 5.19 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.8 ttm -137.63 -28.96 0.88 Allowed 'General case' 0 N--CA 1.458 -0.066 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.466 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 3.3 t70 -66.84 142.62 57.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.7 1.136 . . . . 0.0 110.617 -177.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.6 8.67 86.2 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.575 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.04 31.75 0.44 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.328 1.064 . . . . 0.0 111.041 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.582 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 19.8 t -74.45 160.9 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.704 0.802 . . . . 0.0 111.637 -172.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.65 10.94 0.3 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.368 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -146.44 5.3 0.93 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.99 -0.444 . . . . 0.0 112.106 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.51 -11.25 28.23 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.126 0.393 . . . . 0.0 112.334 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -172.14 114.24 0.32 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.088 0.955 . . . . 0.0 108.563 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.582 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 80.2 mm-40 -130.28 -50.78 1.1 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.555 171.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.96 155.99 46.86 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 46.5 mmt-85 -152.18 109.95 3.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.814 1.646 . . . . 0.0 107.299 168.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 2.1 p -139.12 125.38 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-O 121.19 0.519 . . . . 0.0 110.891 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -155.92 179.92 8.74 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.043 1.737 . . . . 0.0 108.382 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.414 ' HE1' ' HE3' ' A' ' 65' ' ' LYS . 15.4 mmt -75.75 144.93 41.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.6 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.16 169.15 16.7 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.231 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -145.3 -3.11 0.75 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.379 0.672 . . . . 0.0 110.905 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.5 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 13.6 m-85 -129.91 168.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.979 0.511 . . . . 0.0 109.911 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.27 171.42 13.7 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 112.745 -0.142 . . . . 0.0 112.745 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -64.43 152.38 89.2 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 123.514 0.725 . . . . 0.0 110.867 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.01 125.99 13.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.464 2.11 . . . . 0.0 112.116 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.22 -22.11 11.4 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.392 2.728 . . . . 0.0 110.389 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -148.5 150.39 33.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.486 1.514 . . . . 0.0 106.999 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 27.6 m -64.17 -43.67 94.4 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -171.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -165.44 7.44 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.301 -0.249 . . . . 0.0 110.902 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -70.46 -1.7 11.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.042 0.937 . . . . 0.0 112.642 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.705 -179.236 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.774 0 O4'-C1'-N19 111.381 3.181 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.41 ' C8 ' ' HD3' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.408 -3.724 2 C1'-O4'-C4' 104.909 -5.212 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.5 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.414 -3.264 1 O4'-C1'-N19 112.479 4.279 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.546 " H5'" ' C8 ' ' B' ' 105' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.133 0 O4'-C1'-N19 111.657 3.457 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.925 0 P-O3'-C3' 123.789 3.408 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.982 0 C1'-O4'-C4' 106.574 -3.362 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 120.254 0.073 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -146.5 -179.4 6.74 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.067 0.547 . . . . 0.0 110.543 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -139.0 36.76 2.14 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 123.943 0.897 . . . . 0.0 109.504 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.32 45.43 1.15 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 51.42 48.2 5.5 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.227 1.011 . . . . 0.0 112.988 -177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.3 157.04 50.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.79 2.327 . . . . 0.0 110.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.77 113.66 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.017 3.145 . . . . 0.0 110.209 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.33 -163.35 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.123 3.215 . . . . 0.0 110.61 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -134.23 29.11 3.7 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.112 0.965 . . . . 0.0 110.14 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.84 -12.53 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.404 1.082 . . . . 0.0 113.406 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.15 4.9 49.08 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.309 0.644 . . . . 0.0 111.448 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.23 21.09 0.49 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -140.89 161.31 38.13 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.399 0.599 . . . . 0.0 111.51 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.9 m -85.05 83.95 7.87 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.696 0.798 . . . . 0.0 111.924 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 m -64.24 79.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.144 1.378 . . . . 0.0 111.299 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.534 HD11 ' CG2' ' A' ' 87' ' ' VAL . 3.1 tm? -79.62 107.44 12.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.55 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.9 ttpp -79.53 140.94 37.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.71 146.92 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.299 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -150.67 -175.75 5.24 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.532 1.145 . . . . 0.0 110.8 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.55 HD21 ' HB2' ' A' ' 83' ' ' ARG . 16.1 t30 94.05 26.97 0.01 OUTLIER 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.728 1.611 . . . . 0.0 113.79 169.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.65 120.02 5.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.383 1.073 . . . . 0.0 108.468 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 23' ' ' TYR . 10.8 m -42.18 -63.85 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.189 0.995 . . . . 0.0 112.274 -172.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' CD2' HG22 ' A' ' 22' ' ' THR . 52.3 p90 165.93 -19.74 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.889 2.875 . . . . 0.0 109.276 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -111.42 -1.07 16.07 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.079 0.952 . . . . 0.0 111.552 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 26' ' ' SER . 2.9 m -78.18 173.47 12.22 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.02 0.928 . . . . 0.0 109.665 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 25' ' ' THR . 93.9 p -145.26 163.02 34.63 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.888 0.475 . . . . 0.0 109.882 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 41.9 Cg_endo -68.16 -26.79 36.02 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.986 1.79 . . . . 0.0 110.446 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.91 -27.38 65.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.465 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 99.7 m -78.35 -45.67 21.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 60' ' ' VAL . 1.3 mm? -59.16 -19.14 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.145 -0.347 . . . . 0.0 110.515 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -78.73 -58.38 3.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.133 -0.461 . . . . 0.0 109.949 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -71.56 -16.24 62.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.59 0.632 . . . . 0.0 111.326 -174.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.64 -32.98 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 123.272 0.629 . . . . 0.0 111.608 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 22.4 m-85 -101.72 -11.52 19.07 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.176 0.443 . . . . 0.0 111.907 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -74.33 -24.71 59.23 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.782 -0.574 . . . . 0.0 110.842 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.91 -22.91 65.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.217 0.462 . . . . 0.0 112.14 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -73.36 -24.85 60.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.699 0.4 . . . . 0.0 111.731 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.78 -84.79 0.07 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -159.64 167.04 29.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.086 0.47 . . . . 0.0 111.564 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.76 147.88 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.02 -17.92 8.63 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' CG ' ' H22' ' B' ' 106' ' ' ' G' . 46.8 t0 -162.42 149.98 13.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 117.057 0.429 . . . . 0.0 110.332 175.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 60' ' ' VAL . 1.5 p -166.31 104.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.577 1.151 . . . . 0.0 108.638 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.71 175.02 13.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.292 0.568 . . . . 0.0 112.244 175.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 mt -126.31 108.71 23.92 Favored Pre-proline 0 N--CA 1.452 -0.374 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.45 -13.69 20.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.741 2.961 . . . . 0.0 112.77 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 34.6 -107.71 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 111.12 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -140.27 12.78 2.39 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.216 1.006 . . . . 0.0 110.307 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 57.87 -12.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -148.76 -2.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.548 1.067 . . . . 0.0 113.009 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.8 p -121.05 -19.15 7.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.859 0.754 . . . . 0.0 110.516 172.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 50.23 21.11 0.73 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.243 1.417 . . . . 0.0 113.952 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.9 -1.24 6.83 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 t 61.21 173.83 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.015 1.326 . . . . 0.0 113.117 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -139.85 -0.68 1.68 Allowed 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.913 0.885 . . . . 0.0 112.446 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.82 18.44 44.13 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.916 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.07 168.88 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.518 1.159 . . . . 0.0 110.874 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.39 105.59 4.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 31.2 t80 -70.66 110.83 5.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 59.3 t -100.61 158.76 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -143.61 125.6 15.32 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 2.0 m-85 -91.61 -179.19 5.29 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 -25.06 1.42 Allowed 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 124.057 0.848 . . . . 0.0 113.26 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.87 128.59 37.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -62.33 -50.91 69.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.225 -0.416 . . . . 0.0 111.347 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.517 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -56.88 -34.61 68.02 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -172.297 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.52 -11.04 21.4 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 118.761 0.71 . . . . 0.0 111.972 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.468 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -72.3 -46.62 54.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.09 -24.65 55.05 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.223 -0.298 . . . . 0.0 111.5 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.06 -40.22 60.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.806 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.053 -0.404 . . . . 0.0 111.312 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.0 ptp -76.68 -40.2 49.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.559 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.55 2.26 14.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.186 0.594 . . . . 0.0 112.179 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.43 -9.19 3.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -145.44 -11.69 0.53 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.14 130.03 44.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 120.371 1.441 . . . . 0.0 109.396 174.51 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.46 29.75 61.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.904 -0.942 . . . . 0.0 113.665 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.52 38.88 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.063 1.432 . . . . 0.0 110.193 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.679 HG22 ' H ' ' A' ' 84' ' ' GLU . 13.1 t -69.85 162.56 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 113.96 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.409 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -158.04 9.33 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.506 179.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.41 1.66 0.53 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.85 -22.18 3.49 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 121.744 -0.598 . . . . 0.0 112.648 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.55 ' HB2' HD21 ' A' ' 20' ' ' ASN . 0.4 OUTLIER 174.99 134.89 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.584 1.954 . . . . 0.0 107.278 177.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.679 ' H ' HG22 ' A' ' 79' ' ' VAL . 76.3 mm-40 -132.23 -36.45 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.297 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' CB ' ' A' ' 84' ' ' GLU . 4.0 mp -152.15 151.81 31.51 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 31.5 mmt180 -152.57 122.65 7.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 167.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.534 ' CG2' HD11 ' A' ' 16' ' ' LEU . 2.0 p -141.05 137.25 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.183 0.516 . . . . 0.0 111.292 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -165.71 171.41 12.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.999 1.319 . . . . 0.0 109.655 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.83 141.42 53.27 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.218 0.607 . . . . 0.0 110.585 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.88 158.65 35.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.579 0.351 . . . . 0.0 110.132 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -147.95 21.16 1.12 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.601 0.76 . . . . 0.0 109.39 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.404 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 6.4 t80 -146.84 152.06 38.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -175.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.25 179.79 22.31 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.046 0.385 . . . . 0.0 113.957 -169.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -62.41 156.91 59.12 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.422 0.689 . . . . 0.0 111.02 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -43.36 114.56 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.202 3.268 . . . . 0.0 114.299 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.87 -23.76 9.12 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.71 2.273 . . . . 0.0 109.334 168.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -156.22 161.84 40.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.811 1.645 . . . . 0.0 107.065 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m -70.67 -41.87 71.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -170.33 20.01 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.909 0.777 . . . . 0.0 112.602 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -130.33 6.26 4.87 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.345 -0.847 . . . . 0.0 112.47 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 117.721 -1.133 . . . . 0.0 110.011 176.748 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.917 1 O4'-C1'-N19 115.087 6.887 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.449 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.413 -3.343 2 C1'-O4'-C4' 104.187 -6.014 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.482 ' C5 ' ' CE1' ' A' ' 59' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.063 2 O4'-C1'-N19 112.729 4.529 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.455 ' OP1' " H4'" ' B' ' 104' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.686 3 P-O3'-C3' 125.146 4.538 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.523 " H3'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.418 -2.893 0 C3'-C2'-C1' 105.048 3.942 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.523 " H3'" " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.797 1 O4'-C1'-N19 112.456 4.256 . 0.022 2o . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.1 p -60.66 146.07 46.9 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.38 0.272 . . . . 0.0 110.724 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 47.96 22.39 0.38 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.399 1.08 . . . . 0.0 112.903 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . -82.39 80.91 1.74 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.462 ' CD ' " H1'" ' B' ' 107' ' ' ' U' . 11.1 ptm180 45.3 46.4 2.97 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.26 1.824 . . . . 0.0 114.337 174.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.46 154.22 65.12 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.127 1.885 . . . . 0.0 109.828 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.5 117.23 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.716 2.944 . . . . 0.0 110.599 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -81.6 -169.94 0.88 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.996 3.131 . . . . 0.0 110.352 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -130.62 20.39 5.12 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.587 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.76 -12.02 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 125.403 1.481 . . . . 0.0 112.343 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.96 0.55 3.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.781 0.832 . . . . 0.0 112.616 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 30.64 0.15 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.088 -0.84 . . . . 0.0 113.954 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.09 23.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.91 1.355 . . . . 0.0 112.43 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -59.35 -26.95 65.49 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.0 m 43.09 59.96 2.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 20.5 tp -65.48 167.3 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 171.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 22.8 pttt -136.49 157.26 47.2 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.555 ' HB ' HG22 ' A' ' 60' ' ' VAL . 86.9 t -131.1 146.85 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -146.83 -175.2 4.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 110.355 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 92.97 24.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.525 1.53 . . . . 0.0 113.594 168.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.413 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -57.36 129.84 43.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.348 0.659 . . . . 0.0 109.378 -178.297 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 24' ' ' ARG . 18.0 m -82.43 170.94 14.7 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -64.08 8.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.175 0.99 . . . . 0.0 113.312 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 22' ' ' THR . 13.2 ptt180 -134.57 19.37 3.6 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.604 1.162 . . . . 0.0 111.969 -174.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -127.17 164.87 20.7 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.05 0.54 . . . . 0.0 110.448 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 85.0 p -149.86 165.16 18.21 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 110.37 -174.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 57.5 Cg_endo -69.42 -28.08 27.32 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.015 2.477 . . . . 0.0 111.192 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.98 -36.26 77.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.4 m -72.15 -44.15 63.55 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.514 HD11 HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -57.35 -21.98 39.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.991 -0.443 . . . . 0.0 111.145 179.397 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.82 -54.15 5.33 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -10.88 58.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.87 0.468 . . . . 0.0 111.869 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -98.95 -32.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 112.031 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.402 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.8 m-85 -100.9 -10.39 20.69 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -71.35 -28.05 63.79 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.766 -0.583 . . . . 0.0 111.14 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.61 -23.46 64.46 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -72.83 -17.59 61.54 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.317 0.247 . . . . 0.0 110.811 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.28 -76.09 0.11 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -164.81 160.52 19.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.239 0.616 . . . . 0.0 110.599 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.2 t -132.42 128.02 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.7 48.07 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -167.38 159.13 12.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.692 0.758 . . . . 0.0 112.912 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.26 141.29 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.71 1.604 . . . . 0.0 106.701 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -157.79 149.37 21.73 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.485 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 58' ' ' ALA . 5.7 mt -136.57 133.21 18.99 Favored Pre-proline 0 C--O 1.232 0.163 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.89 156.51 4.65 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.375 2.716 . . . . 0.0 111.915 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -140.34 9.54 2.28 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.409 ' HA ' ' C5 ' ' B' ' 105' ' ' ' A' . 6.0 m-20 43.88 18.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -174.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.515 ' HD2' " H1'" ' B' ' 105' ' ' ' A' 0.251 8.3 ptm180 40.13 8.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.44 3.096 . . . . 0.0 116.832 -178.393 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -162.82 -20.95 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.753 1.221 . . . . 0.0 112.971 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -96.56 -22.25 17.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.037 1.289 . . . . 0.0 110.385 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.99 31.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.812 1.645 . . . . 0.0 113.69 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.23 -160.2 0.08 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -135.83 168.23 19.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.295 0.638 . . . . 0.0 109.781 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.4 ttm105 -146.31 0.98 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.11 20.7 38.08 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.765 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.5 169.37 24.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.059 1.43 . . . . 0.0 111.538 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -141.9 93.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 108.556 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.505 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 19.6 t80 -62.72 103.32 0.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.555 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.3 m -100.84 168.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 172.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.4 ptm180 -142.1 139.83 32.33 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 17.3 m-85 -109.4 165.92 11.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.292 0.637 . . . . 0.0 110.465 177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -33.64 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.2 122.41 24.31 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -60.48 -50.98 71.4 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.631 -0.223 . . . . 0.0 110.403 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.6 -29.63 70.65 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.254 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -90.11 -15.77 30.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.718 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -79.75 -39.37 31.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.38 -25.86 51.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.426 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.89 -47.83 42.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.444 0.565 . . . . 0.0 110.785 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.43 73.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.976 -0.452 . . . . 0.0 110.783 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.1 ttp -73.99 -41.39 61.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.877 0.471 . . . . 0.0 110.05 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.91 3.14 27.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 122.446 -0.159 . . . . 0.0 111.42 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.48 -5.5 4.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.3 ttm -140.44 -27.34 0.74 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.97 134.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.466 1.03 . . . . 0.0 110.221 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.49 85.85 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.539 -0.589 . . . . 0.0 112.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.77 33.23 0.43 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.811 0.806 . . . . 0.0 110.8 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.577 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 48.6 t -69.93 166.16 2.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.64 0.776 . . . . 0.0 112.269 -172.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.406 ' N ' HG12 ' A' ' 79' ' ' VAL . 1.1 pt? -154.86 5.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -144.79 4.66 1.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.46 6.15 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.51 ' C ' HG13 ' A' ' 79' ' ' VAL . 5.2 ptp180 -176.14 143.33 0.53 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.004 1.722 . . . . 0.0 107.318 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 mm-40 -141.52 -46.94 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 169.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.488 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -140.96 152.7 45.17 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.941 0.496 . . . . 0.0 111.937 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.2 mmm180 -148.19 109.09 4.24 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 18' ' ' VAL . 33.9 t -134.95 127.18 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 C-N-CA 122.74 0.416 . . . . 0.0 110.876 -173.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -158.08 173.24 17.04 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.506 1.122 . . . . 0.0 109.412 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.2 mmt -69.59 146.08 52.02 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.786 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.89 165.93 22.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.704 0.402 . . . . 0.0 111.353 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -137.51 -0.04 2.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.717 0.807 . . . . 0.0 109.416 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.612 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 40.3 m-85 -139.66 156.11 47.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.328 0.651 . . . . 0.0 109.26 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.25 -16.39 6.15 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HD3' ' HD2' ' A' ' 95' ' ' PRO . 21.2 tpp180 -170.46 139.91 1.46 Allowed Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' HD3' ' A' ' 94' ' ' ARG . 26.7 Cg_endo -60.67 119.7 7.02 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.047 1.831 . . . . 0.0 109.128 171.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.52 -29.43 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.598 2.198 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -153.45 93.56 1.71 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.553 0.692 . . . . 0.0 112.081 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.7 m -146.92 -8.13 0.47 Allowed 'General case' 0 N--CA 1.458 -0.035 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.122 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -150.63 11.16 0.67 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.582 0.628 . . . . 0.0 111.73 -171.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -145.34 9.02 1.21 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.002 0.521 . . . . 0.0 111.316 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.054 -177.834 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.67 0 O4'-C1'-N19 111.617 3.417 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.146 2 O4'-C1'-N19 114.275 6.075 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.612 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.919 3 O4'-C1'-N19 114.091 5.891 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.515 " H1'" ' HD2' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.863 3 C5'-C4'-C3' 106.508 -5.994 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.977 1 P-O3'-C3' 126.538 5.698 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.462 " H1'" ' CD ' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.897 0 O4'-C1'-N19 111.691 3.491 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.805 0.336 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -148.27 -162.93 1.66 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.647 0.779 . . . . 0.0 109.869 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -47.88 -31.08 4.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.473 1.109 . . . . 0.0 112.979 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.493 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 86.12 36.77 9.65 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.779 175.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 38.81 50.37 2.55 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 125.076 1.35 . . . . 0.0 113.994 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.91 159.25 50.9 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.742 2.295 . . . . 0.0 110.282 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.53 117.83 4.69 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.59 2.86 . . . . 0.0 110.088 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.55 -170.01 0.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.137 3.225 . . . . 0.0 110.408 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -132.53 25.88 4.42 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.397 0.679 . . . . 0.0 109.459 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 m -58.66 -4.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.332 1.453 . . . . 0.0 112.926 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.79 5.73 47.31 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.271 0.629 . . . . 0.0 110.795 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.66 17.83 0.49 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.7 ptt? -143.31 164.1 31.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.601 0.701 . . . . 0.0 110.856 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -81.07 84.94 6.38 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 110.952 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -68.21 97.32 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.489 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 2.1 tm? -116.54 124.61 50.29 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.025 0.44 . . . . 0.0 109.914 -176.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.3 ttpm? -102.58 146.89 27.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.256 1.423 . . . . 0.0 114.123 -167.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.457 ' HB ' HG22 ' A' ' 60' ' ' VAL . 52.1 t -124.48 146.4 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.229 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -151.62 -171.52 3.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 110.484 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 81.65 37.57 0.07 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.158 1.383 . . . . 0.0 113.199 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' H ' ' HA ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -63.66 175.2 1.14 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.386 1.074 . . . . 0.0 109.299 175.344 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 24' ' ' ARG . 5.2 m -129.05 167.58 17.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.82 0.848 . . . . 0.0 109.345 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -64.4 4.87 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.455 0.702 . . . . 0.0 112.475 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.424 ' H ' ' C ' ' A' ' 22' ' ' THR . 14.8 ptm180 -129.13 18.86 5.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.787 1.235 . . . . 0.0 110.228 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -129.99 163.17 27.03 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.776 0.83 . . . . 0.0 109.382 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.7 p -148.5 164.73 20.44 Favored Pre-proline 0 C--O 1.233 0.201 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 -174.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.9 Cg_endo -68.98 -27.76 29.84 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.792 1.661 . . . . 0.0 111.467 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.06 -32.33 72.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.742 0.701 . . . . 0.0 109.648 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.1 m -74.15 -44.03 55.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.448 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -59.88 -20.82 59.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.074 -0.391 . . . . 0.0 111.075 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -56.15 4.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -8.18 50.64 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.983 0.513 . . . . 0.0 112.194 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.4 t -100.79 -31.84 3.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 C-N-CA 123.069 0.547 . . . . 0.0 112.027 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.448 ' CD1' HD13 ' A' ' 30' ' ' LEU . 26.1 m-85 -101.67 -9.76 20.61 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.509 0.595 . . . . 0.0 111.602 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.83 -28.27 62.45 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.728 -0.607 . . . . 0.0 111.463 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.88 -23.0 65.95 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -71.83 -20.26 61.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.398 -0.335 . . . . 0.0 111.007 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -82.58 0.1 OUTLIER Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 175.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -159.63 160.29 34.11 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.236 0.614 . . . . 0.0 110.351 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.44 143.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.12 -15.24 24.28 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.271 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -154.45 142.65 20.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.588 0.694 . . . . 0.0 110.356 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.489 HG13 HG12 ' A' ' 60' ' ' VAL . 46.5 t -153.9 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 107.829 173.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 163.69 38.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mm -90.5 110.32 40.24 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.15 -41.83 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.315 2.677 . . . . 0.0 114.688 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -82.41 165.69 20.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.083 0.856 . . . . 0.0 109.963 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 50.68 46.63 25.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.055 0.542 . . . . 0.0 112.057 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.488 ' HD3' " H1'" ' B' ' 105' ' ' ' A' . 18.6 ptt180 -54.7 -4.59 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.496 ' CD1' HG23 ' A' ' 51' ' ' THR . 15.6 p90 -146.77 7.1 0.94 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.871 0.76 . . . . 0.0 112.456 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.496 HG23 ' CD1' ' A' ' 50' ' ' TYR . 27.2 p -125.98 -14.1 6.16 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.844 -0.535 . . . . 0.0 111.264 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.32 27.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.855 2.062 . . . . 0.0 114.421 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.95 11.01 2.42 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.949 -0.469 . . . . 0.0 112.011 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -138.45 159.59 41.69 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.919 0.488 . . . . 0.0 110.339 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -170.51 15.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.969 0.908 . . . . 0.0 111.808 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.3 -12.4 58.16 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 118.154 0.434 . . . . 0.0 112.388 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HA ' ' H ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -158.73 168.78 25.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.936 0.894 . . . . 0.0 109.921 176.133 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 95.43 2.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.472 ' CZ ' ' C5 ' ' B' ' 104' ' ' ' G' . 16.9 t80 -63.12 121.34 13.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.2 m -119.38 166.94 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 3.6 ptm180 -145.3 131.22 19.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.554 0.533 . . . . 0.0 111.898 175.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 26.7 m-85 -93.41 172.9 7.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.238 1.015 . . . . 0.0 109.295 171.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.413 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -126.78 -33.91 2.45 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 123.917 0.761 . . . . 0.0 112.754 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.1 133.04 34.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.45 -52.91 63.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.424 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -29.28 70.19 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -85.48 -21.35 28.72 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.899 0.318 . . . . 0.0 110.772 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -81.11 -45.45 16.44 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.391 0.676 . . . . 0.0 109.889 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -77.59 -24.62 49.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.243 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.82 -45.38 43.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.966 0.803 . . . . 0.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -30.08 71.09 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 110.64 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ttp -75.72 -43.27 47.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.392 0.277 . . . . 0.0 110.599 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.02 -0.33 27.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.531 0.15 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.03 -6.32 6.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.7 ttm -136.38 -27.33 1.07 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.482 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -62.65 137.67 58.32 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.393 1.451 . . . . 0.0 108.56 176.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.3 59.63 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.741 -0.477 . . . . 0.0 112.048 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.547 ' O ' HD21 ' A' ' 85' ' ' LEU . . . -131.22 70.24 1.47 Allowed 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.759 HG22 ' N ' ' A' ' 80' ' ' LEU . 9.9 p -45.19 167.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 -167.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.759 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -144.39 -6.79 0.71 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.241 -2.254 . . . . 0.0 116.675 169.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.522 ' H ' HG22 ' A' ' 79' ' ' VAL . 11.8 t70 -157.0 6.95 0.16 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.275 0.943 . . . . 0.0 112.993 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.568 ' H ' ' CG2' ' A' ' 79' ' ' VAL . . . 96.38 16.37 37.67 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 121.812 -0.555 . . . . 0.0 111.801 -174.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -147.2 60.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 123.257 1.503 . . . . 0.0 107.526 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 84' ' ' GLU . 1.3 mp0 -50.3 128.91 20.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 112.794 -2.003 . . . . 0.0 114.381 -166.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.004 ' H ' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -40.02 137.48 0.96 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.759 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mmt-85 -130.52 128.87 42.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.6 p -145.02 120.82 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.109 0.564 . . . . 0.0 109.751 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -154.19 165.13 37.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.22 1.408 . . . . 0.0 108.746 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -56.61 166.02 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.555 1.142 . . . . 0.0 112.87 -173.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.37 143.84 49.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.383 0.673 . . . . 0.0 111.485 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -151.72 -0.67 0.33 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.381 0.672 . . . . 0.0 111.436 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.618 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 13.6 m-30 -78.54 55.39 1.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.127 0.971 . . . . 0.0 112.985 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.72 -149.87 5.13 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 118.301 0.5 . . . . 0.0 112.415 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -153.08 156.47 32.69 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.284 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -32.71 100.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 125.114 3.876 . . . . 0.0 116.367 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -83.61 -24.96 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.421 2.748 . . . . 0.0 110.176 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -150.56 -166.75 2.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.92 1.688 . . . . 0.0 108.481 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.9 p -126.64 -79.11 0.59 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -160.61 17.86 0.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.728 0.24 . . . . 0.0 110.883 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -134.78 11.25 3.67 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 122.941 0.496 . . . . 0.0 111.638 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.169 -178.148 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.847 2 O4'-C1'-N19 115.878 7.678 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.399 2 C1'-O4'-C4' 103.71 -6.545 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.618 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.415 -3.19 0 N19-C1'-C2' 107.958 -3.401 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.488 " H1'" ' HD3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 C3'-C2'-C1' 104.743 3.604 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.796 1 O4'-C1'-N19 112.493 4.293 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.493 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.422 -2.56 2 C4'-C3'-C2' 98.395 -4.305 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.6 mtp . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.2 p -148.96 155.94 41.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.31 0.644 . . . . 0.0 110.416 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 45.93 24.63 0.25 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.756 1.222 . . . . 0.0 113.408 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.85 -45.9 90.99 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.462 -0.632 . . . . 0.0 111.844 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 16.2 ptm180 -166.49 40.2 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 55.8 Cg_endo -66.0 128.07 18.97 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.487 -1.774 . . . . 0.0 107.487 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.28 113.06 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.582 2.855 . . . . 0.0 111.408 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -88.9 -162.1 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.207 3.271 . . . . 0.0 109.507 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -138.67 33.03 2.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 0.0 109.753 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -1.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.325 1.45 . . . . 0.0 113.495 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -105.73 7.59 32.59 Favored 'General case' 0 CA--C 1.527 0.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.526 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.05 17.83 0.32 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.483 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 14.9 ptt? -141.01 169.67 17.18 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.538 0.669 . . . . 0.0 110.804 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.3 m -62.1 166.81 4.42 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.4 m -147.64 61.36 1.14 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 18.9 tp -63.18 155.37 28.37 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.548 ' HE2' ' C5 ' ' B' ' 103' ' ' ' G' . 13.9 pttp -127.43 143.38 51.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.351 0.407 . . . . 0.0 110.173 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -128.17 151.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.003 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -151.48 -170.98 3.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 109.902 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 82.71 28.1 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.842 1.257 . . . . 0.0 113.049 171.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.41 125.07 15.02 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.684 0.794 . . . . 0.0 109.483 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 24' ' ' ARG . 11.9 m -75.17 168.91 19.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.742 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -65.21 8.49 0.14 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.271 1.028 . . . . 0.0 112.781 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.8 ptt180 -134.56 16.98 3.64 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.486 1.114 . . . . 0.0 111.315 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 26' ' ' SER . 1.9 m -120.91 166.57 13.63 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -172.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.9 p -152.72 164.78 19.23 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.425 1.09 . . . . 0.0 109.052 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 55.3 Cg_endo -68.96 -29.36 27.86 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.686 2.257 . . . . 0.0 111.688 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.83 -36.57 75.72 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.081 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.8 m -72.17 -42.37 65.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -54.64 -25.81 29.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.903 -0.498 . . . . 0.0 111.184 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -79.17 -54.6 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -62.49 -29.99 70.94 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.601 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.38 -32.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 122.974 0.51 . . . . 0.0 110.909 -173.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.424 ' CD1' HD13 ' A' ' 30' ' ' LEU . 24.6 m-85 -102.59 -9.74 19.87 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.27 -25.52 60.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.762 -0.586 . . . . 0.0 111.192 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -68.88 -23.32 64.2 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.004 0.366 . . . . 0.0 111.924 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -72.86 -16.28 61.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.439 0.296 . . . . 0.0 111.252 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.07 -80.59 0.13 Allowed Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -162.3 161.68 27.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.672 0.389 . . . . 0.0 110.443 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -136.98 145.87 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.97 -45.22 6.76 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -169.31 167.68 10.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.684 0.394 . . . . 0.0 110.595 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 HG22 ' A' ' 60' ' ' VAL . 16.2 m -121.47 152.12 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -149.33 140.92 23.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.348 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.87 108.17 7.62 Favored Pre-proline 0 CA--C 1.53 0.179 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.04 -21.39 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.566 2.844 . . . . 0.0 112.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 36.63 -103.75 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.77 1.228 . . . . 0.0 110.98 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -142.88 11.93 1.83 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.381 1.073 . . . . 0.0 109.949 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.466 ' HD3' ' CG ' ' A' ' 99' ' ' HIS . 35.9 ttt85 55.18 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.523 1.929 . . . . 0.0 115.764 -178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -141.96 -2.14 1.19 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.314 1.415 . . . . 0.0 113.612 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.03 -20.37 5.78 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.148 0.431 . . . . 0.0 110.878 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 48.45 24.4 0.73 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.147 1.379 . . . . 0.0 113.843 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.74 19.53 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -142.25 168.81 18.86 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.241 0.543 . . . . 0.0 112.082 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -175.29 20.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.475 1.91 . . . . 0.0 110.113 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.83 -9.06 44.37 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.707 -0.621 . . . . 0.0 113.332 -172.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -159.63 163.88 34.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.892 0.877 . . . . 0.0 109.181 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.86 95.32 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.57 96.74 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 18' ' ' VAL . 60.7 t -92.75 148.28 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 17.4 ttt180 -126.1 115.73 20.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.905 0.753 . . . . 0.0 111.739 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 18.3 m-85 -96.78 163.36 13.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.961 0.104 . . . . 0.0 110.914 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.483 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.1 OUTLIER -127.49 -25.36 3.18 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.085 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.12 119.17 26.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -57.47 -49.29 76.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.809 0.277 . . . . 0.0 110.61 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -62.6 -32.63 73.66 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -88.25 -16.03 34.28 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.39 -47.76 12.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.86 -27.35 66.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.118 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.4 -40.83 57.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.509 0.595 . . . . 0.0 110.84 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.49 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.13 -0.356 . . . . 0.0 111.261 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.8 ptp -77.73 -37.4 49.35 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.0 1.02 22.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.978 0.511 . . . . 0.0 111.836 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.78 -4.93 3.62 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttm -138.06 -28.01 0.88 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.45 134.66 56.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.916 0.78 . . . . 0.0 110.037 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.98 9.96 84.62 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.414 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.9 30.15 0.38 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.081 0.941 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.546 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 42.9 t -72.72 162.49 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.431 1.092 . . . . 0.0 112.234 -172.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.28 16.25 0.21 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.836 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -144.61 4.67 1.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.189 0.595 . . . . 0.0 111.472 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.3 -9.13 57.48 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.404 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.92 123.1 0.51 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.523 1.129 . . . . 0.0 108.533 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.7 mm-40 -138.31 -47.32 0.52 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.518 169.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -137.81 153.57 49.63 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.184 0.516 . . . . 0.0 111.937 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.4 mmm180 -149.0 108.24 3.93 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.772 1.629 . . . . 0.0 106.968 168.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.36 140.7 47.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.293 0.237 . . . . 0.0 111.345 -176.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -171.49 175.84 3.97 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.712 1.605 . . . . 0.0 108.046 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.8 mmt -75.45 146.98 40.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.92 51.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -132.38 19.6 4.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.76 139.68 29.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.46 -165.32 13.63 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 122.878 0.275 . . . . 0.0 112.457 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -45.18 127.85 5.72 Favored Pre-proline 0 CA--C 1.526 0.043 0 C-N-CA 123.813 0.845 . . . . 0.0 110.158 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.401 ' HG3' " H5'" ' B' ' 105' ' ' ' A' . 47.1 Cg_endo -67.98 142.59 57.27 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.813 2.342 . . . . 0.0 110.467 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.68 -34.09 4.52 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.038 2.492 . . . . 0.0 110.668 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -167.8 136.2 2.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.057 0.543 . . . . 0.0 110.704 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m -149.94 0.58 0.47 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.517 1.127 . . . . 0.0 111.192 172.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.466 ' CG ' ' HD3' ' A' ' 49' ' ' ARG . 86.1 t60 -153.31 131.36 11.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.648 0.379 . . . . 0.0 110.025 -172.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -157.61 1.4 0.11 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 C--O 1.251 1.178 0 CA-C-O 116.914 -1.517 . . . . 0.0 111.561 -178.621 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.023 2 O4'-C1'-N19 112.446 4.246 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.548 ' C5 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.422 -2.548 2 O4'-C1'-N19 116.696 8.496 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.435 ' P ' " H1'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.414 -3.289 1 O4'-C1'-N19 114.079 5.879 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.401 " H5'" ' HG3' ' A' ' 95' ' ' PRO . . . . . . . . 0 P--O5' 1.624 3.056 1 C5'-C4'-C3' 107.317 -5.456 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.406 " H4'" ' OP2' ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.82 1 C4'-C3'-C2' 98.531 -4.169 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.406 ' OP2' " H4'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 C4'-C3'-C2' 100.137 -2.563 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m -58.18 136.83 57.34 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 122.798 0.439 . . . . 0.0 110.724 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 44.33 29.4 0.37 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.367 1.467 . . . . 0.0 113.117 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.47 62.68 3.78 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.958 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 17.2 mtp180 106.64 21.59 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 127.325 2.25 . . . . 0.0 116.002 167.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 82.2 Cg_endo -71.82 149.81 54.63 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.593 1.605 . . . . 0.0 110.148 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.41 144.73 29.28 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.453 2.768 . . . . 0.0 111.141 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.55 -169.26 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.761 3.64 . . . . 0.0 110.134 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -131.69 17.38 4.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.781 0.832 . . . . 0.0 109.403 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.27 -5.85 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 125.593 1.557 . . . . 0.0 112.877 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.16 -0.32 3.27 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 112.991 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.83 36.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.217 -0.768 . . . . 0.0 113.702 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 165.06 28.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.652 1.226 . . . . 0.0 112.457 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -73.64 93.14 2.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 123.761 0.824 . . . . 0.0 110.844 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -70.44 85.27 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.026 0.931 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.585 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.7 tm? -106.57 134.1 50.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.8 155.34 46.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -168.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.49 155.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -174.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -152.22 -171.09 3.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.679 1.192 . . . . 0.0 110.454 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 87.18 27.36 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.256 1.422 . . . . 0.0 113.145 171.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.77 125.77 15.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.122 0.969 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 23' ' ' TYR . 7.4 m -77.34 171.92 14.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.264 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.519 ' H ' HG22 ' A' ' 22' ' ' THR . 52.5 p90 -63.36 6.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.774 1.23 . . . . 0.0 114.09 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -134.6 15.0 3.7 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.488 0.586 . . . . 0.0 112.084 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 26' ' ' SER . 1.4 m -117.7 165.19 13.91 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -153.3 167.21 13.95 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.648 1.179 . . . . 0.0 109.431 -174.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 43.4 Cg_endo -69.46 -28.47 26.67 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.247 1.965 . . . . 0.0 111.675 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.75 -34.38 75.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.3 m -77.66 -43.77 30.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -57.87 -21.19 41.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.811 -0.555 . . . . 0.0 110.703 178.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -56.51 4.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -61.37 -31.04 70.93 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.645 0.202 . . . . 0.0 110.597 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.28 -34.92 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 122.765 0.426 . . . . 0.0 111.06 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CD1' HD13 ' A' ' 30' ' ' LEU . 16.6 m-85 -99.34 -10.68 21.99 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.63 -27.07 61.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.445 0.566 . . . . 0.0 111.233 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -67.25 -22.65 65.67 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -74.04 -23.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.377 0.271 . . . . 0.0 110.988 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.86 -79.56 0.09 OUTLIER Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.143 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -157.31 164.8 37.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.94 133.68 44.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.07 -38.54 7.83 Favored Glycine 0 CA--C 1.519 0.344 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -158.42 161.02 37.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.879 0.872 . . . . 0.0 109.64 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.628 HG23 HG22 ' A' ' 60' ' ' VAL . 2.1 p -139.07 74.37 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-O 123.301 1.524 . . . . 0.0 107.05 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.468 ' CD2' ' C5 ' ' B' ' 106' ' ' ' G' . 1.7 t80 -83.13 143.64 30.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.299 -169.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.8 mt -140.14 130.36 13.84 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.44 151.1 5.02 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.158 2.572 . . . . 0.0 111.712 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.05 19.19 3.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.262 0.625 . . . . 0.0 109.631 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 50' ' ' TYR . 64.9 m-20 42.47 26.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.11 0.964 . . . . 0.0 112.767 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 9.6 ptt180 42.88 3.26 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.642 2.777 . . . . 0.0 116.312 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.406 ' H ' ' C ' ' A' ' 48' ' ' ASP . 30.0 p90 -165.87 -4.11 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 113.915 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -116.78 -18.9 10.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.154 1.343 . . . . 0.0 111.633 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.69 30.6 0.54 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 125.775 1.63 . . . . 0.0 113.64 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.46 -159.39 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.664 0.786 . . . . 0.0 109.095 171.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.4 t -138.01 172.85 12.32 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.979 0.511 . . . . 0.0 111.384 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -137.02 3.53 2.67 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.514 0.725 . . . . 0.0 111.762 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.34 54.26 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.347 -0.696 . . . . 0.0 112.887 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.81 169.6 23.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.672 1.236 . . . . 0.0 111.318 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.39 101.67 3.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.604 ' CE2' ' C5 ' ' B' ' 104' ' ' ' G' . 51.5 t80 -69.33 89.48 0.48 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.071 1.349 . . . . 0.0 109.066 -175.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.628 HG22 HG23 ' A' ' 43' ' ' VAL . 68.0 t -75.39 158.59 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 172.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -138.98 128.21 24.05 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.8 m-85 -106.05 173.69 6.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.19 1.396 . . . . 0.0 109.555 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.6 -38.31 0.74 Allowed 'General case' 0 C--N 1.339 0.127 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.79 124.62 32.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.427 -0.796 . . . . 0.0 109.133 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -53.75 -49.39 68.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.848 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -58.73 -24.9 62.34 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.001 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.8 p30 -110.42 -6.57 14.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.714 0.688 . . . . 0.0 111.287 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.585 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.34 -46.63 22.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.39 -31.06 48.19 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.569 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -71.27 -43.9 66.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.482 1.037 . . . . 0.0 111.089 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.41 75.12 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 118.146 0.43 . . . . 0.0 110.278 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttp -72.22 -42.52 65.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.751 0.42 . . . . 0.0 110.627 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.19 3.51 23.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.332 -0.23 . . . . 0.0 111.24 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.35 -6.32 4.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.0 ttm -137.47 -28.17 0.92 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.452 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -63.1 137.87 58.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 118.016 -1.473 . . . . 0.0 109.865 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.7 10.71 80.27 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.903 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 33.0 0.4 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.262 1.031 . . . . 0.0 110.547 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.637 HG22 ' H ' ' A' ' 81' ' ' ASP . 9.8 p -73.28 174.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -170.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.577 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.3 pt? -152.69 4.92 0.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.622 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.637 ' H ' HG22 ' A' ' 79' ' ' VAL . 36.8 t70 -141.52 -3.72 1.15 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.548 0.339 . . . . 0.0 111.886 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.87 -10.55 32.15 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.55 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.41 128.18 3.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 79' ' ' VAL . 13.1 mm-40 -144.24 -49.54 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.2 mm? -138.64 154.61 48.65 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.103 0.561 . . . . 0.0 112.294 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.7 mmt180 -152.03 112.52 4.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.868 1.667 . . . . 0.0 106.506 166.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.57 125.69 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.232 0.539 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -154.07 163.67 39.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.361 1.464 . . . . 0.0 108.36 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 mmt -61.01 140.94 57.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.577 0.751 . . . . 0.0 110.356 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 156.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -145.74 18.92 1.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.259 1.024 . . . . 0.0 108.661 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.472 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 3.3 t80 -148.75 135.8 20.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.32 176.38 21.71 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.333 0.407 . . . . 0.0 113.523 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -63.3 135.87 96.44 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 123.729 0.812 . . . . 0.0 110.266 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.438 ' HG3' " C5'" ' B' ' 105' ' ' ' A' . 36.0 Cg_endo -65.98 134.05 35.7 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.767 2.312 . . . . 0.0 109.799 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.72 -20.99 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.329 2.686 . . . . 0.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -150.73 157.33 42.83 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.608 1.163 . . . . 0.0 107.88 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p -65.41 -14.41 60.83 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -162.59 25.96 0.1 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.822 1.192 . . . . 0.0 112.13 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -145.51 168.57 20.28 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.083 -0.385 . . . . 0.0 109.986 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.255 -179.743 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.15 1 O4'-C1'-N19 115.388 7.188 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.593 1 C1'-O4'-C4' 105.327 -4.748 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.604 ' C5 ' ' CE2' ' A' ' 59' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.192 0 P-O3'-C3' 123.523 3.186 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.439 " H1'" ' HB3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.839 0 O5'-C5'-C4' 114.368 2.977 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.468 ' C5 ' ' CD2' ' A' ' 44' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.107 0 C5'-C4'-C3' 109.589 -3.941 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.457 " C3'" ' HD2' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.412 -3.41 2 C1'-O4'-C4' 104.119 -6.091 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m -144.8 -175.11 4.54 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.325 0.65 . . . . 0.0 110.27 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -130.53 -22.56 2.71 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.835 0.454 . . . . 0.0 111.481 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.448 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 78.39 32.09 43.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.219 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.445 ' HD3' " H1'" ' B' ' 107' ' ' ' U' . 11.3 ptm180 34.68 57.69 2.19 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.07 1.348 . . . . 0.0 113.034 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.65 150.89 79.71 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.016 2.477 . . . . 0.0 110.464 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.22 122.06 8.05 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.539 2.826 . . . . 0.0 110.571 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -80.88 -167.94 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.775 2.983 . . . . 0.0 110.433 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -129.61 29.35 5.06 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.679 0.792 . . . . 0.0 110.319 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 m -56.23 -12.74 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.678 1.191 . . . . 0.0 112.585 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.07 -0.94 5.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.227 1.011 . . . . 0.0 112.931 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.41 28.74 0.14 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.341 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.34 166.37 25.28 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.856 1.328 . . . . 0.0 112.082 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.408 ' OG1' ' HE3' ' A' ' 65' ' ' LYS . 91.1 m -82.99 90.13 6.97 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.869 0.868 . . . . 0.0 111.285 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.9 m -67.21 85.97 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.889 0.876 . . . . 0.0 110.428 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 31.8 tp -70.95 162.92 28.51 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.245 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 25.3 ttpp -133.55 143.61 48.82 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.123 0.969 . . . . 0.0 110.529 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 30' ' ' LEU . 95.0 t -131.42 146.43 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -150.67 -169.74 3.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.777 1.631 . . . . 0.0 110.406 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.49 27.13 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.755 1.622 . . . . 0.0 113.563 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.22 123.43 11.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.762 0.825 . . . . 0.0 109.959 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 24' ' ' ARG . 10.4 m -72.25 168.04 19.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -64.69 9.7 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 113.123 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 22' ' ' THR . 23.5 ptt180 -135.06 17.88 3.46 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.474 1.11 . . . . 0.0 111.397 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -125.29 162.83 23.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.661 0.385 . . . . 0.0 111.385 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.465 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 62.9 m -148.72 163.79 24.33 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.682 1.193 . . . . 0.0 109.018 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 26' ' ' SER . 55.3 Cg_endo -69.18 -30.54 24.81 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.277 1.985 . . . . 0.0 111.697 -175.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.34 -35.24 79.85 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.942 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.8 m -74.36 -44.19 53.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -56.34 -22.26 29.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.853 -0.53 . . . . 0.0 110.52 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -57.67 3.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.31 -30.71 71.35 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.771 0.319 . . . . 0.0 110.75 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.06 -32.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.481 ' CD1' HD13 ' A' ' 30' ' ' LEU . 19.5 m-85 -100.64 -11.67 19.82 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.47 -26.73 64.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.494 -0.754 . . . . 0.0 110.928 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.49 -23.82 65.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.7 -16.38 59.53 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 122.64 0.376 . . . . 0.0 111.603 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.26 -82.16 0.11 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -158.94 165.27 34.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.045 0.45 . . . . 0.0 111.048 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.3 123.11 49.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.82 -23.77 51.65 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -164.68 155.68 14.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.117 0.484 . . . . 0.0 110.896 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.62 125.3 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -159.11 157.61 31.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.95 -167.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.407 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 9.9 mt -127.06 88.8 53.52 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 158.93 4.38 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.102 3.202 . . . . 0.0 111.425 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 49' ' ' ARG . 82.3 mtm-85 -146.19 157.18 43.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.76 3.66 1.38 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 47' ' ' ARG . 9.2 ttm-85 62.55 -2.42 0.36 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.181 1.392 . . . . 0.0 114.008 172.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.443 ' CD1' HG23 ' A' ' 51' ' ' THR . 39.9 p90 -149.37 0.19 0.5 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.443 HG23 ' CD1' ' A' ' 50' ' ' TYR . 20.8 p -127.56 -22.49 3.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.635 0.652 . . . . 0.0 111.386 171.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.0 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.687 1.995 . . . . 0.0 114.877 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.41 5.47 8.74 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.985 -0.447 . . . . 0.0 111.521 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.5 p -65.94 -23.07 66.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -34.8 116.66 0.34 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.803 1.241 . . . . 0.0 112.509 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.24 -6.85 0.28 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.679 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 172.0 15.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.808 0.843 . . . . 0.0 110.231 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.89 94.88 2.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 18.8 t80 -64.79 109.54 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG11 HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -114.1 159.86 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.2 ptm180 -136.85 145.18 44.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.063 -175.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.442 ' HB2' ' CB ' ' A' ' 16' ' ' LEU . 4.7 m-85 -114.8 177.58 4.6 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.77 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.66 -32.7 0.99 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.85 127.69 32.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.229 0.468 . . . . 0.0 109.988 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HE3' ' OG1' ' A' ' 14' ' ' THR . 2.6 tppp? -60.38 -56.75 17.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -33.21 68.12 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -84.93 -23.93 28.61 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.977 0.353 . . . . 0.0 110.507 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -76.58 -44.15 35.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.48 -19.3 58.15 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.002 -0.436 . . . . 0.0 111.349 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -79.47 -39.94 30.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.588 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.09 76.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.951 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.1 ptp -75.37 -39.45 59.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.658 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -77.2 1.56 18.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.279 0.632 . . . . 0.0 111.702 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.22 -6.35 3.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttm -138.41 -27.07 0.88 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.06 137.65 57.82 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.926 0.784 . . . . 0.0 110.058 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 10.36 86.01 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 119.607 -0.552 . . . . 0.0 112.439 175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.13 30.99 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.076 0.938 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.574 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 43.0 t -75.22 163.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 124.335 1.054 . . . . 0.0 112.176 -171.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.82 10.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.241 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.6 4.75 2.62 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.464 0.705 . . . . 0.0 111.486 -175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.46 -8.49 58.6 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.417 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -172.47 123.18 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.397 1.079 . . . . 0.0 108.643 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.574 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.4 mm-40 -137.9 -47.85 0.55 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 169.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -137.78 153.94 49.63 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 111.753 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.2 mmm180 -148.04 109.34 4.34 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.049 1.739 . . . . 0.0 106.721 167.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.53 134.71 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -168.11 173.03 8.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -76.25 139.94 41.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.168 0.587 . . . . 0.0 110.364 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.57 162.39 29.54 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.499 0.32 . . . . 0.0 110.568 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -144.86 15.25 1.55 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 108.991 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.711 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 23.1 m-85 -135.1 166.41 23.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.45 168.28 14.35 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 117.912 0.324 . . . . 0.0 112.923 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 157.86 17.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.101 0.96 . . . . 0.0 111.526 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -33.56 97.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 1 C-N-CA 126.314 4.676 . . . . 0.0 115.924 -176.214 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 72.8 Cg_endo -77.88 -56.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.499 2.133 . . . . 0.0 109.276 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 15.6 t0 -176.45 123.03 0.16 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.566 1.146 . . . . 0.0 109.95 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.411 ' HB2' " H5'" ' B' ' 105' ' ' ' A' . 17.7 m -156.19 8.5 0.23 Allowed 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 124.334 1.054 . . . . 0.0 110.793 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -144.87 18.0 1.62 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -166.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -62.54 168.65 3.51 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.041 0.537 . . . . 0.0 111.731 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 117.132 -1.413 . . . . 0.0 109.798 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.386 1 O4'-C1'-N19 114.477 6.277 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' ' G' . . . . . 0.531 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.845 2 O4'-C1'-N19 115.681 7.481 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ' G' . . . . . 0.711 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.743 0 P-O3'-C3' 124.059 3.632 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ' A' . . . . . 0.411 " H5'" ' HB2' ' A' ' 98' ' ' SER . . . . . . . . 0 O4'--C4' 1.418 -2.908 2 C3'-C2'-C1' 105.287 4.208 OUTLIER-EPSILON 0.01 1z . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.423 ' C8 ' ' HB3' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 P-O3'-C3' 124.293 3.828 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.448 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.421 -2.679 1 C5'-C4'-C3' 108.484 -4.677 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.377 0.132 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.46 -81.55 0.03 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -153.86 69.09 6.32 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 125.342 1.457 . . . . 0.0 110.346 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 118.04 5.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.087 2.525 . . . . 0.0 109.986 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.08 113.8 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.83 3.02 . . . . 0.0 110.894 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -87.83 -167.88 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.928 3.085 . . . . 0.0 109.849 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -137.59 41.71 2.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 109.511 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 17.7 m -52.7 -14.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.941 1.696 . . . . 0.0 113.693 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -88.4 5.23 43.21 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.124 0.569 . . . . 0.0 111.303 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.02 19.82 0.66 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.45 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 5.1 ptt? -139.39 166.61 24.11 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.793 0.796 . . . . 0.0 111.835 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -63.34 -26.54 68.81 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t 44.03 58.85 3.45 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.19 0.996 . . . . 0.0 112.478 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 23.4 tp -63.91 164.4 10.38 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 20.4 ttpp -137.21 142.08 42.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.339 1.055 . . . . 0.0 109.986 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -135.39 152.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 174.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -153.37 -167.78 2.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.107 1.363 . . . . 0.0 110.542 -174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 82.9 28.29 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.69 1.596 . . . . 0.0 113.309 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.64 126.18 22.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.795 0.838 . . . . 0.0 109.303 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -68.91 168.25 14.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -62.52 3.29 0.21 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -139.14 18.5 2.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.771 0.829 . . . . 0.0 112.078 -174.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -112.38 165.56 12.09 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.895 0.478 . . . . 0.0 110.391 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 82.8 p -149.59 167.06 13.78 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.319 1.048 . . . . 0.0 109.038 -176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.4 Cg_endo -68.98 -26.75 30.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.403 2.069 . . . . 0.0 111.68 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.86 -33.78 74.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.997 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -74.9 -44.38 49.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -58.67 -20.91 52.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.8 -0.562 . . . . 0.0 111.103 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -82.02 -56.62 3.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -62.91 -24.75 67.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.684 0.22 . . . . 0.0 110.481 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.9 t -83.11 -34.96 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.715 0.406 . . . . 0.0 110.644 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CD1' HD13 ' A' ' 30' ' ' LEU . 20.2 m-85 -99.27 -10.96 21.72 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -72.71 -26.61 61.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.634 -0.666 . . . . 0.0 111.441 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.98 -22.93 64.07 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -73.28 -20.89 60.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.844 0.458 . . . . 0.0 111.267 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.05 -88.92 0.1 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -154.23 164.47 38.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.37 0.605 . . . . 0.0 111.733 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.66 133.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.29 -24.43 24.32 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -161.65 152.69 18.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.077 0.465 . . . . 0.0 110.084 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -149.87 103.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 176.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -150.18 161.63 42.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.101 -167.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 mt -134.35 132.21 20.89 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.33 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.11 -29.69 32.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.962 2.441 . . . . 0.0 111.325 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 36.92 30.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.257 1.823 . . . . 0.0 114.708 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 51.39 12.31 0.14 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.674 0.79 . . . . 0.0 112.812 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 52.53 -14.18 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.879 2.472 . . . . 0.0 116.064 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -155.47 4.12 0.19 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.686 1.13 . . . . 0.0 113.271 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 -25.6 3.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.846 0.748 . . . . 0.0 112.054 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.1 21.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.962 2.105 . . . . 0.0 115.008 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.95 -11.66 59.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.772 -0.58 . . . . 0.0 112.371 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.5 t -83.56 -78.11 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.048 0.385 . . . . 0.0 110.684 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.66 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.255 2.222 . . . . 0.0 115.894 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.11 -2.64 32.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.79 -0.569 . . . . 0.0 112.559 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -155.71 169.86 23.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.124 0.57 . . . . 0.0 110.097 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.79 103.54 3.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -66.11 92.2 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.695 0.798 . . . . 0.0 108.889 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 30' ' ' LEU . 92.5 t -87.27 155.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.9 ttt180 -138.31 131.84 30.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 123.148 0.28 . . . . 0.0 111.236 -172.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 6.4 m-85 -115.11 170.8 8.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.657 0.265 . . . . 0.0 111.143 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -32.96 2.02 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.42 122.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.04 -54.23 49.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.421 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -58.86 -33.18 70.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -85.32 -21.22 29.03 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.983 0.356 . . . . 0.0 110.542 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.85 -42.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.941 0.496 . . . . 0.0 110.22 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -73.84 -25.57 60.14 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.05 -0.407 . . . . 0.0 110.511 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.15 -47.68 34.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.232 0.469 . . . . 0.0 110.393 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -31.53 71.72 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.347 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.8 ttp -74.01 -42.75 59.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.119 0.568 . . . . 0.0 110.452 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.8 2.96 24.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.024 0.13 . . . . 0.0 111.215 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.24 -5.59 4.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttm -137.88 -29.4 0.85 Allowed 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -64.15 140.23 58.85 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.932 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.8 6.98 83.18 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.72 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.8 32.06 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.165 0.983 . . . . 0.0 110.784 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.585 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 23.0 t -73.99 164.61 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.846 0.858 . . . . 0.0 111.569 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.7 5.06 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.9 3.3 1.82 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.145 0.43 . . . . 0.0 112.076 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.63 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.313 0.482 . . . . 0.0 112.632 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -172.44 115.19 0.31 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.268 1.027 . . . . 0.0 109.008 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.585 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 79.6 mm-40 -130.88 -50.45 1.04 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.119 171.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.438 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -140.53 153.54 46.21 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.304 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 22.6 mmt180 -151.79 113.96 4.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 167.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.34 135.79 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-O 121.227 0.536 . . . . 0.0 110.445 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.5 173.05 10.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.423 1.489 . . . . 0.0 108.275 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.51 147.62 50.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.524 0.73 . . . . 0.0 111.102 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.73 150.18 29.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -141.99 21.17 2.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -145.55 143.56 30.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.15 179.36 21.02 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 117.885 0.312 . . . . 0.0 112.876 -169.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -57.64 148.81 54.95 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.018 0.527 . . . . 0.0 110.981 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.02 135.64 21.37 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.65 2.9 . . . . 0.0 111.089 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.36 -39.9 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.589 2.192 . . . . 0.0 109.379 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.04 136.33 1.46 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.486 1.115 . . . . 0.0 109.503 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--N 1.333 -0.13 0 C-N-CA 124.062 0.945 . . . . 0.0 110.287 178.347 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.777 0.322 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.31 -73.38 2.6 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -178.73 52.4 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.07 139.63 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.544 2.163 . . . . 0.0 110.595 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.93 115.37 3.28 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.657 2.905 . . . . 0.0 110.097 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.27 -166.97 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.842 3.028 . . . . 0.0 110.571 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -132.41 28.69 4.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.244 1.018 . . . . 0.0 110.463 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.5 m -53.98 -18.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 124.771 1.228 . . . . 0.0 113.425 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -77.5 4.58 10.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.341 0.656 . . . . 0.0 111.912 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 16.66 0.67 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.017 -0.879 . . . . 0.0 112.324 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.07 166.91 23.37 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 1.206 . . . . 0.0 113.38 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -61.26 -27.67 68.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -167.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.1 m 44.48 38.55 2.67 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.561 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -62.58 132.88 53.86 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.704 -0.623 . . . . 0.0 109.844 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 68.8 tttt -97.68 148.88 22.88 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.524 0.73 . . . . 0.0 112.518 -170.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 60' ' ' VAL . 98.2 t -127.12 147.96 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -155.32 -176.83 6.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.479 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 51.9 t30 84.96 38.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.179 1.392 . . . . 0.0 113.4 171.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.4 138.09 57.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.846 0.859 . . . . 0.0 108.96 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.429 HG22 ' CD1' ' A' ' 23' ' ' TYR . 6.7 m -80.4 166.16 21.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.737 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CD1' HG22 ' A' ' 22' ' ' THR . 52.6 p90 -62.88 6.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.431 1.092 . . . . 0.0 113.373 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 22' ' ' THR . 34.8 ptt180 -135.06 20.34 3.46 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.965 1.306 . . . . 0.0 111.337 -174.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -123.87 165.02 18.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.817 0.447 . . . . 0.0 110.531 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.474 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.8 p -149.4 165.5 17.49 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 124.047 0.939 . . . . 0.0 109.351 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 61.9 Cg_endo -71.15 -25.16 22.66 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.052 1.835 . . . . 0.0 111.868 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.43 -34.19 75.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 121.839 -0.538 . . . . 0.0 109.674 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.5 m -75.63 -43.28 48.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.484 HD11 HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -56.19 -23.48 35.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.623 -0.673 . . . . 0.0 111.093 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -80.61 -55.63 4.71 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -61.29 -28.74 69.4 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.042 0.383 . . . . 0.0 110.645 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -80.48 -33.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 122.94 0.496 . . . . 0.0 111.542 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 30' ' ' LEU . 28.7 m-85 -103.07 -9.27 19.87 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.44 -24.32 57.03 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.733 -0.604 . . . . 0.0 111.016 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.91 -22.55 63.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.249 0.477 . . . . 0.0 112.169 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.26 -17.49 61.89 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 122.342 0.257 . . . . 0.0 111.123 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.2 -76.38 0.17 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -164.14 162.49 22.86 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.547 0.739 . . . . 0.0 110.445 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -136.42 144.16 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.23 -24.48 19.16 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -162.36 149.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 117.085 0.443 . . . . 0.0 111.062 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 60' ' ' VAL . 87.0 t -139.26 113.59 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -146.4 160.47 42.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.2 92.1 40.08 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.651 0.38 . . . . 0.0 110.85 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -49.14 135.06 30.6 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 124.049 3.166 . . . . 0.0 111.147 173.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -164.78 164.68 21.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.09 117.48 10.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -67.48 16.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -169.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.458 ' CD2' HG23 ' A' ' 51' ' ' THR . 10.2 p90 -146.89 -3.05 0.6 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.692 1.197 . . . . 0.0 112.001 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.458 HG23 ' CD2' ' A' ' 50' ' ' TYR . 44.6 p -123.68 -24.72 4.45 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.72 0.691 . . . . 0.0 110.371 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptt 49.88 26.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.979 1.712 . . . . 0.0 113.119 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.66 5.88 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.9 m 58.92 -178.18 0.08 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -141.62 0.09 1.42 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.55 16.97 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.887 0.767 . . . . 0.0 113.432 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -153.91 169.63 22.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.321 1.06 . . . . 0.0 110.026 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.0 96.69 3.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -63.04 115.94 4.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.507 HG12 HG13 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -116.99 163.16 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -139.06 125.58 20.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.826 0.704 . . . . 0.0 110.587 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 21.8 m-85 -96.34 158.62 15.35 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.561 0.744 . . . . 0.0 109.936 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.514 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -114.56 -30.98 6.35 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.653 0.595 . . . . 0.0 112.348 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.77 119.39 21.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -61.49 -45.13 95.51 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.341 0.257 . . . . 0.0 110.644 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.502 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -67.13 -28.96 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -90.96 -13.34 33.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.561 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.97 -42.78 25.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -77.42 -25.24 50.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.614 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.33 -47.11 36.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.646 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.87 73.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.4 ttp -73.3 -42.16 62.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.781 0.432 . . . . 0.0 110.369 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.02 3.21 27.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.263 -0.273 . . . . 0.0 111.558 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.53 -6.52 4.68 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.8 ttm -139.45 -26.54 0.81 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.14 134.72 56.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.396 0.998 . . . . 0.0 110.755 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 8.67 85.68 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.128 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.41 33.4 0.35 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.19 0.995 . . . . 0.0 111.098 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.591 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 46.1 t -69.42 164.52 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.012 0.925 . . . . 0.0 112.209 -173.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.404 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -157.97 9.95 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.68 -178.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -149.88 4.4 0.56 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.107 0.867 . . . . 0.0 113.249 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.55 -20.35 4.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.852 -0.53 . . . . 0.0 111.974 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.511 ' C ' HG13 ' A' ' 79' ' ' VAL . 6.2 ptp180 -175.23 143.65 0.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.112 1.765 . . . . 0.0 106.651 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.591 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.2 mm-40 -141.59 -47.62 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.643 169.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.482 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.92 159.29 42.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.79 0.805 . . . . 0.0 112.124 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 10.1 mmm180 -152.33 114.34 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 16' ' ' LEU . 21.3 t -136.88 127.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -167.46 165.17 14.94 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.86 142.21 58.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.366 -172.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.65 167.81 6.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.133 0.573 . . . . 0.0 111.524 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -139.39 -8.19 1.3 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 123.346 0.658 . . . . 0.0 110.993 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -140.25 173.61 11.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -116.79 175.61 15.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 117.719 0.236 . . . . 0.0 112.834 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -60.36 142.21 90.65 Favored Pre-proline 0 C--O 1.233 0.19 0 C-N-CA 123.737 0.815 . . . . 0.0 110.136 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.05 130.41 31.63 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.321 2.681 . . . . 0.0 113.403 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.66 -25.31 9.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.761 2.307 . . . . 0.0 109.324 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -159.31 161.61 35.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.127 1.371 . . . . 0.0 107.679 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.111 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 110.965 -0.013 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.77 45.42 27.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.534 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 38.94 50.39 2.63 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.161 1.384 . . . . 0.0 114.36 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.01 149.28 52.61 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.209 2.606 . . . . 0.0 110.89 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.93 123.84 8.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.254 2.636 . . . . 0.0 110.499 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -81.85 -165.98 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.813 3.009 . . . . 0.0 110.367 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.69 30.17 4.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.922 0.889 . . . . 0.0 109.691 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 33.7 m -57.06 -12.23 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.607 1.163 . . . . 0.0 112.646 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.83 -0.04 8.22 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.919 0.887 . . . . 0.0 112.388 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.93 32.29 0.18 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.889 -0.951 . . . . 0.0 113.472 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.1 ptt? -142.89 164.86 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.546 1.173 . . . . 0.0 111.675 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -60.63 -28.01 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -170.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m 43.24 59.25 3.03 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 16.3 tp -66.42 169.58 7.24 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 13.9 pttt -139.09 155.58 47.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.402 0.546 . . . . 0.0 111.05 171.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 60' ' ' VAL . 57.2 t -134.15 145.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -150.06 -174.59 4.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.48 1.112 . . . . 0.0 109.815 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 83' ' ' ARG . 8.0 t30 92.52 29.88 0.01 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.221 1.409 . . . . 0.0 112.968 169.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.92 117.74 3.19 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.538 1.135 . . . . 0.0 109.802 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 23' ' ' TYR . 3.0 m -67.44 171.09 6.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' H ' HG22 ' A' ' 22' ' ' THR . 48.9 p90 -62.84 3.09 0.25 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.094 0.958 . . . . 0.0 113.01 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ptt-85 -134.26 14.28 3.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.388 0.675 . . . . 0.0 111.85 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -113.34 165.51 12.36 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.3 p -150.89 167.94 11.98 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.57 1.148 . . . . 0.0 108.839 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 62.4 Cg_endo -69.52 -35.02 14.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.264 1.976 . . . . 0.0 110.721 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -61.51 -36.07 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.117 0.484 . . . . 0.0 109.886 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -71.79 -44.23 64.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.506 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -54.65 -23.88 19.18 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.227 -0.296 . . . . 0.0 111.585 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -78.77 -56.56 4.31 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -65.29 -20.38 66.39 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.778 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.75 -32.1 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.636 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -106.16 -7.92 17.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.982 0.513 . . . . 0.0 112.277 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.47 -26.14 55.04 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.217 0.462 . . . . 0.0 111.155 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -67.64 -23.69 65.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.223 0.465 . . . . 0.0 112.244 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.89 -17.76 61.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.667 0.387 . . . . 0.0 111.526 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.84 -82.26 0.11 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.78 163.09 37.05 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.159 0.584 . . . . 0.0 110.789 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -135.3 140.25 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.59 -21.5 21.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -161.86 155.86 21.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.703 0.752 . . . . 0.0 111.713 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 60' ' ' VAL . 61.1 t -147.46 125.34 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 46' ' ' PRO . 1.6 t80 -157.48 152.66 25.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.53 71.2 52.33 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 20.4 Cg_endo -93.29 -6.45 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.616 1 C-N-CA 126.48 4.787 . . . . 0.0 117.979 -167.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -48.86 -36.43 16.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.366 1.439 . . . . 0.0 111.97 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -144.17 101.51 3.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 168.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -62.12 8.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.717 1.607 . . . . 0.0 114.908 -169.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.507 ' CD1' HG23 ' A' ' 51' ' ' THR . 18.6 p90 -150.84 6.09 0.51 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.33 1.052 . . . . 0.0 112.279 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.507 HG23 ' CD1' ' A' ' 50' ' ' TYR . 11.5 p -130.57 -29.02 2.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.866 0.757 . . . . 0.0 111.72 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.93 23.87 0.31 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.466 1.506 . . . . 0.0 113.029 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.65 11.18 0.2 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -131.92 25.47 4.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.472 0.709 . . . . 0.0 110.207 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 8.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.995 1.718 . . . . 0.0 114.831 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.38 -3.46 2.95 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.492 0.587 . . . . 0.0 111.768 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -152.88 168.04 27.09 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.407 1.083 . . . . 0.0 109.082 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.32 97.23 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.3 109.92 1.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.1 m -107.27 170.03 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.4 ptm180 -144.53 145.65 31.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.764 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 23.2 m-85 -112.73 166.71 11.11 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.068 0.547 . . . . 0.0 109.926 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.455 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.87 -30.91 2.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.698 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.07 125.4 30.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -61.21 -54.2 47.24 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.401 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -58.92 -32.14 69.29 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -86.76 -18.19 31.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.952 0.342 . . . . 0.0 110.762 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.36 -43.96 16.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 122.709 0.404 . . . . 0.0 110.147 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -73.25 -26.62 61.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.267 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -73.82 -46.47 44.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.322 0.51 . . . . 0.0 110.717 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.97 72.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.5 ttp -75.07 -40.98 59.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.105 0.562 . . . . 0.0 110.347 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.9 2.99 31.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.065 0.146 . . . . 0.0 111.279 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.83 -5.83 4.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.2 ttm -137.42 -28.95 0.9 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.445 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.1 t70 -64.51 137.86 58.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 120.161 1.346 . . . . 0.0 110.007 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.73 16.42 79.21 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.729 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.85 29.46 1.02 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.115 0.958 . . . . 0.0 110.371 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.487 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 41.2 t -72.66 170.47 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.168 1.387 . . . . 0.0 112.486 -170.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.44 ' N ' HG12 ' A' ' 79' ' ' VAL . 1.1 pt? -153.82 3.32 0.27 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -139.69 2.08 1.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.75 -20.02 4.38 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.241 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -177.77 135.22 0.17 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.995 1.318 . . . . 0.0 108.074 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.487 ' HG3' ' HA ' ' A' ' 79' ' ' VAL . 9.6 mt-10 -140.85 -37.56 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.019 171.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -144.4 149.98 36.98 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.703 0.401 . . . . 0.0 111.872 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.4 mmt180 -151.79 106.56 3.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.623 1.569 . . . . 0.0 106.879 166.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -133.87 126.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 CA-C-O 121.226 0.536 . . . . 0.0 110.495 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -156.59 175.29 14.24 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 125.67 1.588 . . . . 0.0 108.923 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.99 145.83 53.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.034 0.934 . . . . 0.0 110.389 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.44 170.34 16.3 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.966 0.506 . . . . 0.0 111.652 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -147.07 3.23 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.167 0.587 . . . . 0.0 110.985 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -131.73 175.17 9.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.314 0.646 . . . . 0.0 109.579 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.0 177.2 16.48 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 121.507 0.504 . . . . 0.0 114.176 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -62.43 160.14 35.8 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.427 1.491 . . . . 0.0 112.634 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -34.05 103.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 126.527 4.818 . . . . 0.0 116.637 178.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.46 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 75.5 Cg_endo -81.12 -60.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.91 2.406 . . . . 0.0 109.433 169.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.46 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 12.8 t0 -179.1 131.14 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.317 1.447 . . . . 0.0 109.882 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.462 0.169 0 C-N-CA 125.297 1.439 . . . . 0.0 110.008 176.322 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.24 36.16 21.71 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.985 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.89 57.25 0.94 Allowed Pre-proline 0 N--CA 1.465 0.284 0 C-N-CA 125.51 1.524 . . . . 0.0 113.146 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.52 147.73 77.41 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.23 2.62 . . . . 0.0 109.668 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 114.97 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.562 2.841 . . . . 0.0 110.649 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.47 -162.65 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.42 3.414 . . . . 0.0 110.182 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -134.51 33.06 3.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.23 0.612 . . . . 0.0 111.14 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 m -64.5 6.13 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.187 1.395 . . . . 0.0 113.373 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.71 2.9 0.86 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.973 0.909 . . . . 0.0 113.194 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.9 -8.88 0.04 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.507 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -65.64 169.69 5.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.592 1.196 . . . . 0.0 111.866 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -58.67 -26.37 63.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m 43.72 37.09 1.46 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.4 tm? -63.75 136.03 57.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.42 155.34 46.57 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -171.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.35 158.03 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.297 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -154.78 -173.74 4.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.167 0.987 . . . . 0.0 110.777 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.612 HD21 ' HB2' ' A' ' 83' ' ' ARG . 20.3 t30 96.81 27.94 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.744 1.617 . . . . 0.0 113.077 168.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 117.58 4.37 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.494 1.117 . . . . 0.0 109.778 -175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -70.8 166.89 20.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -62.95 10.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.964 1.306 . . . . 0.0 113.907 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -130.04 17.8 5.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.893 0.877 . . . . 0.0 111.618 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 26' ' ' SER . 1.3 m -126.82 170.32 12.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 -173.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 25' ' ' THR . 94.4 p -152.7 163.74 22.56 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.253 1.021 . . . . 0.0 109.296 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.8 -28.08 25.49 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.506 2.137 . . . . 0.0 111.717 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.57 -33.03 74.2 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.95 -0.469 . . . . 0.0 109.822 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.0 m -75.51 -46.48 32.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -56.94 -19.8 20.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -55.78 5.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -62.74 -31.27 72.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.188 0.995 . . . . 0.0 110.968 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.01 -32.71 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.442 0.297 . . . . 0.0 111.619 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.0 m-85 -98.67 -11.23 22.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.977 0.353 . . . . 0.0 111.941 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.55 -27.74 62.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.689 -0.632 . . . . 0.0 111.679 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.35 -22.54 65.58 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -73.78 -18.67 60.94 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.72 0.408 . . . . 0.0 111.129 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.88 -79.37 0.1 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -158.62 165.06 35.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 110.398 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -133.88 138.7 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.98 -26.61 7.4 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -163.08 161.35 25.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.916 0.358 . . . . 0.0 110.33 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.404 ' CG2' HG22 ' A' ' 60' ' ' VAL . 1.5 p -168.73 110.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.25 176.13 13.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.543 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mt -125.2 85.87 57.63 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.13 -23.71 17.83 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.449 3.433 . . . . 0.0 113.281 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 2.1 tpp180 -64.01 115.77 5.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 41.58 69.22 0.37 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 110.222 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -54.6 5.55 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.045 2.138 . . . . 0.0 116.61 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -143.54 7.41 1.5 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.514 1.125 . . . . 0.0 110.81 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -124.76 -38.23 2.39 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.02 24.7 0.13 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.228 2.211 . . . . 0.0 113.142 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -65.02 -21.2 66.81 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -76.93 -49.7 14.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.573 0.349 . . . . 0.0 110.824 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 37.07 31.64 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.627 1.971 . . . . 0.0 114.783 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.34 -10.47 74.68 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.59 -0.694 . . . . 0.0 112.016 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -163.13 169.11 19.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.603 0.701 . . . . 0.0 111.084 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 102.63 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -67.92 94.78 0.49 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG21 HD12 ' A' ' 30' ' ' LEU . 59.4 t -81.35 160.74 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -143.84 134.94 25.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.043 0.537 . . . . 0.0 109.987 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -117.28 148.27 41.83 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.484 1.113 . . . . 0.0 109.836 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.597 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -99.59 -27.21 13.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -173.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.66 134.2 55.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 110.458 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.66 -45.6 93.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.745 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -33.77 76.56 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.98 0.809 . . . . 0.0 111.969 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.7 -24.71 36.03 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.68 -47.29 19.55 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.072 0.949 . . . . 0.0 110.839 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.09 -27.29 60.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.79 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -70.97 -40.46 71.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.278 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.39 73.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.024 -0.422 . . . . 0.0 111.333 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.5 ptp -78.8 -37.61 40.36 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.509 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -77.12 -0.73 25.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.23 0.612 . . . . 0.0 111.743 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.87 -4.99 4.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.7 ttm -138.02 -25.57 0.97 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.7 t70 -63.52 138.31 58.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 118.398 -1.321 . . . . 0.0 110.005 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.76 14.96 77.98 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.914 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.08 36.71 0.52 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.041 0.921 . . . . 0.0 110.257 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.636 HG22 ' H ' ' A' ' 80' ' ' LEU . 6.2 p -72.12 176.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -169.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.636 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.1 pt? -151.78 -1.22 0.32 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.723 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.541 ' H ' HG22 ' A' ' 79' ' ' VAL . 37.3 t70 -144.45 -0.77 0.95 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.45 -19.09 6.0 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.612 ' HB2' HD21 ' A' ' 20' ' ' ASN . 0.1 OUTLIER -165.96 136.04 3.43 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' N ' HG23 ' A' ' 79' ' ' VAL . 19.7 mm-40 -144.79 -41.82 0.24 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.89 150.29 44.41 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.834 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -152.27 108.11 3.35 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 126.121 1.769 . . . . 0.0 106.659 168.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -134.96 134.77 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.238 0.542 . . . . 0.0 111.284 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 89' ' ' MET . 31.4 tt0 -166.26 168.02 15.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.322 1.449 . . . . 0.0 108.11 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.428 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 11.6 mmt -61.28 142.31 56.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.176 0.99 . . . . 0.0 110.773 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 155.52 38.15 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.889 0.476 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -140.11 9.81 2.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.499 0.72 . . . . 0.0 109.608 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -131.43 169.18 16.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.015 0.926 . . . . 0.0 109.335 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.3 -177.64 14.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -56.02 145.0 56.57 Favored Pre-proline 0 C--O 1.233 0.194 0 C-N-CA 123.271 0.629 . . . . 0.0 110.501 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.01 145.75 56.63 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.44 2.76 . . . . 0.0 112.276 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.0 -23.39 4.58 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.451 3.434 . . . . 0.0 112.198 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -149.96 164.53 35.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.601 1.16 . . . . 0.0 108.965 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.126 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.97 92.51 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.414 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.8 ptm85 -168.91 42.87 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.527 1.163 . . . . 0.0 113.539 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 69.2 Cg_endo -68.99 136.11 34.12 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.52 1.48 . . . . 0.0 108.93 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.64 116.29 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.846 3.031 . . . . 0.0 110.98 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.61 -162.05 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.912 3.075 . . . . 0.0 110.142 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.67 30.5 2.85 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.489 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 31.2 m -63.48 -7.05 2.6 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 C-N-CA 123.881 0.872 . . . . 0.0 112.624 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.51 0.26 15.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.75 0.82 . . . . 0.0 112.812 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.25 51.43 0.13 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.252 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.489 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 11.7 ptp -132.39 173.8 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.821 0.811 . . . . 0.0 112.957 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -70.21 -22.5 62.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.173 0.989 . . . . 0.0 112.066 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 m 42.09 59.85 2.47 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.442 1.097 . . . . 0.0 113.618 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 22.5 tp -61.66 162.22 8.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 17.2 pttp -132.1 151.4 51.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.107 0.412 . . . . 0.0 110.655 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.17 143.04 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -149.31 -177.85 6.07 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 124.187 0.93 . . . . 0.0 110.413 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 t30 91.12 26.21 0.02 OUTLIER 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.158 1.383 . . . . 0.0 113.38 169.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.17 121.5 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.985 0.914 . . . . 0.0 109.682 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 24' ' ' ARG . 13.4 m -67.75 167.75 12.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -63.61 8.99 0.07 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.657 1.183 . . . . 0.0 113.471 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' THR . 29.6 ptt180 -133.58 16.44 3.99 Favored 'General case' 0 C--N 1.335 -0.041 0 C-N-CA 123.858 0.863 . . . . 0.0 111.818 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -124.05 165.63 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.459 0.303 . . . . 0.0 111.246 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 59.5 p -151.68 168.57 10.92 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.706 1.202 . . . . 0.0 109.256 -175.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 56.7 Cg_endo -68.94 -27.57 30.31 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.319 2.013 . . . . 0.0 111.713 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.85 -30.62 68.15 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.478 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 97.0 m -75.1 -45.08 43.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -59.02 -19.14 40.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.905 -0.497 . . . . 0.0 110.935 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -81.48 -56.63 3.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.385 0.539 . . . . 0.0 110.604 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.478 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -69.91 -15.46 63.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.276 -175.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.84 -30.93 4.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 123.419 0.688 . . . . 0.0 111.363 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.1 m-85 -103.12 -9.94 19.27 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.438 0.563 . . . . 0.0 112.288 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.97 -26.43 62.26 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.751 -0.593 . . . . 0.0 111.187 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.78 -24.14 64.38 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.68 -17.01 61.68 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.47 -80.43 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -162.53 167.24 23.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.023 0.529 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -133.09 138.95 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.19 -25.27 14.56 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -162.74 154.19 17.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.883 0.473 . . . . 0.0 110.17 174.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 60' ' ' VAL . 1.4 p -150.33 107.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -151.36 162.25 41.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.513 -166.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.76 126.43 15.74 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.48 42.46 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.702 3.601 . . . . 0.0 110.413 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -44.42 -44.8 8.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.928 1.291 . . . . 0.0 111.561 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -178.34 165.02 1.78 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.36 1.464 . . . . 0.0 108.898 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.79 -5.66 2.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.633 169.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -168.3 14.93 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.564 1.146 . . . . 0.0 111.717 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 p -129.45 -14.58 4.18 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -168.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 43.14 24.1 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.608 1.563 . . . . 0.0 113.772 -172.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.63 -155.95 0.08 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.081 0.952 . . . . 0.0 110.358 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 m -156.09 169.59 24.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.224 1.41 . . . . 0.0 109.615 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 27.2 mmt180 -130.03 -172.42 2.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.932 0.893 . . . . 0.0 108.897 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.57 29.61 5.83 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.264 0.935 . . . . 0.0 112.406 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 55' ' ' ARG . 38.0 p90 -153.63 170.95 19.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.479 0.712 . . . . 0.0 109.576 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.89 101.78 3.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -67.22 91.74 0.25 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.444 0.698 . . . . 0.0 109.387 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.527 HG21 HD12 ' A' ' 30' ' ' LEU . 48.6 t -81.53 159.35 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 172.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.1 ttt180 -140.24 131.74 27.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.688 0.395 . . . . 0.0 110.421 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.5 m-85 -113.58 157.92 21.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.057 0.39 . . . . 0.0 111.647 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.495 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -113.18 -34.6 5.62 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.1 128.05 33.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -64.56 -50.53 66.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.396 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -29.54 68.81 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.55 -20.72 31.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.5 49.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -77.36 -19.99 55.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.493 -0.13 . . . . 0.0 111.271 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.78 -41.58 44.09 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.199 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.4 75.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.161 -0.337 . . . . 0.0 111.395 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.0 ptp -75.52 -41.33 55.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.766 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -75.51 1.29 14.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.572 0.749 . . . . 0.0 111.705 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -5.96 3.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.3 ttm -141.23 -25.82 0.72 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -62.57 137.97 58.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.708 1.14 . . . . 0.0 111.101 -177.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.92 9.18 75.2 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.373 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.42 29.34 0.51 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.683 HG12 ' N ' ' A' ' 84' ' ' GLU . 4.9 m -66.48 175.29 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 126.345 1.858 . . . . 0.0 113.847 -172.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.93 -1.3 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -143.49 4.3 1.36 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.433 0.56 . . . . 0.0 112.08 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.92 -27.4 3.33 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -157.36 160.08 38.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.178 0.489 . . . . 0.0 110.027 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.683 ' N ' HG12 ' A' ' 79' ' ' VAL . 16.4 mt-10 -160.62 -43.91 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.628 1.171 . . . . 0.0 109.68 165.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.46 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.2 mm? -139.47 153.84 47.61 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.9 mmt180 -153.76 107.21 2.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.256 1.822 . . . . 0.0 106.183 166.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.6 p -134.23 127.83 51.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 123.029 0.532 . . . . 0.0 110.134 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -156.74 -175.01 5.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.489 1.916 . . . . 0.0 108.112 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.2 mmt -82.84 142.27 31.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.13 155.66 40.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.374 0.269 . . . . 0.0 111.249 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -137.93 9.17 2.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.416 1.087 . . . . 0.0 110.488 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.2 175.63 8.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 109.678 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.68 175.78 17.82 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 117.943 0.338 . . . . 0.0 113.054 -173.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -61.73 156.41 55.33 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.109 0.964 . . . . 0.0 111.399 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -27.49 95.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 1 C-N-CA 126.413 4.742 . . . . 0.0 117.292 -176.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.72 -26.07 1.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.56 2.84 . . . . 0.0 110.083 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -158.13 -177.63 6.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.772 1.629 . . . . 0.0 107.273 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.389 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.86 -80.22 1.84 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 170.87 68.6 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.573 1.149 . . . . 0.0 111.5 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.15 167.23 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.397 2.731 . . . . 0.0 111.216 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -98.15 71.83 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.637 1 C-N-CA 125.491 4.127 . . . . 0.0 112.945 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.72 -166.32 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.984 3.123 . . . . 0.0 110.294 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -131.57 34.16 3.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.442 0.697 . . . . 0.0 109.819 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.31 -11.98 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.021 0.928 . . . . 0.0 112.04 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.71 -6.57 47.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.774 0.83 . . . . 0.0 111.909 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.79 -8.16 0.07 OUTLIER Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.546 -0.585 . . . . 0.0 114.053 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.8 mtp -60.68 162.25 6.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.569 1.185 . . . . 0.0 111.013 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -60.34 -23.72 64.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.336 0.254 . . . . 0.0 110.659 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 t 42.92 55.36 4.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.536 1.134 . . . . 0.0 112.859 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 19.3 tp -61.39 159.04 13.3 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -143.98 140.4 29.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.517 0.599 . . . . 0.0 110.75 175.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 60' ' ' VAL . 4.9 p -134.12 149.89 30.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 123.002 0.521 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -151.41 -170.12 3.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.902 1.281 . . . . 0.0 109.868 -176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 t30 87.73 26.76 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.918 1.287 . . . . 0.0 112.125 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.21 127.39 21.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.534 1.134 . . . . 0.0 109.412 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 23' ' ' TYR . 7.1 m -76.22 169.54 18.02 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.295 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.455 ' H ' HG22 ' A' ' 22' ' ' THR . 53.6 p90 -63.13 5.74 0.14 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.921 1.288 . . . . 0.0 114.009 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -133.53 14.25 4.09 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.693 0.679 . . . . 0.0 112.013 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 26' ' ' SER . 3.2 m -114.87 165.82 12.43 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.92 0.391 . . . . 0.0 110.919 -173.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 86.7 p -150.42 167.16 13.54 Favored Pre-proline 0 CA--C 1.529 0.139 0 C-N-CA 124.219 1.008 . . . . 0.0 109.63 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.2 Cg_endo -69.78 -34.25 14.9 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.684 2.256 . . . . 0.0 110.274 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.21 -36.17 83.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -72.78 -43.95 62.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -57.12 -21.56 33.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.272 -0.267 . . . . 0.0 110.833 -178.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -80.42 -56.66 4.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -7.97 41.74 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -97.67 -31.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.776 0.43 . . . . 0.0 111.644 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.5 m-85 -101.11 -12.1 19.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.507 0.594 . . . . 0.0 111.874 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.84 -24.17 59.73 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.901 -0.499 . . . . 0.0 111.242 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.61 -23.73 64.49 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.786 -0.571 . . . . 0.0 112.077 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -75.27 -17.64 60.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.468 0.307 . . . . 0.0 111.391 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.53 -85.83 0.09 OUTLIER Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -157.32 162.4 39.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.067 0.547 . . . . 0.0 110.342 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.9 t -134.43 142.05 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -75.92 -46.82 12.71 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.18 171.85 4.0 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.318 0.58 . . . . 0.0 110.661 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG12 HG22 ' A' ' 60' ' ' VAL . 14.4 m -124.97 143.62 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 172.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -152.18 150.71 30.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.742 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mt -139.59 76.01 30.94 Favored Pre-proline 0 CA--C 1.528 0.131 0 C-N-CA 123.317 0.647 . . . . 0.0 109.946 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 95.4 Cg_endo -77.25 178.21 7.92 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 124.529 3.486 . . . . 0.0 111.798 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 46' ' ' PRO . 28.7 tpt180 129.52 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 129.175 2.99 . . . . 0.0 108.281 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 50' ' ' TYR . 20.2 m-20 -147.58 87.42 1.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 174.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -63.96 14.3 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.54 1.536 . . . . 0.0 114.862 -170.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.525 ' CD1' HG23 ' A' ' 51' ' ' THR . 11.5 p90 -145.25 5.14 1.09 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.295 1.438 . . . . 0.0 110.822 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.525 HG23 ' CD1' ' A' ' 50' ' ' TYR . 7.0 p -133.38 -33.71 1.1 Allowed 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.135 -0.353 . . . . 0.0 111.154 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 34.29 33.49 0.01 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.956 2.102 . . . . 0.0 113.553 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -6.59 45.73 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.9 t -67.42 162.94 21.94 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.225 0.466 . . . . 0.0 110.849 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -155.26 7.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.3 -12.59 81.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.29 169.46 23.14 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.682 0.793 . . . . 0.0 109.796 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.23 95.65 1.73 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -62.8 97.19 0.1 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 43' ' ' VAL . 37.8 t -99.66 152.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 6.9 ptm180 -137.03 143.76 42.88 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 15.8 m-85 -113.64 160.5 18.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.479 0.712 . . . . 0.0 111.472 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.499 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -110.79 -36.1 5.79 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.71 133.64 34.79 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -66.54 -54.67 21.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.131 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.468 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -59.36 -34.22 72.12 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -83.11 -20.0 35.67 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.151 0.432 . . . . 0.0 110.872 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -81.99 -44.99 15.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 122.632 0.373 . . . . 0.0 110.162 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.97 -26.37 64.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.237 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.17 -47.49 43.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.068 0.394 . . . . 0.0 111.171 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.06 -31.75 72.96 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 122.004 -0.435 . . . . 0.0 110.499 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttp -74.32 -43.71 55.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.053 0.541 . . . . 0.0 110.423 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -79.73 1.9 24.8 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.91 -5.25 5.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.7 ttm -136.41 -28.69 1.0 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.534 ' HB2' HG12 ' A' ' 87' ' ' VAL . 4.6 t70 -63.89 136.2 57.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.852 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.68 10.69 83.18 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.779 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.17 34.58 0.47 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.945 0.872 . . . . 0.0 109.903 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 81' ' ' ASP . 8.8 p -73.83 174.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.595 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.2 pt? -151.98 3.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.703 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.616 ' H ' HG22 ' A' ' 79' ' ' VAL . 36.3 t70 -142.83 -3.5 0.99 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.35 -10.5 30.99 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.573 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.62 129.02 4.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.139 0.975 . . . . 0.0 108.643 173.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 79' ' ' VAL . 11.3 mm-40 -144.42 -50.25 0.28 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 170.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.4 mm? -138.69 152.98 48.49 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 122.828 0.451 . . . . 0.0 111.666 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -150.38 103.09 3.11 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 166.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 76' ' ' ASP . 4.3 p -131.47 132.99 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.944 0.402 . . . . 0.0 111.145 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -153.21 176.28 12.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.911 1.284 . . . . 0.0 109.595 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.8 mmt -76.7 133.9 39.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.5 0.72 . . . . 0.0 109.069 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.63 149.94 47.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.723 0.297 . . . . 0.0 110.773 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -139.31 18.28 2.58 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.287 1.035 . . . . 0.0 108.917 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -145.33 144.71 30.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -119.79 174.85 15.67 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.739 0.699 . . . . 0.0 114.431 -168.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -61.2 139.53 94.48 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.804 1.242 . . . . 0.0 109.969 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.82 146.78 54.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.848 3.032 . . . . 0.0 112.937 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.81 -24.36 3.42 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.232 3.288 . . . . 0.0 111.545 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -152.36 160.67 43.28 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.526 1.131 . . . . 0.0 109.1 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 p . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.815 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.584 0.23 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.06 -81.94 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 125.268 1.413 . . . . 0.0 109.677 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -152.8 55.98 1.61 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 111.502 -167.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.81 118.42 5.59 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.551 2.167 . . . . 0.0 111.356 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.32 119.08 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.562 2.842 . . . . 0.0 110.883 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -84.38 -166.59 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.16 3.24 . . . . 0.0 110.501 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -134.92 36.86 3.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.181 0.992 . . . . 0.0 110.017 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.33 11.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.638 1.575 . . . . 0.0 114.337 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.96 0.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.24 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -5.14 0.09 OUTLIER Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.168 0.44 . . . . 0.0 113.363 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 7.5 ptt? -62.6 166.74 5.0 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.168 0.984 . . . . 0.0 112.718 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -59.15 -26.59 64.88 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.5 m 42.17 59.19 2.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.204 1.001 . . . . 0.0 113.512 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 22.1 tp -62.72 164.35 7.92 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 19.0 ttpp -135.72 145.08 46.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.043 0.937 . . . . 0.0 110.74 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.589 ' HB ' HG22 ' A' ' 60' ' ' VAL . 92.4 t -130.31 148.69 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.792 0.837 . . . . 0.0 108.952 173.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -152.26 -169.32 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.7 1.6 . . . . 0.0 110.138 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 83.93 27.37 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.403 1.481 . . . . 0.0 113.51 170.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.2 119.33 4.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.149 0.98 . . . . 0.0 109.93 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 23' ' ' TYR . 19.9 m -70.71 169.87 13.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.476 ' H ' HG22 ' A' ' 22' ' ' THR . 54.7 p90 -62.53 5.22 0.12 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 113.741 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -130.71 14.29 5.38 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.313 0.645 . . . . 0.0 112.018 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 26' ' ' SER . 2.4 m -120.24 164.91 15.54 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.088 -173.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.528 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 97.5 p -149.08 168.01 11.86 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 124.283 1.033 . . . . 0.0 109.38 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.06 -29.66 22.07 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.627 2.218 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.32 -35.0 78.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.6 m -74.1 -44.74 52.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.552 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -56.75 -20.78 23.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.248 -0.282 . . . . 0.0 110.855 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -79.46 -57.34 3.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -14.44 63.0 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.76 -32.25 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.394 0.678 . . . . 0.0 111.502 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 30' ' ' LEU . 23.0 m-85 -103.38 -9.49 19.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.3 -27.45 63.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.241 0.473 . . . . 0.0 110.908 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -68.45 -23.52 64.61 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.97 -16.89 61.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.187 0.195 . . . . 0.0 111.504 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.12 -80.73 0.13 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -160.29 164.84 32.29 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.992 0.517 . . . . 0.0 110.52 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.32 144.81 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -175.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.64 -21.45 7.88 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.38 157.81 28.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.472 0.636 . . . . 0.0 110.095 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.402 HG23 HG12 ' A' ' 60' ' ' VAL . 2.2 p -169.15 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.138 0.975 . . . . 0.0 108.414 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.14 167.54 28.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.5 mm -98.07 103.52 17.95 Favored Pre-proline 0 N--CA 1.456 -0.141 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.82 -46.28 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.549 2.166 . . . . 0.0 111.478 -171.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.39 -178.83 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.79 2.436 . . . . 0.0 116.392 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.97 106.84 8.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -54.22 0.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.39 2.276 . . . . 0.0 114.697 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CD2' HG23 ' A' ' 51' ' ' THR . 40.6 p90 -137.71 0.57 2.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.835 0.743 . . . . 0.0 112.309 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.465 HG23 ' CD2' ' A' ' 50' ' ' TYR . 28.7 p -127.05 -19.51 4.37 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.677 0.672 . . . . 0.0 111.216 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.404 1.881 . . . . 0.0 113.983 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -125.7 7.2 7.49 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -72.49 -6.73 45.83 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -40.24 141.71 0.46 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.773 1.629 . . . . 0.0 112.426 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.14 -3.56 0.91 Allowed Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.933 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -155.03 166.92 32.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.898 0.879 . . . . 0.0 109.573 174.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 106.76 4.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -70.21 110.85 5.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.589 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -113.04 164.68 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.3 ttt180 -142.87 139.74 30.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 11.0 m-85 -116.92 164.97 13.89 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.564 0.54 . . . . 0.0 110.717 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.436 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -123.48 -31.57 3.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.232 0.613 . . . . 0.0 112.462 -177.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.54 125.32 30.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.1 -52.32 64.36 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.433 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -60.11 -33.61 72.36 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -84.02 -19.73 33.98 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.53 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.04 -42.86 18.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.89 -26.59 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.816 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.11 -40.33 62.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.313 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -33.41 75.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.232 -0.292 . . . . 0.0 111.592 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.0 ptp -78.06 -37.48 46.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.08 1.74 23.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.141 0.576 . . . . 0.0 111.807 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.33 -6.86 4.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.0 ttm -138.89 -26.71 0.85 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.93 136.16 55.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.229 0.922 . . . . 0.0 110.181 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.97 9.9 86.61 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.162 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.67 32.61 0.42 Allowed 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.309 1.055 . . . . 0.0 110.263 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.527 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 38.7 t -74.62 164.49 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.367 1.067 . . . . 0.0 112.094 -170.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -154.96 10.53 0.34 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.472 0.709 . . . . 0.0 112.217 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.35 5.09 2.24 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.87 0.468 . . . . 0.0 111.507 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.54 -9.84 57.44 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.93 124.92 0.55 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.694 1.198 . . . . 0.0 108.131 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.527 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 29.3 mm-40 -137.97 -48.89 0.56 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.249 0.22 . . . . 0.0 110.451 169.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -136.78 156.44 48.51 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 121.419 0.628 . . . . 0.0 112.296 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.0 mmm180 -148.05 109.08 4.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.955 1.702 . . . . 0.0 106.577 167.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.22 134.23 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -169.58 173.86 6.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.0 mmt -75.64 136.61 40.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.166 0.586 . . . . 0.0 109.909 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.49 151.58 45.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -140.52 21.4 2.37 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.662 0.785 . . . . 0.0 109.597 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -143.88 158.0 43.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.31 178.38 17.73 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.894 0.717 . . . . 0.0 114.894 -168.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.442 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 55.7 mtp180 -62.54 161.66 25.51 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 125.312 1.445 . . . . 0.0 111.034 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 94' ' ' ARG . 13.5 Cg_exo -28.92 96.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 1 C-N-CA 126.001 4.468 . . . . 0.0 114.952 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.47 -57.29 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.706 2.271 . . . . 0.0 110.504 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -168.33 21.12 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.199 0.599 . . . . 0.0 111.712 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 C--N 1.33 -0.247 0 C-N-CA 124.008 0.923 . . . . 0.0 112.842 -175.332 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.427 0.156 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.36 -32.06 0.16 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.71 2.1 . . . . 0.0 114.609 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 5' ' ' ARG 0.25 11.8 ptm85 146.06 65.63 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 128.879 2.872 . . . . 0.0 109.643 176.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -58.84 116.61 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.78 2.987 . . . . 0.0 111.324 -168.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -100.98 74.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.962 1 C-N-CA 125.981 4.454 . . . . 0.0 113.758 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.99 -162.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.802 2.334 . . . . 0.0 109.803 170.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -66.05 32.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.744 1.218 . . . . 0.0 113.805 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.481 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 10.5 m -56.68 -9.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.64 -12.83 61.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.888 0.475 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.29 15.15 0.03 OUTLIER Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.188 -0.784 . . . . 0.0 113.802 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 12.8 ptp -65.69 176.5 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.662 1.231 . . . . 0.0 112.263 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -70.08 -24.91 63.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.321 0.648 . . . . 0.0 112.323 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m 46.6 36.86 3.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.492 1.117 . . . . 0.0 113.868 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.2 tm? -65.87 132.84 49.62 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 17.7 pttt -117.04 161.02 20.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -130.51 147.83 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -151.59 -175.83 5.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.297 1.439 . . . . 0.0 110.34 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 58.9 t30 86.44 37.73 0.02 OUTLIER 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 113.455 169.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.43 163.55 10.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 24' ' ' ARG . 20.0 m -116.61 169.53 9.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.611 0.765 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -61.63 4.11 0.11 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.336 1.054 . . . . 0.0 113.438 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.0 ptm180 -136.03 19.11 3.22 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.398 1.079 . . . . 0.0 110.991 -175.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 26' ' ' SER . 1.9 m -124.17 167.38 14.34 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.246 0.618 . . . . 0.0 110.276 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.3 p -152.29 165.78 16.76 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.605 0.762 . . . . 0.0 109.754 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.4 Cg_endo -69.58 -27.65 27.07 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.811 2.34 . . . . 0.0 110.03 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -68.13 -37.71 81.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -72.76 -43.53 62.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.93 -19.74 32.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.337 -0.227 . . . . 0.0 111.031 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.64 -55.81 4.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -7.51 37.88 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.194 0.452 . . . . 0.0 112.009 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.435 HG12 ' HE1' ' A' ' 75' ' ' MET . 60.4 t -98.21 -31.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.317 0.647 . . . . 0.0 111.113 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.432 ' CD1' HD13 ' A' ' 30' ' ' LEU . 22.5 m-85 -102.84 -11.26 18.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.98 -24.99 60.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 121.914 -0.491 . . . . 0.0 110.921 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -68.65 -24.04 64.49 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -72.84 -19.51 61.3 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 122.611 0.364 . . . . 0.0 111.52 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.48 -82.99 0.1 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -158.18 164.58 36.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.928 0.491 . . . . 0.0 110.979 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.5 t -135.29 138.58 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.92 -24.0 18.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -163.26 156.08 18.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.915 0.358 . . . . 0.0 110.453 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 60' ' ' VAL . 2.5 p -153.13 112.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -148.97 159.14 44.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -165.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -121.68 93.48 48.67 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 124.353 1.061 . . . . 0.0 108.938 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.65 33.23 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.599 3.532 . . . . 0.0 112.505 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -65.38 164.02 14.51 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.66 111.0 1.11 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.39 9.11 1.11 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CD1' HG23 ' A' ' 51' ' ' THR . 12.0 p90 -144.85 -0.96 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 111.823 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.487 HG23 ' CD1' ' A' ' 50' ' ' TYR . 13.1 p -124.25 -8.04 7.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.381 0.537 . . . . 0.0 110.271 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.87 20.34 0.34 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.215 2.206 . . . . 0.0 113.173 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.7 102.36 0.74 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -57.06 166.57 1.02 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.427 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.34 -4.07 4.34 Favored 'General case' 0 N--CA 1.46 0.075 0 C-N-CA 123.87 0.868 . . . . 0.0 110.732 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.18 68.74 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.192 -0.782 . . . . 0.0 113.144 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.98 172.11 17.98 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.942 1.371 . . . . 0.0 111.746 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 92.71 2.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.472 1.109 . . . . 0.0 108.394 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -62.88 110.8 1.88 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -107.81 167.42 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -140.21 145.08 36.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.58 146.71 47.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.822 0.849 . . . . 0.0 110.694 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.667 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -99.51 -32.63 11.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.812 -177.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.92 127.07 33.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.762 0.425 . . . . 0.0 110.426 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.45 -51.73 58.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -59.8 -33.69 72.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.61 -21.17 30.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.97 0.35 . . . . 0.0 110.341 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.39 -46.98 18.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.391 0.677 . . . . 0.0 110.225 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.52 -17.51 59.22 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.208 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.6 -40.02 35.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.095 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.38 75.5 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.141 -0.349 . . . . 0.0 111.293 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.454 ' HA ' HG13 ' A' ' 87' ' ' VAL . 12.2 ptp -74.68 -42.82 57.74 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.362 0.601 . . . . 0.0 109.682 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.99 1.25 13.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.805 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.37 -10.02 4.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.435 ' HE1' HG12 ' A' ' 33' ' ' VAL . 4.6 ttp -146.84 -17.63 0.41 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.43 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -61.84 136.94 58.18 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.715 1.143 . . . . 0.0 110.273 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.07 8.87 65.69 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.611 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.05 29.71 0.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.483 1.141 . . . . 0.0 112.039 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.675 HG12 ' N ' ' A' ' 84' ' ' GLU . 3.9 m -65.61 175.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.418 1.887 . . . . 0.0 114.127 -172.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 0.47 0.82 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -142.31 3.9 1.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.986 0.812 . . . . 0.0 111.992 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.4 -27.42 3.4 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -158.71 160.48 36.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.675 ' N ' HG12 ' A' ' 79' ' ' VAL . 21.1 mt-10 -160.12 -44.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.702 1.201 . . . . 0.0 110.095 166.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.0 mm? -141.78 151.94 43.3 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.231 0.612 . . . . 0.0 112.217 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 29.8 mmt180 -153.49 114.13 4.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 165.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 72' ' ' MET . 1.4 p -139.38 116.82 11.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.499 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -151.53 164.92 35.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.081 1.352 . . . . 0.0 108.489 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.6 mmt -61.82 142.64 57.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.345 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.11 169.8 14.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.638 0.775 . . . . 0.0 110.76 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -142.65 2.98 1.44 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.196 0.598 . . . . 0.0 110.558 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -133.79 166.84 21.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.23 179.28 17.38 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -61.17 145.29 90.16 Favored Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 122.506 0.322 . . . . 0.0 110.776 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.31 150.63 17.48 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.539 2.826 . . . . 0.0 111.834 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.19 -42.44 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.132 2.555 . . . . 0.0 111.025 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.42 148.34 2.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.256 1.022 . . . . 0.0 110.017 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 173.054 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.82 0.343 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 47.56 59.7 5.79 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.566 1.555 . . . . 0.0 113.51 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 39.34 62.53 5.04 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 126.378 1.871 . . . . 0.0 112.668 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.46 155.66 24.84 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.714 2.943 . . . . 0.0 109.645 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.61 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.416 2.744 . . . . 0.0 109.247 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HB2' HG13 ' A' ' 10' ' ' VAL . 35.1 Cg_endo -83.92 -172.35 1.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.837 3.025 . . . . 0.0 111.93 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -133.35 23.77 4.1 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.075 1.35 . . . . 0.0 108.535 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 8' ' ' PRO . 29.9 m -65.23 -2.26 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 125.555 1.542 . . . . 0.0 112.858 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.55 9.47 1.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.066 0.946 . . . . 0.0 112.209 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.43 40.0 0.33 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.643 -0.532 . . . . 0.0 112.634 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.3 ptp -135.25 175.11 9.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.927 0.863 . . . . 0.0 112.293 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -71.1 -23.3 62.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.171 0.588 . . . . 0.0 112.405 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.7 m 43.56 57.08 4.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.86 0.864 . . . . 0.0 113.296 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.466 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 17.5 tp -65.11 166.3 9.8 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 20.0 pttp -138.28 154.94 49.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.838 170.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.499 ' HB ' HG22 ' A' ' 60' ' ' VAL . 83.1 t -130.88 143.09 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -148.92 -175.5 4.97 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.928 0.891 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 41.6 t30 83.82 37.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.76 1.224 . . . . 0.0 113.673 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 158.83 11.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.867 0.867 . . . . 0.0 108.958 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 24' ' ' ARG . 6.8 m -118.78 171.54 8.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.639 0.775 . . . . 0.0 109.959 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CD2' HG22 ' A' ' 22' ' ' THR . 53.4 p90 -63.52 7.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.829 1.252 . . . . 0.0 112.969 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 22' ' ' THR . 8.3 ptm180 -132.17 17.78 4.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.039 1.336 . . . . 0.0 110.401 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.52 167.37 19.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.015 0.526 . . . . 0.0 110.72 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 95.5 p -154.71 164.05 22.27 Favored Pre-proline 0 N--CA 1.464 0.254 0 C-N-CA 123.994 0.918 . . . . 0.0 109.127 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 49.5 Cg_endo -68.29 -30.16 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.064 1.842 . . . . 0.0 111.701 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.34 -33.88 73.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.09 -44.56 65.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.427 HD11 HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -57.78 -21.3 41.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.145 -0.347 . . . . 0.0 111.222 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -81.28 -57.01 3.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.027 -0.42 . . . . 0.0 109.895 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -9.16 42.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.903 0.481 . . . . 0.0 111.854 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.91 -31.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.214 0.606 . . . . 0.0 111.807 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.5 m-85 -100.44 -11.45 20.18 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.397 0.544 . . . . 0.0 111.907 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.828 -0.545 . . . . 0.0 111.429 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.37 -23.23 63.72 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -71.04 -31.01 67.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.499 0.32 . . . . 0.0 110.48 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.76 -76.48 0.07 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -162.37 165.71 26.1 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 117.198 0.499 . . . . 0.0 110.577 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.5 t -137.53 138.05 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -71.98 -45.08 43.8 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.99 171.65 6.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.129 0.49 . . . . 0.0 110.265 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -159.36 128.57 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.979 0.911 . . . . 0.0 109.68 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.58 175.9 10.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.528 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -116.6 88.26 23.94 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 124.049 0.94 . . . . 0.0 109.367 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.49 150.92 52.52 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.838 3.025 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -179.16 -178.81 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.034 0.934 . . . . 0.0 108.565 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -58.01 109.18 0.69 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -67.58 19.14 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.581 1.552 . . . . 0.0 115.125 -168.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CD2' HG23 ' A' ' 51' ' ' THR . 5.7 p90 -149.89 -19.24 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.061 0.944 . . . . 0.0 111.991 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.46 HG23 ' CD2' ' A' ' 50' ' ' TYR . 27.8 p -103.75 -25.27 13.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.662 173.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.2 31.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.609 1.963 . . . . 0.0 113.966 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.24 -15.73 62.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.084 0.554 . . . . 0.0 112.292 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -97.12 155.74 16.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 111.359 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -171.63 16.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.399 1.079 . . . . 0.0 111.221 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.71 2.03 75.39 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.34 -0.85 . . . . 0.0 113.229 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.21 169.08 24.92 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.038 0.919 . . . . 0.0 110.219 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.67 92.35 2.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.27 110.58 1.68 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -105.6 163.76 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.8 ptm180 -139.06 142.58 38.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.756 0.66 . . . . 0.0 110.678 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 16.1 m-85 -116.57 150.87 37.3 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.799 0.687 . . . . 0.0 111.557 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.613 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -95.83 -50.56 4.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 123.986 0.804 . . . . 0.0 112.008 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.67 135.17 49.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.947 0.499 . . . . 0.0 110.857 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -69.06 -52.38 29.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 178.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.457 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.68 -31.9 73.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -77.36 -26.34 51.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.871 0.367 . . . . 0.0 110.086 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -78.48 -40.91 34.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 122.031 -0.418 . . . . 0.0 110.512 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.71 -22.3 56.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.87 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.87 -40.06 48.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.948 0.794 . . . . 0.0 109.937 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.89 74.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.323 -0.236 . . . . 0.0 111.464 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.7 ptp -77.42 -39.69 46.1 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.322 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.63 0.64 19.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.133 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.72 -6.28 4.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.1 ttm -139.15 -24.0 0.89 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.64 135.89 57.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.151 0.887 . . . . 0.0 110.099 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.39 10.19 78.62 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.093 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.1 35.01 0.42 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.015 0.908 . . . . 0.0 110.797 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.626 HG22 ' H ' ' A' ' 80' ' ' LEU . 10.0 p -69.09 174.78 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.626 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.2 pt? -152.73 -0.12 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.648 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.553 ' H ' HG22 ' A' ' 79' ' ' VAL . 32.5 t70 -145.37 0.02 0.88 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.06 -18.61 6.17 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.625 ' C ' HG23 ' A' ' 79' ' ' VAL . 6.9 ptp180 -161.49 142.04 10.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 171.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 85' ' ' LEU . 23.3 mm-40 -147.12 -50.38 0.19 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.61 151.3 45.9 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.0 mmm180 -147.79 109.73 4.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 105.804 167.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.82 134.64 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.116 0.567 . . . . 0.0 109.96 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 89' ' ' MET . 36.6 tt0 -169.9 177.67 4.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.408 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 14.1 mmt -73.95 144.83 45.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.841 0.456 . . . . 0.0 109.786 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.78 163.93 15.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.467 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -133.73 -1.29 3.08 Favored 'General case' 0 C--O 1.23 0.051 0 C-N-CA 122.517 0.327 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.58 169.92 15.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.99 179.08 16.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.49 120.17 29.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.84 139.3 47.25 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.493 2.128 . . . . 0.0 111.659 -171.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.43 -17.99 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.492 3.461 . . . . 0.0 112.217 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -140.08 -169.2 2.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.46 1.104 . . . . 0.0 109.592 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p . . . . . 0 N--CA 1.46 0.065 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -174.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.634 0.254 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.09 59.28 0.47 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 45.47 46.98 3.46 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 127.331 2.252 . . . . 0.0 115.753 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.35 154.88 41.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.538 2.159 . . . . 0.0 108.508 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.54 112.87 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.395 2.73 . . . . 0.0 109.994 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -84.39 -165.68 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.355 2.703 . . . . 0.0 110.678 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -133.26 24.55 4.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.855 0.862 . . . . 0.0 109.607 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 31.1 m -64.72 -5.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 124.356 1.062 . . . . 0.0 112.553 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 6.8 2.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.38 41.07 0.41 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.557 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 9.1 ptp -134.43 172.9 12.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.948 0.874 . . . . 0.0 112.593 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -69.21 -23.72 63.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.593 0.757 . . . . 0.0 112.73 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 m 44.84 36.57 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.579 1.151 . . . . 0.0 113.904 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -60.67 133.16 55.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 20.7 ttpp -106.6 147.18 29.78 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.889 0.875 . . . . 0.0 112.052 -171.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' HB ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -132.81 154.64 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.932 171.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -154.2 -171.61 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.265 1.426 . . . . 0.0 110.593 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 93.8 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.615 1.966 . . . . 0.0 113.339 169.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 127.94 31.32 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.433 1.093 . . . . 0.0 109.461 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' ARG . 9.5 m -77.09 168.53 19.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.905 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -63.92 6.11 0.19 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.038 . . . . 0.0 112.669 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 32.7 ptt180 -137.52 19.4 2.91 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.591 1.156 . . . . 0.0 111.218 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -119.18 166.11 13.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.055 0.542 . . . . 0.0 110.431 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 92.7 p -150.71 164.85 18.91 Favored Pre-proline 0 CA--C 1.529 0.141 0 C-N-CA 124.243 1.017 . . . . 0.0 109.397 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.98 -23.75 29.42 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.473 2.115 . . . . 0.0 110.915 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.87 -35.13 72.23 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -76.18 -43.25 43.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -56.96 -21.74 32.59 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.974 -0.454 . . . . 0.0 110.892 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.49 -56.13 4.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.92 -30.38 69.01 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.085 0.402 . . . . 0.0 110.334 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -78.5 -34.76 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.977 0.511 . . . . 0.0 111.004 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -99.1 -11.34 21.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -74.19 -24.48 59.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.542 0.61 . . . . 0.0 110.778 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -67.68 -24.99 65.48 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -74.56 -19.48 60.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.486 -0.293 . . . . 0.0 111.697 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.29 -80.76 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.476 -0.392 . . . . 0.0 112.173 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.12 166.15 33.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.7 t -137.1 137.36 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -80.49 -45.07 8.18 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -156.72 155.42 31.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.147 0.979 . . . . 0.0 108.444 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.431 HG23 HG22 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -139.01 117.15 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -147.99 164.01 35.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.681 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -134.45 92.57 20.23 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -48.36 142.39 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.125 3.217 . . . . 0.0 111.735 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -159.06 160.18 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.981 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.44 121.84 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.97 17.56 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.447 ' CD2' HG23 ' A' ' 51' ' ' THR . 10.1 p90 -150.94 -5.15 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.275 1.03 . . . . 0.0 112.387 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.447 HG23 ' CD2' ' A' ' 50' ' ' TYR . 35.3 p -119.52 -19.45 8.15 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.054 0.843 . . . . 0.0 110.333 171.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.46 24.58 1.63 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.069 1.748 . . . . 0.0 113.768 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.02 -164.19 0.13 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.236 0.615 . . . . 0.0 110.158 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -137.52 169.73 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.406 0.682 . . . . 0.0 110.836 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -138.18 7.62 2.66 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.344 0.658 . . . . 0.0 112.392 -172.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.77 20.8 35.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.578 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -152.41 165.41 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.57 1.185 . . . . 0.0 111.033 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.89 3.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.81 100.35 0.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 18' ' ' VAL . 84.5 t -92.16 154.22 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -132.13 140.22 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.8 m-85 -119.92 143.66 47.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.193 0.597 . . . . 0.0 110.35 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.697 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -85.77 -32.71 21.69 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.94 131.14 55.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.375 0.607 . . . . 0.0 111.282 -170.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.15 -46.37 89.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.509 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.615 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -59.45 -34.54 72.64 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.21 -9.88 24.93 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.357 0.526 . . . . 0.0 110.68 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.89 -44.99 25.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -75.67 -29.11 58.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.299 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.41 -41.68 80.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.592 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.73 76.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.257 -0.277 . . . . 0.0 111.533 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.7 ptp -77.4 -39.99 45.21 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.576 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.99 1.52 17.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.332 0.653 . . . . 0.0 111.719 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.51 -8.7 4.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.3 ttp -142.93 -19.98 0.65 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.03 135.38 57.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.398 1.454 . . . . 0.0 110.125 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.14 78.06 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.045 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.39 29.31 0.51 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.083 0.942 . . . . 0.0 110.966 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 84' ' ' GLU . 5.3 m -67.91 174.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 126.194 1.798 . . . . 0.0 113.361 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.79 9.99 0.92 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.809 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -139.41 7.31 2.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.162 0.585 . . . . 0.0 110.317 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.07 -17.33 48.58 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.82 136.7 7.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.409 0.683 . . . . 0.0 109.189 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.566 ' N ' HG12 ' A' ' 79' ' ' VAL . 81.2 mm-40 -150.76 -43.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 110.27 170.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -137.59 151.71 48.63 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.043 0.537 . . . . 0.0 112.122 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 29.0 mmt180 -152.28 112.92 4.14 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 166.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.13 133.12 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.364 0.602 . . . . 0.0 110.73 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -167.96 162.24 13.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.125 1.37 . . . . 0.0 108.546 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 mmt -59.15 139.26 57.08 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.732 0.813 . . . . 0.0 111.336 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.74 52.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -129.89 16.56 5.74 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.232 1.013 . . . . 0.0 108.378 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -147.28 142.38 27.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.29 1.436 . . . . 0.0 107.175 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.28 -176.11 17.43 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -170.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -53.76 132.18 56.54 Favored Pre-proline 0 N--CA 1.455 -0.212 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.29 143.14 52.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.143 2.562 . . . . 0.0 112.486 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.24 -21.84 10.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.199 3.266 . . . . 0.0 111.699 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -146.88 162.57 38.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.463 1.105 . . . . 0.0 108.092 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.45 35.32 20.45 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.855 0.741 . . . . 0.0 112.647 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 34.05 50.65 0.88 Allowed Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.486 1.514 . . . . 0.0 114.433 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.39 151.45 42.78 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.115 2.543 . . . . 0.0 110.692 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.21 117.97 4.23 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.784 2.99 . . . . 0.0 110.353 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.94 -169.01 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.02 3.146 . . . . 0.0 109.915 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -121.53 21.44 10.93 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.695 0.798 . . . . 0.0 109.31 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.27 -8.28 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.663 1.185 . . . . 0.0 113.274 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.49 4.09 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.961 -0.462 . . . . 0.0 111.131 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.54 28.12 1.2 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.42 1.01 . . . . 0.0 110.743 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.9 mtm -129.65 165.57 21.54 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.464 0.632 . . . . 0.0 111.405 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -67.0 -22.6 65.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 t 44.16 60.19 2.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 15.9 tp -65.49 166.13 10.92 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.2 ptmt -138.35 148.06 44.15 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 123.342 0.657 . . . . 0.0 110.913 172.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.569 ' HB ' HG22 ' A' ' 60' ' ' VAL . 94.7 t -129.41 143.06 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -153.01 -173.81 4.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.979 0.911 . . . . 0.0 109.738 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.406 ' CG ' ' HE ' ' A' ' 83' ' ' ARG . 15.2 t30 88.44 29.85 0.03 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.792 1.237 . . . . 0.0 112.558 171.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.56 134.97 35.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.055 1.342 . . . . 0.0 109.752 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 m -74.28 168.01 20.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -64.66 4.25 0.42 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.846 0.858 . . . . 0.0 112.853 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -135.28 18.69 3.39 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.187 0.995 . . . . 0.0 111.482 -175.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -119.2 165.1 14.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 122.935 0.494 . . . . 0.0 110.289 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.7 p -147.46 166.57 15.68 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.525 0.73 . . . . 0.0 110.03 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.2 Cg_endo -70.65 -32.08 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.858 2.372 . . . . 0.0 110.896 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.24 -35.33 80.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -73.23 -45.32 56.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.423 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -55.46 -21.04 14.53 Favored 'General case' 0 N--CA 1.457 -0.095 0 O-C-N 122.203 -0.31 . . . . 0.0 111.418 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -78.66 -57.8 3.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -64.99 -21.61 66.87 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.735 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.7 t -84.03 -32.88 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 119.612 -0.232 . . . . 0.0 111.007 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CD1' HD13 ' A' ' 30' ' ' LEU . 19.3 m-85 -102.14 -10.2 19.85 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.0 -26.33 62.19 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.081 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -68.41 -23.19 64.61 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.86 -16.08 61.14 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.444 0.298 . . . . 0.0 111.035 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.31 -66.42 0.27 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-O 119.94 -0.366 . . . . 0.0 112.405 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -165.02 168.45 17.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.667 0.387 . . . . 0.0 110.59 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -141.85 135.31 29.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.92 -22.1 16.59 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -158.84 155.69 28.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.289 0.545 . . . . 0.0 110.425 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -170.89 100.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.79 1.236 . . . . 0.0 109.944 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.6 177.26 10.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 mm -106.57 98.51 20.6 Favored Pre-proline 0 C--N 1.34 0.193 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.49 -41.78 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.501 2.801 . . . . 0.0 115.953 -166.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -70.39 155.12 41.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.866 0.757 . . . . 0.0 110.947 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 37.41 70.49 0.18 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.564 1.146 . . . . 0.0 112.139 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -57.04 5.4 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.117 1.767 . . . . 0.0 115.559 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -145.28 1.21 0.94 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.207 1.003 . . . . 0.0 112.297 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -121.15 -12.08 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.169 0.44 . . . . 0.0 110.189 173.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.76 29.13 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 127.765 2.426 . . . . 0.0 113.619 -176.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.13 -176.08 1.34 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.47 0.653 . . . . 0.0 109.299 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t 50.75 24.96 1.9 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.291 1.036 . . . . 0.0 112.142 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 9.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.172 1.789 . . . . 0.0 114.095 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.64 0.655 . . . . 0.0 112.254 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -155.95 166.91 32.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.8 0.8 . . . . 0.0 110.522 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.22 101.7 3.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.91 118.31 11.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.569 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -119.5 165.29 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.3 ptm180 -144.54 149.66 36.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.35 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.8 m-85 -117.18 164.8 14.23 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.089 0.868 . . . . 0.0 111.078 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.4 -27.15 10.12 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -120.59 149.33 42.63 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.149 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.12 -45.83 83.48 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.131 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.627 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -66.42 -40.0 89.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -80.74 -15.92 55.22 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.102 0.865 . . . . 0.0 110.959 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.1 -47.45 9.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.046 0.538 . . . . 0.0 110.16 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -68.35 -25.07 64.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.448 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.68 -47.46 31.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.904 0.32 . . . . 0.0 110.549 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.33 73.69 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.056 0.389 . . . . 0.0 110.623 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.8 ttp -73.4 -43.01 61.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.755 0.422 . . . . 0.0 110.031 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.26 2.33 24.97 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.171 -0.331 . . . . 0.0 111.521 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.23 -7.28 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.9 ttm -137.6 -26.44 0.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.67 134.75 56.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.537 1.062 . . . . 0.0 109.831 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.7 42.73 86.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 21.92 12.55 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 122.125 0.964 . . . . 0.0 110.269 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.635 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 6.1 t -63.55 162.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -165.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.497 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -157.45 13.26 0.23 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.96 -177.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' H ' HG12 ' A' ' 79' ' ' VAL . 61.3 m-20 -135.61 8.8 3.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.19 0.596 . . . . 0.0 110.861 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.03 -13.38 58.9 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.518 ' N ' HG11 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -177.36 133.55 0.18 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.438 1.895 . . . . 0.0 106.473 176.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 79' ' ' VAL . 20.4 pt-20 -146.15 -32.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.338 168.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.492 ' CD2' ' HG3' ' A' ' 84' ' ' GLU . 1.5 mm? -141.41 140.06 33.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -174.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 33.1 mmt180 -149.62 116.76 6.02 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 125.579 1.552 . . . . 0.0 106.991 167.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -134.52 142.98 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.752 0.821 . . . . 0.0 110.2 -174.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -170.49 -178.79 2.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.451 0.701 . . . . 0.0 110.22 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.7 mmt -75.51 139.6 42.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.463 0.705 . . . . 0.0 109.455 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 164.53 26.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.408 0.683 . . . . 0.0 111.225 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -142.94 9.23 1.71 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.744 0.418 . . . . 0.0 110.981 172.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -126.18 167.02 15.98 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.056 0.942 . . . . 0.0 109.142 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.1 173.62 14.91 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-O 120.999 0.221 . . . . 0.0 113.245 -173.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -65.37 159.91 62.97 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.109 0.963 . . . . 0.0 111.464 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -37.82 104.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.862 1 C-N-CA 125.618 4.212 . . . . 0.0 115.492 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.47 -26.83 1.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.06 2.507 . . . . 0.0 109.632 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -160.42 168.7 24.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.8 1.64 . . . . 0.0 106.786 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.282 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.32 -44.27 58.08 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.463 -0.632 . . . . 0.0 113.721 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.498 ' H ' ' HD3' ' A' ' 6' ' ' PRO . 18.4 ptt-85 -160.2 24.52 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.498 ' HD3' ' H ' ' A' ' 5' ' ' ARG . 74.4 Cg_endo -70.63 144.07 48.37 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 CA-C-N 121.614 1.612 . . . . 0.0 108.51 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.67 115.25 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.357 2.705 . . . . 0.0 110.779 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.0 -164.2 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.727 2.951 . . . . 0.0 109.841 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -133.27 25.47 4.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.621 0.769 . . . . 0.0 110.238 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 m -55.2 -15.82 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.817 0.847 . . . . 0.0 111.822 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.75 -4.13 32.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.008 0.923 . . . . 0.0 112.219 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.9 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.598 -0.557 . . . . 0.0 112.797 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.0 ptt? -135.63 162.65 32.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.002 0.901 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 m -76.05 82.44 2.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 122.888 0.475 . . . . 0.0 109.827 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.4 m -65.87 67.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.946 1.698 . . . . 0.0 110.459 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.577 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.6 tm? -86.36 131.52 34.19 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -128.63 153.67 47.03 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.862 HG12 HG22 ' A' ' 60' ' ' VAL . 5.9 p -131.48 153.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.783 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -152.75 -173.19 4.48 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.291 1.436 . . . . 0.0 109.738 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 83' ' ' ARG . 34.5 t30 86.76 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.737 1.215 . . . . 0.0 112.666 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.0 134.2 55.59 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.386 1.075 . . . . 0.0 109.132 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -81.17 169.05 17.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.981 176.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -62.46 1.18 0.38 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -125.69 12.72 7.99 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.595 0.634 . . . . 0.0 112.001 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -116.09 165.22 13.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.322 0.249 . . . . 0.0 110.996 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -150.19 165.15 18.14 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 124.226 1.01 . . . . 0.0 109.19 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 60.6 Cg_endo -70.43 -25.78 25.12 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.205 1.936 . . . . 0.0 111.604 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.76 -32.42 69.55 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.898 -0.502 . . . . 0.0 109.954 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.4 m -77.43 -44.91 27.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.48 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -56.66 -22.4 34.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.636 -0.665 . . . . 0.0 110.496 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -78.38 -57.98 3.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -61.09 -30.61 70.45 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.645 0.202 . . . . 0.0 110.539 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.88 -34.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 123.442 0.464 . . . . 0.0 110.811 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.6 m-85 -98.74 -13.12 20.36 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.25 -25.73 63.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.895 -0.503 . . . . 0.0 110.91 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -69.45 -23.22 63.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.888 -0.508 . . . . 0.0 112.243 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -74.62 -16.94 60.77 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.459 0.304 . . . . 0.0 111.653 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.65 -85.71 0.1 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -160.77 162.5 32.41 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.992 0.517 . . . . 0.0 110.893 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 t -137.42 137.76 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.61 -36.22 9.66 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -164.05 159.2 20.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.366 0.583 . . . . 0.0 111.194 174.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -158.01 117.96 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.681 1.192 . . . . 0.0 108.335 -176.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.07 176.98 11.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.374 0.607 . . . . 0.0 112.518 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 58' ' ' ALA . 18.7 mt -129.81 91.73 39.29 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 124.035 0.934 . . . . 0.0 108.6 -173.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.79 8.68 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.879 3.719 . . . . 0.0 113.733 -172.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -52.75 -43.15 65.58 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.013 0.824 . . . . 0.0 109.834 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -149.37 116.69 6.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -71.17 12.19 0.34 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.5 ' CD2' HG23 ' A' ' 51' ' ' THR . 15.7 p90 -146.28 2.77 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.937 0.895 . . . . 0.0 111.34 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.5 HG23 ' CD2' ' A' ' 50' ' ' TYR . 17.1 p -129.15 -36.02 1.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.478 0.581 . . . . 0.0 109.769 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.55 41.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 126.683 1.993 . . . . 0.0 113.214 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -129.39 1.34 5.09 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 t -64.03 -43.88 94.24 Favored 'General case' 0 CA--C 1.526 0.047 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 58.94 157.54 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.403 1.881 . . . . 0.0 113.582 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.41 -21.5 0.55 Allowed Glycine 0 CA--C 1.526 0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.329 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.56 166.13 29.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.029 0.931 . . . . 0.0 109.464 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -153.2 94.51 1.84 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -66.24 101.55 0.74 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -173.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.862 HG22 HG12 ' A' ' 18' ' ' VAL . 2.3 m -94.82 167.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 171.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 61' ' ' ARG . 10.5 ttt180 -145.94 116.43 7.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.213 0.946 . . . . 0.0 110.601 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 13.6 m-85 -92.48 169.76 10.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.229 1.012 . . . . 0.0 109.711 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -124.71 -37.06 2.52 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 123.989 0.806 . . . . 0.0 112.469 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.42 127.92 32.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.325 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -60.91 -53.72 53.8 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -58.35 -32.35 68.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -89.09 -17.85 28.43 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.084 0.402 . . . . 0.0 110.999 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.577 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.95 -45.62 20.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -75.42 -25.85 57.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.585 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.99 -46.89 40.87 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.719 0.69 . . . . 0.0 111.103 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.8 73.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.122 0.419 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.427 ' HA ' HG13 ' A' ' 87' ' ' VAL . 9.9 ttp -73.86 -41.23 62.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.55 0.34 . . . . 0.0 110.952 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.46 2.87 26.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.426 0.103 . . . . 0.0 111.231 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.19 -6.1 4.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.6 ttm -137.13 -27.81 0.96 Allowed 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.596 ' HB2' HG12 ' A' ' 87' ' ' VAL . 6.2 t70 -63.19 136.46 57.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.945 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.45 85.65 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.542 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.64 34.22 0.48 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.02 0.91 . . . . 0.0 110.49 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.648 HG22 ' H ' ' A' ' 80' ' ' LEU . 9.6 p -69.83 172.1 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.648 ' H ' HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -156.58 5.47 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.972 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' HG22 ' A' ' 79' ' ' VAL . 37.3 t70 -148.26 -2.44 0.52 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.0 -17.14 7.66 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.622 ' C ' HG23 ' A' ' 79' ' ' VAL . 5.3 ptp180 -161.0 140.55 10.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.519 ' C ' HD22 ' A' ' 85' ' ' LEU . 10.0 mm-40 -146.57 -49.57 0.2 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.519 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.4 mm? -139.95 150.36 44.43 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 124.064 0.852 . . . . 0.0 112.445 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -148.66 98.84 2.93 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 167.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.676 ' HB ' HG23 ' A' ' 18' ' ' VAL . 7.1 p -126.45 129.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 121.336 0.588 . . . . 0.0 110.097 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -165.78 164.38 18.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.356 1.063 . . . . 0.0 109.138 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.4 mmt -57.97 136.84 57.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.895 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 155.74 27.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -136.52 4.71 2.88 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.623 0.369 . . . . 0.0 110.838 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.95 163.81 28.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.4 172.71 15.2 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -66.16 156.05 85.78 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.58 0.352 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.81 146.77 30.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.579 2.853 . . . . 0.0 111.722 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.4 -24.33 5.46 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.194 3.263 . . . . 0.0 111.855 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -154.13 161.47 41.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.359 1.064 . . . . 0.0 109.121 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.519 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.59 65.05 4.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 42.63 49.5 4.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.433 1.493 . . . . 0.0 114.745 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.83 154.03 63.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.249 1.966 . . . . 0.0 108.522 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.77 115.99 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.263 2.642 . . . . 0.0 110.679 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.17 -163.79 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.859 3.039 . . . . 0.0 109.885 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -132.17 20.19 4.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.516 0.726 . . . . 0.0 110.343 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -56.71 -12.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.428 1.091 . . . . 0.0 112.244 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.34 -1.0 9.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.749 0.819 . . . . 0.0 112.496 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.69 30.06 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.77 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.17 168.15 20.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.807 1.304 . . . . 0.0 112.461 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -57.95 -28.32 64.21 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -168.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.4 m 42.1 58.97 2.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 113.172 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 17.6 tp -65.17 167.15 8.55 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 14.9 pttt -136.95 157.63 46.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.107 0.412 . . . . 0.0 111.82 170.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -133.78 148.13 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -150.42 -175.43 5.09 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.662 1.185 . . . . 0.0 110.677 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 t30 91.92 28.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.741 1.616 . . . . 0.0 114.121 168.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 120.66 9.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.25 1.02 . . . . 0.0 109.867 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 23' ' ' TYR . 11.7 m -75.09 171.58 13.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' H ' HG22 ' A' ' 22' ' ' THR . 54.7 p90 -63.96 7.2 0.13 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.113 0.965 . . . . 0.0 112.949 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 22' ' ' THR . 19.3 ptt180 -131.08 14.88 5.19 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.982 0.913 . . . . 0.0 111.838 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 26' ' ' SER . 1.4 m -122.8 166.43 14.98 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.466 0.306 . . . . 0.0 111.068 -173.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.503 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 91.4 p -151.86 166.4 15.32 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.67 -29.24 19.84 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.576 2.184 . . . . 0.0 110.904 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -67.63 -33.92 75.94 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.0 m -75.25 -44.87 43.66 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.479 HD12 HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -56.26 -19.84 15.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.315 0.246 . . . . 0.0 111.117 178.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -80.4 -57.98 3.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -12.31 60.35 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG12 ' HE1' ' A' ' 75' ' ' MET . 55.8 t -91.97 -32.86 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.189 0.595 . . . . 0.0 111.514 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.72 -9.71 18.9 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -26.01 61.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.18 0.446 . . . . 0.0 111.018 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -69.76 -23.78 63.42 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -72.56 -19.2 61.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.842 0.457 . . . . 0.0 111.468 176.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.0 -86.46 0.1 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -156.25 165.12 37.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 111.447 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.52 137.24 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.49 1.116 . . . . 0.0 108.062 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -22.09 23.21 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -163.67 153.85 15.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.403 0.62 . . . . 0.0 110.63 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.44 HG23 HG22 ' A' ' 60' ' ' VAL . 1.6 p -150.92 104.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -146.92 161.79 40.02 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.966 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.4 mt -136.34 126.36 16.17 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.892 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.54 52.21 2.81 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.708 3.605 . . . . 0.0 110.434 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -73.26 70.62 1.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.051 0.94 . . . . 0.0 110.081 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 p30 45.62 -162.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.722 1.609 . . . . 0.0 114.142 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 177.58 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.465 1.906 . . . . 0.0 108.199 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -157.34 12.03 0.22 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.448 1.099 . . . . 0.0 111.456 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.7 p -124.18 -7.16 7.69 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.042 0.537 . . . . 0.0 112.035 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.64 42.05 1.92 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.108 1.763 . . . . 0.0 113.971 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.08 -177.79 4.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.187 0.595 . . . . 0.0 110.303 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -142.59 -176.93 5.05 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -172.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.552 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 75.0 mmt-85 -132.25 -2.1 3.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.256 0.622 . . . . 0.0 112.325 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.7 24.44 76.71 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.009 0.368 . . . . 0.0 113.05 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 9.6 p90 -151.6 171.61 17.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.01 0.905 . . . . 0.0 110.692 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.76 103.82 4.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -69.57 92.44 0.64 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.772 0.829 . . . . 0.0 108.879 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.479 HG21 HD12 ' A' ' 30' ' ' LEU . 40.5 t -79.99 160.94 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 13.7 ttt180 -141.97 130.46 22.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.355 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.1 m-85 -113.03 165.71 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.025 0.375 . . . . 0.0 111.059 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -33.44 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.26 123.39 26.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -60.36 -53.59 55.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -84.95 -21.84 29.43 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.17 -43.54 21.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 122.779 0.432 . . . . 0.0 110.461 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -72.05 -28.56 63.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.214 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -40.73 64.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.393 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.52 74.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.137 -0.352 . . . . 0.0 111.441 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.8 ptp -78.71 -38.29 39.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.68 3.13 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.961 0.504 . . . . 0.0 111.674 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -9.7 3.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.417 ' HE1' HG12 ' A' ' 33' ' ' VAL . 4.6 ttp -146.79 -13.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.27 125.51 23.54 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.762 1.165 . . . . 0.0 108.756 173.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.87 28.11 61.41 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.576 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.65 38.33 0.44 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.775 1.288 . . . . 0.0 109.554 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.621 HG22 ' H ' ' A' ' 80' ' ' LEU . 4.8 p -71.81 173.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -168.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.621 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.1 pt? -152.0 -0.32 0.32 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.27 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' H ' HG22 ' A' ' 79' ' ' VAL . 38.0 t70 -144.95 -1.17 0.87 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.43 -17.31 6.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.558 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -164.34 133.38 3.71 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 79' ' ' VAL . 20.1 mm-40 -143.81 -39.75 0.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.413 HD12 ' CB ' ' A' ' 84' ' ' GLU . 3.5 mp -147.63 151.18 35.77 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 123.697 0.623 . . . . 0.0 112.608 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.1 mmm180 -147.43 121.56 9.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.72 139.27 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.081 0 C-N-CA 122.67 0.388 . . . . 0.0 110.03 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -169.08 174.93 5.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.752 1.221 . . . . 0.0 109.225 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 mmt -73.97 143.27 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.962 0.905 . . . . 0.0 109.981 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.54 155.68 37.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.474 0.31 . . . . 0.0 110.555 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.56 13.42 2.34 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.766 0.826 . . . . 0.0 109.722 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -129.97 158.07 40.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.874 0.87 . . . . 0.0 109.109 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.48 177.95 20.29 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -60.66 156.06 46.77 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 122.235 -0.568 . . . . 0.0 110.131 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.32 120.94 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.322 2.681 . . . . 0.0 113.309 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.51 -45.77 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.125 1.883 . . . . 0.0 108.671 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -161.39 125.49 3.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.172 1.789 . . . . 0.0 107.833 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.826 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.42 -69.01 0.53 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 125.001 1.286 . . . . 0.0 111.697 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.41 59.65 0.64 Allowed Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -171.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.77 153.76 64.13 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.961 2.441 . . . . 0.0 109.326 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.87 116.04 4.53 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.412 2.741 . . . . 0.0 110.544 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -87.58 -162.52 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.062 3.175 . . . . 0.0 110.298 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -136.25 33.4 2.82 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.976 0.91 . . . . 0.0 109.757 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.434 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 33.7 m -61.43 -1.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 124.409 1.083 . . . . 0.0 113.802 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.53 -13.05 60.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.541 0.61 . . . . 0.0 112.256 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.45 20.75 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.91 -0.383 . . . . 0.0 112.933 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.451 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . 8.1 ptp -60.47 156.9 15.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.84 0.82 . . . . 0.0 113.206 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -72.23 -18.84 61.8 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.888 0.875 . . . . 0.0 110.466 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 t 45.45 59.54 3.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.044 1.338 . . . . 0.0 113.03 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 68' ' ' ALA . 20.7 tp -65.7 165.39 12.69 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 16.8 pttt -134.53 154.89 51.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.531 0.332 . . . . 0.0 110.83 170.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.54 ' HB ' HG22 ' A' ' 60' ' ' VAL . 61.1 t -134.31 148.43 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -148.81 -171.08 3.78 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.997 1.719 . . . . 0.0 109.273 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.88 90.23 0.09 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.497 1.119 . . . . 0.0 111.929 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.5 122.89 49.04 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 m -69.03 165.92 19.16 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.18 -0.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.288 1.035 . . . . 0.0 113.562 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -129.4 23.19 5.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.167 0.987 . . . . 0.0 110.92 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -123.94 165.35 17.57 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.796 0.331 . . . . 0.0 110.73 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.4 p -150.05 165.79 16.7 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.192 0.997 . . . . 0.0 109.527 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 39.1 Cg_endo -66.18 -29.38 47.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.178 1.918 . . . . 0.0 110.911 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.09 -31.9 71.83 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.883 -0.51 . . . . 0.0 110.284 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 100.0 m -74.63 -44.71 49.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -58.84 -20.01 46.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.044 -0.41 . . . . 0.0 110.957 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -81.1 -57.05 3.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -8.89 39.06 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.867 0.467 . . . . 0.0 111.857 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.56 -30.94 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.318 0.647 . . . . 0.0 111.717 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 30' ' ' LEU . 22.7 m-85 -101.73 -12.05 18.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.249 0.477 . . . . 0.0 112.284 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.47 -27.27 64.1 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.011 -0.431 . . . . 0.0 111.37 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.51 -24.08 65.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -72.04 -21.95 61.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.238 0.215 . . . . 0.0 111.184 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -81.24 0.1 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -159.13 165.84 32.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.044 0.45 . . . . 0.0 111.357 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.9 147.16 29.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 -19.34 8.59 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.57 153.45 25.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.194 0.497 . . . . 0.0 110.374 174.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 60' ' ' VAL . 1.5 p -169.13 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.154 0.982 . . . . 0.0 110.044 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.83 179.63 9.02 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 112.204 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.432 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 13.4 mt -117.73 123.26 29.87 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.98 43.93 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 125.364 4.042 . . . . 0.0 112.054 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 92.6 mtt180 -54.89 160.96 1.76 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -54.73 119.42 5.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -67.16 13.27 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -167.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CD2' HG23 ' A' ' 51' ' ' THR . 13.0 p90 -144.72 0.2 0.96 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.666 1.186 . . . . 0.0 111.57 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.471 HG23 ' CD2' ' A' ' 50' ' ' TYR . 30.5 p -127.69 -23.78 3.37 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.709 0.686 . . . . 0.0 110.929 171.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.97 35.62 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.367 1.867 . . . . 0.0 113.815 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.23 1.93 12.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.413 ' HB2' ' HA ' ' A' ' 47' ' ' ARG . 3.3 m -73.37 170.08 15.82 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.386 0.539 . . . . 0.0 111.153 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 176.92 165.92 0.52 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.386 1.474 . . . . 0.0 110.174 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.31 -22.11 0.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -158.04 170.58 21.99 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 108.6 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.24 105.07 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -68.31 116.56 9.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.54 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -116.04 167.83 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 172.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.1 ptm180 -144.58 146.02 32.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.663 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 11.0 m-85 -116.01 162.65 17.07 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.464 0.477 . . . . 0.0 111.239 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -122.27 -32.19 3.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.64 131.13 34.63 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' HE3' ' HE1' ' A' ' 89' ' ' MET . 0.2 OUTLIER -65.06 -45.56 84.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.249 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -172.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.5 p30 -106.52 -7.01 17.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.347 0.521 . . . . 0.0 111.077 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -74.65 -40.43 61.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.92 -29.99 44.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.343 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -67.91 -40.06 83.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.297 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.53 75.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.851 0.296 . . . . 0.0 111.525 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.407 ' HA ' HG13 ' A' ' 87' ' ' VAL . 10.6 ptp -77.15 -40.19 46.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.725 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.07 -0.98 20.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.04 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.61 -6.34 5.19 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.8 ttm -137.63 -28.96 0.88 Allowed 'General case' 0 N--CA 1.458 -0.066 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.466 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 3.3 t70 -66.84 142.62 57.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.7 1.136 . . . . 0.0 110.617 -177.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.6 8.67 86.2 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.575 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.04 31.75 0.44 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.328 1.064 . . . . 0.0 111.041 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.582 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 19.8 t -74.45 160.9 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.704 0.802 . . . . 0.0 111.637 -172.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.65 10.94 0.3 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.368 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -146.44 5.3 0.93 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.99 -0.444 . . . . 0.0 112.106 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.51 -11.25 28.23 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.126 0.393 . . . . 0.0 112.334 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -172.14 114.24 0.32 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.088 0.955 . . . . 0.0 108.563 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.582 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 80.2 mm-40 -130.28 -50.78 1.1 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.555 171.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.96 155.99 46.86 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 46.5 mmt-85 -152.18 109.95 3.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.814 1.646 . . . . 0.0 107.299 168.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 2.1 p -139.12 125.38 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-O 121.19 0.519 . . . . 0.0 110.891 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -155.92 179.92 8.74 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.043 1.737 . . . . 0.0 108.382 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.414 ' HE1' ' HE3' ' A' ' 65' ' ' LYS . 15.4 mmt -75.75 144.93 41.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.6 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.16 169.15 16.7 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.231 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -145.3 -3.11 0.75 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.379 0.672 . . . . 0.0 110.905 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -129.91 168.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.979 0.511 . . . . 0.0 109.911 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.27 171.42 13.7 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 112.745 -0.142 . . . . 0.0 112.745 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -64.43 152.38 89.2 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 123.514 0.725 . . . . 0.0 110.867 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.01 125.99 13.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.464 2.11 . . . . 0.0 112.116 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.22 -22.11 11.4 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.392 2.728 . . . . 0.0 110.389 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -148.5 150.39 33.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.486 1.514 . . . . 0.0 106.999 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -171.508 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 . . . . . 0 CA--C 1.527 0.072 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.32 45.43 1.15 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 51.42 48.2 5.5 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.227 1.011 . . . . 0.0 112.988 -177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.3 157.04 50.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.79 2.327 . . . . 0.0 110.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.77 113.66 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.017 3.145 . . . . 0.0 110.209 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.33 -163.35 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.123 3.215 . . . . 0.0 110.61 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -134.23 29.11 3.7 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.112 0.965 . . . . 0.0 110.14 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.84 -12.53 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.404 1.082 . . . . 0.0 113.406 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.15 4.9 49.08 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.309 0.644 . . . . 0.0 111.448 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.23 21.09 0.49 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -140.89 161.31 38.13 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.399 0.599 . . . . 0.0 111.51 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.9 m -85.05 83.95 7.87 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.696 0.798 . . . . 0.0 111.924 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 m -64.24 79.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.144 1.378 . . . . 0.0 111.299 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.534 HD11 ' CG2' ' A' ' 87' ' ' VAL . 3.1 tm? -79.62 107.44 12.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.55 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.9 ttpp -79.53 140.94 37.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.71 146.92 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.299 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -150.67 -175.75 5.24 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.532 1.145 . . . . 0.0 110.8 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.55 HD21 ' HB2' ' A' ' 83' ' ' ARG . 16.1 t30 94.05 26.97 0.01 OUTLIER 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.728 1.611 . . . . 0.0 113.79 169.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.65 120.02 5.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.383 1.073 . . . . 0.0 108.468 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 23' ' ' TYR . 10.8 m -42.18 -63.85 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.189 0.995 . . . . 0.0 112.274 -172.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' CD2' HG22 ' A' ' 22' ' ' THR . 52.3 p90 165.93 -19.74 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.889 2.875 . . . . 0.0 109.276 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -111.42 -1.07 16.07 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.079 0.952 . . . . 0.0 111.552 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 26' ' ' SER . 2.9 m -78.18 173.47 12.22 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.02 0.928 . . . . 0.0 109.665 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 25' ' ' THR . 93.9 p -145.26 163.02 34.63 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.888 0.475 . . . . 0.0 109.882 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 41.9 Cg_endo -68.16 -26.79 36.02 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.986 1.79 . . . . 0.0 110.446 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.91 -27.38 65.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.465 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 99.7 m -78.35 -45.67 21.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 60' ' ' VAL . 1.3 mm? -59.16 -19.14 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.145 -0.347 . . . . 0.0 110.515 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -78.73 -58.38 3.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.133 -0.461 . . . . 0.0 109.949 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.465 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -71.56 -16.24 62.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.59 0.632 . . . . 0.0 111.326 -174.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.64 -32.98 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 123.272 0.629 . . . . 0.0 111.608 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 22.4 m-85 -101.72 -11.52 19.07 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.176 0.443 . . . . 0.0 111.907 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -74.33 -24.71 59.23 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.782 -0.574 . . . . 0.0 110.842 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.91 -22.91 65.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.217 0.462 . . . . 0.0 112.14 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -73.36 -24.85 60.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.699 0.4 . . . . 0.0 111.731 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.78 -84.79 0.07 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -159.64 167.04 29.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.086 0.47 . . . . 0.0 111.564 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.76 147.88 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.02 -17.92 8.63 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -162.42 149.98 13.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 117.057 0.429 . . . . 0.0 110.332 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 60' ' ' VAL . 1.5 p -166.31 104.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.577 1.151 . . . . 0.0 108.638 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.71 175.02 13.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.292 0.568 . . . . 0.0 112.244 175.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 mt -126.31 108.71 23.92 Favored Pre-proline 0 N--CA 1.452 -0.374 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.45 -13.69 20.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.741 2.961 . . . . 0.0 112.77 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 34.6 -107.71 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 111.12 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -140.27 12.78 2.39 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.216 1.006 . . . . 0.0 110.307 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 57.87 -12.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -148.76 -2.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.548 1.067 . . . . 0.0 113.009 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.8 p -121.05 -19.15 7.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.859 0.754 . . . . 0.0 110.516 172.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 50.23 21.11 0.73 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.243 1.417 . . . . 0.0 113.952 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.9 -1.24 6.83 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 t 61.21 173.83 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.015 1.326 . . . . 0.0 113.117 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -139.85 -0.68 1.68 Allowed 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.913 0.885 . . . . 0.0 112.446 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.82 18.44 44.13 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.916 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.07 168.88 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.518 1.159 . . . . 0.0 110.874 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.39 105.59 4.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -70.66 110.83 5.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 59.3 t -100.61 158.76 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -143.61 125.6 15.32 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 2.0 m-85 -91.61 -179.19 5.29 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -134.97 -25.06 1.42 Allowed 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 124.057 0.848 . . . . 0.0 113.26 178.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.87 128.59 37.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -62.33 -50.91 69.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.225 -0.416 . . . . 0.0 111.347 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.517 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -56.88 -34.61 68.02 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -172.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.52 -11.04 21.4 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 118.761 0.71 . . . . 0.0 111.972 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.468 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -72.3 -46.62 54.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.09 -24.65 55.05 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.223 -0.298 . . . . 0.0 111.5 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.06 -40.22 60.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.806 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.053 -0.404 . . . . 0.0 111.312 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.0 ptp -76.68 -40.2 49.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.559 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.55 2.26 14.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.186 0.594 . . . . 0.0 112.179 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.43 -9.19 3.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -145.44 -11.69 0.53 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.14 130.03 44.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 120.371 1.441 . . . . 0.0 109.396 174.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.46 29.75 61.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.904 -0.942 . . . . 0.0 113.665 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.52 38.88 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.063 1.432 . . . . 0.0 110.193 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.679 HG22 ' H ' ' A' ' 84' ' ' GLU . 13.1 t -69.85 162.56 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 113.96 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.409 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -158.04 9.33 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.506 179.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.41 1.66 0.53 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.85 -22.18 3.49 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 121.744 -0.598 . . . . 0.0 112.648 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.55 ' HB2' HD21 ' A' ' 20' ' ' ASN . 0.4 OUTLIER 174.99 134.89 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.584 1.954 . . . . 0.0 107.278 177.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.679 ' H ' HG22 ' A' ' 79' ' ' VAL . 76.3 mm-40 -132.23 -36.45 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.297 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' CB ' ' A' ' 84' ' ' GLU . 4.0 mp -152.15 151.81 31.51 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 31.5 mmt180 -152.57 122.65 7.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 167.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.534 ' CG2' HD11 ' A' ' 16' ' ' LEU . 2.0 p -141.05 137.25 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.183 0.516 . . . . 0.0 111.292 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -165.71 171.41 12.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.999 1.319 . . . . 0.0 109.655 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.83 141.42 53.27 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.218 0.607 . . . . 0.0 110.585 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.88 158.65 35.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.579 0.351 . . . . 0.0 110.132 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -147.95 21.16 1.12 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.601 0.76 . . . . 0.0 109.39 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -146.84 152.06 38.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.25 179.79 22.31 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.046 0.385 . . . . 0.0 113.957 -169.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -62.41 156.91 59.12 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.422 0.689 . . . . 0.0 111.02 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -43.36 114.56 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.202 3.268 . . . . 0.0 114.299 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.87 -23.76 9.12 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.71 2.273 . . . . 0.0 109.334 168.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -156.22 161.84 40.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.811 1.645 . . . . 0.0 107.065 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.144 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.39 80.91 1.74 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 45.3 46.4 2.97 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.26 1.824 . . . . 0.0 114.337 174.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.46 154.22 65.12 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.127 1.885 . . . . 0.0 109.828 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.5 117.23 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.716 2.944 . . . . 0.0 110.599 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -81.6 -169.94 0.88 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.996 3.131 . . . . 0.0 110.352 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -130.62 20.39 5.12 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.587 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.76 -12.02 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 125.403 1.481 . . . . 0.0 112.343 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.96 0.55 3.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.781 0.832 . . . . 0.0 112.616 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 30.64 0.15 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.088 -0.84 . . . . 0.0 113.954 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.09 23.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.91 1.355 . . . . 0.0 112.43 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -59.35 -26.95 65.49 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.0 m 43.09 59.96 2.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 20.5 tp -65.48 167.3 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 171.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 22.8 pttt -136.49 157.26 47.2 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.555 ' HB ' HG22 ' A' ' 60' ' ' VAL . 86.9 t -131.1 146.85 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -146.83 -175.2 4.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 110.355 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 92.97 24.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.525 1.53 . . . . 0.0 113.594 168.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.413 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -57.36 129.84 43.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.348 0.659 . . . . 0.0 109.378 -178.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 24' ' ' ARG . 18.0 m -82.43 170.94 14.7 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -64.08 8.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.175 0.99 . . . . 0.0 113.312 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 22' ' ' THR . 13.2 ptt180 -134.57 19.37 3.6 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.604 1.162 . . . . 0.0 111.969 -174.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -127.17 164.87 20.7 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.05 0.54 . . . . 0.0 110.448 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 85.0 p -149.86 165.16 18.21 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 110.37 -174.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 57.5 Cg_endo -69.42 -28.08 27.32 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.015 2.477 . . . . 0.0 111.192 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.98 -36.26 77.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.4 m -72.15 -44.15 63.55 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.514 HD11 HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -57.35 -21.98 39.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.991 -0.443 . . . . 0.0 111.145 179.397 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.82 -54.15 5.33 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -10.88 58.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.87 0.468 . . . . 0.0 111.869 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -98.95 -32.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 112.031 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.402 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.8 m-85 -100.9 -10.39 20.69 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -71.35 -28.05 63.79 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.766 -0.583 . . . . 0.0 111.14 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.61 -23.46 64.46 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -72.83 -17.59 61.54 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.317 0.247 . . . . 0.0 110.811 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.28 -76.09 0.11 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -164.81 160.52 19.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.239 0.616 . . . . 0.0 110.599 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.2 t -132.42 128.02 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.7 48.07 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -167.38 159.13 12.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.692 0.758 . . . . 0.0 112.912 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.26 141.29 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.71 1.604 . . . . 0.0 106.701 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -157.79 149.37 21.73 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.485 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 58' ' ' ALA . 5.7 mt -136.57 133.21 18.99 Favored Pre-proline 0 C--O 1.232 0.163 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.89 156.51 4.65 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.375 2.716 . . . . 0.0 111.915 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -140.34 9.54 2.28 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 43.88 18.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.251 8.3 ptm180 40.13 8.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.44 3.096 . . . . 0.0 116.832 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -162.82 -20.95 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.753 1.221 . . . . 0.0 112.971 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -96.56 -22.25 17.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.037 1.289 . . . . 0.0 110.385 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.99 31.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.812 1.645 . . . . 0.0 113.69 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.23 -160.2 0.08 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -135.83 168.23 19.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.295 0.638 . . . . 0.0 109.781 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.4 ttm105 -146.31 0.98 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.11 20.7 38.08 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.765 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.5 169.37 24.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.059 1.43 . . . . 0.0 111.538 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -141.9 93.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 108.556 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.72 103.32 0.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.555 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.3 m -100.84 168.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 172.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.4 ptm180 -142.1 139.83 32.33 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 17.3 m-85 -109.4 165.92 11.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.292 0.637 . . . . 0.0 110.465 177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -33.64 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.2 122.41 24.31 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -60.48 -50.98 71.4 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.631 -0.223 . . . . 0.0 110.403 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.6 -29.63 70.65 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.254 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -90.11 -15.77 30.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.718 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -79.75 -39.37 31.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.38 -25.86 51.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.426 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.89 -47.83 42.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.444 0.565 . . . . 0.0 110.785 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.43 73.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.976 -0.452 . . . . 0.0 110.783 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.1 ttp -73.99 -41.39 61.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.877 0.471 . . . . 0.0 110.05 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.91 3.14 27.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 122.446 -0.159 . . . . 0.0 111.42 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.48 -5.5 4.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.3 ttm -140.44 -27.34 0.74 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.97 134.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.466 1.03 . . . . 0.0 110.221 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.49 85.85 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.539 -0.589 . . . . 0.0 112.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.77 33.23 0.43 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.811 0.806 . . . . 0.0 110.8 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.577 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 48.6 t -69.93 166.16 2.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.64 0.776 . . . . 0.0 112.269 -172.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.406 ' N ' HG12 ' A' ' 79' ' ' VAL . 1.1 pt? -154.86 5.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -144.79 4.66 1.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.46 6.15 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.51 ' C ' HG13 ' A' ' 79' ' ' VAL . 5.2 ptp180 -176.14 143.33 0.53 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.004 1.722 . . . . 0.0 107.318 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 mm-40 -141.52 -46.94 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 169.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.488 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -140.96 152.7 45.17 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.941 0.496 . . . . 0.0 111.937 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.2 mmm180 -148.19 109.09 4.24 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 18' ' ' VAL . 33.9 t -134.95 127.18 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 C-N-CA 122.74 0.416 . . . . 0.0 110.876 -173.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -158.08 173.24 17.04 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.506 1.122 . . . . 0.0 109.412 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.2 mmt -69.59 146.08 52.02 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.786 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.89 165.93 22.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.704 0.402 . . . . 0.0 111.353 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -137.51 -0.04 2.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.717 0.807 . . . . 0.0 109.416 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -139.66 156.11 47.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.328 0.651 . . . . 0.0 109.26 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.25 -16.39 6.15 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HD3' ' HD2' ' A' ' 95' ' ' PRO . 21.2 tpp180 -170.46 139.91 1.46 Allowed Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' HD3' ' A' ' 94' ' ' ARG . 26.7 Cg_endo -60.67 119.7 7.02 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.047 1.831 . . . . 0.0 109.128 171.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.52 -29.43 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.598 2.198 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -153.45 93.56 1.71 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.553 0.692 . . . . 0.0 112.081 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.7 m . . . . . 0 N--CA 1.458 -0.035 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.122 176.537 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.12 36.77 9.65 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.779 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 38.81 50.37 2.55 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 125.076 1.35 . . . . 0.0 113.994 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.91 159.25 50.9 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.742 2.295 . . . . 0.0 110.282 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.53 117.83 4.69 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.59 2.86 . . . . 0.0 110.088 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.55 -170.01 0.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.137 3.225 . . . . 0.0 110.408 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -132.53 25.88 4.42 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.397 0.679 . . . . 0.0 109.459 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 m -58.66 -4.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.332 1.453 . . . . 0.0 112.926 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.79 5.73 47.31 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.271 0.629 . . . . 0.0 110.795 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.66 17.83 0.49 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.7 ptt? -143.31 164.1 31.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.601 0.701 . . . . 0.0 110.856 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -81.07 84.94 6.38 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 110.952 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -68.21 97.32 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.489 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 2.1 tm? -116.54 124.61 50.29 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.025 0.44 . . . . 0.0 109.914 -176.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.3 ttpm? -102.58 146.89 27.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.256 1.423 . . . . 0.0 114.123 -167.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.457 ' HB ' HG22 ' A' ' 60' ' ' VAL . 52.1 t -124.48 146.4 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.229 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -151.62 -171.52 3.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 110.484 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 81.65 37.57 0.07 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.158 1.383 . . . . 0.0 113.199 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' H ' ' HA ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -63.66 175.2 1.14 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.386 1.074 . . . . 0.0 109.299 175.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 24' ' ' ARG . 5.2 m -129.05 167.58 17.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.82 0.848 . . . . 0.0 109.345 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -64.4 4.87 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.455 0.702 . . . . 0.0 112.475 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.424 ' H ' ' C ' ' A' ' 22' ' ' THR . 14.8 ptm180 -129.13 18.86 5.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.787 1.235 . . . . 0.0 110.228 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -129.99 163.17 27.03 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.776 0.83 . . . . 0.0 109.382 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.7 p -148.5 164.73 20.44 Favored Pre-proline 0 C--O 1.233 0.201 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 -174.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.9 Cg_endo -68.98 -27.76 29.84 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.792 1.661 . . . . 0.0 111.467 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.06 -32.33 72.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.742 0.701 . . . . 0.0 109.648 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.1 m -74.15 -44.03 55.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.448 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -59.88 -20.82 59.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.074 -0.391 . . . . 0.0 111.075 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -56.15 4.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -8.18 50.64 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.983 0.513 . . . . 0.0 112.194 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.4 t -100.79 -31.84 3.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 C-N-CA 123.069 0.547 . . . . 0.0 112.027 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.448 ' CD1' HD13 ' A' ' 30' ' ' LEU . 26.1 m-85 -101.67 -9.76 20.61 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.509 0.595 . . . . 0.0 111.602 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.83 -28.27 62.45 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.728 -0.607 . . . . 0.0 111.463 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.88 -23.0 65.95 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -71.83 -20.26 61.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.398 -0.335 . . . . 0.0 111.007 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -82.58 0.1 OUTLIER Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 175.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -159.63 160.29 34.11 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.236 0.614 . . . . 0.0 110.351 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.44 143.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.12 -15.24 24.28 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.271 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -154.45 142.65 20.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.588 0.694 . . . . 0.0 110.356 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.489 HG13 HG12 ' A' ' 60' ' ' VAL . 46.5 t -153.9 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 107.829 173.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 163.69 38.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mm -90.5 110.32 40.24 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.15 -41.83 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.315 2.677 . . . . 0.0 114.688 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -82.41 165.69 20.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.083 0.856 . . . . 0.0 109.963 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 50.68 46.63 25.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.055 0.542 . . . . 0.0 112.057 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.471 ' HG2' ' CD2' ' A' ' 50' ' ' TYR . 18.6 ptt180 -54.7 -4.59 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.496 ' CD1' HG23 ' A' ' 51' ' ' THR . 15.6 p90 -146.77 7.1 0.94 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.871 0.76 . . . . 0.0 112.456 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.496 HG23 ' CD1' ' A' ' 50' ' ' TYR . 27.2 p -125.98 -14.1 6.16 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.844 -0.535 . . . . 0.0 111.264 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.32 27.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.855 2.062 . . . . 0.0 114.421 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.95 11.01 2.42 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.949 -0.469 . . . . 0.0 112.011 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -138.45 159.59 41.69 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.919 0.488 . . . . 0.0 110.339 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -170.51 15.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.969 0.908 . . . . 0.0 111.808 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.3 -12.4 58.16 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 118.154 0.434 . . . . 0.0 112.388 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HA ' ' H ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -158.73 168.78 25.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.936 0.894 . . . . 0.0 109.921 176.133 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 95.43 2.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -63.12 121.34 13.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.2 m -119.38 166.94 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 3.6 ptm180 -145.3 131.22 19.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.554 0.533 . . . . 0.0 111.898 175.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 26.7 m-85 -93.41 172.9 7.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.238 1.015 . . . . 0.0 109.295 171.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.413 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -126.78 -33.91 2.45 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 123.917 0.761 . . . . 0.0 112.754 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.1 133.04 34.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.45 -52.91 63.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.424 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -29.28 70.19 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -85.48 -21.35 28.72 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.899 0.318 . . . . 0.0 110.772 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -81.11 -45.45 16.44 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.391 0.676 . . . . 0.0 109.889 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -77.59 -24.62 49.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.243 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.82 -45.38 43.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.966 0.803 . . . . 0.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -30.08 71.09 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 110.64 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ttp -75.72 -43.27 47.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.392 0.277 . . . . 0.0 110.599 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.02 -0.33 27.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.531 0.15 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.03 -6.32 6.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.7 ttm -136.38 -27.33 1.07 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.482 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -62.65 137.67 58.32 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.393 1.451 . . . . 0.0 108.56 176.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.3 59.63 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.741 -0.477 . . . . 0.0 112.048 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.547 ' O ' HD21 ' A' ' 85' ' ' LEU . . . -131.22 70.24 1.47 Allowed 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.759 HG22 ' N ' ' A' ' 80' ' ' LEU . 9.9 p -45.19 167.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 -167.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.759 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -144.39 -6.79 0.71 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.241 -2.254 . . . . 0.0 116.675 169.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.522 ' H ' HG22 ' A' ' 79' ' ' VAL . 11.8 t70 -157.0 6.95 0.16 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.275 0.943 . . . . 0.0 112.993 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.568 ' H ' ' CG2' ' A' ' 79' ' ' VAL . . . 96.38 16.37 37.67 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 121.812 -0.555 . . . . 0.0 111.801 -174.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -147.2 60.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 123.257 1.503 . . . . 0.0 107.526 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 84' ' ' GLU . 1.3 mp0 -50.3 128.91 20.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 112.794 -2.003 . . . . 0.0 114.381 -166.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.004 ' H ' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -40.02 137.48 0.96 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.759 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mmt-85 -130.52 128.87 42.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.6 p -145.02 120.82 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.109 0.564 . . . . 0.0 109.751 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -154.19 165.13 37.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.22 1.408 . . . . 0.0 108.746 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -56.61 166.02 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.555 1.142 . . . . 0.0 112.87 -173.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.37 143.84 49.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.383 0.673 . . . . 0.0 111.485 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -151.72 -0.67 0.33 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.381 0.672 . . . . 0.0 111.436 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -78.54 55.39 1.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.127 0.971 . . . . 0.0 112.985 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.72 -149.87 5.13 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 118.301 0.5 . . . . 0.0 112.415 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -153.08 156.47 32.69 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.284 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -32.71 100.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 125.114 3.876 . . . . 0.0 116.367 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -83.61 -24.96 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.421 2.748 . . . . 0.0 110.176 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -150.56 -166.75 2.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.92 1.688 . . . . 0.0 108.481 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.232 0.162 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.489 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.85 -45.9 90.99 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.462 -0.632 . . . . 0.0 111.844 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 16.2 ptm180 -166.49 40.2 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 55.8 Cg_endo -66.0 128.07 18.97 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.487 -1.774 . . . . 0.0 107.487 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.28 113.06 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.582 2.855 . . . . 0.0 111.408 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -88.9 -162.1 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.207 3.271 . . . . 0.0 109.507 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -138.67 33.03 2.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 0.0 109.753 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -1.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.325 1.45 . . . . 0.0 113.495 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -105.73 7.59 32.59 Favored 'General case' 0 CA--C 1.527 0.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.526 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.05 17.83 0.32 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.483 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 14.9 ptt? -141.01 169.67 17.18 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.538 0.669 . . . . 0.0 110.804 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.3 m -62.1 166.81 4.42 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.4 m -147.64 61.36 1.14 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 18.9 tp -63.18 155.37 28.37 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 13.9 pttp -127.43 143.38 51.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.351 0.407 . . . . 0.0 110.173 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -128.17 151.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.003 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -151.48 -170.98 3.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 109.902 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 82.71 28.1 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.842 1.257 . . . . 0.0 113.049 171.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.41 125.07 15.02 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.684 0.794 . . . . 0.0 109.483 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 24' ' ' ARG . 11.9 m -75.17 168.91 19.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.742 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -65.21 8.49 0.14 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.271 1.028 . . . . 0.0 112.781 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.8 ptt180 -134.56 16.98 3.64 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.486 1.114 . . . . 0.0 111.315 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 26' ' ' SER . 1.9 m -120.91 166.57 13.63 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -172.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.9 p -152.72 164.78 19.23 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.425 1.09 . . . . 0.0 109.052 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 55.3 Cg_endo -68.96 -29.36 27.86 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.686 2.257 . . . . 0.0 111.688 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.83 -36.57 75.72 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.081 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.8 m -72.17 -42.37 65.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -54.64 -25.81 29.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.903 -0.498 . . . . 0.0 111.184 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -79.17 -54.6 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -62.49 -29.99 70.94 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.601 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.38 -32.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 122.974 0.51 . . . . 0.0 110.909 -173.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.424 ' CD1' HD13 ' A' ' 30' ' ' LEU . 24.6 m-85 -102.59 -9.74 19.87 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.27 -25.52 60.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.762 -0.586 . . . . 0.0 111.192 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -68.88 -23.32 64.2 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.004 0.366 . . . . 0.0 111.924 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -72.86 -16.28 61.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.439 0.296 . . . . 0.0 111.252 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.07 -80.59 0.13 Allowed Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -162.3 161.68 27.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.672 0.389 . . . . 0.0 110.443 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -136.98 145.87 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.97 -45.22 6.76 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -169.31 167.68 10.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.684 0.394 . . . . 0.0 110.595 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 HG22 ' A' ' 60' ' ' VAL . 16.2 m -121.47 152.12 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -149.33 140.92 23.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.348 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.87 108.17 7.62 Favored Pre-proline 0 CA--C 1.53 0.179 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.04 -21.39 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.566 2.844 . . . . 0.0 112.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 36.63 -103.75 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.77 1.228 . . . . 0.0 110.98 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -142.88 11.93 1.83 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.381 1.073 . . . . 0.0 109.949 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 55.18 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.523 1.929 . . . . 0.0 115.764 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -141.96 -2.14 1.19 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.314 1.415 . . . . 0.0 113.612 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.03 -20.37 5.78 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.148 0.431 . . . . 0.0 110.878 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 48.45 24.4 0.73 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.147 1.379 . . . . 0.0 113.843 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.74 19.53 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -142.25 168.81 18.86 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.241 0.543 . . . . 0.0 112.082 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -175.29 20.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.475 1.91 . . . . 0.0 110.113 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.83 -9.06 44.37 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.707 -0.621 . . . . 0.0 113.332 -172.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -159.63 163.88 34.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.892 0.877 . . . . 0.0 109.181 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.86 95.32 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.57 96.74 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 18' ' ' VAL . 60.7 t -92.75 148.28 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 17.4 ttt180 -126.1 115.73 20.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.905 0.753 . . . . 0.0 111.739 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 18.3 m-85 -96.78 163.36 13.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.961 0.104 . . . . 0.0 110.914 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.483 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.1 OUTLIER -127.49 -25.36 3.18 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.12 119.17 26.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -57.47 -49.29 76.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.809 0.277 . . . . 0.0 110.61 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -62.6 -32.63 73.66 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -88.25 -16.03 34.28 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.39 -47.76 12.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.86 -27.35 66.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.118 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.4 -40.83 57.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.509 0.595 . . . . 0.0 110.84 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.49 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.13 -0.356 . . . . 0.0 111.261 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.8 ptp -77.73 -37.4 49.35 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.0 1.02 22.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.978 0.511 . . . . 0.0 111.836 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.78 -4.93 3.62 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttm -138.06 -28.01 0.88 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.45 134.66 56.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.916 0.78 . . . . 0.0 110.037 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.98 9.96 84.62 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.414 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.9 30.15 0.38 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.081 0.941 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.546 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 42.9 t -72.72 162.49 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.431 1.092 . . . . 0.0 112.234 -172.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.28 16.25 0.21 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.836 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -144.61 4.67 1.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.189 0.595 . . . . 0.0 111.472 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.3 -9.13 57.48 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.92 123.1 0.51 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.523 1.129 . . . . 0.0 108.533 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.546 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.7 mm-40 -138.31 -47.32 0.52 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.518 169.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -137.81 153.57 49.63 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.184 0.516 . . . . 0.0 111.937 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.4 mmm180 -149.0 108.24 3.93 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.772 1.629 . . . . 0.0 106.968 168.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.36 140.7 47.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.293 0.237 . . . . 0.0 111.345 -176.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -171.49 175.84 3.97 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.712 1.605 . . . . 0.0 108.046 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.8 mmt -75.45 146.98 40.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.92 51.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -132.38 19.6 4.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.76 139.68 29.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.46 -165.32 13.63 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 122.878 0.275 . . . . 0.0 112.457 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -45.18 127.85 5.72 Favored Pre-proline 0 CA--C 1.526 0.043 0 C-N-CA 123.813 0.845 . . . . 0.0 110.158 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.98 142.59 57.27 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.813 2.342 . . . . 0.0 110.467 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.68 -34.09 4.52 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.038 2.492 . . . . 0.0 110.668 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -167.8 136.2 2.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.057 0.543 . . . . 0.0 110.704 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 CA--C 1.528 0.103 0 C-N-CA 124.517 1.127 . . . . 0.0 111.192 172.013 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.47 62.68 3.78 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.958 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 17.2 mtp180 106.64 21.59 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 127.325 2.25 . . . . 0.0 116.002 167.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 82.2 Cg_endo -71.82 149.81 54.63 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.593 1.605 . . . . 0.0 110.148 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.41 144.73 29.28 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.453 2.768 . . . . 0.0 111.141 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.55 -169.26 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.761 3.64 . . . . 0.0 110.134 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -131.69 17.38 4.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.781 0.832 . . . . 0.0 109.403 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.27 -5.85 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 125.593 1.557 . . . . 0.0 112.877 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.16 -0.32 3.27 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 112.991 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.83 36.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.217 -0.768 . . . . 0.0 113.702 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 165.06 28.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.652 1.226 . . . . 0.0 112.457 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -73.64 93.14 2.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 123.761 0.824 . . . . 0.0 110.844 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -70.44 85.27 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.026 0.931 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.585 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.7 tm? -106.57 134.1 50.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.8 155.34 46.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -168.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.49 155.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -174.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -152.22 -171.09 3.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.679 1.192 . . . . 0.0 110.454 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 87.18 27.36 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.256 1.422 . . . . 0.0 113.145 171.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.77 125.77 15.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.122 0.969 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 23' ' ' TYR . 7.4 m -77.34 171.92 14.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.264 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.519 ' H ' HG22 ' A' ' 22' ' ' THR . 52.5 p90 -63.36 6.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.774 1.23 . . . . 0.0 114.09 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -134.6 15.0 3.7 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.488 0.586 . . . . 0.0 112.084 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 26' ' ' SER . 1.4 m -117.7 165.19 13.91 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -153.3 167.21 13.95 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.648 1.179 . . . . 0.0 109.431 -174.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 43.4 Cg_endo -69.46 -28.47 26.67 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.247 1.965 . . . . 0.0 111.675 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.75 -34.38 75.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.3 m -77.66 -43.77 30.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -57.87 -21.19 41.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.811 -0.555 . . . . 0.0 110.703 178.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -56.51 4.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -61.37 -31.04 70.93 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.645 0.202 . . . . 0.0 110.597 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.28 -34.92 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 122.765 0.426 . . . . 0.0 111.06 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CD1' HD13 ' A' ' 30' ' ' LEU . 16.6 m-85 -99.34 -10.68 21.99 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.63 -27.07 61.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.445 0.566 . . . . 0.0 111.233 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -67.25 -22.65 65.67 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -74.04 -23.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.377 0.271 . . . . 0.0 110.988 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.86 -79.56 0.09 OUTLIER Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.143 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -157.31 164.8 37.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.94 133.68 44.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.07 -38.54 7.83 Favored Glycine 0 CA--C 1.519 0.344 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -158.42 161.02 37.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.879 0.872 . . . . 0.0 109.64 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.628 HG23 HG22 ' A' ' 60' ' ' VAL . 2.1 p -139.07 74.37 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-O 123.301 1.524 . . . . 0.0 107.05 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -83.13 143.64 30.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.299 -169.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.8 mt -140.14 130.36 13.84 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.44 151.1 5.02 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.158 2.572 . . . . 0.0 111.712 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.05 19.19 3.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.262 0.625 . . . . 0.0 109.631 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 50' ' ' TYR . 64.9 m-20 42.47 26.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.11 0.964 . . . . 0.0 112.767 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 42.88 3.26 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.642 2.777 . . . . 0.0 116.312 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.406 ' H ' ' C ' ' A' ' 48' ' ' ASP . 30.0 p90 -165.87 -4.11 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 113.915 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -116.78 -18.9 10.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.154 1.343 . . . . 0.0 111.633 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.69 30.6 0.54 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 125.775 1.63 . . . . 0.0 113.64 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.46 -159.39 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.664 0.786 . . . . 0.0 109.095 171.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.4 t -138.01 172.85 12.32 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.979 0.511 . . . . 0.0 111.384 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -137.02 3.53 2.67 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.514 0.725 . . . . 0.0 111.762 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.34 54.26 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.347 -0.696 . . . . 0.0 112.887 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.81 169.6 23.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.672 1.236 . . . . 0.0 111.318 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.39 101.67 3.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -69.33 89.48 0.48 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.071 1.349 . . . . 0.0 109.066 -175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.628 HG22 HG23 ' A' ' 43' ' ' VAL . 68.0 t -75.39 158.59 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 172.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -138.98 128.21 24.05 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.8 m-85 -106.05 173.69 6.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.19 1.396 . . . . 0.0 109.555 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -135.6 -38.31 0.74 Allowed 'General case' 0 C--N 1.339 0.127 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.79 124.62 32.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.427 -0.796 . . . . 0.0 109.133 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -53.75 -49.39 68.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.848 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -58.73 -24.9 62.34 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.8 p30 -110.42 -6.57 14.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.714 0.688 . . . . 0.0 111.287 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.585 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.34 -46.63 22.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.39 -31.06 48.19 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.569 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -71.27 -43.9 66.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.482 1.037 . . . . 0.0 111.089 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.41 75.12 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 118.146 0.43 . . . . 0.0 110.278 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttp -72.22 -42.52 65.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.751 0.42 . . . . 0.0 110.627 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.19 3.51 23.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.332 -0.23 . . . . 0.0 111.24 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.35 -6.32 4.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.0 ttm -137.47 -28.17 0.92 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.452 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -63.1 137.87 58.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 118.016 -1.473 . . . . 0.0 109.865 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.7 10.71 80.27 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.903 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 33.0 0.4 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.262 1.031 . . . . 0.0 110.547 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.637 HG22 ' H ' ' A' ' 81' ' ' ASP . 9.8 p -73.28 174.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -170.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.577 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.3 pt? -152.69 4.92 0.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.622 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.637 ' H ' HG22 ' A' ' 79' ' ' VAL . 36.8 t70 -141.52 -3.72 1.15 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.548 0.339 . . . . 0.0 111.886 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.87 -10.55 32.15 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.55 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.41 128.18 3.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 79' ' ' VAL . 13.1 mm-40 -144.24 -49.54 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.2 mm? -138.64 154.61 48.65 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.103 0.561 . . . . 0.0 112.294 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.7 mmt180 -152.03 112.52 4.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.868 1.667 . . . . 0.0 106.506 166.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.57 125.69 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.232 0.539 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -154.07 163.67 39.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.361 1.464 . . . . 0.0 108.36 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 mmt -61.01 140.94 57.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.577 0.751 . . . . 0.0 110.356 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 156.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -145.74 18.92 1.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.259 1.024 . . . . 0.0 108.661 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.75 135.8 20.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -176.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.32 176.38 21.71 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.333 0.407 . . . . 0.0 113.523 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -63.3 135.87 96.44 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 123.729 0.812 . . . . 0.0 110.266 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.98 134.05 35.7 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.767 2.312 . . . . 0.0 109.799 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.72 -20.99 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.329 2.686 . . . . 0.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -150.73 157.33 42.83 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.608 1.163 . . . . 0.0 107.88 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -175.153 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.39 32.09 43.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.219 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 34.68 57.69 2.19 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.07 1.348 . . . . 0.0 113.034 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.65 150.89 79.71 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.016 2.477 . . . . 0.0 110.464 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.22 122.06 8.05 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.539 2.826 . . . . 0.0 110.571 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -80.88 -167.94 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.775 2.983 . . . . 0.0 110.433 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -129.61 29.35 5.06 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.679 0.792 . . . . 0.0 110.319 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 m -56.23 -12.74 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.678 1.191 . . . . 0.0 112.585 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.07 -0.94 5.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.227 1.011 . . . . 0.0 112.931 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.41 28.74 0.14 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.341 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.34 166.37 25.28 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.856 1.328 . . . . 0.0 112.082 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.408 ' OG1' ' HE3' ' A' ' 65' ' ' LYS . 91.1 m -82.99 90.13 6.97 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.869 0.868 . . . . 0.0 111.285 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.9 m -67.21 85.97 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.889 0.876 . . . . 0.0 110.428 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 31.8 tp -70.95 162.92 28.51 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.245 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.453 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 25.3 ttpp -133.55 143.61 48.82 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.123 0.969 . . . . 0.0 110.529 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 30' ' ' LEU . 95.0 t -131.42 146.43 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -150.67 -169.74 3.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.777 1.631 . . . . 0.0 110.406 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.49 27.13 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.755 1.622 . . . . 0.0 113.563 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.22 123.43 11.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.762 0.825 . . . . 0.0 109.959 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 24' ' ' ARG . 10.4 m -72.25 168.04 19.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -64.69 9.7 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 113.123 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 22' ' ' THR . 23.5 ptt180 -135.06 17.88 3.46 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.474 1.11 . . . . 0.0 111.397 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -125.29 162.83 23.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.661 0.385 . . . . 0.0 111.385 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.465 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 62.9 m -148.72 163.79 24.33 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.682 1.193 . . . . 0.0 109.018 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 26' ' ' SER . 55.3 Cg_endo -69.18 -30.54 24.81 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.277 1.985 . . . . 0.0 111.697 -175.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.34 -35.24 79.85 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.942 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.8 m -74.36 -44.19 53.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -56.34 -22.26 29.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.853 -0.53 . . . . 0.0 110.52 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -57.67 3.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.31 -30.71 71.35 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.771 0.319 . . . . 0.0 110.75 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.06 -32.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.481 ' CD1' HD13 ' A' ' 30' ' ' LEU . 19.5 m-85 -100.64 -11.67 19.82 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.47 -26.73 64.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.494 -0.754 . . . . 0.0 110.928 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.49 -23.82 65.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.7 -16.38 59.53 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 122.64 0.376 . . . . 0.0 111.603 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.26 -82.16 0.11 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -158.94 165.27 34.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.045 0.45 . . . . 0.0 111.048 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.3 123.11 49.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.82 -23.77 51.65 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -164.68 155.68 14.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.117 0.484 . . . . 0.0 110.896 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.62 125.3 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -159.11 157.61 31.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.95 -167.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.407 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 9.9 mt -127.06 88.8 53.52 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 158.93 4.38 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.102 3.202 . . . . 0.0 111.425 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 49' ' ' ARG . 82.3 mtm-85 -146.19 157.18 43.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.76 3.66 1.38 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 47' ' ' ARG . 9.2 ttm-85 62.55 -2.42 0.36 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.181 1.392 . . . . 0.0 114.008 172.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.443 ' CD1' HG23 ' A' ' 51' ' ' THR . 39.9 p90 -149.37 0.19 0.5 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.443 HG23 ' CD1' ' A' ' 50' ' ' TYR . 20.8 p -127.56 -22.49 3.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.635 0.652 . . . . 0.0 111.386 171.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.0 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.687 1.995 . . . . 0.0 114.877 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.41 5.47 8.74 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.985 -0.447 . . . . 0.0 111.521 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.5 p -65.94 -23.07 66.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -34.8 116.66 0.34 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.803 1.241 . . . . 0.0 112.509 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.24 -6.85 0.28 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.679 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 172.0 15.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.808 0.843 . . . . 0.0 110.231 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.89 94.88 2.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -64.79 109.54 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.463 HG11 HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -114.1 159.86 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.2 ptm180 -136.85 145.18 44.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.063 -175.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' HB2' ' CB ' ' A' ' 16' ' ' LEU . 4.7 m-85 -114.8 177.58 4.6 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.77 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -134.66 -32.7 0.99 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.85 127.69 32.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.229 0.468 . . . . 0.0 109.988 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HE3' ' OG1' ' A' ' 14' ' ' THR . 2.6 tppp? -60.38 -56.75 17.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -33.21 68.12 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -84.93 -23.93 28.61 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.977 0.353 . . . . 0.0 110.507 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -76.58 -44.15 35.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.48 -19.3 58.15 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.002 -0.436 . . . . 0.0 111.349 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -79.47 -39.94 30.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.588 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.09 76.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.951 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.1 ptp -75.37 -39.45 59.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.658 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -77.2 1.56 18.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.279 0.632 . . . . 0.0 111.702 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.22 -6.35 3.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttm -138.41 -27.07 0.88 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.06 137.65 57.82 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.926 0.784 . . . . 0.0 110.058 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 10.36 86.01 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 119.607 -0.552 . . . . 0.0 112.439 175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.13 30.99 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.076 0.938 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.574 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 43.0 t -75.22 163.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 124.335 1.054 . . . . 0.0 112.176 -171.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.82 10.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.241 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.6 4.75 2.62 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.464 0.705 . . . . 0.0 111.486 -175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.46 -8.49 58.6 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.417 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -172.47 123.18 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.397 1.079 . . . . 0.0 108.643 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.574 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.4 mm-40 -137.9 -47.85 0.55 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 169.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -137.78 153.94 49.63 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 111.753 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.2 mmm180 -148.04 109.34 4.34 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.049 1.739 . . . . 0.0 106.721 167.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.53 134.71 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -168.11 173.03 8.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -76.25 139.94 41.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.168 0.587 . . . . 0.0 110.364 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.57 162.39 29.54 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.499 0.32 . . . . 0.0 110.568 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -144.86 15.25 1.55 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 108.991 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -135.1 166.41 23.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.45 168.28 14.35 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 117.912 0.324 . . . . 0.0 112.923 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 157.86 17.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.101 0.96 . . . . 0.0 111.526 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -33.56 97.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 1 C-N-CA 126.314 4.676 . . . . 0.0 115.924 -176.214 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 72.8 Cg_endo -77.88 -56.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.499 2.133 . . . . 0.0 109.276 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 15.6 t0 -176.45 123.03 0.16 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.566 1.146 . . . . 0.0 109.95 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 C--N 1.333 -0.109 0 C-N-CA 124.334 1.054 . . . . 0.0 110.793 177.517 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.7 m -147.06 170.53 16.96 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.155 0.582 . . . . 0.0 110.448 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -60.07 -43.91 95.1 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.925 0.49 . . . . 0.0 111.335 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.46 -81.55 0.03 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.473 ' HD2' " H1'" ' B' ' 107' ' ' ' U' . 28.1 mtp180 -153.86 69.09 6.32 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 125.342 1.457 . . . . 0.0 110.346 -171.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 118.04 5.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.087 2.525 . . . . 0.0 109.986 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.08 113.8 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.83 3.02 . . . . 0.0 110.894 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -87.83 -167.88 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.928 3.085 . . . . 0.0 109.849 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -137.59 41.71 2.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.236 1.014 . . . . 0.0 109.511 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 17.7 m -52.7 -14.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.941 1.696 . . . . 0.0 113.693 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -88.4 5.23 43.21 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.124 0.569 . . . . 0.0 111.303 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.02 19.82 0.66 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.45 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 5.1 ptt? -139.39 166.61 24.11 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.793 0.796 . . . . 0.0 111.835 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -63.34 -26.54 68.81 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t 44.03 58.85 3.45 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.19 0.996 . . . . 0.0 112.478 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 23.4 tp -63.91 164.4 10.38 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.566 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 20.4 ttpp -137.21 142.08 42.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.339 1.055 . . . . 0.0 109.986 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -135.39 152.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 174.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -153.37 -167.78 2.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.107 1.363 . . . . 0.0 110.542 -174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 82.9 28.29 0.11 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.69 1.596 . . . . 0.0 113.309 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.64 126.18 22.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.795 0.838 . . . . 0.0 109.303 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -68.91 168.25 14.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -62.52 3.29 0.21 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -139.14 18.5 2.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.771 0.829 . . . . 0.0 112.078 -174.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -112.38 165.56 12.09 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.895 0.478 . . . . 0.0 110.391 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 82.8 p -149.59 167.06 13.78 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.319 1.048 . . . . 0.0 109.038 -176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.4 Cg_endo -68.98 -26.75 30.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.403 2.069 . . . . 0.0 111.68 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.86 -33.78 74.38 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.997 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -74.9 -44.38 49.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -58.67 -20.91 52.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.8 -0.562 . . . . 0.0 111.103 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -82.02 -56.62 3.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -62.91 -24.75 67.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.684 0.22 . . . . 0.0 110.481 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.9 t -83.11 -34.96 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.715 0.406 . . . . 0.0 110.644 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CD1' HD13 ' A' ' 30' ' ' LEU . 20.2 m-85 -99.27 -10.96 21.72 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -72.71 -26.61 61.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.634 -0.666 . . . . 0.0 111.441 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.98 -22.93 64.07 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -73.28 -20.89 60.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.844 0.458 . . . . 0.0 111.267 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.05 -88.92 0.1 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -154.23 164.47 38.5 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.37 0.605 . . . . 0.0 111.733 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.66 133.88 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.29 -24.43 24.32 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -161.65 152.69 18.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.077 0.465 . . . . 0.0 110.084 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -149.87 103.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 176.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -150.18 161.63 42.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.101 -167.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 mt -134.35 132.21 20.89 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.33 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.11 -29.69 32.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.962 2.441 . . . . 0.0 111.325 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 36.92 30.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.257 1.823 . . . . 0.0 114.708 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 51.39 12.31 0.14 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.674 0.79 . . . . 0.0 112.812 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 52.53 -14.18 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.879 2.472 . . . . 0.0 116.064 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -155.47 4.12 0.19 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.686 1.13 . . . . 0.0 113.271 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 -25.6 3.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.846 0.748 . . . . 0.0 112.054 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.1 21.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.962 2.105 . . . . 0.0 115.008 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.95 -11.66 59.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.772 -0.58 . . . . 0.0 112.371 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.5 t -83.56 -78.11 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.048 0.385 . . . . 0.0 110.684 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 39.66 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.255 2.222 . . . . 0.0 115.894 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.11 -2.64 32.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.79 -0.569 . . . . 0.0 112.559 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -155.71 169.86 23.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.124 0.57 . . . . 0.0 110.097 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.79 103.54 3.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -66.11 92.2 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.695 0.798 . . . . 0.0 108.889 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 30' ' ' LEU . 92.5 t -87.27 155.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.9 ttt180 -138.31 131.84 30.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 123.148 0.28 . . . . 0.0 111.236 -172.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 6.4 m-85 -115.11 170.8 8.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.657 0.265 . . . . 0.0 111.143 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -32.96 2.02 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.42 122.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -59.04 -54.23 49.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -58.86 -33.18 70.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -85.32 -21.22 29.03 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.983 0.356 . . . . 0.0 110.542 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.85 -42.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.941 0.496 . . . . 0.0 110.22 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -73.84 -25.57 60.14 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.05 -0.407 . . . . 0.0 110.511 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.15 -47.68 34.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.232 0.469 . . . . 0.0 110.393 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -31.53 71.72 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.347 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.8 ttp -74.01 -42.75 59.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.119 0.568 . . . . 0.0 110.452 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.8 2.96 24.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.024 0.13 . . . . 0.0 111.215 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.24 -5.59 4.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.8 ttm -137.88 -29.4 0.85 Allowed 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -64.15 140.23 58.85 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.932 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.8 6.98 83.18 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.72 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.8 32.06 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.165 0.983 . . . . 0.0 110.784 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.585 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 23.0 t -73.99 164.61 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.846 0.858 . . . . 0.0 111.569 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.7 5.06 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.9 3.3 1.82 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.145 0.43 . . . . 0.0 112.076 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.63 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.313 0.482 . . . . 0.0 112.632 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -172.44 115.19 0.31 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.268 1.027 . . . . 0.0 109.008 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.585 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 79.6 mm-40 -130.88 -50.45 1.04 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.119 171.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.438 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -140.53 153.54 46.21 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.304 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 22.6 mmt180 -151.79 113.96 4.51 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 167.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.34 135.79 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-O 121.227 0.536 . . . . 0.0 110.445 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.5 173.05 10.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.423 1.489 . . . . 0.0 108.275 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.51 147.62 50.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.524 0.73 . . . . 0.0 111.102 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.73 150.18 29.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -141.99 21.17 2.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.417 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 3.0 t80 -145.55 143.56 30.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -174.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.15 179.36 21.02 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 117.885 0.312 . . . . 0.0 112.876 -169.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -57.64 148.81 54.95 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.018 0.527 . . . . 0.0 110.981 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.02 135.64 21.37 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.65 2.9 . . . . 0.0 111.089 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.36 -39.9 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.589 2.192 . . . . 0.0 109.379 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.04 136.33 1.46 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.486 1.115 . . . . 0.0 109.503 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.5 m -154.58 11.38 0.38 Allowed 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.062 0.945 . . . . 0.0 110.287 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -136.99 6.97 2.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -146.75 171.88 14.49 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.261 0.624 . . . . 0.0 109.881 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.253 1.251 0 CA-C-O 117.252 -1.356 . . . . 0.0 109.778 -179.53 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . 0.43 " C4'" " H5'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.417 -3.029 1 O4'-C1'-N19 115.736 7.536 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.566 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.161 1 C5'-C4'-C3' 109.148 -4.235 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.417 ' N2 ' ' CD2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.413 -3.293 0 C5'-C4'-C3' 109.761 -3.826 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.014 0 O4'-C1'-N19 112.136 3.936 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.947 0 P-O3'-C3' 124.478 3.981 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.473 " H1'" ' HD2' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.422 -2.618 1 O4'-C1'-N19 112.376 4.176 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.426 0.155 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.1 p -149.86 174.2 12.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.276 0.63 . . . . 0.0 110.706 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -61.35 -45.8 92.89 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.631 0.772 . . . . 0.0 110.843 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.485 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 81.31 -73.38 2.6 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -178.73 52.4 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.07 139.63 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.544 2.163 . . . . 0.0 110.595 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.93 115.37 3.28 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.657 2.905 . . . . 0.0 110.097 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.27 -166.97 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.842 3.028 . . . . 0.0 110.571 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -132.41 28.69 4.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.244 1.018 . . . . 0.0 110.463 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.5 m -53.98 -18.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 124.771 1.228 . . . . 0.0 113.425 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -77.5 4.58 10.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.341 0.656 . . . . 0.0 111.912 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 16.66 0.67 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.017 -0.879 . . . . 0.0 112.324 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.07 166.91 23.37 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 1.206 . . . . 0.0 113.38 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -61.26 -27.67 68.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -167.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.1 m 44.48 38.55 2.67 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.561 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -62.58 132.88 53.86 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.704 -0.623 . . . . 0.0 109.844 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 68.8 tttt -97.68 148.88 22.88 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.524 0.73 . . . . 0.0 112.518 -170.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 60' ' ' VAL . 98.2 t -127.12 147.96 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -155.32 -176.83 6.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.479 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 51.9 t30 84.96 38.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.179 1.392 . . . . 0.0 113.4 171.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.4 138.09 57.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.846 0.859 . . . . 0.0 108.96 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.429 HG22 ' CD1' ' A' ' 23' ' ' TYR . 6.7 m -80.4 166.16 21.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.737 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CD1' HG22 ' A' ' 22' ' ' THR . 52.6 p90 -62.88 6.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.431 1.092 . . . . 0.0 113.373 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 22' ' ' THR . 34.8 ptt180 -135.06 20.34 3.46 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.965 1.306 . . . . 0.0 111.337 -174.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -123.87 165.02 18.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.817 0.447 . . . . 0.0 110.531 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.474 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.8 p -149.4 165.5 17.49 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 124.047 0.939 . . . . 0.0 109.351 -175.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 61.9 Cg_endo -71.15 -25.16 22.66 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.052 1.835 . . . . 0.0 111.868 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.43 -34.19 75.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 O-C-N 121.839 -0.538 . . . . 0.0 109.674 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.5 m -75.63 -43.28 48.62 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.484 HD11 HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -56.19 -23.48 35.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.623 -0.673 . . . . 0.0 111.093 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -80.61 -55.63 4.71 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -61.29 -28.74 69.4 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.042 0.383 . . . . 0.0 110.645 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -80.48 -33.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 122.94 0.496 . . . . 0.0 111.542 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 30' ' ' LEU . 28.7 m-85 -103.07 -9.27 19.87 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.44 -24.32 57.03 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.733 -0.604 . . . . 0.0 111.016 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.91 -22.55 63.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.249 0.477 . . . . 0.0 112.169 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.26 -17.49 61.89 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 122.342 0.257 . . . . 0.0 111.123 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.2 -76.38 0.17 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -164.14 162.49 22.86 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.547 0.739 . . . . 0.0 110.445 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -136.42 144.16 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.23 -24.48 19.16 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -162.36 149.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 117.085 0.443 . . . . 0.0 111.062 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 60' ' ' VAL . 87.0 t -139.26 113.59 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -146.4 160.47 42.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.2 92.1 40.08 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.651 0.38 . . . . 0.0 110.85 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -49.14 135.06 30.6 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 124.049 3.166 . . . . 0.0 111.147 173.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -164.78 164.68 21.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.09 117.48 10.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.4 ' HD2' " H1'" ' B' ' 105' ' ' ' A' . 9.0 ptm180 -67.48 16.72 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -169.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.458 ' CD2' HG23 ' A' ' 51' ' ' THR . 10.2 p90 -146.89 -3.05 0.6 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.692 1.197 . . . . 0.0 112.001 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.458 HG23 ' CD2' ' A' ' 50' ' ' TYR . 44.6 p -123.68 -24.72 4.45 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.72 0.691 . . . . 0.0 110.371 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 mptt 49.88 26.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.979 1.712 . . . . 0.0 113.119 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.66 5.88 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.9 m 58.92 -178.18 0.08 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -141.62 0.09 1.42 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.55 16.97 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.887 0.767 . . . . 0.0 113.432 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.403 ' CE2' " H5'" ' B' ' 103' ' ' ' G' . 49.1 p90 -153.91 169.63 22.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.321 1.06 . . . . 0.0 110.026 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.0 96.69 3.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.444 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 21.6 t80 -63.04 115.94 4.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.507 HG12 HG13 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -116.99 163.16 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -139.06 125.58 20.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.826 0.704 . . . . 0.0 110.587 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 21.8 m-85 -96.34 158.62 15.35 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.561 0.744 . . . . 0.0 109.936 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.514 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -114.56 -30.98 6.35 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 123.653 0.595 . . . . 0.0 112.348 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.77 119.39 21.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -61.49 -45.13 95.51 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.341 0.257 . . . . 0.0 110.644 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.502 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -67.13 -28.96 68.57 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -90.96 -13.34 33.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.561 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.97 -42.78 25.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -77.42 -25.24 50.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.614 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.33 -47.11 36.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.646 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.87 73.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.4 ttp -73.3 -42.16 62.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.781 0.432 . . . . 0.0 110.369 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.02 3.21 27.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.263 -0.273 . . . . 0.0 111.558 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.53 -6.52 4.68 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.8 ttm -139.45 -26.54 0.81 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.14 134.72 56.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.396 0.998 . . . . 0.0 110.755 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 8.67 85.68 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.128 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.41 33.4 0.35 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.19 0.995 . . . . 0.0 111.098 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.591 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 46.1 t -69.42 164.52 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.012 0.925 . . . . 0.0 112.209 -173.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.404 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -157.97 9.95 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.68 -178.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -149.88 4.4 0.56 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.107 0.867 . . . . 0.0 113.249 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.55 -20.35 4.93 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.852 -0.53 . . . . 0.0 111.974 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.511 ' C ' HG13 ' A' ' 79' ' ' VAL . 6.2 ptp180 -175.23 143.65 0.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.112 1.765 . . . . 0.0 106.651 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.591 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.2 mm-40 -141.59 -47.62 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.643 169.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.482 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.92 159.29 42.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.79 0.805 . . . . 0.0 112.124 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 10.1 mmm180 -152.33 114.34 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 16' ' ' LEU . 21.3 t -136.88 127.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -167.46 165.17 14.94 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.86 142.21 58.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.366 -172.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.65 167.81 6.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.133 0.573 . . . . 0.0 111.524 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -139.39 -8.19 1.3 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 123.346 0.658 . . . . 0.0 110.993 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.487 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 4.6 m-85 -140.25 173.61 11.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -116.79 175.61 15.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 117.719 0.236 . . . . 0.0 112.834 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -60.36 142.21 90.65 Favored Pre-proline 0 C--O 1.233 0.19 0 C-N-CA 123.737 0.815 . . . . 0.0 110.136 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.455 ' CG ' H5'' ' B' ' 105' ' ' ' A' . 76.7 Cg_exo -51.05 130.41 31.63 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.321 2.681 . . . . 0.0 113.403 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.66 -25.31 9.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.761 2.307 . . . . 0.0 109.324 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -159.31 161.61 35.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.127 1.371 . . . . 0.0 107.679 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p -71.45 89.41 0.94 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.6 t60 51.46 24.36 2.18 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.471 1.108 . . . . 0.0 112.348 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 50.83 28.83 3.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.933 0.893 . . . . 0.0 112.477 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.253 1.245 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.606 -179.192 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.945 1 O4'-C1'-N19 115.752 7.552 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.484 " H4'" ' OP1' ' B' ' 104' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.407 -3.87 0 C1'-O4'-C4' 106.63 -3.3 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.487 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.562 1 P-O3'-C3' 125.953 5.211 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.455 H5'' ' CG ' ' A' ' 95' ' ' PRO . . . . . . . . 0 O4'--C4' 1.416 -3.071 1 P-O3'-C3' 125.271 4.642 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 0 P-O3'-C3' 124.472 3.977 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.485 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.781 0 O4'-C1'-N19 111.724 3.524 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.9 p -153.88 -174.03 4.8 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.066 0.546 . . . . 0.0 110.21 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -57.81 -30.17 65.5 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.893 0.477 . . . . 0.0 110.965 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.77 45.42 27.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.534 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 38.94 50.39 2.63 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.161 1.384 . . . . 0.0 114.36 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.01 149.28 52.61 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.209 2.606 . . . . 0.0 110.89 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.93 123.84 8.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.254 2.636 . . . . 0.0 110.499 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -81.85 -165.98 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.813 3.009 . . . . 0.0 110.367 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.69 30.17 4.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.922 0.889 . . . . 0.0 109.691 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 33.7 m -57.06 -12.23 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.607 1.163 . . . . 0.0 112.646 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.83 -0.04 8.22 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.919 0.887 . . . . 0.0 112.388 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.93 32.29 0.18 Allowed Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.889 -0.951 . . . . 0.0 113.472 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.1 ptt? -142.89 164.86 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.546 1.173 . . . . 0.0 111.675 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -60.63 -28.01 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -170.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.3 m 43.24 59.25 3.03 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 16.3 tp -66.42 169.58 7.24 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 13.9 pttt -139.09 155.58 47.81 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.402 0.546 . . . . 0.0 111.05 171.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 60' ' ' VAL . 57.2 t -134.15 145.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -150.06 -174.59 4.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.48 1.112 . . . . 0.0 109.815 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 83' ' ' ARG . 8.0 t30 92.52 29.88 0.01 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.221 1.409 . . . . 0.0 112.968 169.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.92 117.74 3.19 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.538 1.135 . . . . 0.0 109.802 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 23' ' ' TYR . 3.0 m -67.44 171.09 6.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' H ' HG22 ' A' ' 22' ' ' THR . 48.9 p90 -62.84 3.09 0.25 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.094 0.958 . . . . 0.0 113.01 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ptt-85 -134.26 14.28 3.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.388 0.675 . . . . 0.0 111.85 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -113.34 165.51 12.36 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 90.3 p -150.89 167.94 11.98 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.57 1.148 . . . . 0.0 108.839 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 62.4 Cg_endo -69.52 -35.02 14.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.264 1.976 . . . . 0.0 110.721 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -61.51 -36.07 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.117 0.484 . . . . 0.0 109.886 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -71.79 -44.23 64.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.506 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -54.65 -23.88 19.18 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.227 -0.296 . . . . 0.0 111.585 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -78.77 -56.56 4.31 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -65.29 -20.38 66.39 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.778 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.75 -32.1 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.636 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -106.16 -7.92 17.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.982 0.513 . . . . 0.0 112.277 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.47 -26.14 55.04 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.217 0.462 . . . . 0.0 111.155 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -67.64 -23.69 65.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.223 0.465 . . . . 0.0 112.244 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.89 -17.76 61.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.667 0.387 . . . . 0.0 111.526 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.84 -82.26 0.11 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.78 163.09 37.05 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.159 0.584 . . . . 0.0 110.789 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -135.3 140.25 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.59 -21.5 21.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' CG ' ' H1 ' ' B' ' 106' ' ' ' G' . 37.8 t0 -161.86 155.86 21.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.703 0.752 . . . . 0.0 111.713 177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 60' ' ' VAL . 61.1 t -147.46 125.34 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 46' ' ' PRO . 1.6 t80 -157.48 152.66 25.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.53 71.2 52.33 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 20.4 Cg_endo -93.29 -6.45 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.616 1 C-N-CA 126.48 4.787 . . . . 0.0 117.979 -167.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -48.86 -36.43 16.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.366 1.439 . . . . 0.0 111.97 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -144.17 101.51 3.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 168.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.494 ' HD3' " H1'" ' B' ' 105' ' ' ' A' . 13.0 ptt180 -62.12 8.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.717 1.607 . . . . 0.0 114.908 -169.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.507 ' CD1' HG23 ' A' ' 51' ' ' THR . 18.6 p90 -150.84 6.09 0.51 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.33 1.052 . . . . 0.0 112.279 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.507 HG23 ' CD1' ' A' ' 50' ' ' TYR . 11.5 p -130.57 -29.02 2.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.866 0.757 . . . . 0.0 111.72 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.93 23.87 0.31 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.466 1.506 . . . . 0.0 113.029 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.65 11.18 0.2 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -131.92 25.47 4.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.472 0.709 . . . . 0.0 110.207 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 8.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.995 1.718 . . . . 0.0 114.831 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.38 -3.46 2.95 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.492 0.587 . . . . 0.0 111.768 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -152.88 168.04 27.09 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.407 1.083 . . . . 0.0 109.082 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.32 97.23 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 39.0 t80 -61.3 109.92 1.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.1 m -107.27 170.03 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.4 ptm180 -144.53 145.65 31.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.764 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 23.2 m-85 -112.73 166.71 11.11 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.068 0.547 . . . . 0.0 109.926 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.455 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.87 -30.91 2.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.698 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.07 125.4 30.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -61.21 -54.2 47.24 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.401 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -58.92 -32.14 69.29 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -86.76 -18.19 31.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.952 0.342 . . . . 0.0 110.762 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.36 -43.96 16.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 122.709 0.404 . . . . 0.0 110.147 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -73.25 -26.62 61.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.267 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -73.82 -46.47 44.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.322 0.51 . . . . 0.0 110.717 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.97 72.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.5 ttp -75.07 -40.98 59.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.105 0.562 . . . . 0.0 110.347 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.9 2.99 31.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.065 0.146 . . . . 0.0 111.279 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.83 -5.83 4.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.2 ttm -137.42 -28.95 0.9 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.445 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.1 t70 -64.51 137.86 58.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 120.161 1.346 . . . . 0.0 110.007 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.73 16.42 79.21 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.729 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.85 29.46 1.02 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.115 0.958 . . . . 0.0 110.371 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.487 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 41.2 t -72.66 170.47 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.168 1.387 . . . . 0.0 112.486 -170.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.44 ' N ' HG12 ' A' ' 79' ' ' VAL . 1.1 pt? -153.82 3.32 0.27 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -139.69 2.08 1.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.75 -20.02 4.38 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.241 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -177.77 135.22 0.17 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.995 1.318 . . . . 0.0 108.074 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.487 ' HG3' ' HA ' ' A' ' 79' ' ' VAL . 9.6 mt-10 -140.85 -37.56 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.019 171.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -144.4 149.98 36.98 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.703 0.401 . . . . 0.0 111.872 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.4 mmt180 -151.79 106.56 3.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.623 1.569 . . . . 0.0 106.879 166.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -133.87 126.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 CA-C-O 121.226 0.536 . . . . 0.0 110.495 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -156.59 175.29 14.24 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 125.67 1.588 . . . . 0.0 108.923 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.99 145.83 53.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.034 0.934 . . . . 0.0 110.389 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.44 170.34 16.3 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.966 0.506 . . . . 0.0 111.652 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -147.07 3.23 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.167 0.587 . . . . 0.0 110.985 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.595 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 19.6 m-85 -131.73 175.17 9.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.314 0.646 . . . . 0.0 109.579 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.0 177.2 16.48 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 121.507 0.504 . . . . 0.0 114.176 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -62.43 160.14 35.8 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.427 1.491 . . . . 0.0 112.634 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -34.05 103.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 126.527 4.818 . . . . 0.0 116.637 178.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.46 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 75.5 Cg_endo -81.12 -60.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.91 2.406 . . . . 0.0 109.433 169.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.46 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 12.8 t0 -179.1 131.14 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.317 1.447 . . . . 0.0 109.882 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.2 m -158.1 12.98 0.2 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.297 1.439 . . . . 0.0 110.008 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -143.79 10.03 1.56 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -166.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -148.03 171.4 15.89 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.729 0.412 . . . . 0.0 110.345 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.253 1.267 0 CA-C-O 117.604 -1.188 . . . . 0.0 110.137 -178.493 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.853 0 O4'-C1'-N19 111.714 3.514 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.406 2 O4'-C1'-N19 112.506 4.306 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.595 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 O4'-C1'-N19 111.56 3.36 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.494 " H1'" ' HD3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C3'-C2'-C1' 104.726 3.584 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.422 ' H1 ' ' CG ' ' A' ' 42' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.701 1 P-O3'-C3' 125.376 4.73 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.403 H5'' " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.417 -2.982 0 O4'-C1'-N19 111.449 3.249 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 ttp . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.6 m 51.18 -177.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.832 1.253 . . . . 0.0 113.579 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -69.71 -31.61 69.73 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.929 -0.482 . . . . 0.0 110.472 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.24 36.16 21.71 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.985 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.89 57.25 0.94 Allowed Pre-proline 0 N--CA 1.465 0.284 0 C-N-CA 125.51 1.524 . . . . 0.0 113.146 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.52 147.73 77.41 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.23 2.62 . . . . 0.0 109.668 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 114.97 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.562 2.841 . . . . 0.0 110.649 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.47 -162.65 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 124.42 3.414 . . . . 0.0 110.182 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -134.51 33.06 3.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.23 0.612 . . . . 0.0 111.14 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 m -64.5 6.13 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.187 1.395 . . . . 0.0 113.373 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.71 2.9 0.86 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.973 0.909 . . . . 0.0 113.194 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.9 -8.88 0.04 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.507 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -65.64 169.69 5.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.592 1.196 . . . . 0.0 111.866 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -58.67 -26.37 63.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m 43.72 37.09 1.46 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.4 tm? -63.75 136.03 57.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.42 155.34 46.57 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -171.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.35 158.03 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.297 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -154.78 -173.74 4.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.167 0.987 . . . . 0.0 110.777 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.612 HD21 ' HB2' ' A' ' 83' ' ' ARG . 20.3 t30 96.81 27.94 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.744 1.617 . . . . 0.0 113.077 168.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 117.58 4.37 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.494 1.117 . . . . 0.0 109.778 -175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -70.8 166.89 20.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -62.95 10.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.964 1.306 . . . . 0.0 113.907 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -130.04 17.8 5.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.893 0.877 . . . . 0.0 111.618 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 26' ' ' SER . 1.3 m -126.82 170.32 12.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 -173.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 25' ' ' THR . 94.4 p -152.7 163.74 22.56 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.253 1.021 . . . . 0.0 109.296 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.8 -28.08 25.49 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.506 2.137 . . . . 0.0 111.717 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.57 -33.03 74.2 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.95 -0.469 . . . . 0.0 109.822 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.0 m -75.51 -46.48 32.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -56.94 -19.8 20.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -55.78 5.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -62.74 -31.27 72.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.188 0.995 . . . . 0.0 110.968 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.01 -32.71 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.442 0.297 . . . . 0.0 111.619 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.0 m-85 -98.67 -11.23 22.22 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.977 0.353 . . . . 0.0 111.941 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.55 -27.74 62.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.689 -0.632 . . . . 0.0 111.679 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.35 -22.54 65.58 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -73.78 -18.67 60.94 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.72 0.408 . . . . 0.0 111.129 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.88 -79.37 0.1 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -158.62 165.06 35.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 110.398 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -133.88 138.7 50.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.98 -26.61 7.4 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -163.08 161.35 25.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.916 0.358 . . . . 0.0 110.33 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' CG2' HG22 ' A' ' 60' ' ' VAL . 1.5 p -168.73 110.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.25 176.13 13.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.543 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mt -125.2 85.87 57.63 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.13 -23.71 17.83 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.449 3.433 . . . . 0.0 113.281 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 2.1 tpp180 -64.01 115.77 5.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 41.58 69.22 0.37 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 110.222 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -54.6 5.55 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.045 2.138 . . . . 0.0 116.61 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -143.54 7.41 1.5 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.514 1.125 . . . . 0.0 110.81 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -124.76 -38.23 2.39 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.02 24.7 0.13 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.228 2.211 . . . . 0.0 113.142 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -65.02 -21.2 66.81 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -76.93 -49.7 14.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.573 0.349 . . . . 0.0 110.824 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 37.07 31.64 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.627 1.971 . . . . 0.0 114.783 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.34 -10.47 74.68 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.59 -0.694 . . . . 0.0 112.016 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -163.13 169.11 19.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.603 0.701 . . . . 0.0 111.084 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 102.63 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE2' ' C5 ' ' B' ' 104' ' ' ' G' . 68.0 t80 -67.92 94.78 0.49 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 -175.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG21 HD12 ' A' ' 30' ' ' LEU . 59.4 t -81.35 160.74 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -143.84 134.94 25.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.043 0.537 . . . . 0.0 109.987 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -117.28 148.27 41.83 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.484 1.113 . . . . 0.0 109.836 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.597 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -99.59 -27.21 13.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -173.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -114.66 134.2 55.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 110.458 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.66 -45.6 93.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.745 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -33.77 76.56 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.98 0.809 . . . . 0.0 111.969 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.7 -24.71 36.03 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.68 -47.29 19.55 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.072 0.949 . . . . 0.0 110.839 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.09 -27.29 60.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.79 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -70.97 -40.46 71.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.278 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.39 73.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.024 -0.422 . . . . 0.0 111.333 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.5 ptp -78.8 -37.61 40.36 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.509 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -77.12 -0.73 25.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.23 0.612 . . . . 0.0 111.743 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.87 -4.99 4.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.7 ttm -138.02 -25.57 0.97 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.7 t70 -63.52 138.31 58.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 118.398 -1.321 . . . . 0.0 110.005 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.76 14.96 77.98 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.914 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.08 36.71 0.52 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.041 0.921 . . . . 0.0 110.257 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.636 HG22 ' H ' ' A' ' 80' ' ' LEU . 6.2 p -72.12 176.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -169.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.636 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.1 pt? -151.78 -1.22 0.32 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.723 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.541 ' H ' HG22 ' A' ' 79' ' ' VAL . 37.3 t70 -144.45 -0.77 0.95 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.45 -19.09 6.0 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.612 ' HB2' HD21 ' A' ' 20' ' ' ASN . 0.1 OUTLIER -165.96 136.04 3.43 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' N ' HG23 ' A' ' 79' ' ' VAL . 19.7 mm-40 -144.79 -41.82 0.24 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.89 150.29 44.41 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.834 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -152.27 108.11 3.35 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 126.121 1.769 . . . . 0.0 106.659 168.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.7 p -134.96 134.77 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.238 0.542 . . . . 0.0 111.284 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 89' ' ' MET . 31.4 tt0 -166.26 168.02 15.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.322 1.449 . . . . 0.0 108.11 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.428 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 11.6 mmt -61.28 142.31 56.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.176 0.99 . . . . 0.0 110.773 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 155.52 38.15 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.889 0.476 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -140.11 9.81 2.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.499 0.72 . . . . 0.0 109.608 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.652 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 20.2 m-85 -131.43 169.18 16.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.015 0.926 . . . . 0.0 109.335 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.3 -177.64 14.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -56.02 145.0 56.57 Favored Pre-proline 0 C--O 1.233 0.194 0 C-N-CA 123.271 0.629 . . . . 0.0 110.501 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.409 ' CG ' H5'' ' B' ' 105' ' ' ' A' . 61.0 Cg_endo -70.01 145.75 56.63 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.44 2.76 . . . . 0.0 112.276 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.0 -23.39 4.58 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.451 3.434 . . . . 0.0 112.198 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -149.96 164.53 35.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.601 1.16 . . . . 0.0 108.965 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.9 p -76.21 -35.32 59.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -167.01 11.22 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.962 0.801 . . . . 0.0 113.157 -174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -141.9 172.9 12.05 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.919 -0.488 . . . . 0.0 111.009 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 117.0 -1.476 . . . . 0.0 110.194 -178.252 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.269 1 O4'-C1'-N19 114.758 6.558 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.409 ' C5 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.41 -3.576 2 C1'-O4'-C4' 104.914 -5.207 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.652 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.76 1 N19-C1'-C2' 106.869 -4.082 OUTLIER-EPSILON 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.459 ' OP1' " H4'" ' B' ' 104' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.19 1 P-O3'-C3' 125.692 4.993 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 2 C5'-C4'-C3' 105.931 -6.379 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.883 0 O4'-C1'-N19 111.196 2.996 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p -59.75 142.84 52.42 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.625 0.37 . . . . 0.0 110.873 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 47.16 18.73 0.09 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.993 1.317 . . . . 0.0 113.556 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.97 92.51 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.8 ptm85 -168.91 42.87 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.527 1.163 . . . . 0.0 113.539 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 69.2 Cg_endo -68.99 136.11 34.12 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.52 1.48 . . . . 0.0 108.93 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.64 116.29 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.846 3.031 . . . . 0.0 110.98 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -86.61 -162.05 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.912 3.075 . . . . 0.0 110.142 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.67 30.5 2.85 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.489 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 31.2 m -63.48 -7.05 2.6 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 C-N-CA 123.881 0.872 . . . . 0.0 112.624 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.51 0.26 15.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.75 0.82 . . . . 0.0 112.812 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.25 51.43 0.13 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.252 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.489 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 11.7 ptp -132.39 173.8 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.821 0.811 . . . . 0.0 112.957 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -70.21 -22.5 62.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.173 0.989 . . . . 0.0 112.066 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 m 42.09 59.85 2.47 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.442 1.097 . . . . 0.0 113.618 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 22.5 tp -61.66 162.22 8.79 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.579 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 17.2 pttp -132.1 151.4 51.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.107 0.412 . . . . 0.0 110.655 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.17 143.04 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -149.31 -177.85 6.07 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 124.187 0.93 . . . . 0.0 110.413 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 t30 91.12 26.21 0.02 OUTLIER 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.158 1.383 . . . . 0.0 113.38 169.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.17 121.5 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.985 0.914 . . . . 0.0 109.682 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 24' ' ' ARG . 13.4 m -67.75 167.75 12.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -63.61 8.99 0.07 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.657 1.183 . . . . 0.0 113.471 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' THR . 29.6 ptt180 -133.58 16.44 3.99 Favored 'General case' 0 C--N 1.335 -0.041 0 C-N-CA 123.858 0.863 . . . . 0.0 111.818 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -124.05 165.63 17.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.459 0.303 . . . . 0.0 111.246 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 59.5 p -151.68 168.57 10.92 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.706 1.202 . . . . 0.0 109.256 -175.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 56.7 Cg_endo -68.94 -27.57 30.31 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.319 2.013 . . . . 0.0 111.713 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.85 -30.62 68.15 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.478 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 97.0 m -75.1 -45.08 43.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -59.02 -19.14 40.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.905 -0.497 . . . . 0.0 110.935 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -81.48 -56.63 3.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.385 0.539 . . . . 0.0 110.604 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.478 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -69.91 -15.46 63.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.276 -175.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.84 -30.93 4.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 123.419 0.688 . . . . 0.0 111.363 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.1 m-85 -103.12 -9.94 19.27 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.438 0.563 . . . . 0.0 112.288 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.97 -26.43 62.26 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.751 -0.593 . . . . 0.0 111.187 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.78 -24.14 64.38 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.68 -17.01 61.68 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.47 -80.43 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -162.53 167.24 23.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.023 0.529 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -133.09 138.95 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.19 -25.27 14.56 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -162.74 154.19 17.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.883 0.473 . . . . 0.0 110.17 174.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 60' ' ' VAL . 1.4 p -150.33 107.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -151.36 162.25 41.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.513 -166.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.76 126.43 15.74 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.48 42.46 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.702 3.601 . . . . 0.0 110.413 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -44.42 -44.8 8.64 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.928 1.291 . . . . 0.0 111.561 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -178.34 165.02 1.78 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.36 1.464 . . . . 0.0 108.898 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.467 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 0.2 OUTLIER -134.79 -5.66 2.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.633 169.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -168.3 14.93 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.564 1.146 . . . . 0.0 111.717 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 p -129.45 -14.58 4.18 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -168.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 43.14 24.1 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.608 1.563 . . . . 0.0 113.772 -172.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.63 -155.95 0.08 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.081 0.952 . . . . 0.0 110.358 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 m -156.09 169.59 24.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.224 1.41 . . . . 0.0 109.615 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 27.2 mmt180 -130.03 -172.42 2.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.932 0.893 . . . . 0.0 108.897 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.57 29.61 5.83 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.264 0.935 . . . . 0.0 112.406 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 55' ' ' ARG . 38.0 p90 -153.63 170.95 19.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.479 0.712 . . . . 0.0 109.576 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.89 101.78 3.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -67.22 91.74 0.25 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.444 0.698 . . . . 0.0 109.387 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.527 HG21 HD12 ' A' ' 30' ' ' LEU . 48.6 t -81.53 159.35 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 172.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.1 ttt180 -140.24 131.74 27.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.688 0.395 . . . . 0.0 110.421 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.5 m-85 -113.58 157.92 21.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.057 0.39 . . . . 0.0 111.647 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.495 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -113.18 -34.6 5.62 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.1 128.05 33.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -64.56 -50.53 66.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.396 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -29.54 68.81 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.55 -20.72 31.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.5 49.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -77.36 -19.99 55.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.493 -0.13 . . . . 0.0 111.271 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.78 -41.58 44.09 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.199 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.4 75.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.161 -0.337 . . . . 0.0 111.395 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.0 ptp -75.52 -41.33 55.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.766 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -75.51 1.29 14.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.572 0.749 . . . . 0.0 111.705 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -5.96 3.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.3 ttm -141.23 -25.82 0.72 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -62.57 137.97 58.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.708 1.14 . . . . 0.0 111.101 -177.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.92 9.18 75.2 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.373 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.42 29.34 0.51 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.683 HG12 ' N ' ' A' ' 84' ' ' GLU . 4.9 m -66.48 175.29 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 126.345 1.858 . . . . 0.0 113.847 -172.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.93 -1.3 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -143.49 4.3 1.36 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.433 0.56 . . . . 0.0 112.08 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.92 -27.4 3.33 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -157.36 160.08 38.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.178 0.489 . . . . 0.0 110.027 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.683 ' N ' HG12 ' A' ' 79' ' ' VAL . 16.4 mt-10 -160.62 -43.91 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.628 1.171 . . . . 0.0 109.68 165.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.46 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.2 mm? -139.47 153.84 47.61 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.9 mmt180 -153.76 107.21 2.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.256 1.822 . . . . 0.0 106.183 166.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.6 p -134.23 127.83 51.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 123.029 0.532 . . . . 0.0 110.134 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -156.74 -175.01 5.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.489 1.916 . . . . 0.0 108.112 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.2 mmt -82.84 142.27 31.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.13 155.66 40.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.374 0.269 . . . . 0.0 111.249 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -137.93 9.17 2.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.416 1.087 . . . . 0.0 110.488 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.601 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 22.8 m-85 -130.2 175.63 8.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 109.678 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.68 175.78 17.82 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 117.943 0.338 . . . . 0.0 113.054 -173.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -61.73 156.41 55.33 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.109 0.964 . . . . 0.0 111.399 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -27.49 95.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 1 C-N-CA 126.413 4.742 . . . . 0.0 117.292 -176.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.72 -26.07 1.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.56 2.84 . . . . 0.0 110.083 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -158.13 -177.63 6.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.772 1.629 . . . . 0.0 107.273 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.452 ' O ' ' C8 ' ' B' ' 105' ' ' ' A' . 22.9 m -67.47 -31.22 71.23 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -169.65 17.56 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.689 1.131 . . . . 0.0 112.587 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -144.65 170.96 15.08 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.812 0.278 . . . . 0.0 110.994 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.182 -1.389 . . . . 0.0 110.056 -177.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.426 2 O4'-C1'-N19 115.342 7.142 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.579 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.41 -3.568 2 O4'-C1'-N19 113.677 5.477 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.601 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.783 0 N19-C1'-C2' 107.103 -3.936 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.467 " H1'" ' HB3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.417 -2.978 1 O4'-C1'-N19 112.53 4.33 . 0.01 1z . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.504 0 C4'-C3'-C2' 99.564 -3.136 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 C5'-C4'-C3' 110.759 -3.16 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -145.62 126.75 14.7 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 60.18 -27.91 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.732 2.013 . . . . 0.0 115.433 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.447 ' CA ' " H4'" ' B' ' 107' ' ' ' U' . . . 83.86 -80.22 1.84 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 170.87 68.6 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.573 1.149 . . . . 0.0 111.5 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.15 167.23 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.397 2.731 . . . . 0.0 111.216 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -98.15 71.83 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.637 1 C-N-CA 125.491 4.127 . . . . 0.0 112.945 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.72 -166.32 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.984 3.123 . . . . 0.0 110.294 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -131.57 34.16 3.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.442 0.697 . . . . 0.0 109.819 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.31 -11.98 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.021 0.928 . . . . 0.0 112.04 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.71 -6.57 47.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.774 0.83 . . . . 0.0 111.909 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.79 -8.16 0.07 OUTLIER Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.546 -0.585 . . . . 0.0 114.053 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.8 mtp -60.68 162.25 6.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.569 1.185 . . . . 0.0 111.013 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -60.34 -23.72 64.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.336 0.254 . . . . 0.0 110.659 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 t 42.92 55.36 4.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.536 1.134 . . . . 0.0 112.859 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 19.3 tp -61.39 159.04 13.3 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -143.98 140.4 29.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.517 0.599 . . . . 0.0 110.75 175.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 60' ' ' VAL . 4.9 p -134.12 149.89 30.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 123.002 0.521 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -151.41 -170.12 3.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.902 1.281 . . . . 0.0 109.868 -176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 t30 87.73 26.76 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.918 1.287 . . . . 0.0 112.125 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.21 127.39 21.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.534 1.134 . . . . 0.0 109.412 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 23' ' ' TYR . 7.1 m -76.22 169.54 18.02 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.295 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.455 ' H ' HG22 ' A' ' 22' ' ' THR . 53.6 p90 -63.13 5.74 0.14 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.921 1.288 . . . . 0.0 114.009 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -133.53 14.25 4.09 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.693 0.679 . . . . 0.0 112.013 -176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 26' ' ' SER . 3.2 m -114.87 165.82 12.43 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.92 0.391 . . . . 0.0 110.919 -173.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 86.7 p -150.42 167.16 13.54 Favored Pre-proline 0 CA--C 1.529 0.139 0 C-N-CA 124.219 1.008 . . . . 0.0 109.63 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.2 Cg_endo -69.78 -34.25 14.9 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.684 2.256 . . . . 0.0 110.274 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.21 -36.17 83.33 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -72.78 -43.95 62.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -57.12 -21.56 33.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.272 -0.267 . . . . 0.0 110.833 -178.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -80.42 -56.66 4.03 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -7.97 41.74 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -97.67 -31.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.776 0.43 . . . . 0.0 111.644 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.5 m-85 -101.11 -12.1 19.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.507 0.594 . . . . 0.0 111.874 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.84 -24.17 59.73 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.901 -0.499 . . . . 0.0 111.242 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -68.61 -23.73 64.49 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.786 -0.571 . . . . 0.0 112.077 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -75.27 -17.64 60.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.468 0.307 . . . . 0.0 111.391 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.53 -85.83 0.09 OUTLIER Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -157.32 162.4 39.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.067 0.547 . . . . 0.0 110.342 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.9 t -134.43 142.05 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -75.92 -46.82 12.71 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.18 171.85 4.0 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.318 0.58 . . . . 0.0 110.661 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG12 HG22 ' A' ' 60' ' ' VAL . 14.4 m -124.97 143.62 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 172.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -152.18 150.71 30.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.742 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mt -139.59 76.01 30.94 Favored Pre-proline 0 CA--C 1.528 0.131 0 C-N-CA 123.317 0.647 . . . . 0.0 109.946 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 95.4 Cg_endo -77.25 178.21 7.92 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 124.529 3.486 . . . . 0.0 111.798 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 46' ' ' PRO . 28.7 tpt180 129.52 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 129.175 2.99 . . . . 0.0 108.281 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 50' ' ' TYR . 20.2 m-20 -147.58 87.42 1.64 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 174.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.54 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 13.7 ptt180 -63.96 14.3 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.54 1.536 . . . . 0.0 114.862 -170.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.525 ' CD1' HG23 ' A' ' 51' ' ' THR . 11.5 p90 -145.25 5.14 1.09 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.295 1.438 . . . . 0.0 110.822 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.525 HG23 ' CD1' ' A' ' 50' ' ' TYR . 7.0 p -133.38 -33.71 1.1 Allowed 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.135 -0.353 . . . . 0.0 111.154 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 34.29 33.49 0.01 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.956 2.102 . . . . 0.0 113.553 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -6.59 45.73 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.9 t -67.42 162.94 21.94 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.225 0.466 . . . . 0.0 110.849 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -155.26 7.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.3 -12.59 81.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.29 169.46 23.14 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.682 0.793 . . . . 0.0 109.796 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.23 95.65 1.73 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.4 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 63.0 t80 -62.8 97.19 0.1 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 43' ' ' VAL . 37.8 t -99.66 152.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 6.9 ptm180 -137.03 143.76 42.88 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 15.8 m-85 -113.64 160.5 18.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.479 0.712 . . . . 0.0 111.472 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.499 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -110.79 -36.1 5.79 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.71 133.64 34.79 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -66.54 -54.67 21.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.358 -0.353 . . . . 0.0 110.131 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.468 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -59.36 -34.22 72.12 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -83.11 -20.0 35.67 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.151 0.432 . . . . 0.0 110.872 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -81.99 -44.99 15.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 122.632 0.373 . . . . 0.0 110.162 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.97 -26.37 64.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.237 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.17 -47.49 43.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.068 0.394 . . . . 0.0 111.171 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.06 -31.75 72.96 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 122.004 -0.435 . . . . 0.0 110.499 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 ttp -74.32 -43.71 55.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.053 0.541 . . . . 0.0 110.423 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -79.73 1.9 24.8 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.91 -5.25 5.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.7 ttm -136.41 -28.69 1.0 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.534 ' HB2' HG12 ' A' ' 87' ' ' VAL . 4.6 t70 -63.89 136.2 57.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.852 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.68 10.69 83.18 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.779 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.17 34.58 0.47 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.945 0.872 . . . . 0.0 109.903 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 81' ' ' ASP . 8.8 p -73.83 174.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.595 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.2 pt? -151.98 3.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.703 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.616 ' H ' HG22 ' A' ' 79' ' ' VAL . 36.3 t70 -142.83 -3.5 0.99 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.35 -10.5 30.99 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.573 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.62 129.02 4.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.139 0.975 . . . . 0.0 108.643 173.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 79' ' ' VAL . 11.3 mm-40 -144.42 -50.25 0.28 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 170.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.4 mm? -138.69 152.98 48.49 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 122.828 0.451 . . . . 0.0 111.666 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -150.38 103.09 3.11 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 166.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 76' ' ' ASP . 4.3 p -131.47 132.99 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.944 0.402 . . . . 0.0 111.145 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -153.21 176.28 12.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.911 1.284 . . . . 0.0 109.595 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.8 mmt -76.7 133.9 39.39 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.5 0.72 . . . . 0.0 109.069 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.63 149.94 47.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.723 0.297 . . . . 0.0 110.773 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -139.31 18.28 2.58 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.287 1.035 . . . . 0.0 108.917 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.487 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 2.8 t80 -145.33 144.71 30.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -119.79 174.85 15.67 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.739 0.699 . . . . 0.0 114.431 -168.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -61.2 139.53 94.48 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.804 1.242 . . . . 0.0 109.969 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.82 146.78 54.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.848 3.032 . . . . 0.0 112.937 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.81 -24.36 3.42 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.232 3.288 . . . . 0.0 111.545 172.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -152.36 160.67 43.28 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.526 1.131 . . . . 0.0 109.1 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 p -72.12 -53.33 13.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -164.29 172.64 13.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.258 0.481 . . . . 0.0 111.146 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -153.34 167.29 29.87 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.231 0.612 . . . . 0.0 110.09 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.084 -1.436 . . . . 0.0 109.938 -179.418 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . 0.534 " H4'" " H5'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.104 1 O4'-C1'-N19 112.352 4.152 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.534 " H5'" " H4'" ' B' ' 102' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.413 -3.357 2 C5'-C4'-C3' 107.62 -5.253 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.487 ' N2 ' ' CD2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.941 0 N19-C1'-C2' 108.614 -2.991 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.54 " H1'" ' HB3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.415 -3.132 0 O4'-C1'-N19 111.618 3.418 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.357 0 O4'-C1'-N19 111.72 3.52 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.447 " H4'" ' CA ' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.716 2 C4'-C3'-C2' 97.468 -5.232 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.9 p -150.03 174.51 12.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.106 0.562 . . . . 0.0 111.003 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -59.74 -41.83 91.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.11 0.564 . . . . 0.0 110.818 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.445 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 64.06 -81.94 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 125.268 1.413 . . . . 0.0 109.677 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -152.8 55.98 1.61 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 111.502 -167.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.81 118.42 5.59 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.551 2.167 . . . . 0.0 111.356 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.32 119.08 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.562 2.842 . . . . 0.0 110.883 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -84.38 -166.59 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.16 3.24 . . . . 0.0 110.501 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -134.92 36.86 3.06 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.181 0.992 . . . . 0.0 110.017 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.33 11.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.638 1.575 . . . . 0.0 114.337 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.96 0.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.992 0.917 . . . . 0.0 113.24 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.67 -5.14 0.09 OUTLIER Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.168 0.44 . . . . 0.0 113.363 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 7.5 ptt? -62.6 166.74 5.0 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.168 0.984 . . . . 0.0 112.718 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.5 m -59.15 -26.59 64.88 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.5 m 42.17 59.19 2.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.204 1.001 . . . . 0.0 113.512 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 22.1 tp -62.72 164.35 7.92 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.536 ' HE2' ' C5 ' ' B' ' 103' ' ' ' G' . 19.0 ttpp -135.72 145.08 46.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.043 0.937 . . . . 0.0 110.74 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.589 ' HB ' HG22 ' A' ' 60' ' ' VAL . 92.4 t -130.31 148.69 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.792 0.837 . . . . 0.0 108.952 173.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -152.26 -169.32 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.7 1.6 . . . . 0.0 110.138 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 83.93 27.37 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.403 1.481 . . . . 0.0 113.51 170.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.2 119.33 4.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.149 0.98 . . . . 0.0 109.93 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 23' ' ' TYR . 19.9 m -70.71 169.87 13.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.476 ' H ' HG22 ' A' ' 22' ' ' THR . 54.7 p90 -62.53 5.22 0.12 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 113.741 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt-85 -130.71 14.29 5.38 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.313 0.645 . . . . 0.0 112.018 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 26' ' ' SER . 2.4 m -120.24 164.91 15.54 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.088 -173.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.528 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 97.5 p -149.08 168.01 11.86 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 124.283 1.033 . . . . 0.0 109.38 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.06 -29.66 22.07 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.627 2.218 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.32 -35.0 78.54 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.6 m -74.1 -44.74 52.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.552 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -56.75 -20.78 23.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.248 -0.282 . . . . 0.0 110.855 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -79.46 -57.34 3.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -14.44 63.0 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.76 -32.25 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.394 0.678 . . . . 0.0 111.502 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 30' ' ' LEU . 23.0 m-85 -103.38 -9.49 19.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.3 -27.45 63.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.241 0.473 . . . . 0.0 110.908 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -68.45 -23.52 64.61 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.97 -16.89 61.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.187 0.195 . . . . 0.0 111.504 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.12 -80.73 0.13 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -160.29 164.84 32.29 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.992 0.517 . . . . 0.0 110.52 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.32 144.81 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -175.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.64 -21.45 7.88 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.38 157.81 28.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.472 0.636 . . . . 0.0 110.095 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.402 HG23 HG12 ' A' ' 60' ' ' VAL . 2.2 p -169.15 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.138 0.975 . . . . 0.0 108.414 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.14 167.54 28.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.5 mm -98.07 103.52 17.95 Favored Pre-proline 0 N--CA 1.456 -0.141 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' CB ' " H4'" ' B' ' 104' ' ' ' G' . 72.6 Cg_endo -72.82 -46.28 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.549 2.166 . . . . 0.0 111.478 -171.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.39 -178.83 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.79 2.436 . . . . 0.0 116.392 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.97 106.84 8.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -54.22 0.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.39 2.276 . . . . 0.0 114.697 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CD2' HG23 ' A' ' 51' ' ' THR . 40.6 p90 -137.71 0.57 2.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.835 0.743 . . . . 0.0 112.309 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.465 HG23 ' CD2' ' A' ' 50' ' ' TYR . 28.7 p -127.05 -19.51 4.37 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.677 0.672 . . . . 0.0 111.216 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mptt 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.404 1.881 . . . . 0.0 113.983 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -125.7 7.2 7.49 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -72.49 -6.73 45.83 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -40.24 141.71 0.46 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.773 1.629 . . . . 0.0 112.426 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.14 -3.56 0.91 Allowed Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.933 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -155.03 166.92 32.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.898 0.879 . . . . 0.0 109.573 174.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 106.76 4.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -70.21 110.85 5.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.589 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -113.04 164.68 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 15.3 ttt180 -142.87 139.74 30.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 11.0 m-85 -116.92 164.97 13.89 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.564 0.54 . . . . 0.0 110.717 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.436 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -123.48 -31.57 3.49 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.232 0.613 . . . . 0.0 112.462 -177.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.54 125.32 30.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.1 -52.32 64.36 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.433 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -60.11 -33.61 72.36 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -84.02 -19.73 33.98 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.53 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.04 -42.86 18.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.89 -26.59 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.816 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.11 -40.33 62.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.313 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -33.41 75.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.232 -0.292 . . . . 0.0 111.592 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.0 ptp -78.06 -37.48 46.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.08 1.74 23.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.141 0.576 . . . . 0.0 111.807 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.33 -6.86 4.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.0 ttm -138.89 -26.71 0.85 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.93 136.16 55.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.229 0.922 . . . . 0.0 110.181 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.97 9.9 86.61 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.162 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.67 32.61 0.42 Allowed 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.309 1.055 . . . . 0.0 110.263 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.527 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 38.7 t -74.62 164.49 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.367 1.067 . . . . 0.0 112.094 -170.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -154.96 10.53 0.34 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.472 0.709 . . . . 0.0 112.217 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.35 5.09 2.24 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.87 0.468 . . . . 0.0 111.507 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.54 -9.84 57.44 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.93 124.92 0.55 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.694 1.198 . . . . 0.0 108.131 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.527 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 29.3 mm-40 -137.97 -48.89 0.56 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.249 0.22 . . . . 0.0 110.451 169.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -136.78 156.44 48.51 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 121.419 0.628 . . . . 0.0 112.296 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.0 mmm180 -148.05 109.08 4.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.955 1.702 . . . . 0.0 106.577 167.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.22 134.23 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -169.58 173.86 6.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.0 mmt -75.64 136.61 40.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.166 0.586 . . . . 0.0 109.909 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.49 151.58 45.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -140.52 21.4 2.37 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.662 0.785 . . . . 0.0 109.597 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -143.88 158.0 43.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.31 178.38 17.73 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.894 0.717 . . . . 0.0 114.894 -168.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.442 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 55.7 mtp180 -62.54 161.66 25.51 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 125.312 1.445 . . . . 0.0 111.034 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 94' ' ' ARG . 13.5 Cg_exo -28.92 96.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 1 C-N-CA 126.001 4.468 . . . . 0.0 114.952 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.47 -57.29 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.706 2.271 . . . . 0.0 110.504 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -168.33 21.12 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.199 0.599 . . . . 0.0 111.712 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.444 ' HB2' " H5'" ' B' ' 105' ' ' ' A' . 16.2 m -64.48 -2.99 2.6 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.008 0.923 . . . . 0.0 112.842 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -144.22 8.49 1.41 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 122.84 0.456 . . . . 0.0 112.018 -170.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.536 ' CG ' ' H ' ' A' ' 101' ' ' SER . 29.2 t60 55.78 -179.97 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.827 1.251 . . . . 0.0 112.733 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.536 ' H ' ' CG ' ' A' ' 100' ' ' HIS . 71.0 m . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.414 -1.279 . . . . 0.0 109.854 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.498 2 O4'-C1'-N19 114.13 5.93 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.536 ' C5 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.088 0 O4'-C1'-N19 112.2 4.0 . 0.06 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.426 " H4'" ' CB ' ' A' ' 46' ' ' PRO . . . . . . . . 0 O4'--C4' 1.416 -3.119 2 O4'-C1'-N19 112.786 4.586 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.444 " H5'" ' HB2' ' A' ' 98' ' ' SER . . . . . . . . 0 O4'--C4' 1.416 -3.119 0 O4'-C1'-N19 112.194 3.994 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.914 0 P-O3'-C3' 124.406 3.922 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.445 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.419 -2.832 1 C5'-C4'-C3' 109.235 -4.176 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.419 0.152 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 m -63.55 167.98 5.13 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.184 0.594 . . . . 0.0 111.611 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -57.64 -48.34 79.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.343 0.657 . . . . 0.0 110.813 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.36 -32.06 0.16 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.71 2.1 . . . . 0.0 114.609 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 5' ' ' ARG 0.25 11.8 ptm85 146.06 65.63 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 128.879 2.872 . . . . 0.0 109.643 176.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -58.84 116.61 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.78 2.987 . . . . 0.0 111.324 -168.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -100.98 74.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.962 1 C-N-CA 125.981 4.454 . . . . 0.0 113.758 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.99 -162.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.802 2.334 . . . . 0.0 109.803 170.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -66.05 32.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.744 1.218 . . . . 0.0 113.805 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.481 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 10.5 m -56.68 -9.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.64 -12.83 61.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.888 0.475 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.29 15.15 0.03 OUTLIER Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.188 -0.784 . . . . 0.0 113.802 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 12.8 ptp -65.69 176.5 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.662 1.231 . . . . 0.0 112.263 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -70.08 -24.91 63.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.321 0.648 . . . . 0.0 112.323 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m 46.6 36.86 3.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.492 1.117 . . . . 0.0 113.868 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.2 tm? -65.87 132.84 49.62 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 17.7 pttt -117.04 161.02 20.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -130.51 147.83 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -151.59 -175.83 5.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.297 1.439 . . . . 0.0 110.34 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 58.9 t30 86.44 37.73 0.02 OUTLIER 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 113.455 169.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.43 163.55 10.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 24' ' ' ARG . 20.0 m -116.61 169.53 9.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.611 0.765 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -61.63 4.11 0.11 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.336 1.054 . . . . 0.0 113.438 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.0 ptm180 -136.03 19.11 3.22 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.398 1.079 . . . . 0.0 110.991 -175.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 26' ' ' SER . 1.9 m -124.17 167.38 14.34 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.246 0.618 . . . . 0.0 110.276 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.3 p -152.29 165.78 16.76 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.605 0.762 . . . . 0.0 109.754 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.4 Cg_endo -69.58 -27.65 27.07 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.811 2.34 . . . . 0.0 110.03 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -68.13 -37.71 81.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.7 m -72.76 -43.53 62.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.93 -19.74 32.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.337 -0.227 . . . . 0.0 111.031 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.64 -55.81 4.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -7.51 37.88 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.194 0.452 . . . . 0.0 112.009 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.435 HG12 ' HE1' ' A' ' 75' ' ' MET . 60.4 t -98.21 -31.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.317 0.647 . . . . 0.0 111.113 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.432 ' CD1' HD13 ' A' ' 30' ' ' LEU . 22.5 m-85 -102.84 -11.26 18.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.98 -24.99 60.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 121.914 -0.491 . . . . 0.0 110.921 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -68.65 -24.04 64.49 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -72.84 -19.51 61.3 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 122.611 0.364 . . . . 0.0 111.52 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.48 -82.99 0.1 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -158.18 164.58 36.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.928 0.491 . . . . 0.0 110.979 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.5 t -135.29 138.58 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.92 -24.0 18.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.432 ' CG ' ' H1 ' ' B' ' 106' ' ' ' G' . 24.2 t0 -163.26 156.08 18.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.915 0.358 . . . . 0.0 110.453 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 60' ' ' VAL . 2.5 p -153.13 112.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -148.97 159.14 44.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -165.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -121.68 93.48 48.67 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 124.353 1.061 . . . . 0.0 108.938 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.65 33.23 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.599 3.532 . . . . 0.0 112.505 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -65.38 164.02 14.51 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.66 111.0 1.11 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.39 9.11 1.11 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CD1' HG23 ' A' ' 51' ' ' THR . 12.0 p90 -144.85 -0.96 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.138 0.975 . . . . 0.0 111.823 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.487 HG23 ' CD1' ' A' ' 50' ' ' TYR . 13.1 p -124.25 -8.04 7.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.381 0.537 . . . . 0.0 110.271 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.87 20.34 0.34 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.215 2.206 . . . . 0.0 113.173 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.7 102.36 0.74 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.2 t -57.06 166.57 1.02 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.427 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.34 -4.07 4.34 Favored 'General case' 0 N--CA 1.46 0.075 0 C-N-CA 123.87 0.868 . . . . 0.0 110.732 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.18 68.74 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.192 -0.782 . . . . 0.0 113.144 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.98 172.11 17.98 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.942 1.371 . . . . 0.0 111.746 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.46 92.71 2.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.472 1.109 . . . . 0.0 108.394 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.442 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 30.6 t80 -62.88 110.8 1.88 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -107.81 167.42 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -140.21 145.08 36.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.58 146.71 47.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.822 0.849 . . . . 0.0 110.694 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.667 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -99.51 -32.63 11.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.812 -177.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.92 127.07 33.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.762 0.425 . . . . 0.0 110.426 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.45 -51.73 58.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -59.8 -33.69 72.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.61 -21.17 30.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.97 0.35 . . . . 0.0 110.341 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.39 -46.98 18.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.391 0.677 . . . . 0.0 110.225 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.52 -17.51 59.22 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.208 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.6 -40.02 35.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.095 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.38 75.5 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.141 -0.349 . . . . 0.0 111.293 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.454 ' HA ' HG13 ' A' ' 87' ' ' VAL . 12.2 ptp -74.68 -42.82 57.74 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.362 0.601 . . . . 0.0 109.682 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -74.99 1.25 13.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.805 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.37 -10.02 4.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.435 ' HE1' HG12 ' A' ' 33' ' ' VAL . 4.6 ttp -146.84 -17.63 0.41 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.43 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -61.84 136.94 58.18 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.715 1.143 . . . . 0.0 110.273 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.07 8.87 65.69 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.611 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.05 29.71 0.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.483 1.141 . . . . 0.0 112.039 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.675 HG12 ' N ' ' A' ' 84' ' ' GLU . 3.9 m -65.61 175.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.418 1.887 . . . . 0.0 114.127 -172.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 0.47 0.82 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -142.31 3.9 1.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.986 0.812 . . . . 0.0 111.992 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.4 -27.42 3.4 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -158.71 160.48 36.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.675 ' N ' HG12 ' A' ' 79' ' ' VAL . 21.1 mt-10 -160.12 -44.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.702 1.201 . . . . 0.0 110.095 166.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.0 mm? -141.78 151.94 43.3 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.231 0.612 . . . . 0.0 112.217 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' A' ' 20' ' ' ASN . 29.8 mmt180 -153.49 114.13 4.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 165.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 72' ' ' MET . 1.4 p -139.38 116.82 11.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.073 0.463 . . . . 0.0 110.499 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -151.53 164.92 35.76 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.081 1.352 . . . . 0.0 108.489 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.6 mmt -61.82 142.64 57.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.345 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.11 169.8 14.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.638 0.775 . . . . 0.0 110.76 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -142.65 2.98 1.44 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.196 0.598 . . . . 0.0 110.558 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.505 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 11.6 m-85 -133.79 166.84 21.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.23 179.28 17.38 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -61.17 145.29 90.16 Favored Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 122.506 0.322 . . . . 0.0 110.776 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.459 ' CB ' H5'' ' B' ' 105' ' ' ' A' . 65.0 Cg_endo -81.31 150.63 17.48 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.539 2.826 . . . . 0.0 111.834 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.19 -42.44 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.132 2.555 . . . . 0.0 111.025 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.42 148.34 2.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.256 1.022 . . . . 0.0 110.017 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.452 ' HB3' " H5'" ' B' ' 105' ' ' ' A' . 3.9 t -164.51 13.31 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 173.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -131.11 177.06 7.74 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.604 0.638 . . . . 0.0 110.902 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -143.13 9.28 1.67 Allowed 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.873 0.469 . . . . 0.0 111.679 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.393 -1.289 . . . . 0.0 110.21 -178.831 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.886 0 O4'-C1'-N19 111.294 3.094 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.544 0 N19-C1'-C2' 108.663 -2.961 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 6d' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.505 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.58 1 P-O3'-C3' 124.933 4.36 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.459 H5'' ' CB ' ' A' ' 95' ' ' PRO . . . . . . . . 0 O4'--C4' 1.419 -2.858 3 O4'-C1'-N19 112.764 4.564 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.447 " H3'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 C2'--C1' 1.506 -2.157 3 O4'-C1'-N19 113.357 5.157 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.447 " H3'" " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.193 2 C1'-O4'-C4' 105.354 -4.718 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.411 0.148 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.8 m -147.46 172.91 13.22 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.158 0.583 . . . . 0.0 110.304 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -60.82 -32.04 71.42 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.134 0.574 . . . . 0.0 111.372 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 47.56 59.7 5.79 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.566 1.555 . . . . 0.0 113.51 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.577 ' HD3' ' C6 ' ' B' ' 107' ' ' ' U' . 8.0 ptm180 39.34 62.53 5.04 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 126.378 1.871 . . . . 0.0 112.668 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.46 155.66 24.84 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.714 2.943 . . . . 0.0 109.645 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.61 113.96 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.416 2.744 . . . . 0.0 109.247 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HB2' HG13 ' A' ' 10' ' ' VAL . 35.1 Cg_endo -83.92 -172.35 1.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.837 3.025 . . . . 0.0 111.93 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -133.35 23.77 4.1 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.075 1.35 . . . . 0.0 108.535 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 8' ' ' PRO . 29.9 m -65.23 -2.26 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 125.555 1.542 . . . . 0.0 112.858 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.55 9.47 1.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.066 0.946 . . . . 0.0 112.209 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.43 40.0 0.33 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.643 -0.532 . . . . 0.0 112.634 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.3 ptp -135.25 175.11 9.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.927 0.863 . . . . 0.0 112.293 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -71.1 -23.3 62.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.171 0.588 . . . . 0.0 112.405 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.7 m 43.56 57.08 4.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.86 0.864 . . . . 0.0 113.296 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.466 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 17.5 tp -65.11 166.3 9.8 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 20.0 pttp -138.28 154.94 49.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.838 170.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.499 ' HB ' HG22 ' A' ' 60' ' ' VAL . 83.1 t -130.88 143.09 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -148.92 -175.5 4.97 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.928 0.891 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 86' ' ' ARG . 41.6 t30 83.82 37.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.76 1.224 . . . . 0.0 113.673 169.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 158.83 11.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.867 0.867 . . . . 0.0 108.958 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 24' ' ' ARG . 6.8 m -118.78 171.54 8.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.639 0.775 . . . . 0.0 109.959 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CD2' HG22 ' A' ' 22' ' ' THR . 53.4 p90 -63.52 7.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.829 1.252 . . . . 0.0 112.969 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 22' ' ' THR . 8.3 ptm180 -132.17 17.78 4.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.039 1.336 . . . . 0.0 110.401 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.52 167.37 19.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.015 0.526 . . . . 0.0 110.72 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 95.5 p -154.71 164.05 22.27 Favored Pre-proline 0 N--CA 1.464 0.254 0 C-N-CA 123.994 0.918 . . . . 0.0 109.127 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 49.5 Cg_endo -68.29 -30.16 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.064 1.842 . . . . 0.0 111.701 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.34 -33.88 73.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.09 -44.56 65.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.427 HD11 HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -57.78 -21.3 41.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.145 -0.347 . . . . 0.0 111.222 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -81.28 -57.01 3.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.027 -0.42 . . . . 0.0 109.895 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -9.16 42.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.903 0.481 . . . . 0.0 111.854 -176.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.91 -31.5 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.214 0.606 . . . . 0.0 111.807 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.5 m-85 -100.44 -11.45 20.18 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.397 0.544 . . . . 0.0 111.907 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.828 -0.545 . . . . 0.0 111.429 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -69.37 -23.23 63.72 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -71.04 -31.01 67.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.499 0.32 . . . . 0.0 110.48 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.76 -76.48 0.07 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -162.37 165.71 26.1 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 117.198 0.499 . . . . 0.0 110.577 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.5 t -137.53 138.05 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -71.98 -45.08 43.8 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.99 171.65 6.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.129 0.49 . . . . 0.0 110.265 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -159.36 128.57 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.979 0.911 . . . . 0.0 109.68 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.58 175.9 10.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.528 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -116.6 88.26 23.94 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 124.049 0.94 . . . . 0.0 109.367 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.49 150.92 52.52 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.838 3.025 . . . . 0.0 110.005 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -179.16 -178.81 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.034 0.934 . . . . 0.0 108.565 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -58.01 109.18 0.69 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.438 ' HD2' " H1'" ' B' ' 105' ' ' ' A' . 14.5 ptm180 -67.58 19.14 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.581 1.552 . . . . 0.0 115.125 -168.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CD2' HG23 ' A' ' 51' ' ' THR . 5.7 p90 -149.89 -19.24 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.061 0.944 . . . . 0.0 111.991 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.46 HG23 ' CD2' ' A' ' 50' ' ' TYR . 27.8 p -103.75 -25.27 13.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.662 173.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.2 31.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.609 1.963 . . . . 0.0 113.966 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.24 -15.73 62.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.084 0.554 . . . . 0.0 112.292 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -97.12 155.74 16.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 111.359 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -171.63 16.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.399 1.079 . . . . 0.0 111.221 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.71 2.03 75.39 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.34 -0.85 . . . . 0.0 113.229 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.21 169.08 24.92 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.038 0.919 . . . . 0.0 110.219 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.67 92.35 2.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.27 110.58 1.68 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -105.6 163.76 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.8 ptm180 -139.06 142.58 38.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.756 0.66 . . . . 0.0 110.678 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 16.1 m-85 -116.57 150.87 37.3 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.799 0.687 . . . . 0.0 111.557 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.613 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -95.83 -50.56 4.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 123.986 0.804 . . . . 0.0 112.008 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.67 135.17 49.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.947 0.499 . . . . 0.0 110.857 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -69.06 -52.38 29.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 178.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.457 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.68 -31.9 73.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -77.36 -26.34 51.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.871 0.367 . . . . 0.0 110.086 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -78.48 -40.91 34.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 122.031 -0.418 . . . . 0.0 110.512 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.71 -22.3 56.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.87 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.87 -40.06 48.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.948 0.794 . . . . 0.0 109.937 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.89 74.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.323 -0.236 . . . . 0.0 111.464 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.7 ptp -77.42 -39.69 46.1 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.322 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.63 0.64 19.5 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.133 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.72 -6.28 4.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.1 ttm -139.15 -24.0 0.89 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.64 135.89 57.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.151 0.887 . . . . 0.0 110.099 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.39 10.19 78.62 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.093 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.1 35.01 0.42 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.015 0.908 . . . . 0.0 110.797 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.626 HG22 ' H ' ' A' ' 80' ' ' LEU . 10.0 p -69.09 174.78 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.626 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.2 pt? -152.73 -0.12 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.648 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.553 ' H ' HG22 ' A' ' 79' ' ' VAL . 32.5 t70 -145.37 0.02 0.88 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.06 -18.61 6.17 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.625 ' C ' HG23 ' A' ' 79' ' ' VAL . 6.9 ptp180 -161.49 142.04 10.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 171.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 85' ' ' LEU . 23.3 mm-40 -147.12 -50.38 0.19 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.61 151.3 45.9 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.0 mmm180 -147.79 109.73 4.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 105.804 167.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.82 134.64 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.116 0.567 . . . . 0.0 109.96 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 89' ' ' MET . 36.6 tt0 -169.9 177.67 4.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.408 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 14.1 mmt -73.95 144.83 45.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.841 0.456 . . . . 0.0 109.786 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.78 163.93 15.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.467 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -133.73 -1.29 3.08 Favored 'General case' 0 C--O 1.23 0.051 0 C-N-CA 122.517 0.327 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.58 169.92 15.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.99 179.08 16.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.49 120.17 29.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.476 ' CG ' " H5'" ' B' ' 105' ' ' ' A' . 43.0 Cg_endo -67.84 139.3 47.25 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.493 2.128 . . . . 0.0 111.659 -171.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.43 -17.99 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.492 3.461 . . . . 0.0 112.217 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -140.08 -169.2 2.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.46 1.104 . . . . 0.0 109.592 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p -140.22 30.86 1.96 Allowed 'General case' 0 N--CA 1.46 0.065 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.6 t60 56.97 16.07 2.64 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -147.65 9.75 0.92 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.226 0.61 . . . . 0.0 110.472 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.434 -1.269 . . . . 0.0 110.081 -178.584 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.287 1 O4'-C1'-N19 114.422 6.222 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.147 0 C4'-C3'-C2' 99.438 -3.262 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.206 0 C5'-C4'-O4' 113.918 3.37 . 0.09 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.476 " H5'" ' CG ' ' A' ' 95' ' ' PRO . . . . . . . . 0 O4'--C4' 1.415 -3.182 1 O4'-C1'-N19 113.848 5.648 OUTLIER-DELTA 0.0 OUTLIER '7D dist 7p' 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.575 " C2'" ' H ' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.422 -2.592 1 O4'-C1'-N19 113.369 5.169 . 0.029 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.577 ' C6 ' ' HD3' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.417 -2.991 1 O4'-C1'-N19 113.68 5.48 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.6 p -148.13 -172.79 4.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.492 0.717 . . . . 0.0 110.058 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -133.66 32.09 3.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.26 0.624 . . . . 0.0 110.684 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.453 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . -117.09 59.28 0.47 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 45.47 46.98 3.46 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 127.331 2.252 . . . . 0.0 115.753 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.35 154.88 41.22 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.538 2.159 . . . . 0.0 108.508 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.54 112.87 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.395 2.73 . . . . 0.0 109.994 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -84.39 -165.68 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.355 2.703 . . . . 0.0 110.678 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -133.26 24.55 4.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.855 0.862 . . . . 0.0 109.607 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 31.1 m -64.72 -5.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 124.356 1.062 . . . . 0.0 112.553 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 6.8 2.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.38 41.07 0.41 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.557 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 10' ' ' VAL . 9.1 ptp -134.43 172.9 12.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.948 0.874 . . . . 0.0 112.593 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -69.21 -23.72 63.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.593 0.757 . . . . 0.0 112.73 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 m 44.84 36.57 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.579 1.151 . . . . 0.0 113.904 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -60.67 133.16 55.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.591 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 20.7 ttpp -106.6 147.18 29.78 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.889 0.875 . . . . 0.0 112.052 -171.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' HB ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -132.81 154.64 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.932 171.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -154.2 -171.61 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.265 1.426 . . . . 0.0 110.593 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 93.8 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.615 1.966 . . . . 0.0 113.339 169.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 127.94 31.32 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.433 1.093 . . . . 0.0 109.461 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' ARG . 9.5 m -77.09 168.53 19.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.905 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -63.92 6.11 0.19 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.038 . . . . 0.0 112.669 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 32.7 ptt180 -137.52 19.4 2.91 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.591 1.156 . . . . 0.0 111.218 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -119.18 166.11 13.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.055 0.542 . . . . 0.0 110.431 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 92.7 p -150.71 164.85 18.91 Favored Pre-proline 0 CA--C 1.529 0.141 0 C-N-CA 124.243 1.017 . . . . 0.0 109.397 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 59.6 Cg_endo -69.98 -23.75 29.42 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.473 2.115 . . . . 0.0 110.915 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.87 -35.13 72.23 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -76.18 -43.25 43.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -56.96 -21.74 32.59 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.974 -0.454 . . . . 0.0 110.892 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -81.49 -56.13 4.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.92 -30.38 69.01 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.085 0.402 . . . . 0.0 110.334 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -78.5 -34.76 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.977 0.511 . . . . 0.0 111.004 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -99.1 -11.34 21.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -74.19 -24.48 59.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.542 0.61 . . . . 0.0 110.778 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -67.68 -24.99 65.48 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -74.56 -19.48 60.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.486 -0.293 . . . . 0.0 111.697 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.29 -80.76 0.1 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.476 -0.392 . . . . 0.0 112.173 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.12 166.15 33.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.7 t -137.1 137.36 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 63' ' ' HIS . . . -80.49 -45.07 8.18 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -156.72 155.42 31.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.147 0.979 . . . . 0.0 108.444 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG23 HG22 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -139.01 117.15 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 175.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -147.99 164.01 35.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.681 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -134.45 92.57 20.23 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -48.36 142.39 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 124.125 3.217 . . . . 0.0 111.735 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -159.06 160.18 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.981 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.44 121.84 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HD2' " H1'" ' B' ' 105' ' ' ' A' . 9.4 ptm180 -67.97 17.56 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.447 ' CD2' HG23 ' A' ' 51' ' ' THR . 10.1 p90 -150.94 -5.15 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.275 1.03 . . . . 0.0 112.387 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.447 HG23 ' CD2' ' A' ' 50' ' ' TYR . 35.3 p -119.52 -19.45 8.15 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.054 0.843 . . . . 0.0 110.333 171.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.46 24.58 1.63 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.069 1.748 . . . . 0.0 113.768 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.02 -164.19 0.13 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.236 0.615 . . . . 0.0 110.158 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -137.52 169.73 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.406 0.682 . . . . 0.0 110.836 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -138.18 7.62 2.66 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.344 0.658 . . . . 0.0 112.392 -172.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.77 20.8 35.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.578 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -152.41 165.41 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.57 1.185 . . . . 0.0 111.033 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.89 3.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.81 100.35 0.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 18' ' ' VAL . 84.5 t -92.16 154.22 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -132.13 140.22 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.8 m-85 -119.92 143.66 47.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.193 0.597 . . . . 0.0 110.35 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.697 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -85.77 -32.71 21.69 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.94 131.14 55.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.375 0.607 . . . . 0.0 111.282 -170.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.15 -46.37 89.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.509 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.615 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -59.45 -34.54 72.64 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.21 -9.88 24.93 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.357 0.526 . . . . 0.0 110.68 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.89 -44.99 25.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -75.67 -29.11 58.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.299 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.41 -41.68 80.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.592 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.73 76.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.257 -0.277 . . . . 0.0 111.533 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.7 ptp -77.4 -39.99 45.21 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.576 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.99 1.52 17.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.332 0.653 . . . . 0.0 111.719 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.51 -8.7 4.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.3 ttp -142.93 -19.98 0.65 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.03 135.38 57.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.398 1.454 . . . . 0.0 110.125 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.14 78.06 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.045 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.39 29.31 0.51 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.083 0.942 . . . . 0.0 110.966 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 84' ' ' GLU . 5.3 m -67.91 174.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 126.194 1.798 . . . . 0.0 113.361 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.79 9.99 0.92 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.809 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -139.41 7.31 2.36 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.162 0.585 . . . . 0.0 110.317 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.07 -17.33 48.58 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.82 136.7 7.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.409 0.683 . . . . 0.0 109.189 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.566 ' N ' HG12 ' A' ' 79' ' ' VAL . 81.2 mm-40 -150.76 -43.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 110.27 170.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -137.59 151.71 48.63 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.043 0.537 . . . . 0.0 112.122 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 29.0 mmt180 -152.28 112.92 4.14 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 166.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.13 133.12 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.364 0.602 . . . . 0.0 110.73 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -167.96 162.24 13.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.125 1.37 . . . . 0.0 108.546 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 mmt -59.15 139.26 57.08 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.732 0.813 . . . . 0.0 111.336 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.74 52.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -129.89 16.56 5.74 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.232 1.013 . . . . 0.0 108.378 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -147.28 142.38 27.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.29 1.436 . . . . 0.0 107.175 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.28 -176.11 17.43 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -170.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -53.76 132.18 56.54 Favored Pre-proline 0 N--CA 1.455 -0.212 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.29 143.14 52.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.143 2.562 . . . . 0.0 112.486 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.24 -21.84 10.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.199 3.266 . . . . 0.0 111.699 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -146.88 162.57 38.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.463 1.105 . . . . 0.0 108.092 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.7 p -59.48 -29.15 67.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -164.72 173.5 11.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.674 0.67 . . . . 0.0 110.14 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -61.62 160.88 10.67 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.083 0.553 . . . . 0.0 111.367 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.561 -1.209 . . . . 0.0 109.96 -179.768 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 110.895 2.695 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.591 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.633 2 O4'-C1'-N19 116.893 8.693 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.442 ' P ' " H1'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.82 2 O4'-C1'-N19 112.75 4.55 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.434 " H1'" ' HD2' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.926 2 C5'-C4'-C3' 104.569 -7.288 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.065 0 O4'-C1'-N19 111.68 3.48 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.453 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.421 -2.696 1 C4'-C3'-C2' 98.355 -4.345 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -153.66 -179.36 7.73 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.83 0.452 . . . . 0.0 110.081 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -63.1 -28.03 69.79 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.312 1.045 . . . . 0.0 111.972 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.45 35.32 20.45 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.855 0.741 . . . . 0.0 112.647 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 34.05 50.65 0.88 Allowed Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.486 1.514 . . . . 0.0 114.433 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.39 151.45 42.78 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.115 2.543 . . . . 0.0 110.692 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.21 117.97 4.23 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.784 2.99 . . . . 0.0 110.353 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.94 -169.01 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.02 3.146 . . . . 0.0 109.915 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -121.53 21.44 10.93 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.695 0.798 . . . . 0.0 109.31 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.27 -8.28 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.663 1.185 . . . . 0.0 113.274 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.49 4.09 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.961 -0.462 . . . . 0.0 111.131 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.54 28.12 1.2 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.42 1.01 . . . . 0.0 110.743 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.9 mtm -129.65 165.57 21.54 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.464 0.632 . . . . 0.0 111.405 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -67.0 -22.6 65.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 t 44.16 60.19 2.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 15.9 tp -65.49 166.13 10.92 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.2 ptmt -138.35 148.06 44.15 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 123.342 0.657 . . . . 0.0 110.913 172.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.569 ' HB ' HG22 ' A' ' 60' ' ' VAL . 94.7 t -129.41 143.06 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -153.01 -173.81 4.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.979 0.911 . . . . 0.0 109.738 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.406 ' CG ' ' HE ' ' A' ' 83' ' ' ARG . 15.2 t30 88.44 29.85 0.03 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.792 1.237 . . . . 0.0 112.558 171.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.56 134.97 35.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.055 1.342 . . . . 0.0 109.752 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 m -74.28 168.01 20.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -64.66 4.25 0.42 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.846 0.858 . . . . 0.0 112.853 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -135.28 18.69 3.39 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.187 0.995 . . . . 0.0 111.482 -175.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -119.2 165.1 14.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 122.935 0.494 . . . . 0.0 110.289 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.7 p -147.46 166.57 15.68 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.525 0.73 . . . . 0.0 110.03 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 74.2 Cg_endo -70.65 -32.08 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.858 2.372 . . . . 0.0 110.896 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -66.24 -35.33 80.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -73.23 -45.32 56.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.423 HD12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -55.46 -21.04 14.53 Favored 'General case' 0 N--CA 1.457 -0.095 0 O-C-N 122.203 -0.31 . . . . 0.0 111.418 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -78.66 -57.8 3.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -64.99 -21.61 66.87 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.735 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.7 t -84.03 -32.88 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 119.612 -0.232 . . . . 0.0 111.007 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CD1' HD13 ' A' ' 30' ' ' LEU . 19.3 m-85 -102.14 -10.2 19.85 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.0 -26.33 62.19 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.081 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -68.41 -23.19 64.61 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.86 -16.08 61.14 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.444 0.298 . . . . 0.0 111.035 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.31 -66.42 0.27 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-O 119.94 -0.366 . . . . 0.0 112.405 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -165.02 168.45 17.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.667 0.387 . . . . 0.0 110.59 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -141.85 135.31 29.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.92 -22.1 16.59 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -158.84 155.69 28.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.289 0.545 . . . . 0.0 110.425 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -170.89 100.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.79 1.236 . . . . 0.0 109.944 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.6 177.26 10.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 mm -106.57 98.51 20.6 Favored Pre-proline 0 C--N 1.34 0.193 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.49 -41.78 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.501 2.801 . . . . 0.0 115.953 -166.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -70.39 155.12 41.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.866 0.757 . . . . 0.0 110.947 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 37.41 70.49 0.18 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.564 1.146 . . . . 0.0 112.139 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.528 ' HD3' " H1'" ' B' ' 105' ' ' ' A' . 30.3 ptt180 -57.04 5.4 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.117 1.767 . . . . 0.0 115.559 -173.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -145.28 1.21 0.94 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.207 1.003 . . . . 0.0 112.297 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -121.15 -12.08 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.169 0.44 . . . . 0.0 110.189 173.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.76 29.13 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 127.765 2.426 . . . . 0.0 113.619 -176.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.13 -176.08 1.34 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.47 0.653 . . . . 0.0 109.299 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t 50.75 24.96 1.9 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.291 1.036 . . . . 0.0 112.142 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 9.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.172 1.789 . . . . 0.0 114.095 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.64 0.655 . . . . 0.0 112.254 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -155.95 166.91 32.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.8 0.8 . . . . 0.0 110.522 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.22 101.7 3.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.416 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 50.0 t80 -68.91 118.31 11.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.569 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -119.5 165.29 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.3 ptm180 -144.54 149.66 36.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.35 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.8 m-85 -117.18 164.8 14.23 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.089 0.868 . . . . 0.0 111.078 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.4 -27.15 10.12 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -120.59 149.33 42.63 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.149 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -65.12 -45.83 83.48 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.131 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.627 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -66.42 -40.0 89.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -80.74 -15.92 55.22 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.102 0.865 . . . . 0.0 110.959 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.1 -47.45 9.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.046 0.538 . . . . 0.0 110.16 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -68.35 -25.07 64.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.448 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.68 -47.46 31.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.904 0.32 . . . . 0.0 110.549 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.33 73.69 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.056 0.389 . . . . 0.0 110.623 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.8 ttp -73.4 -43.01 61.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.755 0.422 . . . . 0.0 110.031 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.26 2.33 24.97 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 122.171 -0.331 . . . . 0.0 111.521 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.23 -7.28 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.9 ttm -137.6 -26.44 0.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.67 134.75 56.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.537 1.062 . . . . 0.0 109.831 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.7 42.73 86.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 21.92 12.55 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 122.125 0.964 . . . . 0.0 110.269 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.635 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 6.1 t -63.55 162.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -165.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.497 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -157.45 13.26 0.23 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.96 -177.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' H ' HG12 ' A' ' 79' ' ' VAL . 61.3 m-20 -135.61 8.8 3.35 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.19 0.596 . . . . 0.0 110.861 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.03 -13.38 58.9 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.518 ' N ' HG11 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -177.36 133.55 0.18 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.438 1.895 . . . . 0.0 106.473 176.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 79' ' ' VAL . 20.4 pt-20 -146.15 -32.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.338 168.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.492 ' CD2' ' HG3' ' A' ' 84' ' ' GLU . 1.5 mm? -141.41 140.06 33.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -174.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 33.1 mmt180 -149.62 116.76 6.02 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 125.579 1.552 . . . . 0.0 106.991 167.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -134.52 142.98 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.752 0.821 . . . . 0.0 110.2 -174.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -170.49 -178.79 2.78 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.451 0.701 . . . . 0.0 110.22 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.7 mmt -75.51 139.6 42.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.463 0.705 . . . . 0.0 109.455 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 164.53 26.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.408 0.683 . . . . 0.0 111.225 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -142.94 9.23 1.71 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.744 0.418 . . . . 0.0 110.981 172.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.734 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 22.1 m-85 -126.18 167.02 15.98 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.056 0.942 . . . . 0.0 109.142 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.1 173.62 14.91 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-O 120.999 0.221 . . . . 0.0 113.245 -173.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -65.37 159.91 62.97 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.109 0.963 . . . . 0.0 111.464 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -37.82 104.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.862 1 C-N-CA 125.618 4.212 . . . . 0.0 115.492 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.47 -26.83 1.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.06 2.507 . . . . 0.0 109.632 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -160.42 168.7 24.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.8 1.64 . . . . 0.0 106.786 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.4 p -82.24 -44.05 16.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -169.77 20.08 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -131.34 0.49 4.09 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.416 -0.803 . . . . 0.0 112.527 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.3 m . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.353 -1.308 . . . . 0.0 110.24 177.61 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.591 0 C5'-C4'-C3' 109.913 -3.724 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.4 2 C1'-O4'-C4' 104.978 -5.136 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.734 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.413 -3.347 2 N19-C1'-C2' 106.221 -4.487 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.528 " H1'" ' HD3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.856 0 C3'-C2'-C1' 104.795 3.661 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.41 " H3'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.165 3 C3'-C2'-C1' 105.809 4.788 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.41 " H3'" " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.413 -3.342 1 C1'-O4'-C4' 105.564 -4.485 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttm . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -149.03 171.6 16.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.291 0.636 . . . . 0.0 110.826 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -78.79 7.85 6.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.46 0.704 . . . . 0.0 111.539 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.509 ' CA ' " H4'" ' B' ' 107' ' ' ' U' . . . -52.32 -44.27 58.08 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.463 -0.632 . . . . 0.0 113.721 -174.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.498 ' H ' ' HD3' ' A' ' 6' ' ' PRO . 18.4 ptt-85 -160.2 24.52 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.498 ' HD3' ' H ' ' A' ' 5' ' ' ARG . 74.4 Cg_endo -70.63 144.07 48.37 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 CA-C-N 121.614 1.612 . . . . 0.0 108.51 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.67 115.25 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.357 2.705 . . . . 0.0 110.779 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.0 -164.2 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.727 2.951 . . . . 0.0 109.841 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -133.27 25.47 4.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.621 0.769 . . . . 0.0 110.238 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 m -55.2 -15.82 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.817 0.847 . . . . 0.0 111.822 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.75 -4.13 32.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.008 0.923 . . . . 0.0 112.219 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.9 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.598 -0.557 . . . . 0.0 112.797 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.0 ptt? -135.63 162.65 32.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.002 0.901 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 m -76.05 82.44 2.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 122.888 0.475 . . . . 0.0 109.827 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.4 m -65.87 67.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.946 1.698 . . . . 0.0 110.459 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.577 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.6 tm? -86.36 131.52 34.19 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -128.63 153.67 47.03 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.862 HG12 HG22 ' A' ' 60' ' ' VAL . 5.9 p -131.48 153.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.783 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -152.75 -173.19 4.48 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.291 1.436 . . . . 0.0 109.738 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 83' ' ' ARG . 34.5 t30 86.76 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.737 1.215 . . . . 0.0 112.666 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.0 134.2 55.59 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.386 1.075 . . . . 0.0 109.132 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -81.17 169.05 17.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.981 176.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -62.46 1.18 0.38 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -125.69 12.72 7.99 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.595 0.634 . . . . 0.0 112.001 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -116.09 165.22 13.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.322 0.249 . . . . 0.0 110.996 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -150.19 165.15 18.14 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 124.226 1.01 . . . . 0.0 109.19 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 60.6 Cg_endo -70.43 -25.78 25.12 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.205 1.936 . . . . 0.0 111.604 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.76 -32.42 69.55 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.898 -0.502 . . . . 0.0 109.954 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.4 m -77.43 -44.91 27.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.48 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -56.66 -22.4 34.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.636 -0.665 . . . . 0.0 110.496 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -78.38 -57.98 3.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -61.09 -30.61 70.45 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.645 0.202 . . . . 0.0 110.539 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.88 -34.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 123.442 0.464 . . . . 0.0 110.811 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CD1' HD13 ' A' ' 30' ' ' LEU . 18.6 m-85 -98.74 -13.12 20.36 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.25 -25.73 63.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.895 -0.503 . . . . 0.0 110.91 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -69.45 -23.22 63.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.888 -0.508 . . . . 0.0 112.243 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -74.62 -16.94 60.77 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.459 0.304 . . . . 0.0 111.653 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.65 -85.71 0.1 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -160.77 162.5 32.41 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.992 0.517 . . . . 0.0 110.893 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 t -137.42 137.76 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.61 -36.22 9.66 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -164.05 159.2 20.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.366 0.583 . . . . 0.0 111.194 174.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -158.01 117.96 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.681 1.192 . . . . 0.0 108.335 -176.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.07 176.98 11.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.374 0.607 . . . . 0.0 112.518 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 58' ' ' ALA . 18.7 mt -129.81 91.73 39.29 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 124.035 0.934 . . . . 0.0 108.6 -173.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.79 8.68 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.879 3.719 . . . . 0.0 113.733 -172.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -52.75 -43.15 65.58 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.013 0.824 . . . . 0.0 109.834 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -149.37 116.69 6.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.541 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 7.8 ptm180 -71.17 12.19 0.34 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.5 ' CD2' HG23 ' A' ' 51' ' ' THR . 15.7 p90 -146.28 2.77 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.937 0.895 . . . . 0.0 111.34 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.5 HG23 ' CD2' ' A' ' 50' ' ' TYR . 17.1 p -129.15 -36.02 1.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.478 0.581 . . . . 0.0 109.769 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.55 41.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.34 0 C-N-CA 126.683 1.993 . . . . 0.0 113.214 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -129.39 1.34 5.09 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 t -64.03 -43.88 94.24 Favored 'General case' 0 CA--C 1.526 0.047 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 58.94 157.54 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.403 1.881 . . . . 0.0 113.582 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.41 -21.5 0.55 Allowed Glycine 0 CA--C 1.526 0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.329 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.56 166.13 29.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.029 0.931 . . . . 0.0 109.464 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -153.2 94.51 1.84 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.426 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 51.1 t80 -66.24 101.55 0.74 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -173.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.862 HG22 HG12 ' A' ' 18' ' ' VAL . 2.3 m -94.82 167.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 171.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 61' ' ' ARG . 10.5 ttt180 -145.94 116.43 7.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.213 0.946 . . . . 0.0 110.601 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 13.6 m-85 -92.48 169.76 10.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.229 1.012 . . . . 0.0 109.711 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -124.71 -37.06 2.52 Favored 'General case' 0 C--N 1.342 0.257 0 O-C-N 123.989 0.806 . . . . 0.0 112.469 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.42 127.92 32.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.325 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -60.91 -53.72 53.8 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -58.35 -32.35 68.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -89.09 -17.85 28.43 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.084 0.402 . . . . 0.0 110.999 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.577 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -78.95 -45.62 20.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -75.42 -25.85 57.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.585 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.99 -46.89 40.87 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.719 0.69 . . . . 0.0 111.103 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.8 73.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.122 0.419 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.427 ' HA ' HG13 ' A' ' 87' ' ' VAL . 9.9 ttp -73.86 -41.23 62.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.55 0.34 . . . . 0.0 110.952 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.46 2.87 26.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.426 0.103 . . . . 0.0 111.231 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.19 -6.1 4.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.6 ttm -137.13 -27.81 0.96 Allowed 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.596 ' HB2' HG12 ' A' ' 87' ' ' VAL . 6.2 t70 -63.19 136.46 57.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.945 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.45 85.65 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.542 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.64 34.22 0.48 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.02 0.91 . . . . 0.0 110.49 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.648 HG22 ' H ' ' A' ' 80' ' ' LEU . 9.6 p -69.83 172.1 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.648 ' H ' HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -156.58 5.47 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.972 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' HG22 ' A' ' 79' ' ' VAL . 37.3 t70 -148.26 -2.44 0.52 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.0 -17.14 7.66 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.622 ' C ' HG23 ' A' ' 79' ' ' VAL . 5.3 ptp180 -161.0 140.55 10.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' C ' HD22 ' A' ' 85' ' ' LEU . 10.0 mm-40 -146.57 -49.57 0.2 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.519 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.4 mm? -139.95 150.36 44.43 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 124.064 0.852 . . . . 0.0 112.445 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -148.66 98.84 2.93 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 167.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.676 ' HB ' HG23 ' A' ' 18' ' ' VAL . 7.1 p -126.45 129.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 121.336 0.588 . . . . 0.0 110.097 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -165.78 164.38 18.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.356 1.063 . . . . 0.0 109.138 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.4 mmt -57.97 136.84 57.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.895 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 155.74 27.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -136.52 4.71 2.88 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.623 0.369 . . . . 0.0 110.838 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.601 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 10.5 m-85 -132.95 163.81 28.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.4 172.71 15.2 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -66.16 156.05 85.78 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.58 0.352 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.81 146.77 30.23 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.579 2.853 . . . . 0.0 111.722 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.4 -24.33 5.46 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.194 3.263 . . . . 0.0 111.855 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -154.13 161.47 41.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.359 1.064 . . . . 0.0 109.121 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.8 p -72.4 -50.53 25.81 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -170.75 -42.58 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.87 0.304 . . . . 0.0 111.219 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -162.13 11.61 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 117.382 -1.294 . . . . 0.0 111.925 -176.572 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.869 0 C5'-C4'-C3' 111.16 -2.893 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.144 2 C1'-O4'-C4' 104.162 -6.042 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.601 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.668 2 O4'-C1'-N19 112.408 4.208 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.541 " H1'" ' HB3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.415 -3.173 1 P-O3'-C3' 125.36 4.716 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C3'-C2'-C1' 104.355 3.172 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.509 " H4'" ' CA ' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.414 -3.223 1 O4'-C1'-N19 112.355 4.155 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 m -59.91 143.93 50.23 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 122.842 0.457 . . . . 0.0 110.188 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 49.84 19.38 0.43 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.378 1.071 . . . . 0.0 112.695 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.537 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . -83.59 65.05 4.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 42.63 49.5 4.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.433 1.493 . . . . 0.0 114.745 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.83 154.03 63.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.249 1.966 . . . . 0.0 108.522 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.77 115.99 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.263 2.642 . . . . 0.0 110.679 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.17 -163.79 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.859 3.039 . . . . 0.0 109.885 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -132.17 20.19 4.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.516 0.726 . . . . 0.0 110.343 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -56.71 -12.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.428 1.091 . . . . 0.0 112.244 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.34 -1.0 9.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.749 0.819 . . . . 0.0 112.496 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.69 30.06 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.77 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.17 168.15 20.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.807 1.304 . . . . 0.0 112.461 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -57.95 -28.32 64.21 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -168.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.4 m 42.1 58.97 2.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 113.172 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 17.6 tp -65.17 167.15 8.55 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 14.9 pttt -136.95 157.63 46.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.107 0.412 . . . . 0.0 111.82 170.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -133.78 148.13 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -150.42 -175.43 5.09 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.662 1.185 . . . . 0.0 110.677 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 t30 91.92 28.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.741 1.616 . . . . 0.0 114.121 168.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 120.66 9.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.25 1.02 . . . . 0.0 109.867 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 23' ' ' TYR . 11.7 m -75.09 171.58 13.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' H ' HG22 ' A' ' 22' ' ' THR . 54.7 p90 -63.96 7.2 0.13 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.113 0.965 . . . . 0.0 112.949 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 22' ' ' THR . 19.3 ptt180 -131.08 14.88 5.19 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.982 0.913 . . . . 0.0 111.838 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 26' ' ' SER . 1.4 m -122.8 166.43 14.98 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.466 0.306 . . . . 0.0 111.068 -173.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.503 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 91.4 p -151.86 166.4 15.32 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 70.4 Cg_endo -70.67 -29.24 19.84 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.576 2.184 . . . . 0.0 110.904 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -67.63 -33.92 75.94 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.0 m -75.25 -44.87 43.66 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.479 HD12 HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -56.26 -19.84 15.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.315 0.246 . . . . 0.0 111.117 178.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -80.4 -57.98 3.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -12.31 60.35 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG12 ' HE1' ' A' ' 75' ' ' MET . 55.8 t -91.97 -32.86 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.189 0.595 . . . . 0.0 111.514 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.72 -9.71 18.9 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -26.01 61.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.18 0.446 . . . . 0.0 111.018 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -69.76 -23.78 63.42 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -72.56 -19.2 61.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.842 0.457 . . . . 0.0 111.468 176.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.0 -86.46 0.1 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -156.25 165.12 37.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 111.447 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.52 137.24 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.49 1.116 . . . . 0.0 108.062 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -22.09 23.21 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -163.67 153.85 15.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.403 0.62 . . . . 0.0 110.63 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.44 HG23 HG22 ' A' ' 60' ' ' VAL . 1.6 p -150.92 104.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -146.92 161.79 40.02 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.966 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.4 mt -136.34 126.36 16.17 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.892 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.54 52.21 2.81 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.708 3.605 . . . . 0.0 110.434 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -73.26 70.62 1.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.051 0.94 . . . . 0.0 110.081 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HA ' ' C6 ' ' B' ' 105' ' ' ' A' . 3.5 p30 45.62 -162.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.722 1.609 . . . . 0.0 114.142 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 177.58 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.465 1.906 . . . . 0.0 108.199 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -157.34 12.03 0.22 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.448 1.099 . . . . 0.0 111.456 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.7 p -124.18 -7.16 7.69 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.042 0.537 . . . . 0.0 112.035 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.64 42.05 1.92 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.108 1.763 . . . . 0.0 113.971 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.08 -177.79 4.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.187 0.595 . . . . 0.0 110.303 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -142.59 -176.93 5.05 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -172.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.552 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 75.0 mmt-85 -132.25 -2.1 3.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.256 0.622 . . . . 0.0 112.325 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.7 24.44 76.71 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.009 0.368 . . . . 0.0 113.05 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 9.6 p90 -151.6 171.61 17.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.01 0.905 . . . . 0.0 110.692 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.76 103.82 4.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -69.57 92.44 0.64 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.772 0.829 . . . . 0.0 108.879 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.479 HG21 HD12 ' A' ' 30' ' ' LEU . 40.5 t -79.99 160.94 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 13.7 ttt180 -141.97 130.46 22.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.355 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.1 m-85 -113.03 165.71 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.025 0.375 . . . . 0.0 111.059 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -33.44 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.26 123.39 26.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -60.36 -53.59 55.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -84.95 -21.84 29.43 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.17 -43.54 21.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 122.779 0.432 . . . . 0.0 110.461 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -72.05 -28.56 63.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.214 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.0 -40.73 64.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.393 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.52 74.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.137 -0.352 . . . . 0.0 111.441 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.8 ptp -78.71 -38.29 39.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.68 3.13 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.961 0.504 . . . . 0.0 111.674 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.23 -9.7 3.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.417 ' HE1' HG12 ' A' ' 33' ' ' VAL . 4.6 ttp -146.79 -13.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.27 125.51 23.54 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.762 1.165 . . . . 0.0 108.756 173.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.87 28.11 61.41 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.576 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.65 38.33 0.44 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.775 1.288 . . . . 0.0 109.554 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.621 HG22 ' H ' ' A' ' 80' ' ' LEU . 4.8 p -71.81 173.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -168.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.621 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.1 pt? -152.0 -0.32 0.32 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.27 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' H ' HG22 ' A' ' 79' ' ' VAL . 38.0 t70 -144.95 -1.17 0.87 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.43 -17.31 6.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.558 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -164.34 133.38 3.71 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 79' ' ' VAL . 20.1 mm-40 -143.81 -39.75 0.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.413 HD12 ' CB ' ' A' ' 84' ' ' GLU . 3.5 mp -147.63 151.18 35.77 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 123.697 0.623 . . . . 0.0 112.608 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.1 mmm180 -147.43 121.56 9.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.72 139.27 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.081 0 C-N-CA 122.67 0.388 . . . . 0.0 110.03 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -169.08 174.93 5.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.752 1.221 . . . . 0.0 109.225 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 mmt -73.97 143.27 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.962 0.905 . . . . 0.0 109.981 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.54 155.68 37.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.474 0.31 . . . . 0.0 110.555 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.56 13.42 2.34 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.766 0.826 . . . . 0.0 109.722 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.462 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 24.3 m-85 -129.97 158.07 40.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.874 0.87 . . . . 0.0 109.109 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.48 177.95 20.29 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -60.66 156.06 46.77 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 122.235 -0.568 . . . . 0.0 110.131 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HG3' " H2'" ' B' ' 104' ' ' ' G' . 78.3 Cg_exo -54.32 120.94 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.322 2.681 . . . . 0.0 113.309 -175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.51 -45.77 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.125 1.883 . . . . 0.0 108.671 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -161.39 125.49 3.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.172 1.789 . . . . 0.0 107.833 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 m -149.46 4.92 0.61 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.826 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -143.9 -25.39 0.55 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -173.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 45.35 23.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.7 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.405 -177.717 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 1 O4'-C1'-N19 116.035 7.835 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.748 2 O4'-C1'-N19 112.506 4.306 . 0.26 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.462 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.412 -3.422 0 C5'-C4'-C3' 111.169 -2.887 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.455 ' C8 ' " C5'" ' B' ' 105' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.998 1 C3'-C2'-C1' 105.475 4.416 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.058 2 P-O3'-C3' 125.354 4.712 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.537 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.415 -3.148 2 C5'-C4'-C3' 107.85 -5.1 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -147.01 170.28 17.45 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.279 0.631 . . . . 0.0 110.426 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -61.94 -56.91 14.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.985 0.514 . . . . 0.0 111.318 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.42 -69.01 0.53 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 125.001 1.286 . . . . 0.0 111.697 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.41 59.65 0.64 Allowed Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -171.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.77 153.76 64.13 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.961 2.441 . . . . 0.0 109.326 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.87 116.04 4.53 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.412 2.741 . . . . 0.0 110.544 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -87.58 -162.52 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.062 3.175 . . . . 0.0 110.298 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -136.25 33.4 2.82 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.976 0.91 . . . . 0.0 109.757 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.434 ' HA ' ' HG2' ' A' ' 13' ' ' MET . 33.7 m -61.43 -1.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 124.409 1.083 . . . . 0.0 113.802 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.53 -13.05 60.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.541 0.61 . . . . 0.0 112.256 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.45 20.75 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.91 -0.383 . . . . 0.0 112.933 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.451 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . 8.1 ptp -60.47 156.9 15.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.84 0.82 . . . . 0.0 113.206 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -72.23 -18.84 61.8 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.888 0.875 . . . . 0.0 110.466 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 t 45.45 59.54 3.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.044 1.338 . . . . 0.0 113.03 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 68' ' ' ALA . 20.7 tp -65.7 165.39 12.69 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 16.8 pttt -134.53 154.89 51.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.531 0.332 . . . . 0.0 110.83 170.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.54 ' HB ' HG22 ' A' ' 60' ' ' VAL . 61.1 t -134.31 148.43 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -148.81 -171.08 3.78 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.997 1.719 . . . . 0.0 109.273 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.88 90.23 0.09 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.497 1.119 . . . . 0.0 111.929 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.5 122.89 49.04 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 m -69.03 165.92 19.16 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.18 -0.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.288 1.035 . . . . 0.0 113.562 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -129.4 23.19 5.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.167 0.987 . . . . 0.0 110.92 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -123.94 165.35 17.57 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.796 0.331 . . . . 0.0 110.73 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.4 p -150.05 165.79 16.7 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.192 0.997 . . . . 0.0 109.527 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 39.1 Cg_endo -66.18 -29.38 47.42 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.178 1.918 . . . . 0.0 110.911 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.09 -31.9 71.83 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.883 -0.51 . . . . 0.0 110.284 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 100.0 m -74.63 -44.71 49.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -58.84 -20.01 46.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.044 -0.41 . . . . 0.0 110.957 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -81.1 -57.05 3.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -8.89 39.06 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.867 0.467 . . . . 0.0 111.857 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.56 -30.94 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.318 0.647 . . . . 0.0 111.717 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 30' ' ' LEU . 22.7 m-85 -101.73 -12.05 18.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.249 0.477 . . . . 0.0 112.284 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.47 -27.27 64.1 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.011 -0.431 . . . . 0.0 111.37 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.51 -24.08 65.53 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -72.04 -21.95 61.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.238 0.215 . . . . 0.0 111.184 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -81.24 0.1 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -159.13 165.84 32.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.044 0.45 . . . . 0.0 111.357 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.9 147.16 29.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 -19.34 8.59 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.57 153.45 25.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.194 0.497 . . . . 0.0 110.374 174.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 60' ' ' VAL . 1.5 p -169.13 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.154 0.982 . . . . 0.0 110.044 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.83 179.63 9.02 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 112.204 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.432 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 13.4 mt -117.73 123.26 29.87 Favored Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.98 43.93 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 1 C-N-CA 125.364 4.042 . . . . 0.0 112.054 -177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 92.6 mtt180 -54.89 160.96 1.76 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -54.73 119.42 5.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.433 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 7.9 ptm180 -67.16 13.27 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -167.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CD2' HG23 ' A' ' 51' ' ' THR . 13.0 p90 -144.72 0.2 0.96 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.666 1.186 . . . . 0.0 111.57 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.471 HG23 ' CD2' ' A' ' 50' ' ' TYR . 30.5 p -127.69 -23.78 3.37 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.709 0.686 . . . . 0.0 110.929 171.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.97 35.62 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.367 1.867 . . . . 0.0 113.815 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.23 1.93 12.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.413 ' HB2' ' HA ' ' A' ' 47' ' ' ARG . 3.3 m -73.37 170.08 15.82 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.386 0.539 . . . . 0.0 111.153 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 176.92 165.92 0.52 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.386 1.474 . . . . 0.0 110.174 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.31 -22.11 0.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -158.04 170.58 21.99 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 108.6 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.24 105.07 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 28.2 t80 -68.31 116.56 9.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -177.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.54 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -116.04 167.83 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 172.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.1 ptm180 -144.58 146.02 32.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.663 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 11.0 m-85 -116.01 162.65 17.07 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.464 0.477 . . . . 0.0 111.239 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -122.27 -32.19 3.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.64 131.13 34.63 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' HE3' ' HE1' ' A' ' 89' ' ' MET . 0.2 OUTLIER -65.06 -45.56 84.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.249 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -64.69 -26.05 68.21 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -172.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.5 p30 -106.52 -7.01 17.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.347 0.521 . . . . 0.0 111.077 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -74.65 -40.43 61.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.92 -29.99 44.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.343 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -67.91 -40.06 83.47 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.297 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.53 75.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.851 0.296 . . . . 0.0 111.525 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.407 ' HA ' HG13 ' A' ' 87' ' ' VAL . 10.6 ptp -77.15 -40.19 46.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.725 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.07 -0.98 20.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.04 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.61 -6.34 5.19 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.8 ttm -137.63 -28.96 0.88 Allowed 'General case' 0 N--CA 1.458 -0.066 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.466 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 3.3 t70 -66.84 142.62 57.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.7 1.136 . . . . 0.0 110.617 -177.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.6 8.67 86.2 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.575 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.04 31.75 0.44 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.328 1.064 . . . . 0.0 111.041 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.582 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 19.8 t -74.45 160.9 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.704 0.802 . . . . 0.0 111.637 -172.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.65 10.94 0.3 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.368 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -146.44 5.3 0.93 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.99 -0.444 . . . . 0.0 112.106 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.51 -11.25 28.23 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.126 0.393 . . . . 0.0 112.334 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -172.14 114.24 0.32 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.088 0.955 . . . . 0.0 108.563 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.582 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 80.2 mm-40 -130.28 -50.78 1.1 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.555 171.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -139.96 155.99 46.86 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 46.5 mmt-85 -152.18 109.95 3.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.814 1.646 . . . . 0.0 107.299 168.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 2.1 p -139.12 125.38 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-O 121.19 0.519 . . . . 0.0 110.891 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -155.92 179.92 8.74 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.043 1.737 . . . . 0.0 108.382 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.414 ' HE1' ' HE3' ' A' ' 65' ' ' LYS . 15.4 mmt -75.75 144.93 41.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.6 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.16 169.15 16.7 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.231 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -145.3 -3.11 0.75 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.379 0.672 . . . . 0.0 110.905 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.5 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 13.6 m-85 -129.91 168.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.979 0.511 . . . . 0.0 109.911 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.27 171.42 13.7 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 112.745 -0.142 . . . . 0.0 112.745 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -64.43 152.38 89.2 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 123.514 0.725 . . . . 0.0 110.867 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.01 125.99 13.87 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.464 2.11 . . . . 0.0 112.116 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.22 -22.11 11.4 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.392 2.728 . . . . 0.0 110.389 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -148.5 150.39 33.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.486 1.514 . . . . 0.0 106.999 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 27.6 m -64.17 -43.67 94.4 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -171.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -165.44 7.44 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.301 -0.249 . . . . 0.0 110.902 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -70.46 -1.7 11.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.042 0.937 . . . . 0.0 112.642 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.705 -179.236 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.774 0 O4'-C1'-N19 111.381 3.181 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.41 ' C8 ' ' HD3' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.408 -3.724 2 C1'-O4'-C4' 104.909 -5.212 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.5 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.414 -3.264 1 O4'-C1'-N19 112.479 4.279 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.546 " H5'" ' C8 ' ' B' ' 105' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.133 0 O4'-C1'-N19 111.657 3.457 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.925 0 P-O3'-C3' 123.789 3.408 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.982 0 C1'-O4'-C4' 106.574 -3.362 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 120.254 0.073 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -146.5 -179.4 6.74 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.067 0.547 . . . . 0.0 110.543 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -139.0 36.76 2.14 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 123.943 0.897 . . . . 0.0 109.504 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.32 45.43 1.15 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 51.42 48.2 5.5 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.227 1.011 . . . . 0.0 112.988 -177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.3 157.04 50.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.79 2.327 . . . . 0.0 110.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.77 113.66 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.017 3.145 . . . . 0.0 110.209 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.33 -163.35 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.123 3.215 . . . . 0.0 110.61 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -134.23 29.11 3.7 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.112 0.965 . . . . 0.0 110.14 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.84 -12.53 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.404 1.082 . . . . 0.0 113.406 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.15 4.9 49.08 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.309 0.644 . . . . 0.0 111.448 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.23 21.09 0.49 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -140.89 161.31 38.13 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.399 0.599 . . . . 0.0 111.51 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.9 m -85.05 83.95 7.87 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.696 0.798 . . . . 0.0 111.924 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 m -64.24 79.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.144 1.378 . . . . 0.0 111.299 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.534 HD11 ' CG2' ' A' ' 87' ' ' VAL . 3.1 tm? -79.62 107.44 12.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.55 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.9 ttpp -79.53 140.94 37.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.71 146.92 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.299 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -150.67 -175.75 5.24 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.532 1.145 . . . . 0.0 110.8 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.55 HD21 ' HB2' ' A' ' 83' ' ' ARG . 16.1 t30 94.05 26.97 0.01 OUTLIER 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.728 1.611 . . . . 0.0 113.79 169.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.65 120.02 5.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.383 1.073 . . . . 0.0 108.468 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 23' ' ' TYR . 10.8 m -42.18 -63.85 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.189 0.995 . . . . 0.0 112.274 -172.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' CD2' HG22 ' A' ' 22' ' ' THR . 52.3 p90 165.93 -19.74 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.889 2.875 . . . . 0.0 109.276 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -111.42 -1.07 16.07 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.079 0.952 . . . . 0.0 111.552 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 26' ' ' SER . 2.9 m -78.18 173.47 12.22 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.02 0.928 . . . . 0.0 109.665 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 25' ' ' THR . 93.9 p -145.26 163.02 34.63 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.888 0.475 . . . . 0.0 109.882 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 41.9 Cg_endo -68.16 -26.79 36.02 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.986 1.79 . . . . 0.0 110.446 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.91 -27.38 65.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.465 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 99.7 m -78.35 -45.67 21.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 60' ' ' VAL . 1.3 mm? -59.16 -19.14 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.145 -0.347 . . . . 0.0 110.515 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -78.73 -58.38 3.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.133 -0.461 . . . . 0.0 109.949 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' CD ' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -71.56 -16.24 62.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.59 0.632 . . . . 0.0 111.326 -174.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.64 -32.98 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 123.272 0.629 . . . . 0.0 111.608 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 22.4 m-85 -101.72 -11.52 19.07 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.176 0.443 . . . . 0.0 111.907 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -74.33 -24.71 59.23 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.782 -0.574 . . . . 0.0 110.842 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.91 -22.91 65.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.217 0.462 . . . . 0.0 112.14 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -73.36 -24.85 60.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.699 0.4 . . . . 0.0 111.731 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.78 -84.79 0.07 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -159.64 167.04 29.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.086 0.47 . . . . 0.0 111.564 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.76 147.88 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.02 -17.92 8.63 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' CG ' ' H22' ' B' ' 106' ' ' ' G' . 46.8 t0 -162.42 149.98 13.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 117.057 0.429 . . . . 0.0 110.332 175.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 60' ' ' VAL . 1.5 p -166.31 104.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.577 1.151 . . . . 0.0 108.638 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.71 175.02 13.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.292 0.568 . . . . 0.0 112.244 175.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 mt -126.31 108.71 23.92 Favored Pre-proline 0 N--CA 1.452 -0.374 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.45 -13.69 20.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.741 2.961 . . . . 0.0 112.77 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 34.6 -107.71 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 111.12 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -140.27 12.78 2.39 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.216 1.006 . . . . 0.0 110.307 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 57.87 -12.23 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -148.76 -2.9 0.47 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.548 1.067 . . . . 0.0 113.009 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.8 p -121.05 -19.15 7.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.859 0.754 . . . . 0.0 110.516 172.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 50.23 21.11 0.73 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.243 1.417 . . . . 0.0 113.952 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.9 -1.24 6.83 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 t 61.21 173.83 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.015 1.326 . . . . 0.0 113.117 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -139.85 -0.68 1.68 Allowed 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.913 0.885 . . . . 0.0 112.446 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.82 18.44 44.13 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.916 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.07 168.88 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.518 1.159 . . . . 0.0 110.874 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.39 105.59 4.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 31.2 t80 -70.66 110.83 5.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 59.3 t -100.61 158.76 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -143.61 125.6 15.32 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 2.0 m-85 -91.61 -179.19 5.29 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -134.97 -25.06 1.42 Allowed 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 124.057 0.848 . . . . 0.0 113.26 178.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -91.87 128.59 37.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -62.33 -50.91 69.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.225 -0.416 . . . . 0.0 111.347 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.517 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -56.88 -34.61 68.02 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -172.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.52 -11.04 21.4 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 118.761 0.71 . . . . 0.0 111.972 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.468 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -72.3 -46.62 54.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 169.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.09 -24.65 55.05 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.223 -0.298 . . . . 0.0 111.5 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.06 -40.22 60.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.806 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.61 74.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.053 -0.404 . . . . 0.0 111.312 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.0 ptp -76.68 -40.2 49.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.559 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -76.55 2.26 14.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.186 0.594 . . . . 0.0 112.179 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.43 -9.19 3.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -145.44 -11.69 0.53 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.14 130.03 44.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 120.371 1.441 . . . . 0.0 109.396 174.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.46 29.75 61.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.904 -0.942 . . . . 0.0 113.665 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.52 38.88 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.063 1.432 . . . . 0.0 110.193 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.679 HG22 ' H ' ' A' ' 84' ' ' GLU . 13.1 t -69.85 162.56 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 113.96 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.409 ' N ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -158.04 9.33 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.506 179.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.41 1.66 0.53 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.85 -22.18 3.49 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 121.744 -0.598 . . . . 0.0 112.648 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.55 ' HB2' HD21 ' A' ' 20' ' ' ASN . 0.4 OUTLIER 174.99 134.89 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.584 1.954 . . . . 0.0 107.278 177.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.679 ' H ' HG22 ' A' ' 79' ' ' VAL . 76.3 mm-40 -132.23 -36.45 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.297 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' CB ' ' A' ' 84' ' ' GLU . 4.0 mp -152.15 151.81 31.51 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 31.5 mmt180 -152.57 122.65 7.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 167.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.534 ' CG2' HD11 ' A' ' 16' ' ' LEU . 2.0 p -141.05 137.25 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.183 0.516 . . . . 0.0 111.292 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -165.71 171.41 12.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.999 1.319 . . . . 0.0 109.655 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.83 141.42 53.27 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.218 0.607 . . . . 0.0 110.585 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.88 158.65 35.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.579 0.351 . . . . 0.0 110.132 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -147.95 21.16 1.12 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.601 0.76 . . . . 0.0 109.39 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.404 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 6.4 t80 -146.84 152.06 38.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -175.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.25 179.79 22.31 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.046 0.385 . . . . 0.0 113.957 -169.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -62.41 156.91 59.12 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.422 0.689 . . . . 0.0 111.02 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -43.36 114.56 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.202 3.268 . . . . 0.0 114.299 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.87 -23.76 9.12 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.71 2.273 . . . . 0.0 109.334 168.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -156.22 161.84 40.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.811 1.645 . . . . 0.0 107.065 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m -70.67 -41.87 71.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -170.33 20.01 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.909 0.777 . . . . 0.0 112.602 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -130.33 6.26 4.87 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.345 -0.847 . . . . 0.0 112.47 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 117.721 -1.133 . . . . 0.0 110.011 176.748 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.917 1 O4'-C1'-N19 115.087 6.887 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.449 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.413 -3.343 2 C1'-O4'-C4' 104.187 -6.014 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.482 ' C5 ' ' CE1' ' A' ' 59' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.063 2 O4'-C1'-N19 112.729 4.529 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.455 ' OP1' " H4'" ' B' ' 104' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.686 3 P-O3'-C3' 125.146 4.538 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.523 " H3'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.418 -2.893 0 C3'-C2'-C1' 105.048 3.942 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.523 " H3'" " H3'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.797 1 O4'-C1'-N19 112.456 4.256 . 0.022 2o . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.1 p -60.66 146.07 46.9 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.38 0.272 . . . . 0.0 110.724 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 47.96 22.39 0.38 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.399 1.08 . . . . 0.0 112.903 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . -82.39 80.91 1.74 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.462 ' CD ' " H1'" ' B' ' 107' ' ' ' U' . 11.1 ptm180 45.3 46.4 2.97 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.26 1.824 . . . . 0.0 114.337 174.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.46 154.22 65.12 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.127 1.885 . . . . 0.0 109.828 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.5 117.23 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.716 2.944 . . . . 0.0 110.599 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -81.6 -169.94 0.88 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.996 3.131 . . . . 0.0 110.352 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -130.62 20.39 5.12 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.587 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.76 -12.02 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 125.403 1.481 . . . . 0.0 112.343 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.96 0.55 3.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.781 0.832 . . . . 0.0 112.616 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 30.64 0.15 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.088 -0.84 . . . . 0.0 113.954 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.09 23.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.91 1.355 . . . . 0.0 112.43 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 m -59.35 -26.95 65.49 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.0 m 43.09 59.96 2.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 20.5 tp -65.48 167.3 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 171.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 22.8 pttt -136.49 157.26 47.2 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.555 ' HB ' HG22 ' A' ' 60' ' ' VAL . 86.9 t -131.1 146.85 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -146.83 -175.2 4.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 110.355 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 92.97 24.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.525 1.53 . . . . 0.0 113.594 168.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.413 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -57.36 129.84 43.61 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.348 0.659 . . . . 0.0 109.378 -178.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 24' ' ' ARG . 18.0 m -82.43 170.94 14.7 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -64.08 8.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.175 0.99 . . . . 0.0 113.312 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 22' ' ' THR . 13.2 ptt180 -134.57 19.37 3.6 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.604 1.162 . . . . 0.0 111.969 -174.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -127.17 164.87 20.7 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.05 0.54 . . . . 0.0 110.448 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 85.0 p -149.86 165.16 18.21 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 110.37 -174.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 57.5 Cg_endo -69.42 -28.08 27.32 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.015 2.477 . . . . 0.0 111.192 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.98 -36.26 77.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.4 m -72.15 -44.15 63.55 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.514 HD11 HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -57.35 -21.98 39.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.991 -0.443 . . . . 0.0 111.145 179.397 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.82 -54.15 5.33 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -10.88 58.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.87 0.468 . . . . 0.0 111.869 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -98.95 -32.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 112.031 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.402 ' CD1' HD13 ' A' ' 30' ' ' LEU . 21.8 m-85 -100.9 -10.39 20.69 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -71.35 -28.05 63.79 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.766 -0.583 . . . . 0.0 111.14 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.61 -23.46 64.46 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -72.83 -17.59 61.54 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.317 0.247 . . . . 0.0 110.811 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.28 -76.09 0.11 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -164.81 160.52 19.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.239 0.616 . . . . 0.0 110.599 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.2 t -132.42 128.02 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.7 48.07 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -167.38 159.13 12.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.692 0.758 . . . . 0.0 112.912 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.26 141.29 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.71 1.604 . . . . 0.0 106.701 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -157.79 149.37 21.73 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.485 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 58' ' ' ALA . 5.7 mt -136.57 133.21 18.99 Favored Pre-proline 0 C--O 1.232 0.163 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.89 156.51 4.65 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.375 2.716 . . . . 0.0 111.915 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -140.34 9.54 2.28 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.409 ' HA ' ' C5 ' ' B' ' 105' ' ' ' A' . 6.0 m-20 43.88 18.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -174.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.515 ' HD2' " H1'" ' B' ' 105' ' ' ' A' 0.251 8.3 ptm180 40.13 8.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.44 3.096 . . . . 0.0 116.832 -178.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -162.82 -20.95 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.753 1.221 . . . . 0.0 112.971 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -96.56 -22.25 17.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.037 1.289 . . . . 0.0 110.385 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.99 31.95 0.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.812 1.645 . . . . 0.0 113.69 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.23 -160.2 0.08 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -135.83 168.23 19.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.295 0.638 . . . . 0.0 109.781 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.4 ttm105 -146.31 0.98 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.11 20.7 38.08 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.765 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.5 169.37 24.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.059 1.43 . . . . 0.0 111.538 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 45' ' ' ILE . . . -141.9 93.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 108.556 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.505 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 19.6 t80 -62.72 103.32 0.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.555 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.3 m -100.84 168.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 172.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 7.4 ptm180 -142.1 139.83 32.33 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 17.3 m-85 -109.4 165.92 11.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.292 0.637 . . . . 0.0 110.465 177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 -33.64 3.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.2 122.41 24.31 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -60.48 -50.98 71.4 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.631 -0.223 . . . . 0.0 110.403 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -64.6 -29.63 70.65 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.254 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -90.11 -15.77 30.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.718 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 16' ' ' LEU . . . -79.75 -39.37 31.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.38 -25.86 51.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.426 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.89 -47.83 42.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.444 0.565 . . . . 0.0 110.785 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.43 73.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.976 -0.452 . . . . 0.0 110.783 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.1 ttp -73.99 -41.39 61.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.877 0.471 . . . . 0.0 110.05 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.91 3.14 27.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 122.446 -0.159 . . . . 0.0 111.42 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.48 -5.5 4.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.3 ttm -140.44 -27.34 0.74 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.97 134.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.466 1.03 . . . . 0.0 110.221 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.49 85.85 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.539 -0.589 . . . . 0.0 112.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.77 33.23 0.43 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.811 0.806 . . . . 0.0 110.8 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.577 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 48.6 t -69.93 166.16 2.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.64 0.776 . . . . 0.0 112.269 -172.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.406 ' N ' HG12 ' A' ' 79' ' ' VAL . 1.1 pt? -154.86 5.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -144.79 4.66 1.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.46 6.15 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.51 ' C ' HG13 ' A' ' 79' ' ' VAL . 5.2 ptp180 -176.14 143.33 0.53 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.004 1.722 . . . . 0.0 107.318 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 77.5 mm-40 -141.52 -46.94 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 169.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.488 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -140.96 152.7 45.17 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.941 0.496 . . . . 0.0 111.937 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.2 mmm180 -148.19 109.09 4.24 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 18' ' ' VAL . 33.9 t -134.95 127.18 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 C-N-CA 122.74 0.416 . . . . 0.0 110.876 -173.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -158.08 173.24 17.04 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.506 1.122 . . . . 0.0 109.412 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.2 mmt -69.59 146.08 52.02 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.786 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.89 165.93 22.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.704 0.402 . . . . 0.0 111.353 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -137.51 -0.04 2.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.717 0.807 . . . . 0.0 109.416 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.612 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 40.3 m-85 -139.66 156.11 47.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.328 0.651 . . . . 0.0 109.26 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.25 -16.39 6.15 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HD3' ' HD2' ' A' ' 95' ' ' PRO . 21.2 tpp180 -170.46 139.91 1.46 Allowed Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' HD3' ' A' ' 94' ' ' ARG . 26.7 Cg_endo -60.67 119.7 7.02 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.047 1.831 . . . . 0.0 109.128 171.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.52 -29.43 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.598 2.198 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -153.45 93.56 1.71 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.553 0.692 . . . . 0.0 112.081 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.7 m -146.92 -8.13 0.47 Allowed 'General case' 0 N--CA 1.458 -0.035 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.122 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -150.63 11.16 0.67 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.582 0.628 . . . . 0.0 111.73 -171.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -145.34 9.02 1.21 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.002 0.521 . . . . 0.0 111.316 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.054 -177.834 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.67 0 O4'-C1'-N19 111.617 3.417 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.146 2 O4'-C1'-N19 114.275 6.075 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.612 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.919 3 O4'-C1'-N19 114.091 5.891 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.515 " H1'" ' HD2' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.863 3 C5'-C4'-C3' 106.508 -5.994 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.977 1 P-O3'-C3' 126.538 5.698 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.462 " H1'" ' CD ' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.897 0 O4'-C1'-N19 111.691 3.491 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.805 0.336 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -148.27 -162.93 1.66 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.647 0.779 . . . . 0.0 109.869 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -47.88 -31.08 4.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.473 1.109 . . . . 0.0 112.979 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.493 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 86.12 36.77 9.65 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.779 175.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 38.81 50.37 2.55 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 125.076 1.35 . . . . 0.0 113.994 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.91 159.25 50.9 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.742 2.295 . . . . 0.0 110.282 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.53 117.83 4.69 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.59 2.86 . . . . 0.0 110.088 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.55 -170.01 0.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.137 3.225 . . . . 0.0 110.408 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -132.53 25.88 4.42 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.397 0.679 . . . . 0.0 109.459 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 m -58.66 -4.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.332 1.453 . . . . 0.0 112.926 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -98.79 5.73 47.31 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.271 0.629 . . . . 0.0 110.795 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.66 17.83 0.49 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 10.7 ptt? -143.31 164.1 31.18 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.601 0.701 . . . . 0.0 110.856 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -81.07 84.94 6.38 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 110.952 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.4 t -68.21 97.32 0.71 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.489 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 2.1 tm? -116.54 124.61 50.29 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.025 0.44 . . . . 0.0 109.914 -176.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.3 ttpm? -102.58 146.89 27.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.256 1.423 . . . . 0.0 114.123 -167.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.457 ' HB ' HG22 ' A' ' 60' ' ' VAL . 52.1 t -124.48 146.4 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.229 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -151.62 -171.52 3.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 110.484 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 81.65 37.57 0.07 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.158 1.383 . . . . 0.0 113.199 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' H ' ' HA ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -63.66 175.2 1.14 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.386 1.074 . . . . 0.0 109.299 175.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 24' ' ' ARG . 5.2 m -129.05 167.58 17.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.82 0.848 . . . . 0.0 109.345 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -64.4 4.87 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.455 0.702 . . . . 0.0 112.475 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.424 ' H ' ' C ' ' A' ' 22' ' ' THR . 14.8 ptm180 -129.13 18.86 5.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.787 1.235 . . . . 0.0 110.228 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -129.99 163.17 27.03 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.776 0.83 . . . . 0.0 109.382 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 99.7 p -148.5 164.73 20.44 Favored Pre-proline 0 C--O 1.233 0.201 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 -174.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 58.9 Cg_endo -68.98 -27.76 29.84 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.792 1.661 . . . . 0.0 111.467 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.06 -32.33 72.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.742 0.701 . . . . 0.0 109.648 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.1 m -74.15 -44.03 55.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.448 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -59.88 -20.82 59.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.074 -0.391 . . . . 0.0 111.075 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -56.15 4.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -8.18 50.64 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.983 0.513 . . . . 0.0 112.194 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.4 t -100.79 -31.84 3.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 C-N-CA 123.069 0.547 . . . . 0.0 112.027 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.448 ' CD1' HD13 ' A' ' 30' ' ' LEU . 26.1 m-85 -101.67 -9.76 20.61 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.509 0.595 . . . . 0.0 111.602 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.83 -28.27 62.45 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.728 -0.607 . . . . 0.0 111.463 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.88 -23.0 65.95 Favored 'General case' 0 C--N 1.338 0.088 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -71.83 -20.26 61.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.398 -0.335 . . . . 0.0 111.007 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.93 -82.58 0.1 OUTLIER Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 175.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -159.63 160.29 34.11 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.236 0.614 . . . . 0.0 110.351 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.44 143.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.12 -15.24 24.28 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.271 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -154.45 142.65 20.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.588 0.694 . . . . 0.0 110.356 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.489 HG13 HG12 ' A' ' 60' ' ' VAL . 46.5 t -153.9 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 107.829 173.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 163.69 38.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mm -90.5 110.32 40.24 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.15 -41.83 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.315 2.677 . . . . 0.0 114.688 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -82.41 165.69 20.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 119.083 0.856 . . . . 0.0 109.963 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 50.68 46.63 25.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.055 0.542 . . . . 0.0 112.057 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.488 ' HD3' " H1'" ' B' ' 105' ' ' ' A' . 18.6 ptt180 -54.7 -4.59 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -175.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.496 ' CD1' HG23 ' A' ' 51' ' ' THR . 15.6 p90 -146.77 7.1 0.94 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.871 0.76 . . . . 0.0 112.456 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.496 HG23 ' CD1' ' A' ' 50' ' ' TYR . 27.2 p -125.98 -14.1 6.16 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.844 -0.535 . . . . 0.0 111.264 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.32 27.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.855 2.062 . . . . 0.0 114.421 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.95 11.01 2.42 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.949 -0.469 . . . . 0.0 112.011 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 t -138.45 159.59 41.69 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.919 0.488 . . . . 0.0 110.339 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -170.51 15.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.969 0.908 . . . . 0.0 111.808 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.3 -12.4 58.16 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 118.154 0.434 . . . . 0.0 112.388 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HA ' ' H ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -158.73 168.78 25.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.936 0.894 . . . . 0.0 109.921 176.133 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 95.43 2.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.472 ' CZ ' ' C5 ' ' B' ' 104' ' ' ' G' . 16.9 t80 -63.12 121.34 13.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 1.2 m -119.38 166.94 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 3.6 ptm180 -145.3 131.22 19.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.554 0.533 . . . . 0.0 111.898 175.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 26.7 m-85 -93.41 172.9 7.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.238 1.015 . . . . 0.0 109.295 171.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.413 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -126.78 -33.91 2.45 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 123.917 0.761 . . . . 0.0 112.754 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.1 133.04 34.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.45 -52.91 63.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.424 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.07 -29.28 70.19 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -174.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -85.48 -21.35 28.72 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.899 0.318 . . . . 0.0 110.772 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -81.11 -45.45 16.44 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.391 0.676 . . . . 0.0 109.889 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -77.59 -24.62 49.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.243 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.82 -45.38 43.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.966 0.803 . . . . 0.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -30.08 71.09 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 110.64 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ttp -75.72 -43.27 47.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.392 0.277 . . . . 0.0 110.599 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.02 -0.33 27.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.531 0.15 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.03 -6.32 6.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.7 ttm -136.38 -27.33 1.07 Allowed 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.482 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -62.65 137.67 58.32 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.393 1.451 . . . . 0.0 108.56 176.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.3 59.63 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.741 -0.477 . . . . 0.0 112.048 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.547 ' O ' HD21 ' A' ' 85' ' ' LEU . . . -131.22 70.24 1.47 Allowed 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.759 HG22 ' N ' ' A' ' 80' ' ' LEU . 9.9 p -45.19 167.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 -167.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.759 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -144.39 -6.79 0.71 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.241 -2.254 . . . . 0.0 116.675 169.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.522 ' H ' HG22 ' A' ' 79' ' ' VAL . 11.8 t70 -157.0 6.95 0.16 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.275 0.943 . . . . 0.0 112.993 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.568 ' H ' ' CG2' ' A' ' 79' ' ' VAL . . . 96.38 16.37 37.67 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 121.812 -0.555 . . . . 0.0 111.801 -174.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -147.2 60.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 123.257 1.503 . . . . 0.0 107.526 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 84' ' ' GLU . 1.3 mp0 -50.3 128.91 20.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 112.794 -2.003 . . . . 0.0 114.381 -166.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.004 ' H ' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -40.02 137.48 0.96 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.759 177.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mmt-85 -130.52 128.87 42.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.6 p -145.02 120.82 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.109 0.564 . . . . 0.0 109.751 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -154.19 165.13 37.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.22 1.408 . . . . 0.0 108.746 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -56.61 166.02 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.555 1.142 . . . . 0.0 112.87 -173.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.37 143.84 49.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.383 0.673 . . . . 0.0 111.485 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -151.72 -0.67 0.33 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.381 0.672 . . . . 0.0 111.436 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.618 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 13.6 m-30 -78.54 55.39 1.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.127 0.971 . . . . 0.0 112.985 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.72 -149.87 5.13 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 118.301 0.5 . . . . 0.0 112.415 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -153.08 156.47 32.69 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.284 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -32.71 100.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 125.114 3.876 . . . . 0.0 116.367 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -83.61 -24.96 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.421 2.748 . . . . 0.0 110.176 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -150.56 -166.75 2.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.92 1.688 . . . . 0.0 108.481 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.9 p -126.64 -79.11 0.59 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -160.61 17.86 0.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.728 0.24 . . . . 0.0 110.883 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -134.78 11.25 3.67 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 122.941 0.496 . . . . 0.0 111.638 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.169 -178.148 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.847 2 O4'-C1'-N19 115.878 7.678 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.399 2 C1'-O4'-C4' 103.71 -6.545 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.618 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.415 -3.19 0 N19-C1'-C2' 107.958 -3.401 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.488 " H1'" ' HD3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 C3'-C2'-C1' 104.743 3.604 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.796 1 O4'-C1'-N19 112.493 4.293 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.493 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.422 -2.56 2 C4'-C3'-C2' 98.395 -4.305 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.6 mtp . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.2 p -148.96 155.94 41.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.31 0.644 . . . . 0.0 110.416 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 45.93 24.63 0.25 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.756 1.222 . . . . 0.0 113.408 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.85 -45.9 90.99 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.462 -0.632 . . . . 0.0 111.844 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 16.2 ptm180 -166.49 40.2 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 55.8 Cg_endo -66.0 128.07 18.97 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.487 -1.774 . . . . 0.0 107.487 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.28 113.06 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.582 2.855 . . . . 0.0 111.408 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -88.9 -162.1 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.207 3.271 . . . . 0.0 109.507 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -138.67 33.03 2.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 0.0 109.753 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.2 -1.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.325 1.45 . . . . 0.0 113.495 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -105.73 7.59 32.59 Favored 'General case' 0 CA--C 1.527 0.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.526 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.05 17.83 0.32 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.483 ' SD ' ' HB3' ' A' ' 63' ' ' HIS . 14.9 ptt? -141.01 169.67 17.18 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.538 0.669 . . . . 0.0 110.804 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.3 m -62.1 166.81 4.42 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.4 m -147.64 61.36 1.14 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 18.9 tp -63.18 155.37 28.37 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.548 ' HE2' ' C5 ' ' B' ' 103' ' ' ' G' . 13.9 pttp -127.43 143.38 51.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.351 0.407 . . . . 0.0 110.173 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -128.17 151.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.003 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -151.48 -170.98 3.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 109.902 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 82.71 28.1 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.842 1.257 . . . . 0.0 113.049 171.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.41 125.07 15.02 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.684 0.794 . . . . 0.0 109.483 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 24' ' ' ARG . 11.9 m -75.17 168.91 19.07 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.742 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -65.21 8.49 0.14 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.271 1.028 . . . . 0.0 112.781 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 22' ' ' THR . 15.8 ptt180 -134.56 16.98 3.64 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.486 1.114 . . . . 0.0 111.315 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 26' ' ' SER . 1.9 m -120.91 166.57 13.63 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -172.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 83.9 p -152.72 164.78 19.23 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.425 1.09 . . . . 0.0 109.052 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 55.3 Cg_endo -68.96 -29.36 27.86 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.686 2.257 . . . . 0.0 111.688 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.83 -36.57 75.72 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.081 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.8 m -72.17 -42.37 65.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -54.64 -25.81 29.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.903 -0.498 . . . . 0.0 111.184 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -79.17 -54.6 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -62.49 -29.99 70.94 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.601 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.38 -32.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 122.974 0.51 . . . . 0.0 110.909 -173.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.424 ' CD1' HD13 ' A' ' 30' ' ' LEU . 24.6 m-85 -102.59 -9.74 19.87 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.27 -25.52 60.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.762 -0.586 . . . . 0.0 111.192 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -68.88 -23.32 64.2 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.004 0.366 . . . . 0.0 111.924 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -72.86 -16.28 61.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.439 0.296 . . . . 0.0 111.252 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.07 -80.59 0.13 Allowed Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -162.3 161.68 27.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.672 0.389 . . . . 0.0 110.443 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -136.98 145.87 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.97 -45.22 6.76 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -169.31 167.68 10.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.684 0.394 . . . . 0.0 110.595 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 HG22 ' A' ' 60' ' ' VAL . 16.2 m -121.47 152.12 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -149.33 140.92 23.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.348 -172.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.87 108.17 7.62 Favored Pre-proline 0 CA--C 1.53 0.179 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.04 -21.39 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.566 2.844 . . . . 0.0 112.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 36.63 -103.75 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.77 1.228 . . . . 0.0 110.98 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -142.88 11.93 1.83 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.381 1.073 . . . . 0.0 109.949 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.466 ' HD3' ' CG ' ' A' ' 99' ' ' HIS . 35.9 ttt85 55.18 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.523 1.929 . . . . 0.0 115.764 -178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -141.96 -2.14 1.19 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.314 1.415 . . . . 0.0 113.612 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.03 -20.37 5.78 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.148 0.431 . . . . 0.0 110.878 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 48.45 24.4 0.73 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.147 1.379 . . . . 0.0 113.843 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.74 19.53 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.1 t -142.25 168.81 18.86 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.241 0.543 . . . . 0.0 112.082 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -175.29 20.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.475 1.91 . . . . 0.0 110.113 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.83 -9.06 44.37 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.707 -0.621 . . . . 0.0 113.332 -172.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -159.63 163.88 34.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.892 0.877 . . . . 0.0 109.181 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.86 95.32 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.57 96.74 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 18' ' ' VAL . 60.7 t -92.75 148.28 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 17.4 ttt180 -126.1 115.73 20.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.905 0.753 . . . . 0.0 111.739 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 18.3 m-85 -96.78 163.36 13.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.961 0.104 . . . . 0.0 110.914 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.483 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 0.1 OUTLIER -127.49 -25.36 3.18 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.12 119.17 26.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -57.47 -49.29 76.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.809 0.277 . . . . 0.0 110.61 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -62.6 -32.63 73.66 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -88.25 -16.03 34.28 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.39 -47.76 12.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.86 -27.35 66.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.118 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.4 -40.83 57.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.509 0.595 . . . . 0.0 110.84 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -33.49 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.13 -0.356 . . . . 0.0 111.261 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.8 ptp -77.73 -37.4 49.35 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.0 1.02 22.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.978 0.511 . . . . 0.0 111.836 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.78 -4.93 3.62 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 21.5 ttm -138.06 -28.01 0.88 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.45 134.66 56.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.916 0.78 . . . . 0.0 110.037 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.98 9.96 84.62 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.414 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.9 30.15 0.38 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.081 0.941 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.546 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 42.9 t -72.72 162.49 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.431 1.092 . . . . 0.0 112.234 -172.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.28 16.25 0.21 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.836 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -144.61 4.67 1.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.189 0.595 . . . . 0.0 111.472 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.3 -9.13 57.48 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.404 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -171.92 123.1 0.51 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.523 1.129 . . . . 0.0 108.533 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.7 mm-40 -138.31 -47.32 0.52 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.518 169.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 84' ' ' GLU . 3.3 mm? -137.81 153.57 49.63 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.184 0.516 . . . . 0.0 111.937 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 86' ' ' ARG . 11.4 mmm180 -149.0 108.24 3.93 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.772 1.629 . . . . 0.0 106.968 168.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.36 140.7 47.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.293 0.237 . . . . 0.0 111.345 -176.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -171.49 175.84 3.97 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.712 1.605 . . . . 0.0 108.046 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.8 mmt -75.45 146.98 40.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.92 51.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -132.38 19.6 4.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.76 139.68 29.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.46 -165.32 13.63 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 122.878 0.275 . . . . 0.0 112.457 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -45.18 127.85 5.72 Favored Pre-proline 0 CA--C 1.526 0.043 0 C-N-CA 123.813 0.845 . . . . 0.0 110.158 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.401 ' HG3' " H5'" ' B' ' 105' ' ' ' A' . 47.1 Cg_endo -67.98 142.59 57.27 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.813 2.342 . . . . 0.0 110.467 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.68 -34.09 4.52 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.038 2.492 . . . . 0.0 110.668 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -167.8 136.2 2.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.057 0.543 . . . . 0.0 110.704 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.2 m -149.94 0.58 0.47 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.517 1.127 . . . . 0.0 111.192 172.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.466 ' CG ' ' HD3' ' A' ' 49' ' ' ARG . 86.1 t60 -153.31 131.36 11.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.648 0.379 . . . . 0.0 110.025 -172.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -157.61 1.4 0.11 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 C--O 1.251 1.178 0 CA-C-O 116.914 -1.517 . . . . 0.0 111.561 -178.621 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.023 2 O4'-C1'-N19 112.446 4.246 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.548 ' C5 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.422 -2.548 2 O4'-C1'-N19 116.696 8.496 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.435 ' P ' " H1'" ' B' ' 103' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.414 -3.289 1 O4'-C1'-N19 114.079 5.879 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.401 " H5'" ' HG3' ' A' ' 95' ' ' PRO . . . . . . . . 0 P--O5' 1.624 3.056 1 C5'-C4'-C3' 107.317 -5.456 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.406 " H4'" ' OP2' ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.82 1 C4'-C3'-C2' 98.531 -4.169 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.406 ' OP2' " H4'" ' B' ' 106' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 C4'-C3'-C2' 100.137 -2.563 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m -58.18 136.83 57.34 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 122.798 0.439 . . . . 0.0 110.724 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 44.33 29.4 0.37 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.367 1.467 . . . . 0.0 113.117 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.47 62.68 3.78 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.958 -176.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 17.2 mtp180 106.64 21.59 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 127.325 2.25 . . . . 0.0 116.002 167.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 82.2 Cg_endo -71.82 149.81 54.63 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.593 1.605 . . . . 0.0 110.148 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.41 144.73 29.28 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.453 2.768 . . . . 0.0 111.141 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.55 -169.26 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.761 3.64 . . . . 0.0 110.134 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -131.69 17.38 4.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.781 0.832 . . . . 0.0 109.403 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.27 -5.85 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 125.593 1.557 . . . . 0.0 112.877 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.16 -0.32 3.27 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.737 0.815 . . . . 0.0 112.991 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.83 36.28 0.08 OUTLIER Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.217 -0.768 . . . . 0.0 113.702 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 165.06 28.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.652 1.226 . . . . 0.0 112.457 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -73.64 93.14 2.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 123.761 0.824 . . . . 0.0 110.844 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -70.44 85.27 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.026 0.931 . . . . 0.0 109.872 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.585 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 1.7 tm? -106.57 134.1 50.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -130.8 155.34 46.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -168.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.49 155.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -174.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -152.22 -171.09 3.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.679 1.192 . . . . 0.0 110.454 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 87.18 27.36 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.256 1.422 . . . . 0.0 113.145 171.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.77 125.77 15.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.122 0.969 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 23' ' ' TYR . 7.4 m -77.34 171.92 14.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.264 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.519 ' H ' HG22 ' A' ' 22' ' ' THR . 52.5 p90 -63.36 6.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.774 1.23 . . . . 0.0 114.09 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -134.6 15.0 3.7 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.488 0.586 . . . . 0.0 112.084 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 26' ' ' SER . 1.4 m -117.7 165.19 13.91 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 89.4 p -153.3 167.21 13.95 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.648 1.179 . . . . 0.0 109.431 -174.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 26' ' ' SER . 43.4 Cg_endo -69.46 -28.47 26.67 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.247 1.965 . . . . 0.0 111.675 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.75 -34.38 75.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.3 m -77.66 -43.77 30.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -57.87 -21.19 41.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.811 -0.555 . . . . 0.0 110.703 178.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -56.51 4.03 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -61.37 -31.04 70.93 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.645 0.202 . . . . 0.0 110.597 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.28 -34.92 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 122.765 0.426 . . . . 0.0 111.06 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CD1' HD13 ' A' ' 30' ' ' LEU . 16.6 m-85 -99.34 -10.68 21.99 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.63 -27.07 61.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.445 0.566 . . . . 0.0 111.233 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -67.25 -22.65 65.67 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -74.04 -23.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.377 0.271 . . . . 0.0 110.988 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.86 -79.56 0.09 OUTLIER Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.143 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -157.31 164.8 37.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.94 133.68 44.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.07 -38.54 7.83 Favored Glycine 0 CA--C 1.519 0.344 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -158.42 161.02 37.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.879 0.872 . . . . 0.0 109.64 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.628 HG23 HG22 ' A' ' 60' ' ' VAL . 2.1 p -139.07 74.37 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-O 123.301 1.524 . . . . 0.0 107.05 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.468 ' CD2' ' C5 ' ' B' ' 106' ' ' ' G' . 1.7 t80 -83.13 143.64 30.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.299 -169.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.8 mt -140.14 130.36 13.84 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.44 151.1 5.02 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.158 2.572 . . . . 0.0 111.712 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.05 19.19 3.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.262 0.625 . . . . 0.0 109.631 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 50' ' ' TYR . 64.9 m-20 42.47 26.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.11 0.964 . . . . 0.0 112.767 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HB3' " H1'" ' B' ' 105' ' ' ' A' . 9.6 ptt180 42.88 3.26 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.642 2.777 . . . . 0.0 116.312 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.406 ' H ' ' C ' ' A' ' 48' ' ' ASP . 30.0 p90 -165.87 -4.11 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 113.915 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -116.78 -18.9 10.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.154 1.343 . . . . 0.0 111.633 177.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.69 30.6 0.54 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 125.775 1.63 . . . . 0.0 113.64 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.46 -159.39 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.664 0.786 . . . . 0.0 109.095 171.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.4 t -138.01 172.85 12.32 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.979 0.511 . . . . 0.0 111.384 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -137.02 3.53 2.67 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.514 0.725 . . . . 0.0 111.762 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.34 54.26 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.347 -0.696 . . . . 0.0 112.887 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.81 169.6 23.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.672 1.236 . . . . 0.0 111.318 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.39 101.67 3.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.604 ' CE2' ' C5 ' ' B' ' 104' ' ' ' G' . 51.5 t80 -69.33 89.48 0.48 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.071 1.349 . . . . 0.0 109.066 -175.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.628 HG22 HG23 ' A' ' 43' ' ' VAL . 68.0 t -75.39 158.59 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 172.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -138.98 128.21 24.05 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 9.8 m-85 -106.05 173.69 6.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.19 1.396 . . . . 0.0 109.555 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -135.6 -38.31 0.74 Allowed 'General case' 0 C--N 1.339 0.127 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.79 124.62 32.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.427 -0.796 . . . . 0.0 109.133 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -53.75 -49.39 68.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.848 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -58.73 -24.9 62.34 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 1.8 p30 -110.42 -6.57 14.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.714 0.688 . . . . 0.0 111.287 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.585 ' HB1' ' CB ' ' A' ' 16' ' ' LEU . . . -77.34 -46.63 22.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.39 -31.06 48.19 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.569 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -71.27 -43.9 66.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.482 1.037 . . . . 0.0 111.089 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.41 75.12 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 118.146 0.43 . . . . 0.0 110.278 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttp -72.22 -42.52 65.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.751 0.42 . . . . 0.0 110.627 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.19 3.51 23.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.332 -0.23 . . . . 0.0 111.24 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.35 -6.32 4.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 14.0 ttm -137.47 -28.17 0.92 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.452 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -63.1 137.87 58.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 118.016 -1.473 . . . . 0.0 109.865 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.7 10.71 80.27 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.903 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 33.0 0.4 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.262 1.031 . . . . 0.0 110.547 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.637 HG22 ' H ' ' A' ' 81' ' ' ASP . 9.8 p -73.28 174.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -170.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.577 ' H ' HG22 ' A' ' 79' ' ' VAL . 1.3 pt? -152.69 4.92 0.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.405 -1.271 . . . . 0.0 112.622 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.637 ' H ' HG22 ' A' ' 79' ' ' VAL . 36.8 t70 -141.52 -3.72 1.15 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.548 0.339 . . . . 0.0 111.886 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.87 -10.55 32.15 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.55 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -161.41 128.18 3.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 79' ' ' VAL . 13.1 mm-40 -144.24 -49.54 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 84' ' ' GLU . 3.2 mm? -138.64 154.61 48.65 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.103 0.561 . . . . 0.0 112.294 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 25.7 mmt180 -152.03 112.52 4.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.868 1.667 . . . . 0.0 106.506 166.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 76' ' ' ASP . 1.5 p -139.57 125.69 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.232 0.539 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -154.07 163.67 39.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.361 1.464 . . . . 0.0 108.36 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 mmt -61.01 140.94 57.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.577 0.751 . . . . 0.0 110.356 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 156.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -145.74 18.92 1.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.259 1.024 . . . . 0.0 108.661 174.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.472 ' CD2' ' N2 ' ' B' ' 104' ' ' ' G' . 3.3 t80 -148.75 135.8 20.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.32 176.38 21.71 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.333 0.407 . . . . 0.0 113.523 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -63.3 135.87 96.44 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 123.729 0.812 . . . . 0.0 110.266 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.438 ' HG3' " C5'" ' B' ' 105' ' ' ' A' . 36.0 Cg_endo -65.98 134.05 35.7 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.767 2.312 . . . . 0.0 109.799 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.72 -20.99 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.329 2.686 . . . . 0.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -150.73 157.33 42.83 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.608 1.163 . . . . 0.0 107.88 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p -65.41 -14.41 60.83 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -162.59 25.96 0.1 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.822 1.192 . . . . 0.0 112.13 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -145.51 168.57 20.28 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.083 -0.385 . . . . 0.0 109.986 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.255 -179.743 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.15 1 O4'-C1'-N19 115.388 7.188 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.593 1 C1'-O4'-C4' 105.327 -4.748 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.604 ' C5 ' ' CE2' ' A' ' 59' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.192 0 P-O3'-C3' 123.523 3.186 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.439 " H1'" ' HB3' ' A' ' 49' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.839 0 O5'-C5'-C4' 114.368 2.977 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.468 ' C5 ' ' CD2' ' A' ' 44' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.107 0 C5'-C4'-C3' 109.589 -3.941 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.457 " C3'" ' HD2' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.412 -3.41 2 C1'-O4'-C4' 104.119 -6.091 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m -144.8 -175.11 4.54 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.325 0.65 . . . . 0.0 110.27 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -130.53 -22.56 2.71 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.835 0.454 . . . . 0.0 111.481 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.448 ' HA2' " H4'" ' B' ' 107' ' ' ' U' . . . 78.39 32.09 43.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.219 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.445 ' HD3' " H1'" ' B' ' 107' ' ' ' U' . 11.3 ptm180 34.68 57.69 2.19 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.07 1.348 . . . . 0.0 113.034 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.65 150.89 79.71 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.016 2.477 . . . . 0.0 110.464 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.22 122.06 8.05 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.539 2.826 . . . . 0.0 110.571 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -80.88 -167.94 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.775 2.983 . . . . 0.0 110.433 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -129.61 29.35 5.06 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.679 0.792 . . . . 0.0 110.319 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 m -56.23 -12.74 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.678 1.191 . . . . 0.0 112.585 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.07 -0.94 5.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.227 1.011 . . . . 0.0 112.931 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.41 28.74 0.14 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.341 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.34 166.37 25.28 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.856 1.328 . . . . 0.0 112.082 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.408 ' OG1' ' HE3' ' A' ' 65' ' ' LYS . 91.1 m -82.99 90.13 6.97 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.869 0.868 . . . . 0.0 111.285 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.9 m -67.21 85.97 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.889 0.876 . . . . 0.0 110.428 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 31.8 tp -70.95 162.92 28.51 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.245 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HE2' ' C4 ' ' B' ' 103' ' ' ' G' . 25.3 ttpp -133.55 143.61 48.82 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.123 0.969 . . . . 0.0 110.529 172.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 30' ' ' LEU . 95.0 t -131.42 146.43 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -150.67 -169.74 3.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.777 1.631 . . . . 0.0 110.406 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.49 27.13 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.755 1.622 . . . . 0.0 113.563 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.22 123.43 11.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.762 0.825 . . . . 0.0 109.959 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 24' ' ' ARG . 10.4 m -72.25 168.04 19.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -64.69 9.7 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 113.123 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 22' ' ' THR . 23.5 ptt180 -135.06 17.88 3.46 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.474 1.11 . . . . 0.0 111.397 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 m -125.29 162.83 23.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.661 0.385 . . . . 0.0 111.385 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.465 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 62.9 m -148.72 163.79 24.33 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.682 1.193 . . . . 0.0 109.018 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 26' ' ' SER . 55.3 Cg_endo -69.18 -30.54 24.81 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.277 1.985 . . . . 0.0 111.697 -175.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.34 -35.24 79.85 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.942 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.8 m -74.36 -44.19 53.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -56.34 -22.26 29.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.853 -0.53 . . . . 0.0 110.52 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -57.67 3.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.31 -30.71 71.35 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.771 0.319 . . . . 0.0 110.75 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.06 -32.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.481 ' CD1' HD13 ' A' ' 30' ' ' LEU . 19.5 m-85 -100.64 -11.67 19.82 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.47 -26.73 64.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.494 -0.754 . . . . 0.0 110.928 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.49 -23.82 65.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.7 -16.38 59.53 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 122.64 0.376 . . . . 0.0 111.603 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.26 -82.16 0.11 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -158.94 165.27 34.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.045 0.45 . . . . 0.0 111.048 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.3 123.11 49.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.82 -23.77 51.65 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -164.68 155.68 14.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.117 0.484 . . . . 0.0 110.896 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.62 125.3 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -159.11 157.61 31.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.95 -167.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.407 ' CD1' ' HD3' ' A' ' 27' ' ' PRO . 9.9 mt -127.06 88.8 53.52 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 158.93 4.38 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.102 3.202 . . . . 0.0 111.425 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 49' ' ' ARG . 82.3 mtm-85 -146.19 157.18 43.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.76 3.66 1.38 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 47' ' ' ARG . 9.2 ttm-85 62.55 -2.42 0.36 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.181 1.392 . . . . 0.0 114.008 172.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.443 ' CD1' HG23 ' A' ' 51' ' ' THR . 39.9 p90 -149.37 0.19 0.5 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.443 HG23 ' CD1' ' A' ' 50' ' ' TYR . 20.8 p -127.56 -22.49 3.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.635 0.652 . . . . 0.0 111.386 171.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.0 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.687 1.995 . . . . 0.0 114.877 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.41 5.47 8.74 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.985 -0.447 . . . . 0.0 111.521 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.5 p -65.94 -23.07 66.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -34.8 116.66 0.34 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.803 1.241 . . . . 0.0 112.509 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.24 -6.85 0.28 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.679 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 172.0 15.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.808 0.843 . . . . 0.0 110.231 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.89 94.88 2.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CE1' ' C5 ' ' B' ' 104' ' ' ' G' . 18.8 t80 -64.79 109.54 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG11 HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -114.1 159.86 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.2 ptm180 -136.85 145.18 44.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.063 -175.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.442 ' HB2' ' CB ' ' A' ' 16' ' ' LEU . 4.7 m-85 -114.8 177.58 4.6 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.77 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -134.66 -32.7 0.99 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.85 127.69 32.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.229 0.468 . . . . 0.0 109.988 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HE3' ' OG1' ' A' ' 14' ' ' THR . 2.6 tppp? -60.38 -56.75 17.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -33.21 68.12 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -84.93 -23.93 28.61 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.977 0.353 . . . . 0.0 110.507 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HA ' HD22 ' A' ' 16' ' ' LEU . . . -76.58 -44.15 35.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.48 -19.3 58.15 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.002 -0.436 . . . . 0.0 111.349 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -79.47 -39.94 30.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.588 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.09 76.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.951 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.1 ptp -75.37 -39.45 59.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.658 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -77.2 1.56 18.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.279 0.632 . . . . 0.0 111.702 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.22 -6.35 3.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ttm -138.41 -27.07 0.88 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -65.06 137.65 57.82 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.926 0.784 . . . . 0.0 110.058 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 10.36 86.01 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 119.607 -0.552 . . . . 0.0 112.439 175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.13 30.99 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.076 0.938 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.574 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 43.0 t -75.22 163.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 124.335 1.054 . . . . 0.0 112.176 -171.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.82 10.14 0.34 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.241 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.6 4.75 2.62 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.464 0.705 . . . . 0.0 111.486 -175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.46 -8.49 58.6 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.417 ' C ' HG13 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -172.47 123.18 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.397 1.079 . . . . 0.0 108.643 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.574 ' CG ' ' HA ' ' A' ' 79' ' ' VAL . 81.4 mm-40 -137.9 -47.85 0.55 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 169.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -137.78 153.94 49.63 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 111.753 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 11.2 mmm180 -148.04 109.34 4.34 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.049 1.739 . . . . 0.0 106.721 167.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.53 134.71 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -168.11 173.03 8.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 mmt -76.25 139.94 41.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.168 0.587 . . . . 0.0 110.364 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.57 162.39 29.54 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.499 0.32 . . . . 0.0 110.568 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -144.86 15.25 1.55 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 108.991 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.711 ' HB2' ' H22' ' B' ' 104' ' ' ' G' . 23.1 m-85 -135.1 166.41 23.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.45 168.28 14.35 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 117.912 0.324 . . . . 0.0 112.923 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 157.86 17.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.101 0.96 . . . . 0.0 111.526 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -33.56 97.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 1 C-N-CA 126.314 4.676 . . . . 0.0 115.924 -176.214 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 97' ' ' ASP . 72.8 Cg_endo -77.88 -56.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.499 2.133 . . . . 0.0 109.276 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 15.6 t0 -176.45 123.03 0.16 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.566 1.146 . . . . 0.0 109.95 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.411 ' HB2' " H5'" ' B' ' 105' ' ' ' A' . 17.7 m -156.19 8.5 0.23 Allowed 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 124.334 1.054 . . . . 0.0 110.793 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -144.87 18.0 1.62 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -166.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -62.54 168.65 3.51 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.041 0.537 . . . . 0.0 111.731 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 117.132 -1.413 . . . . 0.0 109.798 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.386 1 O4'-C1'-N19 114.477 6.277 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' ' G' . . . . . 0.531 ' C4 ' ' HE2' ' A' ' 17' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.845 2 O4'-C1'-N19 115.681 7.481 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ' G' . . . . . 0.711 ' H22' ' HB2' ' A' ' 92' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.743 0 P-O3'-C3' 124.059 3.632 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ' A' . . . . . 0.411 " H5'" ' HB2' ' A' ' 98' ' ' SER . . . . . . . . 0 O4'--C4' 1.418 -2.908 2 C3'-C2'-C1' 105.287 4.208 OUTLIER-EPSILON 0.01 1z . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.423 ' C8 ' ' HB3' ' A' ' 5' ' ' ARG . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 P-O3'-C3' 124.293 3.828 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.448 " H4'" ' HA2' ' A' ' 4' ' ' GLY . . . . . . . . 0 O4'--C4' 1.421 -2.679 1 C5'-C4'-C3' 108.484 -4.677 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 stop_ save_